data_3gb1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3gb1 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.224 0.535 . . . . 1.05 110.234 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.15 144.34 42.84 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.167 -1.42 . . . . 0.96 107.167 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -115.56 140.03 49.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.37 -0.831 . . . . 2.71 110.358 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.1 tp -120.14 129.98 54.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.723 -0.611 . . . . 1.05 109.67 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.1 mt -107.77 125.21 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.632 -1.247 . . . . 1.37 107.632 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.8 mt -103.87 115.44 30.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.255 -0.903 . . . . 1.06 111.03 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -111.59 59.78 0.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.53 -0.915 . . . . 2.48 108.53 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.98 165.48 53.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.23 -1.548 . . . . 0.22 109.23 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -63.75 -39.98 95.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.881 -1.364 . . . . 3.22 108.221 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -118.5 -20.01 8.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.11 -0.7 . . . . 2.04 109.11 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.7 tp -98.23 118.19 34.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.518 -0.739 . . . . 1.21 109.223 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.83 126.8 35.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.287 -1.005 . . . . 2.64 108.287 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.84 -177.96 48.34 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 118.988 -1.577 . . . . 0.24 109.921 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -148.07 157.67 43.64 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.455 -0.943 . . . . 2.37 108.455 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -156.36 167.48 30.29 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.314 -0.866 . . . . 1.01 108.757 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 p -133.65 161.02 35.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.346 -0.846 . . . . 1.03 109.169 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -156.35 162.29 40.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 1.03 109.112 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.87 135.48 44.46 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.574 -0.899 . . . . 2.75 108.574 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.46 140.78 23.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 1.01 108.601 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.01 -26.42 35.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.364 -0.835 . . . . 1.08 109.806 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -159.94 176.59 11.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 1.09 109.739 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.74 -32.52 72.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 1.05 109.796 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.19 77.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.99 109.961 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.432 ' H ' ' HG1' ' A' ' 25' ' ' THR . 2.4 p -70.15 -35.5 74.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 1.88 109.12 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.02 87.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 1.04 108.8 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.14 -49.82 72.85 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.226 -0.99 . . . . 1.12 109.192 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -63.84 -43.66 95.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.784 -1.197 . . . . 2.95 111.897 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.68 -54.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 1.11 110.503 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -63.8 -39.71 94.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.948 -1.095 . . . . 0.3 110.531 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -60.52 -45.68 92.95 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.375 -0.828 . . . . 3.33 109.252 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -67.33 -43.61 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.576 -0.898 . . . . 2.45 108.576 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.7 t80 -59.98 -46.56 89.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.744 . . . . 0.91 109.033 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.72 94.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.846 -0.798 . . . . 1.04 108.846 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.0 -45.04 95.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.026 -0.731 . . . . 2.47 109.026 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.66 -25.3 66.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 1.14 109.701 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 71.1 m-20 -95.92 6.72 48.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.196 -0.94 . . . . 1.85 109.713 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.23 37.61 91.22 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.079 -1.058 . . . . 0.35 110.46 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.91 122.26 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.297 -1.119 . . . . 1.13 109.876 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -132.93 136.95 46.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.27 -1.381 . . . . 2.19 107.27 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.44 -156.48 16.22 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.87 -1.634 . . . . 1.15 109.647 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -91.82 128.55 37.69 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.955 -1.128 . . . . 2.22 107.955 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.69 133.62 40.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.24 110.453 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.5 p -131.68 147.9 52.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.966 -1.124 . . . . 1.09 107.966 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.44 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 62.1 t80 -134.76 135.86 42.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.93 109.966 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -112.04 109.48 19.25 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.28 108.711 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 48.2 t0 -66.35 -32.71 74.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 1.12 110.254 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -43.86 94.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 1.08 110.079 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.9 p -102.62 0.41 33.23 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.213 -0.93 . . . . 1.08 110.537 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mttm 50.12 40.5 21.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.859 -1.151 . . . . 2.82 108.985 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.3 m -118.84 130.01 55.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.647 0.737 . . . . 1.0 109.975 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 55.1 m-85 -97.65 137.01 37.21 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.078 -1.453 . . . . 0.21 107.078 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.1 m -129.51 134.15 47.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.823 -1.173 . . . . 1.04 108.614 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.35 129.99 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.142 -1.059 . . . . 1.05 108.142 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -121.98 127.81 50.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.448 -0.782 . . . . 1.06 110.218 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.995 -1.002 . . . . 2.34 108.585 179.243 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.246 -0.65 . . . . 1.04 109.246 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.29 146.49 39.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.5 -0.926 . . . . 0.89 108.5 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.12 141.93 46.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.362 -0.836 . . . . 2.47 109.032 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.6 tp -120.1 126.23 50.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.708 -0.849 . . . . 1.01 108.708 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.26 123.41 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.164 -1.421 . . . . 1.15 107.164 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.38 114.11 28.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.286 -0.884 . . . . 1.06 110.092 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -114.66 68.59 0.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.124 -1.436 . . . . 0.19 107.124 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.1 165.15 48.66 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.813 -1.315 . . . . 0.24 109.813 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -66.91 -35.36 79.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.499 -1.297 . . . . 3.13 107.499 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -119.83 -23.19 6.53 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.252 -0.648 . . . . 1.43 109.252 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 9' ' ' GLY . 54.2 tp -98.35 121.48 40.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 1.23 109.269 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -136.89 126.78 25.77 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.179 -0.951 . . . . 2.49 109.638 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.44 -168.31 41.43 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.636 -1.269 . . . . 0.3 110.196 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -149.3 159.36 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.974 . . . . 1.68 109.655 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -151.94 167.35 28.64 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.732 -0.84 . . . . 1.09 108.732 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -138.03 159.65 41.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 1.07 109.278 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -154.93 159.96 40.81 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.714 -0.847 . . . . 0.99 108.714 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -102.22 132.91 47.86 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.53 -0.915 . . . . 2.22 108.53 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.69 144.57 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.105 -0.997 . . . . 1.07 109.477 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.86 -29.7 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.489 -0.757 . . . . 1.15 110.368 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -158.02 175.66 13.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.91 -1.119 . . . . 1.16 110.181 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.89 80.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.536 -0.727 . . . . 1.05 110.033 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.28 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.91 -1.119 . . . . 1.09 110.008 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 p -74.21 -34.89 63.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.726 -1.234 . . . . 1.12 109.827 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.0 92.26 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.807 -0.812 . . . . 1.02 108.807 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.51 -49.02 73.7 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.964 -1.095 . . . . 1.06 109.904 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.59 -40.04 92.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.261 -0.899 . . . . 3.05 110.506 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.9 -53.1 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.149 -0.969 . . . . 1.05 110.662 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -66.72 -39.5 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 0.15 110.596 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -60.42 -42.27 95.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.745 -1.222 . . . . 2.56 108.819 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -67.56 -43.63 80.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 2.33 108.948 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 65.5 t80 -60.03 -44.87 94.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.504 -0.748 . . . . 0.99 109.311 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.67 96.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.332 -0.855 . . . . 1.03 109.229 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -61.9 -42.36 98.98 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.363 -0.836 . . . . 1.97 109.101 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.21 -26.62 67.85 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.095 -1.003 . . . . 1.29 109.304 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.447 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 5.0 m120 -97.59 9.05 43.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.74 110.027 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.72 81.79 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.884 -1.15 . . . . 0.72 110.456 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.3 t -106.91 127.89 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.183 -1.186 . . . . 1.1 109.738 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -137.67 145.3 42.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.668 -1.234 . . . . 1.33 107.668 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.91 -156.19 21.07 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.875 -1.631 . . . . 0.29 110.334 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.64 131.11 36.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.579 -0.897 . . . . 2.07 108.579 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -101.08 136.54 40.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.15 110.545 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.5 p -133.9 148.77 51.27 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.771 -1.196 . . . . 1.11 107.771 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.12 134.32 42.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 0.9 110.205 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -111.49 108.28 17.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.328 -0.99 . . . . 0.24 108.328 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -67.27 -29.8 69.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 1.16 109.865 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.9 91.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.361 -0.837 . . . . 1.1 110.306 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.2 p -104.84 0.0 27.61 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.357 -0.84 . . . . 1.14 109.992 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 50.04 39.89 20.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 2.63 108.173 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -119.93 132.13 55.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.404 0.621 . . . . 1.05 110.712 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -99.3 140.04 34.05 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.486 -1.301 . . . . 0.11 107.486 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.6 m -130.62 131.28 44.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.655 -1.278 . . . . 1.03 108.706 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.79 129.65 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.496 -0.927 . . . . 1.02 108.496 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.3 127.74 52.64 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.504 -0.748 . . . . 1.05 110.444 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.965 -1.016 . . . . 1.95 109.197 179.813 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.7 m . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.597 -0.52 . . . . 1.04 109.597 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -117.67 145.81 44.14 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.857 -0.794 . . . . 0.89 108.857 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.415 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 63.5 tttp -114.74 144.15 43.93 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.328 -0.857 . . . . 2.47 109.184 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -121.78 128.94 52.27 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.135 -0.691 . . . . 1.01 109.135 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.9 122.3 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.747 -1.205 . . . . 1.15 107.747 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -100.69 113.82 27.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 1.06 109.262 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -116.34 68.73 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.323 -1.362 . . . . 0.19 107.323 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 169.3 52.95 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.146 -1.581 . . . . 0.24 109.146 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 8.9 ptpp? -64.8 -35.75 82.12 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.196 -1.179 . . . . 3.13 107.919 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -124.86 -19.11 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.427 -0.583 . . . . 1.43 109.427 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.0 tp -96.09 119.97 35.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.996 . . . . 1.23 109.098 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -134.54 125.8 28.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 2.49 109.472 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.93 -178.7 48.64 Favored Glycine 0 N--CA 1.487 2.036 0 C-N-CA 119.556 -1.307 . . . . 0.3 110.262 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 4' ' ' LYS . 19.3 pt-20 -148.54 157.3 43.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.757 -0.849 . . . . 1.68 108.929 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.02 170.03 21.43 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.377 -0.827 . . . . 1.09 109.281 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 p -135.87 159.17 42.51 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.84 -0.8 . . . . 1.07 108.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -157.61 161.67 38.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.862 . . . . 0.99 109.515 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 56.0 mp0 -105.92 135.74 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.836 -0.802 . . . . 2.22 108.836 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.24 146.4 26.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 1.07 109.118 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.37 -30.1 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.466 -0.771 . . . . 1.15 109.569 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -159.46 176.88 11.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 1.16 109.584 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -35.3 77.85 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.29 -0.881 . . . . 1.05 110.078 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -39.04 59.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.916 -1.115 . . . . 1.09 110.273 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.3 p -75.08 -32.14 61.4 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.5 -1.375 . . . . 1.12 109.518 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.68 99.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.264 -0.898 . . . . 1.02 108.828 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -56.94 -49.52 75.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.646 -1.222 . . . . 1.06 108.998 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -63.54 -44.03 95.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.541 -0.724 . . . . 3.05 110.823 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.06 -52.59 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.021 -1.049 . . . . 1.05 110.837 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -61.64 -37.9 85.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.006 . . . . 0.15 109.957 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -61.46 -43.04 99.57 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.91 -1.119 . . . . 2.56 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.62 -43.97 75.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.904 -1.123 . . . . 2.33 109.07 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 57.4 t80 -60.03 -47.84 84.2 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.292 -0.88 . . . . 0.99 108.749 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.98 99.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.454 -0.779 . . . . 1.03 109.138 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -59.99 -41.89 93.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.297 -1.001 . . . . 1.97 108.297 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.72 -19.78 66.03 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.001 -0.74 . . . . 1.29 109.001 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' OD1' ' CD1' ' A' ' 33' ' ' TYR . 31.0 m120 -95.08 4.31 53.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.74 109.96 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.04 32.9 65.61 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.675 -1.25 . . . . 0.72 110.087 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.4 t -110.22 122.99 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.184 -1.186 . . . . 1.1 108.916 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 31.5 p-10 -148.97 97.65 2.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.915 -1.116 . . . . 1.33 110.465 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.06 -130.68 1.37 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.31 -1.424 . . . . 0.29 111.342 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.11 132.43 38.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.963 -1.316 . . . . 2.07 110.316 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -107.76 139.48 42.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.429 0.633 . . . . 0.15 110.267 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.1 p -136.86 150.27 48.17 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.08 -1.081 . . . . 1.11 108.08 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -134.36 135.9 43.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.272 -0.893 . . . . 0.9 110.643 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -111.94 108.28 17.58 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.166 -1.05 . . . . 0.24 108.166 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -67.61 -29.99 69.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 1.16 110.366 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.04 93.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 1.1 110.409 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.0 p -105.81 0.02 25.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.37 -0.831 . . . . 1.14 110.124 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 mttm 50.33 41.34 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.131 . . . . 2.63 108.506 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.95 129.95 54.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.478 0.656 . . . . 1.05 110.069 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -98.87 139.64 34.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.679 -1.23 . . . . 0.11 107.679 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.5 m -128.7 130.41 47.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.762 -1.211 . . . . 1.03 108.437 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.06 129.42 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.285 -1.005 . . . . 1.02 108.285 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -120.96 126.0 48.83 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.114 -0.699 . . . . 1.05 109.114 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' CD ' ' HZ3' ' A' ' 10' ' ' LYS . 68.6 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.071 -0.966 . . . . 1.95 109.729 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.483 -0.562 . . . . 1.04 109.483 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.528 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 90.8 m-85 -114.52 145.26 42.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.463 -0.94 . . . . 0.89 108.463 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -115.74 142.72 46.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.392 -0.818 . . . . 2.47 109.453 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.98 127.33 51.7 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.969 -0.752 . . . . 1.01 108.969 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.4 123.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.317 -1.364 . . . . 1.15 107.317 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.34 112.75 25.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 1.06 110.168 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -112.1 69.0 0.68 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.765 -1.568 . . . . 0.19 106.765 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.78 167.69 50.31 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.59 -1.404 . . . . 0.24 109.59 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -67.77 -39.05 84.15 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.414 -1.051 . . . . 3.13 108.524 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 p -120.0 -20.03 7.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.887 -0.508 . . . . 1.43 109.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.92 118.55 36.81 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.339 -0.851 . . . . 1.23 109.89 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -130.71 131.43 44.79 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.67 0.748 . . . . 2.49 109.15 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.1 -178.96 48.61 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.08 -1.533 . . . . 0.3 110.716 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.04 151.13 43.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.451 -0.944 . . . . 1.68 108.451 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 t -150.82 165.02 34.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 1.09 108.592 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.1 p -134.38 159.38 41.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 1.07 108.97 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -154.41 158.98 40.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.772 -0.825 . . . . 0.99 108.772 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.6 132.0 50.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.632 -0.877 . . . . 2.22 108.632 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.63 142.94 27.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.05 . . . . 1.07 109.093 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.93 -28.82 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 1.15 110.091 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -158.97 177.31 11.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.043 -1.035 . . . . 1.16 109.937 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.528 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -65.71 -38.42 89.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.457 -0.777 . . . . 1.05 109.591 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.11 -37.76 62.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.082 -1.011 . . . . 1.09 110.003 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.4 m -68.82 -39.96 79.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.692 -1.255 . . . . 1.12 109.806 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.02 93.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.246 -0.909 . . . . 1.02 109.372 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.17 -53.88 47.32 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.152 -1.019 . . . . 1.06 111.595 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -68.51 -36.14 78.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.678 -1.264 . . . . 3.05 110.655 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.84 -53.83 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.943 -1.098 . . . . 1.05 110.519 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.11 -37.42 87.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.15 110.433 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.98 -41.47 92.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.834 -1.166 . . . . 2.56 109.296 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -68.71 -42.13 78.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 2.33 109.102 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.498 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 62.6 t80 -59.95 -46.96 87.73 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.99 108.95 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.08 96.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 1.03 108.958 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.02 -45.62 92.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 1.97 109.159 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -62.28 -24.68 67.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -0.868 . . . . 1.29 109.548 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 7.4 m120 -98.51 7.04 46.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.215 -0.928 . . . . 0.74 109.99 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.17 33.62 83.6 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.92 -1.133 . . . . 0.72 110.491 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.18 128.39 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.147 -1.208 . . . . 1.1 110.539 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.501 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 96.7 m-20 -112.3 -98.62 0.42 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.511 -0.922 . . . . 1.33 108.511 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.69 167.53 3.72 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.29 112.455 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.5 mp0 -77.21 138.27 39.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.583 -1.266 . . . . 2.07 107.583 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -99.91 133.78 43.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.98 . . . . 0.15 110.351 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 p -134.32 148.76 50.81 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.815 -1.18 . . . . 1.11 107.815 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -136.04 136.91 40.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.186 -0.946 . . . . 0.9 110.464 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.82 110.01 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.568 -0.901 . . . . 0.24 108.568 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 52.4 t0 -67.94 -30.5 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.927 . . . . 1.16 110.461 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.3 93.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.148 -0.97 . . . . 1.1 109.892 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.3 p -105.92 -0.28 25.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.51 -0.744 . . . . 1.14 110.048 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.408 ' NZ ' ' CZ ' ' A' ' 3' ' ' TYR . 23.6 mtpp 49.98 41.71 23.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 2.63 108.401 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.34 131.08 55.66 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.547 0.689 . . . . 1.05 110.506 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -100.46 139.88 35.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.455 -1.313 . . . . 0.11 107.455 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -131.98 132.51 43.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.817 -1.177 . . . . 1.03 108.963 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.8 p -120.3 128.29 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.029 -1.1 . . . . 1.02 108.029 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.1 m -121.36 127.57 51.37 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.359 -0.838 . . . . 1.05 110.731 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 67.3 mm-40 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.947 -1.025 . . . . 1.95 109.453 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.233 0.54 . . . . 1.04 110.288 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.06 147.05 39.37 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.848 -1.168 . . . . 0.89 107.848 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -116.05 141.11 48.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 2.47 109.458 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.5 tp -120.66 127.99 52.58 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.742 -0.836 . . . . 1.01 108.742 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.38 123.68 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.215 -1.402 . . . . 1.15 107.215 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -103.91 114.36 28.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 1.06 110.543 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -118.75 68.52 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.132 -1.433 . . . . 0.19 107.132 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.546 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . . . -78.67 172.56 55.27 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.672 -1.771 . . . . 0.24 108.672 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -66.23 -35.59 80.82 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.841 -1.388 . . . . 3.13 107.929 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -123.95 -18.59 5.92 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.844 -0.535 . . . . 1.43 110.288 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 tp -98.94 113.58 25.8 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.015 -1.053 . . . . 1.23 109.822 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -126.21 127.28 45.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 2.49 109.317 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.97 -179.84 48.81 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.192 -1.48 . . . . 0.3 110.621 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -143.53 153.67 42.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.995 . . . . 1.68 108.869 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -152.82 168.5 25.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 1.09 109.065 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.5 p -138.46 160.02 40.61 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.881 -0.785 . . . . 1.07 108.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -156.65 162.86 39.82 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.264 -0.898 . . . . 0.99 109.188 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -106.48 135.01 48.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.367 -0.833 . . . . 2.22 108.917 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.0 145.53 27.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 1.07 108.898 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.42 -29.24 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 1.15 110.266 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -158.51 177.53 11.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.086 -1.009 . . . . 1.16 110.172 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.74 82.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.638 -0.664 . . . . 1.05 110.287 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.95 -37.08 60.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.833 -1.167 . . . . 1.09 109.769 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.415 ' H ' ' HG1' ' A' ' 25' ' ' THR . 2.2 p -72.23 -36.88 69.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.668 -1.27 . . . . 1.12 109.605 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.29 90.57 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.656 -0.868 . . . . 1.02 108.656 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.21 -50.08 73.98 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.221 -0.991 . . . . 1.06 110.196 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -66.29 -40.78 90.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.072 -1.017 . . . . 3.05 110.688 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.0 -53.82 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.078 -1.014 . . . . 1.05 110.597 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -63.68 -38.09 89.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.15 110.678 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -60.08 -44.04 95.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.817 -1.177 . . . . 2.56 109.582 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -68.36 -41.44 80.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 2.33 108.673 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 58.1 t80 -59.94 -48.33 82.12 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.487 -0.758 . . . . 0.99 109.05 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.87 99.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 1.03 109.096 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 35' ' ' ASN . 1.9 m120 -60.54 -43.33 97.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.292 -0.88 . . . . 1.97 108.897 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -64.25 -22.39 66.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 1.29 109.338 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.582 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 65.8 m-80 -98.46 6.76 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.286 -0.884 . . . . 0.74 109.877 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.78 36.21 91.94 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.164 -1.175 . . . . 0.72 110.164 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.59 127.42 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.277 -1.131 . . . . 1.1 109.935 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.471 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 92.9 m-20 -111.68 -97.15 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.5 -1.296 . . . . 1.33 107.5 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.93 166.91 2.06 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-O 122.052 0.807 . . . . 0.29 112.407 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.55 139.16 41.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.389 -1.337 . . . . 2.07 107.389 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.66 135.48 42.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.15 111.077 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 p -133.4 147.24 51.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.588 -0.893 . . . . 1.11 108.588 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 52.6 t80 -134.63 135.88 42.45 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.242 -0.911 . . . . 0.9 110.186 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 50' ' ' LYS . 55.2 t0 -113.11 109.96 19.67 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.941 -0.762 . . . . 0.24 108.941 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.8 t0 -68.87 -30.6 69.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.07 -1.019 . . . . 1.16 109.966 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.99 94.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.838 . . . . 1.1 110.112 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -110.97 -0.15 16.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.651 -0.655 . . . . 1.14 109.642 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 46' ' ' ASP . 56.7 mttp 48.9 41.81 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.137 -0.977 . . . . 2.63 109.208 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -115.74 131.12 57.03 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.483 0.659 . . . . 1.05 109.553 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.5 m-85 -100.61 139.91 35.62 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.092 -1.077 . . . . 0.11 108.092 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -132.23 131.98 42.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.671 -1.268 . . . . 1.03 108.672 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.0 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.617 -1.253 . . . . 1.02 107.617 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -120.07 126.54 51.02 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.226 -0.921 . . . . 1.05 110.293 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 118.03 -0.986 . . . . 1.95 109.231 179.564 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.239 0.542 . . . . 1.04 110.008 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -119.35 146.41 45.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.74 -0.837 . . . . 0.89 108.74 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -116.91 144.82 44.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.409 -0.807 . . . . 2.47 109.804 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.3 tp -118.95 129.8 55.36 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.502 -0.749 . . . . 1.01 109.005 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.43 122.18 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.058 -1.46 . . . . 1.15 107.058 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.8 mt -101.76 117.52 35.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.174 -0.954 . . . . 1.06 110.2 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -124.59 66.43 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.565 -1.272 . . . . 0.19 107.565 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 176.38 54.68 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.497 -1.441 . . . . 0.24 109.497 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -66.07 -39.71 90.3 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.15 -1.206 . . . . 3.13 108.668 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -17.39 7.12 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.874 -0.516 . . . . 1.43 110.523 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.66 121.9 41.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.025 -1.047 . . . . 1.23 109.564 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -135.16 127.59 30.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.393 -0.817 . . . . 2.49 109.417 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -173.77 46.54 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.382 -1.39 . . . . 0.3 110.515 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -149.02 156.9 42.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.622 -0.929 . . . . 1.68 109.15 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -154.01 170.04 22.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 1.09 109.61 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 p -137.39 159.24 42.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.782 . . . . 1.07 109.13 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -157.52 162.7 38.85 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.335 -0.853 . . . . 0.99 108.9 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -101.21 133.77 45.27 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.306 -0.998 . . . . 2.22 108.306 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.88 142.12 27.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.178 -0.951 . . . . 1.07 108.949 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.99 -31.24 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.864 . . . . 1.15 109.552 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -157.69 179.21 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 1.16 110.106 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.15 -38.27 87.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.466 -0.771 . . . . 1.05 109.527 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.38 61.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.177 -0.952 . . . . 1.09 109.971 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.5 m -69.94 -40.05 75.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.641 -1.287 . . . . 1.12 109.749 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.64 82.06 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.444 -0.947 . . . . 1.02 108.444 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.06 -45.7 71.77 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.687 -1.205 . . . . 1.06 108.602 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.07 -46.1 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.64 -0.662 . . . . 3.05 110.764 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.27 -52.85 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.286 -0.884 . . . . 1.05 111.088 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -67.48 -39.95 85.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.996 -1.065 . . . . 0.15 110.551 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.68 -43.06 98.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.55 -1.344 . . . . 2.56 109.229 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.5 -44.49 82.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 2.33 108.911 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.3 t80 -60.13 -46.46 89.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.421 -0.799 . . . . 0.99 109.046 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -45.78 90.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 1.03 109.33 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.08 -43.93 95.13 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.665 -0.865 . . . . 1.97 108.665 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.07 -20.32 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 1.29 109.05 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.531 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 31.6 m120 -97.76 6.63 47.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.288 -0.883 . . . . 0.74 109.897 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.46 32.63 67.94 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.021 -1.085 . . . . 0.72 111.184 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.5 t -110.52 124.99 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.03 -1.276 . . . . 1.1 109.186 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 73.6 m-20 -150.67 99.78 2.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 1.33 110.281 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 -132.24 1.73 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.342 -1.409 . . . . 0.29 110.995 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.57 125.62 37.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.851 -1.382 . . . . 2.07 110.677 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -103.03 137.08 41.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.672 -0.643 . . . . 0.15 109.515 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -136.1 150.03 48.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.832 -1.173 . . . . 1.11 107.832 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -137.1 137.87 39.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.225 -0.922 . . . . 0.9 110.444 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -112.55 110.07 20.01 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.387 -0.968 . . . . 0.24 108.387 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -65.67 -30.92 71.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 1.16 110.374 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.15 93.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 1.1 110.272 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -104.33 -0.11 28.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.39 -0.819 . . . . 1.14 110.778 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp 50.07 40.21 20.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.758 -1.214 . . . . 2.63 108.246 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.97 131.53 55.2 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.633 0.73 . . . . 1.05 110.621 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -100.3 140.02 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.346 -1.353 . . . . 0.11 107.346 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.1 m -130.8 132.62 45.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 1.03 108.576 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.8 130.1 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.802 -0.814 . . . . 1.02 108.802 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 m -128.07 129.78 47.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.484 0.659 . . . . 1.05 110.169 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 74.2 mm-40 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.978 -1.01 . . . . 1.95 109.551 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.346 -0.613 . . . . 1.04 109.346 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.656 ' HH ' ' N ' ' A' ' 23' ' ' ALA . 94.8 m-85 -117.5 145.45 44.2 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.362 -0.977 . . . . 0.89 108.362 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -113.21 145.35 41.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.343 -0.848 . . . . 2.47 109.647 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.62 127.66 51.08 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.564 -0.71 . . . . 1.01 109.592 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.5 mm -103.54 121.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.621 -1.622 . . . . 1.15 106.621 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.2 mt -100.33 111.47 23.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.947 -1.096 . . . . 1.06 109.528 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.54 69.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.543 -1.28 . . . . 0.19 107.543 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 163.96 48.1 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.345 -1.502 . . . . 0.24 109.345 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -66.8 -37.57 84.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.529 -1.286 . . . . 3.13 107.529 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.2 p -115.16 -22.37 9.5 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.576 -0.527 . . . . 1.43 109.576 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 9' ' ' GLY . 19.0 tp -102.29 127.99 49.03 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.342 -0.849 . . . . 1.23 109.556 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -139.91 128.1 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 2.49 109.472 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.46 -174.33 46.86 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.107 -1.521 . . . . 0.3 110.85 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -147.88 155.69 41.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.717 -0.873 . . . . 1.68 109.036 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.665 ' HG1' ' N ' ' A' ' 17' ' ' THR . 5.8 t -153.97 169.36 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 1.09 109.615 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.665 ' N ' ' HG1' ' A' ' 16' ' ' THR . 70.3 p -134.48 158.58 43.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.359 -0.838 . . . . 1.07 109.439 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -155.38 159.53 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.99 109.047 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -103.99 134.12 47.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.249 -0.907 . . . . 2.22 108.879 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.12 143.32 27.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 1.07 109.073 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 m -60.39 -28.9 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 1.15 109.741 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -157.53 174.96 14.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.198 -0.938 . . . . 1.16 109.894 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.656 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -67.57 -38.29 83.87 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 1.05 109.874 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.25 -36.22 52.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.941 -1.1 . . . . 1.09 109.607 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 p -73.45 -34.75 65.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.756 -1.215 . . . . 1.12 109.76 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.88 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.286 -1.005 . . . . 1.02 108.286 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -49.91 75.12 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.784 -1.167 . . . . 1.06 109.953 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -64.63 -41.43 96.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.747 -1.221 . . . . 3.05 110.405 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.55 -53.67 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 1.05 110.842 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -64.41 -39.22 93.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.15 111.07 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 67.2 mttm -61.78 -40.29 94.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.237 . . . . 2.56 110.156 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -69.45 -43.79 72.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.875 -1.141 . . . . 2.33 108.804 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.614 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -60.46 -46.65 89.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.394 -0.816 . . . . 0.99 109.53 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.12 94.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 1.03 109.76 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 31' ' ' LYS . 81.4 m-20 -61.59 -40.07 93.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 1.97 109.369 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.74 -23.96 67.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.183 -0.948 . . . . 1.29 109.532 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.614 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.6 m-20 -95.23 9.92 37.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.216 -0.927 . . . . 0.74 109.944 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.71 81.8 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.811 -1.315 . . . . 0.72 109.811 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.02 126.12 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.333 -1.098 . . . . 1.1 109.999 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 52.0 t0 -141.2 146.09 36.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 1.33 107.996 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.11 -150.28 12.13 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.234 -1.46 . . . . 0.29 110.206 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -92.05 132.35 36.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.568 -0.96 . . . . 2.07 108.525 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -100.38 136.49 40.19 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.246 -0.909 . . . . 0.15 110.331 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 p -138.74 150.41 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.39 -0.967 . . . . 1.11 108.39 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -132.0 136.57 47.38 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.303 -0.873 . . . . 0.9 110.275 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.71 106.23 15.38 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.319 -0.993 . . . . 0.24 108.319 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -66.73 -33.73 76.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 1.16 110.811 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.33 -40.04 95.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.965 -1.085 . . . . 1.1 109.881 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -102.79 0.75 33.24 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.552 -0.718 . . . . 1.14 110.277 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp 49.92 41.21 22.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 2.63 108.474 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -123.32 137.44 54.84 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.677 0.751 . . . . 1.05 110.969 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -100.69 139.25 36.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.383 -1.34 . . . . 0.11 107.383 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -130.27 130.76 44.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.653 -1.28 . . . . 1.03 108.519 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.51 128.18 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.089 -1.078 . . . . 1.02 108.089 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -120.02 128.31 53.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 1.05 110.214 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.938 -1.03 . . . . 1.95 109.351 -179.69 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.238 0.542 . . . . 1.04 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.82 148.83 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.895 -1.15 . . . . 0.89 107.895 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -116.25 140.52 49.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.103 -0.998 . . . . 2.47 109.081 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 26.7 tp -123.17 128.68 50.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.681 -0.637 . . . . 1.01 109.31 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 124.8 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.266 -1.383 . . . . 1.15 107.266 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.4 mt -102.34 115.59 30.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 1.06 109.029 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -113.37 70.63 0.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.521 -1.289 . . . . 0.19 107.521 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.77 167.54 52.92 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.709 -1.756 . . . . 0.24 108.709 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -67.24 -37.11 83.01 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.137 -1.214 . . . . 3.13 107.733 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -120.24 -18.73 7.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.153 0.502 . . . . 1.43 109.654 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.06 120.01 39.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.235 -0.915 . . . . 1.23 109.577 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -132.68 127.54 35.04 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.317 -0.865 . . . . 2.49 109.902 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -175.81 47.65 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.654 -1.26 . . . . 0.3 110.257 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.55 158.62 44.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -1.001 . . . . 1.68 109.313 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -153.22 170.03 21.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.391 -0.818 . . . . 1.09 109.72 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.4 p -137.87 160.04 40.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.8 . . . . 1.07 109.317 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -155.4 159.96 40.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.99 109.058 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -107.46 135.19 49.36 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.317 -0.994 . . . . 2.22 108.317 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.82 149.92 31.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 1.07 109.677 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.07 -29.08 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 1.15 110.053 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -158.07 171.89 19.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.916 -1.115 . . . . 1.16 110.304 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.56 83.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.567 -0.708 . . . . 1.05 110.175 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.58 -37.33 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.995 -1.066 . . . . 1.09 109.772 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -72.98 -34.59 66.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.682 -1.262 . . . . 1.12 109.638 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.17 90.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.37 -0.974 . . . . 1.02 108.37 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.46 -49.18 70.68 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.185 -1.006 . . . . 1.06 109.315 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HZ1' ' CB ' ' A' ' 28' ' ' LYS . 8.2 ttpm? -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.358 -0.839 . . . . 3.05 110.564 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.322 -0.861 . . . . 1.05 111.346 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -65.09 -39.9 93.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.83 -1.169 . . . . 0.15 111.37 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -63.37 -41.1 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 2.56 110.146 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.11 -42.47 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 2.33 108.893 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 65.2 t80 -60.14 -46.77 88.54 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.708 -0.849 . . . . 0.99 108.708 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.19 99.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.491 -0.756 . . . . 1.03 109.376 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -60.05 -40.84 90.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 1.97 109.15 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.25 -20.01 65.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 1.29 109.424 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 97.9 m-20 -96.56 4.8 51.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.093 -1.004 . . . . 0.74 109.992 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.6 36.34 54.13 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.933 -1.127 . . . . 0.72 110.959 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.8 t -116.26 122.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.155 -1.203 . . . . 1.1 108.559 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 73.9 m-20 -150.28 101.09 2.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -0.961 . . . . 1.33 110.818 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 -128.78 1.21 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.438 -1.363 . . . . 0.29 110.687 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -94.02 130.32 40.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.896 -1.355 . . . . 2.07 110.417 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -103.05 136.19 43.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.715 -0.616 . . . . 0.15 109.541 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.0 p -134.21 147.74 50.76 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.752 -1.203 . . . . 1.11 107.752 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -137.42 138.29 39.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.9 110.452 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -115.06 110.05 18.99 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.769 -0.826 . . . . 0.24 108.769 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 47.2 t0 -67.06 -28.74 68.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 1.16 109.719 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.97 95.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 1.1 110.013 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.0 p -107.55 0.45 22.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.474 -0.766 . . . . 1.14 110.218 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 50.07 41.88 24.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.757 -1.201 . . . . 2.63 107.757 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.29 130.81 55.59 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.638 0.732 . . . . 1.05 110.603 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -101.89 139.42 37.55 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.779 -1.193 . . . . 0.11 107.779 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.0 m -130.98 132.63 45.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.833 -1.167 . . . . 1.03 108.294 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.32 130.55 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.593 -0.891 . . . . 1.02 108.593 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.03 126.91 51.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.639 -0.663 . . . . 1.05 109.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.992 -1.004 . . . . 1.95 109.367 -179.463 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.512 -0.551 . . . . 1.04 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.68 140.99 49.78 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.712 -0.848 . . . . 0.89 108.712 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.573 ' CB ' ' HZ3' ' A' ' 4' ' ' LYS . 7.2 ttpm? -113.81 143.34 44.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.539 -0.725 . . . . 2.47 109.052 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.4 tp -119.19 129.38 54.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.849 -0.797 . . . . 1.01 108.849 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -106.34 124.36 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.95 -1.5 . . . . 1.15 106.95 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.13 116.09 31.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 1.06 110.336 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.27 67.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.378 -1.712 . . . . 0.19 106.378 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.52 173.11 53.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.778 -1.329 . . . . 0.24 109.778 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.06 -40.03 82.85 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.29 -1.123 . . . . 3.13 108.231 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.1 m -121.64 -19.33 6.88 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.858 -0.526 . . . . 1.43 109.891 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.0 tp -98.57 119.54 37.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.059 -1.026 . . . . 1.23 109.515 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -136.39 129.07 30.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.161 -0.962 . . . . 2.49 109.526 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.21 -171.07 44.25 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.417 -1.373 . . . . 0.3 110.065 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -148.18 157.27 43.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.63 -0.923 . . . . 1.68 109.124 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.41 ' HG1' ' N ' ' A' ' 17' ' ' THR . 3.3 t -153.15 171.58 18.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.815 . . . . 1.09 108.878 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.41 ' N ' ' HG1' ' A' ' 16' ' ' THR . 81.7 p -137.83 159.98 40.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 1.07 109.857 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -156.91 160.81 39.47 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.49 -0.756 . . . . 0.99 109.214 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -104.97 136.87 43.63 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.358 -0.979 . . . . 2.22 108.358 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.5 141.78 26.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.082 -1.011 . . . . 1.07 109.453 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 m -60.44 -30.86 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.435 -0.791 . . . . 1.15 109.347 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -156.87 174.32 15.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 1.16 109.564 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.25 81.53 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.37 -0.831 . . . . 1.05 110.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.38 -36.11 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 1.09 109.716 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -71.25 -38.25 71.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.226 . . . . 1.12 109.605 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.91 85.86 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.511 -0.922 . . . . 1.02 108.511 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.02 -42.36 89.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.629 -1.228 . . . . 1.06 109.301 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.03 -43.83 81.78 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.627 -1.296 . . . . 3.05 110.449 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.11 -53.23 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.915 . . . . 1.05 111.845 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -66.56 -40.1 88.83 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.901 -1.124 . . . . 0.15 111.88 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.53 -40.16 95.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 2.56 110.177 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.9 -40.68 75.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.898 -1.126 . . . . 2.33 108.685 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.58 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.4 t80 -59.99 -44.56 94.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.99 108.982 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.29 96.73 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.396 -0.815 . . . . 1.03 108.962 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.98 -44.06 94.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.392 -0.817 . . . . 1.97 108.818 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.15 -24.19 67.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 1.29 109.341 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.58 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 81.2 m-20 -99.03 9.7 42.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.935 . . . . 0.74 109.052 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.89 36.77 93.29 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.515 -1.434 . . . . 0.72 109.515 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.3 125.88 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.319 -1.107 . . . . 1.1 109.892 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 96.4 m-20 -110.86 -98.63 0.41 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.294 -1.002 . . . . 1.33 108.294 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.81 165.21 4.79 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.083 0.824 . . . . 0.29 112.005 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.0 135.49 39.99 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.385 -1.339 . . . . 2.07 107.385 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -98.08 133.37 42.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.025 -1.047 . . . . 0.15 110.435 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -133.03 148.31 52.24 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.029 -1.1 . . . . 1.11 108.029 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -133.13 132.42 41.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.452 -0.78 . . . . 0.9 110.063 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -113.34 110.05 19.72 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.764 -0.828 . . . . 0.24 108.764 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -68.46 -29.5 68.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 1.16 110.625 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.92 89.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 1.1 110.313 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 78.6 p -104.87 -0.16 27.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.378 -0.826 . . . . 1.14 109.721 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.02 40.97 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.005 -1.06 . . . . 2.63 108.438 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.1 m -120.04 130.89 54.91 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.597 0.713 . . . . 1.05 110.723 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.34 139.12 34.59 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.953 -1.499 . . . . 0.11 106.953 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 100.0 m -132.04 131.88 42.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.715 -1.241 . . . . 1.03 108.853 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.6 p -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.036 -1.098 . . . . 1.02 108.036 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -121.45 128.32 52.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.39 -0.819 . . . . 1.05 110.788 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.035 -0.983 . . . . 1.95 109.298 179.456 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.502 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 98.3 m . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.231 0.539 . . . . 1.04 109.776 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -112.89 147.86 36.15 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.095 -1.076 . . . . 0.89 108.095 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.45 140.12 50.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.338 -0.851 . . . . 2.47 109.079 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 tp -116.76 127.98 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.238 -1.023 . . . . 1.01 108.238 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 6' ' ' ILE . 84.7 mt -101.52 121.23 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.091 -1.448 . . . . 1.15 107.091 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.2 110.85 22.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.032 -1.043 . . . . 1.06 109.918 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -116.49 67.76 0.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.811 -1.552 . . . . 0.19 106.811 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.67 164.93 47.38 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.163 -1.575 . . . . 0.24 109.163 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.142 -1.21 . . . . 3.13 108.261 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.6 m -111.31 -25.06 9.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.831 -0.543 . . . . 1.43 109.674 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 9' ' ' GLY . 40.5 tp -103.09 124.12 47.94 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.343 -0.848 . . . . 1.23 109.899 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.32 126.39 29.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 2.49 108.99 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.77 44.83 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.187 -1.482 . . . . 0.3 110.592 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -149.46 158.15 43.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.688 -0.889 . . . . 1.68 109.147 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.75 170.1 22.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 1.09 109.519 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.0 p -137.3 159.89 40.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 1.07 109.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -154.6 159.29 40.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.604 -0.887 . . . . 0.99 108.604 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -101.54 131.95 47.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.134 -0.979 . . . . 2.22 108.552 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.19 143.68 27.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 1.07 109.157 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.01 -29.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.446 -0.784 . . . . 1.15 109.797 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -158.78 174.75 14.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.055 -1.028 . . . . 1.16 110.196 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.26 82.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.595 -0.691 . . . . 1.05 110.311 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.0 64.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.032 -1.043 . . . . 1.09 110.368 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 p -72.48 -35.6 68.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.62 -1.3 . . . . 1.12 110.012 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.0 81.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.471 -0.768 . . . . 1.02 108.982 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.51 -42.35 87.51 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.613 -1.235 . . . . 1.06 109.815 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.8 -42.68 73.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 3.05 110.24 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.12 -52.19 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 1.05 110.768 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -61.8 -38.12 86.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.945 -1.097 . . . . 0.15 110.07 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -59.99 -41.77 92.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.885 -1.134 . . . . 2.56 109.782 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.92 -40.65 83.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.037 -1.039 . . . . 2.33 108.537 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.463 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 57.9 t80 -59.94 -49.64 76.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.772 -0.825 . . . . 0.99 108.772 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.58 84.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 1.03 109.351 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -60.04 -43.13 95.57 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 1.97 108.649 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.41 -25.39 65.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.077 -1.015 . . . . 1.29 108.783 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 18.9 m120 -100.01 9.86 42.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.74 109.926 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.03 34.7 88.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.012 -1.235 . . . . 0.72 110.012 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.04 128.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.306 -1.114 . . . . 1.1 109.937 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 95.9 m-20 -110.02 -99.74 0.39 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.622 -0.881 . . . . 1.33 108.622 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.02 161.6 3.37 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 121.977 0.765 . . . . 0.29 111.849 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.68 138.01 42.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.396 -1.335 . . . . 2.07 107.396 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -99.76 135.8 40.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -0.993 . . . . 0.15 111.115 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.68 149.75 50.54 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.213 -1.032 . . . . 1.11 108.213 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 65.6 t80 -135.97 134.57 38.74 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.9 110.065 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -111.76 110.02 20.17 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.687 -0.857 . . . . 0.24 108.687 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.24 -31.71 72.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 1.16 110.253 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.7 88.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 1.1 110.436 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.9 p -105.09 -0.98 26.16 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.386 -0.821 . . . . 1.14 110.158 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.1 mtpm? 49.98 40.03 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 2.63 108.931 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 132.14 55.38 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.528 0.68 . . . . 1.05 110.452 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.0 m-85 -99.6 139.8 34.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.384 -1.339 . . . . 0.11 107.384 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -131.58 132.45 44.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.71 -1.244 . . . . 1.03 108.83 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -121.88 129.31 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.35 -0.982 . . . . 1.02 108.35 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -120.02 127.2 52.38 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.477 -0.765 . . . . 1.05 111.016 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.058 -0.972 . . . . 1.95 109.163 179.191 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.532 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 95.6 m . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.25 0.548 . . . . 1.04 109.685 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -112.1 150.29 30.94 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.891 -1.151 . . . . 0.89 107.891 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -116.48 143.4 45.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.067 -1.02 . . . . 2.47 109.418 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.2 tp -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.688 -0.632 . . . . 1.01 109.84 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.5 mt -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.572 -1.27 . . . . 1.15 107.572 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.8 mt -102.85 115.94 31.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.25 -0.906 . . . . 1.06 110.01 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -116.95 70.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.666 -1.235 . . . . 0.19 107.666 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.91 170.1 53.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.093 -1.603 . . . . 0.24 109.093 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 56' ' ' GLU . 62.4 mttp -64.38 -36.94 85.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.075 -1.25 . . . . 3.13 107.627 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.0 p -123.07 -15.27 7.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.903 -0.498 . . . . 1.43 109.889 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.79 122.1 41.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.98 -1.075 . . . . 1.23 109.969 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.92 126.68 27.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.295 -0.878 . . . . 2.49 109.814 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.27 -177.41 48.39 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.387 -1.387 . . . . 0.3 110.154 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.77 157.03 42.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.517 -0.99 . . . . 1.68 108.977 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -156.73 173.24 17.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.474 -0.766 . . . . 1.09 109.523 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.2 p -137.23 160.54 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.378 -0.826 . . . . 1.07 109.211 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 t -154.0 159.81 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.793 -0.817 . . . . 0.99 108.793 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -102.84 131.94 49.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.265 -0.897 . . . . 2.22 109.137 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.07 145.62 26.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 1.07 109.105 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.61 -26.89 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 1.15 110.341 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -157.77 174.71 14.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.888 -1.133 . . . . 1.16 110.431 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.36 81.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.518 -0.739 . . . . 1.05 109.208 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.94 60.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 1.09 109.828 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.7 p -73.12 -35.13 66.48 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.668 -1.27 . . . . 1.12 109.6 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.7 94.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.581 -0.896 . . . . 1.02 108.581 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.27 -48.07 83.0 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.348 -1.341 . . . . 1.06 109.27 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -65.91 -44.67 84.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 3.05 111.013 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -52.86 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.946 -1.096 . . . . 1.05 110.456 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -61.06 -36.51 79.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.15 110.156 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -60.02 -40.5 89.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 2.56 109.261 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.02 -41.43 74.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 2.33 108.923 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 58.1 t80 -60.06 -49.66 76.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.99 109.461 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -45.28 94.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 1.03 109.549 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.96 -41.68 92.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.334 -0.854 . . . . 1.97 109.272 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.21 -23.44 67.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 1.29 109.138 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 5.8 m120 -97.05 6.74 48.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.74 109.592 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.04 63.52 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.059 -1.067 . . . . 0.72 111.282 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 44.0 t -114.81 125.57 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.035 -1.274 . . . . 1.1 108.796 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 75.1 m-20 -149.66 101.92 3.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.254 -0.904 . . . . 1.33 110.399 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.41 -130.54 1.33 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.128 -1.51 . . . . 0.29 111.301 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -92.29 131.66 37.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.943 -1.328 . . . . 2.07 110.539 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.674 -0.641 . . . . 0.15 110.015 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 p -138.2 150.71 47.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.097 -1.075 . . . . 1.11 108.097 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.97 137.24 39.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -0.911 . . . . 0.9 110.532 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -113.28 109.98 19.63 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.904 -0.776 . . . . 0.24 108.904 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.7 t0 -67.01 -30.93 71.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 1.16 110.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 1.1 109.688 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -104.07 -0.65 28.45 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.363 -0.835 . . . . 1.14 109.807 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.0 mtpm? 49.66 42.79 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.881 -1.137 . . . . 2.63 108.453 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -120.05 134.69 55.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.454 0.645 . . . . 1.05 110.713 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -100.4 138.28 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.392 -1.336 . . . . 0.11 107.392 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -128.8 130.17 46.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.692 -1.255 . . . . 1.03 108.03 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.28 130.11 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.539 -0.912 . . . . 1.02 108.539 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.8 m -120.0 128.37 53.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.207 -0.664 . . . . 1.05 109.207 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 63.9 tt0 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.972 -1.014 . . . . 1.95 109.288 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.243 0.544 . . . . 1.04 109.582 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -113.42 146.92 38.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.749 -1.204 . . . . 0.89 107.749 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.685 ' HZ3' ' HG1' ' A' ' 51' ' ' THR . 7.8 ttpm? -118.22 141.59 48.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.23 -0.919 . . . . 2.47 109.824 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.5 tp -120.11 128.38 53.4 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.045 -0.724 . . . . 1.01 109.045 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.1 123.28 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.027 -1.471 . . . . 1.15 107.027 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 114.06 27.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 1.06 109.67 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.6 71.39 0.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.031 -1.47 . . . . 0.19 107.031 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.11 169.59 53.03 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.082 -1.207 . . . . 0.24 110.082 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -65.76 -39.84 91.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -1.039 . . . . 3.13 108.224 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.9 m -124.28 -18.42 5.82 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.419 -0.586 . . . . 1.43 109.419 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.7 119.98 39.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 1.23 109.037 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -135.31 133.63 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.253 -0.904 . . . . 2.49 109.598 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.82 -173.64 46.45 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.461 -1.352 . . . . 0.3 110.272 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -149.44 158.2 43.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.577 -0.954 . . . . 1.68 109.202 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.466 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 4.3 t -154.49 171.6 19.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 1.09 109.324 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.7 p -137.33 159.92 40.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 1.07 109.332 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -155.0 158.8 39.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.823 . . . . 0.99 109.094 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.59 133.57 48.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.459 -0.941 . . . . 2.22 108.459 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.55 146.25 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 1.07 109.306 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 m -59.55 -30.78 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 1.15 109.564 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -159.33 174.61 14.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.981 . . . . 1.16 110.015 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.32 81.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.411 -0.805 . . . . 1.05 110.358 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.37 -37.32 62.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.872 -1.142 . . . . 1.09 109.708 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 p -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.692 -1.255 . . . . 1.12 109.576 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.19 81.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.359 -0.978 . . . . 1.02 108.359 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.13 -47.44 81.13 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.645 -1.222 . . . . 1.06 109.439 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.71 -41.13 88.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 3.05 110.248 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -68.27 -54.98 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.06 -1.025 . . . . 1.05 110.814 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -63.69 -38.66 91.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.15 111.358 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.79 -40.72 96.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.701 -1.249 . . . . 2.56 110.049 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.23 -43.86 73.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.971 -1.08 . . . . 2.33 109.162 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 81.4 t80 -60.17 -46.98 87.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.446 -0.784 . . . . 0.99 109.899 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.34 96.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 1.03 108.656 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.41 -41.16 96.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.561 -0.903 . . . . 1.97 108.561 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.64 -25.05 68.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 1.29 109.607 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 6.3 m120 -94.8 7.43 45.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.946 . . . . 0.74 109.791 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.12 30.34 75.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.678 -1.369 . . . . 0.72 109.678 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.0 t -105.45 125.81 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -1.165 . . . . 1.1 109.756 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 40.0 t0 -138.64 142.32 39.07 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.98 -1.119 . . . . 1.33 107.98 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.78 -150.13 11.6 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.247 -1.454 . . . . 0.29 110.135 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -94.48 137.66 33.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.531 -0.982 . . . . 2.07 108.822 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -104.89 138.33 41.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.367 -0.833 . . . . 0.15 110.77 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -136.24 149.86 48.7 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.885 -1.154 . . . . 1.11 107.885 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -137.03 137.35 39.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.185 -0.947 . . . . 0.9 110.492 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.6 109.95 20.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.316 -0.994 . . . . 0.24 108.316 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.9 t0 -67.35 -30.67 70.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 1.16 110.167 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.86 91.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 1.1 110.34 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.4 p -105.93 -0.07 25.39 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.391 -0.818 . . . . 1.14 110.278 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 50.02 41.46 23.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.927 -1.108 . . . . 2.63 108.542 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.685 ' HG1' ' HZ3' ' A' ' 4' ' ' LYS . 97.2 m -119.03 130.5 55.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.734 0.778 . . . . 1.05 110.451 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -99.36 139.08 35.54 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.568 -1.271 . . . . 0.11 107.568 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.6 m -130.69 131.35 44.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 1.03 108.195 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.27 129.35 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.423 -0.954 . . . . 1.02 108.423 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.1 m -120.41 127.07 51.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.423 -0.798 . . . . 1.05 110.188 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.027 -0.987 . . . . 1.95 109.253 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.4 m . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.384 0.611 . . . . 1.04 109.655 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -113.72 145.41 41.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.361 -0.978 . . . . 0.89 108.361 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -115.96 142.94 46.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 2.47 108.912 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.9 tp -119.92 126.62 51.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.573 -0.899 . . . . 1.01 108.573 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.48 123.73 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.151 -1.425 . . . . 1.15 107.151 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 mt -102.73 112.89 25.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 1.06 110.383 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.97 68.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.839 -1.541 . . . . 0.19 106.839 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.31 168.2 51.51 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.965 -1.254 . . . . 0.24 109.965 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HZ2' ' C ' ' A' ' 56' ' ' GLU . 61.6 mttp -65.9 -37.65 86.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.703 -1.221 . . . . 3.13 107.703 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -122.19 -19.79 6.42 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.151 -0.477 . . . . 1.43 109.866 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 tp -99.5 120.93 40.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 1.23 109.422 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -135.61 128.46 31.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.304 -0.873 . . . . 2.49 109.517 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.42 -175.03 47.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.303 -1.427 . . . . 0.3 110.446 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.36 152.57 41.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.646 -0.914 . . . . 1.68 108.86 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -152.65 168.02 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 1.09 108.801 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.1 p -138.65 160.54 39.37 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 1.07 109.737 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -157.37 162.84 39.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.99 108.594 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 43.7 mp0 -106.37 136.78 45.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.796 -0.816 . . . . 2.22 108.796 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.04 144.76 28.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 1.07 108.899 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -60.04 -30.73 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.229 -0.919 . . . . 1.15 109.393 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -157.73 176.96 11.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 1.16 110.112 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.31 -38.12 87.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.526 -0.734 . . . . 1.05 109.496 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.9 61.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.982 -1.074 . . . . 1.09 109.553 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.2 m -69.97 -40.06 75.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.69 -1.256 . . . . 1.12 109.811 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.02 87.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.857 -0.794 . . . . 1.02 108.857 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.21 -45.44 79.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.442 -1.303 . . . . 1.06 108.824 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -67.83 -44.23 77.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 3.05 111.157 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.87 -53.01 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 1.05 111.34 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.98 -37.56 87.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.861 -1.149 . . . . 0.15 110.299 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -59.94 -42.32 93.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.805 -1.184 . . . . 2.56 109.8 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -68.67 -40.14 80.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.078 -1.014 . . . . 2.33 108.741 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.4 t80 -59.95 -46.81 88.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.99 109.028 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.84 92.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.83 . . . . 1.03 109.144 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -60.01 -45.93 91.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.439 -0.788 . . . . 1.97 110.137 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.33 -25.16 65.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.051 -1.03 . . . . 1.29 109.396 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 83.3 m-20 -99.71 9.47 43.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.74 109.785 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.04 35.13 91.6 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.981 -1.104 . . . . 0.72 110.491 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 71.1 t -108.89 127.85 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.147 -1.208 . . . . 1.1 109.979 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 96.0 m-20 -140.38 148.33 41.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.485 -0.931 . . . . 1.33 108.485 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.41 -159.57 28.64 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.44 -1.362 . . . . 0.29 110.061 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -85.87 132.1 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.029 -1.1 . . . . 2.07 108.029 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -101.76 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.135 -0.978 . . . . 0.15 110.683 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.5 p -136.44 150.04 48.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.627 -0.879 . . . . 1.11 108.627 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 61.1 t80 -134.19 137.73 44.64 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.414 -0.804 . . . . 0.9 110.335 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -115.84 109.98 18.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.834 -0.802 . . . . 0.24 108.834 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -67.81 -29.2 68.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 1.16 110.455 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.02 94.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 1.1 110.32 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 p -109.18 0.13 19.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.582 -0.699 . . . . 1.14 110.209 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtmp? 50.14 42.11 24.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.851 -1.156 . . . . 2.63 108.588 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -118.79 130.06 55.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.725 0.774 . . . . 1.05 110.166 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 31.5 m-85 -99.11 139.51 34.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.949 -1.5 . . . . 0.11 106.949 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.6 m -131.96 132.82 43.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.782 -1.199 . . . . 1.03 108.463 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.345 -0.983 . . . . 1.02 108.345 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.3 m -119.38 126.73 52.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.51 -0.744 . . . . 1.05 109.518 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' C ' ' HZ2' ' A' ' 10' ' ' LYS . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.086 -0.959 . . . . 1.95 109.7 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.39 -0.596 . . . . 1.04 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.79 145.49 43.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.807 -0.812 . . . . 0.89 108.807 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -114.38 143.42 44.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 2.47 108.906 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.9 tp -119.8 126.91 52.17 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.735 -0.839 . . . . 1.01 108.735 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.9 mt -102.45 121.03 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.034 -1.469 . . . . 1.15 107.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.07 115.01 29.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.025 . . . . 1.06 109.879 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -122.48 66.0 0.94 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.628 -1.619 . . . . 0.19 106.628 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -78.6 171.89 55.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.799 -1.72 . . . . 0.24 108.799 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.38 -39.69 89.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.028 -1.278 . . . . 3.13 108.238 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.2 p -114.57 -20.12 10.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.841 -0.537 . . . . 1.43 109.757 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 9' ' ' GLY . 58.9 tp -99.93 121.65 41.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -0.918 . . . . 1.23 109.942 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -133.2 122.88 24.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.863 . . . . 2.49 108.948 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.08 -171.64 44.77 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.341 -1.409 . . . . 0.3 110.64 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 2.1 pm0 -150.46 158.61 44.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.519 -0.989 . . . . 1.68 109.591 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 t -154.55 170.37 21.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.518 -0.739 . . . . 1.09 109.707 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.3 p -138.16 160.13 40.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.33 -0.856 . . . . 1.07 109.494 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 t -155.46 162.19 40.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.959 -0.756 . . . . 0.99 108.959 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -100.22 132.08 45.8 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.088 -1.079 . . . . 2.22 108.088 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.39 143.24 26.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.943 -1.098 . . . . 1.07 109.477 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.46 -30.67 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.577 -0.702 . . . . 1.15 110.439 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -159.87 179.93 8.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.84 -1.162 . . . . 1.16 110.322 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -37.64 75.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.249 -0.907 . . . . 1.05 110.355 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.27 -38.52 68.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.186 . . . . 1.09 110.898 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -73.07 -34.44 66.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.271 -1.518 . . . . 1.12 109.388 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.59 86.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.65 -0.87 . . . . 1.02 108.65 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.34 -48.16 77.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.829 -1.149 . . . . 1.06 110.02 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.61 -41.14 88.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 3.05 110.96 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.3 -54.83 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 1.05 111.081 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -63.76 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.01 -1.056 . . . . 0.15 110.456 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' NZ ' ' CB ' ' A' ' 31' ' ' LYS . 6.7 ttpm? -61.9 -42.64 99.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.801 -1.187 . . . . 2.56 109.935 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -67.54 -42.8 82.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.95 -1.094 . . . . 2.33 108.542 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 63.9 t80 -60.02 -47.83 84.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.425 0.631 . . . . 0.99 109.612 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.59 99.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.474 -0.766 . . . . 1.03 109.443 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -59.95 -40.66 89.73 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.191 -1.04 . . . . 1.97 108.191 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.61 -24.37 67.77 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.644 -0.66 . . . . 1.29 109.369 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 4.9 m120 -97.63 6.94 47.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.74 109.769 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.07 34.32 70.29 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.954 -1.117 . . . . 0.72 110.711 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.87 124.52 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.03 -1.276 . . . . 1.1 108.972 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.47 101.09 2.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.003 -1.061 . . . . 1.33 110.713 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.07 -130.06 1.3 Allowed Glycine 0 N--CA 1.497 2.733 0 C-N-CA 119.268 -1.444 . . . . 0.29 111.336 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -93.78 129.3 40.2 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.972 -1.311 . . . . 2.07 110.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.55 139.97 41.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.67 -0.644 . . . . 0.15 110.059 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -136.08 149.46 48.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.756 -1.201 . . . . 1.11 107.756 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.95 135.4 41.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.9 109.924 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.45 109.55 19.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.299 -1.0 . . . . 0.24 108.299 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -68.19 -30.69 69.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.16 110.224 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.8 91.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 1.1 110.514 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.3 p -104.97 0.26 27.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 1.14 110.066 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm 50.63 40.95 25.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 2.63 108.257 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -119.79 130.54 54.99 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.536 0.684 . . . . 1.05 110.8 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -99.45 137.79 37.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.055 -1.461 . . . . 0.11 107.055 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.0 m -130.2 131.27 45.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.748 -1.22 . . . . 1.03 108.216 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.92 127.4 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.447 -0.946 . . . . 1.02 108.447 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -123.61 125.24 44.47 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.846 -0.798 . . . . 1.05 108.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.99 -1.005 . . . . 1.95 109.635 -179.865 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.41 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 23.9 m . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.022 -0.733 . . . . 1.04 109.022 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.06 147.17 42.6 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.979 -0.748 . . . . 0.89 108.979 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -118.07 143.77 46.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.487 -0.758 . . . . 2.47 109.267 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.5 129.07 54.53 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.011 -0.737 . . . . 1.01 109.011 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.46 123.72 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.066 -1.457 . . . . 1.15 107.066 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.5 mt -104.49 116.44 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.208 -0.933 . . . . 1.06 111.035 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -114.88 71.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.113 -1.44 . . . . 0.19 107.113 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 168.91 52.61 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.434 -1.466 . . . . 0.24 109.434 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -66.05 -39.37 90.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.182 -1.187 . . . . 3.13 108.17 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.0 p -124.44 -16.56 6.31 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.023 0.44 . . . . 1.43 109.944 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -103.19 120.01 39.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.288 -0.883 . . . . 1.23 109.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -130.89 131.11 44.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.514 -0.741 . . . . 2.49 109.411 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.78 48.24 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.257 -1.449 . . . . 0.3 110.697 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 52.2 mp0 -143.88 153.26 42.14 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.479 -0.934 . . . . 1.68 108.479 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.645 ' HG1' ' H ' ' A' ' 17' ' ' THR . 4.4 t -152.51 169.17 23.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.085 -1.009 . . . . 1.09 109.34 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.645 ' H ' ' HG1' ' A' ' 16' ' ' THR . 31.9 p -135.44 159.82 40.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.353 -0.842 . . . . 1.07 109.502 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 t -157.28 160.12 38.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.99 109.216 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 55.8 mp0 -103.25 135.67 44.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.903 . . . . 2.22 108.678 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.54 144.6 27.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 1.07 109.264 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.88 -30.94 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 1.15 109.809 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -157.69 177.23 11.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.16 109.621 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.23 84.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.447 -0.783 . . . . 1.05 109.495 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -36.83 63.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.036 -1.04 . . . . 1.09 109.577 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.8 m -69.99 -39.63 75.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.785 -1.197 . . . . 1.12 109.651 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.71 78.83 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.735 -0.839 . . . . 1.02 108.735 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.76 -41.67 87.13 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.657 -1.217 . . . . 1.06 109.686 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.93 -45.17 71.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 3.05 110.477 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 -51.11 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.551 -0.718 . . . . 1.05 110.6 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -66.51 -38.6 87.58 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.091 -1.044 . . . . 0.15 110.549 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.0 -44.7 94.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.727 -1.233 . . . . 2.56 109.538 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -67.61 -40.88 84.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.028 -1.045 . . . . 2.33 108.573 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.2 t80 -59.99 -48.34 82.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.638 . . . . 0.99 109.78 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.21 94.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 1.03 109.546 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -60.0 -42.26 93.86 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.163 -0.961 . . . . 1.97 109.107 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.42 -26.47 67.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 1.29 109.696 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.8 m-20 -99.03 10.02 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.168 -0.958 . . . . 0.74 109.494 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.5 38.25 96.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.731 -1.348 . . . . 0.72 109.731 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.19 126.71 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -1.102 . . . . 1.1 110.172 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 52.4 t0 -110.19 -99.88 0.4 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.295 -1.002 . . . . 1.33 108.295 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.26 163.89 3.61 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 122.167 0.871 . . . . 0.29 112.368 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -75.2 138.48 41.99 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.348 -1.352 . . . . 2.07 107.348 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -99.57 134.99 41.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.15 110.809 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.6 p -133.57 148.19 51.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.316 -0.994 . . . . 1.11 108.316 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 66.8 t80 -130.61 134.31 46.88 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.86 . . . . 0.9 110.155 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' LYS . 62.0 t0 -112.88 107.19 15.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.738 -0.838 . . . . 0.24 108.738 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 56.5 t0 -67.36 -32.15 72.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.166 -0.959 . . . . 1.16 110.238 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 1.1 109.938 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -107.89 0.04 21.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.459 -0.775 . . . . 1.14 110.213 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 46' ' ' ASP . 9.5 mtmp? 49.74 42.02 22.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.806 -1.184 . . . . 2.63 108.294 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -120.01 131.44 55.14 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.625 0.726 . . . . 1.05 110.287 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.6 m-85 -99.88 137.83 37.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.28 -1.378 . . . . 0.11 107.28 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -131.0 131.7 44.52 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.804 -1.185 . . . . 1.03 108.245 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.5 p -120.58 128.06 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.077 -1.082 . . . . 1.02 108.077 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.22 125.86 49.21 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.402 -0.811 . . . . 1.05 110.845 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 38.2 mp0 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 118.034 -0.984 . . . . 1.95 109.438 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.458 -0.571 . . . . 1.04 109.458 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 95.2 m-85 -112.77 146.86 38.05 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.892 -1.151 . . . . 0.89 107.892 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -115.82 142.38 46.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.169 -0.957 . . . . 2.47 109.7 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.9 tp -122.4 128.11 50.54 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.057 -0.72 . . . . 1.01 109.057 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.69 124.16 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.605 -1.258 . . . . 1.15 107.605 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.3 mt -101.43 114.78 29.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 1.06 110.13 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.13 67.63 0.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.057 -1.46 . . . . 0.19 107.057 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.01 172.52 54.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.631 -1.387 . . . . 0.24 109.631 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -65.99 -39.06 90.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.221 -1.164 . . . . 3.13 108.365 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -17.57 6.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.917 -0.489 . . . . 1.43 109.859 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.3 tp -99.3 117.33 33.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 1.23 109.563 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.58 128.69 39.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.867 0.841 . . . . 2.49 109.514 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.15 -175.26 47.37 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.508 -1.329 . . . . 0.3 110.317 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -148.96 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.699 -0.883 . . . . 1.68 109.045 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.548 ' HG1' ' N ' ' A' ' 17' ' ' THR . 5.2 t -154.24 171.16 19.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 1.09 109.391 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.548 ' N ' ' HG1' ' A' ' 16' ' ' THR . 26.8 p -137.09 159.99 40.29 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.897 -0.779 . . . . 1.07 108.897 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -154.89 159.58 40.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.99 109.25 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -102.7 132.42 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.288 -0.882 . . . . 2.22 108.884 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.12 143.81 27.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 1.07 108.935 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.44 -27.23 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 1.15 109.858 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -157.96 172.21 18.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 1.16 109.939 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.504 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -67.52 -37.68 83.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.516 -0.74 . . . . 1.05 109.941 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.48 -37.2 62.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.049 -1.032 . . . . 1.09 110.069 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.6 p -73.38 -34.41 65.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.615 -1.303 . . . . 1.12 109.809 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.9 87.33 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.325 -0.991 . . . . 1.02 108.325 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.67 -45.72 85.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.864 -1.134 . . . . 1.06 109.58 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.28 -42.7 83.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.078 . . . . 3.05 109.821 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.59 -54.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 1.05 110.737 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.44 -39.04 93.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.15 110.478 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -60.79 -42.45 97.57 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.721 -1.237 . . . . 2.56 109.823 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -69.61 -42.35 74.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 2.33 108.702 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.625 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.9 t80 -59.95 -44.94 94.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.665 -0.865 . . . . 0.99 108.665 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.92 99.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 1.03 109.387 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.1 -40.07 88.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 1.97 108.533 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.98 -24.22 67.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 78.1 m-20 -99.17 7.3 45.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.207 -0.933 . . . . 0.74 110.495 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.12 35.58 71.02 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.917 -1.135 . . . . 0.72 111.349 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 67.1 t -111.93 125.09 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.968 -1.313 . . . . 1.1 109.348 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 78.5 m-20 -148.47 98.8 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.252 -0.905 . . . . 1.33 110.47 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.83 -136.85 2.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.168 -1.491 . . . . 0.29 111.015 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.79 131.57 35.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.087 -1.243 . . . . 2.07 110.608 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -108.25 139.3 43.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.674 -0.641 . . . . 0.15 110.013 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 p -136.68 149.99 48.23 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 1.11 108.586 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 71.4 t80 -133.79 136.03 44.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.364 -0.835 . . . . 0.9 110.451 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -114.03 109.71 18.89 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.403 -0.962 . . . . 0.24 108.403 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.26 -29.11 67.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 1.16 110.17 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.02 94.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.005 . . . . 1.1 109.92 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -106.95 0.7 23.96 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.491 -0.756 . . . . 1.14 110.24 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.611 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 16.4 mtpp 50.51 41.66 25.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 2.63 108.451 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 132.64 55.52 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.66 0.743 . . . . 1.05 110.906 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 48.3 m-85 -99.99 139.36 35.77 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.167 -1.42 . . . . 0.11 107.167 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -130.33 131.52 45.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.665 -1.272 . . . . 1.03 108.343 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.7 p -124.85 130.01 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.862 . . . . 1.02 108.674 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.6 m -125.37 129.25 49.54 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.658 -0.651 . . . . 1.05 109.87 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.946 -1.026 . . . . 1.95 109.491 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 108.971 -0.751 . . . . 1.04 108.971 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.3 144.93 43.6 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.006 -0.739 . . . . 0.89 109.006 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -115.69 141.14 48.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 2.47 109.004 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.8 tp -120.05 128.97 54.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 1.01 109.336 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -105.81 123.06 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 106.983 -1.488 . . . . 1.15 106.983 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.06 115.89 31.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.311 -0.868 . . . . 1.06 110.311 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -116.59 72.8 0.83 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.967 -1.123 . . . . 0.19 107.967 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.62 169.47 54.31 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.219 -1.553 . . . . 0.24 109.219 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.656 ' HZ2' ' HG1' ' A' ' 11' ' ' THR . 19.8 pttp -62.37 -35.99 80.89 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.137 -1.213 . . . . 3.13 108.082 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.656 ' HG1' ' HZ2' ' A' ' 10' ' ' LYS . 6.3 p -129.06 -11.92 4.69 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.555 -0.535 . . . . 1.43 109.555 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.6 tp -99.96 118.69 36.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.27 -0.894 . . . . 1.23 109.104 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -130.63 127.75 39.57 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 2.49 109.606 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 -177.84 48.39 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.184 -1.484 . . . . 0.3 110.555 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.17 157.15 43.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.666 -0.903 . . . . 1.68 109.014 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.52 ' HG1' ' N ' ' A' ' 17' ' ' THR . 3.0 t -152.99 169.97 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 1.09 109.145 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.52 ' N ' ' HG1' ' A' ' 16' ' ' THR . 33.4 p -136.49 159.61 41.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 1.07 109.309 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 t -155.67 159.0 39.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.387 -0.821 . . . . 0.99 109.138 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.37 134.04 45.06 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.042 -1.095 . . . . 2.22 108.042 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.43 26.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.928 -1.108 . . . . 1.07 109.491 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.05 -31.25 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 1.15 109.673 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD1' ' OG1' ' A' ' 25' ' ' THR . 40.2 p-10 -158.32 175.2 14.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 1.16 110.07 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.08 81.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.501 -0.749 . . . . 1.05 109.989 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.18 -36.92 61.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.008 -1.058 . . . . 1.09 109.871 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.405 ' OG1' ' OD1' ' A' ' 22' ' ' ASP . 5.9 p -74.16 -34.23 63.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.243 . . . . 1.12 109.519 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.971 -1.122 . . . . 1.02 107.971 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.07 -49.83 74.66 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.762 -1.175 . . . . 1.06 108.872 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -63.46 -44.77 93.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.83 . . . . 3.05 110.821 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.36 -53.28 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.053 -1.029 . . . . 1.05 110.763 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -63.46 -37.82 88.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.15 110.456 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.685 -1.259 . . . . 2.56 109.83 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.57 -40.75 76.57 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.012 -1.055 . . . . 2.33 108.58 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.46 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 51.1 t80 -60.06 -47.77 84.5 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.749 -0.834 . . . . 0.99 108.749 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.16 99.42 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.918 -0.771 . . . . 1.03 108.918 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -60.0 -42.58 94.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.184 -1.043 . . . . 1.97 108.184 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.398 -0.814 . . . . 1.29 109.097 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.6 m-80 -98.13 6.37 47.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.283 -0.886 . . . . 0.74 109.466 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.29 34.64 90.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.143 -1.183 . . . . 0.72 110.143 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.4 t -112.05 128.82 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.391 -1.064 . . . . 1.1 110.513 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 2.0 p-10 -110.52 -98.49 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.505 -1.294 . . . . 1.33 107.505 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 68.64 164.86 3.46 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-O 122.01 0.783 . . . . 0.29 111.841 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -76.31 137.46 39.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.998 -1.482 . . . . 2.07 106.998 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -98.0 134.94 40.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.15 110.544 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.38 148.77 50.73 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.996 -1.113 . . . . 1.11 107.996 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.2 t80 -135.97 135.1 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.326 -0.859 . . . . 0.9 110.29 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.65 109.95 19.8 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.31 -0.996 . . . . 0.24 108.31 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -68.68 -29.32 67.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 1.16 110.292 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.93 95.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.133 -0.98 . . . . 1.1 109.988 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.0 p -108.07 0.3 21.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.611 -0.681 . . . . 1.14 109.82 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.9 mttm 48.58 43.04 20.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.065 . . . . 2.63 108.502 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 131.75 55.26 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.543 0.687 . . . . 1.05 109.836 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.3 m-85 -100.05 138.93 36.45 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.851 -1.166 . . . . 0.11 107.851 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -131.36 131.68 43.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.803 -1.186 . . . . 1.03 108.52 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.19 130.15 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.296 -1.001 . . . . 1.02 108.296 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -117.53 124.83 49.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.504 -0.748 . . . . 1.05 109.701 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.039 -0.981 . . . . 1.95 109.588 -179.504 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 121.372 0.606 . . . . 1.04 110.377 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -109.57 150.94 27.45 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.774 -1.195 . . . . 0.89 107.774 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -118.1 140.04 50.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.08 -1.013 . . . . 2.47 109.232 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 tp -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.926 -0.768 . . . . 1.01 108.926 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.31 124.55 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.779 -1.193 . . . . 1.15 107.779 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.36 116.56 32.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 1.06 109.9 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -114.33 72.32 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.584 -1.265 . . . . 0.19 107.584 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.68 169.06 53.1 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.45 -1.46 . . . . 0.24 109.45 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.35 -37.93 88.55 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.312 -1.111 . . . . 3.13 108.006 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.7 p -123.78 -16.15 6.75 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.73 -0.471 . . . . 1.43 109.73 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 tp -101.74 120.18 39.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.305 -0.872 . . . . 1.23 109.573 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.15 127.9 40.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.802 . . . . 2.49 108.966 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.97 -179.22 48.65 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.174 -1.489 . . . . 0.3 110.584 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -149.48 158.2 43.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.947 . . . . 1.68 109.556 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.47 172.52 17.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.45 -0.781 . . . . 1.09 109.703 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -137.31 160.01 40.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.407 -0.808 . . . . 1.07 109.532 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 t -154.88 159.09 40.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.99 108.994 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -103.02 134.73 45.97 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.503 -0.925 . . . . 2.22 108.503 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.68 144.91 25.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 1.07 109.807 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 m -61.5 -30.68 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.573 -0.705 . . . . 1.15 110.296 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 24' ' ' ALA . 3.3 p30 -159.3 -179.99 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.917 -1.114 . . . . 1.16 109.825 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.39 75.0 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.076 -1.015 . . . . 1.05 110.5 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -55.12 -39.37 69.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.839 -1.163 . . . . 1.09 111.088 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -74.46 -32.83 62.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.244 -1.535 . . . . 1.12 109.339 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.806 -0.813 . . . . 1.02 108.806 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.71 -47.29 82.8 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.787 -1.165 . . . . 1.06 109.436 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -64.34 -43.02 95.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 3.05 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.83 -54.47 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.305 -0.872 . . . . 1.05 111.034 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -62.84 -38.87 92.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.077 -1.014 . . . . 0.15 110.783 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -61.62 -42.57 99.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.818 -1.177 . . . . 2.56 109.897 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -67.26 -43.0 82.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.84 -1.163 . . . . 2.33 108.619 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -47.57 85.28 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -0.774 . . . . 0.99 109.308 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.84 99.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 1.03 109.255 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.84 -42.46 97.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.97 109.059 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -62.49 -21.72 65.71 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -0.912 . . . . 1.29 108.958 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.9 m-20 -99.77 8.92 43.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.74 109.41 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.78 35.56 91.44 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.193 -1.163 . . . . 0.72 110.193 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.8 t -111.5 128.62 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.267 -1.137 . . . . 1.1 109.801 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.473 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 8.9 t70 -111.68 -96.59 0.42 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.108 -1.071 . . . . 1.33 108.108 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 68.33 164.42 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 121.237 -0.915 . . . . 0.29 112.087 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.68 137.47 42.18 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.319 -1.363 . . . . 2.07 107.319 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.18 135.61 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.958 . . . . 0.15 110.956 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -135.61 149.92 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.152 -1.055 . . . . 1.11 108.152 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 49.6 t80 -135.36 135.17 40.49 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.9 109.646 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -114.21 110.14 19.49 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.286 -0.635 . . . . 0.24 109.286 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.47 -29.54 69.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 1.16 109.852 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -40.46 94.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 1.1 110.167 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 76.9 p -107.94 -0.73 21.22 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.842 . . . . 1.14 110.049 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 48.9 42.48 20.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.037 -1.039 . . . . 2.63 108.694 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -120.08 130.26 54.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.822 -0.626 . . . . 1.05 109.786 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.4 m-85 -98.66 138.37 35.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.274 -1.38 . . . . 0.11 107.274 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.7 m -132.07 132.34 43.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.677 -1.264 . . . . 1.03 108.792 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.62 126.73 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.931 -1.137 . . . . 1.02 107.931 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.92 127.8 52.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.345 -0.847 . . . . 1.05 111.005 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 29.9 mp0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.014 -0.993 . . . . 1.95 109.466 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.53 -0.544 . . . . 1.04 109.53 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.83 145.56 42.01 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.677 -0.86 . . . . 0.89 108.677 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -116.64 142.13 47.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.372 -0.83 . . . . 2.47 109.073 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 tp -121.9 129.41 52.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.728 . . . . 1.01 109.798 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.0 mt -105.97 123.3 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.748 -1.575 . . . . 1.15 106.748 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.41 117.09 33.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 1.06 110.437 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.01 71.22 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.258 -1.386 . . . . 0.19 107.258 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 173.74 54.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.212 -1.555 . . . . 0.24 109.212 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -65.16 -39.93 93.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.189 -1.183 . . . . 3.13 108.102 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.7 p -124.99 -14.63 6.58 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.649 -0.5 . . . . 1.43 109.649 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.7 tp -99.7 114.94 28.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -0.974 . . . . 1.23 109.418 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 129.07 42.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.426 -0.796 . . . . 2.49 109.256 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.58 -175.1 47.41 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.285 -1.436 . . . . 0.3 110.312 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -148.28 156.82 43.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.608 -0.936 . . . . 1.68 108.96 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.557 ' HG1' ' H ' ' A' ' 17' ' ' THR . 5.2 t -154.67 172.9 17.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 1.09 109.604 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.557 ' H ' ' HG1' ' A' ' 16' ' ' THR . 40.1 p -137.68 159.13 42.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.752 . . . . 1.07 109.064 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -155.65 160.06 40.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.838 . . . . 0.99 108.874 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -104.31 133.82 48.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.272 -0.893 . . . . 2.22 108.931 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.17 146.27 26.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 1.07 109.614 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.24 -30.69 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.78 . . . . 1.15 110.194 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -159.79 179.99 8.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 1.16 110.093 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.79 82.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.628 -0.67 . . . . 1.05 110.653 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -37.03 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.874 -1.142 . . . . 1.09 110.431 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 p -73.49 -36.04 65.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.55 -1.344 . . . . 1.12 109.845 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.9 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.039 -1.097 . . . . 1.02 108.039 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.66 -45.73 85.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.13 -1.028 . . . . 1.06 110.203 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -67.35 -40.72 85.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.123 . . . . 3.05 110.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.37 -53.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 1.05 110.871 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -67.25 -40.01 86.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.923 -1.11 . . . . 0.15 110.664 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.75 -46.18 91.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.876 -1.14 . . . . 2.56 109.945 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.65 -43.01 81.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.095 -1.003 . . . . 2.33 108.782 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.9 t80 -60.09 -45.09 94.09 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.401 -0.812 . . . . 0.99 109.606 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.373 -0.829 . . . . 1.03 109.49 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -62.43 -40.12 95.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 1.97 109.007 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.62 -24.58 67.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 1.29 109.426 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 73.0 m-20 -97.14 10.08 40.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.74 109.198 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.0 93.97 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.321 -1.512 . . . . 0.72 109.321 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.4 t -109.94 123.75 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.356 -1.085 . . . . 1.1 109.867 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 97.6 m-20 -140.44 146.89 38.87 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.151 -1.055 . . . . 1.33 108.151 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.39 -155.49 22.47 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.077 -1.535 . . . . 0.29 110.105 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -88.03 130.66 34.91 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.85 -1.167 . . . . 2.07 107.85 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -103.0 138.92 39.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.15 110.463 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.8 p -136.83 150.05 48.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.341 -0.985 . . . . 1.11 108.341 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.3 t80 -135.69 137.09 41.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.435 -0.791 . . . . 0.9 110.233 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.447 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 60.0 t0 -111.93 109.95 20.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.901 -0.777 . . . . 0.24 108.901 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 51.9 t0 -67.15 -32.45 73.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 1.16 110.179 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.51 94.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 1.1 110.213 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.447 ' HG1' ' CG ' ' A' ' 46' ' ' ASP . 67.3 p -108.15 0.14 21.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.561 -0.712 . . . . 1.14 110.44 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 49.98 41.68 23.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.836 -1.165 . . . . 2.63 108.404 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -118.97 131.09 56.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.66 0.743 . . . . 1.05 110.264 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 44.4 m-85 -99.97 139.19 35.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.527 -1.286 . . . . 0.11 107.527 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 m -131.94 132.18 43.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.838 -1.164 . . . . 1.03 108.361 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.49 129.93 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.485 -0.932 . . . . 1.02 108.485 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -119.99 127.33 52.52 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.551 -0.718 . . . . 1.05 110.134 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 7.7 mp0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.975 -1.012 . . . . 1.95 109.238 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.283 0.563 . . . . 1.04 109.53 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.2 149.0 41.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.623 -0.88 . . . . 0.89 108.623 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -114.81 143.84 44.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.332 -0.855 . . . . 2.47 109.877 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.8 tp -121.31 127.14 51.02 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.858 -0.793 . . . . 1.01 108.858 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.9 mt -106.87 123.36 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.523 -1.288 . . . . 1.15 107.523 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -102.28 114.13 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 1.06 109.68 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' OD1' ' NZ ' ' A' ' 13' ' ' LYS . 43.2 t30 -114.88 71.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.72 -1.215 . . . . 0.19 107.72 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 166.43 49.76 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.416 -1.474 . . . . 0.24 109.416 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.437 ' NZ ' ' C ' ' A' ' 56' ' ' GLU . 60.0 mttp -67.41 -35.21 78.81 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -1.152 . . . . 3.13 108.027 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -22.42 4.99 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.929 -0.482 . . . . 1.43 109.849 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.37 119.96 39.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.306 -0.871 . . . . 1.23 109.338 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 8' ' ' ASN . 66.1 mttm -133.08 131.74 40.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.287 -0.883 . . . . 2.49 109.648 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.02 -179.97 48.8 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.273 -1.441 . . . . 0.3 110.426 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -142.0 151.97 42.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.609 -0.936 . . . . 1.68 108.73 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.419 ' HG1' ' H ' ' A' ' 17' ' ' THR . 8.8 t -151.89 167.65 27.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 1.09 109.074 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.419 ' H ' ' HG1' ' A' ' 16' ' ' THR . 30.2 p -139.88 160.82 39.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 1.07 109.411 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -155.72 161.17 40.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.686 -0.857 . . . . 0.99 108.686 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -103.45 135.03 45.82 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.484 -0.932 . . . . 2.22 108.484 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.9 144.28 27.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 1.07 109.549 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.36 -30.07 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.821 . . . . 1.15 109.634 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -158.35 171.06 20.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 1.16 109.582 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.78 81.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 1.05 109.796 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.71 68.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.115 . . . . 1.09 109.909 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.9 m -69.96 -37.17 75.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 1.12 109.722 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.83 75.2 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.588 -0.893 . . . . 1.02 108.588 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.43 -47.31 72.96 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.943 -1.103 . . . . 1.06 109.524 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 8.2 mptt -67.96 -40.2 83.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.794 -1.191 . . . . 3.05 110.459 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.24 -53.39 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 1.05 111.361 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -64.7 -39.98 94.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.887 -1.133 . . . . 0.15 111.045 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -62.14 -40.01 94.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.719 -1.238 . . . . 2.56 109.932 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.94 -1.1 . . . . 2.33 108.795 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 68.6 t80 -59.89 -48.63 80.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 0.99 109.606 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -43.22 99.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.366 -0.834 . . . . 1.03 109.151 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.06 -42.53 94.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.641 -0.874 . . . . 1.97 108.641 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.72 -22.21 66.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 1.29 109.289 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.524 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 32.2 m120 -96.27 6.91 47.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.246 -0.909 . . . . 0.74 109.988 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.79 75.38 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.76 -1.21 . . . . 0.72 110.201 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 126.97 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.282 -1.128 . . . . 1.1 109.621 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -142.92 148.69 37.34 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.353 -0.98 . . . . 1.33 108.353 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.07 -150.45 14.73 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.173 -1.489 . . . . 0.29 110.147 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 59.1 mp0 -89.17 129.33 35.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.976 -1.12 . . . . 2.07 107.976 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -100.4 138.35 37.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.15 110.066 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.6 p -136.37 150.04 48.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.13 -1.063 . . . . 1.11 108.13 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -134.37 135.55 42.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.441 -0.787 . . . . 0.9 109.7 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -111.23 108.68 18.4 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.186 -1.042 . . . . 0.24 108.186 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -67.58 -30.81 70.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 1.16 110.197 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.02 94.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 1.1 110.112 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -104.72 0.09 27.96 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.486 -0.759 . . . . 1.14 110.417 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 49.97 40.43 21.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.886 -1.134 . . . . 2.63 108.215 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 131.05 55.01 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.685 0.755 . . . . 1.05 110.497 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -98.66 137.85 36.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.037 -1.468 . . . . 0.11 107.037 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.3 m -129.99 130.87 45.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 1.03 108.074 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.26 129.39 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.123 -1.066 . . . . 1.02 108.123 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -118.32 124.71 48.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 1.05 109.172 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' C ' ' NZ ' ' A' ' 10' ' ' LYS . 83.3 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.971 -1.014 . . . . 1.95 109.575 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.15 0.5 . . . . 1.04 109.758 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.09 145.02 40.5 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.26 -1.015 . . . . 0.89 108.26 178.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -115.97 139.95 49.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.288 -1.004 . . . . 2.47 108.288 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.52 127.71 52.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.512 -0.921 . . . . 1.01 108.512 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.0 mt -105.87 123.3 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.118 -1.438 . . . . 1.15 107.118 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.3 mt -103.67 115.01 29.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 1.06 110.034 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.71 71.15 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.353 -1.351 . . . . 0.19 107.353 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 167.12 50.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.513 -1.435 . . . . 0.24 109.513 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -64.98 -36.23 83.72 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.662 -1.236 . . . . 3.13 107.662 178.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -19.51 5.3 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.849 -0.426 . . . . 1.43 109.849 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.82 119.99 38.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.082 -1.011 . . . . 1.23 109.126 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -133.67 129.12 36.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.49 109.722 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.85 -175.08 47.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.46 -1.353 . . . . 0.3 110.443 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.53 156.95 43.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.981 . . . . 1.68 109.444 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -154.33 169.96 22.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 1.09 109.353 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -137.85 160.46 39.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 1.07 109.311 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 t -156.08 162.0 40.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.99 108.971 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 4.0 tm-20 -102.94 134.8 45.76 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.675 -0.861 . . . . 2.22 108.675 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 19' ' ' GLU . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.19 -0.944 . . . . 1.07 108.939 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.2 m -60.09 -29.89 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 1.15 109.356 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -158.14 176.5 12.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 1.16 109.834 -179.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.41 88.41 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 1.05 109.85 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.55 49.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.946 -1.096 . . . . 1.09 109.433 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.5 m -69.47 -39.99 77.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.827 -1.171 . . . . 1.12 109.942 179.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.37 97.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.312 -0.868 . . . . 1.02 109.137 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.29 -56.76 12.68 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.46 -0.896 . . . . 1.06 111.091 -178.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -69.48 -37.4 77.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 3.05 111.83 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.48 -53.49 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.425 -1.422 . . . . 1.05 110.637 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -61.81 -35.75 79.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.022 -1.049 . . . . 0.15 110.266 -179.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.03 -40.77 90.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.946 -1.096 . . . . 2.56 108.952 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -69.41 -41.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 2.33 108.795 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.5 t80 -60.03 -49.93 75.72 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.048 -0.723 . . . . 0.99 109.048 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.77 96.28 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.476 -0.765 . . . . 1.03 109.362 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.46 -40.74 97.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 1.97 109.554 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.99 -25.7 67.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 1.29 109.271 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.2 m-20 -97.9 9.08 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.74 108.741 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.43 37.63 94.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.332 -1.107 . . . . 0.72 110.332 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.75 129.81 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.22 -1.165 . . . . 1.1 110.403 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 89.5 m-20 -111.65 -96.2 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.012 -1.107 . . . . 1.33 108.012 178.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.71 166.27 4.16 Favored Glycine 0 N--CA 1.491 2.351 0 CA-C-O 122.156 0.865 . . . . 0.29 112.27 177.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.52 138.6 39.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.361 -1.348 . . . . 2.07 107.361 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -100.22 135.76 41.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.119 -0.988 . . . . 0.15 110.91 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.4 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.005 -1.109 . . . . 1.11 108.005 179.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -135.32 134.97 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.233 -0.917 . . . . 0.9 110.693 -177.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.28 110.0 20.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.677 -0.86 . . . . 0.24 108.677 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -65.61 -31.7 72.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.16 110.363 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.56 -40.0 88.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 1.1 110.756 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.7 p -105.06 -0.41 26.76 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 1.14 110.469 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 50.02 40.34 21.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.888 -1.132 . . . . 2.63 108.068 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.02 54.51 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.645 0.736 . . . . 1.05 110.137 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -98.67 139.96 33.59 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.118 -1.438 . . . . 0.11 107.118 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.2 m -129.43 131.25 46.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.764 -1.21 . . . . 1.03 108.417 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.7 p -120.22 128.93 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.934 -1.136 . . . . 1.02 107.934 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -119.92 125.72 49.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 1.05 109.757 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.999 -1.0 . . . . 1.95 109.516 -179.691 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.388 -0.597 . . . . 1.04 109.388 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.581 ' HH ' ' N ' ' A' ' 23' ' ' ALA . 91.5 m-85 -117.93 148.69 41.92 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.772 -0.825 . . . . 0.89 108.772 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -117.07 145.28 43.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 2.47 109.324 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -119.45 127.53 53.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.547 -0.908 . . . . 1.01 108.547 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.09 121.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.023 -1.473 . . . . 1.15 107.023 178.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.8 mt -102.55 116.81 33.35 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 1.06 110.308 -178.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.0 68.29 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.509 -1.293 . . . . 0.19 107.509 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.5 171.55 54.13 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.505 -1.438 . . . . 0.24 109.505 179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -66.26 -39.86 89.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -1.128 . . . . 3.13 108.148 178.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.1 p -120.01 -20.09 7.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.999 -0.438 . . . . 1.43 109.848 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.8 tp -99.98 120.07 39.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 1.23 109.415 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -136.47 130.61 32.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 2.49 109.833 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.57 -173.62 46.42 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.392 -1.385 . . . . 0.3 110.905 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.521 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 46.4 mp0 -144.34 153.55 42.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.982 . . . . 1.68 108.958 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -153.17 168.54 25.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 1.09 109.446 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 p -139.36 159.78 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.863 . . . . 1.07 109.167 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -156.74 164.24 38.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.953 -0.758 . . . . 0.99 108.953 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -103.37 133.98 47.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.379 -0.826 . . . . 2.22 109.01 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.14 143.39 28.22 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.6 -0.889 . . . . 1.07 108.6 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -59.94 -29.61 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 1.15 109.535 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -157.74 175.19 14.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 1.16 110.022 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.581 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -66.94 -38.13 85.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.552 -0.717 . . . . 1.05 109.871 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.24 -36.58 61.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.112 . . . . 1.09 109.912 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 p -73.43 -33.47 64.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.608 -1.307 . . . . 1.12 109.732 178.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.18 81.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.237 -1.023 . . . . 1.02 108.237 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.01 -44.93 83.31 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.823 -1.151 . . . . 1.06 109.558 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.7 -42.72 85.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.882 -1.136 . . . . 3.05 110.579 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.63 -52.0 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 1.05 111.243 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.67 -40.03 88.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.025 -1.047 . . . . 0.15 111.269 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -63.51 -41.28 98.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.503 -1.373 . . . . 2.56 109.997 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -70.0 -45.68 66.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.879 -1.138 . . . . 2.33 108.939 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.545 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 72.9 t80 -60.02 -47.98 83.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.495 -0.753 . . . . 0.99 109.453 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.59 98.64 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.478 -0.764 . . . . 1.03 109.474 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.95 -40.49 89.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.392 -0.818 . . . . 1.97 108.974 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -65.08 -19.26 65.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.784 -0.821 . . . . 1.29 108.784 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.545 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 97.4 m-20 -94.68 6.7 48.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.74 109.788 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.2 30.25 63.17 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.9 -1.143 . . . . 0.72 111.153 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.02 124.26 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.901 -1.352 . . . . 1.1 108.527 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 27.7 p-10 -150.58 99.61 2.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 1.33 110.593 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.2 -125.48 0.86 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.174 -1.489 . . . . 0.29 111.317 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.79 130.3 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.898 -1.354 . . . . 2.07 110.851 -178.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -107.23 139.59 41.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 0.15 110.27 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.5 p -137.77 150.02 46.9 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.419 -0.956 . . . . 1.11 108.419 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CE1' ' CE1' ' A' ' 52' ' ' PHE . 48.9 t80 -137.79 137.75 38.53 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.175 -0.953 . . . . 0.9 110.337 -179.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.719 -0.845 . . . . 0.24 108.719 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.51 -31.05 71.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.346 -0.846 . . . . 1.16 110.928 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.9 94.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 1.1 110.537 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -103.55 0.04 30.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.381 -0.824 . . . . 1.14 110.383 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.499 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 20.4 mtpp 49.91 40.12 20.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.11 . . . . 2.63 108.255 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -120.1 131.12 54.95 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.498 0.666 . . . . 1.05 110.14 -178.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 54.3 m-85 -99.96 138.83 36.49 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.447 -1.316 . . . . 0.11 107.447 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.7 m -130.06 131.55 45.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 1.03 108.709 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.5 p -121.67 127.68 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.577 -0.898 . . . . 1.02 108.577 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -125.47 127.51 46.6 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.532 -0.73 . . . . 1.05 109.803 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.019 -0.991 . . . . 1.95 109.289 179.811 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.176 0.512 . . . . 1.04 109.776 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.456 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 95.8 m-85 -114.31 141.93 46.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.691 -0.855 . . . . 0.89 108.691 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.7 140.17 48.47 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.733 -0.84 . . . . 2.47 108.733 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.6 tp -120.06 128.76 53.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.347 -0.846 . . . . 1.01 109.516 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -104.96 122.38 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.208 -1.404 . . . . 1.15 107.208 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.74 115.45 30.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -0.987 . . . . 1.06 110.282 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -118.75 72.37 0.88 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.826 -1.176 . . . . 0.19 107.826 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 171.06 54.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.351 -1.5 . . . . 0.24 109.351 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.66 -39.85 94.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.05 -1.265 . . . . 3.13 108.173 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -124.67 -16.1 6.34 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.204 -0.665 . . . . 1.43 109.204 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 9' ' ' GLY . 60.1 tp -99.8 118.04 35.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.323 -0.86 . . . . 1.23 108.794 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -135.83 133.78 38.18 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 2.49 109.916 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.54 -176.21 47.86 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.495 -1.336 . . . . 0.3 110.403 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -145.03 151.61 38.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.505 -0.924 . . . . 1.68 108.505 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -152.62 170.16 20.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 1.09 109.422 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -137.74 159.88 40.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -0.771 . . . . 1.07 109.196 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 t -156.97 162.27 39.6 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.368 -0.832 . . . . 0.99 108.796 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -106.58 136.6 46.08 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.778 -0.823 . . . . 2.22 108.778 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.91 148.52 29.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 1.07 109.39 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.9 -33.35 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.392 -0.817 . . . . 1.15 110.086 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -159.85 179.98 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 1.16 110.088 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.456 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -66.74 -40.03 88.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.534 -0.728 . . . . 1.05 110.469 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -37.56 63.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.873 -1.142 . . . . 1.09 110.228 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.4 m -69.99 -39.98 75.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.673 -1.267 . . . . 1.12 110.148 179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.05 88.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.803 . . . . 1.02 109.09 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.97 -46.37 82.24 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.769 -1.172 . . . . 1.06 109.57 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -67.39 -44.11 79.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.435 -0.79 . . . . 3.05 110.67 -179.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.37 -53.11 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 1.05 110.99 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -63.62 -38.76 92.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.935 -1.103 . . . . 0.15 110.4 -179.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -60.07 -45.13 93.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.856 -1.153 . . . . 2.56 109.999 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -69.07 -42.1 76.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.025 -1.047 . . . . 2.33 109.1 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.615 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -59.98 -44.65 94.36 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.717 -0.846 . . . . 0.99 108.717 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.58 -43.6 96.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 1.03 109.013 179.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -60.28 -42.39 95.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.24 -0.913 . . . . 1.97 108.814 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.9 -25.26 67.46 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.398 -0.814 . . . . 1.29 109.344 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.615 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 94.2 m-20 -100.13 8.94 43.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.392 -0.817 . . . . 0.74 109.419 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.99 36.2 92.79 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.225 -1.15 . . . . 0.72 110.225 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.13 124.79 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.196 -1.179 . . . . 1.1 109.974 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 80.2 m-20 -110.62 -98.74 0.4 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.07 -1.085 . . . . 1.33 108.07 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.29 165.97 2.73 Favored Glycine 0 N--CA 1.488 2.121 0 CA-C-O 122.146 0.859 . . . . 0.29 112.134 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -77.79 135.49 37.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.067 -1.457 . . . . 2.07 107.067 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -98.58 135.66 39.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.125 -0.985 . . . . 0.15 110.66 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.6 p -132.77 148.24 52.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.747 -1.205 . . . . 1.11 107.747 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 55.5 t80 -135.07 135.63 41.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.261 -0.899 . . . . 0.9 110.372 -178.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -113.03 110.05 19.84 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.607 -0.886 . . . . 0.24 108.607 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.7 t0 -68.0 -30.27 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.16 110.348 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.29 93.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 1.1 110.058 -179.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -107.85 0.08 21.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.476 -0.765 . . . . 1.14 110.106 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 49.98 43.52 25.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.928 -1.107 . . . . 2.63 108.581 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.81 130.23 54.82 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.592 0.71 . . . . 1.05 110.473 -178.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.527 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.9 m-85 -101.37 139.91 36.39 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.231 -1.396 . . . . 0.11 107.231 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.0 m -132.83 134.01 44.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.786 -1.196 . . . . 1.03 108.756 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -122.81 129.8 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.608 -0.886 . . . . 1.02 108.608 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -122.67 126.81 48.36 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.415 -0.803 . . . . 1.05 110.654 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.94 -1.028 . . . . 1.95 109.482 179.038 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.6 m . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.18 -0.674 . . . . 1.04 109.18 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.565 ' HH ' ' N ' ' A' ' 23' ' ' ALA . 94.3 m-85 -114.73 148.85 37.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.463 -0.773 . . . . 0.89 109.047 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -118.75 142.44 47.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.406 -0.808 . . . . 2.47 109.228 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.9 tp -120.84 129.43 53.54 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.483 -0.76 . . . . 1.01 109.279 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 6' ' ' ILE . 31.8 mm -106.58 123.08 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.404 -1.332 . . . . 1.15 107.404 179.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.47 115.2 30.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.242 -0.911 . . . . 1.06 110.412 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -117.57 70.15 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.352 -1.351 . . . . 0.19 107.352 178.115 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.78 54.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.977 -1.249 . . . . 0.24 109.977 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.2 -39.8 93.33 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -1.1 . . . . 3.13 108.333 178.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -15.62 6.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.947 -0.471 . . . . 1.43 109.778 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.9 tp -100.01 120.04 39.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.095 -1.003 . . . . 1.23 109.517 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -131.89 127.06 35.67 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.331 -0.856 . . . . 2.49 109.364 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.99 -177.9 48.26 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.178 -1.487 . . . . 0.3 110.676 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -148.31 156.89 43.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.625 -0.926 . . . . 1.68 109.179 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.429 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 5.6 t -154.21 170.52 21.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.347 -0.845 . . . . 1.09 109.629 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.9 p -137.98 160.02 40.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.385 -0.822 . . . . 1.07 109.415 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 t -155.08 160.52 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.99 109.239 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -104.36 133.55 49.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.344 -0.848 . . . . 2.22 108.757 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.95 146.07 27.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.006 -1.059 . . . . 1.07 109.637 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.61 -30.15 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.389 -0.819 . . . . 1.15 109.975 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' C ' ' HH ' ' A' ' 3' ' ' TYR . 42.7 p-10 -158.5 174.91 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 1.16 110.163 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.565 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -68.83 -38.17 79.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.553 -0.717 . . . . 1.05 110.372 -179.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.94 -37.82 61.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.793 -1.192 . . . . 1.09 110.092 -179.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 p -74.14 -33.06 63.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.637 -1.289 . . . . 1.12 109.685 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.18 93.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.406 -0.809 . . . . 1.02 108.934 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.67 -46.28 84.45 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.838 -1.145 . . . . 1.06 109.637 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -67.13 -40.09 86.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 3.05 110.304 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.47 -53.17 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.972 . . . . 1.05 110.673 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -63.99 -38.07 89.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.15 110.551 -178.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -59.93 -40.16 87.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.624 -1.298 . . . . 2.56 109.126 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -69.38 -41.77 76.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.125 -0.984 . . . . 2.33 109.042 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 59.3 t80 -60.03 -46.6 88.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.99 109.576 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.97 95.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 1.03 109.308 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -40.66 90.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.148 -0.97 . . . . 1.97 108.976 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -64.51 -26.12 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.284 -0.885 . . . . 1.29 109.984 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.627 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 69.6 m-80 -99.75 4.99 45.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.017 -1.052 . . . . 0.74 110.103 -179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.4 60.82 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.034 -1.079 . . . . 0.72 111.599 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.3 t -110.67 122.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.892 -1.357 . . . . 1.1 108.39 178.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 71.1 m-20 -150.6 101.04 2.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 1.33 110.659 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.36 -131.84 1.49 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 119.297 -1.43 . . . . 0.29 111.083 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 57.8 mp0 -88.81 128.11 35.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.952 -1.322 . . . . 2.07 110.164 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -104.11 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.692 -0.63 . . . . 0.15 109.999 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.9 p -131.49 147.19 52.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.93 -1.137 . . . . 1.11 107.93 178.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 53.7 t80 -133.25 132.36 41.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.338 -0.851 . . . . 0.9 110.207 -178.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -114.65 109.94 18.99 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.381 -0.97 . . . . 0.24 108.381 178.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -69.51 -27.67 65.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 1.16 110.267 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.92 95.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 1.1 109.926 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.9 p -106.02 0.18 25.43 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.546 -0.721 . . . . 1.14 110.036 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtpm? 50.02 39.96 20.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.882 -1.136 . . . . 2.63 108.289 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -120.01 132.87 55.63 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 1.05 110.593 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 56.3 m-85 -100.36 139.67 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.252 -1.388 . . . . 0.11 107.252 177.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 m -130.24 131.97 45.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.763 -1.21 . . . . 1.03 108.339 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.83 129.25 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.34 -0.985 . . . . 1.02 108.34 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -124.56 128.19 48.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.621 -0.674 . . . . 1.05 110.115 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.038 -0.982 . . . . 1.95 109.296 179.8 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.6 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.325 -0.62 . . . . 1.04 109.325 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -112.35 145.37 40.18 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.366 -0.976 . . . . 0.89 108.366 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -113.43 139.97 48.47 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.124 -0.985 . . . . 2.47 108.8 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.4 tp -120.91 126.6 50.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.754 -0.832 . . . . 1.01 108.754 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.62 124.01 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.61 -1.256 . . . . 1.15 107.61 178.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.0 mt -104.24 114.13 28.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 1.06 110.231 -179.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -113.5 72.46 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.395 -1.335 . . . . 0.19 107.395 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.55 169.46 53.53 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.665 -1.374 . . . . 0.24 109.665 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -64.87 -38.51 91.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -1.129 . . . . 3.13 108.517 178.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 p -130.62 -16.58 3.37 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.527 -0.546 . . . . 1.43 109.527 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -101.76 117.36 34.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.249 -1.019 . . . . 1.23 108.249 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -133.71 137.87 45.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.207 -0.933 . . . . 2.49 110.416 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -180.0 -178.25 48.43 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.688 -1.244 . . . . 0.3 110.194 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.56 154.71 41.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.507 -0.923 . . . . 1.68 108.507 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -154.63 170.7 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.842 . . . . 1.09 109.502 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -138.32 160.03 40.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.919 -0.771 . . . . 1.07 108.919 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 t -156.7 161.42 39.85 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.273 -0.892 . . . . 0.99 109.239 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -102.92 134.97 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.696 -0.853 . . . . 2.22 108.696 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.61 144.87 27.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 1.07 108.912 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.03 -30.58 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 1.15 109.467 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -159.73 178.51 9.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 1.16 110.02 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.76 -37.92 82.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.456 -0.777 . . . . 1.05 110.048 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.51 -37.38 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.965 -1.085 . . . . 1.09 110.136 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.8 m -69.92 -39.19 76.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.634 -1.291 . . . . 1.12 109.66 179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.89 87.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.595 -0.69 . . . . 1.02 109.196 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.97 -45.81 82.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.883 -1.127 . . . . 1.06 109.504 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -67.82 -43.38 79.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 3.05 110.679 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.94 -52.53 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.32 -0.863 . . . . 1.05 111.62 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -64.22 -38.47 91.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.802 -1.186 . . . . 0.15 110.482 -178.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -60.04 -44.07 94.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.84 -1.162 . . . . 2.56 109.692 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.512 ' NE2' ' OD2' ' A' ' 36' ' ' ASP . 1.6 tm0? -67.91 -41.7 82.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 2.33 108.705 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.7 t80 -60.0 -49.02 79.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.622 -0.674 . . . . 0.99 109.503 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.42 93.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 1.03 109.057 179.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -60.17 -44.58 94.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 1.97 109.366 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' NE2' ' A' ' 32' ' ' GLN . 82.3 m-20 -62.72 -24.04 67.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 1.29 109.24 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.623 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.0 m-20 -97.63 7.01 47.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.816 . . . . 0.74 109.667 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.18 31.59 77.93 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.053 -1.07 . . . . 0.72 110.851 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.99 127.41 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.174 -1.192 . . . . 1.1 109.836 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 87.5 m-20 -109.99 -99.82 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.092 -1.077 . . . . 1.33 108.092 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.96 163.51 4.17 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-O 122.028 0.793 . . . . 0.29 112.339 177.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 58.1 mp0 -75.55 137.15 40.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.321 -1.363 . . . . 2.07 107.321 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -99.89 135.0 41.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 0.15 110.927 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.6 p -135.23 150.05 50.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.632 -1.247 . . . . 1.11 107.632 178.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -135.27 138.9 43.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.294 -0.879 . . . . 0.9 110.566 -178.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -113.66 109.99 19.48 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.65 -0.87 . . . . 0.24 108.65 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 36.5 t0 -67.5 -31.39 71.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.16 110.312 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.973 . . . . 1.1 110.573 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -105.4 0.64 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.519 -0.738 . . . . 1.14 110.14 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm 50.58 42.45 26.87 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.855 -1.165 . . . . 2.63 107.855 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -120.0 131.14 55.05 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.719 0.771 . . . . 1.05 110.945 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -99.72 138.21 37.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.115 -1.439 . . . . 0.11 107.115 177.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -130.63 131.95 45.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.662 -1.274 . . . . 1.03 109.076 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -124.23 130.02 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.402 -0.962 . . . . 1.02 108.402 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.91 126.5 51.05 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.664 -0.648 . . . . 1.05 110.181 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.981 -1.009 . . . . 1.95 109.576 -179.901 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.281 0.562 . . . . 1.04 109.929 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.71 148.03 38.84 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.369 -0.975 . . . . 0.89 108.369 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -116.5 140.89 48.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.257 -0.902 . . . . 2.47 109.08 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.7 tp -120.42 129.56 53.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.601 -0.687 . . . . 1.01 109.581 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 6' ' ' ILE . 96.6 mt -106.68 122.76 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.746 -1.576 . . . . 1.15 106.746 177.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.97 116.5 32.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.892 . . . . 1.06 109.679 -178.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -114.87 71.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 0.19 107.601 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.32 168.18 48.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.396 -1.482 . . . . 0.24 109.396 179.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.47 -39.51 77.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.187 -1.184 . . . . 3.13 108.459 178.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -117.82 -22.96 7.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.783 -0.573 . . . . 1.43 109.662 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.8 tp -101.45 120.37 40.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 1.23 109.264 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -134.38 129.9 36.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.957 . . . . 2.49 109.536 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.53 -174.0 46.58 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.369 -1.396 . . . . 0.3 110.391 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -148.56 157.21 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.631 -0.923 . . . . 1.68 108.932 179.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -154.8 170.8 20.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.922 . . . . 1.09 109.664 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.4 p -137.97 160.13 40.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 1.07 109.086 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -156.19 162.95 40.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.384 -0.822 . . . . 0.99 109.061 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -102.31 133.81 46.61 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.677 -0.861 . . . . 2.22 108.677 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.34 143.16 25.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.096 . . . . 1.07 109.525 -179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.79 -29.81 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 1.15 110.051 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -157.93 176.53 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.16 109.915 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.34 -37.58 80.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 1.05 109.827 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.82 -37.34 59.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.017 . . . . 1.09 109.94 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 p -73.31 -34.5 65.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.692 -1.255 . . . . 1.12 109.388 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.35 93.18 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.35 -50.05 74.18 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.634 -1.226 . . . . 1.06 109.754 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -65.88 -41.43 91.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 3.05 110.141 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.88 -55.35 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.1 -1.0 . . . . 1.05 110.259 -178.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -65.12 -39.75 93.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.15 110.298 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -60.53 -44.06 96.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 2.56 109.637 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -69.23 -42.78 75.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.968 -1.082 . . . . 2.33 108.797 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 77.2 t80 -60.02 -45.92 91.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.463 -0.773 . . . . 0.99 109.18 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.24 95.95 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.507 -0.746 . . . . 1.03 109.016 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -61.32 -40.93 96.03 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 1.97 109.192 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.86 -25.1 66.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 1.29 109.513 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 92.9 m-20 -97.9 9.99 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 0.74 109.881 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.15 92.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.835 -1.306 . . . . 0.72 109.835 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.99 125.54 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.287 -1.125 . . . . 1.1 109.482 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 21.3 p-10 -141.76 148.5 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.214 -1.032 . . . . 1.33 108.214 179.017 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.43 -147.75 10.92 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.219 -1.467 . . . . 0.29 110.053 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -93.14 131.32 38.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 2.07 108.445 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -100.71 137.4 39.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 0.15 110.098 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.0 p -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.446 -0.946 . . . . 1.11 108.446 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 59.3 t80 -134.09 136.39 43.89 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.408 -0.808 . . . . 0.9 110.162 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -112.16 109.27 18.87 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.314 -0.995 . . . . 0.24 108.314 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.17 -31.2 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.973 . . . . 1.16 110.287 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.04 90.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 1.1 110.318 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.435 ' C ' ' HZ1' ' A' ' 50' ' ' LYS . 80.3 p -104.98 -0.76 26.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.251 -0.905 . . . . 1.14 110.011 -179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.435 ' HZ1' ' C ' ' A' ' 49' ' ' THR . 0.0 OUTLIER 50.06 40.77 22.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 2.63 108.362 -179.755 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.58 54.86 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.616 0.722 . . . . 1.05 110.141 -178.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 33.3 m-85 -98.75 138.32 36.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 0.11 106.999 178.278 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -131.99 132.21 43.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.878 -1.139 . . . . 1.03 108.139 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.18 132.15 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.481 -0.933 . . . . 1.02 108.481 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.7 m -119.1 126.38 51.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.608 -0.683 . . . . 1.05 109.631 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.055 -0.974 . . . . 1.95 109.584 -179.36 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.218 -0.66 . . . . 1.04 109.218 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.72 147.7 40.6 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.771 -0.826 . . . . 0.89 108.771 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -117.29 143.8 45.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.405 -0.809 . . . . 2.47 109.651 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.8 tp -119.58 126.61 51.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.591 -0.892 . . . . 1.01 108.591 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.55 122.79 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.194 -1.41 . . . . 1.15 107.194 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.4 mt -100.3 117.14 33.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 1.06 110.265 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -122.2 66.55 0.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.334 -1.358 . . . . 0.19 107.334 178.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.33 169.87 53.04 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 0.24 109.794 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.554 ' CB ' ' HZ2' ' A' ' 10' ' ' LYS . 7.6 ttpm? -63.61 -39.88 95.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.272 -1.134 . . . . 3.13 108.582 177.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.09 -19.92 6.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.955 -0.466 . . . . 1.43 109.896 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.37 119.98 38.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.228 -0.92 . . . . 1.23 109.401 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -135.14 129.99 34.73 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.268 -0.895 . . . . 2.49 109.832 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.61 -177.38 48.42 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.338 -1.411 . . . . 0.3 110.584 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -142.52 151.14 41.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.607 -0.937 . . . . 1.68 108.676 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -152.72 167.37 29.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 1.09 109.241 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.7 p -137.67 160.19 39.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 1.07 109.502 -179.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 t -153.77 159.94 42.09 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.672 -0.862 . . . . 0.99 108.672 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -101.43 131.95 47.28 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.45 -0.944 . . . . 2.22 108.45 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.17 142.75 27.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 1.07 109.22 -179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.06 -28.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -0.778 . . . . 1.15 109.877 -179.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -158.43 174.72 14.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 1.16 110.099 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.09 82.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.548 -0.72 . . . . 1.05 110.061 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.02 54.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.912 -1.117 . . . . 1.09 109.728 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.8 p -72.41 -34.86 68.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.775 -1.203 . . . . 1.12 109.459 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.89 94.05 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.617 -0.883 . . . . 1.02 108.617 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.11 -49.88 74.54 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.934 -1.107 . . . . 1.06 109.914 -179.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -66.85 -40.61 87.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.866 -1.146 . . . . 3.05 110.762 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.86 -53.6 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.949 -1.095 . . . . 1.05 110.891 -178.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -62.75 -37.33 86.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.907 -1.121 . . . . 0.15 110.211 -178.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -61.46 -40.52 94.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.875 -1.14 . . . . 2.56 109.338 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.84 -43.3 72.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.818 -1.176 . . . . 2.33 108.31 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.562 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 63.8 t80 -59.99 -49.49 77.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.662 -0.866 . . . . 0.99 108.662 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.63 93.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.575 -0.703 . . . . 1.03 109.417 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -60.05 -41.17 91.73 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.829 -0.804 . . . . 1.97 108.829 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.94 -23.1 67.23 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.352 -0.843 . . . . 1.29 109.112 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.562 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 81.2 m-20 -97.11 8.39 44.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.74 109.974 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.04 32.32 69.49 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.942 -1.123 . . . . 0.72 111.004 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.8 t -109.99 124.92 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.996 -1.297 . . . . 1.1 109.089 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 32.7 p-10 -152.23 100.67 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.062 -1.024 . . . . 1.33 110.34 179.21 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 -130.19 1.37 Allowed Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.204 -1.474 . . . . 0.29 111.044 -178.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -89.94 125.2 35.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.916 -1.344 . . . . 2.07 110.359 -178.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -102.53 136.54 42.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.15 110.115 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -136.19 149.58 48.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.982 -1.118 . . . . 1.11 107.982 178.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -137.47 136.22 37.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.239 -0.913 . . . . 0.9 109.958 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -114.52 111.25 21.09 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.854 -0.795 . . . . 0.24 108.854 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 49.5 t0 -67.37 -28.84 68.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 1.16 110.234 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.12 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 1.1 110.376 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 p -105.95 -0.04 25.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 1.14 109.765 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 50.03 41.44 23.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 2.63 108.42 -179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.98 133.2 55.62 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.571 0.7 . . . . 1.05 110.366 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.0 139.43 36.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.393 -1.336 . . . . 0.11 107.393 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.2 m -130.04 131.86 45.98 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.759 -1.213 . . . . 1.03 108.476 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.62 129.15 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.61 -0.885 . . . . 1.02 108.61 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -124.01 129.94 51.76 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.471 0.653 . . . . 1.05 110.272 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.029 -0.986 . . . . 1.95 109.48 -179.7 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.446 -0.576 . . . . 1.04 109.446 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.94 147.58 43.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.722 -0.844 . . . . 0.89 108.722 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -118.24 143.61 46.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 2.47 109.441 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.23 130.0 55.24 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.103 -0.703 . . . . 1.01 109.103 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 122.58 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.919 -1.512 . . . . 1.15 106.919 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -103.2 116.73 33.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 1.06 110.543 -178.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -116.96 69.38 0.75 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.732 -1.21 . . . . 0.19 107.732 178.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 168.6 47.71 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.529 -1.429 . . . . 0.24 109.529 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.73 -38.91 84.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 3.13 109.172 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.3 p -117.2 -21.0 9.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.62 -0.675 . . . . 1.43 110.056 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -106.8 120.0 40.83 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.35 -0.844 . . . . 1.23 109.45 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.57 133.61 42.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 2.49 109.055 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.48 -170.28 43.38 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.075 -1.536 . . . . 0.3 110.644 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.85 155.89 42.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.661 -0.906 . . . . 1.68 108.98 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -151.87 169.28 22.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.468 -0.77 . . . . 1.09 109.291 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.9 p -138.86 159.69 41.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.258 -0.901 . . . . 1.07 109.544 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 t -156.38 160.81 39.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.977 -0.749 . . . . 0.99 108.977 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.97 134.05 44.54 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.543 -0.91 . . . . 2.22 108.543 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.3 139.18 24.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.055 -1.028 . . . . 1.07 109.23 -179.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.91 -26.7 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 1.15 109.495 -179.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 25' ' ' THR . 45.4 p-10 -157.12 170.72 21.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.16 109.734 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.7 83.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.546 -0.721 . . . . 1.05 110.105 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.55 -36.47 61.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.892 -1.13 . . . . 1.09 110.016 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 22' ' ' ASP . 11.8 p -73.7 -34.81 65.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.627 -1.296 . . . . 1.12 109.564 178.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.09 92.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.384 -0.822 . . . . 1.02 109.05 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.26 -44.62 79.88 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.679 -1.209 . . . . 1.06 109.131 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' NZ ' ' CB ' ' A' ' 28' ' ' LYS . 8.6 mtpm? -67.23 -41.64 85.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.319 -0.863 . . . . 3.05 110.573 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.59 -51.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 1.05 110.503 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -67.46 -39.92 85.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.944 -1.098 . . . . 0.15 110.736 -179.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -61.96 -42.37 99.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.725 -1.234 . . . . 2.56 109.612 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -69.14 -41.8 76.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.112 -0.993 . . . . 2.33 108.441 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.564 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.6 t80 -60.05 -48.41 81.83 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.569 0.7 . . . . 0.99 109.175 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.53 97.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.579 -0.701 . . . . 1.03 109.31 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.06 -41.77 93.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.834 . . . . 1.97 109.011 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.83 -25.13 67.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 1.29 109.757 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.564 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.2 m-20 -96.79 10.02 40.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.139 -0.976 . . . . 0.74 110.189 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.62 34.04 87.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.975 -1.25 . . . . 0.72 109.975 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.89 126.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.242 -1.152 . . . . 1.1 109.498 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -142.63 150.12 39.84 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 1.33 108.806 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.77 -148.16 12.07 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 118.746 -1.692 . . . . 0.29 110.489 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -90.99 129.42 37.0 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.358 -0.979 . . . . 2.07 108.358 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.32 137.11 39.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.15 110.025 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -134.45 149.49 50.75 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.133 -1.062 . . . . 1.11 108.133 179.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.416 ' CD1' ' CE1' ' A' ' 52' ' ' PHE . 43.2 t80 -132.78 134.59 44.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.303 -0.873 . . . . 0.9 110.228 -178.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -112.81 109.85 19.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.801 -0.814 . . . . 0.24 108.801 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.6 -31.03 69.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.923 . . . . 1.16 110.513 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.95 94.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 1.1 110.437 -179.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -106.91 0.85 24.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.455 -0.778 . . . . 1.14 110.43 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 50.18 40.11 21.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.909 -1.119 . . . . 2.63 108.435 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 130.87 54.95 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.536 0.684 . . . . 1.05 110.648 -178.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CE1' ' CD1' ' A' ' 45' ' ' TYR . 68.6 m-85 -99.65 141.11 32.88 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.628 -1.249 . . . . 0.11 107.628 178.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 m -130.48 131.39 45.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.807 -1.183 . . . . 1.03 108.451 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.37 130.3 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.365 -0.976 . . . . 1.02 108.365 179.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.4 m -119.97 126.28 50.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.498 -0.752 . . . . 1.05 109.778 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.973 -1.013 . . . . 1.95 109.546 -179.863 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.233 -0.655 . . . . 1.04 109.233 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.459 ' HH ' ' N ' ' A' ' 23' ' ' ALA . 95.8 m-85 -114.95 146.54 41.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.537 -0.912 . . . . 0.89 108.537 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -117.36 140.81 49.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.748 -0.834 . . . . 2.47 108.748 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 tp -118.92 129.31 55.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.842 -0.799 . . . . 1.01 108.842 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.9 mt -106.17 122.39 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.487 -1.301 . . . . 1.15 107.487 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.37 112.88 25.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 1.06 109.185 -179.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.67 71.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.687 -1.227 . . . . 0.19 107.687 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.09 165.57 43.51 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.492 -1.443 . . . . 0.24 109.492 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' NZ ' ' C ' ' A' ' 56' ' ' GLU . 10.5 mptt -68.07 -35.29 77.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.192 -1.181 . . . . 3.13 107.872 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -117.67 -25.55 6.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.746 -0.596 . . . . 1.43 110.077 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 tp -101.56 122.2 43.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.151 -0.968 . . . . 1.23 109.733 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -136.48 130.74 33.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.225 -0.922 . . . . 2.49 109.618 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.62 -172.72 45.69 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.531 -1.319 . . . . 0.3 110.499 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.11 156.28 42.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.598 -0.942 . . . . 1.68 109.285 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -153.15 170.66 19.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 1.09 109.247 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.7 p -137.84 159.95 40.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.329 -0.857 . . . . 1.07 109.397 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -156.25 160.17 39.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.99 109.624 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.78 134.31 47.3 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.251 -1.018 . . . . 2.22 108.251 179.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.01 144.2 26.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 1.07 109.417 -179.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -60.31 -31.11 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 1.15 109.859 -179.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -158.81 176.47 12.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 1.16 110.175 -179.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.459 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -67.58 -38.85 84.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 1.05 109.723 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.79 -38.05 64.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 1.09 109.772 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m -70.02 -39.8 75.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.665 -1.272 . . . . 1.12 109.994 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.501 -0.749 . . . . 1.02 109.301 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -57.88 -40.99 81.58 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.458 -1.297 . . . . 1.06 109.088 -179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -69.89 -43.32 72.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 3.05 109.864 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.94 -52.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 1.05 111.072 -178.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -62.86 -39.35 94.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.15 110.286 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -60.59 -44.54 96.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.75 -1.218 . . . . 2.56 109.604 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.96 -45.06 78.9 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.113 -0.992 . . . . 2.33 108.424 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.8 t80 -59.96 -48.89 79.86 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.63 -0.669 . . . . 0.99 109.262 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.36 96.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 1.03 109.274 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.0 -41.56 92.38 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.384 -0.969 . . . . 1.97 108.384 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.4 -22.56 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.4 -0.813 . . . . 1.29 109.006 179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.8 m-20 -96.71 9.43 41.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.74 109.703 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 33.51 87.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.836 -1.306 . . . . 0.72 109.836 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.95 130.01 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.412 -1.052 . . . . 1.1 110.214 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 71.9 m-20 -111.61 -95.03 0.43 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.525 -1.287 . . . . 1.33 107.525 178.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.91 164.42 3.5 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.486 -0.759 . . . . 0.29 111.962 177.202 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 56.1 mp0 -75.43 137.69 41.16 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.107 -1.442 . . . . 2.07 107.107 178.208 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -100.07 135.26 41.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.15 110.829 -178.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -136.67 150.57 48.56 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.11 -1.07 . . . . 1.11 108.11 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -135.77 137.89 42.09 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.174 -0.954 . . . . 0.9 110.609 -178.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -112.8 110.05 19.92 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.947 -0.76 . . . . 0.24 108.947 179.345 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 42.2 t0 -66.7 -32.71 74.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 1.16 110.47 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.95 95.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.031 -1.043 . . . . 1.1 110.315 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -106.76 -0.13 23.73 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.423 -0.798 . . . . 1.14 110.557 -179.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 49.51 41.23 20.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.838 -1.164 . . . . 2.63 108.697 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.01 130.64 55.78 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.612 0.72 . . . . 1.05 110.13 -178.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -98.81 138.66 35.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.369 -1.345 . . . . 0.11 107.369 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -130.56 131.74 45.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.77 -1.206 . . . . 1.03 108.391 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.178 -1.045 . . . . 1.02 108.178 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.66 126.57 51.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.507 -0.745 . . . . 1.05 110.123 -179.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' C ' ' NZ ' ' A' ' 10' ' ' LYS . 54.5 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.849 -1.072 . . . . 1.95 109.118 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 108.72 -0.844 . . . . 1.04 108.72 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -114.8 143.12 45.59 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.74 -0.837 . . . . 0.89 108.74 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -115.7 140.33 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.854 -0.795 . . . . 2.47 108.854 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 43.1 tp -117.7 127.81 54.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.747 -0.834 . . . . 1.01 108.747 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.29 121.86 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.692 -1.596 . . . . 1.15 106.692 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -100.02 110.52 22.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.036 -1.04 . . . . 1.06 108.966 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -114.07 68.33 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.649 -1.612 . . . . 0.19 106.649 178.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 171.03 54.75 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.679 -1.368 . . . . 0.24 109.679 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.66 -39.42 94.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.023 -1.103 . . . . 3.13 108.023 178.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 p -125.05 -13.96 6.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.177 -0.465 . . . . 1.43 109.787 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.5 tp -98.13 119.96 37.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.156 -0.965 . . . . 1.23 109.043 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -133.29 126.54 31.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.351 -0.843 . . . . 2.49 109.427 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -176.22 47.88 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.559 -1.305 . . . . 0.3 110.243 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.52 156.4 42.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.714 -0.874 . . . . 1.68 108.669 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -154.93 170.72 21.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.365 -0.834 . . . . 1.09 109.632 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.9 p -136.81 158.9 43.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 1.07 109.235 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 t -154.73 160.23 41.2 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.486 -0.931 . . . . 0.99 108.486 179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.94 133.56 48.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 2.22 109.467 -179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.05 143.1 25.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.942 . . . . 1.07 108.825 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.55 -26.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 1.15 109.859 -179.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -159.49 176.31 12.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.056 -1.028 . . . . 1.16 109.87 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.31 80.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.521 -0.737 . . . . 1.05 110.095 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.3 63.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.917 -1.114 . . . . 1.09 110.053 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -72.23 -36.16 69.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.536 -1.352 . . . . 1.12 109.862 179.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.07 91.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.748 . . . . 1.02 108.994 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.12 -50.01 72.28 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.897 -1.121 . . . . 1.06 110.024 -178.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -65.15 -40.15 93.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.883 -1.136 . . . . 3.05 110.826 -179.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.0 t -69.94 -54.04 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 1.05 111.586 -178.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -64.03 -39.51 94.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.942 -1.099 . . . . 0.15 111.284 -178.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.76 -40.06 96.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.809 -1.182 . . . . 2.56 109.957 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -69.41 -42.66 74.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.713 -1.242 . . . . 2.33 109.145 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.462 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 65.9 t80 -59.98 -46.01 90.84 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.879 . . . . 0.99 108.628 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.9 97.82 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.855 -0.795 . . . . 1.03 108.855 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -60.08 -44.84 94.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.492 -0.755 . . . . 1.97 109.741 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.32 -23.96 67.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 1.29 109.85 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.462 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 4.4 m120 -96.44 7.48 46.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -0.963 . . . . 0.74 109.554 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.69 31.79 73.69 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.804 -1.189 . . . . 0.72 110.158 179.117 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.43 125.99 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.19 -1.182 . . . . 1.1 109.531 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 57.6 t0 -140.77 146.54 37.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.264 -1.013 . . . . 1.33 108.264 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.63 -153.03 16.52 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.171 -1.49 . . . . 0.29 110.134 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.59 134.35 34.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -1.053 . . . . 2.07 108.442 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -101.48 135.96 42.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 0.15 110.296 -179.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.2 p -135.0 149.11 50.13 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.324 -0.991 . . . . 1.11 108.324 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 69.6 t80 -135.35 136.2 41.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.376 -0.828 . . . . 0.9 110.098 -178.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -112.77 109.97 19.79 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.685 -0.857 . . . . 0.24 108.685 179.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.9 t0 -65.62 -31.34 72.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 1.16 110.47 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.138 -0.976 . . . . 1.1 110.372 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.8 p -106.62 -0.09 24.02 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.337 -0.852 . . . . 1.14 110.559 -179.036 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 50.01 41.25 22.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.745 -1.222 . . . . 2.63 108.361 -179.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.99 130.94 54.99 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.708 0.766 . . . . 1.05 110.391 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 58.7 m-85 -99.62 139.97 34.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.271 -1.381 . . . . 0.11 107.271 178.178 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.0 m -130.43 131.53 45.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.672 -1.268 . . . . 1.03 108.037 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.21 128.97 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.045 -1.094 . . . . 1.02 108.045 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.8 m -119.96 127.97 53.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 1.05 109.984 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.004 -0.998 . . . . 1.95 109.626 -179.316 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 108.917 -0.772 . . . . 1.04 108.917 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.73 150.04 40.44 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.129 -0.693 . . . . 0.89 109.129 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -118.6 143.69 46.63 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.571 -0.706 . . . . 2.47 109.717 -179.031 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.0 tp -119.22 127.45 53.28 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.714 -0.847 . . . . 1.01 108.714 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.25 122.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.945 -1.502 . . . . 1.15 106.945 178.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.0 mt -103.24 111.6 24.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.92 . . . . 1.06 109.873 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.5 71.55 0.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.267 -1.383 . . . . 0.19 107.267 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 165.61 49.33 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.367 -1.493 . . . . 0.24 109.367 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -67.83 -36.86 81.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.218 -1.166 . . . . 3.13 108.421 178.246 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.6 m -120.73 -22.19 6.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.913 -0.492 . . . . 1.43 109.787 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.1 tp -104.69 120.48 41.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.328 -0.858 . . . . 1.23 109.421 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -132.86 133.58 43.49 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.348 -0.845 . . . . 2.49 109.896 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.3 -176.24 47.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.438 -1.363 . . . . 0.3 110.604 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.3 pm0 -147.19 155.67 42.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.719 -0.871 . . . . 1.68 108.969 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 t -154.86 170.25 22.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 1.09 109.675 -179.586 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -134.89 158.3 44.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.483 -0.761 . . . . 1.07 109.031 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -154.46 158.7 40.34 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.65 -0.871 . . . . 0.99 108.65 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 56.6 mp0 -102.58 134.1 46.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.214 -0.929 . . . . 2.22 109.185 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' CB ' ' HG1' ' A' ' 25' ' ' THR . . . -148.19 143.45 27.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.112 -0.992 . . . . 1.07 108.774 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.06 -28.24 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 1.15 109.251 -179.273 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -158.74 176.93 11.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 1.16 109.912 -179.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.5 84.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 1.05 109.879 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.29 -37.72 62.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.04 -1.037 . . . . 1.09 110.212 -179.486 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.4 ' HG1' ' CB ' ' A' ' 20' ' ' ALA . 12.1 p -71.55 -35.94 70.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.546 -1.346 . . . . 1.12 109.59 179.052 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.52 89.76 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.351 -0.843 . . . . 1.02 108.865 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.9 -49.99 74.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.987 -1.085 . . . . 1.06 110.133 -178.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -66.65 -42.53 86.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 3.05 110.623 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.3 t -69.67 -53.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.983 . . . . 1.05 110.713 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -61.03 -37.96 84.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.917 -1.114 . . . . 0.15 109.512 -179.406 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.06 -43.51 95.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 2.56 110.009 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.41 -42.31 79.15 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 2.33 108.677 179.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.596 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -48.69 80.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.99 110.087 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.95 93.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 1.03 109.657 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -61.39 -39.95 92.58 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 1.97 109.202 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -62.28 -24.66 67.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 1.29 109.959 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.596 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 98.5 m-20 -96.35 8.79 43.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.007 . . . . 0.74 110.09 -179.227 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.82 31.71 81.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.441 -1.464 . . . . 0.72 109.441 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.6 t -107.47 126.3 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -1.084 . . . . 1.1 109.302 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -140.11 147.47 40.29 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.093 -1.077 . . . . 1.33 108.093 179.391 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.59 -154.25 19.52 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.227 -1.463 . . . . 0.29 109.943 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 38.4 mp0 -87.76 132.83 34.01 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.217 -1.031 . . . . 2.07 108.217 179.061 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -99.93 135.51 41.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 0.15 110.098 -179.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.2 p -136.73 150.04 48.19 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 1.11 108.523 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 58.7 t80 -133.48 133.63 42.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.412 -0.805 . . . . 0.9 109.812 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -111.21 107.76 17.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.485 -0.931 . . . . 0.24 108.485 179.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.96 -30.67 70.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 1.16 110.045 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.45 98.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 1.1 109.87 -179.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 p -104.74 1.06 28.91 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.48 -0.762 . . . . 1.14 109.887 -179.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.6 mttt 50.03 39.9 20.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 2.63 108.554 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.4 m -120.03 134.35 55.27 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.474 0.654 . . . . 1.05 110.831 -178.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 53.1 m-85 -99.82 139.25 35.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.11 107.271 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -131.29 130.68 43.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.561 -1.337 . . . . 1.03 108.6 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.28 127.69 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.788 -1.189 . . . . 1.02 107.788 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.1 m -120.01 127.13 52.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.452 -0.78 . . . . 1.05 109.728 -179.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.037 -0.982 . . . . 1.95 109.45 -179.682 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 109.641 -0.503 . . . . 1.04 109.641 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -114.96 147.43 40.05 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.869 -0.789 . . . . 0.89 108.869 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -119.73 141.46 49.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.482 -0.761 . . . . 2.47 109.465 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.7 tp -120.65 129.85 53.88 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.915 -0.772 . . . . 1.01 108.915 179.436 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.53 124.83 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.806 -1.183 . . . . 1.15 107.806 178.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.5 mt -102.06 114.58 28.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 1.06 110.012 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.57 68.52 0.7 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.339 -1.356 . . . . 0.19 107.339 178.357 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.99 49.15 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.742 -1.343 . . . . 0.24 109.742 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -67.05 -37.55 84.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.368 -1.078 . . . . 3.13 108.157 178.231 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 m -119.55 -22.9 6.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.939 -0.475 . . . . 1.43 110.104 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 tp -101.59 120.27 40.06 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.18 -0.95 . . . . 1.23 109.649 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -132.12 128.67 38.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.49 109.211 179.335 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.45 -173.88 46.59 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.185 -1.484 . . . . 0.3 110.608 179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.4 pm0 -150.26 159.56 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.625 -0.927 . . . . 1.68 109.442 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.54 ' HG1' ' N ' ' A' ' 17' ' ' THR . 4.3 t -152.62 170.01 21.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.521 -0.737 . . . . 1.09 109.269 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.54 ' N ' ' HG1' ' A' ' 16' ' ' THR . 80.7 p -136.54 158.44 44.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.245 -0.91 . . . . 1.07 109.081 -179.651 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 t -156.55 161.9 39.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.357 -0.839 . . . . 0.99 109.061 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -101.26 132.29 46.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.317 -0.994 . . . . 2.22 108.317 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.48 142.17 26.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 1.07 109.551 -179.5 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.58 -30.36 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 1.15 110.603 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -158.58 179.4 9.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.931 -1.106 . . . . 1.16 110.295 -179.266 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.93 75.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.55 -0.719 . . . . 1.05 110.539 -179.111 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.66 65.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.776 -1.203 . . . . 1.09 109.866 -179.164 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -70.53 -39.95 73.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.741 -1.224 . . . . 1.12 109.846 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.96 92.15 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.532 -0.73 . . . . 1.02 109.258 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.82 -43.22 94.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.745 -1.182 . . . . 1.06 110.105 -179.129 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -69.73 -42.69 73.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.26 -0.9 . . . . 3.05 110.69 -179.24 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.61 -53.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 1.05 111.173 -178.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -60.23 -35.84 76.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.019 -1.051 . . . . 0.15 109.864 -178.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.13 -41.51 92.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.897 -1.127 . . . . 2.56 108.915 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -68.47 -44.82 73.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.094 -1.003 . . . . 2.33 108.755 179.372 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.511 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.1 t80 -60.34 -48.2 82.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.99 109.489 179.673 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.41 97.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 1.03 109.244 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -60.12 -39.94 88.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.229 -0.92 . . . . 1.97 108.538 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.87 -23.81 67.5 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.467 -0.771 . . . . 1.29 109.286 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.511 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 9.8 m120 -96.77 6.31 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.09 -1.006 . . . . 0.74 109.46 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.06 33.23 78.4 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.864 -1.16 . . . . 0.72 110.259 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.0 t -111.16 125.38 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.091 -1.241 . . . . 1.1 108.918 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 69.6 m-20 -152.25 103.62 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.984 -1.073 . . . . 1.33 110.993 179.737 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.03 -130.13 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.557 -1.306 . . . . 0.29 110.907 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 42.2 mp0 -93.99 130.98 39.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.937 -1.331 . . . . 2.07 110.141 -178.516 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -104.09 139.3 39.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.672 -0.643 . . . . 0.15 110.244 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 p -134.31 147.77 50.65 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.963 -1.125 . . . . 1.11 107.963 178.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 60.3 t80 -135.84 135.16 39.57 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.188 -0.945 . . . . 0.9 110.211 -178.685 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -112.97 110.28 20.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.921 -0.77 . . . . 0.24 108.921 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 63.5 t0 -65.06 -31.83 73.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 1.16 110.528 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.99 92.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 1.1 110.616 -179.185 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -104.81 -0.69 26.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 1.14 110.554 -179.04 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 50.02 40.02 20.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.817 -1.177 . . . . 2.63 108.156 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.9 m -120.02 131.2 55.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.672 0.749 . . . . 1.05 110.282 -178.2 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m-85 -98.62 138.9 35.13 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.504 -1.295 . . . . 0.11 107.504 178.435 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -131.77 131.07 42.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.697 -1.252 . . . . 1.03 107.791 179.154 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.02 129.86 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.288 -1.005 . . . . 1.02 108.288 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -121.65 125.85 47.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.569 -0.707 . . . . 1.05 109.729 -179.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 27.1 mp0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.915 -1.04 . . . . 1.95 109.502 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.2 mtt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.434 0.635 . . . . 3.88 109.365 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m -90.7 129.03 36.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 1.05 110.234 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.15 144.34 42.84 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.167 -1.42 . . . . 0.96 107.167 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -115.56 140.03 49.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.37 -0.831 . . . . 2.71 110.358 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.1 tp -120.14 129.98 54.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.723 -0.611 . . . . 1.05 109.67 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.1 mt -107.77 125.21 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.632 -1.247 . . . . 1.37 107.632 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.8 mt -103.87 115.44 30.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.255 -0.903 . . . . 1.06 111.03 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -111.59 59.78 0.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.53 -0.915 . . . . 2.48 108.53 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.98 165.48 53.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.23 -1.548 . . . . 0.22 109.23 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -63.75 -39.98 95.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.881 -1.364 . . . . 3.22 108.221 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -118.5 -20.01 8.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.11 -0.7 . . . . 2.04 109.11 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.7 tp -98.23 118.19 34.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.518 -0.739 . . . . 1.21 109.223 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.83 126.8 35.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.287 -1.005 . . . . 2.64 108.287 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.84 -177.96 48.34 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 118.988 -1.577 . . . . 0.24 109.921 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -148.07 157.67 43.64 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.455 -0.943 . . . . 2.37 108.455 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -156.36 167.48 30.29 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.314 -0.866 . . . . 1.01 108.757 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 p -133.65 161.02 35.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.346 -0.846 . . . . 1.03 109.169 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -156.35 162.29 40.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 1.03 109.112 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.87 135.48 44.46 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.574 -0.899 . . . . 2.75 108.574 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.46 140.78 23.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 1.01 108.601 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.01 -26.42 35.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.364 -0.835 . . . . 1.08 109.806 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -159.94 176.59 11.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 1.09 109.739 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.74 -32.52 72.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 1.05 109.796 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.19 77.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.99 109.961 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.432 ' H ' ' HG1' ' A' ' 25' ' ' THR . 2.4 p -70.15 -35.5 74.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 1.88 109.12 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.02 87.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 1.04 108.8 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.14 -49.82 72.85 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.226 -0.99 . . . . 1.12 109.192 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -63.84 -43.66 95.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.784 -1.197 . . . . 2.95 111.897 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.68 -54.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 1.11 110.503 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -63.8 -39.71 94.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.948 -1.095 . . . . 0.3 110.531 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -60.52 -45.68 92.95 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.375 -0.828 . . . . 3.33 109.252 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -67.33 -43.61 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.576 -0.898 . . . . 2.45 108.576 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.7 t80 -59.98 -46.56 89.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.744 . . . . 0.91 109.033 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.72 94.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.846 -0.798 . . . . 1.04 108.846 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.0 -45.04 95.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.026 -0.731 . . . . 2.47 109.026 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.66 -25.3 66.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 1.14 109.701 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 71.1 m-20 -95.92 6.72 48.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.196 -0.94 . . . . 1.85 109.713 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.23 37.61 91.22 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.079 -1.058 . . . . 0.35 110.46 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.91 122.26 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.297 -1.119 . . . . 1.13 109.876 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -132.93 136.95 46.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.27 -1.381 . . . . 2.19 107.27 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.44 -156.48 16.22 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.87 -1.634 . . . . 1.15 109.647 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -91.82 128.55 37.69 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.955 -1.128 . . . . 2.22 107.955 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.69 133.62 40.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.24 110.453 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.5 p -131.68 147.9 52.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.966 -1.124 . . . . 1.09 107.966 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.44 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 62.1 t80 -134.76 135.86 42.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.93 109.966 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -112.04 109.48 19.25 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.28 108.711 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 48.2 t0 -66.35 -32.71 74.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 1.12 110.254 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -43.86 94.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 1.08 110.079 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.9 p -102.62 0.41 33.23 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.213 -0.93 . . . . 1.08 110.537 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mttm 50.12 40.5 21.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.859 -1.151 . . . . 2.82 108.985 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.3 m -118.84 130.01 55.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.647 0.737 . . . . 1.0 109.975 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 55.1 m-85 -97.65 137.01 37.21 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.078 -1.453 . . . . 0.21 107.078 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.1 m -129.51 134.15 47.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.823 -1.173 . . . . 1.04 108.614 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.35 129.99 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.142 -1.059 . . . . 1.05 108.142 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -121.98 127.81 50.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.448 -0.782 . . . . 1.06 110.218 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.995 -1.002 . . . . 2.34 108.585 179.243 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.478 0.656 . . . . 3.33 109.832 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.7 m -93.74 135.61 34.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.397 -0.815 . . . . 1.04 109.246 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.29 146.49 39.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.5 -0.926 . . . . 0.89 108.5 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.12 141.93 46.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.362 -0.836 . . . . 2.47 109.032 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.6 tp -120.1 126.23 50.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.708 -0.849 . . . . 1.01 108.708 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.26 123.41 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.164 -1.421 . . . . 1.15 107.164 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.38 114.11 28.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.286 -0.884 . . . . 1.06 110.092 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -114.66 68.59 0.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.124 -1.436 . . . . 0.19 107.124 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.1 165.15 48.66 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.813 -1.315 . . . . 0.24 109.813 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -66.91 -35.36 79.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.499 -1.297 . . . . 3.13 107.499 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -119.83 -23.19 6.53 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.252 -0.648 . . . . 1.43 109.252 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 9' ' ' GLY . 54.2 tp -98.35 121.48 40.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 1.23 109.269 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -136.89 126.78 25.77 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.179 -0.951 . . . . 2.49 109.638 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.44 -168.31 41.43 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.636 -1.269 . . . . 0.3 110.196 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -149.3 159.36 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.974 . . . . 1.68 109.655 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -151.94 167.35 28.64 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.732 -0.84 . . . . 1.09 108.732 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -138.03 159.65 41.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 1.07 109.278 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -154.93 159.96 40.81 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.714 -0.847 . . . . 0.99 108.714 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -102.22 132.91 47.86 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.53 -0.915 . . . . 2.22 108.53 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.69 144.57 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.105 -0.997 . . . . 1.07 109.477 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.86 -29.7 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.489 -0.757 . . . . 1.15 110.368 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -158.02 175.66 13.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.91 -1.119 . . . . 1.16 110.181 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.89 80.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.536 -0.727 . . . . 1.05 110.033 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.28 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.91 -1.119 . . . . 1.09 110.008 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 p -74.21 -34.89 63.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.726 -1.234 . . . . 1.12 109.827 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.0 92.26 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.807 -0.812 . . . . 1.02 108.807 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.51 -49.02 73.7 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.964 -1.095 . . . . 1.06 109.904 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.59 -40.04 92.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.261 -0.899 . . . . 3.05 110.506 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.9 -53.1 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.149 -0.969 . . . . 1.05 110.662 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -66.72 -39.5 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 0.15 110.596 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -60.42 -42.27 95.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.745 -1.222 . . . . 2.56 108.819 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -67.56 -43.63 80.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 2.33 108.948 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 65.5 t80 -60.03 -44.87 94.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.504 -0.748 . . . . 0.99 109.311 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.67 96.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.332 -0.855 . . . . 1.03 109.229 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -61.9 -42.36 98.98 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.363 -0.836 . . . . 1.97 109.101 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.21 -26.62 67.85 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.095 -1.003 . . . . 1.29 109.304 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.447 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 5.0 m120 -97.59 9.05 43.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.74 110.027 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.72 81.79 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.884 -1.15 . . . . 0.72 110.456 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.3 t -106.91 127.89 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.183 -1.186 . . . . 1.1 109.738 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -137.67 145.3 42.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.668 -1.234 . . . . 1.33 107.668 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.91 -156.19 21.07 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.875 -1.631 . . . . 0.29 110.334 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.64 131.11 36.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.579 -0.897 . . . . 2.07 108.579 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -101.08 136.54 40.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.15 110.545 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.5 p -133.9 148.77 51.27 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.771 -1.196 . . . . 1.11 107.771 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.12 134.32 42.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 0.9 110.205 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -111.49 108.28 17.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.328 -0.99 . . . . 0.24 108.328 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -67.27 -29.8 69.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 1.16 109.865 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.9 91.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.361 -0.837 . . . . 1.1 110.306 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.2 p -104.84 0.0 27.61 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.357 -0.84 . . . . 1.14 109.992 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 50.04 39.89 20.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 2.63 108.173 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -119.93 132.13 55.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.404 0.621 . . . . 1.05 110.712 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -99.3 140.04 34.05 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.486 -1.301 . . . . 0.11 107.486 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.6 m -130.62 131.28 44.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.655 -1.278 . . . . 1.03 108.706 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.79 129.65 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.496 -0.927 . . . . 1.02 108.496 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.3 127.74 52.64 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.504 -0.748 . . . . 1.05 110.444 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.965 -1.016 . . . . 1.95 109.197 179.813 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.371 -0.603 . . . . 3.33 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.7 m -91.05 133.73 35.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.322 -0.861 . . . . 1.04 109.597 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -117.67 145.81 44.14 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.857 -0.794 . . . . 0.89 108.857 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.415 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 63.5 tttp -114.74 144.15 43.93 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.328 -0.857 . . . . 2.47 109.184 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -121.78 128.94 52.27 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.135 -0.691 . . . . 1.01 109.135 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.9 122.3 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.747 -1.205 . . . . 1.15 107.747 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -100.69 113.82 27.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 1.06 109.262 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -116.34 68.73 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.323 -1.362 . . . . 0.19 107.323 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 169.3 52.95 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.146 -1.581 . . . . 0.24 109.146 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 8.9 ptpp? -64.8 -35.75 82.12 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.196 -1.179 . . . . 3.13 107.919 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -124.86 -19.11 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.427 -0.583 . . . . 1.43 109.427 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.0 tp -96.09 119.97 35.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.996 . . . . 1.23 109.098 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -134.54 125.8 28.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 2.49 109.472 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.93 -178.7 48.64 Favored Glycine 0 N--CA 1.487 2.036 0 C-N-CA 119.556 -1.307 . . . . 0.3 110.262 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 4' ' ' LYS . 19.3 pt-20 -148.54 157.3 43.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.757 -0.849 . . . . 1.68 108.929 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.02 170.03 21.43 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.377 -0.827 . . . . 1.09 109.281 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 p -135.87 159.17 42.51 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.84 -0.8 . . . . 1.07 108.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -157.61 161.67 38.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.862 . . . . 0.99 109.515 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 56.0 mp0 -105.92 135.74 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.836 -0.802 . . . . 2.22 108.836 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.24 146.4 26.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 1.07 109.118 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.37 -30.1 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.466 -0.771 . . . . 1.15 109.569 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -159.46 176.88 11.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 1.16 109.584 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -35.3 77.85 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.29 -0.881 . . . . 1.05 110.078 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -39.04 59.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.916 -1.115 . . . . 1.09 110.273 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.3 p -75.08 -32.14 61.4 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.5 -1.375 . . . . 1.12 109.518 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.68 99.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.264 -0.898 . . . . 1.02 108.828 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -56.94 -49.52 75.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.646 -1.222 . . . . 1.06 108.998 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -63.54 -44.03 95.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.541 -0.724 . . . . 3.05 110.823 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.06 -52.59 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.021 -1.049 . . . . 1.05 110.837 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -61.64 -37.9 85.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.006 . . . . 0.15 109.957 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -61.46 -43.04 99.57 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.91 -1.119 . . . . 2.56 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.62 -43.97 75.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.904 -1.123 . . . . 2.33 109.07 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 57.4 t80 -60.03 -47.84 84.2 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.292 -0.88 . . . . 0.99 108.749 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.98 99.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.454 -0.779 . . . . 1.03 109.138 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -59.99 -41.89 93.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.297 -1.001 . . . . 1.97 108.297 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.72 -19.78 66.03 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.001 -0.74 . . . . 1.29 109.001 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' OD1' ' CD1' ' A' ' 33' ' ' TYR . 31.0 m120 -95.08 4.31 53.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.74 109.96 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.04 32.9 65.61 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.675 -1.25 . . . . 0.72 110.087 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.4 t -110.22 122.99 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.184 -1.186 . . . . 1.1 108.916 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 31.5 p-10 -148.97 97.65 2.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.915 -1.116 . . . . 1.33 110.465 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.06 -130.68 1.37 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.31 -1.424 . . . . 0.29 111.342 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.11 132.43 38.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.963 -1.316 . . . . 2.07 110.316 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -107.76 139.48 42.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.429 0.633 . . . . 0.15 110.267 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.1 p -136.86 150.27 48.17 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.08 -1.081 . . . . 1.11 108.08 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -134.36 135.9 43.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.272 -0.893 . . . . 0.9 110.643 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -111.94 108.28 17.58 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.166 -1.05 . . . . 0.24 108.166 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -67.61 -29.99 69.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 1.16 110.366 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.04 93.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 1.1 110.409 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.0 p -105.81 0.02 25.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.37 -0.831 . . . . 1.14 110.124 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 mttm 50.33 41.34 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.131 . . . . 2.63 108.506 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.95 129.95 54.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.478 0.656 . . . . 1.05 110.069 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -98.87 139.64 34.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.679 -1.23 . . . . 0.11 107.679 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.5 m -128.7 130.41 47.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.762 -1.211 . . . . 1.03 108.437 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.06 129.42 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.285 -1.005 . . . . 1.02 108.285 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -120.96 126.0 48.83 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.114 -0.699 . . . . 1.05 109.114 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' CD ' ' HZ3' ' A' ' 10' ' ' LYS . 68.6 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.071 -0.966 . . . . 1.95 109.729 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.51 0.671 . . . . 3.33 109.234 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 m -92.44 133.74 35.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.476 -0.765 . . . . 1.04 109.483 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.528 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 90.8 m-85 -114.52 145.26 42.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.463 -0.94 . . . . 0.89 108.463 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -115.74 142.72 46.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.392 -0.818 . . . . 2.47 109.453 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.98 127.33 51.7 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.969 -0.752 . . . . 1.01 108.969 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.4 123.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.317 -1.364 . . . . 1.15 107.317 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.34 112.75 25.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 1.06 110.168 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -112.1 69.0 0.68 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.765 -1.568 . . . . 0.19 106.765 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.78 167.69 50.31 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.59 -1.404 . . . . 0.24 109.59 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -67.77 -39.05 84.15 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.414 -1.051 . . . . 3.13 108.524 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 p -120.0 -20.03 7.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.887 -0.508 . . . . 1.43 109.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.92 118.55 36.81 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.339 -0.851 . . . . 1.23 109.89 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -130.71 131.43 44.79 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.67 0.748 . . . . 2.49 109.15 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.1 -178.96 48.61 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.08 -1.533 . . . . 0.3 110.716 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.04 151.13 43.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.451 -0.944 . . . . 1.68 108.451 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 t -150.82 165.02 34.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 1.09 108.592 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.1 p -134.38 159.38 41.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 1.07 108.97 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -154.41 158.98 40.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.772 -0.825 . . . . 0.99 108.772 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.6 132.0 50.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.632 -0.877 . . . . 2.22 108.632 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.63 142.94 27.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.05 . . . . 1.07 109.093 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.93 -28.82 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 1.15 110.091 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -158.97 177.31 11.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.043 -1.035 . . . . 1.16 109.937 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.528 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -65.71 -38.42 89.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.457 -0.777 . . . . 1.05 109.591 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.11 -37.76 62.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.082 -1.011 . . . . 1.09 110.003 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.4 m -68.82 -39.96 79.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.692 -1.255 . . . . 1.12 109.806 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.02 93.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.246 -0.909 . . . . 1.02 109.372 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.17 -53.88 47.32 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.152 -1.019 . . . . 1.06 111.595 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -68.51 -36.14 78.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.678 -1.264 . . . . 3.05 110.655 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.84 -53.83 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.943 -1.098 . . . . 1.05 110.519 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.11 -37.42 87.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.15 110.433 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.98 -41.47 92.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.834 -1.166 . . . . 2.56 109.296 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -68.71 -42.13 78.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 2.33 109.102 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.498 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 62.6 t80 -59.95 -46.96 87.73 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.99 108.95 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.08 96.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 1.03 108.958 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.02 -45.62 92.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 1.97 109.159 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -62.28 -24.68 67.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -0.868 . . . . 1.29 109.548 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 7.4 m120 -98.51 7.04 46.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.215 -0.928 . . . . 0.74 109.99 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.17 33.62 83.6 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.92 -1.133 . . . . 0.72 110.491 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.18 128.39 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.147 -1.208 . . . . 1.1 110.539 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.501 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 96.7 m-20 -112.3 -98.62 0.42 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.511 -0.922 . . . . 1.33 108.511 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.69 167.53 3.72 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.29 112.455 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.5 mp0 -77.21 138.27 39.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.583 -1.266 . . . . 2.07 107.583 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -99.91 133.78 43.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.98 . . . . 0.15 110.351 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 p -134.32 148.76 50.81 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.815 -1.18 . . . . 1.11 107.815 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -136.04 136.91 40.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.186 -0.946 . . . . 0.9 110.464 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.82 110.01 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.568 -0.901 . . . . 0.24 108.568 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 52.4 t0 -67.94 -30.5 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.927 . . . . 1.16 110.461 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.3 93.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.148 -0.97 . . . . 1.1 109.892 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.3 p -105.92 -0.28 25.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.51 -0.744 . . . . 1.14 110.048 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.408 ' NZ ' ' CZ ' ' A' ' 3' ' ' TYR . 23.6 mtpp 49.98 41.71 23.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 2.63 108.401 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.34 131.08 55.66 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.547 0.689 . . . . 1.05 110.506 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -100.46 139.88 35.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.455 -1.313 . . . . 0.11 107.455 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -131.98 132.51 43.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.817 -1.177 . . . . 1.03 108.963 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.8 p -120.3 128.29 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.029 -1.1 . . . . 1.02 108.029 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.1 m -121.36 127.57 51.37 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.359 -0.838 . . . . 1.05 110.731 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 67.3 mm-40 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.947 -1.025 . . . . 1.95 109.453 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 tpp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.782 -0.822 . . . . 3.33 108.782 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.5 m -93.08 129.1 39.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.814 -1.179 . . . . 1.04 110.288 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.06 147.05 39.37 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.848 -1.168 . . . . 0.89 107.848 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -116.05 141.11 48.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 2.47 109.458 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.5 tp -120.66 127.99 52.58 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.742 -0.836 . . . . 1.01 108.742 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.38 123.68 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.215 -1.402 . . . . 1.15 107.215 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -103.91 114.36 28.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 1.06 110.543 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -118.75 68.52 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.132 -1.433 . . . . 0.19 107.132 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.546 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . . . -78.67 172.56 55.27 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.672 -1.771 . . . . 0.24 108.672 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -66.23 -35.59 80.82 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.841 -1.388 . . . . 3.13 107.929 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -123.95 -18.59 5.92 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.844 -0.535 . . . . 1.43 110.288 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 tp -98.94 113.58 25.8 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.015 -1.053 . . . . 1.23 109.822 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -126.21 127.28 45.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 2.49 109.317 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.97 -179.84 48.81 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.192 -1.48 . . . . 0.3 110.621 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -143.53 153.67 42.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.995 . . . . 1.68 108.869 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -152.82 168.5 25.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 1.09 109.065 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.5 p -138.46 160.02 40.61 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.881 -0.785 . . . . 1.07 108.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -156.65 162.86 39.82 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.264 -0.898 . . . . 0.99 109.188 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -106.48 135.01 48.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.367 -0.833 . . . . 2.22 108.917 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.0 145.53 27.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 1.07 108.898 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.42 -29.24 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 1.15 110.266 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -158.51 177.53 11.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.086 -1.009 . . . . 1.16 110.172 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.74 82.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.638 -0.664 . . . . 1.05 110.287 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.95 -37.08 60.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.833 -1.167 . . . . 1.09 109.769 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.415 ' H ' ' HG1' ' A' ' 25' ' ' THR . 2.2 p -72.23 -36.88 69.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.668 -1.27 . . . . 1.12 109.605 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.29 90.57 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.656 -0.868 . . . . 1.02 108.656 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.21 -50.08 73.98 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.221 -0.991 . . . . 1.06 110.196 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -66.29 -40.78 90.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.072 -1.017 . . . . 3.05 110.688 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.0 -53.82 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.078 -1.014 . . . . 1.05 110.597 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -63.68 -38.09 89.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.15 110.678 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -60.08 -44.04 95.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.817 -1.177 . . . . 2.56 109.582 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -68.36 -41.44 80.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 2.33 108.673 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 58.1 t80 -59.94 -48.33 82.12 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.487 -0.758 . . . . 0.99 109.05 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.87 99.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 1.03 109.096 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 35' ' ' ASN . 1.9 m120 -60.54 -43.33 97.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.292 -0.88 . . . . 1.97 108.897 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -64.25 -22.39 66.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 1.29 109.338 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.582 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 65.8 m-80 -98.46 6.76 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.286 -0.884 . . . . 0.74 109.877 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.78 36.21 91.94 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.164 -1.175 . . . . 0.72 110.164 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.59 127.42 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.277 -1.131 . . . . 1.1 109.935 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.471 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 92.9 m-20 -111.68 -97.15 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.5 -1.296 . . . . 1.33 107.5 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.93 166.91 2.06 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-O 122.052 0.807 . . . . 0.29 112.407 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.55 139.16 41.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.389 -1.337 . . . . 2.07 107.389 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.66 135.48 42.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.15 111.077 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 p -133.4 147.24 51.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.588 -0.893 . . . . 1.11 108.588 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 52.6 t80 -134.63 135.88 42.45 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.242 -0.911 . . . . 0.9 110.186 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 50' ' ' LYS . 55.2 t0 -113.11 109.96 19.67 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.941 -0.762 . . . . 0.24 108.941 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.8 t0 -68.87 -30.6 69.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.07 -1.019 . . . . 1.16 109.966 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.99 94.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.838 . . . . 1.1 110.112 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -110.97 -0.15 16.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.651 -0.655 . . . . 1.14 109.642 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 46' ' ' ASP . 56.7 mttp 48.9 41.81 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.137 -0.977 . . . . 2.63 109.208 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -115.74 131.12 57.03 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.483 0.659 . . . . 1.05 109.553 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.5 m-85 -100.61 139.91 35.62 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.092 -1.077 . . . . 0.11 108.092 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -132.23 131.98 42.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.671 -1.268 . . . . 1.03 108.672 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.0 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.617 -1.253 . . . . 1.02 107.617 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -120.07 126.54 51.02 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.226 -0.921 . . . . 1.05 110.293 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 118.03 -0.986 . . . . 1.95 109.231 179.564 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.055 -0.72 . . . . 3.33 109.055 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 m -92.6 135.94 33.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.491 -0.756 . . . . 1.04 110.008 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -119.35 146.41 45.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.74 -0.837 . . . . 0.89 108.74 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -116.91 144.82 44.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.409 -0.807 . . . . 2.47 109.804 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.3 tp -118.95 129.8 55.36 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.502 -0.749 . . . . 1.01 109.005 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.43 122.18 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.058 -1.46 . . . . 1.15 107.058 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.8 mt -101.76 117.52 35.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.174 -0.954 . . . . 1.06 110.2 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -124.59 66.43 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.565 -1.272 . . . . 0.19 107.565 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 176.38 54.68 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.497 -1.441 . . . . 0.24 109.497 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -66.07 -39.71 90.3 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.15 -1.206 . . . . 3.13 108.668 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -17.39 7.12 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.874 -0.516 . . . . 1.43 110.523 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.66 121.9 41.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.025 -1.047 . . . . 1.23 109.564 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -135.16 127.59 30.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.393 -0.817 . . . . 2.49 109.417 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -173.77 46.54 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.382 -1.39 . . . . 0.3 110.515 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -149.02 156.9 42.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.622 -0.929 . . . . 1.68 109.15 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -154.01 170.04 22.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 1.09 109.61 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 p -137.39 159.24 42.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.782 . . . . 1.07 109.13 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -157.52 162.7 38.85 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.335 -0.853 . . . . 0.99 108.9 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -101.21 133.77 45.27 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.306 -0.998 . . . . 2.22 108.306 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.88 142.12 27.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.178 -0.951 . . . . 1.07 108.949 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.99 -31.24 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.864 . . . . 1.15 109.552 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -157.69 179.21 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 1.16 110.106 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.15 -38.27 87.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.466 -0.771 . . . . 1.05 109.527 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.38 61.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.177 -0.952 . . . . 1.09 109.971 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.5 m -69.94 -40.05 75.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.641 -1.287 . . . . 1.12 109.749 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.64 82.06 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.444 -0.947 . . . . 1.02 108.444 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.06 -45.7 71.77 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.687 -1.205 . . . . 1.06 108.602 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.07 -46.1 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.64 -0.662 . . . . 3.05 110.764 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.27 -52.85 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.286 -0.884 . . . . 1.05 111.088 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -67.48 -39.95 85.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.996 -1.065 . . . . 0.15 110.551 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.68 -43.06 98.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.55 -1.344 . . . . 2.56 109.229 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.5 -44.49 82.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 2.33 108.911 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.3 t80 -60.13 -46.46 89.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.421 -0.799 . . . . 0.99 109.046 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -45.78 90.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 1.03 109.33 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.08 -43.93 95.13 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.665 -0.865 . . . . 1.97 108.665 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.07 -20.32 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 1.29 109.05 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.531 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 31.6 m120 -97.76 6.63 47.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.288 -0.883 . . . . 0.74 109.897 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.46 32.63 67.94 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.021 -1.085 . . . . 0.72 111.184 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.5 t -110.52 124.99 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.03 -1.276 . . . . 1.1 109.186 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 73.6 m-20 -150.67 99.78 2.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 1.33 110.281 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 -132.24 1.73 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.342 -1.409 . . . . 0.29 110.995 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.57 125.62 37.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.851 -1.382 . . . . 2.07 110.677 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -103.03 137.08 41.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.672 -0.643 . . . . 0.15 109.515 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -136.1 150.03 48.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.832 -1.173 . . . . 1.11 107.832 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -137.1 137.87 39.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.225 -0.922 . . . . 0.9 110.444 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -112.55 110.07 20.01 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.387 -0.968 . . . . 0.24 108.387 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -65.67 -30.92 71.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 1.16 110.374 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.15 93.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 1.1 110.272 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -104.33 -0.11 28.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.39 -0.819 . . . . 1.14 110.778 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp 50.07 40.21 20.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.758 -1.214 . . . . 2.63 108.246 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.97 131.53 55.2 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.633 0.73 . . . . 1.05 110.621 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -100.3 140.02 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.346 -1.353 . . . . 0.11 107.346 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.1 m -130.8 132.62 45.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 1.03 108.576 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.8 130.1 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.802 -0.814 . . . . 1.02 108.802 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 m -128.07 129.78 47.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.484 0.659 . . . . 1.05 110.169 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 74.2 mm-40 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.978 -1.01 . . . . 1.95 109.551 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' ALA . 79.7 mmm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.385 -0.598 . . . . 3.33 109.385 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m -94.01 131.63 39.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.078 -1.014 . . . . 1.04 109.346 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.656 ' HH ' ' N ' ' A' ' 23' ' ' ALA . 94.8 m-85 -117.5 145.45 44.2 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.362 -0.977 . . . . 0.89 108.362 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -113.21 145.35 41.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.343 -0.848 . . . . 2.47 109.647 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.62 127.66 51.08 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.564 -0.71 . . . . 1.01 109.592 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.5 mm -103.54 121.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.621 -1.622 . . . . 1.15 106.621 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.2 mt -100.33 111.47 23.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.947 -1.096 . . . . 1.06 109.528 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.54 69.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.543 -1.28 . . . . 0.19 107.543 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 163.96 48.1 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.345 -1.502 . . . . 0.24 109.345 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -66.8 -37.57 84.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.529 -1.286 . . . . 3.13 107.529 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.2 p -115.16 -22.37 9.5 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.576 -0.527 . . . . 1.43 109.576 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 9' ' ' GLY . 19.0 tp -102.29 127.99 49.03 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.342 -0.849 . . . . 1.23 109.556 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -139.91 128.1 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 2.49 109.472 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.46 -174.33 46.86 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.107 -1.521 . . . . 0.3 110.85 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -147.88 155.69 41.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.717 -0.873 . . . . 1.68 109.036 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.665 ' HG1' ' N ' ' A' ' 17' ' ' THR . 5.8 t -153.97 169.36 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 1.09 109.615 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.665 ' N ' ' HG1' ' A' ' 16' ' ' THR . 70.3 p -134.48 158.58 43.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.359 -0.838 . . . . 1.07 109.439 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -155.38 159.53 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.99 109.047 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -103.99 134.12 47.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.249 -0.907 . . . . 2.22 108.879 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 1' ' ' MET . . . -148.12 143.32 27.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 1.07 109.073 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 m -60.39 -28.9 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 1.15 109.741 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -157.53 174.96 14.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.198 -0.938 . . . . 1.16 109.894 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.656 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -67.57 -38.29 83.87 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 1.05 109.874 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.25 -36.22 52.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.941 -1.1 . . . . 1.09 109.607 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 p -73.45 -34.75 65.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.756 -1.215 . . . . 1.12 109.76 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.88 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.286 -1.005 . . . . 1.02 108.286 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -49.91 75.12 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.784 -1.167 . . . . 1.06 109.953 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -64.63 -41.43 96.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.747 -1.221 . . . . 3.05 110.405 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.55 -53.67 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 1.05 110.842 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -64.41 -39.22 93.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.15 111.07 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 67.2 mttm -61.78 -40.29 94.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.237 . . . . 2.56 110.156 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -69.45 -43.79 72.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.875 -1.141 . . . . 2.33 108.804 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.614 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -60.46 -46.65 89.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.394 -0.816 . . . . 0.99 109.53 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.12 94.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 1.03 109.76 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 31' ' ' LYS . 81.4 m-20 -61.59 -40.07 93.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 1.97 109.369 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.74 -23.96 67.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.183 -0.948 . . . . 1.29 109.532 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.614 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.6 m-20 -95.23 9.92 37.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.216 -0.927 . . . . 0.74 109.944 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.71 81.8 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.811 -1.315 . . . . 0.72 109.811 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.02 126.12 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.333 -1.098 . . . . 1.1 109.999 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 52.0 t0 -141.2 146.09 36.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 1.33 107.996 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.11 -150.28 12.13 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.234 -1.46 . . . . 0.29 110.206 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -92.05 132.35 36.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.568 -0.96 . . . . 2.07 108.525 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -100.38 136.49 40.19 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.246 -0.909 . . . . 0.15 110.331 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 p -138.74 150.41 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.39 -0.967 . . . . 1.11 108.39 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -132.0 136.57 47.38 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.303 -0.873 . . . . 0.9 110.275 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.71 106.23 15.38 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.319 -0.993 . . . . 0.24 108.319 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -66.73 -33.73 76.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 1.16 110.811 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.33 -40.04 95.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.965 -1.085 . . . . 1.1 109.881 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -102.79 0.75 33.24 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.552 -0.718 . . . . 1.14 110.277 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp 49.92 41.21 22.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 2.63 108.474 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -123.32 137.44 54.84 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.677 0.751 . . . . 1.05 110.969 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -100.69 139.25 36.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.383 -1.34 . . . . 0.11 107.383 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -130.27 130.76 44.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.653 -1.28 . . . . 1.03 108.519 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.51 128.18 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.089 -1.078 . . . . 1.02 108.089 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -120.02 128.31 53.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 1.05 110.214 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.938 -1.03 . . . . 1.95 109.351 -179.69 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' SD ' ' NZ ' ' A' ' 50' ' ' LYS . 24.6 ttt . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.305 -0.628 . . . . 3.33 109.305 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.4 m -91.19 131.61 36.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.237 -0.915 . . . . 1.04 109.806 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.82 148.83 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.895 -1.15 . . . . 0.89 107.895 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -116.25 140.52 49.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.103 -0.998 . . . . 2.47 109.081 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 26.7 tp -123.17 128.68 50.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.681 -0.637 . . . . 1.01 109.31 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 124.8 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.266 -1.383 . . . . 1.15 107.266 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.4 mt -102.34 115.59 30.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 1.06 109.029 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -113.37 70.63 0.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.521 -1.289 . . . . 0.19 107.521 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.77 167.54 52.92 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.709 -1.756 . . . . 0.24 108.709 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -67.24 -37.11 83.01 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.137 -1.214 . . . . 3.13 107.733 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -120.24 -18.73 7.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.153 0.502 . . . . 1.43 109.654 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.06 120.01 39.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.235 -0.915 . . . . 1.23 109.577 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -132.68 127.54 35.04 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.317 -0.865 . . . . 2.49 109.902 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -175.81 47.65 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.654 -1.26 . . . . 0.3 110.257 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.55 158.62 44.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -1.001 . . . . 1.68 109.313 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -153.22 170.03 21.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.391 -0.818 . . . . 1.09 109.72 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.4 p -137.87 160.04 40.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.8 . . . . 1.07 109.317 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -155.4 159.96 40.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.99 109.058 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -107.46 135.19 49.36 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.317 -0.994 . . . . 2.22 108.317 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.82 149.92 31.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 1.07 109.677 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.07 -29.08 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 1.15 110.053 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -158.07 171.89 19.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.916 -1.115 . . . . 1.16 110.304 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.56 83.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.567 -0.708 . . . . 1.05 110.175 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.58 -37.33 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.995 -1.066 . . . . 1.09 109.772 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -72.98 -34.59 66.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.682 -1.262 . . . . 1.12 109.638 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.17 90.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.37 -0.974 . . . . 1.02 108.37 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.46 -49.18 70.68 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.185 -1.006 . . . . 1.06 109.315 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HZ1' ' CB ' ' A' ' 28' ' ' LYS . 8.2 ttpm? -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.358 -0.839 . . . . 3.05 110.564 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.322 -0.861 . . . . 1.05 111.346 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -65.09 -39.9 93.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.83 -1.169 . . . . 0.15 111.37 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -63.37 -41.1 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 2.56 110.146 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.11 -42.47 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 2.33 108.893 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 65.2 t80 -60.14 -46.77 88.54 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.708 -0.849 . . . . 0.99 108.708 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.19 99.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.491 -0.756 . . . . 1.03 109.376 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -60.05 -40.84 90.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 1.97 109.15 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.25 -20.01 65.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 1.29 109.424 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 97.9 m-20 -96.56 4.8 51.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.093 -1.004 . . . . 0.74 109.992 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.6 36.34 54.13 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.933 -1.127 . . . . 0.72 110.959 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.8 t -116.26 122.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.155 -1.203 . . . . 1.1 108.559 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 73.9 m-20 -150.28 101.09 2.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -0.961 . . . . 1.33 110.818 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 -128.78 1.21 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.438 -1.363 . . . . 0.29 110.687 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -94.02 130.32 40.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.896 -1.355 . . . . 2.07 110.417 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -103.05 136.19 43.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.715 -0.616 . . . . 0.15 109.541 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.0 p -134.21 147.74 50.76 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.752 -1.203 . . . . 1.11 107.752 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -137.42 138.29 39.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.9 110.452 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -115.06 110.05 18.99 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.769 -0.826 . . . . 0.24 108.769 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 47.2 t0 -67.06 -28.74 68.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 1.16 109.719 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.97 95.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 1.1 110.013 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.0 p -107.55 0.45 22.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.474 -0.766 . . . . 1.14 110.218 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 32.1 mmtp 50.07 41.88 24.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.757 -1.201 . . . . 2.63 107.757 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.29 130.81 55.59 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.638 0.732 . . . . 1.05 110.603 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -101.89 139.42 37.55 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.779 -1.193 . . . . 0.11 107.779 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.0 m -130.98 132.63 45.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.833 -1.167 . . . . 1.03 108.294 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -124.32 130.55 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.593 -0.891 . . . . 1.02 108.593 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.03 126.91 51.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.639 -0.663 . . . . 1.05 109.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.992 -1.004 . . . . 1.95 109.367 -179.463 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.065 -0.717 . . . . 3.33 109.065 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -91.71 133.5 35.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 1.04 109.512 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.68 140.99 49.78 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.712 -0.848 . . . . 0.89 108.712 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.573 ' CB ' ' HZ3' ' A' ' 4' ' ' LYS . 7.2 ttpm? -113.81 143.34 44.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.539 -0.725 . . . . 2.47 109.052 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.4 tp -119.19 129.38 54.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.849 -0.797 . . . . 1.01 108.849 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -106.34 124.36 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.95 -1.5 . . . . 1.15 106.95 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.13 116.09 31.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 1.06 110.336 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.27 67.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.378 -1.712 . . . . 0.19 106.378 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.52 173.11 53.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.778 -1.329 . . . . 0.24 109.778 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.06 -40.03 82.85 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.29 -1.123 . . . . 3.13 108.231 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.1 m -121.64 -19.33 6.88 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.858 -0.526 . . . . 1.43 109.891 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.0 tp -98.57 119.54 37.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.059 -1.026 . . . . 1.23 109.515 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -136.39 129.07 30.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.161 -0.962 . . . . 2.49 109.526 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.21 -171.07 44.25 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.417 -1.373 . . . . 0.3 110.065 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -148.18 157.27 43.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.63 -0.923 . . . . 1.68 109.124 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.41 ' HG1' ' N ' ' A' ' 17' ' ' THR . 3.3 t -153.15 171.58 18.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.815 . . . . 1.09 108.878 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.41 ' N ' ' HG1' ' A' ' 16' ' ' THR . 81.7 p -137.83 159.98 40.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 1.07 109.857 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -156.91 160.81 39.47 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.49 -0.756 . . . . 0.99 109.214 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -104.97 136.87 43.63 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.358 -0.979 . . . . 2.22 108.358 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.5 141.78 26.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.082 -1.011 . . . . 1.07 109.453 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 m -60.44 -30.86 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.435 -0.791 . . . . 1.15 109.347 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -156.87 174.32 15.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 1.16 109.564 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.25 81.53 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.37 -0.831 . . . . 1.05 110.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.38 -36.11 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 1.09 109.716 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -71.25 -38.25 71.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.226 . . . . 1.12 109.605 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.91 85.86 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.511 -0.922 . . . . 1.02 108.511 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.02 -42.36 89.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.629 -1.228 . . . . 1.06 109.301 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.03 -43.83 81.78 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.627 -1.296 . . . . 3.05 110.449 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.11 -53.23 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.915 . . . . 1.05 111.845 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -66.56 -40.1 88.83 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.901 -1.124 . . . . 0.15 111.88 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.53 -40.16 95.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 2.56 110.177 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.9 -40.68 75.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.898 -1.126 . . . . 2.33 108.685 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.58 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.4 t80 -59.99 -44.56 94.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.99 108.982 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.29 96.73 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.396 -0.815 . . . . 1.03 108.962 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.98 -44.06 94.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.392 -0.817 . . . . 1.97 108.818 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.15 -24.19 67.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 1.29 109.341 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.58 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 81.2 m-20 -99.03 9.7 42.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.935 . . . . 0.74 109.052 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.89 36.77 93.29 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.515 -1.434 . . . . 0.72 109.515 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.3 125.88 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.319 -1.107 . . . . 1.1 109.892 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 96.4 m-20 -110.86 -98.63 0.41 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.294 -1.002 . . . . 1.33 108.294 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.81 165.21 4.79 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.083 0.824 . . . . 0.29 112.005 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.0 135.49 39.99 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.385 -1.339 . . . . 2.07 107.385 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -98.08 133.37 42.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.025 -1.047 . . . . 0.15 110.435 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -133.03 148.31 52.24 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.029 -1.1 . . . . 1.11 108.029 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -133.13 132.42 41.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.452 -0.78 . . . . 0.9 110.063 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -113.34 110.05 19.72 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.764 -0.828 . . . . 0.24 108.764 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -68.46 -29.5 68.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 1.16 110.625 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.92 89.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 1.1 110.313 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 78.6 p -104.87 -0.16 27.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.378 -0.826 . . . . 1.14 109.721 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.02 40.97 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.005 -1.06 . . . . 2.63 108.438 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.1 m -120.04 130.89 54.91 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.597 0.713 . . . . 1.05 110.723 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.34 139.12 34.59 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.953 -1.499 . . . . 0.11 106.953 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 100.0 m -132.04 131.88 42.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.715 -1.241 . . . . 1.03 108.853 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.6 p -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.036 -1.098 . . . . 1.02 108.036 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -121.45 128.32 52.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.39 -0.819 . . . . 1.05 110.788 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.035 -0.983 . . . . 1.95 109.298 179.456 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.486 ' CG ' ' H ' ' A' ' 2' ' ' THR . 4.3 tpt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.443 0.639 . . . . 3.33 109.397 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.502 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 98.3 m -93.41 131.64 38.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.578 -0.701 . . . . 1.04 109.776 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -112.89 147.86 36.15 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.095 -1.076 . . . . 0.89 108.095 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.45 140.12 50.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.338 -0.851 . . . . 2.47 109.079 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 tp -116.76 127.98 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.238 -1.023 . . . . 1.01 108.238 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 6' ' ' ILE . 84.7 mt -101.52 121.23 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.091 -1.448 . . . . 1.15 107.091 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.2 110.85 22.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.032 -1.043 . . . . 1.06 109.918 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -116.49 67.76 0.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.811 -1.552 . . . . 0.19 106.811 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.67 164.93 47.38 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.163 -1.575 . . . . 0.24 109.163 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.142 -1.21 . . . . 3.13 108.261 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.6 m -111.31 -25.06 9.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.831 -0.543 . . . . 1.43 109.674 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 9' ' ' GLY . 40.5 tp -103.09 124.12 47.94 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.343 -0.848 . . . . 1.23 109.899 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.32 126.39 29.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 2.49 108.99 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.77 44.83 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.187 -1.482 . . . . 0.3 110.592 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -149.46 158.15 43.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.688 -0.889 . . . . 1.68 109.147 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.75 170.1 22.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 1.09 109.519 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.0 p -137.3 159.89 40.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 1.07 109.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -154.6 159.29 40.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.604 -0.887 . . . . 0.99 108.604 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -101.54 131.95 47.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.134 -0.979 . . . . 2.22 108.552 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.19 143.68 27.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 1.07 109.157 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.01 -29.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.446 -0.784 . . . . 1.15 109.797 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -158.78 174.75 14.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.055 -1.028 . . . . 1.16 110.196 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.26 82.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.595 -0.691 . . . . 1.05 110.311 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.0 64.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.032 -1.043 . . . . 1.09 110.368 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 p -72.48 -35.6 68.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.62 -1.3 . . . . 1.12 110.012 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.0 81.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.471 -0.768 . . . . 1.02 108.982 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.51 -42.35 87.51 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.613 -1.235 . . . . 1.06 109.815 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.8 -42.68 73.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 3.05 110.24 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.12 -52.19 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 1.05 110.768 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -61.8 -38.12 86.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.945 -1.097 . . . . 0.15 110.07 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -59.99 -41.77 92.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.885 -1.134 . . . . 2.56 109.782 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.92 -40.65 83.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.037 -1.039 . . . . 2.33 108.537 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.463 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 57.9 t80 -59.94 -49.64 76.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.772 -0.825 . . . . 0.99 108.772 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.58 84.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 1.03 109.351 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -60.04 -43.13 95.57 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 1.97 108.649 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.41 -25.39 65.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.077 -1.015 . . . . 1.29 108.783 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 18.9 m120 -100.01 9.86 42.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.74 109.926 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.03 34.7 88.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.012 -1.235 . . . . 0.72 110.012 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.04 128.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.306 -1.114 . . . . 1.1 109.937 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 95.9 m-20 -110.02 -99.74 0.39 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.622 -0.881 . . . . 1.33 108.622 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.02 161.6 3.37 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 121.977 0.765 . . . . 0.29 111.849 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.68 138.01 42.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.396 -1.335 . . . . 2.07 107.396 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -99.76 135.8 40.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -0.993 . . . . 0.15 111.115 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.68 149.75 50.54 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.213 -1.032 . . . . 1.11 108.213 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 65.6 t80 -135.97 134.57 38.74 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.9 110.065 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -111.76 110.02 20.17 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.687 -0.857 . . . . 0.24 108.687 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.24 -31.71 72.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 1.16 110.253 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.7 88.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 1.1 110.436 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.9 p -105.09 -0.98 26.16 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.386 -0.821 . . . . 1.14 110.158 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.1 mtpm? 49.98 40.03 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 2.63 108.931 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 132.14 55.38 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.528 0.68 . . . . 1.05 110.452 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.0 m-85 -99.6 139.8 34.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.384 -1.339 . . . . 0.11 107.384 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -131.58 132.45 44.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.71 -1.244 . . . . 1.03 108.83 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -121.88 129.31 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.35 -0.982 . . . . 1.02 108.35 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -120.02 127.2 52.38 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.477 -0.765 . . . . 1.05 111.016 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.058 -0.972 . . . . 1.95 109.163 179.191 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mmm . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.026 -0.731 . . . . 3.33 109.026 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.532 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 95.6 m -95.6 128.8 42.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 1.04 109.685 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -112.1 150.29 30.94 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.891 -1.151 . . . . 0.89 107.891 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -116.48 143.4 45.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.067 -1.02 . . . . 2.47 109.418 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.2 tp -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.688 -0.632 . . . . 1.01 109.84 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.5 mt -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.572 -1.27 . . . . 1.15 107.572 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.8 mt -102.85 115.94 31.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.25 -0.906 . . . . 1.06 110.01 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -116.95 70.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.666 -1.235 . . . . 0.19 107.666 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.91 170.1 53.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.093 -1.603 . . . . 0.24 109.093 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 56' ' ' GLU . 62.4 mttp -64.38 -36.94 85.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.075 -1.25 . . . . 3.13 107.627 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.0 p -123.07 -15.27 7.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.903 -0.498 . . . . 1.43 109.889 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.79 122.1 41.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.98 -1.075 . . . . 1.23 109.969 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.92 126.68 27.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.295 -0.878 . . . . 2.49 109.814 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.27 -177.41 48.39 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.387 -1.387 . . . . 0.3 110.154 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.77 157.03 42.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.517 -0.99 . . . . 1.68 108.977 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -156.73 173.24 17.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.474 -0.766 . . . . 1.09 109.523 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.2 p -137.23 160.54 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.378 -0.826 . . . . 1.07 109.211 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 t -154.0 159.81 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.793 -0.817 . . . . 0.99 108.793 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -102.84 131.94 49.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.265 -0.897 . . . . 2.22 109.137 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.07 145.62 26.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 1.07 109.105 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.61 -26.89 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 1.15 110.341 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -157.77 174.71 14.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.888 -1.133 . . . . 1.16 110.431 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.36 81.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.518 -0.739 . . . . 1.05 109.208 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.94 60.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 1.09 109.828 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.7 p -73.12 -35.13 66.48 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.668 -1.27 . . . . 1.12 109.6 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.7 94.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.581 -0.896 . . . . 1.02 108.581 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.27 -48.07 83.0 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.348 -1.341 . . . . 1.06 109.27 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -65.91 -44.67 84.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 3.05 111.013 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -52.86 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.946 -1.096 . . . . 1.05 110.456 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -61.06 -36.51 79.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.15 110.156 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -60.02 -40.5 89.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 2.56 109.261 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.02 -41.43 74.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 2.33 108.923 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 58.1 t80 -60.06 -49.66 76.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.99 109.461 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -45.28 94.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 1.03 109.549 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.96 -41.68 92.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.334 -0.854 . . . . 1.97 109.272 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.21 -23.44 67.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 1.29 109.138 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 5.8 m120 -97.05 6.74 48.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.74 109.592 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.04 63.52 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.059 -1.067 . . . . 0.72 111.282 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 44.0 t -114.81 125.57 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.035 -1.274 . . . . 1.1 108.796 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 75.1 m-20 -149.66 101.92 3.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.254 -0.904 . . . . 1.33 110.399 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.41 -130.54 1.33 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.128 -1.51 . . . . 0.29 111.301 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -92.29 131.66 37.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.943 -1.328 . . . . 2.07 110.539 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.674 -0.641 . . . . 0.15 110.015 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 p -138.2 150.71 47.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.097 -1.075 . . . . 1.11 108.097 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.97 137.24 39.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -0.911 . . . . 0.9 110.532 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -113.28 109.98 19.63 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.904 -0.776 . . . . 0.24 108.904 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.7 t0 -67.01 -30.93 71.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 1.16 110.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 1.1 109.688 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -104.07 -0.65 28.45 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.363 -0.835 . . . . 1.14 109.807 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.0 mtpm? 49.66 42.79 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.881 -1.137 . . . . 2.63 108.453 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -120.05 134.69 55.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.454 0.645 . . . . 1.05 110.713 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -100.4 138.28 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.392 -1.336 . . . . 0.11 107.392 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -128.8 130.17 46.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.692 -1.255 . . . . 1.03 108.03 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.28 130.11 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.539 -0.912 . . . . 1.02 108.539 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.8 m -120.0 128.37 53.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.207 -0.664 . . . . 1.05 109.207 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 63.9 tt0 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.972 -1.014 . . . . 1.95 109.288 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.7 mpp? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.246 -0.65 . . . . 3.33 109.246 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.2 m -92.25 131.15 37.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.141 -0.974 . . . . 1.04 109.582 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -113.42 146.92 38.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.749 -1.204 . . . . 0.89 107.749 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.685 ' HZ3' ' HG1' ' A' ' 51' ' ' THR . 7.8 ttpm? -118.22 141.59 48.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.23 -0.919 . . . . 2.47 109.824 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.5 tp -120.11 128.38 53.4 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.045 -0.724 . . . . 1.01 109.045 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.1 123.28 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.027 -1.471 . . . . 1.15 107.027 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 114.06 27.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 1.06 109.67 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.6 71.39 0.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.031 -1.47 . . . . 0.19 107.031 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.11 169.59 53.03 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.082 -1.207 . . . . 0.24 110.082 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -65.76 -39.84 91.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -1.039 . . . . 3.13 108.224 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.9 m -124.28 -18.42 5.82 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.419 -0.586 . . . . 1.43 109.419 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.7 119.98 39.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 1.23 109.037 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -135.31 133.63 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.253 -0.904 . . . . 2.49 109.598 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.82 -173.64 46.45 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.461 -1.352 . . . . 0.3 110.272 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -149.44 158.2 43.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.577 -0.954 . . . . 1.68 109.202 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.466 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 4.3 t -154.49 171.6 19.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 1.09 109.324 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.7 p -137.33 159.92 40.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 1.07 109.332 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -155.0 158.8 39.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.823 . . . . 0.99 109.094 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.59 133.57 48.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.459 -0.941 . . . . 2.22 108.459 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.55 146.25 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 1.07 109.306 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 m -59.55 -30.78 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 1.15 109.564 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -159.33 174.61 14.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.981 . . . . 1.16 110.015 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.32 81.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.411 -0.805 . . . . 1.05 110.358 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.37 -37.32 62.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.872 -1.142 . . . . 1.09 109.708 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 p -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.692 -1.255 . . . . 1.12 109.576 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.19 81.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.359 -0.978 . . . . 1.02 108.359 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.13 -47.44 81.13 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.645 -1.222 . . . . 1.06 109.439 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.71 -41.13 88.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 3.05 110.248 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -68.27 -54.98 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.06 -1.025 . . . . 1.05 110.814 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -63.69 -38.66 91.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.15 111.358 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.79 -40.72 96.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.701 -1.249 . . . . 2.56 110.049 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.23 -43.86 73.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.971 -1.08 . . . . 2.33 109.162 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 81.4 t80 -60.17 -46.98 87.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.446 -0.784 . . . . 0.99 109.899 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.34 96.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 1.03 108.656 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.41 -41.16 96.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.561 -0.903 . . . . 1.97 108.561 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.64 -25.05 68.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 1.29 109.607 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 6.3 m120 -94.8 7.43 45.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.946 . . . . 0.74 109.791 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.12 30.34 75.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.678 -1.369 . . . . 0.72 109.678 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.0 t -105.45 125.81 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -1.165 . . . . 1.1 109.756 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 40.0 t0 -138.64 142.32 39.07 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.98 -1.119 . . . . 1.33 107.98 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.78 -150.13 11.6 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.247 -1.454 . . . . 0.29 110.135 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -94.48 137.66 33.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.531 -0.982 . . . . 2.07 108.822 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -104.89 138.33 41.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.367 -0.833 . . . . 0.15 110.77 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -136.24 149.86 48.7 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.885 -1.154 . . . . 1.11 107.885 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -137.03 137.35 39.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.185 -0.947 . . . . 0.9 110.492 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.6 109.95 20.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.316 -0.994 . . . . 0.24 108.316 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.9 t0 -67.35 -30.67 70.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 1.16 110.167 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.86 91.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 1.1 110.34 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.4 p -105.93 -0.07 25.39 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.391 -0.818 . . . . 1.14 110.278 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 50.02 41.46 23.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.927 -1.108 . . . . 2.63 108.542 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.685 ' HG1' ' HZ3' ' A' ' 4' ' ' LYS . 97.2 m -119.03 130.5 55.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.734 0.778 . . . . 1.05 110.451 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -99.36 139.08 35.54 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.568 -1.271 . . . . 0.11 107.568 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.6 m -130.69 131.35 44.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 1.03 108.195 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.27 129.35 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.423 -0.954 . . . . 1.02 108.423 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.1 m -120.41 127.07 51.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.423 -0.798 . . . . 1.05 110.188 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.027 -0.987 . . . . 1.95 109.253 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 21' ' ' VAL . 62.2 mtt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.384 -0.599 . . . . 3.33 109.384 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.4 m -92.71 134.69 34.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 1.04 109.655 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -113.72 145.41 41.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.361 -0.978 . . . . 0.89 108.361 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -115.96 142.94 46.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 2.47 108.912 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.9 tp -119.92 126.62 51.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.573 -0.899 . . . . 1.01 108.573 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.48 123.73 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.151 -1.425 . . . . 1.15 107.151 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 mt -102.73 112.89 25.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 1.06 110.383 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.97 68.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.839 -1.541 . . . . 0.19 106.839 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.31 168.2 51.51 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.965 -1.254 . . . . 0.24 109.965 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HZ2' ' C ' ' A' ' 56' ' ' GLU . 61.6 mttp -65.9 -37.65 86.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.703 -1.221 . . . . 3.13 107.703 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -122.19 -19.79 6.42 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.151 -0.477 . . . . 1.43 109.866 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 tp -99.5 120.93 40.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 1.23 109.422 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -135.61 128.46 31.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.304 -0.873 . . . . 2.49 109.517 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.42 -175.03 47.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.303 -1.427 . . . . 0.3 110.446 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.36 152.57 41.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.646 -0.914 . . . . 1.68 108.86 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -152.65 168.02 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 1.09 108.801 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.1 p -138.65 160.54 39.37 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 1.07 109.737 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -157.37 162.84 39.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.99 108.594 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 43.7 mp0 -106.37 136.78 45.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.796 -0.816 . . . . 2.22 108.796 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.04 144.76 28.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 1.07 108.899 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' ' SD ' ' A' ' 1' ' ' MET . 19.8 m -60.04 -30.73 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.229 -0.919 . . . . 1.15 109.393 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -157.73 176.96 11.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 1.16 110.112 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.31 -38.12 87.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.526 -0.734 . . . . 1.05 109.496 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.9 61.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.982 -1.074 . . . . 1.09 109.553 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.2 m -69.97 -40.06 75.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.69 -1.256 . . . . 1.12 109.811 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.02 87.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.857 -0.794 . . . . 1.02 108.857 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.21 -45.44 79.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.442 -1.303 . . . . 1.06 108.824 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -67.83 -44.23 77.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 3.05 111.157 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.87 -53.01 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 1.05 111.34 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.98 -37.56 87.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.861 -1.149 . . . . 0.15 110.299 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -59.94 -42.32 93.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.805 -1.184 . . . . 2.56 109.8 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -68.67 -40.14 80.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.078 -1.014 . . . . 2.33 108.741 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.4 t80 -59.95 -46.81 88.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.99 109.028 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.84 92.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.83 . . . . 1.03 109.144 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -60.01 -45.93 91.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.439 -0.788 . . . . 1.97 110.137 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.33 -25.16 65.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.051 -1.03 . . . . 1.29 109.396 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 83.3 m-20 -99.71 9.47 43.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.74 109.785 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.04 35.13 91.6 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.981 -1.104 . . . . 0.72 110.491 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 71.1 t -108.89 127.85 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.147 -1.208 . . . . 1.1 109.979 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 96.0 m-20 -140.38 148.33 41.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.485 -0.931 . . . . 1.33 108.485 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.41 -159.57 28.64 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.44 -1.362 . . . . 0.29 110.061 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -85.87 132.1 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.029 -1.1 . . . . 2.07 108.029 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -101.76 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.135 -0.978 . . . . 0.15 110.683 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.5 p -136.44 150.04 48.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.627 -0.879 . . . . 1.11 108.627 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 61.1 t80 -134.19 137.73 44.64 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.414 -0.804 . . . . 0.9 110.335 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -115.84 109.98 18.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.834 -0.802 . . . . 0.24 108.834 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -67.81 -29.2 68.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 1.16 110.455 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.02 94.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 1.1 110.32 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 p -109.18 0.13 19.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.582 -0.699 . . . . 1.14 110.209 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtmp? 50.14 42.11 24.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.851 -1.156 . . . . 2.63 108.588 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -118.79 130.06 55.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.725 0.774 . . . . 1.05 110.166 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 31.5 m-85 -99.11 139.51 34.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.949 -1.5 . . . . 0.11 106.949 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.6 m -131.96 132.82 43.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.782 -1.199 . . . . 1.03 108.463 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.345 -0.983 . . . . 1.02 108.345 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.3 m -119.38 126.73 52.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.51 -0.744 . . . . 1.05 109.518 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' C ' ' HZ2' ' A' ' 10' ' ' LYS . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.086 -0.959 . . . . 1.95 109.7 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.022 -0.733 . . . . 3.33 109.022 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.1 m -91.94 133.79 35.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.022 . . . . 1.04 109.39 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.79 145.49 43.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.807 -0.812 . . . . 0.89 108.807 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -114.38 143.42 44.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 2.47 108.906 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.9 tp -119.8 126.91 52.17 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.735 -0.839 . . . . 1.01 108.735 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.9 mt -102.45 121.03 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.034 -1.469 . . . . 1.15 107.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.07 115.01 29.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.025 . . . . 1.06 109.879 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -122.48 66.0 0.94 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.628 -1.619 . . . . 0.19 106.628 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -78.6 171.89 55.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.799 -1.72 . . . . 0.24 108.799 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.38 -39.69 89.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.028 -1.278 . . . . 3.13 108.238 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.2 p -114.57 -20.12 10.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.841 -0.537 . . . . 1.43 109.757 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 9' ' ' GLY . 58.9 tp -99.93 121.65 41.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -0.918 . . . . 1.23 109.942 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -133.2 122.88 24.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.863 . . . . 2.49 108.948 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.08 -171.64 44.77 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.341 -1.409 . . . . 0.3 110.64 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 2.1 pm0 -150.46 158.61 44.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.519 -0.989 . . . . 1.68 109.591 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 t -154.55 170.37 21.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.518 -0.739 . . . . 1.09 109.707 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.3 p -138.16 160.13 40.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.33 -0.856 . . . . 1.07 109.494 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 t -155.46 162.19 40.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.959 -0.756 . . . . 0.99 108.959 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -100.22 132.08 45.8 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.088 -1.079 . . . . 2.22 108.088 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.39 143.24 26.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.943 -1.098 . . . . 1.07 109.477 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.46 -30.67 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.577 -0.702 . . . . 1.15 110.439 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -159.87 179.93 8.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.84 -1.162 . . . . 1.16 110.322 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -37.64 75.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.249 -0.907 . . . . 1.05 110.355 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.27 -38.52 68.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.186 . . . . 1.09 110.898 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -73.07 -34.44 66.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.271 -1.518 . . . . 1.12 109.388 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.59 86.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.65 -0.87 . . . . 1.02 108.65 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.34 -48.16 77.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.829 -1.149 . . . . 1.06 110.02 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.61 -41.14 88.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 3.05 110.96 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.3 -54.83 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 1.05 111.081 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -63.76 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.01 -1.056 . . . . 0.15 110.456 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' NZ ' ' CB ' ' A' ' 31' ' ' LYS . 6.7 ttpm? -61.9 -42.64 99.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.801 -1.187 . . . . 2.56 109.935 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -67.54 -42.8 82.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.95 -1.094 . . . . 2.33 108.542 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 63.9 t80 -60.02 -47.83 84.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.425 0.631 . . . . 0.99 109.612 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.59 99.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.474 -0.766 . . . . 1.03 109.443 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -59.95 -40.66 89.73 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.191 -1.04 . . . . 1.97 108.191 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.61 -24.37 67.77 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.644 -0.66 . . . . 1.29 109.369 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 4.9 m120 -97.63 6.94 47.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.74 109.769 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.07 34.32 70.29 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.954 -1.117 . . . . 0.72 110.711 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.87 124.52 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.03 -1.276 . . . . 1.1 108.972 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.47 101.09 2.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.003 -1.061 . . . . 1.33 110.713 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.07 -130.06 1.3 Allowed Glycine 0 N--CA 1.497 2.733 0 C-N-CA 119.268 -1.444 . . . . 0.29 111.336 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -93.78 129.3 40.2 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.972 -1.311 . . . . 2.07 110.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.55 139.97 41.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.67 -0.644 . . . . 0.15 110.059 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -136.08 149.46 48.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.756 -1.201 . . . . 1.11 107.756 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.95 135.4 41.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.9 109.924 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.45 109.55 19.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.299 -1.0 . . . . 0.24 108.299 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -68.19 -30.69 69.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.16 110.224 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.8 91.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 1.1 110.514 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.3 p -104.97 0.26 27.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 1.14 110.066 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm 50.63 40.95 25.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 2.63 108.257 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -119.79 130.54 54.99 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.536 0.684 . . . . 1.05 110.8 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -99.45 137.79 37.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.055 -1.461 . . . . 0.11 107.055 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.0 m -130.2 131.27 45.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.748 -1.22 . . . . 1.03 108.216 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.92 127.4 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.447 -0.946 . . . . 1.02 108.447 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -123.61 125.24 44.47 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.846 -0.798 . . . . 1.05 108.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.99 -1.005 . . . . 1.95 109.635 -179.865 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.386 -0.598 . . . . 3.33 109.386 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.41 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 23.9 m -89.84 133.05 34.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 1.04 109.022 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.06 147.17 42.6 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.979 -0.748 . . . . 0.89 108.979 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -118.07 143.77 46.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.487 -0.758 . . . . 2.47 109.267 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.5 129.07 54.53 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.011 -0.737 . . . . 1.01 109.011 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.46 123.72 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.066 -1.457 . . . . 1.15 107.066 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.5 mt -104.49 116.44 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.208 -0.933 . . . . 1.06 111.035 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -114.88 71.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.113 -1.44 . . . . 0.19 107.113 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 168.91 52.61 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.434 -1.466 . . . . 0.24 109.434 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -66.05 -39.37 90.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.182 -1.187 . . . . 3.13 108.17 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.0 p -124.44 -16.56 6.31 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.023 0.44 . . . . 1.43 109.944 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -103.19 120.01 39.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.288 -0.883 . . . . 1.23 109.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -130.89 131.11 44.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.514 -0.741 . . . . 2.49 109.411 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.78 48.24 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.257 -1.449 . . . . 0.3 110.697 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 52.2 mp0 -143.88 153.26 42.14 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.479 -0.934 . . . . 1.68 108.479 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.645 ' HG1' ' H ' ' A' ' 17' ' ' THR . 4.4 t -152.51 169.17 23.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.085 -1.009 . . . . 1.09 109.34 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.645 ' H ' ' HG1' ' A' ' 16' ' ' THR . 31.9 p -135.44 159.82 40.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.353 -0.842 . . . . 1.07 109.502 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 t -157.28 160.12 38.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.99 109.216 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 55.8 mp0 -103.25 135.67 44.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.903 . . . . 2.22 108.678 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.54 144.6 27.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 1.07 109.264 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.88 -30.94 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 1.15 109.809 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -157.69 177.23 11.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.16 109.621 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.23 84.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.447 -0.783 . . . . 1.05 109.495 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -36.83 63.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.036 -1.04 . . . . 1.09 109.577 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.8 m -69.99 -39.63 75.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.785 -1.197 . . . . 1.12 109.651 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.71 78.83 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.735 -0.839 . . . . 1.02 108.735 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.76 -41.67 87.13 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.657 -1.217 . . . . 1.06 109.686 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.93 -45.17 71.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 3.05 110.477 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 -51.11 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.551 -0.718 . . . . 1.05 110.6 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -66.51 -38.6 87.58 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.091 -1.044 . . . . 0.15 110.549 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.0 -44.7 94.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.727 -1.233 . . . . 2.56 109.538 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -67.61 -40.88 84.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.028 -1.045 . . . . 2.33 108.573 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.2 t80 -59.99 -48.34 82.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.638 . . . . 0.99 109.78 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.21 94.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 1.03 109.546 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -60.0 -42.26 93.86 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.163 -0.961 . . . . 1.97 109.107 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.42 -26.47 67.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 1.29 109.696 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.8 m-20 -99.03 10.02 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.168 -0.958 . . . . 0.74 109.494 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.5 38.25 96.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.731 -1.348 . . . . 0.72 109.731 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.19 126.71 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -1.102 . . . . 1.1 110.172 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 52.4 t0 -110.19 -99.88 0.4 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.295 -1.002 . . . . 1.33 108.295 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.26 163.89 3.61 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 122.167 0.871 . . . . 0.29 112.368 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -75.2 138.48 41.99 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.348 -1.352 . . . . 2.07 107.348 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -99.57 134.99 41.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.15 110.809 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.6 p -133.57 148.19 51.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.316 -0.994 . . . . 1.11 108.316 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 66.8 t80 -130.61 134.31 46.88 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.86 . . . . 0.9 110.155 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' LYS . 62.0 t0 -112.88 107.19 15.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.738 -0.838 . . . . 0.24 108.738 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 56.5 t0 -67.36 -32.15 72.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.166 -0.959 . . . . 1.16 110.238 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 1.1 109.938 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -107.89 0.04 21.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.459 -0.775 . . . . 1.14 110.213 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 46' ' ' ASP . 9.5 mtmp? 49.74 42.02 22.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.806 -1.184 . . . . 2.63 108.294 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -120.01 131.44 55.14 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.625 0.726 . . . . 1.05 110.287 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.6 m-85 -99.88 137.83 37.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.28 -1.378 . . . . 0.11 107.28 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -131.0 131.7 44.52 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.804 -1.185 . . . . 1.03 108.245 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.5 p -120.58 128.06 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.077 -1.082 . . . . 1.02 108.077 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.22 125.86 49.21 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.402 -0.811 . . . . 1.05 110.845 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 38.2 mp0 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 118.034 -0.984 . . . . 1.95 109.438 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 mtt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.425 0.631 . . . . 3.33 109.679 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.6 m -92.46 131.29 37.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 1.04 109.458 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 95.2 m-85 -112.77 146.86 38.05 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.892 -1.151 . . . . 0.89 107.892 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -115.82 142.38 46.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.169 -0.957 . . . . 2.47 109.7 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.9 tp -122.4 128.11 50.54 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.057 -0.72 . . . . 1.01 109.057 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.69 124.16 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.605 -1.258 . . . . 1.15 107.605 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.3 mt -101.43 114.78 29.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 1.06 110.13 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.13 67.63 0.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.057 -1.46 . . . . 0.19 107.057 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.01 172.52 54.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.631 -1.387 . . . . 0.24 109.631 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -65.99 -39.06 90.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.221 -1.164 . . . . 3.13 108.365 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -17.57 6.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.917 -0.489 . . . . 1.43 109.859 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.3 tp -99.3 117.33 33.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 1.23 109.563 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.58 128.69 39.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.867 0.841 . . . . 2.49 109.514 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.15 -175.26 47.37 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.508 -1.329 . . . . 0.3 110.317 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -148.96 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.699 -0.883 . . . . 1.68 109.045 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.548 ' HG1' ' N ' ' A' ' 17' ' ' THR . 5.2 t -154.24 171.16 19.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 1.09 109.391 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.548 ' N ' ' HG1' ' A' ' 16' ' ' THR . 26.8 p -137.09 159.99 40.29 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.897 -0.779 . . . . 1.07 108.897 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -154.89 159.58 40.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.99 109.25 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -102.7 132.42 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.288 -0.882 . . . . 2.22 108.884 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.12 143.81 27.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 1.07 108.935 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.44 -27.23 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 1.15 109.858 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -157.96 172.21 18.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 1.16 109.939 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.504 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -67.52 -37.68 83.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.516 -0.74 . . . . 1.05 109.941 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.48 -37.2 62.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.049 -1.032 . . . . 1.09 110.069 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.6 p -73.38 -34.41 65.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.615 -1.303 . . . . 1.12 109.809 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.9 87.33 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.325 -0.991 . . . . 1.02 108.325 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.67 -45.72 85.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.864 -1.134 . . . . 1.06 109.58 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.28 -42.7 83.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.078 . . . . 3.05 109.821 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.59 -54.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 1.05 110.737 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.44 -39.04 93.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.15 110.478 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -60.79 -42.45 97.57 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.721 -1.237 . . . . 2.56 109.823 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -69.61 -42.35 74.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 2.33 108.702 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.625 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.9 t80 -59.95 -44.94 94.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.665 -0.865 . . . . 0.99 108.665 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.92 99.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 1.03 109.387 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.1 -40.07 88.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 1.97 108.533 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.98 -24.22 67.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 78.1 m-20 -99.17 7.3 45.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.207 -0.933 . . . . 0.74 110.495 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.12 35.58 71.02 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.917 -1.135 . . . . 0.72 111.349 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 67.1 t -111.93 125.09 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.968 -1.313 . . . . 1.1 109.348 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 78.5 m-20 -148.47 98.8 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.252 -0.905 . . . . 1.33 110.47 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.83 -136.85 2.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.168 -1.491 . . . . 0.29 111.015 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.79 131.57 35.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.087 -1.243 . . . . 2.07 110.608 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -108.25 139.3 43.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.674 -0.641 . . . . 0.15 110.013 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 p -136.68 149.99 48.23 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 1.11 108.586 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 71.4 t80 -133.79 136.03 44.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.364 -0.835 . . . . 0.9 110.451 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -114.03 109.71 18.89 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.403 -0.962 . . . . 0.24 108.403 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.26 -29.11 67.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 1.16 110.17 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.02 94.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.005 . . . . 1.1 109.92 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -106.95 0.7 23.96 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.491 -0.756 . . . . 1.14 110.24 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.611 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 16.4 mtpp 50.51 41.66 25.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 2.63 108.451 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 132.64 55.52 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.66 0.743 . . . . 1.05 110.906 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 48.3 m-85 -99.99 139.36 35.77 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.167 -1.42 . . . . 0.11 107.167 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -130.33 131.52 45.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.665 -1.272 . . . . 1.03 108.343 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.7 p -124.85 130.01 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.862 . . . . 1.02 108.674 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.6 m -125.37 129.25 49.54 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.658 -0.651 . . . . 1.05 109.87 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.946 -1.026 . . . . 1.95 109.491 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 2' ' ' THR . 28.4 ttp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 108.91 -0.774 . . . . 3.33 108.91 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.422 ' H ' ' HG2' ' A' ' 1' ' ' MET . 32.5 m -91.27 134.51 34.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.332 -0.855 . . . . 1.04 108.971 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.3 144.93 43.6 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.006 -0.739 . . . . 0.89 109.006 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -115.69 141.14 48.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 2.47 109.004 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.8 tp -120.05 128.97 54.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 1.01 109.336 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -105.81 123.06 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 106.983 -1.488 . . . . 1.15 106.983 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.06 115.89 31.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.311 -0.868 . . . . 1.06 110.311 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -116.59 72.8 0.83 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.967 -1.123 . . . . 0.19 107.967 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.62 169.47 54.31 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.219 -1.553 . . . . 0.24 109.219 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.656 ' HZ2' ' HG1' ' A' ' 11' ' ' THR . 19.8 pttp -62.37 -35.99 80.89 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.137 -1.213 . . . . 3.13 108.082 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.656 ' HG1' ' HZ2' ' A' ' 10' ' ' LYS . 6.3 p -129.06 -11.92 4.69 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.555 -0.535 . . . . 1.43 109.555 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.6 tp -99.96 118.69 36.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.27 -0.894 . . . . 1.23 109.104 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -130.63 127.75 39.57 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 2.49 109.606 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 -177.84 48.39 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.184 -1.484 . . . . 0.3 110.555 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.17 157.15 43.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.666 -0.903 . . . . 1.68 109.014 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.52 ' HG1' ' N ' ' A' ' 17' ' ' THR . 3.0 t -152.99 169.97 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 1.09 109.145 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.52 ' N ' ' HG1' ' A' ' 16' ' ' THR . 33.4 p -136.49 159.61 41.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 1.07 109.309 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 t -155.67 159.0 39.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.387 -0.821 . . . . 0.99 109.138 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.37 134.04 45.06 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.042 -1.095 . . . . 2.22 108.042 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.43 26.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.928 -1.108 . . . . 1.07 109.491 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.05 -31.25 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 1.15 109.673 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD1' ' OG1' ' A' ' 25' ' ' THR . 40.2 p-10 -158.32 175.2 14.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 1.16 110.07 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.08 81.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.501 -0.749 . . . . 1.05 109.989 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.18 -36.92 61.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.008 -1.058 . . . . 1.09 109.871 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.405 ' OG1' ' OD1' ' A' ' 22' ' ' ASP . 5.9 p -74.16 -34.23 63.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.243 . . . . 1.12 109.519 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.971 -1.122 . . . . 1.02 107.971 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.07 -49.83 74.66 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.762 -1.175 . . . . 1.06 108.872 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -63.46 -44.77 93.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.83 . . . . 3.05 110.821 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.36 -53.28 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.053 -1.029 . . . . 1.05 110.763 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -63.46 -37.82 88.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.15 110.456 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.685 -1.259 . . . . 2.56 109.83 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.57 -40.75 76.57 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.012 -1.055 . . . . 2.33 108.58 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.46 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 51.1 t80 -60.06 -47.77 84.5 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.749 -0.834 . . . . 0.99 108.749 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.16 99.42 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.918 -0.771 . . . . 1.03 108.918 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -60.0 -42.58 94.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.184 -1.043 . . . . 1.97 108.184 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.398 -0.814 . . . . 1.29 109.097 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.6 m-80 -98.13 6.37 47.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.283 -0.886 . . . . 0.74 109.466 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.29 34.64 90.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.143 -1.183 . . . . 0.72 110.143 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.4 t -112.05 128.82 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.391 -1.064 . . . . 1.1 110.513 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 2.0 p-10 -110.52 -98.49 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.505 -1.294 . . . . 1.33 107.505 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 68.64 164.86 3.46 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-O 122.01 0.783 . . . . 0.29 111.841 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -76.31 137.46 39.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.998 -1.482 . . . . 2.07 106.998 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -98.0 134.94 40.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.15 110.544 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.38 148.77 50.73 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.996 -1.113 . . . . 1.11 107.996 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.2 t80 -135.97 135.1 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.326 -0.859 . . . . 0.9 110.29 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.65 109.95 19.8 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.31 -0.996 . . . . 0.24 108.31 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -68.68 -29.32 67.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 1.16 110.292 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.93 95.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.133 -0.98 . . . . 1.1 109.988 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.0 p -108.07 0.3 21.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.611 -0.681 . . . . 1.14 109.82 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.9 mttm 48.58 43.04 20.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.065 . . . . 2.63 108.502 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 131.75 55.26 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.543 0.687 . . . . 1.05 109.836 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.3 m-85 -100.05 138.93 36.45 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.851 -1.166 . . . . 0.11 107.851 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -131.36 131.68 43.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.803 -1.186 . . . . 1.03 108.52 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.19 130.15 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.296 -1.001 . . . . 1.02 108.296 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -117.53 124.83 49.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.504 -0.748 . . . . 1.05 109.701 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.039 -0.981 . . . . 1.95 109.588 -179.504 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 2' ' ' THR . 4.3 ppp? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.408 -0.59 . . . . 3.33 109.408 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.534 ' O ' ' SD ' ' A' ' 1' ' ' MET . 86.7 m -95.07 127.99 41.55 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.916 -1.115 . . . . 1.04 110.377 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -109.57 150.94 27.45 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.774 -1.195 . . . . 0.89 107.774 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -118.1 140.04 50.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.08 -1.013 . . . . 2.47 109.232 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 tp -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.926 -0.768 . . . . 1.01 108.926 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.31 124.55 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.779 -1.193 . . . . 1.15 107.779 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.36 116.56 32.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 1.06 109.9 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -114.33 72.32 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.584 -1.265 . . . . 0.19 107.584 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.68 169.06 53.1 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.45 -1.46 . . . . 0.24 109.45 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.35 -37.93 88.55 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.312 -1.111 . . . . 3.13 108.006 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.7 p -123.78 -16.15 6.75 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.73 -0.471 . . . . 1.43 109.73 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 tp -101.74 120.18 39.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.305 -0.872 . . . . 1.23 109.573 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.15 127.9 40.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.802 . . . . 2.49 108.966 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.97 -179.22 48.65 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.174 -1.489 . . . . 0.3 110.584 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -149.48 158.2 43.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.947 . . . . 1.68 109.556 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.47 172.52 17.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.45 -0.781 . . . . 1.09 109.703 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -137.31 160.01 40.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.407 -0.808 . . . . 1.07 109.532 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 t -154.88 159.09 40.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.99 108.994 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -103.02 134.73 45.97 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.503 -0.925 . . . . 2.22 108.503 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.68 144.91 25.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 1.07 109.807 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 m -61.5 -30.68 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.573 -0.705 . . . . 1.15 110.296 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 24' ' ' ALA . 3.3 p30 -159.3 -179.99 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.917 -1.114 . . . . 1.16 109.825 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.39 75.0 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.076 -1.015 . . . . 1.05 110.5 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -55.12 -39.37 69.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.839 -1.163 . . . . 1.09 111.088 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -74.46 -32.83 62.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.244 -1.535 . . . . 1.12 109.339 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.806 -0.813 . . . . 1.02 108.806 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.71 -47.29 82.8 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.787 -1.165 . . . . 1.06 109.436 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -64.34 -43.02 95.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 3.05 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.83 -54.47 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.305 -0.872 . . . . 1.05 111.034 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -62.84 -38.87 92.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.077 -1.014 . . . . 0.15 110.783 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -61.62 -42.57 99.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.818 -1.177 . . . . 2.56 109.897 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -67.26 -43.0 82.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.84 -1.163 . . . . 2.33 108.619 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -47.57 85.28 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -0.774 . . . . 0.99 109.308 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.84 99.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 1.03 109.255 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.84 -42.46 97.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.97 109.059 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -62.49 -21.72 65.71 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -0.912 . . . . 1.29 108.958 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.9 m-20 -99.77 8.92 43.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.74 109.41 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.78 35.56 91.44 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.193 -1.163 . . . . 0.72 110.193 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.8 t -111.5 128.62 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.267 -1.137 . . . . 1.1 109.801 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.473 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 8.9 t70 -111.68 -96.59 0.42 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.108 -1.071 . . . . 1.33 108.108 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 68.33 164.42 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 121.237 -0.915 . . . . 0.29 112.087 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.68 137.47 42.18 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.319 -1.363 . . . . 2.07 107.319 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.18 135.61 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.958 . . . . 0.15 110.956 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -135.61 149.92 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.152 -1.055 . . . . 1.11 108.152 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 49.6 t80 -135.36 135.17 40.49 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.9 109.646 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -114.21 110.14 19.49 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.286 -0.635 . . . . 0.24 109.286 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.47 -29.54 69.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 1.16 109.852 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -40.46 94.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 1.1 110.167 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 76.9 p -107.94 -0.73 21.22 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.842 . . . . 1.14 110.049 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 48.9 42.48 20.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.037 -1.039 . . . . 2.63 108.694 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -120.08 130.26 54.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.822 -0.626 . . . . 1.05 109.786 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.4 m-85 -98.66 138.37 35.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.274 -1.38 . . . . 0.11 107.274 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.7 m -132.07 132.34 43.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.677 -1.264 . . . . 1.03 108.792 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.62 126.73 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.931 -1.137 . . . . 1.02 107.931 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.92 127.8 52.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.345 -0.847 . . . . 1.05 111.005 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 29.9 mp0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.014 -0.993 . . . . 1.95 109.466 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.301 -0.629 . . . . 3.33 109.301 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.5 m -92.08 131.64 37.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.052 -1.03 . . . . 1.04 109.53 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.83 145.56 42.01 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.677 -0.86 . . . . 0.89 108.677 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -116.64 142.13 47.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.372 -0.83 . . . . 2.47 109.073 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 tp -121.9 129.41 52.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.728 . . . . 1.01 109.798 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.0 mt -105.97 123.3 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.748 -1.575 . . . . 1.15 106.748 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.41 117.09 33.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 1.06 110.437 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.01 71.22 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.258 -1.386 . . . . 0.19 107.258 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 173.74 54.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.212 -1.555 . . . . 0.24 109.212 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -65.16 -39.93 93.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.189 -1.183 . . . . 3.13 108.102 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.7 p -124.99 -14.63 6.58 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.649 -0.5 . . . . 1.43 109.649 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.7 tp -99.7 114.94 28.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -0.974 . . . . 1.23 109.418 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 129.07 42.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.426 -0.796 . . . . 2.49 109.256 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.58 -175.1 47.41 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.285 -1.436 . . . . 0.3 110.312 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -148.28 156.82 43.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.608 -0.936 . . . . 1.68 108.96 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.557 ' HG1' ' H ' ' A' ' 17' ' ' THR . 5.2 t -154.67 172.9 17.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 1.09 109.604 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.557 ' H ' ' HG1' ' A' ' 16' ' ' THR . 40.1 p -137.68 159.13 42.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.752 . . . . 1.07 109.064 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -155.65 160.06 40.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.838 . . . . 0.99 108.874 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -104.31 133.82 48.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.272 -0.893 . . . . 2.22 108.931 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.17 146.27 26.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 1.07 109.614 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.24 -30.69 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.78 . . . . 1.15 110.194 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -159.79 179.99 8.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 1.16 110.093 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.79 82.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.628 -0.67 . . . . 1.05 110.653 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -37.03 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.874 -1.142 . . . . 1.09 110.431 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 p -73.49 -36.04 65.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.55 -1.344 . . . . 1.12 109.845 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.9 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.039 -1.097 . . . . 1.02 108.039 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.66 -45.73 85.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.13 -1.028 . . . . 1.06 110.203 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -67.35 -40.72 85.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.123 . . . . 3.05 110.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.37 -53.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 1.05 110.871 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -67.25 -40.01 86.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.923 -1.11 . . . . 0.15 110.664 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.75 -46.18 91.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.876 -1.14 . . . . 2.56 109.945 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.65 -43.01 81.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.095 -1.003 . . . . 2.33 108.782 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.9 t80 -60.09 -45.09 94.09 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.401 -0.812 . . . . 0.99 109.606 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.373 -0.829 . . . . 1.03 109.49 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -62.43 -40.12 95.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 1.97 109.007 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.62 -24.58 67.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 1.29 109.426 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 73.0 m-20 -97.14 10.08 40.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.74 109.198 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.0 93.97 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.321 -1.512 . . . . 0.72 109.321 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.4 t -109.94 123.75 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.356 -1.085 . . . . 1.1 109.867 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 97.6 m-20 -140.44 146.89 38.87 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.151 -1.055 . . . . 1.33 108.151 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.39 -155.49 22.47 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.077 -1.535 . . . . 0.29 110.105 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -88.03 130.66 34.91 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.85 -1.167 . . . . 2.07 107.85 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -103.0 138.92 39.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.15 110.463 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.8 p -136.83 150.05 48.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.341 -0.985 . . . . 1.11 108.341 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.3 t80 -135.69 137.09 41.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.435 -0.791 . . . . 0.9 110.233 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.447 ' CG ' ' HG1' ' A' ' 49' ' ' THR . 60.0 t0 -111.93 109.95 20.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.901 -0.777 . . . . 0.24 108.901 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 51.9 t0 -67.15 -32.45 73.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 1.16 110.179 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.51 94.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 1.1 110.213 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.447 ' HG1' ' CG ' ' A' ' 46' ' ' ASP . 67.3 p -108.15 0.14 21.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.561 -0.712 . . . . 1.14 110.44 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 49.98 41.68 23.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.836 -1.165 . . . . 2.63 108.404 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -118.97 131.09 56.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.66 0.743 . . . . 1.05 110.264 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 44.4 m-85 -99.97 139.19 35.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.527 -1.286 . . . . 0.11 107.527 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 m -131.94 132.18 43.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.838 -1.164 . . . . 1.03 108.361 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.49 129.93 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.485 -0.932 . . . . 1.02 108.485 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -119.99 127.33 52.52 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.551 -0.718 . . . . 1.05 110.134 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 7.7 mp0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.975 -1.012 . . . . 1.95 109.238 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.344 -0.613 . . . . 3.33 109.344 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m -95.22 134.2 38.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.224 -0.923 . . . . 1.04 109.53 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.2 149.0 41.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.623 -0.88 . . . . 0.89 108.623 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -114.81 143.84 44.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.332 -0.855 . . . . 2.47 109.877 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.8 tp -121.31 127.14 51.02 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.858 -0.793 . . . . 1.01 108.858 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.9 mt -106.87 123.36 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.523 -1.288 . . . . 1.15 107.523 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -102.28 114.13 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 1.06 109.68 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' OD1' ' NZ ' ' A' ' 13' ' ' LYS . 43.2 t30 -114.88 71.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.72 -1.215 . . . . 0.19 107.72 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 166.43 49.76 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.416 -1.474 . . . . 0.24 109.416 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' NZ ' ' C ' ' A' ' 56' ' ' GLU . 60.0 mttp -67.41 -35.21 78.81 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -1.152 . . . . 3.13 108.027 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -22.42 4.99 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.929 -0.482 . . . . 1.43 109.849 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.37 119.96 39.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.306 -0.871 . . . . 1.23 109.338 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 8' ' ' ASN . 66.1 mttm -133.08 131.74 40.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.287 -0.883 . . . . 2.49 109.648 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.02 -179.97 48.8 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.273 -1.441 . . . . 0.3 110.426 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -142.0 151.97 42.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.609 -0.936 . . . . 1.68 108.73 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.419 ' HG1' ' H ' ' A' ' 17' ' ' THR . 8.8 t -151.89 167.65 27.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 1.09 109.074 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.419 ' H ' ' HG1' ' A' ' 16' ' ' THR . 30.2 p -139.88 160.82 39.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 1.07 109.411 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -155.72 161.17 40.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.686 -0.857 . . . . 0.99 108.686 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -103.45 135.03 45.82 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.484 -0.932 . . . . 2.22 108.484 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.9 144.28 27.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 1.07 109.549 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.36 -30.07 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.821 . . . . 1.15 109.634 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -158.35 171.06 20.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 1.16 109.582 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.78 81.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 1.05 109.796 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.71 68.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.115 . . . . 1.09 109.909 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.9 m -69.96 -37.17 75.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 1.12 109.722 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.83 75.2 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.588 -0.893 . . . . 1.02 108.588 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.43 -47.31 72.96 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.943 -1.103 . . . . 1.06 109.524 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 8.2 mptt -67.96 -40.2 83.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.794 -1.191 . . . . 3.05 110.459 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.24 -53.39 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 1.05 111.361 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -64.7 -39.98 94.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.887 -1.133 . . . . 0.15 111.045 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -62.14 -40.01 94.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.719 -1.238 . . . . 2.56 109.932 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.94 -1.1 . . . . 2.33 108.795 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 68.6 t80 -59.89 -48.63 80.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 0.99 109.606 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -43.22 99.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.366 -0.834 . . . . 1.03 109.151 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.06 -42.53 94.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.641 -0.874 . . . . 1.97 108.641 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.72 -22.21 66.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 1.29 109.289 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 32.2 m120 -96.27 6.91 47.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.246 -0.909 . . . . 0.74 109.988 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.79 75.38 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.76 -1.21 . . . . 0.72 110.201 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 126.97 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.282 -1.128 . . . . 1.1 109.621 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -142.92 148.69 37.34 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.353 -0.98 . . . . 1.33 108.353 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.07 -150.45 14.73 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.173 -1.489 . . . . 0.29 110.147 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 59.1 mp0 -89.17 129.33 35.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.976 -1.12 . . . . 2.07 107.976 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -100.4 138.35 37.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.15 110.066 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.6 p -136.37 150.04 48.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.13 -1.063 . . . . 1.11 108.13 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -134.37 135.55 42.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.441 -0.787 . . . . 0.9 109.7 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -111.23 108.68 18.4 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.186 -1.042 . . . . 0.24 108.186 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -67.58 -30.81 70.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 1.16 110.197 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.02 94.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 1.1 110.112 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -104.72 0.09 27.96 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.486 -0.759 . . . . 1.14 110.417 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 49.97 40.43 21.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.886 -1.134 . . . . 2.63 108.215 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 131.05 55.01 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.685 0.755 . . . . 1.05 110.497 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -98.66 137.85 36.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.037 -1.468 . . . . 0.11 107.037 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.3 m -129.99 130.87 45.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 1.03 108.074 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.26 129.39 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.123 -1.066 . . . . 1.02 108.123 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -118.32 124.71 48.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 1.05 109.172 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' C ' ' NZ ' ' A' ' 10' ' ' LYS . 83.3 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.971 -1.014 . . . . 1.95 109.575 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 tpp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.494 0.664 . . . . 3.33 109.214 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m -91.22 134.76 34.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.428 -0.795 . . . . 1.04 109.758 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.09 145.02 40.5 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.26 -1.015 . . . . 0.89 108.26 178.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -115.97 139.95 49.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.288 -1.004 . . . . 2.47 108.288 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.52 127.71 52.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.512 -0.921 . . . . 1.01 108.512 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.0 mt -105.87 123.3 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.118 -1.438 . . . . 1.15 107.118 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.3 mt -103.67 115.01 29.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 1.06 110.034 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.71 71.15 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.353 -1.351 . . . . 0.19 107.353 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 167.12 50.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.513 -1.435 . . . . 0.24 109.513 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -64.98 -36.23 83.72 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.662 -1.236 . . . . 3.13 107.662 178.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -19.51 5.3 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.849 -0.426 . . . . 1.43 109.849 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.82 119.99 38.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.082 -1.011 . . . . 1.23 109.126 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -133.67 129.12 36.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.49 109.722 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.85 -175.08 47.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.46 -1.353 . . . . 0.3 110.443 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.53 156.95 43.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.981 . . . . 1.68 109.444 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -154.33 169.96 22.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 1.09 109.353 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -137.85 160.46 39.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 1.07 109.311 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.4 t -156.08 162.0 40.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.99 108.971 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 4.0 tm-20 -102.94 134.8 45.76 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.675 -0.861 . . . . 2.22 108.675 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 19' ' ' GLU . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.19 -0.944 . . . . 1.07 108.939 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.2 m -60.09 -29.89 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 1.15 109.356 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -158.14 176.5 12.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 1.16 109.834 -179.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.41 88.41 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 1.05 109.85 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.55 49.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.946 -1.096 . . . . 1.09 109.433 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.5 m -69.47 -39.99 77.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.827 -1.171 . . . . 1.12 109.942 179.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.37 97.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.312 -0.868 . . . . 1.02 109.137 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.29 -56.76 12.68 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.46 -0.896 . . . . 1.06 111.091 -178.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -69.48 -37.4 77.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 3.05 111.83 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.48 -53.49 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.425 -1.422 . . . . 1.05 110.637 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -61.81 -35.75 79.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.022 -1.049 . . . . 0.15 110.266 -179.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.03 -40.77 90.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.946 -1.096 . . . . 2.56 108.952 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -69.41 -41.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 2.33 108.795 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.5 t80 -60.03 -49.93 75.72 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.048 -0.723 . . . . 0.99 109.048 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.77 96.28 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.476 -0.765 . . . . 1.03 109.362 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.46 -40.74 97.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 1.97 109.554 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.99 -25.7 67.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 1.29 109.271 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.2 m-20 -97.9 9.08 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.74 108.741 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.43 37.63 94.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.332 -1.107 . . . . 0.72 110.332 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.75 129.81 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.22 -1.165 . . . . 1.1 110.403 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 89.5 m-20 -111.65 -96.2 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.012 -1.107 . . . . 1.33 108.012 178.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.71 166.27 4.16 Favored Glycine 0 N--CA 1.491 2.351 0 CA-C-O 122.156 0.865 . . . . 0.29 112.27 177.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.52 138.6 39.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.361 -1.348 . . . . 2.07 107.361 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -100.22 135.76 41.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.119 -0.988 . . . . 0.15 110.91 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.4 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.005 -1.109 . . . . 1.11 108.005 179.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -135.32 134.97 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.233 -0.917 . . . . 0.9 110.693 -177.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.28 110.0 20.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.677 -0.86 . . . . 0.24 108.677 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -65.61 -31.7 72.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.16 110.363 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.56 -40.0 88.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 1.1 110.756 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.7 p -105.06 -0.41 26.76 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 1.14 110.469 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 50.02 40.34 21.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.888 -1.132 . . . . 2.63 108.068 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.02 54.51 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.645 0.736 . . . . 1.05 110.137 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -98.67 139.96 33.59 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.118 -1.438 . . . . 0.11 107.118 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.2 m -129.43 131.25 46.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.764 -1.21 . . . . 1.03 108.417 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.7 p -120.22 128.93 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.934 -1.136 . . . . 1.02 107.934 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -119.92 125.72 49.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 1.05 109.757 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.999 -1.0 . . . . 1.95 109.516 -179.691 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.401 0.619 . . . . 3.33 109.722 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.2 m -91.99 133.68 35.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.309 -0.869 . . . . 1.04 109.388 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.581 ' HH ' ' N ' ' A' ' 23' ' ' ALA . 91.5 m-85 -117.93 148.69 41.92 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.772 -0.825 . . . . 0.89 108.772 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -117.07 145.28 43.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 2.47 109.324 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -119.45 127.53 53.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.547 -0.908 . . . . 1.01 108.547 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.09 121.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.023 -1.473 . . . . 1.15 107.023 178.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.8 mt -102.55 116.81 33.35 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 1.06 110.308 -178.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.0 68.29 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.509 -1.293 . . . . 0.19 107.509 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.5 171.55 54.13 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.505 -1.438 . . . . 0.24 109.505 179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -66.26 -39.86 89.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -1.128 . . . . 3.13 108.148 178.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.1 p -120.01 -20.09 7.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.999 -0.438 . . . . 1.43 109.848 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.8 tp -99.98 120.07 39.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 1.23 109.415 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -136.47 130.61 32.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 2.49 109.833 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.57 -173.62 46.42 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.392 -1.385 . . . . 0.3 110.905 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.521 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 46.4 mp0 -144.34 153.55 42.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.982 . . . . 1.68 108.958 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -153.17 168.54 25.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 1.09 109.446 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 p -139.36 159.78 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.863 . . . . 1.07 109.167 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -156.74 164.24 38.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.953 -0.758 . . . . 0.99 108.953 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -103.37 133.98 47.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.379 -0.826 . . . . 2.22 109.01 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.14 143.39 28.22 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.6 -0.889 . . . . 1.07 108.6 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -59.94 -29.61 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 1.15 109.535 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -157.74 175.19 14.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 1.16 110.022 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.581 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -66.94 -38.13 85.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.552 -0.717 . . . . 1.05 109.871 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.24 -36.58 61.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.112 . . . . 1.09 109.912 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 p -73.43 -33.47 64.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.608 -1.307 . . . . 1.12 109.732 178.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.18 81.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.237 -1.023 . . . . 1.02 108.237 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.01 -44.93 83.31 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.823 -1.151 . . . . 1.06 109.558 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.7 -42.72 85.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.882 -1.136 . . . . 3.05 110.579 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.63 -52.0 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 1.05 111.243 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.67 -40.03 88.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.025 -1.047 . . . . 0.15 111.269 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -63.51 -41.28 98.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.503 -1.373 . . . . 2.56 109.997 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -70.0 -45.68 66.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.879 -1.138 . . . . 2.33 108.939 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.545 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 72.9 t80 -60.02 -47.98 83.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.495 -0.753 . . . . 0.99 109.453 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.59 98.64 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.478 -0.764 . . . . 1.03 109.474 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.95 -40.49 89.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.392 -0.818 . . . . 1.97 108.974 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -65.08 -19.26 65.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.784 -0.821 . . . . 1.29 108.784 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.545 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 97.4 m-20 -94.68 6.7 48.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.74 109.788 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.2 30.25 63.17 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.9 -1.143 . . . . 0.72 111.153 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.02 124.26 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.901 -1.352 . . . . 1.1 108.527 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 27.7 p-10 -150.58 99.61 2.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 1.33 110.593 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.2 -125.48 0.86 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.174 -1.489 . . . . 0.29 111.317 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.79 130.3 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.898 -1.354 . . . . 2.07 110.851 -178.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -107.23 139.59 41.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 0.15 110.27 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.5 p -137.77 150.02 46.9 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.419 -0.956 . . . . 1.11 108.419 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CE1' ' CE1' ' A' ' 52' ' ' PHE . 48.9 t80 -137.79 137.75 38.53 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.175 -0.953 . . . . 0.9 110.337 -179.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.719 -0.845 . . . . 0.24 108.719 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.51 -31.05 71.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.346 -0.846 . . . . 1.16 110.928 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.9 94.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 1.1 110.537 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -103.55 0.04 30.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.381 -0.824 . . . . 1.14 110.383 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 20.4 mtpp 49.91 40.12 20.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.11 . . . . 2.63 108.255 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -120.1 131.12 54.95 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.498 0.666 . . . . 1.05 110.14 -178.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 54.3 m-85 -99.96 138.83 36.49 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.447 -1.316 . . . . 0.11 107.447 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.7 m -130.06 131.55 45.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 1.03 108.709 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.5 p -121.67 127.68 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.577 -0.898 . . . . 1.02 108.577 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -125.47 127.51 46.6 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.532 -0.73 . . . . 1.05 109.803 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.019 -0.991 . . . . 1.95 109.289 179.811 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.366 0.603 . . . . 3.33 109.382 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m -89.51 136.23 33.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.39 -0.819 . . . . 1.04 109.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.456 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 95.8 m-85 -114.31 141.93 46.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.691 -0.855 . . . . 0.89 108.691 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.7 140.17 48.47 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.733 -0.84 . . . . 2.47 108.733 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.6 tp -120.06 128.76 53.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.347 -0.846 . . . . 1.01 109.516 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -104.96 122.38 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.208 -1.404 . . . . 1.15 107.208 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.74 115.45 30.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -0.987 . . . . 1.06 110.282 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -118.75 72.37 0.88 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.826 -1.176 . . . . 0.19 107.826 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 171.06 54.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.351 -1.5 . . . . 0.24 109.351 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.66 -39.85 94.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.05 -1.265 . . . . 3.13 108.173 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -124.67 -16.1 6.34 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.204 -0.665 . . . . 1.43 109.204 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 9' ' ' GLY . 60.1 tp -99.8 118.04 35.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.323 -0.86 . . . . 1.23 108.794 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -135.83 133.78 38.18 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 2.49 109.916 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.54 -176.21 47.86 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.495 -1.336 . . . . 0.3 110.403 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -145.03 151.61 38.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.505 -0.924 . . . . 1.68 108.505 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -152.62 170.16 20.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 1.09 109.422 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -137.74 159.88 40.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -0.771 . . . . 1.07 109.196 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 t -156.97 162.27 39.6 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.368 -0.832 . . . . 0.99 108.796 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -106.58 136.6 46.08 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.778 -0.823 . . . . 2.22 108.778 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.91 148.52 29.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 1.07 109.39 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.9 -33.35 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.392 -0.817 . . . . 1.15 110.086 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -159.85 179.98 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 1.16 110.088 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.456 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -66.74 -40.03 88.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.534 -0.728 . . . . 1.05 110.469 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -37.56 63.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.873 -1.142 . . . . 1.09 110.228 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.4 m -69.99 -39.98 75.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.673 -1.267 . . . . 1.12 110.148 179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.05 88.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.803 . . . . 1.02 109.09 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.97 -46.37 82.24 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.769 -1.172 . . . . 1.06 109.57 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -67.39 -44.11 79.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.435 -0.79 . . . . 3.05 110.67 -179.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.37 -53.11 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 1.05 110.99 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -63.62 -38.76 92.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.935 -1.103 . . . . 0.15 110.4 -179.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -60.07 -45.13 93.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.856 -1.153 . . . . 2.56 109.999 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -69.07 -42.1 76.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.025 -1.047 . . . . 2.33 109.1 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.615 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -59.98 -44.65 94.36 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.717 -0.846 . . . . 0.99 108.717 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.58 -43.6 96.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 1.03 109.013 179.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -60.28 -42.39 95.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.24 -0.913 . . . . 1.97 108.814 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.9 -25.26 67.46 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.398 -0.814 . . . . 1.29 109.344 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.615 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 94.2 m-20 -100.13 8.94 43.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.392 -0.817 . . . . 0.74 109.419 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.99 36.2 92.79 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.225 -1.15 . . . . 0.72 110.225 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.13 124.79 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.196 -1.179 . . . . 1.1 109.974 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 80.2 m-20 -110.62 -98.74 0.4 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.07 -1.085 . . . . 1.33 108.07 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.29 165.97 2.73 Favored Glycine 0 N--CA 1.488 2.121 0 CA-C-O 122.146 0.859 . . . . 0.29 112.134 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -77.79 135.49 37.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.067 -1.457 . . . . 2.07 107.067 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -98.58 135.66 39.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.125 -0.985 . . . . 0.15 110.66 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.6 p -132.77 148.24 52.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.747 -1.205 . . . . 1.11 107.747 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 55.5 t80 -135.07 135.63 41.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.261 -0.899 . . . . 0.9 110.372 -178.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -113.03 110.05 19.84 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.607 -0.886 . . . . 0.24 108.607 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.7 t0 -68.0 -30.27 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.16 110.348 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.29 93.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 1.1 110.058 -179.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -107.85 0.08 21.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.476 -0.765 . . . . 1.14 110.106 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 49.98 43.52 25.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.928 -1.107 . . . . 2.63 108.581 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.81 130.23 54.82 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.592 0.71 . . . . 1.05 110.473 -178.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.527 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.9 m-85 -101.37 139.91 36.39 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.231 -1.396 . . . . 0.11 107.231 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.0 m -132.83 134.01 44.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.786 -1.196 . . . . 1.03 108.756 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -122.81 129.8 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.608 -0.886 . . . . 1.02 108.608 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -122.67 126.81 48.36 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.415 -0.803 . . . . 1.05 110.654 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.94 -1.028 . . . . 1.95 109.482 179.038 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.429 0.633 . . . . 3.33 109.829 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.6 m -91.32 134.54 34.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.544 -0.722 . . . . 1.04 109.18 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.565 ' HH ' ' N ' ' A' ' 23' ' ' ALA . 94.3 m-85 -114.73 148.85 37.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.463 -0.773 . . . . 0.89 109.047 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -118.75 142.44 47.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.406 -0.808 . . . . 2.47 109.228 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.9 tp -120.84 129.43 53.54 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.483 -0.76 . . . . 1.01 109.279 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 6' ' ' ILE . 31.8 mm -106.58 123.08 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.404 -1.332 . . . . 1.15 107.404 179.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.47 115.2 30.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.242 -0.911 . . . . 1.06 110.412 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -117.57 70.15 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.352 -1.351 . . . . 0.19 107.352 178.115 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.78 54.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.977 -1.249 . . . . 0.24 109.977 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.2 -39.8 93.33 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -1.1 . . . . 3.13 108.333 178.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -15.62 6.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.947 -0.471 . . . . 1.43 109.778 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.9 tp -100.01 120.04 39.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.095 -1.003 . . . . 1.23 109.517 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -131.89 127.06 35.67 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.331 -0.856 . . . . 2.49 109.364 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.99 -177.9 48.26 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.178 -1.487 . . . . 0.3 110.676 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -148.31 156.89 43.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.625 -0.926 . . . . 1.68 109.179 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.429 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 5.6 t -154.21 170.52 21.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.347 -0.845 . . . . 1.09 109.629 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.9 p -137.98 160.02 40.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.385 -0.822 . . . . 1.07 109.415 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 t -155.08 160.52 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.99 109.239 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -104.36 133.55 49.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.344 -0.848 . . . . 2.22 108.757 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.95 146.07 27.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.006 -1.059 . . . . 1.07 109.637 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.61 -30.15 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.389 -0.819 . . . . 1.15 109.975 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' C ' ' HH ' ' A' ' 3' ' ' TYR . 42.7 p-10 -158.5 174.91 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 1.16 110.163 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -68.83 -38.17 79.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.553 -0.717 . . . . 1.05 110.372 -179.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.94 -37.82 61.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.793 -1.192 . . . . 1.09 110.092 -179.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 p -74.14 -33.06 63.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.637 -1.289 . . . . 1.12 109.685 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.18 93.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.406 -0.809 . . . . 1.02 108.934 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.67 -46.28 84.45 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.838 -1.145 . . . . 1.06 109.637 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -67.13 -40.09 86.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 3.05 110.304 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.47 -53.17 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.972 . . . . 1.05 110.673 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -63.99 -38.07 89.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.15 110.551 -178.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -59.93 -40.16 87.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.624 -1.298 . . . . 2.56 109.126 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -69.38 -41.77 76.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.125 -0.984 . . . . 2.33 109.042 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 59.3 t80 -60.03 -46.6 88.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.99 109.576 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.97 95.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 1.03 109.308 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -40.66 90.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.148 -0.97 . . . . 1.97 108.976 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -64.51 -26.12 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.284 -0.885 . . . . 1.29 109.984 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.627 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 69.6 m-80 -99.75 4.99 45.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.017 -1.052 . . . . 0.74 110.103 -179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.4 60.82 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.034 -1.079 . . . . 0.72 111.599 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.3 t -110.67 122.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.892 -1.357 . . . . 1.1 108.39 178.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 71.1 m-20 -150.6 101.04 2.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 1.33 110.659 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.36 -131.84 1.49 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 119.297 -1.43 . . . . 0.29 111.083 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 57.8 mp0 -88.81 128.11 35.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.952 -1.322 . . . . 2.07 110.164 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -104.11 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.692 -0.63 . . . . 0.15 109.999 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.9 p -131.49 147.19 52.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.93 -1.137 . . . . 1.11 107.93 178.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 53.7 t80 -133.25 132.36 41.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.338 -0.851 . . . . 0.9 110.207 -178.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -114.65 109.94 18.99 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.381 -0.97 . . . . 0.24 108.381 178.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -69.51 -27.67 65.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 1.16 110.267 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.92 95.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 1.1 109.926 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.9 p -106.02 0.18 25.43 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.546 -0.721 . . . . 1.14 110.036 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtpm? 50.02 39.96 20.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.882 -1.136 . . . . 2.63 108.289 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -120.01 132.87 55.63 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 1.05 110.593 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 56.3 m-85 -100.36 139.67 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.252 -1.388 . . . . 0.11 107.252 177.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 m -130.24 131.97 45.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.763 -1.21 . . . . 1.03 108.339 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.83 129.25 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.34 -0.985 . . . . 1.02 108.34 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -124.56 128.19 48.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.621 -0.674 . . . . 1.05 110.115 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.038 -0.982 . . . . 1.95 109.296 179.8 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.265 0.555 . . . . 3.33 109.695 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.6 m -91.36 133.31 35.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.827 . . . . 1.04 109.325 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -112.35 145.37 40.18 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.366 -0.976 . . . . 0.89 108.366 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -113.43 139.97 48.47 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.124 -0.985 . . . . 2.47 108.8 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.4 tp -120.91 126.6 50.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.754 -0.832 . . . . 1.01 108.754 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.62 124.01 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.61 -1.256 . . . . 1.15 107.61 178.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.0 mt -104.24 114.13 28.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 1.06 110.231 -179.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -113.5 72.46 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.395 -1.335 . . . . 0.19 107.395 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.55 169.46 53.53 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.665 -1.374 . . . . 0.24 109.665 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -64.87 -38.51 91.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -1.129 . . . . 3.13 108.517 178.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 p -130.62 -16.58 3.37 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.527 -0.546 . . . . 1.43 109.527 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -101.76 117.36 34.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.249 -1.019 . . . . 1.23 108.249 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -133.71 137.87 45.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.207 -0.933 . . . . 2.49 110.416 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -180.0 -178.25 48.43 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.688 -1.244 . . . . 0.3 110.194 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.56 154.71 41.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.507 -0.923 . . . . 1.68 108.507 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -154.63 170.7 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.842 . . . . 1.09 109.502 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -138.32 160.03 40.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.919 -0.771 . . . . 1.07 108.919 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 t -156.7 161.42 39.85 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.273 -0.892 . . . . 0.99 109.239 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -102.92 134.97 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.696 -0.853 . . . . 2.22 108.696 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.61 144.87 27.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 1.07 108.912 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.03 -30.58 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 1.15 109.467 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -159.73 178.51 9.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 1.16 110.02 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.76 -37.92 82.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.456 -0.777 . . . . 1.05 110.048 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.51 -37.38 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.965 -1.085 . . . . 1.09 110.136 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.8 m -69.92 -39.19 76.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.634 -1.291 . . . . 1.12 109.66 179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.89 87.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.595 -0.69 . . . . 1.02 109.196 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.97 -45.81 82.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.883 -1.127 . . . . 1.06 109.504 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -67.82 -43.38 79.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 3.05 110.679 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.94 -52.53 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.32 -0.863 . . . . 1.05 111.62 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -64.22 -38.47 91.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.802 -1.186 . . . . 0.15 110.482 -178.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -60.04 -44.07 94.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.84 -1.162 . . . . 2.56 109.692 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.512 ' NE2' ' OD2' ' A' ' 36' ' ' ASP . 1.6 tm0? -67.91 -41.7 82.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 2.33 108.705 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.7 t80 -60.0 -49.02 79.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.622 -0.674 . . . . 0.99 109.503 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.42 93.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 1.03 109.057 179.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -60.17 -44.58 94.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 1.97 109.366 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' NE2' ' A' ' 32' ' ' GLN . 82.3 m-20 -62.72 -24.04 67.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 1.29 109.24 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.623 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.0 m-20 -97.63 7.01 47.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.816 . . . . 0.74 109.667 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.18 31.59 77.93 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.053 -1.07 . . . . 0.72 110.851 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.99 127.41 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.174 -1.192 . . . . 1.1 109.836 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 87.5 m-20 -109.99 -99.82 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.092 -1.077 . . . . 1.33 108.092 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.96 163.51 4.17 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-O 122.028 0.793 . . . . 0.29 112.339 177.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 58.1 mp0 -75.55 137.15 40.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.321 -1.363 . . . . 2.07 107.321 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -99.89 135.0 41.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 0.15 110.927 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.6 p -135.23 150.05 50.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.632 -1.247 . . . . 1.11 107.632 178.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -135.27 138.9 43.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.294 -0.879 . . . . 0.9 110.566 -178.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -113.66 109.99 19.48 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.65 -0.87 . . . . 0.24 108.65 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 36.5 t0 -67.5 -31.39 71.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.16 110.312 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.973 . . . . 1.1 110.573 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -105.4 0.64 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.519 -0.738 . . . . 1.14 110.14 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm 50.58 42.45 26.87 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.855 -1.165 . . . . 2.63 107.855 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -120.0 131.14 55.05 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.719 0.771 . . . . 1.05 110.945 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -99.72 138.21 37.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.115 -1.439 . . . . 0.11 107.115 177.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -130.63 131.95 45.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.662 -1.274 . . . . 1.03 109.076 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -124.23 130.02 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.402 -0.962 . . . . 1.02 108.402 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.91 126.5 51.05 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.664 -0.648 . . . . 1.05 110.181 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.981 -1.009 . . . . 1.95 109.576 -179.901 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.366 -0.605 . . . . 3.33 109.366 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 m -93.58 131.76 38.55 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.018 -1.051 . . . . 1.04 109.929 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.71 148.03 38.84 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.369 -0.975 . . . . 0.89 108.369 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -116.5 140.89 48.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.257 -0.902 . . . . 2.47 109.08 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.7 tp -120.42 129.56 53.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.601 -0.687 . . . . 1.01 109.581 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 6' ' ' ILE . 96.6 mt -106.68 122.76 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.746 -1.576 . . . . 1.15 106.746 177.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.97 116.5 32.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.892 . . . . 1.06 109.679 -178.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -114.87 71.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 0.19 107.601 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.32 168.18 48.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.396 -1.482 . . . . 0.24 109.396 179.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.47 -39.51 77.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.187 -1.184 . . . . 3.13 108.459 178.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -117.82 -22.96 7.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.783 -0.573 . . . . 1.43 109.662 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.8 tp -101.45 120.37 40.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 1.23 109.264 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -134.38 129.9 36.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.957 . . . . 2.49 109.536 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.53 -174.0 46.58 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.369 -1.396 . . . . 0.3 110.391 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -148.56 157.21 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.631 -0.923 . . . . 1.68 108.932 179.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -154.8 170.8 20.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.922 . . . . 1.09 109.664 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.4 p -137.97 160.13 40.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 1.07 109.086 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -156.19 162.95 40.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.384 -0.822 . . . . 0.99 109.061 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -102.31 133.81 46.61 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.677 -0.861 . . . . 2.22 108.677 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.34 143.16 25.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.096 . . . . 1.07 109.525 -179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.79 -29.81 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 1.15 110.051 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -157.93 176.53 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.16 109.915 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.34 -37.58 80.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 1.05 109.827 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.82 -37.34 59.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.017 . . . . 1.09 109.94 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 p -73.31 -34.5 65.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.692 -1.255 . . . . 1.12 109.388 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.35 93.18 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.35 -50.05 74.18 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.634 -1.226 . . . . 1.06 109.754 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -65.88 -41.43 91.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 3.05 110.141 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.88 -55.35 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.1 -1.0 . . . . 1.05 110.259 -178.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -65.12 -39.75 93.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.15 110.298 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -60.53 -44.06 96.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 2.56 109.637 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -69.23 -42.78 75.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.968 -1.082 . . . . 2.33 108.797 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 77.2 t80 -60.02 -45.92 91.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.463 -0.773 . . . . 0.99 109.18 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.24 95.95 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.507 -0.746 . . . . 1.03 109.016 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -61.32 -40.93 96.03 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 1.97 109.192 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.86 -25.1 66.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 1.29 109.513 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 92.9 m-20 -97.9 9.99 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 0.74 109.881 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.15 92.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.835 -1.306 . . . . 0.72 109.835 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.99 125.54 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.287 -1.125 . . . . 1.1 109.482 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 21.3 p-10 -141.76 148.5 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.214 -1.032 . . . . 1.33 108.214 179.017 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.43 -147.75 10.92 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.219 -1.467 . . . . 0.29 110.053 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -93.14 131.32 38.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 2.07 108.445 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -100.71 137.4 39.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 0.15 110.098 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.0 p -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.446 -0.946 . . . . 1.11 108.446 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 59.3 t80 -134.09 136.39 43.89 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.408 -0.808 . . . . 0.9 110.162 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -112.16 109.27 18.87 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.314 -0.995 . . . . 0.24 108.314 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.17 -31.2 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.973 . . . . 1.16 110.287 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.04 90.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 1.1 110.318 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.435 ' C ' ' HZ1' ' A' ' 50' ' ' LYS . 80.3 p -104.98 -0.76 26.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.251 -0.905 . . . . 1.14 110.011 -179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.435 ' HZ1' ' C ' ' A' ' 49' ' ' THR . 0.0 OUTLIER 50.06 40.77 22.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 2.63 108.362 -179.755 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.58 54.86 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.616 0.722 . . . . 1.05 110.141 -178.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 33.3 m-85 -98.75 138.32 36.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 0.11 106.999 178.278 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -131.99 132.21 43.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.878 -1.139 . . . . 1.03 108.139 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.18 132.15 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.481 -0.933 . . . . 1.02 108.481 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.7 m -119.1 126.38 51.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.608 -0.683 . . . . 1.05 109.631 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.055 -0.974 . . . . 1.95 109.584 -179.36 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' SD ' ' NZ ' ' A' ' 50' ' ' LYS . 67.8 mtt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.329 -0.619 . . . . 3.33 109.329 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -91.0 132.85 35.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 1.04 109.218 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.72 147.7 40.6 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.771 -0.826 . . . . 0.89 108.771 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -117.29 143.8 45.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.405 -0.809 . . . . 2.47 109.651 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.8 tp -119.58 126.61 51.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.591 -0.892 . . . . 1.01 108.591 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.55 122.79 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.194 -1.41 . . . . 1.15 107.194 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.4 mt -100.3 117.14 33.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 1.06 110.265 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -122.2 66.55 0.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.334 -1.358 . . . . 0.19 107.334 178.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.33 169.87 53.04 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 0.24 109.794 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.554 ' CB ' ' HZ2' ' A' ' 10' ' ' LYS . 7.6 ttpm? -63.61 -39.88 95.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.272 -1.134 . . . . 3.13 108.582 177.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.09 -19.92 6.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.955 -0.466 . . . . 1.43 109.896 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.37 119.98 38.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.228 -0.92 . . . . 1.23 109.401 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -135.14 129.99 34.73 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.268 -0.895 . . . . 2.49 109.832 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.61 -177.38 48.42 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.338 -1.411 . . . . 0.3 110.584 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -142.52 151.14 41.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.607 -0.937 . . . . 1.68 108.676 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -152.72 167.37 29.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 1.09 109.241 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.7 p -137.67 160.19 39.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 1.07 109.502 -179.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 t -153.77 159.94 42.09 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.672 -0.862 . . . . 0.99 108.672 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -101.43 131.95 47.28 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.45 -0.944 . . . . 2.22 108.45 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.17 142.75 27.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 1.07 109.22 -179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.06 -28.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -0.778 . . . . 1.15 109.877 -179.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -158.43 174.72 14.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 1.16 110.099 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.09 82.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.548 -0.72 . . . . 1.05 110.061 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.02 54.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.912 -1.117 . . . . 1.09 109.728 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.8 p -72.41 -34.86 68.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.775 -1.203 . . . . 1.12 109.459 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.89 94.05 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.617 -0.883 . . . . 1.02 108.617 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.11 -49.88 74.54 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.934 -1.107 . . . . 1.06 109.914 -179.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -66.85 -40.61 87.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.866 -1.146 . . . . 3.05 110.762 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.86 -53.6 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.949 -1.095 . . . . 1.05 110.891 -178.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -62.75 -37.33 86.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.907 -1.121 . . . . 0.15 110.211 -178.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -61.46 -40.52 94.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.875 -1.14 . . . . 2.56 109.338 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.84 -43.3 72.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.818 -1.176 . . . . 2.33 108.31 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.562 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 63.8 t80 -59.99 -49.49 77.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.662 -0.866 . . . . 0.99 108.662 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.63 93.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.575 -0.703 . . . . 1.03 109.417 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -60.05 -41.17 91.73 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.829 -0.804 . . . . 1.97 108.829 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.94 -23.1 67.23 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.352 -0.843 . . . . 1.29 109.112 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.562 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 81.2 m-20 -97.11 8.39 44.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.74 109.974 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.04 32.32 69.49 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.942 -1.123 . . . . 0.72 111.004 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.8 t -109.99 124.92 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.996 -1.297 . . . . 1.1 109.089 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 32.7 p-10 -152.23 100.67 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.062 -1.024 . . . . 1.33 110.34 179.21 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 -130.19 1.37 Allowed Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.204 -1.474 . . . . 0.29 111.044 -178.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -89.94 125.2 35.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.916 -1.344 . . . . 2.07 110.359 -178.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -102.53 136.54 42.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.15 110.115 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -136.19 149.58 48.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.982 -1.118 . . . . 1.11 107.982 178.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -137.47 136.22 37.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.239 -0.913 . . . . 0.9 109.958 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -114.52 111.25 21.09 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.854 -0.795 . . . . 0.24 108.854 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 49.5 t0 -67.37 -28.84 68.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 1.16 110.234 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.12 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 1.1 110.376 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 p -105.95 -0.04 25.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 1.14 109.765 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 68.9 mttm 50.03 41.44 23.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 2.63 108.42 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.98 133.2 55.62 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.571 0.7 . . . . 1.05 110.366 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.0 139.43 36.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.393 -1.336 . . . . 0.11 107.393 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.2 m -130.04 131.86 45.98 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.759 -1.213 . . . . 1.03 108.476 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.62 129.15 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.61 -0.885 . . . . 1.02 108.61 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -124.01 129.94 51.76 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.471 0.653 . . . . 1.05 110.272 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.029 -0.986 . . . . 1.95 109.48 -179.7 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.6 mtp . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.033 -0.728 . . . . 3.33 109.033 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 m -92.44 133.85 35.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 1.04 109.446 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.94 147.58 43.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.722 -0.844 . . . . 0.89 108.722 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -118.24 143.61 46.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 2.47 109.441 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.23 130.0 55.24 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.103 -0.703 . . . . 1.01 109.103 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 122.58 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.919 -1.512 . . . . 1.15 106.919 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -103.2 116.73 33.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 1.06 110.543 -178.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -116.96 69.38 0.75 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.732 -1.21 . . . . 0.19 107.732 178.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 168.6 47.71 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.529 -1.429 . . . . 0.24 109.529 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.73 -38.91 84.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 3.13 109.172 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.3 p -117.2 -21.0 9.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.62 -0.675 . . . . 1.43 110.056 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -106.8 120.0 40.83 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.35 -0.844 . . . . 1.23 109.45 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.57 133.61 42.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 2.49 109.055 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.48 -170.28 43.38 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.075 -1.536 . . . . 0.3 110.644 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.85 155.89 42.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.661 -0.906 . . . . 1.68 108.98 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -151.87 169.28 22.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.468 -0.77 . . . . 1.09 109.291 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.9 p -138.86 159.69 41.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.258 -0.901 . . . . 1.07 109.544 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 t -156.38 160.81 39.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.977 -0.749 . . . . 0.99 108.977 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.97 134.05 44.54 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.543 -0.91 . . . . 2.22 108.543 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.3 139.18 24.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.055 -1.028 . . . . 1.07 109.23 -179.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.91 -26.7 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 1.15 109.495 -179.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 25' ' ' THR . 45.4 p-10 -157.12 170.72 21.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.16 109.734 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.7 83.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.546 -0.721 . . . . 1.05 110.105 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.55 -36.47 61.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.892 -1.13 . . . . 1.09 110.016 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 22' ' ' ASP . 11.8 p -73.7 -34.81 65.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.627 -1.296 . . . . 1.12 109.564 178.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.09 92.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.384 -0.822 . . . . 1.02 109.05 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.26 -44.62 79.88 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.679 -1.209 . . . . 1.06 109.131 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' NZ ' ' CB ' ' A' ' 28' ' ' LYS . 8.6 mtpm? -67.23 -41.64 85.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.319 -0.863 . . . . 3.05 110.573 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.59 -51.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 1.05 110.503 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -67.46 -39.92 85.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.944 -1.098 . . . . 0.15 110.736 -179.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -61.96 -42.37 99.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.725 -1.234 . . . . 2.56 109.612 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -69.14 -41.8 76.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.112 -0.993 . . . . 2.33 108.441 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.564 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.6 t80 -60.05 -48.41 81.83 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.569 0.7 . . . . 0.99 109.175 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.53 97.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.579 -0.701 . . . . 1.03 109.31 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.06 -41.77 93.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.834 . . . . 1.97 109.011 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.83 -25.13 67.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 1.29 109.757 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.564 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.2 m-20 -96.79 10.02 40.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.139 -0.976 . . . . 0.74 110.189 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.62 34.04 87.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.975 -1.25 . . . . 0.72 109.975 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.89 126.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.242 -1.152 . . . . 1.1 109.498 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -142.63 150.12 39.84 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 1.33 108.806 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.77 -148.16 12.07 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 118.746 -1.692 . . . . 0.29 110.489 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -90.99 129.42 37.0 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.358 -0.979 . . . . 2.07 108.358 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.32 137.11 39.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.15 110.025 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -134.45 149.49 50.75 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.133 -1.062 . . . . 1.11 108.133 179.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.416 ' CD1' ' CE1' ' A' ' 52' ' ' PHE . 43.2 t80 -132.78 134.59 44.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.303 -0.873 . . . . 0.9 110.228 -178.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -112.81 109.85 19.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.801 -0.814 . . . . 0.24 108.801 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.6 -31.03 69.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.923 . . . . 1.16 110.513 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.95 94.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 1.1 110.437 -179.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -106.91 0.85 24.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.455 -0.778 . . . . 1.14 110.43 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 50.18 40.11 21.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.909 -1.119 . . . . 2.63 108.435 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 130.87 54.95 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.536 0.684 . . . . 1.05 110.648 -178.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CE1' ' CD1' ' A' ' 45' ' ' TYR . 68.6 m-85 -99.65 141.11 32.88 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.628 -1.249 . . . . 0.11 107.628 178.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 m -130.48 131.39 45.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.807 -1.183 . . . . 1.03 108.451 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.37 130.3 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.365 -0.976 . . . . 1.02 108.365 179.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.4 m -119.97 126.28 50.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.498 -0.752 . . . . 1.05 109.778 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.973 -1.013 . . . . 1.95 109.546 -179.863 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 21' ' ' VAL . 61.7 mtt . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.304 0.573 . . . . 3.33 109.458 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.7 m -90.88 132.71 35.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 1.04 109.233 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' HH ' ' N ' ' A' ' 23' ' ' ALA . 95.8 m-85 -114.95 146.54 41.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.537 -0.912 . . . . 0.89 108.537 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -117.36 140.81 49.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.748 -0.834 . . . . 2.47 108.748 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 tp -118.92 129.31 55.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.842 -0.799 . . . . 1.01 108.842 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.9 mt -106.17 122.39 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.487 -1.301 . . . . 1.15 107.487 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.37 112.88 25.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 1.06 109.185 -179.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.67 71.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.687 -1.227 . . . . 0.19 107.687 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.09 165.57 43.51 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.492 -1.443 . . . . 0.24 109.492 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' NZ ' ' C ' ' A' ' 56' ' ' GLU . 10.5 mptt -68.07 -35.29 77.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.192 -1.181 . . . . 3.13 107.872 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -117.67 -25.55 6.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.746 -0.596 . . . . 1.43 110.077 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 tp -101.56 122.2 43.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.151 -0.968 . . . . 1.23 109.733 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -136.48 130.74 33.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.225 -0.922 . . . . 2.49 109.618 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.62 -172.72 45.69 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.531 -1.319 . . . . 0.3 110.499 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.11 156.28 42.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.598 -0.942 . . . . 1.68 109.285 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -153.15 170.66 19.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 1.09 109.247 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.7 p -137.84 159.95 40.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.329 -0.857 . . . . 1.07 109.397 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -156.25 160.17 39.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.99 109.624 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.78 134.31 47.3 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.251 -1.018 . . . . 2.22 108.251 179.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.01 144.2 26.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 1.07 109.417 -179.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' SD ' ' A' ' 1' ' ' MET . 33.5 m -60.31 -31.11 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 1.15 109.859 -179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -158.81 176.47 12.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 1.16 110.175 -179.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.459 ' N ' ' HH ' ' A' ' 3' ' ' TYR . . . -67.58 -38.85 84.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 1.05 109.723 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.79 -38.05 64.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 1.09 109.772 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m -70.02 -39.8 75.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.665 -1.272 . . . . 1.12 109.994 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.501 -0.749 . . . . 1.02 109.301 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -57.88 -40.99 81.58 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.458 -1.297 . . . . 1.06 109.088 -179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -69.89 -43.32 72.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 3.05 109.864 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.94 -52.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 1.05 111.072 -178.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -62.86 -39.35 94.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.15 110.286 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -60.59 -44.54 96.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.75 -1.218 . . . . 2.56 109.604 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.96 -45.06 78.9 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.113 -0.992 . . . . 2.33 108.424 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.8 t80 -59.96 -48.89 79.86 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.63 -0.669 . . . . 0.99 109.262 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.36 96.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 1.03 109.274 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.0 -41.56 92.38 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.384 -0.969 . . . . 1.97 108.384 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.4 -22.56 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.4 -0.813 . . . . 1.29 109.006 179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.8 m-20 -96.71 9.43 41.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.74 109.703 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 33.51 87.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.836 -1.306 . . . . 0.72 109.836 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.95 130.01 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.412 -1.052 . . . . 1.1 110.214 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 71.9 m-20 -111.61 -95.03 0.43 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.525 -1.287 . . . . 1.33 107.525 178.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.91 164.42 3.5 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.486 -0.759 . . . . 0.29 111.962 177.202 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 56.1 mp0 -75.43 137.69 41.16 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.107 -1.442 . . . . 2.07 107.107 178.208 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -100.07 135.26 41.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.15 110.829 -178.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -136.67 150.57 48.56 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.11 -1.07 . . . . 1.11 108.11 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -135.77 137.89 42.09 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.174 -0.954 . . . . 0.9 110.609 -178.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -112.8 110.05 19.92 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.947 -0.76 . . . . 0.24 108.947 179.345 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 42.2 t0 -66.7 -32.71 74.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 1.16 110.47 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.95 95.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.031 -1.043 . . . . 1.1 110.315 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -106.76 -0.13 23.73 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.423 -0.798 . . . . 1.14 110.557 -179.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 49.51 41.23 20.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.838 -1.164 . . . . 2.63 108.697 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.01 130.64 55.78 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.612 0.72 . . . . 1.05 110.13 -178.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -98.81 138.66 35.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.369 -1.345 . . . . 0.11 107.369 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -130.56 131.74 45.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.77 -1.206 . . . . 1.03 108.391 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.178 -1.045 . . . . 1.02 108.178 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.66 126.57 51.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.507 -0.745 . . . . 1.05 110.123 -179.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' C ' ' NZ ' ' A' ' 10' ' ' LYS . 54.5 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.849 -1.072 . . . . 1.95 109.118 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.268 0.556 . . . . 3.33 109.754 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.8 m -88.42 132.17 34.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 1.04 108.72 179.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -114.8 143.12 45.59 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.74 -0.837 . . . . 0.89 108.74 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -115.7 140.33 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.854 -0.795 . . . . 2.47 108.854 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 43.1 tp -117.7 127.81 54.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.747 -0.834 . . . . 1.01 108.747 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.29 121.86 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.692 -1.596 . . . . 1.15 106.692 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -100.02 110.52 22.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.036 -1.04 . . . . 1.06 108.966 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -114.07 68.33 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.649 -1.612 . . . . 0.19 106.649 178.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 171.03 54.75 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.679 -1.368 . . . . 0.24 109.679 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.66 -39.42 94.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.023 -1.103 . . . . 3.13 108.023 178.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 p -125.05 -13.96 6.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.177 -0.465 . . . . 1.43 109.787 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.5 tp -98.13 119.96 37.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.156 -0.965 . . . . 1.23 109.043 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -133.29 126.54 31.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.351 -0.843 . . . . 2.49 109.427 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -176.22 47.88 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.559 -1.305 . . . . 0.3 110.243 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.52 156.4 42.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.714 -0.874 . . . . 1.68 108.669 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -154.93 170.72 21.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.365 -0.834 . . . . 1.09 109.632 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.9 p -136.81 158.9 43.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 1.07 109.235 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 t -154.73 160.23 41.2 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.486 -0.931 . . . . 0.99 108.486 179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.94 133.56 48.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 2.22 109.467 -179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.05 143.1 25.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.942 . . . . 1.07 108.825 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.55 -26.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 1.15 109.859 -179.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -159.49 176.31 12.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.056 -1.028 . . . . 1.16 109.87 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.31 80.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.521 -0.737 . . . . 1.05 110.095 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.3 63.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.917 -1.114 . . . . 1.09 110.053 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -72.23 -36.16 69.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.536 -1.352 . . . . 1.12 109.862 179.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.07 91.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.748 . . . . 1.02 108.994 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.12 -50.01 72.28 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.897 -1.121 . . . . 1.06 110.024 -178.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -65.15 -40.15 93.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.883 -1.136 . . . . 3.05 110.826 -179.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.0 t -69.94 -54.04 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 1.05 111.586 -178.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -64.03 -39.51 94.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.942 -1.099 . . . . 0.15 111.284 -178.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.76 -40.06 96.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.809 -1.182 . . . . 2.56 109.957 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -69.41 -42.66 74.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.713 -1.242 . . . . 2.33 109.145 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.462 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 65.9 t80 -59.98 -46.01 90.84 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.879 . . . . 0.99 108.628 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.9 97.82 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.855 -0.795 . . . . 1.03 108.855 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -60.08 -44.84 94.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.492 -0.755 . . . . 1.97 109.741 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.32 -23.96 67.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 1.29 109.85 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 4.4 m120 -96.44 7.48 46.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -0.963 . . . . 0.74 109.554 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.69 31.79 73.69 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.804 -1.189 . . . . 0.72 110.158 179.117 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.43 125.99 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.19 -1.182 . . . . 1.1 109.531 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 57.6 t0 -140.77 146.54 37.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.264 -1.013 . . . . 1.33 108.264 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.63 -153.03 16.52 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.171 -1.49 . . . . 0.29 110.134 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.59 134.35 34.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -1.053 . . . . 2.07 108.442 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -101.48 135.96 42.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 0.15 110.296 -179.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.2 p -135.0 149.11 50.13 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.324 -0.991 . . . . 1.11 108.324 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 69.6 t80 -135.35 136.2 41.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.376 -0.828 . . . . 0.9 110.098 -178.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -112.77 109.97 19.79 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.685 -0.857 . . . . 0.24 108.685 179.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.9 t0 -65.62 -31.34 72.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 1.16 110.47 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.138 -0.976 . . . . 1.1 110.372 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.8 p -106.62 -0.09 24.02 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.337 -0.852 . . . . 1.14 110.559 -179.036 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 50.01 41.25 22.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.745 -1.222 . . . . 2.63 108.361 -179.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.99 130.94 54.99 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.708 0.766 . . . . 1.05 110.391 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 58.7 m-85 -99.62 139.97 34.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.271 -1.381 . . . . 0.11 107.271 178.178 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.0 m -130.43 131.53 45.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.672 -1.268 . . . . 1.03 108.037 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.21 128.97 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.045 -1.094 . . . . 1.02 108.045 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.8 m -119.96 127.97 53.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 1.05 109.984 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.004 -0.998 . . . . 1.95 109.626 -179.316 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' ' NZ ' ' A' ' 50' ' ' LYS . 54.4 mtt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.31 0.576 . . . . 3.33 109.608 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.3 m -92.59 132.89 36.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 1.04 108.917 179.425 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.73 150.04 40.44 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.129 -0.693 . . . . 0.89 109.129 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -118.6 143.69 46.63 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.571 -0.706 . . . . 2.47 109.717 -179.031 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.0 tp -119.22 127.45 53.28 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.714 -0.847 . . . . 1.01 108.714 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.25 122.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.945 -1.502 . . . . 1.15 106.945 178.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.0 mt -103.24 111.6 24.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.92 . . . . 1.06 109.873 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.5 71.55 0.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.267 -1.383 . . . . 0.19 107.267 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 165.61 49.33 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.367 -1.493 . . . . 0.24 109.367 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -67.83 -36.86 81.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.218 -1.166 . . . . 3.13 108.421 178.246 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.6 m -120.73 -22.19 6.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.913 -0.492 . . . . 1.43 109.787 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.1 tp -104.69 120.48 41.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.328 -0.858 . . . . 1.23 109.421 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -132.86 133.58 43.49 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.348 -0.845 . . . . 2.49 109.896 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.3 -176.24 47.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.438 -1.363 . . . . 0.3 110.604 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.3 pm0 -147.19 155.67 42.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.719 -0.871 . . . . 1.68 108.969 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 t -154.86 170.25 22.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 1.09 109.675 -179.586 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -134.89 158.3 44.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.483 -0.761 . . . . 1.07 109.031 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -154.46 158.7 40.34 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.65 -0.871 . . . . 0.99 108.65 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 56.6 mp0 -102.58 134.1 46.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.214 -0.929 . . . . 2.22 109.185 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' CB ' ' HG1' ' A' ' 25' ' ' THR . . . -148.19 143.45 27.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.112 -0.992 . . . . 1.07 108.774 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.06 -28.24 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 1.15 109.251 -179.273 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -158.74 176.93 11.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 1.16 109.912 -179.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.5 84.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 1.05 109.879 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.29 -37.72 62.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.04 -1.037 . . . . 1.09 110.212 -179.486 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.4 ' HG1' ' CB ' ' A' ' 20' ' ' ALA . 12.1 p -71.55 -35.94 70.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.546 -1.346 . . . . 1.12 109.59 179.052 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.52 89.76 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.351 -0.843 . . . . 1.02 108.865 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.9 -49.99 74.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.987 -1.085 . . . . 1.06 110.133 -178.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -66.65 -42.53 86.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 3.05 110.623 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.3 t -69.67 -53.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.983 . . . . 1.05 110.713 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -61.03 -37.96 84.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.917 -1.114 . . . . 0.15 109.512 -179.406 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.06 -43.51 95.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 2.56 110.009 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.41 -42.31 79.15 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 2.33 108.677 179.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.596 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -48.69 80.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.99 110.087 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.95 93.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 1.03 109.657 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -61.39 -39.95 92.58 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 1.97 109.202 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -62.28 -24.66 67.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 1.29 109.959 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.596 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 98.5 m-20 -96.35 8.79 43.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.007 . . . . 0.74 110.09 -179.227 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.82 31.71 81.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.441 -1.464 . . . . 0.72 109.441 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.6 t -107.47 126.3 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -1.084 . . . . 1.1 109.302 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -140.11 147.47 40.29 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.093 -1.077 . . . . 1.33 108.093 179.391 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.59 -154.25 19.52 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.227 -1.463 . . . . 0.29 109.943 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 38.4 mp0 -87.76 132.83 34.01 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.217 -1.031 . . . . 2.07 108.217 179.061 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -99.93 135.51 41.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 0.15 110.098 -179.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.2 p -136.73 150.04 48.19 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 1.11 108.523 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 58.7 t80 -133.48 133.63 42.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.412 -0.805 . . . . 0.9 109.812 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -111.21 107.76 17.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.485 -0.931 . . . . 0.24 108.485 179.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.96 -30.67 70.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 1.16 110.045 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.45 98.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 1.1 109.87 -179.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 p -104.74 1.06 28.91 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.48 -0.762 . . . . 1.14 109.887 -179.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.588 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 91.6 mttt 50.03 39.9 20.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 2.63 108.554 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.4 m -120.03 134.35 55.27 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.474 0.654 . . . . 1.05 110.831 -178.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 53.1 m-85 -99.82 139.25 35.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.11 107.271 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -131.29 130.68 43.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.561 -1.337 . . . . 1.03 108.6 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.28 127.69 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.788 -1.189 . . . . 1.02 107.788 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.1 m -120.01 127.13 52.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.452 -0.78 . . . . 1.05 109.728 -179.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.037 -0.982 . . . . 1.95 109.45 -179.682 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.208 -0.664 . . . . 3.33 109.208 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.6 m -89.44 134.72 33.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.089 -1.007 . . . . 1.04 109.641 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -114.96 147.43 40.05 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.869 -0.789 . . . . 0.89 108.869 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -119.73 141.46 49.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.482 -0.761 . . . . 2.47 109.465 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.7 tp -120.65 129.85 53.88 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.915 -0.772 . . . . 1.01 108.915 179.436 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.53 124.83 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.806 -1.183 . . . . 1.15 107.806 178.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.5 mt -102.06 114.58 28.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 1.06 110.012 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.57 68.52 0.7 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.339 -1.356 . . . . 0.19 107.339 178.357 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.99 49.15 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.742 -1.343 . . . . 0.24 109.742 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -67.05 -37.55 84.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.368 -1.078 . . . . 3.13 108.157 178.231 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 m -119.55 -22.9 6.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.939 -0.475 . . . . 1.43 110.104 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 tp -101.59 120.27 40.06 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.18 -0.95 . . . . 1.23 109.649 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -132.12 128.67 38.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.49 109.211 179.335 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.45 -173.88 46.59 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.185 -1.484 . . . . 0.3 110.608 179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.4 pm0 -150.26 159.56 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.625 -0.927 . . . . 1.68 109.442 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.54 ' HG1' ' N ' ' A' ' 17' ' ' THR . 4.3 t -152.62 170.01 21.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.521 -0.737 . . . . 1.09 109.269 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.54 ' N ' ' HG1' ' A' ' 16' ' ' THR . 80.7 p -136.54 158.44 44.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.245 -0.91 . . . . 1.07 109.081 -179.651 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 t -156.55 161.9 39.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.357 -0.839 . . . . 0.99 109.061 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -101.26 132.29 46.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.317 -0.994 . . . . 2.22 108.317 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.48 142.17 26.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 1.07 109.551 -179.5 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.58 -30.36 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 1.15 110.603 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -158.58 179.4 9.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.931 -1.106 . . . . 1.16 110.295 -179.266 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.93 75.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.55 -0.719 . . . . 1.05 110.539 -179.111 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.66 65.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.776 -1.203 . . . . 1.09 109.866 -179.164 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -70.53 -39.95 73.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.741 -1.224 . . . . 1.12 109.846 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.96 92.15 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.532 -0.73 . . . . 1.02 109.258 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.82 -43.22 94.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.745 -1.182 . . . . 1.06 110.105 -179.129 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -69.73 -42.69 73.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.26 -0.9 . . . . 3.05 110.69 -179.24 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.61 -53.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 1.05 111.173 -178.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -60.23 -35.84 76.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.019 -1.051 . . . . 0.15 109.864 -178.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.13 -41.51 92.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.897 -1.127 . . . . 2.56 108.915 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -68.47 -44.82 73.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.094 -1.003 . . . . 2.33 108.755 179.372 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.511 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.1 t80 -60.34 -48.2 82.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.99 109.489 179.673 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.41 97.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 1.03 109.244 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -60.12 -39.94 88.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.229 -0.92 . . . . 1.97 108.538 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.87 -23.81 67.5 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.467 -0.771 . . . . 1.29 109.286 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 9.8 m120 -96.77 6.31 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.09 -1.006 . . . . 0.74 109.46 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.06 33.23 78.4 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.864 -1.16 . . . . 0.72 110.259 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.0 t -111.16 125.38 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.091 -1.241 . . . . 1.1 108.918 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 69.6 m-20 -152.25 103.62 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.984 -1.073 . . . . 1.33 110.993 179.737 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.03 -130.13 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.557 -1.306 . . . . 0.29 110.907 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 42.2 mp0 -93.99 130.98 39.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.937 -1.331 . . . . 2.07 110.141 -178.516 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -104.09 139.3 39.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.672 -0.643 . . . . 0.15 110.244 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 p -134.31 147.77 50.65 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.963 -1.125 . . . . 1.11 107.963 178.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 60.3 t80 -135.84 135.16 39.57 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.188 -0.945 . . . . 0.9 110.211 -178.685 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -112.97 110.28 20.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.921 -0.77 . . . . 0.24 108.921 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 63.5 t0 -65.06 -31.83 73.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 1.16 110.528 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.99 92.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 1.1 110.616 -179.185 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -104.81 -0.69 26.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 1.14 110.554 -179.04 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 50.02 40.02 20.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.817 -1.177 . . . . 2.63 108.156 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.9 m -120.02 131.2 55.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.672 0.749 . . . . 1.05 110.282 -178.2 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m-85 -98.62 138.9 35.13 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.504 -1.295 . . . . 0.11 107.504 178.435 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -131.77 131.07 42.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.697 -1.252 . . . . 1.03 107.791 179.154 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.02 129.86 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.288 -1.005 . . . . 1.02 108.288 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -121.65 125.85 47.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.569 -0.707 . . . . 1.05 109.729 -179.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 27.1 mp0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.915 -1.04 . . . . 1.95 109.502 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.224 0.535 . . . . 0.34 110.234 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.15 144.34 42.84 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.167 -1.42 . . . . 0.35 107.167 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -115.56 140.03 49.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.37 -0.831 . . . . 2.19 110.358 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.1 tp -120.14 129.98 54.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.723 -0.611 . . . . 0.17 109.67 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.1 mt -107.77 125.21 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.632 -1.247 . . . . 0.65 107.632 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.8 mt -103.87 115.44 30.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.255 -0.903 . . . . 0.25 111.03 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -111.59 59.78 0.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.53 -0.915 . . . . 1.76 108.53 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.98 165.48 53.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.23 -1.548 . . . . 0.21 109.23 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -63.75 -39.98 95.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.881 -1.364 . . . . 2.78 108.221 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -118.5 -20.01 8.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.11 -0.7 . . . . 1.38 109.11 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.7 tp -98.23 118.19 34.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.518 -0.739 . . . . 0.48 109.223 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.83 126.8 35.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.287 -1.005 . . . . 2.17 108.287 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.84 -177.96 48.34 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 118.988 -1.577 . . . . 0.21 109.921 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -148.07 157.67 43.64 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.455 -0.943 . . . . 2.37 108.455 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -156.36 167.48 30.29 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.314 -0.866 . . . . 0.19 108.757 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 p -133.65 161.02 35.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.346 -0.846 . . . . 0.26 109.169 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.9 t -156.35 162.29 40.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 0.19 109.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.87 135.48 44.46 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.574 -0.899 . . . . 2.75 108.574 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.541 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.46 140.78 23.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.16 108.601 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.01 -26.42 35.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.364 -0.835 . . . . 0.28 109.806 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -159.94 176.59 11.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 1.09 109.739 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.74 -32.52 72.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.22 109.796 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.19 77.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.23 109.961 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.541 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 2.4 p -70.15 -35.5 74.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 1.24 109.12 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.02 87.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.16 108.8 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.14 -49.82 72.85 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.226 -0.99 . . . . 1.12 109.192 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -63.84 -43.66 95.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.784 -1.197 . . . . 2.45 111.897 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.68 -54.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.27 110.503 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 5' ' ' LEU . 28.3 m-85 -63.8 -39.71 94.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.948 -1.095 . . . . 0.23 110.531 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -60.52 -45.68 92.95 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.375 -0.828 . . . . 2.88 109.252 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -67.33 -43.61 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.576 -0.898 . . . . 2.01 108.576 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.7 t80 -59.98 -46.56 89.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.744 . . . . 0.37 109.033 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.72 94.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.846 -0.798 . . . . 0.25 108.846 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.0 -45.04 95.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.026 -0.731 . . . . 1.97 109.026 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.66 -25.3 66.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 1.14 109.701 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 71.1 m-20 -95.92 6.72 48.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.196 -0.94 . . . . 1.17 109.713 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.23 37.61 91.22 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.079 -1.058 . . . . 0.3 110.46 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.91 122.26 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.297 -1.119 . . . . 0.32 109.876 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -132.93 136.95 46.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.27 -1.381 . . . . 2.19 107.27 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.44 -156.48 16.22 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.87 -1.634 . . . . 0.67 109.647 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -91.82 128.55 37.69 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.955 -1.128 . . . . 2.22 107.955 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.69 133.62 40.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.21 110.453 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.5 p -131.68 147.9 52.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.966 -1.124 . . . . 0.24 107.966 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.44 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 62.1 t80 -134.76 135.86 42.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.32 109.966 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -112.04 109.48 19.25 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.28 108.711 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 48.2 t0 -66.35 -32.71 74.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 1.12 110.254 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -43.86 94.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.26 110.079 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.9 p -102.62 0.41 33.23 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.213 -0.93 . . . . 0.27 110.537 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mttm 50.12 40.5 21.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.859 -1.151 . . . . 2.36 108.985 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.3 m -118.84 130.01 55.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.647 0.737 . . . . 0.15 109.975 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 55.1 m-85 -97.65 137.01 37.21 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.078 -1.453 . . . . 0.17 107.078 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.1 m -129.51 134.15 47.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.823 -1.173 . . . . 0.14 108.614 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.8 p -125.35 129.99 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.142 -1.059 . . . . 0.2 108.142 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -121.98 127.81 50.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.448 -0.782 . . . . 0.29 110.218 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.995 -1.002 . . . . 2.34 108.585 179.243 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.246 -0.65 . . . . 0.31 109.246 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.29 146.49 39.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.5 -0.926 . . . . 0.19 108.5 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.12 141.93 46.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.362 -0.836 . . . . 1.98 109.032 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 30' ' ' PHE . 22.6 tp -120.1 126.23 50.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.708 -0.849 . . . . 0.13 108.708 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.26 123.41 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.164 -1.421 . . . . 0.36 107.164 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.472 HD23 HG12 ' A' ' 54' ' ' VAL . 93.6 mt -102.38 114.11 28.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.286 -0.884 . . . . 0.25 110.092 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -114.66 68.59 0.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.124 -1.436 . . . . 0.18 107.124 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.1 165.15 48.66 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.813 -1.315 . . . . 0.24 109.813 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -66.91 -35.36 79.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.499 -1.297 . . . . 2.71 107.499 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -119.83 -23.19 6.53 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.252 -0.648 . . . . 0.92 109.252 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 9' ' ' GLY . 54.2 tp -98.35 121.48 40.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.6 109.269 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -136.89 126.78 25.77 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.179 -0.951 . . . . 2.02 109.638 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.44 -168.31 41.43 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.636 -1.269 . . . . 0.24 110.196 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -149.3 159.36 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.974 . . . . 1.68 109.655 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -151.94 167.35 28.64 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.732 -0.84 . . . . 0.34 108.732 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -138.03 159.65 41.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.21 109.278 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -154.93 159.96 40.81 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.714 -0.847 . . . . 0.23 108.714 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -102.22 132.91 47.86 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.53 -0.915 . . . . 2.22 108.53 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.69 144.57 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.105 -0.997 . . . . 0.39 109.477 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.86 -29.7 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.489 -0.757 . . . . 0.55 110.368 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -158.02 175.66 13.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.91 -1.119 . . . . 1.16 110.181 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.89 80.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.536 -0.727 . . . . 0.26 110.033 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.28 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.91 -1.119 . . . . 0.29 110.008 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 p -74.21 -34.89 63.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.726 -1.234 . . . . 0.44 109.827 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.0 92.26 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.807 -0.812 . . . . 0.18 108.807 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.51 -49.02 73.7 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.964 -1.095 . . . . 1.06 109.904 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.59 -40.04 92.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.261 -0.899 . . . . 2.67 110.506 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.9 -53.1 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.149 -0.969 . . . . 0.23 110.662 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.551 ' CD1' HD22 ' A' ' 5' ' ' LEU . 35.6 m-85 -66.72 -39.5 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 0.15 110.596 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -60.42 -42.27 95.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.745 -1.222 . . . . 2.07 108.819 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -67.56 -43.63 80.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 1.84 108.948 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.597 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.5 t80 -60.03 -44.87 94.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.504 -0.748 . . . . 0.3 109.311 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.67 96.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.332 -0.855 . . . . 0.25 109.229 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -61.9 -42.36 98.98 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.363 -0.836 . . . . 1.23 109.101 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.21 -26.62 67.85 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.095 -1.003 . . . . 1.29 109.304 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.597 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 77.1 m-20 -97.59 9.05 43.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.64 110.027 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.72 81.79 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.884 -1.15 . . . . 0.72 110.456 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.3 t -106.91 127.89 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.183 -1.186 . . . . 0.4 109.738 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -137.67 145.3 42.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.668 -1.234 . . . . 1.33 107.668 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.91 -156.19 21.07 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.875 -1.631 . . . . 0.26 110.334 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.64 131.11 36.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.579 -0.897 . . . . 2.07 108.579 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -101.08 136.54 40.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.13 110.545 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.5 p -133.9 148.77 51.27 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.771 -1.196 . . . . 0.22 107.771 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.12 134.32 42.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 0.12 110.205 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -111.49 108.28 17.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.328 -0.99 . . . . 0.24 108.328 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -67.27 -29.8 69.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 1.16 109.865 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.9 91.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.361 -0.837 . . . . 0.3 110.306 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.2 p -104.84 0.0 27.61 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.357 -0.84 . . . . 0.42 109.992 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 50.04 39.89 20.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 2.16 108.173 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -119.93 132.13 55.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.404 0.621 . . . . 0.28 110.712 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -99.3 140.04 34.05 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.486 -1.301 . . . . 0.09 107.486 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.6 m -130.62 131.28 44.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.655 -1.278 . . . . 0.14 108.706 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD23 ' A' ' 7' ' ' LEU . 4.2 p -122.79 129.65 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.496 -0.927 . . . . 0.12 108.496 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.3 127.74 52.64 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.504 -0.748 . . . . 0.29 110.444 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.965 -1.016 . . . . 1.95 109.197 179.813 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.7 m . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.597 -0.52 . . . . 0.31 109.597 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -117.67 145.81 44.14 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.857 -0.794 . . . . 0.19 108.857 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -114.74 144.15 43.93 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.328 -0.857 . . . . 1.98 109.184 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 30' ' ' PHE . 30.6 tp -121.78 128.94 52.27 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.135 -0.691 . . . . 0.13 109.135 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.9 122.3 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.747 -1.205 . . . . 0.36 107.747 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -100.69 113.82 27.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.25 109.262 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -116.34 68.73 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.323 -1.362 . . . . 0.18 107.323 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 169.3 52.95 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.146 -1.581 . . . . 0.24 109.146 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -64.8 -35.75 82.12 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.196 -1.179 . . . . 2.71 107.919 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -124.86 -19.11 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.427 -0.583 . . . . 0.92 109.427 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.0 tp -96.09 119.97 35.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.996 . . . . 0.6 109.098 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -134.54 125.8 28.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 2.02 109.472 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.93 -178.7 48.64 Favored Glycine 0 N--CA 1.487 2.036 0 C-N-CA 119.556 -1.307 . . . . 0.24 110.262 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.54 157.3 43.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.757 -0.849 . . . . 1.68 108.929 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.02 170.03 21.43 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.377 -0.827 . . . . 0.34 109.281 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 p -135.87 159.17 42.51 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.84 -0.8 . . . . 0.21 108.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.5 t -157.61 161.67 38.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.862 . . . . 0.23 109.515 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 56.0 mp0 -105.92 135.74 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.836 -0.802 . . . . 2.22 108.836 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -150.24 146.4 26.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.39 109.118 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.37 -30.1 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.466 -0.771 . . . . 0.55 109.569 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -159.46 176.88 11.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 1.16 109.584 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -35.3 77.85 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.29 -0.881 . . . . 0.26 110.078 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -39.04 59.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.916 -1.115 . . . . 0.29 110.273 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.625 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 26.3 p -75.08 -32.14 61.4 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.5 -1.375 . . . . 0.44 109.518 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.68 99.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.264 -0.898 . . . . 0.18 108.828 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -56.94 -49.52 75.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.646 -1.222 . . . . 1.06 108.998 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -63.54 -44.03 95.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.541 -0.724 . . . . 2.67 110.823 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.06 -52.59 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.021 -1.049 . . . . 0.23 110.837 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.3 m-85 -61.64 -37.9 85.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.006 . . . . 0.15 109.957 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -61.46 -43.04 99.57 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.91 -1.119 . . . . 2.07 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.62 -43.97 75.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.904 -1.123 . . . . 1.84 109.07 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 57.4 t80 -60.03 -47.84 84.2 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.292 -0.88 . . . . 0.3 108.749 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.98 99.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.454 -0.779 . . . . 0.25 109.138 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -59.99 -41.89 93.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.72 -19.78 66.03 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.001 -0.74 . . . . 1.29 109.001 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' OD1' ' CD1' ' A' ' 33' ' ' TYR . 31.0 m120 -95.08 4.31 53.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.64 109.96 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.04 32.9 65.61 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.675 -1.25 . . . . 0.72 110.087 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.4 t -110.22 122.99 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.184 -1.186 . . . . 0.4 108.916 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 31.5 p-10 -148.97 97.65 2.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.915 -1.116 . . . . 1.33 110.465 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.06 -130.68 1.37 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.31 -1.424 . . . . 0.26 111.342 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.11 132.43 38.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.963 -1.316 . . . . 2.07 110.316 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -107.76 139.48 42.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.429 0.633 . . . . 0.13 110.267 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.1 p -136.86 150.27 48.17 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.08 -1.081 . . . . 0.22 108.08 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -134.36 135.9 43.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.272 -0.893 . . . . 0.12 110.643 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -111.94 108.28 17.58 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.166 -1.05 . . . . 0.24 108.166 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -67.61 -29.99 69.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 1.16 110.366 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.04 93.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.3 110.409 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.0 p -105.81 0.02 25.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.37 -0.831 . . . . 0.42 110.124 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 mttm 50.33 41.34 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.131 . . . . 2.16 108.506 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.95 129.95 54.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.478 0.656 . . . . 0.28 110.069 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -98.87 139.64 34.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.679 -1.23 . . . . 0.09 107.679 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.5 m -128.7 130.41 47.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.762 -1.211 . . . . 0.14 108.437 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.06 129.42 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.285 -1.005 . . . . 0.12 108.285 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -120.96 126.0 48.83 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.114 -0.699 . . . . 0.29 109.114 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.071 -0.966 . . . . 1.95 109.729 -179.076 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.483 -0.562 . . . . 0.31 109.483 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.528 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 90.8 m-85 -114.52 145.26 42.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.463 -0.94 . . . . 0.19 108.463 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -115.74 142.72 46.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.392 -0.818 . . . . 1.98 109.453 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 30' ' ' PHE . 40.2 tp -120.98 127.33 51.7 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.969 -0.752 . . . . 0.13 108.969 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.4 123.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.317 -1.364 . . . . 0.36 107.317 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.34 112.75 25.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.25 110.168 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -112.1 69.0 0.68 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.765 -1.568 . . . . 0.18 106.765 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.78 167.69 50.31 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.59 -1.404 . . . . 0.24 109.59 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -67.77 -39.05 84.15 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.414 -1.051 . . . . 2.71 108.524 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 p -120.0 -20.03 7.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.887 -0.508 . . . . 0.92 109.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.92 118.55 36.81 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.339 -0.851 . . . . 0.6 109.89 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -130.71 131.43 44.79 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.67 0.748 . . . . 2.02 109.15 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.1 -178.96 48.61 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.08 -1.533 . . . . 0.24 110.716 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.04 151.13 43.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.451 -0.944 . . . . 1.68 108.451 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 t -150.82 165.02 34.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.34 108.592 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.1 p -134.38 159.38 41.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 0.21 108.97 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -154.41 158.98 40.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.772 -0.825 . . . . 0.23 108.772 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.6 132.0 50.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.632 -0.877 . . . . 2.22 108.632 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.63 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -147.63 142.94 27.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.05 . . . . 0.39 109.093 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.93 -28.82 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.55 110.091 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -158.97 177.31 11.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.043 -1.035 . . . . 1.16 109.937 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.528 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -65.71 -38.42 89.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.457 -0.777 . . . . 0.26 109.591 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.11 -37.76 62.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.082 -1.011 . . . . 0.29 110.003 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.63 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 85.4 m -68.82 -39.96 79.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.692 -1.255 . . . . 0.44 109.806 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.02 93.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.246 -0.909 . . . . 0.18 109.372 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.17 -53.88 47.32 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.152 -1.019 . . . . 1.06 111.595 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -68.51 -36.14 78.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.678 -1.264 . . . . 2.67 110.655 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.84 -53.83 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.943 -1.098 . . . . 0.23 110.519 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD1' HD22 ' A' ' 5' ' ' LEU . 32.0 m-85 -63.11 -37.42 87.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.15 110.433 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.98 -41.47 92.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.834 -1.166 . . . . 2.07 109.296 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -68.71 -42.13 78.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 1.84 109.102 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.648 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.6 t80 -59.95 -46.96 87.73 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.3 108.95 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.08 96.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.25 108.958 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.02 -45.62 92.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 1.23 109.159 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -62.28 -24.68 67.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -0.868 . . . . 1.29 109.548 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.648 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 75.1 m-20 -98.51 7.04 46.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.215 -0.928 . . . . 0.64 109.99 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.17 33.62 83.6 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.92 -1.133 . . . . 0.72 110.491 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.18 128.39 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.147 -1.208 . . . . 0.4 110.539 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.501 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 96.7 m-20 -112.3 -98.62 0.42 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.511 -0.922 . . . . 1.33 108.511 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.69 167.53 3.72 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.26 112.455 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.5 mp0 -77.21 138.27 39.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.583 -1.266 . . . . 2.07 107.583 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -99.91 133.78 43.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.98 . . . . 0.13 110.351 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 p -134.32 148.76 50.81 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.815 -1.18 . . . . 0.22 107.815 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -136.04 136.91 40.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.186 -0.946 . . . . 0.12 110.464 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.82 110.01 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.568 -0.901 . . . . 0.24 108.568 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 52.4 t0 -67.94 -30.5 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.927 . . . . 1.16 110.461 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.3 93.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.148 -0.97 . . . . 0.3 109.892 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.3 p -105.92 -0.28 25.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.51 -0.744 . . . . 0.42 110.048 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.408 ' NZ ' ' CZ ' ' A' ' 3' ' ' TYR . 23.6 mtpp 49.98 41.71 23.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 2.16 108.401 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.34 131.08 55.66 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.547 0.689 . . . . 0.28 110.506 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -100.46 139.88 35.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.455 -1.313 . . . . 0.09 107.455 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -131.98 132.51 43.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.817 -1.177 . . . . 0.14 108.963 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.8 p -120.3 128.29 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.029 -1.1 . . . . 0.12 108.029 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.1 m -121.36 127.57 51.37 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.359 -0.838 . . . . 0.29 110.731 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 67.3 mm-40 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.947 -1.025 . . . . 1.95 109.453 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.233 0.54 . . . . 0.31 110.288 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.06 147.05 39.37 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.848 -1.168 . . . . 0.19 107.848 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -116.05 141.11 48.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 1.98 109.458 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.5 tp -120.66 127.99 52.58 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.742 -0.836 . . . . 0.13 108.742 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.38 123.68 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.215 -1.402 . . . . 0.36 107.215 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -103.91 114.36 28.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.25 110.543 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -118.75 68.52 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.132 -1.433 . . . . 0.18 107.132 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.531 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . . . -78.67 172.56 55.27 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.672 -1.771 . . . . 0.24 108.672 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -66.23 -35.59 80.82 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.841 -1.388 . . . . 2.71 107.929 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -123.95 -18.59 5.92 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.844 -0.535 . . . . 0.92 110.288 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 tp -98.94 113.58 25.8 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.015 -1.053 . . . . 0.6 109.822 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -126.21 127.28 45.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 2.02 109.317 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.97 -179.84 48.81 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.192 -1.48 . . . . 0.24 110.621 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -143.53 153.67 42.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.995 . . . . 1.68 108.869 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -152.82 168.5 25.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.34 109.065 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.5 p -138.46 160.02 40.61 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.881 -0.785 . . . . 0.21 108.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -156.65 162.86 39.82 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.264 -0.898 . . . . 0.23 109.188 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -106.48 135.01 48.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.367 -0.833 . . . . 2.22 108.917 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.0 145.53 27.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.39 108.898 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.42 -29.24 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.55 110.266 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -158.51 177.53 11.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.086 -1.009 . . . . 1.16 110.172 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.74 82.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.638 -0.664 . . . . 0.26 110.287 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.95 -37.08 60.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.833 -1.167 . . . . 0.29 109.769 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 p -72.23 -36.88 69.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.668 -1.27 . . . . 0.44 109.605 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.29 90.57 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.656 -0.868 . . . . 0.18 108.656 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.21 -50.08 73.98 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.221 -0.991 . . . . 1.06 110.196 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -66.29 -40.78 90.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.072 -1.017 . . . . 2.67 110.688 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.0 -53.82 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.078 -1.014 . . . . 0.23 110.597 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -63.68 -38.09 89.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.15 110.678 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -60.08 -44.04 95.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.817 -1.177 . . . . 2.07 109.582 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -68.36 -41.44 80.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 1.84 108.673 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 58.1 t80 -59.94 -48.33 82.12 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.487 -0.758 . . . . 0.3 109.05 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.87 99.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.25 109.096 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -60.54 -43.33 97.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.292 -0.88 . . . . 1.23 108.897 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -64.25 -22.39 66.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 1.29 109.338 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.582 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 65.8 m-80 -98.46 6.76 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.286 -0.884 . . . . 0.64 109.877 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.78 36.21 91.94 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.164 -1.175 . . . . 0.72 110.164 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.59 127.42 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.277 -1.131 . . . . 0.4 109.935 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.471 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 92.9 m-20 -111.68 -97.15 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.5 -1.296 . . . . 1.33 107.5 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.93 166.91 2.06 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-O 122.052 0.807 . . . . 0.26 112.407 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.55 139.16 41.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.389 -1.337 . . . . 2.07 107.389 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.66 135.48 42.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.13 111.077 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 p -133.4 147.24 51.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.588 -0.893 . . . . 0.22 108.588 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 52.6 t80 -134.63 135.88 42.45 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.242 -0.911 . . . . 0.12 110.186 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 50' ' ' LYS . 55.2 t0 -113.11 109.96 19.67 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.941 -0.762 . . . . 0.24 108.941 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.8 t0 -68.87 -30.6 69.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.07 -1.019 . . . . 1.16 109.966 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.99 94.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.838 . . . . 0.3 110.112 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -110.97 -0.15 16.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.651 -0.655 . . . . 0.42 109.642 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 46' ' ' ASP . 56.7 mttp 48.9 41.81 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.137 -0.977 . . . . 2.16 109.208 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -115.74 131.12 57.03 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.483 0.659 . . . . 0.28 109.553 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.5 m-85 -100.61 139.91 35.62 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.092 -1.077 . . . . 0.09 108.092 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -132.23 131.98 42.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.671 -1.268 . . . . 0.14 108.672 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.0 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.617 -1.253 . . . . 0.12 107.617 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -120.07 126.54 51.02 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.226 -0.921 . . . . 0.29 110.293 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 118.03 -0.986 . . . . 1.95 109.231 179.564 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.239 0.542 . . . . 0.31 110.008 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -119.35 146.41 45.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.74 -0.837 . . . . 0.19 108.74 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -116.91 144.82 44.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.409 -0.807 . . . . 1.98 109.804 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.3 tp -118.95 129.8 55.36 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.502 -0.749 . . . . 0.13 109.005 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.43 122.18 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.058 -1.46 . . . . 0.36 107.058 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.8 mt -101.76 117.52 35.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.174 -0.954 . . . . 0.25 110.2 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -124.59 66.43 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.565 -1.272 . . . . 0.18 107.565 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 176.38 54.68 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.497 -1.441 . . . . 0.24 109.497 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -66.07 -39.71 90.3 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.15 -1.206 . . . . 2.71 108.668 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -17.39 7.12 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.874 -0.516 . . . . 0.92 110.523 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.66 121.9 41.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.025 -1.047 . . . . 0.6 109.564 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -135.16 127.59 30.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.393 -0.817 . . . . 2.02 109.417 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -173.77 46.54 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.382 -1.39 . . . . 0.24 110.515 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -149.02 156.9 42.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.622 -0.929 . . . . 1.68 109.15 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -154.01 170.04 22.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.34 109.61 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 p -137.39 159.24 42.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.782 . . . . 0.21 109.13 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -157.52 162.7 38.85 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.335 -0.853 . . . . 0.23 108.9 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -101.21 133.77 45.27 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.306 -0.998 . . . . 2.22 108.306 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -146.88 142.12 27.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.178 -0.951 . . . . 0.39 108.949 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.99 -31.24 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.864 . . . . 0.55 109.552 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -157.69 179.21 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 1.16 110.106 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.15 -38.27 87.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.466 -0.771 . . . . 0.26 109.527 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.38 61.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.177 -0.952 . . . . 0.29 109.971 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.628 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.5 m -69.94 -40.05 75.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.641 -1.287 . . . . 0.44 109.749 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.64 82.06 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.444 -0.947 . . . . 0.18 108.444 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.06 -45.7 71.77 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.687 -1.205 . . . . 1.06 108.602 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.07 -46.1 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.64 -0.662 . . . . 2.67 110.764 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.27 -52.85 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.286 -0.884 . . . . 0.23 111.088 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -67.48 -39.95 85.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.996 -1.065 . . . . 0.15 110.551 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.68 -43.06 98.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.55 -1.344 . . . . 2.07 109.229 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.5 -44.49 82.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 1.84 108.911 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.3 t80 -60.13 -46.46 89.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.421 -0.799 . . . . 0.3 109.046 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -45.78 90.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.25 109.33 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.08 -43.93 95.13 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.665 -0.865 . . . . 1.23 108.665 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.07 -20.32 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 1.29 109.05 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.531 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 31.6 m120 -97.76 6.63 47.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.288 -0.883 . . . . 0.64 109.897 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.46 32.63 67.94 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.021 -1.085 . . . . 0.72 111.184 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.5 t -110.52 124.99 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.03 -1.276 . . . . 0.4 109.186 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 73.6 m-20 -150.67 99.78 2.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 1.33 110.281 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 -132.24 1.73 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.342 -1.409 . . . . 0.26 110.995 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.57 125.62 37.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.851 -1.382 . . . . 2.07 110.677 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -103.03 137.08 41.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.672 -0.643 . . . . 0.13 109.515 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -136.1 150.03 48.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.832 -1.173 . . . . 0.22 107.832 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -137.1 137.87 39.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.225 -0.922 . . . . 0.12 110.444 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -112.55 110.07 20.01 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.387 -0.968 . . . . 0.24 108.387 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -65.67 -30.92 71.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 1.16 110.374 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.15 93.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.3 110.272 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -104.33 -0.11 28.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.39 -0.819 . . . . 0.42 110.778 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp 50.07 40.21 20.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.758 -1.214 . . . . 2.16 108.246 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.97 131.53 55.2 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.633 0.73 . . . . 0.28 110.621 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -100.3 140.02 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.346 -1.353 . . . . 0.09 107.346 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.1 m -130.8 132.62 45.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.14 108.576 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.8 130.1 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.802 -0.814 . . . . 0.12 108.802 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 m -128.07 129.78 47.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.484 0.659 . . . . 0.29 110.169 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 74.2 mm-40 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.978 -1.01 . . . . 1.95 109.551 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.346 -0.613 . . . . 0.31 109.346 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -117.5 145.45 44.2 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.362 -0.977 . . . . 0.19 108.362 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -113.21 145.35 41.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.343 -0.848 . . . . 1.98 109.647 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.481 HD22 ' CD1' ' A' ' 30' ' ' PHE . 59.1 tp -121.62 127.66 51.08 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.564 -0.71 . . . . 0.13 109.592 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.5 mm -103.54 121.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.621 -1.622 . . . . 0.36 106.621 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.2 mt -100.33 111.47 23.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.947 -1.096 . . . . 0.25 109.528 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.54 69.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.543 -1.28 . . . . 0.18 107.543 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 163.96 48.1 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.345 -1.502 . . . . 0.24 109.345 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -66.8 -37.57 84.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.529 -1.286 . . . . 2.71 107.529 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.2 p -115.16 -22.37 9.5 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.576 -0.527 . . . . 0.92 109.576 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 9' ' ' GLY . 19.0 tp -102.29 127.99 49.03 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.342 -0.849 . . . . 0.6 109.556 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -139.91 128.1 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 2.02 109.472 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.46 -174.33 46.86 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.107 -1.521 . . . . 0.24 110.85 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -147.88 155.69 41.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.717 -0.873 . . . . 1.68 109.036 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -153.97 169.36 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 0.34 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.3 p -134.48 158.58 43.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.359 -0.838 . . . . 0.21 109.439 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 7.7 t -155.38 159.53 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.23 109.047 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -103.99 134.12 47.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.249 -0.907 . . . . 2.22 108.879 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.12 143.32 27.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.39 109.073 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 21' ' ' VAL . 14.3 m -60.39 -28.9 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.55 109.741 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -157.53 174.96 14.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.198 -0.938 . . . . 1.16 109.894 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.29 83.87 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.26 109.874 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.25 -36.22 52.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.941 -1.1 . . . . 0.29 109.607 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.553 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 6.1 p -73.45 -34.75 65.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.756 -1.215 . . . . 0.44 109.76 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.88 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.286 -1.005 . . . . 0.18 108.286 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -49.91 75.12 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.784 -1.167 . . . . 1.06 109.953 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -64.63 -41.43 96.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.747 -1.221 . . . . 2.67 110.405 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.55 -53.67 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 0.23 110.842 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.6 m-85 -64.41 -39.22 93.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.15 111.07 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -61.78 -40.29 94.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.237 . . . . 2.07 110.156 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -69.45 -43.79 72.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.875 -1.141 . . . . 1.84 108.804 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.614 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -60.46 -46.65 89.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.394 -0.816 . . . . 0.3 109.53 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.12 94.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.25 109.76 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -61.59 -40.07 93.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 1.23 109.369 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.74 -23.96 67.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.183 -0.948 . . . . 1.29 109.532 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.614 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.6 m-20 -95.23 9.92 37.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.216 -0.927 . . . . 0.64 109.944 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.71 81.8 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.811 -1.315 . . . . 0.72 109.811 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.02 126.12 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.333 -1.098 . . . . 0.4 109.999 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 52.0 t0 -141.2 146.09 36.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 1.33 107.996 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.11 -150.28 12.13 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.234 -1.46 . . . . 0.26 110.206 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -92.05 132.35 36.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.568 -0.96 . . . . 2.07 108.525 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -100.38 136.49 40.19 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.246 -0.909 . . . . 0.13 110.331 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 p -138.74 150.41 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.39 -0.967 . . . . 0.22 108.39 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -132.0 136.57 47.38 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.303 -0.873 . . . . 0.12 110.275 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.71 106.23 15.38 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.319 -0.993 . . . . 0.24 108.319 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -66.73 -33.73 76.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 1.16 110.811 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.33 -40.04 95.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.965 -1.085 . . . . 0.3 109.881 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -102.79 0.75 33.24 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.552 -0.718 . . . . 0.42 110.277 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp 49.92 41.21 22.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 2.16 108.474 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -123.32 137.44 54.84 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.677 0.751 . . . . 0.28 110.969 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -100.69 139.25 36.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.383 -1.34 . . . . 0.09 107.383 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -130.27 130.76 44.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.653 -1.28 . . . . 0.14 108.519 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.51 128.18 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.089 -1.078 . . . . 0.12 108.089 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -120.02 128.31 53.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.29 110.214 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.938 -1.03 . . . . 1.95 109.351 -179.69 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.238 0.542 . . . . 0.31 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.82 148.83 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.895 -1.15 . . . . 0.19 107.895 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -116.25 140.52 49.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.103 -0.998 . . . . 1.98 109.081 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 30' ' ' PHE . 26.7 tp -123.17 128.68 50.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.681 -0.637 . . . . 0.13 109.31 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 124.8 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.266 -1.383 . . . . 0.36 107.266 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 54' ' ' VAL . 92.4 mt -102.34 115.59 30.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.25 109.029 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -113.37 70.63 0.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.521 -1.289 . . . . 0.18 107.521 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.77 167.54 52.92 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.709 -1.756 . . . . 0.24 108.709 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -67.24 -37.11 83.01 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.137 -1.214 . . . . 2.71 107.733 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -120.24 -18.73 7.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.153 0.502 . . . . 0.92 109.654 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.06 120.01 39.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.235 -0.915 . . . . 0.6 109.577 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -132.68 127.54 35.04 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.317 -0.865 . . . . 2.02 109.902 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -175.81 47.65 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.654 -1.26 . . . . 0.24 110.257 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.55 158.62 44.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -1.001 . . . . 1.68 109.313 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -153.22 170.03 21.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.391 -0.818 . . . . 0.34 109.72 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.4 p -137.87 160.04 40.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.8 . . . . 0.21 109.317 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.437 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -155.4 159.96 40.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.23 109.058 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -107.46 135.19 49.36 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.317 -0.994 . . . . 2.22 108.317 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.82 149.92 31.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.39 109.677 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.07 -29.08 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.55 110.053 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -158.07 171.89 19.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.916 -1.115 . . . . 1.16 110.304 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.56 83.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.567 -0.708 . . . . 0.26 110.175 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.58 -37.33 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.995 -1.066 . . . . 0.29 109.772 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -72.98 -34.59 66.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.682 -1.262 . . . . 0.44 109.638 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.17 90.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.37 -0.974 . . . . 0.18 108.37 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.46 -49.18 70.68 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.185 -1.006 . . . . 1.06 109.315 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.358 -0.839 . . . . 2.67 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.322 -0.861 . . . . 0.23 111.346 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CD1' HD22 ' A' ' 5' ' ' LEU . 27.2 m-85 -65.09 -39.9 93.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.83 -1.169 . . . . 0.15 111.37 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -63.37 -41.1 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 2.07 110.146 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.11 -42.47 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 1.84 108.893 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 65.2 t80 -60.14 -46.77 88.54 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.708 -0.849 . . . . 0.3 108.708 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.19 99.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.491 -0.756 . . . . 0.25 109.376 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -60.05 -40.84 90.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 1.23 109.15 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.25 -20.01 65.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 1.29 109.424 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 97.9 m-20 -96.56 4.8 51.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.093 -1.004 . . . . 0.64 109.992 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.6 36.34 54.13 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.933 -1.127 . . . . 0.72 110.959 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.8 t -116.26 122.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.155 -1.203 . . . . 0.4 108.559 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 73.9 m-20 -150.28 101.09 2.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -0.961 . . . . 1.33 110.818 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 -128.78 1.21 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.438 -1.363 . . . . 0.26 110.687 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -94.02 130.32 40.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.896 -1.355 . . . . 2.07 110.417 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -103.05 136.19 43.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.715 -0.616 . . . . 0.13 109.541 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.0 p -134.21 147.74 50.76 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.752 -1.203 . . . . 0.22 107.752 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -137.42 138.29 39.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.12 110.452 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -115.06 110.05 18.99 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.769 -0.826 . . . . 0.24 108.769 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 47.2 t0 -67.06 -28.74 68.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 1.16 109.719 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.97 95.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.3 110.013 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.0 p -107.55 0.45 22.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.474 -0.766 . . . . 0.42 110.218 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 50.07 41.88 24.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.757 -1.201 . . . . 2.16 107.757 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.29 130.81 55.59 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.638 0.732 . . . . 0.28 110.603 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -101.89 139.42 37.55 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.779 -1.193 . . . . 0.09 107.779 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.0 m -130.98 132.63 45.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.833 -1.167 . . . . 0.14 108.294 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 7' ' ' LEU . 2.9 p -124.32 130.55 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.593 -0.891 . . . . 0.12 108.593 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.03 126.91 51.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.639 -0.663 . . . . 0.29 109.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.992 -1.004 . . . . 1.95 109.367 -179.463 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.512 -0.551 . . . . 0.31 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.68 140.99 49.78 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.712 -0.848 . . . . 0.19 108.712 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.81 143.34 44.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.539 -0.725 . . . . 1.98 109.052 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 52' ' ' PHE . 44.4 tp -119.19 129.38 54.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.849 -0.797 . . . . 0.13 108.849 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -106.34 124.36 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.95 -1.5 . . . . 0.36 106.95 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.13 116.09 31.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.25 110.336 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.27 67.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.378 -1.712 . . . . 0.18 106.378 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.52 173.11 53.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.778 -1.329 . . . . 0.24 109.778 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.06 -40.03 82.85 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.29 -1.123 . . . . 2.71 108.231 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.1 m -121.64 -19.33 6.88 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.858 -0.526 . . . . 0.92 109.891 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.0 tp -98.57 119.54 37.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.059 -1.026 . . . . 0.6 109.515 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -136.39 129.07 30.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.161 -0.962 . . . . 2.02 109.526 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.21 -171.07 44.25 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.417 -1.373 . . . . 0.24 110.065 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -148.18 157.27 43.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.63 -0.923 . . . . 1.68 109.124 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.15 171.58 18.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.815 . . . . 0.34 108.878 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -137.83 159.98 40.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 0.21 109.857 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.432 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 3.5 t -156.91 160.81 39.47 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.49 -0.756 . . . . 0.23 109.214 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -104.97 136.87 43.63 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.358 -0.979 . . . . 2.22 108.358 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.5 141.78 26.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.082 -1.011 . . . . 0.39 109.453 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 m -60.44 -30.86 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.435 -0.791 . . . . 0.55 109.347 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -156.87 174.32 15.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 1.16 109.564 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.25 81.53 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.37 -0.831 . . . . 0.26 110.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.38 -36.11 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.29 109.716 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -71.25 -38.25 71.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.226 . . . . 0.44 109.605 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.91 85.86 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.511 -0.922 . . . . 0.18 108.511 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.02 -42.36 89.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.629 -1.228 . . . . 1.06 109.301 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.03 -43.83 81.78 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.627 -1.296 . . . . 2.67 110.449 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.11 -53.23 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.915 . . . . 0.23 111.845 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.432 ' CZ ' HG22 ' A' ' 18' ' ' THR . 41.2 m-85 -66.56 -40.1 88.83 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.901 -1.124 . . . . 0.15 111.88 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.53 -40.16 95.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 2.07 110.177 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.9 -40.68 75.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.898 -1.126 . . . . 1.84 108.685 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.58 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.4 t80 -59.99 -44.56 94.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.3 108.982 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.29 96.73 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.396 -0.815 . . . . 0.25 108.962 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.98 -44.06 94.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.392 -0.817 . . . . 1.23 108.818 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.15 -24.19 67.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 1.29 109.341 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.58 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 81.2 m-20 -99.03 9.7 42.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.935 . . . . 0.64 109.052 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.89 36.77 93.29 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.515 -1.434 . . . . 0.72 109.515 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.3 125.88 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.319 -1.107 . . . . 0.4 109.892 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 96.4 m-20 -110.86 -98.63 0.41 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.294 -1.002 . . . . 1.33 108.294 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.81 165.21 4.79 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.083 0.824 . . . . 0.26 112.005 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.0 135.49 39.99 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.385 -1.339 . . . . 2.07 107.385 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -98.08 133.37 42.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.025 -1.047 . . . . 0.13 110.435 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -133.03 148.31 52.24 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.029 -1.1 . . . . 0.22 108.029 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -133.13 132.42 41.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.452 -0.78 . . . . 0.12 110.063 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -113.34 110.05 19.72 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.764 -0.828 . . . . 0.24 108.764 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -68.46 -29.5 68.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 1.16 110.625 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.92 89.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.3 110.313 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 78.6 p -104.87 -0.16 27.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.378 -0.826 . . . . 0.42 109.721 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.02 40.97 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.005 -1.06 . . . . 2.16 108.438 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.1 m -120.04 130.89 54.91 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.597 0.713 . . . . 0.28 110.723 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' O ' HD12 ' A' ' 5' ' ' LEU . 56.8 m-85 -98.34 139.12 34.59 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.953 -1.499 . . . . 0.09 106.953 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 100.0 m -132.04 131.88 42.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.715 -1.241 . . . . 0.14 108.853 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.6 p -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.036 -1.098 . . . . 0.12 108.036 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -121.45 128.32 52.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.39 -0.819 . . . . 0.29 110.788 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.035 -0.983 . . . . 1.95 109.298 179.456 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.502 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 98.3 m . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.231 0.539 . . . . 0.31 109.776 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -112.89 147.86 36.15 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.095 -1.076 . . . . 0.19 108.095 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.45 140.12 50.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.338 -0.851 . . . . 1.98 109.079 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' A' ' 30' ' ' PHE . 36.1 tp -116.76 127.98 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.238 -1.023 . . . . 0.13 108.238 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.7 mt -101.52 121.23 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.091 -1.448 . . . . 0.36 107.091 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.2 110.85 22.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.032 -1.043 . . . . 0.25 109.918 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -116.49 67.76 0.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.811 -1.552 . . . . 0.18 106.811 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.67 164.93 47.38 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.163 -1.575 . . . . 0.24 109.163 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.142 -1.21 . . . . 2.71 108.261 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.6 m -111.31 -25.06 9.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.831 -0.543 . . . . 0.92 109.674 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 9' ' ' GLY . 40.5 tp -103.09 124.12 47.94 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.343 -0.848 . . . . 0.6 109.899 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.32 126.39 29.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 2.02 108.99 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.77 44.83 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.187 -1.482 . . . . 0.24 110.592 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -149.46 158.15 43.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.688 -0.889 . . . . 1.68 109.147 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.75 170.1 22.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.34 109.519 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.0 p -137.3 159.89 40.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.21 109.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -154.6 159.29 40.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.604 -0.887 . . . . 0.23 108.604 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -101.54 131.95 47.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.134 -0.979 . . . . 2.22 108.552 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.19 143.68 27.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.39 109.157 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.01 -29.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.446 -0.784 . . . . 0.55 109.797 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -158.78 174.75 14.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.055 -1.028 . . . . 1.16 110.196 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.26 82.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.595 -0.691 . . . . 0.26 110.311 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.0 64.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.032 -1.043 . . . . 0.29 110.368 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 p -72.48 -35.6 68.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.62 -1.3 . . . . 0.44 110.012 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.0 81.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.471 -0.768 . . . . 0.18 108.982 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.51 -42.35 87.51 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.613 -1.235 . . . . 1.06 109.815 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.8 -42.68 73.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 2.67 110.24 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.12 -52.19 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.23 110.768 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CD1' HD22 ' A' ' 5' ' ' LEU . 19.6 m-85 -61.8 -38.12 86.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.945 -1.097 . . . . 0.15 110.07 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -59.99 -41.77 92.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.885 -1.134 . . . . 2.07 109.782 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.92 -40.65 83.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.037 -1.039 . . . . 1.84 108.537 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.463 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 57.9 t80 -59.94 -49.64 76.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.772 -0.825 . . . . 0.3 108.772 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.58 84.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.25 109.351 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -60.04 -43.13 95.57 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 1.23 108.649 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.41 -25.39 65.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.077 -1.015 . . . . 1.29 108.783 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 18.9 m120 -100.01 9.86 42.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.64 109.926 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.03 34.7 88.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.012 -1.235 . . . . 0.72 110.012 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.04 128.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.306 -1.114 . . . . 0.4 109.937 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 95.9 m-20 -110.02 -99.74 0.39 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.622 -0.881 . . . . 1.33 108.622 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.02 161.6 3.37 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 121.977 0.765 . . . . 0.26 111.849 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.68 138.01 42.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.396 -1.335 . . . . 2.07 107.396 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -99.76 135.8 40.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -0.993 . . . . 0.13 111.115 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.68 149.75 50.54 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.213 -1.032 . . . . 0.22 108.213 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 65.6 t80 -135.97 134.57 38.74 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.12 110.065 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -111.76 110.02 20.17 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.687 -0.857 . . . . 0.24 108.687 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.24 -31.71 72.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 1.16 110.253 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.7 88.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.3 110.436 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.9 p -105.09 -0.98 26.16 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.386 -0.821 . . . . 0.42 110.158 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.1 mtpm? 49.98 40.03 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 2.16 108.931 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 132.14 55.38 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.528 0.68 . . . . 0.28 110.452 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.0 m-85 -99.6 139.8 34.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.384 -1.339 . . . . 0.09 107.384 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -131.58 132.45 44.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.71 -1.244 . . . . 0.14 108.83 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -121.88 129.31 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.35 -0.982 . . . . 0.12 108.35 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -120.02 127.2 52.38 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.477 -0.765 . . . . 0.29 111.016 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.058 -0.972 . . . . 1.95 109.163 179.191 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.532 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 95.6 m . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.25 0.548 . . . . 0.31 109.685 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -112.1 150.29 30.94 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.891 -1.151 . . . . 0.19 107.891 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -116.48 143.4 45.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.067 -1.02 . . . . 1.98 109.418 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 30' ' ' PHE . 35.2 tp -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.688 -0.632 . . . . 0.13 109.84 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.5 mt -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.572 -1.27 . . . . 0.36 107.572 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 54' ' ' VAL . 79.8 mt -102.85 115.94 31.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.25 -0.906 . . . . 0.25 110.01 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -116.95 70.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.666 -1.235 . . . . 0.18 107.666 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.91 170.1 53.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.093 -1.603 . . . . 0.24 109.093 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.413 ' NZ ' ' O ' ' A' ' 56' ' ' GLU . 62.4 mttp -64.38 -36.94 85.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.075 -1.25 . . . . 2.71 107.627 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.0 p -123.07 -15.27 7.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.903 -0.498 . . . . 0.92 109.889 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.79 122.1 41.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.98 -1.075 . . . . 0.6 109.969 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.92 126.68 27.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.295 -0.878 . . . . 2.02 109.814 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.27 -177.41 48.39 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.387 -1.387 . . . . 0.24 110.154 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.77 157.03 42.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.517 -0.99 . . . . 1.68 108.977 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -156.73 173.24 17.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.474 -0.766 . . . . 0.34 109.523 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.2 p -137.23 160.54 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.378 -0.826 . . . . 0.21 109.211 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 7.3 t -154.0 159.81 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.793 -0.817 . . . . 0.23 108.793 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -102.84 131.94 49.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.265 -0.897 . . . . 2.22 109.137 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.676 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -150.07 145.62 26.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.39 109.105 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 21' ' ' VAL . 15.8 m -62.61 -26.89 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.55 110.341 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -157.77 174.71 14.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.888 -1.133 . . . . 1.16 110.431 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.36 81.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.518 -0.739 . . . . 0.26 109.208 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.94 60.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.29 109.828 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.676 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 20.7 p -73.12 -35.13 66.48 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.668 -1.27 . . . . 0.44 109.6 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.7 94.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.581 -0.896 . . . . 0.18 108.581 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.27 -48.07 83.0 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.348 -1.341 . . . . 1.06 109.27 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -65.91 -44.67 84.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 2.67 111.013 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -52.86 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.946 -1.096 . . . . 0.23 110.456 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CD1' HD22 ' A' ' 5' ' ' LEU . 20.9 m-85 -61.06 -36.51 79.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.15 110.156 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -60.02 -40.5 89.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 2.07 109.261 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.02 -41.43 74.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 1.84 108.923 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.63 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 58.1 t80 -60.06 -49.66 76.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.3 109.461 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -45.28 94.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.25 109.549 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.96 -41.68 92.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.334 -0.854 . . . . 1.23 109.272 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.21 -23.44 67.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 1.29 109.138 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 61.3 m-20 -97.05 6.74 48.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.64 109.592 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.04 63.52 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.059 -1.067 . . . . 0.72 111.282 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 44.0 t -114.81 125.57 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.035 -1.274 . . . . 0.4 108.796 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 75.1 m-20 -149.66 101.92 3.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.254 -0.904 . . . . 1.33 110.399 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.41 -130.54 1.33 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.128 -1.51 . . . . 0.26 111.301 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -92.29 131.66 37.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.943 -1.328 . . . . 2.07 110.539 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.674 -0.641 . . . . 0.13 110.015 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 p -138.2 150.71 47.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.097 -1.075 . . . . 0.22 108.097 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.97 137.24 39.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -0.911 . . . . 0.12 110.532 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -113.28 109.98 19.63 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.904 -0.776 . . . . 0.24 108.904 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.7 t0 -67.01 -30.93 71.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 1.16 110.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.3 109.688 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -104.07 -0.65 28.45 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.363 -0.835 . . . . 0.42 109.807 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.0 mtpm? 49.66 42.79 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.881 -1.137 . . . . 2.16 108.453 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -120.05 134.69 55.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.454 0.645 . . . . 0.28 110.713 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -100.4 138.28 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.392 -1.336 . . . . 0.09 107.392 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -128.8 130.17 46.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.692 -1.255 . . . . 0.14 108.03 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.423 HG12 HD23 ' A' ' 7' ' ' LEU . 5.6 p -125.28 130.11 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.539 -0.912 . . . . 0.12 108.539 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.8 m -120.0 128.37 53.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.207 -0.664 . . . . 0.29 109.207 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 63.9 tt0 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.972 -1.014 . . . . 1.95 109.288 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.243 0.544 . . . . 0.31 109.582 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -113.42 146.92 38.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.749 -1.204 . . . . 0.19 107.749 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.22 141.59 48.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.23 -0.919 . . . . 1.98 109.824 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.5 tp -120.11 128.38 53.4 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.045 -0.724 . . . . 0.13 109.045 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.1 123.28 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.027 -1.471 . . . . 0.36 107.027 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 114.06 27.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.25 109.67 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.6 71.39 0.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.031 -1.47 . . . . 0.18 107.031 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.11 169.59 53.03 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.082 -1.207 . . . . 0.24 110.082 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -65.76 -39.84 91.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -1.039 . . . . 2.71 108.224 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.9 m -124.28 -18.42 5.82 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.419 -0.586 . . . . 0.92 109.419 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.7 119.98 39.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.6 109.037 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -135.31 133.63 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.253 -0.904 . . . . 2.02 109.598 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.82 -173.64 46.45 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.461 -1.352 . . . . 0.24 110.272 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -149.44 158.2 43.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.577 -0.954 . . . . 1.68 109.202 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.466 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 4.3 t -154.49 171.6 19.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 0.34 109.324 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.7 p -137.33 159.92 40.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.21 109.332 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.462 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.5 t -155.0 158.8 39.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.823 . . . . 0.23 109.094 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.59 133.57 48.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.459 -0.941 . . . . 2.22 108.459 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.55 146.25 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.39 109.306 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 21' ' ' VAL . 14.5 m -59.55 -30.78 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.55 109.564 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -159.33 174.61 14.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.981 . . . . 1.16 110.015 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.32 81.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.411 -0.805 . . . . 0.26 110.358 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.37 -37.32 62.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.872 -1.142 . . . . 0.29 109.708 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.441 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 21.4 p -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.692 -1.255 . . . . 0.44 109.576 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.19 81.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.359 -0.978 . . . . 0.18 108.359 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.13 -47.44 81.13 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.645 -1.222 . . . . 1.06 109.439 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.71 -41.13 88.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 2.67 110.248 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -68.27 -54.98 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.06 -1.025 . . . . 0.23 110.814 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 18' ' ' THR . 28.2 m-85 -63.69 -38.66 91.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.15 111.358 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.79 -40.72 96.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.701 -1.249 . . . . 2.07 110.049 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.23 -43.86 73.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.971 -1.08 . . . . 1.84 109.162 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.667 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 81.4 t80 -60.17 -46.98 87.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.446 -0.784 . . . . 0.3 109.899 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.34 96.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.25 108.656 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -61.41 -41.16 96.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.561 -0.903 . . . . 1.23 108.561 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.64 -25.05 68.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 1.29 109.607 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.667 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 80.5 m-20 -94.8 7.43 45.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.946 . . . . 0.64 109.791 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.12 30.34 75.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.678 -1.369 . . . . 0.72 109.678 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.0 t -105.45 125.81 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -1.165 . . . . 0.4 109.756 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 40.0 t0 -138.64 142.32 39.07 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.98 -1.119 . . . . 1.33 107.98 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.78 -150.13 11.6 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.247 -1.454 . . . . 0.26 110.135 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -94.48 137.66 33.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.531 -0.982 . . . . 2.07 108.822 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -104.89 138.33 41.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.367 -0.833 . . . . 0.13 110.77 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -136.24 149.86 48.7 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.885 -1.154 . . . . 0.22 107.885 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -137.03 137.35 39.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.185 -0.947 . . . . 0.12 110.492 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.6 109.95 20.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.316 -0.994 . . . . 0.24 108.316 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.9 t0 -67.35 -30.67 70.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 1.16 110.167 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.86 91.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.3 110.34 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.4 p -105.93 -0.07 25.39 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.391 -0.818 . . . . 0.42 110.278 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 50.02 41.46 23.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.927 -1.108 . . . . 2.16 108.542 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -119.03 130.5 55.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.734 0.778 . . . . 0.28 110.451 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -99.36 139.08 35.54 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.568 -1.271 . . . . 0.09 107.568 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.6 m -130.69 131.35 44.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.14 108.195 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.27 129.35 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.423 -0.954 . . . . 0.12 108.423 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.1 m -120.41 127.07 51.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.423 -0.798 . . . . 0.29 110.188 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.027 -0.987 . . . . 1.95 109.253 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.4 m . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.384 0.611 . . . . 0.31 109.655 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -113.72 145.41 41.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.361 -0.978 . . . . 0.19 108.361 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -115.96 142.94 46.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 1.98 108.912 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.558 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.9 tp -119.92 126.62 51.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.573 -0.899 . . . . 0.13 108.573 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.48 123.73 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.151 -1.425 . . . . 0.36 107.151 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 mt -102.73 112.89 25.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.25 110.383 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.97 68.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.839 -1.541 . . . . 0.18 106.839 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.31 168.2 51.51 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.965 -1.254 . . . . 0.24 109.965 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -65.9 -37.65 86.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.703 -1.221 . . . . 2.71 107.703 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -122.19 -19.79 6.42 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.151 -0.477 . . . . 0.92 109.866 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 tp -99.5 120.93 40.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 0.6 109.422 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -135.61 128.46 31.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.304 -0.873 . . . . 2.02 109.517 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.42 -175.03 47.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.303 -1.427 . . . . 0.24 110.446 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.36 152.57 41.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.646 -0.914 . . . . 1.68 108.86 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -152.65 168.02 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.34 108.801 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.1 p -138.65 160.54 39.37 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.21 109.737 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 10.4 t -157.37 162.84 39.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.23 108.594 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 43.7 mp0 -106.37 136.78 45.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.796 -0.816 . . . . 2.22 108.796 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.04 144.76 28.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.39 108.899 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -60.04 -30.73 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.229 -0.919 . . . . 0.55 109.393 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -157.73 176.96 11.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 1.16 110.112 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.31 -38.12 87.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.526 -0.734 . . . . 0.26 109.496 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.9 61.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.982 -1.074 . . . . 0.29 109.553 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.621 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 90.2 m -69.97 -40.06 75.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.69 -1.256 . . . . 0.44 109.811 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.02 87.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.857 -0.794 . . . . 0.18 108.857 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.21 -45.44 79.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.442 -1.303 . . . . 1.06 108.824 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -67.83 -44.23 77.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 2.67 111.157 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.87 -53.01 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.23 111.34 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.558 ' CD1' HD22 ' A' ' 5' ' ' LEU . 23.8 m-85 -63.98 -37.56 87.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.861 -1.149 . . . . 0.15 110.299 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -59.94 -42.32 93.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.805 -1.184 . . . . 2.07 109.8 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -68.67 -40.14 80.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.078 -1.014 . . . . 1.84 108.741 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.4 t80 -59.95 -46.81 88.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.3 109.028 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.84 92.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.83 . . . . 0.25 109.144 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -60.01 -45.93 91.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.439 -0.788 . . . . 1.23 110.137 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.33 -25.16 65.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.051 -1.03 . . . . 1.29 109.396 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 83.3 m-20 -99.71 9.47 43.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.64 109.785 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.04 35.13 91.6 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.981 -1.104 . . . . 0.72 110.491 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 71.1 t -108.89 127.85 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.147 -1.208 . . . . 0.4 109.979 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 96.0 m-20 -140.38 148.33 41.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.485 -0.931 . . . . 1.33 108.485 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.41 -159.57 28.64 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.44 -1.362 . . . . 0.26 110.061 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -85.87 132.1 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.029 -1.1 . . . . 2.07 108.029 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -101.76 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.135 -0.978 . . . . 0.13 110.683 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.5 p -136.44 150.04 48.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 61.1 t80 -134.19 137.73 44.64 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.414 -0.804 . . . . 0.12 110.335 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -115.84 109.98 18.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.834 -0.802 . . . . 0.24 108.834 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -67.81 -29.2 68.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 1.16 110.455 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.02 94.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.3 110.32 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 p -109.18 0.13 19.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.582 -0.699 . . . . 0.42 110.209 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtmp? 50.14 42.11 24.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.851 -1.156 . . . . 2.16 108.588 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -118.79 130.06 55.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.725 0.774 . . . . 0.28 110.166 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 31.5 m-85 -99.11 139.51 34.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.949 -1.5 . . . . 0.09 106.949 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.6 m -131.96 132.82 43.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.782 -1.199 . . . . 0.14 108.463 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.1 p -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.345 -0.983 . . . . 0.12 108.345 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.3 m -119.38 126.73 52.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.51 -0.744 . . . . 0.29 109.518 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' OE2' HG13 ' A' ' 39' ' ' VAL . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.086 -0.959 . . . . 1.95 109.7 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.39 -0.596 . . . . 0.31 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.79 145.49 43.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.807 -0.812 . . . . 0.19 108.807 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -114.38 143.42 44.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.98 108.906 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 30' ' ' PHE . 25.9 tp -119.8 126.91 52.17 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.735 -0.839 . . . . 0.13 108.735 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.9 mt -102.45 121.03 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.034 -1.469 . . . . 0.36 107.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.07 115.01 29.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.025 . . . . 0.25 109.879 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -122.48 66.0 0.94 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.628 -1.619 . . . . 0.18 106.628 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -78.6 171.89 55.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.799 -1.72 . . . . 0.24 108.799 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.38 -39.69 89.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.028 -1.278 . . . . 2.71 108.238 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.2 p -114.57 -20.12 10.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.841 -0.537 . . . . 0.92 109.757 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 9' ' ' GLY . 58.9 tp -99.93 121.65 41.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -0.918 . . . . 0.6 109.942 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -133.2 122.88 24.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.863 . . . . 2.02 108.948 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.08 -171.64 44.77 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.341 -1.409 . . . . 0.24 110.64 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 2.1 pm0 -150.46 158.61 44.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.519 -0.989 . . . . 1.68 109.591 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 t -154.55 170.37 21.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.518 -0.739 . . . . 0.34 109.707 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.3 p -138.16 160.13 40.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.33 -0.856 . . . . 0.21 109.494 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 t -155.46 162.19 40.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.959 -0.756 . . . . 0.23 108.959 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -100.22 132.08 45.8 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.088 -1.079 . . . . 2.22 108.088 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.711 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -148.39 143.24 26.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.943 -1.098 . . . . 0.39 109.477 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.46 -30.67 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.577 -0.702 . . . . 0.55 110.439 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -159.87 179.93 8.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.84 -1.162 . . . . 1.16 110.322 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -37.64 75.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.249 -0.907 . . . . 0.26 110.355 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.27 -38.52 68.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.186 . . . . 0.29 110.898 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.711 HG23 ' HB1' ' A' ' 20' ' ' ALA . 1.3 t -73.07 -34.44 66.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.271 -1.518 . . . . 0.44 109.388 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.59 86.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.65 -0.87 . . . . 0.18 108.65 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.34 -48.16 77.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.829 -1.149 . . . . 1.06 110.02 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.61 -41.14 88.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 2.67 110.96 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.3 -54.83 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 0.23 111.081 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.459 ' CD1' HD22 ' A' ' 5' ' ' LEU . 38.3 m-85 -63.76 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.01 -1.056 . . . . 0.15 110.456 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' HZ3' ' HB3' ' A' ' 31' ' ' LYS . 6.7 ttpm? -61.9 -42.64 99.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.801 -1.187 . . . . 2.07 109.935 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -67.54 -42.8 82.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.95 -1.094 . . . . 1.84 108.542 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.636 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 63.9 t80 -60.02 -47.83 84.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.425 0.631 . . . . 0.3 109.612 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.59 99.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.474 -0.766 . . . . 0.25 109.443 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -59.95 -40.66 89.73 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.191 -1.04 . . . . 1.23 108.191 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.61 -24.37 67.77 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.644 -0.66 . . . . 1.29 109.369 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 65.4 m-20 -97.63 6.94 47.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.64 109.769 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.07 34.32 70.29 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.954 -1.117 . . . . 0.72 110.711 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.87 124.52 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.03 -1.276 . . . . 0.4 108.972 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.47 101.09 2.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.003 -1.061 . . . . 1.33 110.713 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.07 -130.06 1.3 Allowed Glycine 0 N--CA 1.497 2.733 0 C-N-CA 119.268 -1.444 . . . . 0.26 111.336 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -93.78 129.3 40.2 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.972 -1.311 . . . . 2.07 110.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.55 139.97 41.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.67 -0.644 . . . . 0.13 110.059 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -136.08 149.46 48.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.756 -1.201 . . . . 0.22 107.756 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.95 135.4 41.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.12 109.924 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.45 109.55 19.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.299 -1.0 . . . . 0.24 108.299 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -68.19 -30.69 69.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.16 110.224 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.8 91.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.3 110.514 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.3 p -104.97 0.26 27.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.42 110.066 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm 50.63 40.95 25.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 2.16 108.257 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -119.79 130.54 54.99 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.536 0.684 . . . . 0.28 110.8 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -99.45 137.79 37.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.055 -1.461 . . . . 0.09 107.055 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.0 m -130.2 131.27 45.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.748 -1.22 . . . . 0.14 108.216 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.8 p -120.92 127.4 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.447 -0.946 . . . . 0.12 108.447 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -123.61 125.24 44.47 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.846 -0.798 . . . . 0.29 108.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.99 -1.005 . . . . 1.95 109.635 -179.865 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.41 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 23.9 m . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.022 -0.733 . . . . 0.31 109.022 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.06 147.17 42.6 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.979 -0.748 . . . . 0.19 108.979 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -118.07 143.77 46.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.487 -0.758 . . . . 1.98 109.267 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 7' ' ' LEU . 34.4 tp -119.5 129.07 54.53 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.011 -0.737 . . . . 0.13 109.011 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.46 123.72 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.066 -1.457 . . . . 0.36 107.066 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 5' ' ' LEU . 85.5 mt -104.49 116.44 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.208 -0.933 . . . . 0.25 111.035 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -114.88 71.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.113 -1.44 . . . . 0.18 107.113 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 168.91 52.61 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.434 -1.466 . . . . 0.24 109.434 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -66.05 -39.37 90.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.182 -1.187 . . . . 2.71 108.17 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.0 p -124.44 -16.56 6.31 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.023 0.44 . . . . 0.92 109.944 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -103.19 120.01 39.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.288 -0.883 . . . . 0.6 109.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -130.89 131.11 44.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.514 -0.741 . . . . 2.02 109.411 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.78 48.24 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.257 -1.449 . . . . 0.24 110.697 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 52.2 mp0 -143.88 153.26 42.14 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.479 -0.934 . . . . 1.68 108.479 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -152.51 169.17 23.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.085 -1.009 . . . . 0.34 109.34 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.9 p -135.44 159.82 40.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.353 -0.842 . . . . 0.21 109.502 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.456 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 10.6 t -157.28 160.12 38.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.23 109.216 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 55.8 mp0 -103.25 135.67 44.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.903 . . . . 2.22 108.678 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.6 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.54 144.6 27.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.39 109.264 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.88 -30.94 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.55 109.809 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -157.69 177.23 11.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.16 109.621 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.23 84.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.447 -0.783 . . . . 0.26 109.495 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -36.83 63.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.036 -1.04 . . . . 0.29 109.577 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.6 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 93.8 m -69.99 -39.63 75.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.785 -1.197 . . . . 0.44 109.651 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.71 78.83 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.735 -0.839 . . . . 0.18 108.735 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.76 -41.67 87.13 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.657 -1.217 . . . . 1.06 109.686 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.93 -45.17 71.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 2.67 110.477 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 -51.11 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.551 -0.718 . . . . 0.23 110.6 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' A' ' 18' ' ' THR . 35.0 m-85 -66.51 -38.6 87.58 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.091 -1.044 . . . . 0.15 110.549 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.0 -44.7 94.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.727 -1.233 . . . . 2.07 109.538 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -67.61 -40.88 84.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.028 -1.045 . . . . 1.84 108.573 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.2 t80 -59.99 -48.34 82.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.638 . . . . 0.3 109.78 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.21 94.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.25 109.546 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -60.0 -42.26 93.86 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.163 -0.961 . . . . 1.23 109.107 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.42 -26.47 67.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 1.29 109.696 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.8 m-20 -99.03 10.02 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.168 -0.958 . . . . 0.64 109.494 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.5 38.25 96.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.731 -1.348 . . . . 0.72 109.731 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.19 126.71 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -1.102 . . . . 0.4 110.172 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 52.4 t0 -110.19 -99.88 0.4 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.295 -1.002 . . . . 1.33 108.295 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.26 163.89 3.61 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 122.167 0.871 . . . . 0.26 112.368 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -75.2 138.48 41.99 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.348 -1.352 . . . . 2.07 107.348 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -99.57 134.99 41.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.13 110.809 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.6 p -133.57 148.19 51.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.316 -0.994 . . . . 0.22 108.316 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 66.8 t80 -130.61 134.31 46.88 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.86 . . . . 0.12 110.155 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' LYS . 62.0 t0 -112.88 107.19 15.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.738 -0.838 . . . . 0.24 108.738 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 56.5 t0 -67.36 -32.15 72.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.166 -0.959 . . . . 1.16 110.238 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.3 109.938 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -107.89 0.04 21.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.459 -0.775 . . . . 0.42 110.213 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 46' ' ' ASP . 9.5 mtmp? 49.74 42.02 22.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.806 -1.184 . . . . 2.16 108.294 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -120.01 131.44 55.14 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.625 0.726 . . . . 0.28 110.287 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.6 m-85 -99.88 137.83 37.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.28 -1.378 . . . . 0.09 107.28 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -131.0 131.7 44.52 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.804 -1.185 . . . . 0.14 108.245 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.5 p -120.58 128.06 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.077 -1.082 . . . . 0.12 108.077 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.22 125.86 49.21 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.402 -0.811 . . . . 0.29 110.845 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 38.2 mp0 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 118.034 -0.984 . . . . 1.95 109.438 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.458 -0.571 . . . . 0.31 109.458 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 95.2 m-85 -112.77 146.86 38.05 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.892 -1.151 . . . . 0.19 107.892 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -115.82 142.38 46.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.169 -0.957 . . . . 1.98 109.7 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' CD1' ' A' ' 30' ' ' PHE . 34.9 tp -122.4 128.11 50.54 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.057 -0.72 . . . . 0.13 109.057 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.69 124.16 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.605 -1.258 . . . . 0.36 107.605 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.3 mt -101.43 114.78 29.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.25 110.13 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.13 67.63 0.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.057 -1.46 . . . . 0.18 107.057 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.01 172.52 54.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.631 -1.387 . . . . 0.24 109.631 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -65.99 -39.06 90.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.221 -1.164 . . . . 2.71 108.365 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -17.57 6.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.917 -0.489 . . . . 0.92 109.859 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.3 tp -99.3 117.33 33.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 0.6 109.563 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.58 128.69 39.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.867 0.841 . . . . 2.02 109.514 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.15 -175.26 47.37 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.508 -1.329 . . . . 0.24 110.317 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -148.96 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.699 -0.883 . . . . 1.68 109.045 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -154.24 171.16 19.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.34 109.391 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 p -137.09 159.99 40.29 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.897 -0.779 . . . . 0.21 108.897 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.435 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.3 t -154.89 159.58 40.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.23 109.25 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -102.7 132.42 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.288 -0.882 . . . . 2.22 108.884 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.477 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.12 143.81 27.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.39 108.935 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.44 -27.23 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.55 109.858 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -157.96 172.21 18.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 1.16 109.939 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.68 83.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.516 -0.74 . . . . 0.26 109.941 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.48 -37.2 62.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.049 -1.032 . . . . 0.29 110.069 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.477 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 17.6 p -73.38 -34.41 65.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.615 -1.303 . . . . 0.44 109.809 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.9 87.33 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.325 -0.991 . . . . 0.18 108.325 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.67 -45.72 85.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.864 -1.134 . . . . 1.06 109.58 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.28 -42.7 83.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.078 . . . . 2.67 109.821 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.59 -54.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.23 110.737 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 5' ' ' LEU . 30.0 m-85 -63.44 -39.04 93.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.15 110.478 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -60.79 -42.45 97.57 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.721 -1.237 . . . . 2.07 109.823 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -69.61 -42.35 74.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 1.84 108.702 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.625 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.9 t80 -59.95 -44.94 94.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.665 -0.865 . . . . 0.3 108.665 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.92 99.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 0.25 109.387 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.1 -40.07 88.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 1.23 108.533 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.98 -24.22 67.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 78.1 m-20 -99.17 7.3 45.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.207 -0.933 . . . . 0.64 110.495 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.12 35.58 71.02 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.917 -1.135 . . . . 0.72 111.349 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 67.1 t -111.93 125.09 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.968 -1.313 . . . . 0.4 109.348 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 78.5 m-20 -148.47 98.8 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.252 -0.905 . . . . 1.33 110.47 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.83 -136.85 2.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.168 -1.491 . . . . 0.26 111.015 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.79 131.57 35.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.087 -1.243 . . . . 2.07 110.608 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -108.25 139.3 43.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.674 -0.641 . . . . 0.13 110.013 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 p -136.68 149.99 48.23 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 0.22 108.586 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 71.4 t80 -133.79 136.03 44.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.364 -0.835 . . . . 0.12 110.451 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -114.03 109.71 18.89 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.403 -0.962 . . . . 0.24 108.403 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.26 -29.11 67.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 1.16 110.17 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.02 94.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.005 . . . . 0.3 109.92 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -106.95 0.7 23.96 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.491 -0.756 . . . . 0.42 110.24 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.611 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 16.4 mtpp 50.51 41.66 25.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 2.16 108.451 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 132.64 55.52 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.66 0.743 . . . . 0.28 110.906 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 48.3 m-85 -99.99 139.36 35.77 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.167 -1.42 . . . . 0.09 107.167 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -130.33 131.52 45.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.665 -1.272 . . . . 0.14 108.343 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.7 p -124.85 130.01 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.862 . . . . 0.12 108.674 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.6 m -125.37 129.25 49.54 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.658 -0.651 . . . . 0.29 109.87 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.946 -1.026 . . . . 1.95 109.491 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 108.971 -0.751 . . . . 0.31 108.971 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.3 144.93 43.6 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.006 -0.739 . . . . 0.19 109.006 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -115.69 141.14 48.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 1.98 109.004 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.499 HD22 ' CD1' ' A' ' 30' ' ' PHE . 38.8 tp -120.05 128.97 54.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.13 109.336 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -105.81 123.06 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 106.983 -1.488 . . . . 0.36 106.983 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.06 115.89 31.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.311 -0.868 . . . . 0.25 110.311 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -116.59 72.8 0.83 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.967 -1.123 . . . . 0.18 107.967 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.62 169.47 54.31 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.219 -1.553 . . . . 0.24 109.219 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -62.37 -35.99 80.89 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.137 -1.213 . . . . 2.71 108.082 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 p -129.06 -11.92 4.69 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.555 -0.535 . . . . 0.92 109.555 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.6 tp -99.96 118.69 36.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.27 -0.894 . . . . 0.6 109.104 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -130.63 127.75 39.57 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 2.02 109.606 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 -177.84 48.39 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.184 -1.484 . . . . 0.24 110.555 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.17 157.15 43.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.666 -0.903 . . . . 1.68 109.014 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -152.99 169.97 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.34 109.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -136.49 159.61 41.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.21 109.309 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 11.5 t -155.67 159.0 39.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.387 -0.821 . . . . 0.23 109.138 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.37 134.04 45.06 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.042 -1.095 . . . . 2.22 108.042 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.43 26.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.928 -1.108 . . . . 0.39 109.491 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.05 -31.25 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.55 109.673 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -158.32 175.2 14.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 1.16 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.08 81.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.501 -0.749 . . . . 0.26 109.989 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.18 -36.92 61.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.008 -1.058 . . . . 0.29 109.871 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 p -74.16 -34.23 63.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.243 . . . . 0.44 109.519 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.971 -1.122 . . . . 0.18 107.971 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.07 -49.83 74.66 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.762 -1.175 . . . . 1.06 108.872 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -63.46 -44.77 93.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.83 . . . . 2.67 110.821 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.36 -53.28 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.053 -1.029 . . . . 0.23 110.763 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.499 ' CD1' HD22 ' A' ' 5' ' ' LEU . 29.2 m-85 -63.46 -37.82 88.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.15 110.456 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.685 -1.259 . . . . 2.07 109.83 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.57 -40.75 76.57 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.012 -1.055 . . . . 1.84 108.58 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -60.06 -47.77 84.5 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.749 -0.834 . . . . 0.3 108.749 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.16 99.42 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.918 -0.771 . . . . 0.25 108.918 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -60.0 -42.58 94.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.398 -0.814 . . . . 1.29 109.097 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -98.13 6.37 47.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.283 -0.886 . . . . 0.64 109.466 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.29 34.64 90.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.143 -1.183 . . . . 0.72 110.143 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.4 t -112.05 128.82 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.391 -1.064 . . . . 0.4 110.513 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 2.0 p-10 -110.52 -98.49 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.505 -1.294 . . . . 1.33 107.505 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 68.64 164.86 3.46 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-O 122.01 0.783 . . . . 0.26 111.841 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -76.31 137.46 39.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.998 -1.482 . . . . 2.07 106.998 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -98.0 134.94 40.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.13 110.544 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.38 148.77 50.73 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.996 -1.113 . . . . 0.22 107.996 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.2 t80 -135.97 135.1 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.326 -0.859 . . . . 0.12 110.29 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.65 109.95 19.8 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.31 -0.996 . . . . 0.24 108.31 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -68.68 -29.32 67.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 1.16 110.292 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.93 95.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.133 -0.98 . . . . 0.3 109.988 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.0 p -108.07 0.3 21.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.611 -0.681 . . . . 0.42 109.82 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.9 mttm 48.58 43.04 20.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.065 . . . . 2.16 108.502 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 131.75 55.26 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.543 0.687 . . . . 0.28 109.836 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.3 m-85 -100.05 138.93 36.45 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.851 -1.166 . . . . 0.09 107.851 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -131.36 131.68 43.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.803 -1.186 . . . . 0.14 108.52 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.19 130.15 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.296 -1.001 . . . . 0.12 108.296 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -117.53 124.83 49.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.504 -0.748 . . . . 0.29 109.701 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.039 -0.981 . . . . 1.95 109.588 -179.504 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 121.372 0.606 . . . . 0.31 110.377 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -109.57 150.94 27.45 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.774 -1.195 . . . . 0.19 107.774 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -118.1 140.04 50.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.08 -1.013 . . . . 1.98 109.232 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 30' ' ' PHE . 37.2 tp -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.926 -0.768 . . . . 0.13 108.926 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.31 124.55 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.779 -1.193 . . . . 0.36 107.779 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.36 116.56 32.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 0.25 109.9 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -114.33 72.32 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.584 -1.265 . . . . 0.18 107.584 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.68 169.06 53.1 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.45 -1.46 . . . . 0.24 109.45 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.35 -37.93 88.55 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.312 -1.111 . . . . 2.71 108.006 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.7 p -123.78 -16.15 6.75 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.73 -0.471 . . . . 0.92 109.73 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 tp -101.74 120.18 39.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.305 -0.872 . . . . 0.6 109.573 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.15 127.9 40.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.802 . . . . 2.02 108.966 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.97 -179.22 48.65 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.174 -1.489 . . . . 0.24 110.584 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -149.48 158.2 43.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.947 . . . . 1.68 109.556 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.47 172.52 17.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.45 -0.781 . . . . 0.34 109.703 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -137.31 160.01 40.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.407 -0.808 . . . . 0.21 109.532 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.514 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 5.2 t -154.88 159.09 40.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.23 108.994 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -103.02 134.73 45.97 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.503 -0.925 . . . . 2.22 108.503 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.814 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -150.68 144.91 25.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 0.39 109.807 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 m -61.5 -30.68 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.573 -0.705 . . . . 0.55 110.296 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 24' ' ' ALA . 3.3 p30 -159.3 -179.99 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.917 -1.114 . . . . 1.16 109.825 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.39 75.0 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.076 -1.015 . . . . 0.26 110.5 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . . . -55.12 -39.37 69.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.839 -1.163 . . . . 0.29 111.088 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.814 HG23 ' HB1' ' A' ' 20' ' ' ALA . 1.3 t -74.46 -32.83 62.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.244 -1.535 . . . . 0.44 109.339 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.806 -0.813 . . . . 0.18 108.806 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.71 -47.29 82.8 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.787 -1.165 . . . . 1.06 109.436 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -64.34 -43.02 95.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 2.67 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.83 -54.47 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.305 -0.872 . . . . 0.23 111.034 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.514 ' CZ ' HG22 ' A' ' 18' ' ' THR . 33.7 m-85 -62.84 -38.87 92.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.077 -1.014 . . . . 0.15 110.783 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -61.62 -42.57 99.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.818 -1.177 . . . . 2.07 109.897 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -67.26 -43.0 82.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.84 -1.163 . . . . 1.84 108.619 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -47.57 85.28 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -0.774 . . . . 0.3 109.308 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.84 99.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.25 109.255 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.84 -42.46 97.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.23 109.059 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -62.49 -21.72 65.71 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -0.912 . . . . 1.29 108.958 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.9 m-20 -99.77 8.92 43.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.64 109.41 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.78 35.56 91.44 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.193 -1.163 . . . . 0.72 110.193 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.8 t -111.5 128.62 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.267 -1.137 . . . . 0.4 109.801 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.473 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 8.9 t70 -111.68 -96.59 0.42 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.108 -1.071 . . . . 1.33 108.108 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 68.33 164.42 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 121.237 -0.915 . . . . 0.26 112.087 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.68 137.47 42.18 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.319 -1.363 . . . . 2.07 107.319 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.18 135.61 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.958 . . . . 0.13 110.956 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -135.61 149.92 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.152 -1.055 . . . . 0.22 108.152 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 49.6 t80 -135.36 135.17 40.49 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.12 109.646 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -114.21 110.14 19.49 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.286 -0.635 . . . . 0.24 109.286 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.47 -29.54 69.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 1.16 109.852 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -40.46 94.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.3 110.167 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 76.9 p -107.94 -0.73 21.22 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.842 . . . . 0.42 110.049 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 48.9 42.48 20.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.037 -1.039 . . . . 2.16 108.694 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -120.08 130.26 54.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.822 -0.626 . . . . 0.28 109.786 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.4 m-85 -98.66 138.37 35.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.274 -1.38 . . . . 0.09 107.274 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.7 m -132.07 132.34 43.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.677 -1.264 . . . . 0.14 108.792 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.62 126.73 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.931 -1.137 . . . . 0.12 107.931 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.92 127.8 52.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.345 -0.847 . . . . 0.29 111.005 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 29.9 mp0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.014 -0.993 . . . . 1.95 109.466 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.53 -0.544 . . . . 0.31 109.53 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.83 145.56 42.01 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.677 -0.86 . . . . 0.19 108.677 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.404 ' HZ2' ' CG1' ' A' ' 6' ' ' ILE . 24.4 ttpp -116.64 142.13 47.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.372 -0.83 . . . . 1.98 109.073 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 30' ' ' PHE . 56.6 tp -121.9 129.41 52.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.728 . . . . 0.13 109.798 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.404 ' CG1' ' HZ2' ' A' ' 4' ' ' LYS . 93.0 mt -105.97 123.3 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.748 -1.575 . . . . 0.36 106.748 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.41 117.09 33.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 0.25 110.437 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.01 71.22 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.258 -1.386 . . . . 0.18 107.258 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 173.74 54.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.212 -1.555 . . . . 0.24 109.212 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -65.16 -39.93 93.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.189 -1.183 . . . . 2.71 108.102 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.7 p -124.99 -14.63 6.58 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.649 -0.5 . . . . 0.92 109.649 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.7 tp -99.7 114.94 28.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -0.974 . . . . 0.6 109.418 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 129.07 42.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.426 -0.796 . . . . 2.02 109.256 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.58 -175.1 47.41 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.285 -1.436 . . . . 0.24 110.312 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -148.28 156.82 43.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.608 -0.936 . . . . 1.68 108.96 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -154.67 172.9 17.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.34 109.604 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 p -137.68 159.13 42.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.752 . . . . 0.21 109.064 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -155.65 160.06 40.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.838 . . . . 0.23 108.874 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -104.31 133.82 48.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.272 -0.893 . . . . 2.22 108.931 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.17 146.27 26.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.39 109.614 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.24 -30.69 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.78 . . . . 0.55 110.194 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -159.79 179.99 8.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 1.16 110.093 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.79 82.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.628 -0.67 . . . . 0.26 110.653 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -37.03 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.874 -1.142 . . . . 0.29 110.431 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 p -73.49 -36.04 65.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.55 -1.344 . . . . 0.44 109.845 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.9 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.039 -1.097 . . . . 0.18 108.039 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.66 -45.73 85.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.13 -1.028 . . . . 1.06 110.203 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -67.35 -40.72 85.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.123 . . . . 2.67 110.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.37 -53.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.23 110.871 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CD1' HD22 ' A' ' 5' ' ' LEU . 41.0 m-85 -67.25 -40.01 86.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.923 -1.11 . . . . 0.15 110.664 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.75 -46.18 91.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.876 -1.14 . . . . 2.07 109.945 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.65 -43.01 81.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.095 -1.003 . . . . 1.84 108.782 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.9 t80 -60.09 -45.09 94.09 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.401 -0.812 . . . . 0.3 109.606 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.373 -0.829 . . . . 0.25 109.49 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -62.43 -40.12 95.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 1.23 109.007 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.62 -24.58 67.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 1.29 109.426 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 73.0 m-20 -97.14 10.08 40.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.64 109.198 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.0 93.97 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.321 -1.512 . . . . 0.72 109.321 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.4 t -109.94 123.75 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.356 -1.085 . . . . 0.4 109.867 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 97.6 m-20 -140.44 146.89 38.87 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.151 -1.055 . . . . 1.33 108.151 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.39 -155.49 22.47 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.077 -1.535 . . . . 0.26 110.105 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -88.03 130.66 34.91 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.85 -1.167 . . . . 2.07 107.85 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -103.0 138.92 39.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.13 110.463 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.8 p -136.83 150.05 48.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.341 -0.985 . . . . 0.22 108.341 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.3 t80 -135.69 137.09 41.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.435 -0.791 . . . . 0.12 110.233 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.93 109.95 20.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.901 -0.777 . . . . 0.24 108.901 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 51.9 t0 -67.15 -32.45 73.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 1.16 110.179 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.51 94.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.3 110.213 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -108.15 0.14 21.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.561 -0.712 . . . . 0.42 110.44 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 49.98 41.68 23.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.836 -1.165 . . . . 2.16 108.404 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -118.97 131.09 56.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.66 0.743 . . . . 0.28 110.264 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 44.4 m-85 -99.97 139.19 35.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.527 -1.286 . . . . 0.09 107.527 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 m -131.94 132.18 43.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.838 -1.164 . . . . 0.14 108.361 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.49 129.93 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.485 -0.932 . . . . 0.12 108.485 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -119.99 127.33 52.52 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.551 -0.718 . . . . 0.29 110.134 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 7.7 mp0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.975 -1.012 . . . . 1.95 109.238 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.283 0.563 . . . . 0.31 109.53 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.2 149.0 41.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.623 -0.88 . . . . 0.19 108.623 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -114.81 143.84 44.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.332 -0.855 . . . . 1.98 109.877 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.424 HD22 ' CD1' ' A' ' 30' ' ' PHE . 27.8 tp -121.31 127.14 51.02 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.858 -0.793 . . . . 0.13 108.858 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.9 mt -106.87 123.36 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.523 -1.288 . . . . 0.36 107.523 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -102.28 114.13 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.25 109.68 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' OD1' ' NZ ' ' A' ' 13' ' ' LYS . 43.2 t30 -114.88 71.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.72 -1.215 . . . . 0.18 107.72 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 166.43 49.76 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.416 -1.474 . . . . 0.24 109.416 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.437 ' NZ ' ' C ' ' A' ' 56' ' ' GLU . 60.0 mttp -67.41 -35.21 78.81 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -1.152 . . . . 2.71 108.027 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -22.42 4.99 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.929 -0.482 . . . . 0.92 109.849 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.37 119.96 39.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.306 -0.871 . . . . 0.6 109.338 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 8' ' ' ASN . 66.1 mttm -133.08 131.74 40.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.287 -0.883 . . . . 2.02 109.648 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.02 -179.97 48.8 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.273 -1.441 . . . . 0.24 110.426 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -142.0 151.97 42.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.609 -0.936 . . . . 1.68 108.73 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -151.89 167.65 27.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.34 109.074 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 p -139.88 160.82 39.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.21 109.411 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.9 t -155.72 161.17 40.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.686 -0.857 . . . . 0.23 108.686 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -103.45 135.03 45.82 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.484 -0.932 . . . . 2.22 108.484 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.9 144.28 27.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.39 109.549 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.36 -30.07 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.821 . . . . 0.55 109.634 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -158.35 171.06 20.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 1.16 109.582 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.78 81.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.26 109.796 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.71 68.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.115 . . . . 0.29 109.909 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.9 m -69.96 -37.17 75.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.44 109.722 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.83 75.2 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.588 -0.893 . . . . 0.18 108.588 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.43 -47.31 72.96 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.943 -1.103 . . . . 1.06 109.524 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 8.2 mptt -67.96 -40.2 83.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.794 -1.191 . . . . 2.67 110.459 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.24 -53.39 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 0.23 111.361 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.9 m-85 -64.7 -39.98 94.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.887 -1.133 . . . . 0.15 111.045 -178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -62.14 -40.01 94.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.719 -1.238 . . . . 2.07 109.932 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.94 -1.1 . . . . 1.84 108.795 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 68.6 t80 -59.89 -48.63 80.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 0.3 109.606 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -43.22 99.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.366 -0.834 . . . . 0.25 109.151 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.06 -42.53 94.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.641 -0.874 . . . . 1.23 108.641 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.72 -22.21 66.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 1.29 109.289 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.524 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 32.2 m120 -96.27 6.91 47.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.246 -0.909 . . . . 0.64 109.988 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.79 75.38 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.76 -1.21 . . . . 0.72 110.201 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 126.97 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.282 -1.128 . . . . 0.4 109.621 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -142.92 148.69 37.34 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.353 -0.98 . . . . 1.33 108.353 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.07 -150.45 14.73 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.173 -1.489 . . . . 0.26 110.147 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 59.1 mp0 -89.17 129.33 35.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.976 -1.12 . . . . 2.07 107.976 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -100.4 138.35 37.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.13 110.066 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.6 p -136.37 150.04 48.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.13 -1.063 . . . . 0.22 108.13 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -134.37 135.55 42.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.441 -0.787 . . . . 0.12 109.7 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -111.23 108.68 18.4 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.186 -1.042 . . . . 0.24 108.186 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -67.58 -30.81 70.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 1.16 110.197 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.02 94.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.3 110.112 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -104.72 0.09 27.96 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.486 -0.759 . . . . 0.42 110.417 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 49.97 40.43 21.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.886 -1.134 . . . . 2.16 108.215 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 131.05 55.01 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.685 0.755 . . . . 0.28 110.497 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -98.66 137.85 36.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.037 -1.468 . . . . 0.09 107.037 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.3 m -129.99 130.87 45.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.14 108.074 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.26 129.39 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.123 -1.066 . . . . 0.12 108.123 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -118.32 124.71 48.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.29 109.172 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' C ' ' NZ ' ' A' ' 10' ' ' LYS . 83.3 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.971 -1.014 . . . . 1.95 109.575 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.15 0.5 . . . . 0.31 109.758 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.09 145.02 40.5 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.26 -1.015 . . . . 0.19 108.26 178.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -115.97 139.95 49.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.288 -1.004 . . . . 1.98 108.288 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 52' ' ' PHE . 24.4 tp -120.52 127.71 52.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.512 -0.921 . . . . 0.13 108.512 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.0 mt -105.87 123.3 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.118 -1.438 . . . . 0.36 107.118 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.427 HD23 HG12 ' A' ' 54' ' ' VAL . 87.3 mt -103.67 115.01 29.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.25 110.034 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.71 71.15 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.353 -1.351 . . . . 0.18 107.353 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 167.12 50.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.513 -1.435 . . . . 0.24 109.513 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -64.98 -36.23 83.72 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.662 -1.236 . . . . 2.71 107.662 178.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -19.51 5.3 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.849 -0.426 . . . . 0.92 109.849 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.82 119.99 38.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.082 -1.011 . . . . 0.6 109.126 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -133.67 129.12 36.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.02 109.722 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.85 -175.08 47.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.46 -1.353 . . . . 0.24 110.443 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.53 156.95 43.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.981 . . . . 1.68 109.444 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -154.33 169.96 22.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.34 109.353 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -137.85 160.46 39.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.21 109.311 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.46 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 3.4 t -156.08 162.0 40.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.23 108.971 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 4.0 tm-20 -102.94 134.8 45.76 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.675 -0.861 . . . . 2.22 108.675 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.19 -0.944 . . . . 0.39 108.939 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.2 m -60.09 -29.89 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.55 109.356 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -158.14 176.5 12.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 1.16 109.834 -179.509 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.41 88.41 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.26 109.85 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.55 49.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.946 -1.096 . . . . 0.29 109.433 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.659 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.5 m -69.47 -39.99 77.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.827 -1.171 . . . . 0.44 109.942 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.37 97.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.312 -0.868 . . . . 0.18 109.137 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.29 -56.76 12.68 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.46 -0.896 . . . . 1.06 111.091 -178.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -69.48 -37.4 77.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.67 111.83 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.48 -53.49 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.425 -1.422 . . . . 0.23 110.637 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CZ ' HG22 ' A' ' 18' ' ' THR . 39.7 m-85 -61.81 -35.75 79.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.022 -1.049 . . . . 0.15 110.266 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.03 -40.77 90.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.946 -1.096 . . . . 2.07 108.952 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -69.41 -41.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 1.84 108.795 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.5 t80 -60.03 -49.93 75.72 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.048 -0.723 . . . . 0.3 109.048 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.77 96.28 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.476 -0.765 . . . . 0.25 109.362 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.46 -40.74 97.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 1.23 109.554 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.99 -25.7 67.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 1.29 109.271 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.2 m-20 -97.9 9.08 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.64 108.741 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.43 37.63 94.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.332 -1.107 . . . . 0.72 110.332 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.75 129.81 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.22 -1.165 . . . . 0.4 110.403 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 89.5 m-20 -111.65 -96.2 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.012 -1.107 . . . . 1.33 108.012 178.268 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.71 166.27 4.16 Favored Glycine 0 N--CA 1.491 2.351 0 CA-C-O 122.156 0.865 . . . . 0.26 112.27 177.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.52 138.6 39.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.361 -1.348 . . . . 2.07 107.361 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -100.22 135.76 41.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.119 -0.988 . . . . 0.13 110.91 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.4 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.005 -1.109 . . . . 0.22 108.005 179.046 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -135.32 134.97 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.233 -0.917 . . . . 0.12 110.693 -177.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.28 110.0 20.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.677 -0.86 . . . . 0.24 108.677 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -65.61 -31.7 72.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.16 110.363 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.56 -40.0 88.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.3 110.756 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.7 p -105.06 -0.41 26.76 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.42 110.469 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 50.02 40.34 21.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.888 -1.132 . . . . 2.16 108.068 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.02 54.51 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.645 0.736 . . . . 0.28 110.137 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.445 ' O ' HD12 ' A' ' 5' ' ' LEU . 45.3 m-85 -98.67 139.96 33.59 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.118 -1.438 . . . . 0.09 107.118 178.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.2 m -129.43 131.25 46.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.764 -1.21 . . . . 0.14 108.417 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG12 HD23 ' A' ' 7' ' ' LEU . 2.7 p -120.22 128.93 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.934 -1.136 . . . . 0.12 107.934 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -119.92 125.72 49.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.29 109.757 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.999 -1.0 . . . . 1.95 109.516 -179.691 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.388 -0.597 . . . . 0.31 109.388 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 91.5 m-85 -117.93 148.69 41.92 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.772 -0.825 . . . . 0.19 108.772 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -117.07 145.28 43.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 1.98 109.324 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 7' ' ' LEU . 46.0 tp -119.45 127.53 53.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.547 -0.908 . . . . 0.13 108.547 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.09 121.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.023 -1.473 . . . . 0.36 107.023 178.29 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 5' ' ' LEU . 85.8 mt -102.55 116.81 33.35 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 0.25 110.308 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.0 68.29 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.509 -1.293 . . . . 0.18 107.509 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.5 171.55 54.13 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.505 -1.438 . . . . 0.24 109.505 179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -66.26 -39.86 89.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -1.128 . . . . 2.71 108.148 178.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.1 p -120.01 -20.09 7.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.999 -0.438 . . . . 0.92 109.848 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.8 tp -99.98 120.07 39.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 0.6 109.415 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -136.47 130.61 32.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 2.02 109.833 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.57 -173.62 46.42 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.392 -1.385 . . . . 0.24 110.905 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.521 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 46.4 mp0 -144.34 153.55 42.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.982 . . . . 1.68 108.958 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -153.17 168.54 25.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.34 109.446 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 p -139.36 159.78 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.863 . . . . 0.21 109.167 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -156.74 164.24 38.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.953 -0.758 . . . . 0.23 108.953 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -103.37 133.98 47.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.379 -0.826 . . . . 2.22 109.01 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.14 143.39 28.22 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.6 -0.889 . . . . 0.39 108.6 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -59.94 -29.61 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.55 109.535 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -157.74 175.19 14.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 1.16 110.022 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.13 85.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.552 -0.717 . . . . 0.26 109.871 -179.459 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.24 -36.58 61.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.112 . . . . 0.29 109.912 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.503 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 5.1 p -73.43 -33.47 64.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.608 -1.307 . . . . 0.44 109.732 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.18 81.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.237 -1.023 . . . . 0.18 108.237 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.01 -44.93 83.31 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.823 -1.151 . . . . 1.06 109.558 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.7 -42.72 85.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.882 -1.136 . . . . 2.67 110.579 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.63 -52.0 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.23 111.243 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.67 -40.03 88.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.025 -1.047 . . . . 0.15 111.269 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -63.51 -41.28 98.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.503 -1.373 . . . . 2.07 109.997 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -70.0 -45.68 66.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.879 -1.138 . . . . 1.84 108.939 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.545 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 72.9 t80 -60.02 -47.98 83.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.495 -0.753 . . . . 0.3 109.453 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.59 98.64 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.478 -0.764 . . . . 0.25 109.474 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.95 -40.49 89.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.392 -0.818 . . . . 1.23 108.974 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -65.08 -19.26 65.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.784 -0.821 . . . . 1.29 108.784 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.545 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 97.4 m-20 -94.68 6.7 48.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.64 109.788 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.2 30.25 63.17 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.9 -1.143 . . . . 0.72 111.153 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.02 124.26 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.901 -1.352 . . . . 0.4 108.527 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 27.7 p-10 -150.58 99.61 2.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 1.33 110.593 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.2 -125.48 0.86 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.174 -1.489 . . . . 0.26 111.317 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.79 130.3 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.898 -1.354 . . . . 2.07 110.851 -178.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -107.23 139.59 41.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 0.13 110.27 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.5 p -137.77 150.02 46.9 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.419 -0.956 . . . . 0.22 108.419 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CE1' ' CE1' ' A' ' 52' ' ' PHE . 48.9 t80 -137.79 137.75 38.53 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.175 -0.953 . . . . 0.12 110.337 -179.077 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.719 -0.845 . . . . 0.24 108.719 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.51 -31.05 71.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.346 -0.846 . . . . 1.16 110.928 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.9 94.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.3 110.537 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -103.55 0.04 30.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.381 -0.824 . . . . 0.42 110.383 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 20.4 mtpp 49.91 40.12 20.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.11 . . . . 2.16 108.255 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -120.1 131.12 54.95 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.498 0.666 . . . . 0.28 110.14 -178.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 54.3 m-85 -99.96 138.83 36.49 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.447 -1.316 . . . . 0.09 107.447 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.7 m -130.06 131.55 45.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.14 108.709 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.5 p -121.67 127.68 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.577 -0.898 . . . . 0.12 108.577 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -125.47 127.51 46.6 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.532 -0.73 . . . . 0.29 109.803 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.019 -0.991 . . . . 1.95 109.289 179.811 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.176 0.512 . . . . 0.31 109.776 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.456 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 95.8 m-85 -114.31 141.93 46.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.691 -0.855 . . . . 0.19 108.691 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.7 140.17 48.47 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.733 -0.84 . . . . 1.98 108.733 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.59 HD22 ' CD1' ' A' ' 30' ' ' PHE . 46.6 tp -120.06 128.76 53.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.347 -0.846 . . . . 0.13 109.516 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -104.96 122.38 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.208 -1.404 . . . . 0.36 107.208 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.74 115.45 30.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -0.987 . . . . 0.25 110.282 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -118.75 72.37 0.88 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.826 -1.176 . . . . 0.18 107.826 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 171.06 54.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.351 -1.5 . . . . 0.24 109.351 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.66 -39.85 94.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.05 -1.265 . . . . 2.71 108.173 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -124.67 -16.1 6.34 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.204 -0.665 . . . . 0.92 109.204 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 9' ' ' GLY . 60.1 tp -99.8 118.04 35.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.323 -0.86 . . . . 0.6 108.794 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -135.83 133.78 38.18 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 2.02 109.916 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.54 -176.21 47.86 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.495 -1.336 . . . . 0.24 110.403 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -145.03 151.61 38.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.505 -0.924 . . . . 1.68 108.505 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -152.62 170.16 20.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.34 109.422 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -137.74 159.88 40.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -0.771 . . . . 0.21 109.196 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.421 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.2 t -156.97 162.27 39.6 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.368 -0.832 . . . . 0.23 108.796 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -106.58 136.6 46.08 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.778 -0.823 . . . . 2.22 108.778 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.91 148.52 29.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.39 109.39 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.9 -33.35 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.392 -0.817 . . . . 0.55 110.086 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -159.85 179.98 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 1.16 110.088 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.456 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -66.74 -40.03 88.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.534 -0.728 . . . . 0.26 110.469 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -37.56 63.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.873 -1.142 . . . . 0.29 110.228 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.4 m -69.99 -39.98 75.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.673 -1.267 . . . . 0.44 110.148 179.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.05 88.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.803 . . . . 0.18 109.09 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.97 -46.37 82.24 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.769 -1.172 . . . . 1.06 109.57 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -67.39 -44.11 79.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.435 -0.79 . . . . 2.67 110.67 -179.151 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.37 -53.11 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.23 110.99 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CD1' HD22 ' A' ' 5' ' ' LEU . 30.3 m-85 -63.62 -38.76 92.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.935 -1.103 . . . . 0.15 110.4 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -60.07 -45.13 93.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.856 -1.153 . . . . 2.07 109.999 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -69.07 -42.1 76.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.025 -1.047 . . . . 1.84 109.1 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.615 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -59.98 -44.65 94.36 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.717 -0.846 . . . . 0.3 108.717 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.58 -43.6 96.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.25 109.013 179.17 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -60.28 -42.39 95.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.24 -0.913 . . . . 1.23 108.814 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.9 -25.26 67.46 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.398 -0.814 . . . . 1.29 109.344 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.615 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 94.2 m-20 -100.13 8.94 43.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.392 -0.817 . . . . 0.64 109.419 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.99 36.2 92.79 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.225 -1.15 . . . . 0.72 110.225 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.13 124.79 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.196 -1.179 . . . . 0.4 109.974 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 80.2 m-20 -110.62 -98.74 0.4 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.07 -1.085 . . . . 1.33 108.07 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.29 165.97 2.73 Favored Glycine 0 N--CA 1.488 2.121 0 CA-C-O 122.146 0.859 . . . . 0.26 112.134 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -77.79 135.49 37.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.067 -1.457 . . . . 2.07 107.067 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -98.58 135.66 39.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.125 -0.985 . . . . 0.13 110.66 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.6 p -132.77 148.24 52.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.747 -1.205 . . . . 0.22 107.747 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 55.5 t80 -135.07 135.63 41.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.261 -0.899 . . . . 0.12 110.372 -178.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -113.03 110.05 19.84 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.607 -0.886 . . . . 0.24 108.607 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.7 t0 -68.0 -30.27 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.16 110.348 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.29 93.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.3 110.058 -179.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -107.85 0.08 21.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.476 -0.765 . . . . 0.42 110.106 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 49.98 43.52 25.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.928 -1.107 . . . . 2.16 108.581 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.81 130.23 54.82 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.592 0.71 . . . . 0.28 110.473 -178.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.527 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.9 m-85 -101.37 139.91 36.39 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.231 -1.396 . . . . 0.09 107.231 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.0 m -132.83 134.01 44.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.786 -1.196 . . . . 0.14 108.756 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -122.81 129.8 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.608 -0.886 . . . . 0.12 108.608 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -122.67 126.81 48.36 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.415 -0.803 . . . . 0.29 110.654 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.94 -1.028 . . . . 1.95 109.482 179.038 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.6 m . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.18 -0.674 . . . . 0.31 109.18 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.73 148.85 37.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.463 -0.773 . . . . 0.19 109.047 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -118.75 142.44 47.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.406 -0.808 . . . . 1.98 109.228 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 30' ' ' PHE . 31.9 tp -120.84 129.43 53.54 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.483 -0.76 . . . . 0.13 109.279 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -106.58 123.08 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.404 -1.332 . . . . 0.36 107.404 179.157 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.47 115.2 30.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.242 -0.911 . . . . 0.25 110.412 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -117.57 70.15 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.352 -1.351 . . . . 0.18 107.352 178.115 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.78 54.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.977 -1.249 . . . . 0.24 109.977 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.2 -39.8 93.33 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -1.1 . . . . 2.71 108.333 178.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -15.62 6.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.947 -0.471 . . . . 0.92 109.778 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.9 tp -100.01 120.04 39.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.095 -1.003 . . . . 0.6 109.517 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -131.89 127.06 35.67 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.331 -0.856 . . . . 2.02 109.364 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.99 -177.9 48.26 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.178 -1.487 . . . . 0.24 110.676 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -148.31 156.89 43.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.625 -0.926 . . . . 1.68 109.179 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.429 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 5.6 t -154.21 170.52 21.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.347 -0.845 . . . . 0.34 109.629 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.9 p -137.98 160.02 40.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.385 -0.822 . . . . 0.21 109.415 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.414 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.9 t -155.08 160.52 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.23 109.239 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -104.36 133.55 49.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.344 -0.848 . . . . 2.22 108.757 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.95 146.07 27.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.006 -1.059 . . . . 0.39 109.637 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.61 -30.15 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.389 -0.819 . . . . 0.55 109.975 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -158.5 174.91 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 1.16 110.163 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.17 79.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.553 -0.717 . . . . 0.26 110.372 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.94 -37.82 61.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.793 -1.192 . . . . 0.29 110.092 -179.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 p -74.14 -33.06 63.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.637 -1.289 . . . . 0.44 109.685 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.18 93.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.406 -0.809 . . . . 0.18 108.934 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.67 -46.28 84.45 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.838 -1.145 . . . . 1.06 109.637 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -67.13 -40.09 86.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 2.67 110.304 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.47 -53.17 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.972 . . . . 0.23 110.673 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' HD22 ' A' ' 5' ' ' LEU . 37.4 m-85 -63.99 -38.07 89.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.15 110.551 -178.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -59.93 -40.16 87.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.624 -1.298 . . . . 2.07 109.126 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -69.38 -41.77 76.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.125 -0.984 . . . . 1.84 109.042 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 59.3 t80 -60.03 -46.6 88.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.3 109.576 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.97 95.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.25 109.308 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -40.66 90.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.148 -0.97 . . . . 1.23 108.976 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -64.51 -26.12 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.284 -0.885 . . . . 1.29 109.984 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.627 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 69.6 m-80 -99.75 4.99 45.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.017 -1.052 . . . . 0.64 110.103 -179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.4 60.82 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.034 -1.079 . . . . 0.72 111.599 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.3 t -110.67 122.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.892 -1.357 . . . . 0.4 108.39 178.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 71.1 m-20 -150.6 101.04 2.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 1.33 110.659 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.36 -131.84 1.49 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 119.297 -1.43 . . . . 0.26 111.083 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 57.8 mp0 -88.81 128.11 35.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.952 -1.322 . . . . 2.07 110.164 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -104.11 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.692 -0.63 . . . . 0.13 109.999 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.9 p -131.49 147.19 52.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.93 -1.137 . . . . 0.22 107.93 178.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 53.7 t80 -133.25 132.36 41.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.338 -0.851 . . . . 0.12 110.207 -178.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -114.65 109.94 18.99 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.381 -0.97 . . . . 0.24 108.381 178.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -69.51 -27.67 65.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 1.16 110.267 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.92 95.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.3 109.926 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.9 p -106.02 0.18 25.43 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.546 -0.721 . . . . 0.42 110.036 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtpm? 50.02 39.96 20.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.882 -1.136 . . . . 2.16 108.289 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -120.01 132.87 55.63 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 0.28 110.593 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 56.3 m-85 -100.36 139.67 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.252 -1.388 . . . . 0.09 107.252 177.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 m -130.24 131.97 45.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.763 -1.21 . . . . 0.14 108.339 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.83 129.25 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.34 -0.985 . . . . 0.12 108.34 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -124.56 128.19 48.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.621 -0.674 . . . . 0.29 110.115 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.038 -0.982 . . . . 1.95 109.296 179.8 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.6 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.325 -0.62 . . . . 0.31 109.325 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -112.35 145.37 40.18 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.366 -0.976 . . . . 0.19 108.366 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -113.43 139.97 48.47 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.124 -0.985 . . . . 1.98 108.8 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.4 tp -120.91 126.6 50.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.754 -0.832 . . . . 0.13 108.754 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.62 124.01 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.61 -1.256 . . . . 0.36 107.61 178.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 54' ' ' VAL . 90.0 mt -104.24 114.13 28.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.25 110.231 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -113.5 72.46 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.395 -1.335 . . . . 0.18 107.395 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.55 169.46 53.53 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.665 -1.374 . . . . 0.24 109.665 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -64.87 -38.51 91.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -1.129 . . . . 2.71 108.517 178.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 p -130.62 -16.58 3.37 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.527 -0.546 . . . . 0.92 109.527 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -101.76 117.36 34.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.249 -1.019 . . . . 0.6 108.249 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -133.71 137.87 45.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.207 -0.933 . . . . 2.02 110.416 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -180.0 -178.25 48.43 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.688 -1.244 . . . . 0.24 110.194 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.56 154.71 41.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.507 -0.923 . . . . 1.68 108.507 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -154.63 170.7 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.842 . . . . 0.34 109.502 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -138.32 160.03 40.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.919 -0.771 . . . . 0.21 108.919 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.1 t -156.7 161.42 39.85 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.273 -0.892 . . . . 0.23 109.239 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -102.92 134.97 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.696 -0.853 . . . . 2.22 108.696 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.61 144.87 27.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 0.39 108.912 -179.613 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.03 -30.58 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.55 109.467 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -159.73 178.51 9.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 1.16 110.02 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.76 -37.92 82.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.456 -0.777 . . . . 0.26 110.048 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.51 -37.38 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.965 -1.085 . . . . 0.29 110.136 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.402 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.8 m -69.92 -39.19 76.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.634 -1.291 . . . . 0.44 109.66 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.89 87.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.595 -0.69 . . . . 0.18 109.196 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.97 -45.81 82.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.883 -1.127 . . . . 1.06 109.504 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -67.82 -43.38 79.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 2.67 110.679 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.94 -52.53 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.32 -0.863 . . . . 0.23 111.62 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.581 ' CD1' HD22 ' A' ' 5' ' ' LEU . 27.1 m-85 -64.22 -38.47 91.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.802 -1.186 . . . . 0.15 110.482 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -60.04 -44.07 94.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.84 -1.162 . . . . 2.07 109.692 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.512 ' NE2' ' OD2' ' A' ' 36' ' ' ASP . 1.6 tm0? -67.91 -41.7 82.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 1.84 108.705 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.7 t80 -60.0 -49.02 79.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.622 -0.674 . . . . 0.3 109.503 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.42 93.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.25 109.057 179.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -60.17 -44.58 94.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 1.23 109.366 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' NE2' ' A' ' 32' ' ' GLN . 82.3 m-20 -62.72 -24.04 67.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 1.29 109.24 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.623 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.0 m-20 -97.63 7.01 47.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.816 . . . . 0.64 109.667 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.18 31.59 77.93 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.053 -1.07 . . . . 0.72 110.851 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.99 127.41 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.174 -1.192 . . . . 0.4 109.836 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 87.5 m-20 -109.99 -99.82 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.092 -1.077 . . . . 1.33 108.092 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.96 163.51 4.17 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-O 122.028 0.793 . . . . 0.26 112.339 177.133 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 58.1 mp0 -75.55 137.15 40.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.321 -1.363 . . . . 2.07 107.321 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -99.89 135.0 41.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 0.13 110.927 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.6 p -135.23 150.05 50.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.632 -1.247 . . . . 0.22 107.632 178.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -135.27 138.9 43.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.294 -0.879 . . . . 0.12 110.566 -178.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -113.66 109.99 19.48 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.65 -0.87 . . . . 0.24 108.65 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 36.5 t0 -67.5 -31.39 71.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.16 110.312 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.973 . . . . 0.3 110.573 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -105.4 0.64 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.519 -0.738 . . . . 0.42 110.14 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm 50.58 42.45 26.87 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.855 -1.165 . . . . 2.16 107.855 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -120.0 131.14 55.05 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.719 0.771 . . . . 0.28 110.945 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -99.72 138.21 37.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.115 -1.439 . . . . 0.09 107.115 177.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -130.63 131.95 45.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.662 -1.274 . . . . 0.14 109.076 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -124.23 130.02 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.402 -0.962 . . . . 0.12 108.402 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.91 126.5 51.05 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.664 -0.648 . . . . 0.29 110.181 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.981 -1.009 . . . . 1.95 109.576 -179.901 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.281 0.562 . . . . 0.31 109.929 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.71 148.03 38.84 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.369 -0.975 . . . . 0.19 108.369 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -116.5 140.89 48.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.257 -0.902 . . . . 1.98 109.08 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 30' ' ' PHE . 65.7 tp -120.42 129.56 53.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.601 -0.687 . . . . 0.13 109.581 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.68 122.76 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.746 -1.576 . . . . 0.36 106.746 177.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.97 116.5 32.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.892 . . . . 0.25 109.679 -178.783 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -114.87 71.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 0.18 107.601 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.32 168.18 48.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.396 -1.482 . . . . 0.24 109.396 179.147 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.47 -39.51 77.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.187 -1.184 . . . . 2.71 108.459 178.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -117.82 -22.96 7.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.783 -0.573 . . . . 0.92 109.662 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.8 tp -101.45 120.37 40.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.6 109.264 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -134.38 129.9 36.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.957 . . . . 2.02 109.536 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.53 -174.0 46.58 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.369 -1.396 . . . . 0.24 110.391 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -148.56 157.21 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.631 -0.923 . . . . 1.68 108.932 179.579 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -154.8 170.8 20.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.922 . . . . 0.34 109.664 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.4 p -137.97 160.13 40.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.21 109.086 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -156.19 162.95 40.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.384 -0.822 . . . . 0.23 109.061 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -102.31 133.81 46.61 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.677 -0.861 . . . . 2.22 108.677 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.34 143.16 25.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.096 . . . . 0.39 109.525 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.79 -29.81 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.55 110.051 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -157.93 176.53 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.16 109.915 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.34 -37.58 80.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 0.26 109.827 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.82 -37.34 59.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.017 . . . . 0.29 109.94 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.405 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 3.2 p -73.31 -34.5 65.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.692 -1.255 . . . . 0.44 109.388 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.35 93.18 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.693 -0.854 . . . . 0.18 108.693 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.35 -50.05 74.18 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.634 -1.226 . . . . 1.06 109.754 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -65.88 -41.43 91.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 2.67 110.141 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.88 -55.35 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.1 -1.0 . . . . 0.23 110.259 -178.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.527 ' CD1' HD22 ' A' ' 5' ' ' LEU . 26.3 m-85 -65.12 -39.75 93.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.15 110.298 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -60.53 -44.06 96.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 2.07 109.637 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -69.23 -42.78 75.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.968 -1.082 . . . . 1.84 108.797 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 77.2 t80 -60.02 -45.92 91.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.463 -0.773 . . . . 0.3 109.18 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.24 95.95 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.507 -0.746 . . . . 0.25 109.016 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -61.32 -40.93 96.03 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 1.23 109.192 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.86 -25.1 66.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 1.29 109.513 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 92.9 m-20 -97.9 9.99 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 0.64 109.881 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.15 92.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.835 -1.306 . . . . 0.72 109.835 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.99 125.54 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.287 -1.125 . . . . 0.4 109.482 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 21.3 p-10 -141.76 148.5 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.214 -1.032 . . . . 1.33 108.214 179.017 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.43 -147.75 10.92 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.219 -1.467 . . . . 0.26 110.053 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -93.14 131.32 38.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 2.07 108.445 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -100.71 137.4 39.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 0.13 110.098 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.0 p -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.446 -0.946 . . . . 0.22 108.446 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 59.3 t80 -134.09 136.39 43.89 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.408 -0.808 . . . . 0.12 110.162 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -112.16 109.27 18.87 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.314 -0.995 . . . . 0.24 108.314 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.17 -31.2 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.973 . . . . 1.16 110.287 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.04 90.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.3 110.318 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.3 p -104.98 -0.76 26.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.251 -0.905 . . . . 0.42 110.011 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 50.06 40.77 22.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 2.16 108.362 -179.755 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.58 54.86 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.616 0.722 . . . . 0.28 110.141 -178.594 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 33.3 m-85 -98.75 138.32 36.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 0.09 106.999 178.278 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -131.99 132.21 43.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.878 -1.139 . . . . 0.14 108.139 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.18 132.15 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.481 -0.933 . . . . 0.12 108.481 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.7 m -119.1 126.38 51.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.608 -0.683 . . . . 0.29 109.631 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.055 -0.974 . . . . 1.95 109.584 -179.36 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.218 -0.66 . . . . 0.31 109.218 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.72 147.7 40.6 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.771 -0.826 . . . . 0.19 108.771 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -117.29 143.8 45.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.405 -0.809 . . . . 1.98 109.651 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 30' ' ' PHE . 40.8 tp -119.58 126.61 51.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.591 -0.892 . . . . 0.13 108.591 179.078 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.55 122.79 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.194 -1.41 . . . . 0.36 107.194 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.4 mt -100.3 117.14 33.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.25 110.265 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -122.2 66.55 0.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.334 -1.358 . . . . 0.18 107.334 178.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.33 169.87 53.04 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 0.24 109.794 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -63.61 -39.88 95.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.272 -1.134 . . . . 2.71 108.582 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.09 -19.92 6.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.955 -0.466 . . . . 0.92 109.896 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.37 119.98 38.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.228 -0.92 . . . . 0.6 109.401 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -135.14 129.99 34.73 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.268 -0.895 . . . . 2.02 109.832 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.61 -177.38 48.42 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.338 -1.411 . . . . 0.24 110.584 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -142.52 151.14 41.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.607 -0.937 . . . . 1.68 108.676 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -152.72 167.37 29.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.34 109.241 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.7 p -137.67 160.19 39.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.21 109.502 -179.16 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.465 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 5.9 t -153.77 159.94 42.09 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.672 -0.862 . . . . 0.23 108.672 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -101.43 131.95 47.28 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.45 -0.944 . . . . 2.22 108.45 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.17 142.75 27.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.39 109.22 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.06 -28.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -0.778 . . . . 0.55 109.877 -179.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -158.43 174.72 14.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 1.16 110.099 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.09 82.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.548 -0.72 . . . . 0.26 110.061 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.02 54.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.912 -1.117 . . . . 0.29 109.728 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.449 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 4.8 p -72.41 -34.86 68.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.775 -1.203 . . . . 0.44 109.459 178.806 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.89 94.05 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.617 -0.883 . . . . 0.18 108.617 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.11 -49.88 74.54 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.934 -1.107 . . . . 1.06 109.914 -179.147 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -66.85 -40.61 87.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.866 -1.146 . . . . 2.67 110.762 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.86 -53.6 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.949 -1.095 . . . . 0.23 110.891 -178.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 18' ' ' THR . 28.1 m-85 -62.75 -37.33 86.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.907 -1.121 . . . . 0.15 110.211 -178.777 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -61.46 -40.52 94.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.875 -1.14 . . . . 2.07 109.338 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.84 -43.3 72.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.818 -1.176 . . . . 1.84 108.31 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.562 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 63.8 t80 -59.99 -49.49 77.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.662 -0.866 . . . . 0.3 108.662 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.63 93.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.575 -0.703 . . . . 0.25 109.417 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -60.05 -41.17 91.73 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.829 -0.804 . . . . 1.23 108.829 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.94 -23.1 67.23 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.352 -0.843 . . . . 1.29 109.112 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.562 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 81.2 m-20 -97.11 8.39 44.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.64 109.974 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.04 32.32 69.49 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.942 -1.123 . . . . 0.72 111.004 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.8 t -109.99 124.92 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.996 -1.297 . . . . 0.4 109.089 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 32.7 p-10 -152.23 100.67 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.062 -1.024 . . . . 1.33 110.34 179.21 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 -130.19 1.37 Allowed Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.204 -1.474 . . . . 0.26 111.044 -178.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -89.94 125.2 35.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.916 -1.344 . . . . 2.07 110.359 -178.291 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -102.53 136.54 42.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.13 110.115 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -136.19 149.58 48.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.982 -1.118 . . . . 0.22 107.982 178.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -137.47 136.22 37.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.239 -0.913 . . . . 0.12 109.958 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -114.52 111.25 21.09 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.854 -0.795 . . . . 0.24 108.854 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 49.5 t0 -67.37 -28.84 68.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 1.16 110.234 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.12 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.3 110.376 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 p -105.95 -0.04 25.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.42 109.765 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 50.03 41.44 23.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 2.16 108.42 -179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.98 133.2 55.62 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.571 0.7 . . . . 0.28 110.366 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.0 139.43 36.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.393 -1.336 . . . . 0.09 107.393 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.2 m -130.04 131.86 45.98 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.759 -1.213 . . . . 0.14 108.476 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.62 129.15 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.61 -0.885 . . . . 0.12 108.61 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -124.01 129.94 51.76 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.471 0.653 . . . . 0.29 110.272 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.029 -0.986 . . . . 1.95 109.48 -179.7 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.446 -0.576 . . . . 0.31 109.446 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.94 147.58 43.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.722 -0.844 . . . . 0.19 108.722 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -118.24 143.61 46.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 1.98 109.441 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.23 130.0 55.24 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.103 -0.703 . . . . 0.13 109.103 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 122.58 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.919 -1.512 . . . . 0.36 106.919 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 54' ' ' VAL . 86.0 mt -103.2 116.73 33.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.25 110.543 -178.434 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -116.96 69.38 0.75 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.732 -1.21 . . . . 0.18 107.732 178.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 168.6 47.71 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.529 -1.429 . . . . 0.24 109.529 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.73 -38.91 84.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 2.71 109.172 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.3 p -117.2 -21.0 9.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.62 -0.675 . . . . 0.92 110.056 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -106.8 120.0 40.83 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.35 -0.844 . . . . 0.6 109.45 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.57 133.61 42.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 2.02 109.055 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.48 -170.28 43.38 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.075 -1.536 . . . . 0.24 110.644 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.85 155.89 42.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.661 -0.906 . . . . 1.68 108.98 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -151.87 169.28 22.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.468 -0.77 . . . . 0.34 109.291 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.9 p -138.86 159.69 41.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.258 -0.901 . . . . 0.21 109.544 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 12.6 t -156.38 160.81 39.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.977 -0.749 . . . . 0.23 108.977 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.97 134.05 44.54 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.543 -0.91 . . . . 2.22 108.543 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.3 139.18 24.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.055 -1.028 . . . . 0.39 109.23 -179.407 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.91 -26.7 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.55 109.495 -179.596 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -157.12 170.72 21.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.16 109.734 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.7 83.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.546 -0.721 . . . . 0.26 110.105 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.55 -36.47 61.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.892 -1.13 . . . . 0.29 110.016 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.429 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 11.8 p -73.7 -34.81 65.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.627 -1.296 . . . . 0.44 109.564 178.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.09 92.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.384 -0.822 . . . . 0.18 109.05 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.26 -44.62 79.88 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.679 -1.209 . . . . 1.06 109.131 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' NZ ' ' CB ' ' A' ' 28' ' ' LYS . 8.6 mtpm? -67.23 -41.64 85.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.319 -0.863 . . . . 2.67 110.573 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.59 -51.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.23 110.503 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CZ ' HG22 ' A' ' 18' ' ' THR . 33.1 m-85 -67.46 -39.92 85.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.944 -1.098 . . . . 0.15 110.736 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -61.96 -42.37 99.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.725 -1.234 . . . . 2.07 109.612 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -69.14 -41.8 76.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.112 -0.993 . . . . 1.84 108.441 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.564 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.6 t80 -60.05 -48.41 81.83 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.569 0.7 . . . . 0.3 109.175 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.53 97.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.579 -0.701 . . . . 0.25 109.31 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.06 -41.77 93.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.834 . . . . 1.23 109.011 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.83 -25.13 67.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 1.29 109.757 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.564 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.2 m-20 -96.79 10.02 40.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.139 -0.976 . . . . 0.64 110.189 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.62 34.04 87.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.975 -1.25 . . . . 0.72 109.975 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.89 126.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.242 -1.152 . . . . 0.4 109.498 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -142.63 150.12 39.84 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 1.33 108.806 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.77 -148.16 12.07 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 118.746 -1.692 . . . . 0.26 110.489 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -90.99 129.42 37.0 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.358 -0.979 . . . . 2.07 108.358 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.32 137.11 39.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.13 110.025 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -134.45 149.49 50.75 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.133 -1.062 . . . . 0.22 108.133 179.029 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.416 ' CD1' ' CE1' ' A' ' 52' ' ' PHE . 43.2 t80 -132.78 134.59 44.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.303 -0.873 . . . . 0.12 110.228 -178.493 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -112.81 109.85 19.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.801 -0.814 . . . . 0.24 108.801 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.6 -31.03 69.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.923 . . . . 1.16 110.513 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.95 94.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.3 110.437 -179.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -106.91 0.85 24.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.455 -0.778 . . . . 0.42 110.43 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 50.18 40.11 21.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.909 -1.119 . . . . 2.16 108.435 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 130.87 54.95 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.536 0.684 . . . . 0.28 110.648 -178.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CE1' ' CD1' ' A' ' 45' ' ' TYR . 68.6 m-85 -99.65 141.11 32.88 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.628 -1.249 . . . . 0.09 107.628 178.102 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 m -130.48 131.39 45.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.807 -1.183 . . . . 0.14 108.451 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 7' ' ' LEU . 2.4 p -123.37 130.3 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.365 -0.976 . . . . 0.12 108.365 179.537 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.4 m -119.97 126.28 50.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.498 -0.752 . . . . 0.29 109.778 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.973 -1.013 . . . . 1.95 109.546 -179.863 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.233 -0.655 . . . . 0.31 109.233 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -114.95 146.54 41.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.537 -0.912 . . . . 0.19 108.537 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -117.36 140.81 49.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.748 -0.834 . . . . 1.98 108.748 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' A' ' 30' ' ' PHE . 37.2 tp -118.92 129.31 55.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.842 -0.799 . . . . 0.13 108.842 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.9 mt -106.17 122.39 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.487 -1.301 . . . . 0.36 107.487 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.37 112.88 25.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.25 109.185 -179.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.67 71.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.687 -1.227 . . . . 0.18 107.687 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.09 165.57 43.51 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.492 -1.443 . . . . 0.24 109.492 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.456 ' HZ3' ' C ' ' A' ' 56' ' ' GLU . 10.5 mptt -68.07 -35.29 77.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.192 -1.181 . . . . 2.71 107.872 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -117.67 -25.55 6.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.746 -0.596 . . . . 0.92 110.077 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 tp -101.56 122.2 43.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.151 -0.968 . . . . 0.6 109.733 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -136.48 130.74 33.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.225 -0.922 . . . . 2.02 109.618 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.62 -172.72 45.69 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.531 -1.319 . . . . 0.24 110.499 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.11 156.28 42.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.598 -0.942 . . . . 1.68 109.285 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -153.15 170.66 19.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 0.34 109.247 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.7 p -137.84 159.95 40.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.329 -0.857 . . . . 0.21 109.397 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -156.25 160.17 39.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.23 109.624 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.78 134.31 47.3 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.251 -1.018 . . . . 2.22 108.251 179.089 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.01 144.2 26.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.39 109.417 -179.354 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -60.31 -31.11 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.55 109.859 -179.529 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -158.81 176.47 12.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 1.16 110.175 -179.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.58 -38.85 84.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.26 109.723 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.79 -38.05 64.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.29 109.772 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m -70.02 -39.8 75.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.665 -1.272 . . . . 0.44 109.994 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.501 -0.749 . . . . 0.18 109.301 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -57.88 -40.99 81.58 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.458 -1.297 . . . . 1.06 109.088 -179.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -69.89 -43.32 72.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 2.67 109.864 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.94 -52.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.23 111.072 -178.326 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD1' HD22 ' A' ' 5' ' ' LEU . 25.8 m-85 -62.86 -39.35 94.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.15 110.286 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -60.59 -44.54 96.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.75 -1.218 . . . . 2.07 109.604 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.96 -45.06 78.9 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.113 -0.992 . . . . 1.84 108.424 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.8 t80 -59.96 -48.89 79.86 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.63 -0.669 . . . . 0.3 109.262 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.36 96.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.25 109.274 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.0 -41.56 92.38 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.384 -0.969 . . . . 1.23 108.384 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.4 -22.56 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.4 -0.813 . . . . 1.29 109.006 179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.8 m-20 -96.71 9.43 41.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.64 109.703 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 33.51 87.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.836 -1.306 . . . . 0.72 109.836 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.95 130.01 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.412 -1.052 . . . . 0.4 110.214 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 71.9 m-20 -111.61 -95.03 0.43 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.525 -1.287 . . . . 1.33 107.525 178.095 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.91 164.42 3.5 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.486 -0.759 . . . . 0.26 111.962 177.202 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.1 mp0 -75.43 137.69 41.16 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.107 -1.442 . . . . 2.07 107.107 178.208 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -100.07 135.26 41.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.13 110.829 -178.608 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -136.67 150.57 48.56 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.11 -1.07 . . . . 0.22 108.11 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -135.77 137.89 42.09 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.174 -0.954 . . . . 0.12 110.609 -178.543 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -112.8 110.05 19.92 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.947 -0.76 . . . . 0.24 108.947 179.345 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 42.2 t0 -66.7 -32.71 74.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 1.16 110.47 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.95 95.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.031 -1.043 . . . . 0.3 110.315 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -106.76 -0.13 23.73 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.423 -0.798 . . . . 0.42 110.557 -179.304 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 49.51 41.23 20.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.838 -1.164 . . . . 2.16 108.697 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.01 130.64 55.78 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.612 0.72 . . . . 0.28 110.13 -178.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -98.81 138.66 35.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.369 -1.345 . . . . 0.09 107.369 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -130.56 131.74 45.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.77 -1.206 . . . . 0.14 108.391 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.178 -1.045 . . . . 0.12 108.178 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.66 126.57 51.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.507 -0.745 . . . . 0.29 110.123 -179.002 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' C ' ' HZ3' ' A' ' 10' ' ' LYS . 54.5 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.849 -1.072 . . . . 1.95 109.118 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 108.72 -0.844 . . . . 0.31 108.72 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -114.8 143.12 45.59 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.74 -0.837 . . . . 0.19 108.74 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -115.7 140.33 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.854 -0.795 . . . . 1.98 108.854 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' CD1' ' A' ' 30' ' ' PHE . 43.1 tp -117.7 127.81 54.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.747 -0.834 . . . . 0.13 108.747 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.29 121.86 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.692 -1.596 . . . . 0.36 106.692 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -100.02 110.52 22.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.036 -1.04 . . . . 0.25 108.966 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -114.07 68.33 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.649 -1.612 . . . . 0.18 106.649 178.519 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 171.03 54.75 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.679 -1.368 . . . . 0.24 109.679 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.66 -39.42 94.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.023 -1.103 . . . . 2.71 108.023 178.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 p -125.05 -13.96 6.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.177 -0.465 . . . . 0.92 109.787 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.5 tp -98.13 119.96 37.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.156 -0.965 . . . . 0.6 109.043 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -133.29 126.54 31.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.351 -0.843 . . . . 2.02 109.427 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -176.22 47.88 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.559 -1.305 . . . . 0.24 110.243 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.52 156.4 42.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.714 -0.874 . . . . 1.68 108.669 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -154.93 170.72 21.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.365 -0.834 . . . . 0.34 109.632 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.9 p -136.81 158.9 43.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.21 109.235 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.4 t -154.73 160.23 41.2 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.486 -0.931 . . . . 0.23 108.486 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.94 133.56 48.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 2.22 109.467 -179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.05 143.1 25.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.942 . . . . 0.39 108.825 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.55 -26.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.55 109.859 -179.204 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -159.49 176.31 12.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.056 -1.028 . . . . 1.16 109.87 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.31 80.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.521 -0.737 . . . . 0.26 110.095 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.3 63.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.917 -1.114 . . . . 0.29 110.053 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.595 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 17.9 p -72.23 -36.16 69.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.536 -1.352 . . . . 0.44 109.862 179.205 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.07 91.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.748 . . . . 0.18 108.994 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.12 -50.01 72.28 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.897 -1.121 . . . . 1.06 110.024 -178.719 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -65.15 -40.15 93.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.883 -1.136 . . . . 2.67 110.826 -179.178 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.0 t -69.94 -54.04 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.23 111.586 -178.273 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 5' ' ' LEU . 33.0 m-85 -64.03 -39.51 94.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.942 -1.099 . . . . 0.15 111.284 -178.46 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.76 -40.06 96.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.809 -1.182 . . . . 2.07 109.957 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -69.41 -42.66 74.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.713 -1.242 . . . . 1.84 109.145 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.612 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.9 t80 -59.98 -46.01 90.84 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.879 . . . . 0.3 108.628 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.9 97.82 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.855 -0.795 . . . . 0.25 108.855 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -60.08 -44.84 94.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.492 -0.755 . . . . 1.23 109.741 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.32 -23.96 67.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 1.29 109.85 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.612 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 65.5 m-20 -96.44 7.48 46.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -0.963 . . . . 0.64 109.554 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.69 31.79 73.69 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.804 -1.189 . . . . 0.72 110.158 179.117 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.43 125.99 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.19 -1.182 . . . . 0.4 109.531 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 57.6 t0 -140.77 146.54 37.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.264 -1.013 . . . . 1.33 108.264 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.63 -153.03 16.52 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.171 -1.49 . . . . 0.26 110.134 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.59 134.35 34.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -1.053 . . . . 2.07 108.442 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -101.48 135.96 42.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 0.13 110.296 -179.42 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.2 p -135.0 149.11 50.13 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.324 -0.991 . . . . 0.22 108.324 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 69.6 t80 -135.35 136.2 41.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.376 -0.828 . . . . 0.12 110.098 -178.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -112.77 109.97 19.79 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.685 -0.857 . . . . 0.24 108.685 179.18 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.9 t0 -65.62 -31.34 72.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 1.16 110.47 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.138 -0.976 . . . . 0.3 110.372 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.8 p -106.62 -0.09 24.02 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.337 -0.852 . . . . 0.42 110.559 -179.036 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 50.01 41.25 22.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.745 -1.222 . . . . 2.16 108.361 -179.417 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.99 130.94 54.99 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.708 0.766 . . . . 0.28 110.391 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 58.7 m-85 -99.62 139.97 34.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.271 -1.381 . . . . 0.09 107.271 178.178 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.0 m -130.43 131.53 45.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.672 -1.268 . . . . 0.14 108.037 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.1 p -122.21 128.97 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.045 -1.094 . . . . 0.12 108.045 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.8 m -119.96 127.97 53.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.29 109.984 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.004 -0.998 . . . . 1.95 109.626 -179.316 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 108.917 -0.772 . . . . 0.31 108.917 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.73 150.04 40.44 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.129 -0.693 . . . . 0.19 109.129 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' A' ' 15' ' ' GLU . 52.9 tttm -118.6 143.69 46.63 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.571 -0.706 . . . . 1.98 109.717 -179.031 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.0 tp -119.22 127.45 53.28 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.714 -0.847 . . . . 0.13 108.714 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.25 122.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.945 -1.502 . . . . 0.36 106.945 178.523 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.0 mt -103.24 111.6 24.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.92 . . . . 0.25 109.873 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.5 71.55 0.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.267 -1.383 . . . . 0.18 107.267 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 165.61 49.33 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.367 -1.493 . . . . 0.24 109.367 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -67.83 -36.86 81.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.218 -1.166 . . . . 2.71 108.421 178.246 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.6 m -120.73 -22.19 6.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.913 -0.492 . . . . 0.92 109.787 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.1 tp -104.69 120.48 41.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.328 -0.858 . . . . 0.6 109.421 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -132.86 133.58 43.49 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.348 -0.845 . . . . 2.02 109.896 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.3 -176.24 47.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.438 -1.363 . . . . 0.24 110.604 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.3 pm0 -147.19 155.67 42.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.719 -0.871 . . . . 1.68 108.969 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 t -154.86 170.25 22.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.34 109.675 -179.586 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -134.89 158.3 44.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.483 -0.761 . . . . 0.21 109.031 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.3 t -154.46 158.7 40.34 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.65 -0.871 . . . . 0.23 108.65 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 56.6 mp0 -102.58 134.1 46.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.214 -0.929 . . . . 2.22 109.185 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.8 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.19 143.45 27.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.112 -0.992 . . . . 0.39 108.774 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.06 -28.24 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.55 109.251 -179.273 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -158.74 176.93 11.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 1.16 109.912 -179.739 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.5 84.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.26 109.879 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.29 -37.72 62.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.04 -1.037 . . . . 0.29 110.212 -179.486 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.8 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 12.1 p -71.55 -35.94 70.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.546 -1.346 . . . . 0.44 109.59 179.052 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.52 89.76 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.351 -0.843 . . . . 0.18 108.865 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.9 -49.99 74.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.987 -1.085 . . . . 1.06 110.133 -178.852 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -66.65 -42.53 86.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 2.67 110.623 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.3 t -69.67 -53.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.983 . . . . 0.23 110.713 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CZ ' HG22 ' A' ' 18' ' ' THR . 16.6 m-85 -61.03 -37.96 84.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.917 -1.114 . . . . 0.15 109.512 -179.406 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.06 -43.51 95.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 2.07 110.009 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.41 -42.31 79.15 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 1.84 108.677 179.598 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.596 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -48.69 80.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.3 110.087 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.95 93.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.25 109.657 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -61.39 -39.95 92.58 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 1.23 109.202 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -62.28 -24.66 67.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 1.29 109.959 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.596 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 98.5 m-20 -96.35 8.79 43.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.007 . . . . 0.64 110.09 -179.227 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.82 31.71 81.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.441 -1.464 . . . . 0.72 109.441 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.6 t -107.47 126.3 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -1.084 . . . . 0.4 109.302 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -140.11 147.47 40.29 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.093 -1.077 . . . . 1.33 108.093 179.391 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.59 -154.25 19.52 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.227 -1.463 . . . . 0.26 109.943 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 38.4 mp0 -87.76 132.83 34.01 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.217 -1.031 . . . . 2.07 108.217 179.061 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -99.93 135.51 41.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 0.13 110.098 -179.302 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.2 p -136.73 150.04 48.19 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.22 108.523 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 58.7 t80 -133.48 133.63 42.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.412 -0.805 . . . . 0.12 109.812 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -111.21 107.76 17.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.485 -0.931 . . . . 0.24 108.485 179.339 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.96 -30.67 70.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 1.16 110.045 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.45 98.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.3 109.87 -179.681 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 p -104.74 1.06 28.91 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.48 -0.762 . . . . 0.42 109.887 -179.703 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.6 mttt 50.03 39.9 20.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 2.16 108.554 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.4 m -120.03 134.35 55.27 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.474 0.654 . . . . 0.28 110.831 -178.371 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 53.1 m-85 -99.82 139.25 35.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.09 107.271 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -131.29 130.68 43.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.561 -1.337 . . . . 0.14 108.6 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.28 127.69 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.788 -1.189 . . . . 0.12 107.788 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.1 m -120.01 127.13 52.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.452 -0.78 . . . . 0.29 109.728 -179.382 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.037 -0.982 . . . . 1.95 109.45 -179.682 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 109.641 -0.503 . . . . 0.31 109.641 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -114.96 147.43 40.05 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.869 -0.789 . . . . 0.19 108.869 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -119.73 141.46 49.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.482 -0.761 . . . . 1.98 109.465 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 30' ' ' PHE . 45.7 tp -120.65 129.85 53.88 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.915 -0.772 . . . . 0.13 108.915 179.436 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.53 124.83 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.806 -1.183 . . . . 0.36 107.806 178.462 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.5 mt -102.06 114.58 28.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 0.25 110.012 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.57 68.52 0.7 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.339 -1.356 . . . . 0.18 107.339 178.357 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.99 49.15 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.742 -1.343 . . . . 0.24 109.742 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -67.05 -37.55 84.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.368 -1.078 . . . . 2.71 108.157 178.231 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 m -119.55 -22.9 6.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.939 -0.475 . . . . 0.92 110.104 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 tp -101.59 120.27 40.06 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.18 -0.95 . . . . 0.6 109.649 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -132.12 128.67 38.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.02 109.211 179.335 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.45 -173.88 46.59 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.185 -1.484 . . . . 0.24 110.608 179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.4 pm0 -150.26 159.56 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.625 -0.927 . . . . 1.68 109.442 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 t -152.62 170.01 21.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.521 -0.737 . . . . 0.34 109.269 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -136.54 158.44 44.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.245 -0.91 . . . . 0.21 109.081 -179.651 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 t -156.55 161.9 39.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.357 -0.839 . . . . 0.23 109.061 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -101.26 132.29 46.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.317 -0.994 . . . . 2.22 108.317 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.48 142.17 26.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.39 109.551 -179.5 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.58 -30.36 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.55 110.603 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -158.58 179.4 9.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.931 -1.106 . . . . 1.16 110.295 -179.266 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.93 75.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.55 -0.719 . . . . 0.26 110.539 -179.111 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.66 65.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.776 -1.203 . . . . 0.29 109.866 -179.164 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -70.53 -39.95 73.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.741 -1.224 . . . . 0.44 109.846 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.96 92.15 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.532 -0.73 . . . . 0.18 109.258 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.82 -43.22 94.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.745 -1.182 . . . . 1.06 110.105 -179.129 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -69.73 -42.69 73.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.26 -0.9 . . . . 2.67 110.69 -179.24 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.61 -53.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.23 111.173 -178.232 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' HD22 ' A' ' 5' ' ' LEU . 32.3 m-85 -60.23 -35.84 76.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.019 -1.051 . . . . 0.15 109.864 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.13 -41.51 92.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.897 -1.127 . . . . 2.07 108.915 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -68.47 -44.82 73.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.094 -1.003 . . . . 1.84 108.755 179.372 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.661 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 66.1 t80 -60.34 -48.2 82.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.3 109.489 179.673 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.41 97.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.25 109.244 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -60.12 -39.94 88.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.229 -0.92 . . . . 1.23 108.538 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.87 -23.81 67.5 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.467 -0.771 . . . . 1.29 109.286 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.661 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.6 m-20 -96.77 6.31 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.09 -1.006 . . . . 0.64 109.46 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.06 33.23 78.4 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.864 -1.16 . . . . 0.72 110.259 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.0 t -111.16 125.38 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.091 -1.241 . . . . 0.4 108.918 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 69.6 m-20 -152.25 103.62 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.984 -1.073 . . . . 1.33 110.993 179.737 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.03 -130.13 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.557 -1.306 . . . . 0.26 110.907 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 42.2 mp0 -93.99 130.98 39.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.937 -1.331 . . . . 2.07 110.141 -178.516 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -104.09 139.3 39.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.672 -0.643 . . . . 0.13 110.244 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 p -134.31 147.77 50.65 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.963 -1.125 . . . . 0.22 107.963 178.838 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 60.3 t80 -135.84 135.16 39.57 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.188 -0.945 . . . . 0.12 110.211 -178.685 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -112.97 110.28 20.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.921 -0.77 . . . . 0.24 108.921 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 63.5 t0 -65.06 -31.83 73.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 1.16 110.528 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.99 92.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.3 110.616 -179.185 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -104.81 -0.69 26.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.42 110.554 -179.04 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 50.02 40.02 20.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.817 -1.177 . . . . 2.16 108.156 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.9 m -120.02 131.2 55.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.672 0.749 . . . . 0.28 110.282 -178.2 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m-85 -98.62 138.9 35.13 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.504 -1.295 . . . . 0.09 107.504 178.435 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -131.77 131.07 42.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.697 -1.252 . . . . 0.14 107.791 179.154 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.02 129.86 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.288 -1.005 . . . . 0.12 108.288 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -121.65 125.85 47.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.569 -0.707 . . . . 0.29 109.729 -179.232 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 27.1 mp0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.915 -1.04 . . . . 1.95 109.502 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.2 mtt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.434 0.635 . . . . 3.54 109.365 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m -90.7 129.03 36.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.34 110.234 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.15 144.34 42.84 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.167 -1.42 . . . . 0.35 107.167 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -115.56 140.03 49.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.37 -0.831 . . . . 2.19 110.358 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.1 tp -120.14 129.98 54.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.723 -0.611 . . . . 0.17 109.67 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.1 mt -107.77 125.21 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.632 -1.247 . . . . 0.65 107.632 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.8 mt -103.87 115.44 30.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.255 -0.903 . . . . 0.25 111.03 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -111.59 59.78 0.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.53 -0.915 . . . . 1.76 108.53 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.98 165.48 53.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.23 -1.548 . . . . 0.21 109.23 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -63.75 -39.98 95.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.881 -1.364 . . . . 2.78 108.221 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -118.5 -20.01 8.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.11 -0.7 . . . . 1.38 109.11 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.7 tp -98.23 118.19 34.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.518 -0.739 . . . . 0.48 109.223 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.83 126.8 35.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.287 -1.005 . . . . 2.17 108.287 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.84 -177.96 48.34 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 118.988 -1.577 . . . . 0.21 109.921 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -148.07 157.67 43.64 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.455 -0.943 . . . . 2.37 108.455 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -156.36 167.48 30.29 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.314 -0.866 . . . . 0.19 108.757 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 p -133.65 161.02 35.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.346 -0.846 . . . . 0.26 109.169 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.9 t -156.35 162.29 40.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 0.19 109.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.87 135.48 44.46 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.574 -0.899 . . . . 2.75 108.574 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.541 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.46 140.78 23.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.16 108.601 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.01 -26.42 35.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.364 -0.835 . . . . 0.28 109.806 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -159.94 176.59 11.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 1.09 109.739 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.74 -32.52 72.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.22 109.796 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.19 77.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.23 109.961 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.541 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 2.4 p -70.15 -35.5 74.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 1.24 109.12 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.02 87.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.16 108.8 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.14 -49.82 72.85 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.226 -0.99 . . . . 1.12 109.192 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -63.84 -43.66 95.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.784 -1.197 . . . . 2.45 111.897 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.68 -54.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.27 110.503 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 5' ' ' LEU . 28.3 m-85 -63.8 -39.71 94.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.948 -1.095 . . . . 0.23 110.531 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -60.52 -45.68 92.95 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.375 -0.828 . . . . 2.88 109.252 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -67.33 -43.61 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.576 -0.898 . . . . 2.01 108.576 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.7 t80 -59.98 -46.56 89.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.744 . . . . 0.37 109.033 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.72 94.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.846 -0.798 . . . . 0.25 108.846 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.0 -45.04 95.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.026 -0.731 . . . . 1.97 109.026 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.66 -25.3 66.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 1.14 109.701 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 71.1 m-20 -95.92 6.72 48.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.196 -0.94 . . . . 1.17 109.713 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.23 37.61 91.22 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.079 -1.058 . . . . 0.3 110.46 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.91 122.26 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.297 -1.119 . . . . 0.32 109.876 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -132.93 136.95 46.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.27 -1.381 . . . . 2.19 107.27 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.44 -156.48 16.22 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.87 -1.634 . . . . 0.67 109.647 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -91.82 128.55 37.69 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.955 -1.128 . . . . 2.22 107.955 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.69 133.62 40.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.21 110.453 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.5 p -131.68 147.9 52.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.966 -1.124 . . . . 0.24 107.966 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.44 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 62.1 t80 -134.76 135.86 42.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.32 109.966 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -112.04 109.48 19.25 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.28 108.711 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 48.2 t0 -66.35 -32.71 74.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 1.12 110.254 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -43.86 94.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.26 110.079 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.9 p -102.62 0.41 33.23 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.213 -0.93 . . . . 0.27 110.537 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mttm 50.12 40.5 21.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.859 -1.151 . . . . 2.36 108.985 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.3 m -118.84 130.01 55.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.647 0.737 . . . . 0.15 109.975 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 55.1 m-85 -97.65 137.01 37.21 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.078 -1.453 . . . . 0.17 107.078 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.1 m -129.51 134.15 47.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.823 -1.173 . . . . 0.14 108.614 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.8 p -125.35 129.99 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.142 -1.059 . . . . 0.2 108.142 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -121.98 127.81 50.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.448 -0.782 . . . . 0.29 110.218 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.995 -1.002 . . . . 2.34 108.585 179.243 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.478 0.656 . . . . 2.91 109.832 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.7 m -93.74 135.61 34.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.397 -0.815 . . . . 0.31 109.246 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.29 146.49 39.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.5 -0.926 . . . . 0.19 108.5 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.12 141.93 46.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.362 -0.836 . . . . 1.98 109.032 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 30' ' ' PHE . 22.6 tp -120.1 126.23 50.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.708 -0.849 . . . . 0.13 108.708 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.26 123.41 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.164 -1.421 . . . . 0.36 107.164 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.472 HD23 HG12 ' A' ' 54' ' ' VAL . 93.6 mt -102.38 114.11 28.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.286 -0.884 . . . . 0.25 110.092 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -114.66 68.59 0.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.124 -1.436 . . . . 0.18 107.124 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.1 165.15 48.66 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.813 -1.315 . . . . 0.24 109.813 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -66.91 -35.36 79.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.499 -1.297 . . . . 2.71 107.499 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -119.83 -23.19 6.53 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.252 -0.648 . . . . 0.92 109.252 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 9' ' ' GLY . 54.2 tp -98.35 121.48 40.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.6 109.269 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -136.89 126.78 25.77 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.179 -0.951 . . . . 2.02 109.638 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.44 -168.31 41.43 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.636 -1.269 . . . . 0.24 110.196 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -149.3 159.36 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.974 . . . . 1.68 109.655 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -151.94 167.35 28.64 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.732 -0.84 . . . . 0.34 108.732 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -138.03 159.65 41.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.21 109.278 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -154.93 159.96 40.81 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.714 -0.847 . . . . 0.23 108.714 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -102.22 132.91 47.86 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.53 -0.915 . . . . 2.22 108.53 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.69 144.57 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.105 -0.997 . . . . 0.39 109.477 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.86 -29.7 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.489 -0.757 . . . . 0.55 110.368 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -158.02 175.66 13.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.91 -1.119 . . . . 1.16 110.181 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.89 80.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.536 -0.727 . . . . 0.26 110.033 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.28 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.91 -1.119 . . . . 0.29 110.008 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 p -74.21 -34.89 63.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.726 -1.234 . . . . 0.44 109.827 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.0 92.26 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.807 -0.812 . . . . 0.18 108.807 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.51 -49.02 73.7 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.964 -1.095 . . . . 1.06 109.904 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.59 -40.04 92.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.261 -0.899 . . . . 2.67 110.506 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.9 -53.1 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.149 -0.969 . . . . 0.23 110.662 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.551 ' CD1' HD22 ' A' ' 5' ' ' LEU . 35.6 m-85 -66.72 -39.5 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 0.15 110.596 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -60.42 -42.27 95.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.745 -1.222 . . . . 2.07 108.819 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -67.56 -43.63 80.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 1.84 108.948 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.597 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.5 t80 -60.03 -44.87 94.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.504 -0.748 . . . . 0.3 109.311 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.67 96.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.332 -0.855 . . . . 0.25 109.229 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -61.9 -42.36 98.98 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.363 -0.836 . . . . 1.23 109.101 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.21 -26.62 67.85 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.095 -1.003 . . . . 1.29 109.304 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.597 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 77.1 m-20 -97.59 9.05 43.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.64 110.027 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.72 81.79 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.884 -1.15 . . . . 0.72 110.456 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.3 t -106.91 127.89 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.183 -1.186 . . . . 0.4 109.738 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -137.67 145.3 42.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.668 -1.234 . . . . 1.33 107.668 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.91 -156.19 21.07 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.875 -1.631 . . . . 0.26 110.334 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.64 131.11 36.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.579 -0.897 . . . . 2.07 108.579 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -101.08 136.54 40.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.13 110.545 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.5 p -133.9 148.77 51.27 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.771 -1.196 . . . . 0.22 107.771 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.12 134.32 42.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 0.12 110.205 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -111.49 108.28 17.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.328 -0.99 . . . . 0.24 108.328 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -67.27 -29.8 69.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 1.16 109.865 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.9 91.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.361 -0.837 . . . . 0.3 110.306 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.2 p -104.84 0.0 27.61 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.357 -0.84 . . . . 0.42 109.992 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 50.04 39.89 20.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 2.16 108.173 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -119.93 132.13 55.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.404 0.621 . . . . 0.28 110.712 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -99.3 140.04 34.05 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.486 -1.301 . . . . 0.09 107.486 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.6 m -130.62 131.28 44.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.655 -1.278 . . . . 0.14 108.706 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD23 ' A' ' 7' ' ' LEU . 4.2 p -122.79 129.65 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.496 -0.927 . . . . 0.12 108.496 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.3 127.74 52.64 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.504 -0.748 . . . . 0.29 110.444 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.965 -1.016 . . . . 1.95 109.197 179.813 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.371 -0.603 . . . . 2.91 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.7 m -91.05 133.73 35.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.322 -0.861 . . . . 0.31 109.597 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -117.67 145.81 44.14 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.857 -0.794 . . . . 0.19 108.857 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -114.74 144.15 43.93 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.328 -0.857 . . . . 1.98 109.184 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 30' ' ' PHE . 30.6 tp -121.78 128.94 52.27 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.135 -0.691 . . . . 0.13 109.135 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.9 122.3 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.747 -1.205 . . . . 0.36 107.747 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -100.69 113.82 27.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.25 109.262 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -116.34 68.73 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.323 -1.362 . . . . 0.18 107.323 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 169.3 52.95 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.146 -1.581 . . . . 0.24 109.146 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -64.8 -35.75 82.12 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.196 -1.179 . . . . 2.71 107.919 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -124.86 -19.11 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.427 -0.583 . . . . 0.92 109.427 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.0 tp -96.09 119.97 35.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.996 . . . . 0.6 109.098 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -134.54 125.8 28.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 2.02 109.472 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.93 -178.7 48.64 Favored Glycine 0 N--CA 1.487 2.036 0 C-N-CA 119.556 -1.307 . . . . 0.24 110.262 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.54 157.3 43.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.757 -0.849 . . . . 1.68 108.929 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.02 170.03 21.43 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.377 -0.827 . . . . 0.34 109.281 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 p -135.87 159.17 42.51 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.84 -0.8 . . . . 0.21 108.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.5 t -157.61 161.67 38.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.862 . . . . 0.23 109.515 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 56.0 mp0 -105.92 135.74 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.836 -0.802 . . . . 2.22 108.836 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -150.24 146.4 26.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.39 109.118 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.37 -30.1 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.466 -0.771 . . . . 0.55 109.569 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -159.46 176.88 11.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 1.16 109.584 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -35.3 77.85 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.29 -0.881 . . . . 0.26 110.078 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -39.04 59.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.916 -1.115 . . . . 0.29 110.273 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.625 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 26.3 p -75.08 -32.14 61.4 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.5 -1.375 . . . . 0.44 109.518 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.68 99.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.264 -0.898 . . . . 0.18 108.828 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -56.94 -49.52 75.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.646 -1.222 . . . . 1.06 108.998 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -63.54 -44.03 95.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.541 -0.724 . . . . 2.67 110.823 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.06 -52.59 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.021 -1.049 . . . . 0.23 110.837 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.3 m-85 -61.64 -37.9 85.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.006 . . . . 0.15 109.957 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -61.46 -43.04 99.57 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.91 -1.119 . . . . 2.07 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.62 -43.97 75.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.904 -1.123 . . . . 1.84 109.07 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 57.4 t80 -60.03 -47.84 84.2 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.292 -0.88 . . . . 0.3 108.749 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.98 99.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.454 -0.779 . . . . 0.25 109.138 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -59.99 -41.89 93.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.72 -19.78 66.03 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.001 -0.74 . . . . 1.29 109.001 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' OD1' ' CD1' ' A' ' 33' ' ' TYR . 31.0 m120 -95.08 4.31 53.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.64 109.96 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.04 32.9 65.61 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.675 -1.25 . . . . 0.72 110.087 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.4 t -110.22 122.99 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.184 -1.186 . . . . 0.4 108.916 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 31.5 p-10 -148.97 97.65 2.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.915 -1.116 . . . . 1.33 110.465 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.06 -130.68 1.37 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.31 -1.424 . . . . 0.26 111.342 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.11 132.43 38.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.963 -1.316 . . . . 2.07 110.316 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -107.76 139.48 42.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.429 0.633 . . . . 0.13 110.267 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.1 p -136.86 150.27 48.17 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.08 -1.081 . . . . 0.22 108.08 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -134.36 135.9 43.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.272 -0.893 . . . . 0.12 110.643 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -111.94 108.28 17.58 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.166 -1.05 . . . . 0.24 108.166 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -67.61 -29.99 69.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 1.16 110.366 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.04 93.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.3 110.409 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.0 p -105.81 0.02 25.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.37 -0.831 . . . . 0.42 110.124 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 mttm 50.33 41.34 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.131 . . . . 2.16 108.506 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.95 129.95 54.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.478 0.656 . . . . 0.28 110.069 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -98.87 139.64 34.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.679 -1.23 . . . . 0.09 107.679 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.5 m -128.7 130.41 47.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.762 -1.211 . . . . 0.14 108.437 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.06 129.42 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.285 -1.005 . . . . 0.12 108.285 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -120.96 126.0 48.83 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.114 -0.699 . . . . 0.29 109.114 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.071 -0.966 . . . . 1.95 109.729 -179.076 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.51 0.671 . . . . 2.91 109.234 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 m -92.44 133.74 35.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.476 -0.765 . . . . 0.31 109.483 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.528 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 90.8 m-85 -114.52 145.26 42.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.463 -0.94 . . . . 0.19 108.463 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -115.74 142.72 46.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.392 -0.818 . . . . 1.98 109.453 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 30' ' ' PHE . 40.2 tp -120.98 127.33 51.7 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.969 -0.752 . . . . 0.13 108.969 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.4 123.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.317 -1.364 . . . . 0.36 107.317 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.34 112.75 25.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.25 110.168 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -112.1 69.0 0.68 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.765 -1.568 . . . . 0.18 106.765 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.78 167.69 50.31 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.59 -1.404 . . . . 0.24 109.59 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -67.77 -39.05 84.15 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.414 -1.051 . . . . 2.71 108.524 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 p -120.0 -20.03 7.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.887 -0.508 . . . . 0.92 109.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.92 118.55 36.81 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.339 -0.851 . . . . 0.6 109.89 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -130.71 131.43 44.79 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.67 0.748 . . . . 2.02 109.15 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.1 -178.96 48.61 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.08 -1.533 . . . . 0.24 110.716 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.04 151.13 43.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.451 -0.944 . . . . 1.68 108.451 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 t -150.82 165.02 34.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.34 108.592 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.1 p -134.38 159.38 41.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 0.21 108.97 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -154.41 158.98 40.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.772 -0.825 . . . . 0.23 108.772 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.6 132.0 50.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.632 -0.877 . . . . 2.22 108.632 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.63 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -147.63 142.94 27.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.05 . . . . 0.39 109.093 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.93 -28.82 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.55 110.091 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -158.97 177.31 11.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.043 -1.035 . . . . 1.16 109.937 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.528 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -65.71 -38.42 89.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.457 -0.777 . . . . 0.26 109.591 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.11 -37.76 62.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.082 -1.011 . . . . 0.29 110.003 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.63 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 85.4 m -68.82 -39.96 79.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.692 -1.255 . . . . 0.44 109.806 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.02 93.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.246 -0.909 . . . . 0.18 109.372 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.17 -53.88 47.32 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.152 -1.019 . . . . 1.06 111.595 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -68.51 -36.14 78.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.678 -1.264 . . . . 2.67 110.655 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.84 -53.83 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.943 -1.098 . . . . 0.23 110.519 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD1' HD22 ' A' ' 5' ' ' LEU . 32.0 m-85 -63.11 -37.42 87.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.15 110.433 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.98 -41.47 92.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.834 -1.166 . . . . 2.07 109.296 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -68.71 -42.13 78.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 1.84 109.102 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.648 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.6 t80 -59.95 -46.96 87.73 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.3 108.95 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.08 96.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.25 108.958 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.02 -45.62 92.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 1.23 109.159 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -62.28 -24.68 67.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -0.868 . . . . 1.29 109.548 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.648 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 75.1 m-20 -98.51 7.04 46.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.215 -0.928 . . . . 0.64 109.99 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.17 33.62 83.6 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.92 -1.133 . . . . 0.72 110.491 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.18 128.39 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.147 -1.208 . . . . 0.4 110.539 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.501 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 96.7 m-20 -112.3 -98.62 0.42 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.511 -0.922 . . . . 1.33 108.511 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.69 167.53 3.72 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.26 112.455 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.5 mp0 -77.21 138.27 39.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.583 -1.266 . . . . 2.07 107.583 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -99.91 133.78 43.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.98 . . . . 0.13 110.351 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 p -134.32 148.76 50.81 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.815 -1.18 . . . . 0.22 107.815 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -136.04 136.91 40.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.186 -0.946 . . . . 0.12 110.464 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.82 110.01 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.568 -0.901 . . . . 0.24 108.568 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 52.4 t0 -67.94 -30.5 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.927 . . . . 1.16 110.461 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.3 93.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.148 -0.97 . . . . 0.3 109.892 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.3 p -105.92 -0.28 25.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.51 -0.744 . . . . 0.42 110.048 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.408 ' NZ ' ' CZ ' ' A' ' 3' ' ' TYR . 23.6 mtpp 49.98 41.71 23.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 2.16 108.401 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.34 131.08 55.66 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.547 0.689 . . . . 0.28 110.506 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -100.46 139.88 35.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.455 -1.313 . . . . 0.09 107.455 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -131.98 132.51 43.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.817 -1.177 . . . . 0.14 108.963 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.8 p -120.3 128.29 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.029 -1.1 . . . . 0.12 108.029 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.1 m -121.36 127.57 51.37 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.359 -0.838 . . . . 0.29 110.731 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 67.3 mm-40 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.947 -1.025 . . . . 1.95 109.453 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 tpp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.782 -0.822 . . . . 2.91 108.782 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.5 m -93.08 129.1 39.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.814 -1.179 . . . . 0.31 110.288 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.06 147.05 39.37 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.848 -1.168 . . . . 0.19 107.848 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -116.05 141.11 48.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 1.98 109.458 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.5 tp -120.66 127.99 52.58 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.742 -0.836 . . . . 0.13 108.742 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.38 123.68 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.215 -1.402 . . . . 0.36 107.215 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -103.91 114.36 28.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.25 110.543 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -118.75 68.52 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.132 -1.433 . . . . 0.18 107.132 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.531 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . . . -78.67 172.56 55.27 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.672 -1.771 . . . . 0.24 108.672 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -66.23 -35.59 80.82 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.841 -1.388 . . . . 2.71 107.929 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -123.95 -18.59 5.92 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.844 -0.535 . . . . 0.92 110.288 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 tp -98.94 113.58 25.8 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.015 -1.053 . . . . 0.6 109.822 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -126.21 127.28 45.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 2.02 109.317 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.97 -179.84 48.81 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.192 -1.48 . . . . 0.24 110.621 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -143.53 153.67 42.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.995 . . . . 1.68 108.869 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -152.82 168.5 25.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.34 109.065 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.5 p -138.46 160.02 40.61 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.881 -0.785 . . . . 0.21 108.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -156.65 162.86 39.82 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.264 -0.898 . . . . 0.23 109.188 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -106.48 135.01 48.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.367 -0.833 . . . . 2.22 108.917 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.0 145.53 27.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.39 108.898 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.42 -29.24 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.55 110.266 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -158.51 177.53 11.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.086 -1.009 . . . . 1.16 110.172 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.74 82.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.638 -0.664 . . . . 0.26 110.287 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.95 -37.08 60.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.833 -1.167 . . . . 0.29 109.769 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 p -72.23 -36.88 69.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.668 -1.27 . . . . 0.44 109.605 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.29 90.57 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.656 -0.868 . . . . 0.18 108.656 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.21 -50.08 73.98 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.221 -0.991 . . . . 1.06 110.196 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -66.29 -40.78 90.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.072 -1.017 . . . . 2.67 110.688 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.0 -53.82 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.078 -1.014 . . . . 0.23 110.597 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -63.68 -38.09 89.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.15 110.678 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -60.08 -44.04 95.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.817 -1.177 . . . . 2.07 109.582 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -68.36 -41.44 80.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 1.84 108.673 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 58.1 t80 -59.94 -48.33 82.12 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.487 -0.758 . . . . 0.3 109.05 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.87 99.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.25 109.096 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -60.54 -43.33 97.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.292 -0.88 . . . . 1.23 108.897 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -64.25 -22.39 66.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 1.29 109.338 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.582 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 65.8 m-80 -98.46 6.76 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.286 -0.884 . . . . 0.64 109.877 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.78 36.21 91.94 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.164 -1.175 . . . . 0.72 110.164 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.59 127.42 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.277 -1.131 . . . . 0.4 109.935 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.471 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 92.9 m-20 -111.68 -97.15 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.5 -1.296 . . . . 1.33 107.5 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.93 166.91 2.06 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-O 122.052 0.807 . . . . 0.26 112.407 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.55 139.16 41.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.389 -1.337 . . . . 2.07 107.389 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.66 135.48 42.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.13 111.077 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 p -133.4 147.24 51.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.588 -0.893 . . . . 0.22 108.588 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 52.6 t80 -134.63 135.88 42.45 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.242 -0.911 . . . . 0.12 110.186 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 50' ' ' LYS . 55.2 t0 -113.11 109.96 19.67 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.941 -0.762 . . . . 0.24 108.941 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.8 t0 -68.87 -30.6 69.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.07 -1.019 . . . . 1.16 109.966 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.99 94.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.838 . . . . 0.3 110.112 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -110.97 -0.15 16.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.651 -0.655 . . . . 0.42 109.642 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 46' ' ' ASP . 56.7 mttp 48.9 41.81 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.137 -0.977 . . . . 2.16 109.208 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -115.74 131.12 57.03 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.483 0.659 . . . . 0.28 109.553 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.5 m-85 -100.61 139.91 35.62 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.092 -1.077 . . . . 0.09 108.092 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -132.23 131.98 42.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.671 -1.268 . . . . 0.14 108.672 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.0 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.617 -1.253 . . . . 0.12 107.617 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -120.07 126.54 51.02 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.226 -0.921 . . . . 0.29 110.293 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 118.03 -0.986 . . . . 1.95 109.231 179.564 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.055 -0.72 . . . . 2.91 109.055 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 m -92.6 135.94 33.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.491 -0.756 . . . . 0.31 110.008 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -119.35 146.41 45.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.74 -0.837 . . . . 0.19 108.74 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -116.91 144.82 44.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.409 -0.807 . . . . 1.98 109.804 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.3 tp -118.95 129.8 55.36 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.502 -0.749 . . . . 0.13 109.005 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.43 122.18 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.058 -1.46 . . . . 0.36 107.058 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.8 mt -101.76 117.52 35.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.174 -0.954 . . . . 0.25 110.2 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -124.59 66.43 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.565 -1.272 . . . . 0.18 107.565 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 176.38 54.68 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.497 -1.441 . . . . 0.24 109.497 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -66.07 -39.71 90.3 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.15 -1.206 . . . . 2.71 108.668 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -17.39 7.12 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.874 -0.516 . . . . 0.92 110.523 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.66 121.9 41.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.025 -1.047 . . . . 0.6 109.564 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -135.16 127.59 30.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.393 -0.817 . . . . 2.02 109.417 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -173.77 46.54 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.382 -1.39 . . . . 0.24 110.515 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -149.02 156.9 42.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.622 -0.929 . . . . 1.68 109.15 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -154.01 170.04 22.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.34 109.61 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 p -137.39 159.24 42.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.782 . . . . 0.21 109.13 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -157.52 162.7 38.85 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.335 -0.853 . . . . 0.23 108.9 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -101.21 133.77 45.27 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.306 -0.998 . . . . 2.22 108.306 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -146.88 142.12 27.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.178 -0.951 . . . . 0.39 108.949 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.99 -31.24 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.864 . . . . 0.55 109.552 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -157.69 179.21 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 1.16 110.106 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.15 -38.27 87.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.466 -0.771 . . . . 0.26 109.527 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.38 61.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.177 -0.952 . . . . 0.29 109.971 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.628 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.5 m -69.94 -40.05 75.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.641 -1.287 . . . . 0.44 109.749 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.64 82.06 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.444 -0.947 . . . . 0.18 108.444 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.06 -45.7 71.77 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.687 -1.205 . . . . 1.06 108.602 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.07 -46.1 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.64 -0.662 . . . . 2.67 110.764 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.27 -52.85 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.286 -0.884 . . . . 0.23 111.088 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -67.48 -39.95 85.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.996 -1.065 . . . . 0.15 110.551 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.68 -43.06 98.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.55 -1.344 . . . . 2.07 109.229 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.5 -44.49 82.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 1.84 108.911 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.3 t80 -60.13 -46.46 89.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.421 -0.799 . . . . 0.3 109.046 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -45.78 90.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.25 109.33 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.08 -43.93 95.13 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.665 -0.865 . . . . 1.23 108.665 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.07 -20.32 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 1.29 109.05 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.531 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 31.6 m120 -97.76 6.63 47.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.288 -0.883 . . . . 0.64 109.897 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.46 32.63 67.94 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.021 -1.085 . . . . 0.72 111.184 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.5 t -110.52 124.99 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.03 -1.276 . . . . 0.4 109.186 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 73.6 m-20 -150.67 99.78 2.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 1.33 110.281 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 -132.24 1.73 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.342 -1.409 . . . . 0.26 110.995 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.57 125.62 37.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.851 -1.382 . . . . 2.07 110.677 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -103.03 137.08 41.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.672 -0.643 . . . . 0.13 109.515 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -136.1 150.03 48.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.832 -1.173 . . . . 0.22 107.832 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -137.1 137.87 39.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.225 -0.922 . . . . 0.12 110.444 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -112.55 110.07 20.01 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.387 -0.968 . . . . 0.24 108.387 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -65.67 -30.92 71.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 1.16 110.374 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.15 93.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.3 110.272 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -104.33 -0.11 28.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.39 -0.819 . . . . 0.42 110.778 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp 50.07 40.21 20.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.758 -1.214 . . . . 2.16 108.246 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.97 131.53 55.2 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.633 0.73 . . . . 0.28 110.621 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -100.3 140.02 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.346 -1.353 . . . . 0.09 107.346 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.1 m -130.8 132.62 45.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.14 108.576 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.8 130.1 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.802 -0.814 . . . . 0.12 108.802 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 m -128.07 129.78 47.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.484 0.659 . . . . 0.29 110.169 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 74.2 mm-40 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.978 -1.01 . . . . 1.95 109.551 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.7 mmm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.385 -0.598 . . . . 2.91 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m -94.01 131.63 39.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.078 -1.014 . . . . 0.31 109.346 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -117.5 145.45 44.2 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.362 -0.977 . . . . 0.19 108.362 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -113.21 145.35 41.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.343 -0.848 . . . . 1.98 109.647 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.481 HD22 ' CD1' ' A' ' 30' ' ' PHE . 59.1 tp -121.62 127.66 51.08 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.564 -0.71 . . . . 0.13 109.592 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.5 mm -103.54 121.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.621 -1.622 . . . . 0.36 106.621 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.2 mt -100.33 111.47 23.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.947 -1.096 . . . . 0.25 109.528 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.54 69.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.543 -1.28 . . . . 0.18 107.543 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 163.96 48.1 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.345 -1.502 . . . . 0.24 109.345 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -66.8 -37.57 84.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.529 -1.286 . . . . 2.71 107.529 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.2 p -115.16 -22.37 9.5 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.576 -0.527 . . . . 0.92 109.576 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 9' ' ' GLY . 19.0 tp -102.29 127.99 49.03 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.342 -0.849 . . . . 0.6 109.556 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -139.91 128.1 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 2.02 109.472 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.46 -174.33 46.86 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.107 -1.521 . . . . 0.24 110.85 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -147.88 155.69 41.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.717 -0.873 . . . . 1.68 109.036 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -153.97 169.36 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 0.34 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.3 p -134.48 158.58 43.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.359 -0.838 . . . . 0.21 109.439 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 7.7 t -155.38 159.53 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.23 109.047 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -103.99 134.12 47.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.249 -0.907 . . . . 2.22 108.879 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.12 143.32 27.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.39 109.073 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 21' ' ' VAL . 14.3 m -60.39 -28.9 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.55 109.741 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -157.53 174.96 14.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.198 -0.938 . . . . 1.16 109.894 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.29 83.87 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.26 109.874 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.25 -36.22 52.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.941 -1.1 . . . . 0.29 109.607 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.553 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 6.1 p -73.45 -34.75 65.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.756 -1.215 . . . . 0.44 109.76 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.88 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.286 -1.005 . . . . 0.18 108.286 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -49.91 75.12 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.784 -1.167 . . . . 1.06 109.953 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -64.63 -41.43 96.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.747 -1.221 . . . . 2.67 110.405 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.55 -53.67 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 0.23 110.842 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.6 m-85 -64.41 -39.22 93.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.15 111.07 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -61.78 -40.29 94.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.237 . . . . 2.07 110.156 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -69.45 -43.79 72.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.875 -1.141 . . . . 1.84 108.804 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.614 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -60.46 -46.65 89.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.394 -0.816 . . . . 0.3 109.53 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.12 94.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.25 109.76 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -61.59 -40.07 93.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 1.23 109.369 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.74 -23.96 67.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.183 -0.948 . . . . 1.29 109.532 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.614 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.6 m-20 -95.23 9.92 37.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.216 -0.927 . . . . 0.64 109.944 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.71 81.8 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.811 -1.315 . . . . 0.72 109.811 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.02 126.12 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.333 -1.098 . . . . 0.4 109.999 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 52.0 t0 -141.2 146.09 36.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 1.33 107.996 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.11 -150.28 12.13 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.234 -1.46 . . . . 0.26 110.206 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -92.05 132.35 36.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.568 -0.96 . . . . 2.07 108.525 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -100.38 136.49 40.19 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.246 -0.909 . . . . 0.13 110.331 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 p -138.74 150.41 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.39 -0.967 . . . . 0.22 108.39 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -132.0 136.57 47.38 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.303 -0.873 . . . . 0.12 110.275 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.71 106.23 15.38 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.319 -0.993 . . . . 0.24 108.319 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -66.73 -33.73 76.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 1.16 110.811 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.33 -40.04 95.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.965 -1.085 . . . . 0.3 109.881 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -102.79 0.75 33.24 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.552 -0.718 . . . . 0.42 110.277 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp 49.92 41.21 22.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 2.16 108.474 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -123.32 137.44 54.84 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.677 0.751 . . . . 0.28 110.969 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -100.69 139.25 36.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.383 -1.34 . . . . 0.09 107.383 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -130.27 130.76 44.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.653 -1.28 . . . . 0.14 108.519 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.51 128.18 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.089 -1.078 . . . . 0.12 108.089 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -120.02 128.31 53.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.29 110.214 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.938 -1.03 . . . . 1.95 109.351 -179.69 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.484 ' SD ' ' NZ ' ' A' ' 50' ' ' LYS . 24.6 ttt . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.305 -0.628 . . . . 2.91 109.305 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.4 m -91.19 131.61 36.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.237 -0.915 . . . . 0.31 109.806 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.82 148.83 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.895 -1.15 . . . . 0.19 107.895 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -116.25 140.52 49.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.103 -0.998 . . . . 1.98 109.081 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 30' ' ' PHE . 26.7 tp -123.17 128.68 50.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.681 -0.637 . . . . 0.13 109.31 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 124.8 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.266 -1.383 . . . . 0.36 107.266 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 54' ' ' VAL . 92.4 mt -102.34 115.59 30.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.25 109.029 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -113.37 70.63 0.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.521 -1.289 . . . . 0.18 107.521 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.77 167.54 52.92 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.709 -1.756 . . . . 0.24 108.709 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -67.24 -37.11 83.01 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.137 -1.214 . . . . 2.71 107.733 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -120.24 -18.73 7.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.153 0.502 . . . . 0.92 109.654 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.06 120.01 39.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.235 -0.915 . . . . 0.6 109.577 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -132.68 127.54 35.04 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.317 -0.865 . . . . 2.02 109.902 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -175.81 47.65 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.654 -1.26 . . . . 0.24 110.257 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.55 158.62 44.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -1.001 . . . . 1.68 109.313 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -153.22 170.03 21.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.391 -0.818 . . . . 0.34 109.72 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.4 p -137.87 160.04 40.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.8 . . . . 0.21 109.317 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.437 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -155.4 159.96 40.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.23 109.058 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -107.46 135.19 49.36 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.317 -0.994 . . . . 2.22 108.317 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.82 149.92 31.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.39 109.677 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.07 -29.08 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.55 110.053 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -158.07 171.89 19.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.916 -1.115 . . . . 1.16 110.304 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.56 83.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.567 -0.708 . . . . 0.26 110.175 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.58 -37.33 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.995 -1.066 . . . . 0.29 109.772 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -72.98 -34.59 66.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.682 -1.262 . . . . 0.44 109.638 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.17 90.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.37 -0.974 . . . . 0.18 108.37 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.46 -49.18 70.68 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.185 -1.006 . . . . 1.06 109.315 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.358 -0.839 . . . . 2.67 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.322 -0.861 . . . . 0.23 111.346 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CD1' HD22 ' A' ' 5' ' ' LEU . 27.2 m-85 -65.09 -39.9 93.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.83 -1.169 . . . . 0.15 111.37 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -63.37 -41.1 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 2.07 110.146 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.11 -42.47 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 1.84 108.893 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 65.2 t80 -60.14 -46.77 88.54 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.708 -0.849 . . . . 0.3 108.708 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.19 99.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.491 -0.756 . . . . 0.25 109.376 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -60.05 -40.84 90.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 1.23 109.15 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.25 -20.01 65.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 1.29 109.424 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 97.9 m-20 -96.56 4.8 51.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.093 -1.004 . . . . 0.64 109.992 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.6 36.34 54.13 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.933 -1.127 . . . . 0.72 110.959 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.8 t -116.26 122.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.155 -1.203 . . . . 0.4 108.559 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 73.9 m-20 -150.28 101.09 2.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -0.961 . . . . 1.33 110.818 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 -128.78 1.21 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.438 -1.363 . . . . 0.26 110.687 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -94.02 130.32 40.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.896 -1.355 . . . . 2.07 110.417 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -103.05 136.19 43.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.715 -0.616 . . . . 0.13 109.541 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.0 p -134.21 147.74 50.76 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.752 -1.203 . . . . 0.22 107.752 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -137.42 138.29 39.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.12 110.452 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -115.06 110.05 18.99 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.769 -0.826 . . . . 0.24 108.769 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 47.2 t0 -67.06 -28.74 68.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 1.16 109.719 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.97 95.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.3 110.013 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.0 p -107.55 0.45 22.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.474 -0.766 . . . . 0.42 110.218 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 32.1 mmtp 50.07 41.88 24.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.757 -1.201 . . . . 2.16 107.757 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.29 130.81 55.59 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.638 0.732 . . . . 0.28 110.603 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -101.89 139.42 37.55 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.779 -1.193 . . . . 0.09 107.779 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.0 m -130.98 132.63 45.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.833 -1.167 . . . . 0.14 108.294 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 7' ' ' LEU . 2.9 p -124.32 130.55 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.593 -0.891 . . . . 0.12 108.593 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.03 126.91 51.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.639 -0.663 . . . . 0.29 109.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.992 -1.004 . . . . 1.95 109.367 -179.463 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.065 -0.717 . . . . 2.91 109.065 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -91.71 133.5 35.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.31 109.512 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.68 140.99 49.78 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.712 -0.848 . . . . 0.19 108.712 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.81 143.34 44.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.539 -0.725 . . . . 1.98 109.052 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 52' ' ' PHE . 44.4 tp -119.19 129.38 54.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.849 -0.797 . . . . 0.13 108.849 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -106.34 124.36 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.95 -1.5 . . . . 0.36 106.95 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.13 116.09 31.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.25 110.336 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.27 67.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.378 -1.712 . . . . 0.18 106.378 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.52 173.11 53.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.778 -1.329 . . . . 0.24 109.778 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.06 -40.03 82.85 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.29 -1.123 . . . . 2.71 108.231 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.1 m -121.64 -19.33 6.88 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.858 -0.526 . . . . 0.92 109.891 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.0 tp -98.57 119.54 37.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.059 -1.026 . . . . 0.6 109.515 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -136.39 129.07 30.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.161 -0.962 . . . . 2.02 109.526 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.21 -171.07 44.25 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.417 -1.373 . . . . 0.24 110.065 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -148.18 157.27 43.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.63 -0.923 . . . . 1.68 109.124 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.15 171.58 18.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.815 . . . . 0.34 108.878 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -137.83 159.98 40.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 0.21 109.857 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.432 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 3.5 t -156.91 160.81 39.47 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.49 -0.756 . . . . 0.23 109.214 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -104.97 136.87 43.63 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.358 -0.979 . . . . 2.22 108.358 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.5 141.78 26.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.082 -1.011 . . . . 0.39 109.453 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 m -60.44 -30.86 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.435 -0.791 . . . . 0.55 109.347 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -156.87 174.32 15.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 1.16 109.564 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.25 81.53 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.37 -0.831 . . . . 0.26 110.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.38 -36.11 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.29 109.716 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -71.25 -38.25 71.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.226 . . . . 0.44 109.605 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.91 85.86 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.511 -0.922 . . . . 0.18 108.511 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.02 -42.36 89.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.629 -1.228 . . . . 1.06 109.301 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.03 -43.83 81.78 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.627 -1.296 . . . . 2.67 110.449 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.11 -53.23 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.915 . . . . 0.23 111.845 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.432 ' CZ ' HG22 ' A' ' 18' ' ' THR . 41.2 m-85 -66.56 -40.1 88.83 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.901 -1.124 . . . . 0.15 111.88 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.53 -40.16 95.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 2.07 110.177 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.9 -40.68 75.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.898 -1.126 . . . . 1.84 108.685 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.58 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.4 t80 -59.99 -44.56 94.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.3 108.982 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.29 96.73 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.396 -0.815 . . . . 0.25 108.962 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.98 -44.06 94.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.392 -0.817 . . . . 1.23 108.818 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.15 -24.19 67.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 1.29 109.341 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.58 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 81.2 m-20 -99.03 9.7 42.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.935 . . . . 0.64 109.052 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.89 36.77 93.29 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.515 -1.434 . . . . 0.72 109.515 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.3 125.88 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.319 -1.107 . . . . 0.4 109.892 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 96.4 m-20 -110.86 -98.63 0.41 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.294 -1.002 . . . . 1.33 108.294 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.81 165.21 4.79 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.083 0.824 . . . . 0.26 112.005 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.0 135.49 39.99 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.385 -1.339 . . . . 2.07 107.385 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -98.08 133.37 42.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.025 -1.047 . . . . 0.13 110.435 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -133.03 148.31 52.24 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.029 -1.1 . . . . 0.22 108.029 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -133.13 132.42 41.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.452 -0.78 . . . . 0.12 110.063 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -113.34 110.05 19.72 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.764 -0.828 . . . . 0.24 108.764 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -68.46 -29.5 68.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 1.16 110.625 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.92 89.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.3 110.313 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 78.6 p -104.87 -0.16 27.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.378 -0.826 . . . . 0.42 109.721 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.02 40.97 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.005 -1.06 . . . . 2.16 108.438 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.1 m -120.04 130.89 54.91 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.597 0.713 . . . . 0.28 110.723 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' O ' HD12 ' A' ' 5' ' ' LEU . 56.8 m-85 -98.34 139.12 34.59 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.953 -1.499 . . . . 0.09 106.953 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 100.0 m -132.04 131.88 42.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.715 -1.241 . . . . 0.14 108.853 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.6 p -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.036 -1.098 . . . . 0.12 108.036 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -121.45 128.32 52.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.39 -0.819 . . . . 0.29 110.788 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.035 -0.983 . . . . 1.95 109.298 179.456 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' CG ' ' H ' ' A' ' 2' ' ' THR . 4.3 tpt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.443 0.639 . . . . 2.91 109.397 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.502 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 98.3 m -93.41 131.64 38.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.578 -0.701 . . . . 0.31 109.776 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -112.89 147.86 36.15 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.095 -1.076 . . . . 0.19 108.095 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.45 140.12 50.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.338 -0.851 . . . . 1.98 109.079 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' A' ' 30' ' ' PHE . 36.1 tp -116.76 127.98 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.238 -1.023 . . . . 0.13 108.238 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.7 mt -101.52 121.23 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.091 -1.448 . . . . 0.36 107.091 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.2 110.85 22.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.032 -1.043 . . . . 0.25 109.918 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -116.49 67.76 0.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.811 -1.552 . . . . 0.18 106.811 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.67 164.93 47.38 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.163 -1.575 . . . . 0.24 109.163 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.142 -1.21 . . . . 2.71 108.261 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.6 m -111.31 -25.06 9.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.831 -0.543 . . . . 0.92 109.674 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 9' ' ' GLY . 40.5 tp -103.09 124.12 47.94 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.343 -0.848 . . . . 0.6 109.899 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.32 126.39 29.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 2.02 108.99 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.77 44.83 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.187 -1.482 . . . . 0.24 110.592 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -149.46 158.15 43.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.688 -0.889 . . . . 1.68 109.147 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.75 170.1 22.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.34 109.519 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.0 p -137.3 159.89 40.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.21 109.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -154.6 159.29 40.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.604 -0.887 . . . . 0.23 108.604 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -101.54 131.95 47.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.134 -0.979 . . . . 2.22 108.552 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.19 143.68 27.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.39 109.157 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.01 -29.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.446 -0.784 . . . . 0.55 109.797 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -158.78 174.75 14.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.055 -1.028 . . . . 1.16 110.196 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.26 82.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.595 -0.691 . . . . 0.26 110.311 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.0 64.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.032 -1.043 . . . . 0.29 110.368 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 p -72.48 -35.6 68.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.62 -1.3 . . . . 0.44 110.012 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.0 81.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.471 -0.768 . . . . 0.18 108.982 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.51 -42.35 87.51 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.613 -1.235 . . . . 1.06 109.815 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.8 -42.68 73.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 2.67 110.24 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.12 -52.19 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.23 110.768 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CD1' HD22 ' A' ' 5' ' ' LEU . 19.6 m-85 -61.8 -38.12 86.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.945 -1.097 . . . . 0.15 110.07 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -59.99 -41.77 92.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.885 -1.134 . . . . 2.07 109.782 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.92 -40.65 83.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.037 -1.039 . . . . 1.84 108.537 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.463 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 57.9 t80 -59.94 -49.64 76.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.772 -0.825 . . . . 0.3 108.772 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.58 84.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.25 109.351 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -60.04 -43.13 95.57 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 1.23 108.649 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.41 -25.39 65.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.077 -1.015 . . . . 1.29 108.783 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 18.9 m120 -100.01 9.86 42.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.64 109.926 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.03 34.7 88.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.012 -1.235 . . . . 0.72 110.012 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.04 128.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.306 -1.114 . . . . 0.4 109.937 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 95.9 m-20 -110.02 -99.74 0.39 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.622 -0.881 . . . . 1.33 108.622 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.02 161.6 3.37 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 121.977 0.765 . . . . 0.26 111.849 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.68 138.01 42.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.396 -1.335 . . . . 2.07 107.396 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -99.76 135.8 40.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -0.993 . . . . 0.13 111.115 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.68 149.75 50.54 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.213 -1.032 . . . . 0.22 108.213 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 65.6 t80 -135.97 134.57 38.74 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.12 110.065 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -111.76 110.02 20.17 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.687 -0.857 . . . . 0.24 108.687 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.24 -31.71 72.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 1.16 110.253 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.7 88.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.3 110.436 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.9 p -105.09 -0.98 26.16 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.386 -0.821 . . . . 0.42 110.158 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.1 mtpm? 49.98 40.03 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 2.16 108.931 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 132.14 55.38 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.528 0.68 . . . . 0.28 110.452 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.0 m-85 -99.6 139.8 34.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.384 -1.339 . . . . 0.09 107.384 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -131.58 132.45 44.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.71 -1.244 . . . . 0.14 108.83 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -121.88 129.31 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.35 -0.982 . . . . 0.12 108.35 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -120.02 127.2 52.38 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.477 -0.765 . . . . 0.29 111.016 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.058 -0.972 . . . . 1.95 109.163 179.191 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mmm . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.026 -0.731 . . . . 2.91 109.026 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.532 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 95.6 m -95.6 128.8 42.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.31 109.685 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -112.1 150.29 30.94 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.891 -1.151 . . . . 0.19 107.891 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -116.48 143.4 45.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.067 -1.02 . . . . 1.98 109.418 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 30' ' ' PHE . 35.2 tp -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.688 -0.632 . . . . 0.13 109.84 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.5 mt -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.572 -1.27 . . . . 0.36 107.572 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 54' ' ' VAL . 79.8 mt -102.85 115.94 31.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.25 -0.906 . . . . 0.25 110.01 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -116.95 70.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.666 -1.235 . . . . 0.18 107.666 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.91 170.1 53.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.093 -1.603 . . . . 0.24 109.093 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' NZ ' ' O ' ' A' ' 56' ' ' GLU . 62.4 mttp -64.38 -36.94 85.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.075 -1.25 . . . . 2.71 107.627 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.0 p -123.07 -15.27 7.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.903 -0.498 . . . . 0.92 109.889 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.79 122.1 41.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.98 -1.075 . . . . 0.6 109.969 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.92 126.68 27.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.295 -0.878 . . . . 2.02 109.814 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.27 -177.41 48.39 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.387 -1.387 . . . . 0.24 110.154 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.77 157.03 42.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.517 -0.99 . . . . 1.68 108.977 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -156.73 173.24 17.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.474 -0.766 . . . . 0.34 109.523 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.2 p -137.23 160.54 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.378 -0.826 . . . . 0.21 109.211 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 7.3 t -154.0 159.81 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.793 -0.817 . . . . 0.23 108.793 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -102.84 131.94 49.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.265 -0.897 . . . . 2.22 109.137 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.676 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -150.07 145.62 26.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.39 109.105 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 21' ' ' VAL . 15.8 m -62.61 -26.89 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.55 110.341 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -157.77 174.71 14.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.888 -1.133 . . . . 1.16 110.431 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.36 81.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.518 -0.739 . . . . 0.26 109.208 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.94 60.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.29 109.828 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.676 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 20.7 p -73.12 -35.13 66.48 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.668 -1.27 . . . . 0.44 109.6 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.7 94.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.581 -0.896 . . . . 0.18 108.581 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.27 -48.07 83.0 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.348 -1.341 . . . . 1.06 109.27 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -65.91 -44.67 84.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 2.67 111.013 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -52.86 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.946 -1.096 . . . . 0.23 110.456 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CD1' HD22 ' A' ' 5' ' ' LEU . 20.9 m-85 -61.06 -36.51 79.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.15 110.156 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -60.02 -40.5 89.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 2.07 109.261 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.02 -41.43 74.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 1.84 108.923 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.63 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 58.1 t80 -60.06 -49.66 76.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.3 109.461 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -45.28 94.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.25 109.549 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.96 -41.68 92.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.334 -0.854 . . . . 1.23 109.272 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.21 -23.44 67.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 1.29 109.138 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 61.3 m-20 -97.05 6.74 48.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.64 109.592 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.04 63.52 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.059 -1.067 . . . . 0.72 111.282 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 44.0 t -114.81 125.57 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.035 -1.274 . . . . 0.4 108.796 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 75.1 m-20 -149.66 101.92 3.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.254 -0.904 . . . . 1.33 110.399 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.41 -130.54 1.33 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.128 -1.51 . . . . 0.26 111.301 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -92.29 131.66 37.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.943 -1.328 . . . . 2.07 110.539 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.674 -0.641 . . . . 0.13 110.015 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 p -138.2 150.71 47.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.097 -1.075 . . . . 0.22 108.097 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.97 137.24 39.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -0.911 . . . . 0.12 110.532 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -113.28 109.98 19.63 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.904 -0.776 . . . . 0.24 108.904 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.7 t0 -67.01 -30.93 71.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 1.16 110.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.3 109.688 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -104.07 -0.65 28.45 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.363 -0.835 . . . . 0.42 109.807 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.0 mtpm? 49.66 42.79 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.881 -1.137 . . . . 2.16 108.453 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -120.05 134.69 55.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.454 0.645 . . . . 0.28 110.713 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -100.4 138.28 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.392 -1.336 . . . . 0.09 107.392 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -128.8 130.17 46.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.692 -1.255 . . . . 0.14 108.03 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.423 HG12 HD23 ' A' ' 7' ' ' LEU . 5.6 p -125.28 130.11 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.539 -0.912 . . . . 0.12 108.539 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.8 m -120.0 128.37 53.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.207 -0.664 . . . . 0.29 109.207 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 63.9 tt0 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.972 -1.014 . . . . 1.95 109.288 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.7 mpp? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.246 -0.65 . . . . 2.91 109.246 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.2 m -92.25 131.15 37.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.141 -0.974 . . . . 0.31 109.582 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -113.42 146.92 38.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.749 -1.204 . . . . 0.19 107.749 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.22 141.59 48.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.23 -0.919 . . . . 1.98 109.824 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.5 tp -120.11 128.38 53.4 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.045 -0.724 . . . . 0.13 109.045 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.1 123.28 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.027 -1.471 . . . . 0.36 107.027 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 114.06 27.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.25 109.67 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.6 71.39 0.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.031 -1.47 . . . . 0.18 107.031 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.11 169.59 53.03 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.082 -1.207 . . . . 0.24 110.082 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -65.76 -39.84 91.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -1.039 . . . . 2.71 108.224 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.9 m -124.28 -18.42 5.82 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.419 -0.586 . . . . 0.92 109.419 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.7 119.98 39.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.6 109.037 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -135.31 133.63 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.253 -0.904 . . . . 2.02 109.598 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.82 -173.64 46.45 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.461 -1.352 . . . . 0.24 110.272 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -149.44 158.2 43.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.577 -0.954 . . . . 1.68 109.202 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.466 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 4.3 t -154.49 171.6 19.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 0.34 109.324 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.7 p -137.33 159.92 40.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.21 109.332 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.462 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.5 t -155.0 158.8 39.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.823 . . . . 0.23 109.094 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.59 133.57 48.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.459 -0.941 . . . . 2.22 108.459 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.55 146.25 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.39 109.306 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 21' ' ' VAL . 14.5 m -59.55 -30.78 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.55 109.564 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -159.33 174.61 14.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.981 . . . . 1.16 110.015 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.32 81.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.411 -0.805 . . . . 0.26 110.358 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.37 -37.32 62.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.872 -1.142 . . . . 0.29 109.708 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.441 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 21.4 p -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.692 -1.255 . . . . 0.44 109.576 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.19 81.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.359 -0.978 . . . . 0.18 108.359 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.13 -47.44 81.13 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.645 -1.222 . . . . 1.06 109.439 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.71 -41.13 88.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 2.67 110.248 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -68.27 -54.98 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.06 -1.025 . . . . 0.23 110.814 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 18' ' ' THR . 28.2 m-85 -63.69 -38.66 91.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.15 111.358 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.79 -40.72 96.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.701 -1.249 . . . . 2.07 110.049 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.23 -43.86 73.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.971 -1.08 . . . . 1.84 109.162 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.667 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 81.4 t80 -60.17 -46.98 87.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.446 -0.784 . . . . 0.3 109.899 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.34 96.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.25 108.656 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -61.41 -41.16 96.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.561 -0.903 . . . . 1.23 108.561 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.64 -25.05 68.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 1.29 109.607 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.667 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 80.5 m-20 -94.8 7.43 45.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.946 . . . . 0.64 109.791 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.12 30.34 75.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.678 -1.369 . . . . 0.72 109.678 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.0 t -105.45 125.81 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -1.165 . . . . 0.4 109.756 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 40.0 t0 -138.64 142.32 39.07 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.98 -1.119 . . . . 1.33 107.98 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.78 -150.13 11.6 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.247 -1.454 . . . . 0.26 110.135 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -94.48 137.66 33.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.531 -0.982 . . . . 2.07 108.822 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -104.89 138.33 41.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.367 -0.833 . . . . 0.13 110.77 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -136.24 149.86 48.7 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.885 -1.154 . . . . 0.22 107.885 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -137.03 137.35 39.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.185 -0.947 . . . . 0.12 110.492 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.6 109.95 20.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.316 -0.994 . . . . 0.24 108.316 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.9 t0 -67.35 -30.67 70.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 1.16 110.167 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.86 91.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.3 110.34 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.4 p -105.93 -0.07 25.39 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.391 -0.818 . . . . 0.42 110.278 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 50.02 41.46 23.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.927 -1.108 . . . . 2.16 108.542 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -119.03 130.5 55.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.734 0.778 . . . . 0.28 110.451 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -99.36 139.08 35.54 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.568 -1.271 . . . . 0.09 107.568 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.6 m -130.69 131.35 44.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.14 108.195 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.27 129.35 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.423 -0.954 . . . . 0.12 108.423 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.1 m -120.41 127.07 51.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.423 -0.798 . . . . 0.29 110.188 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.027 -0.987 . . . . 1.95 109.253 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 21' ' ' VAL . 62.2 mtt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.384 -0.599 . . . . 2.91 109.384 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.4 m -92.71 134.69 34.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.31 109.655 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -113.72 145.41 41.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.361 -0.978 . . . . 0.19 108.361 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -115.96 142.94 46.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 1.98 108.912 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.558 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.9 tp -119.92 126.62 51.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.573 -0.899 . . . . 0.13 108.573 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.48 123.73 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.151 -1.425 . . . . 0.36 107.151 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 mt -102.73 112.89 25.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.25 110.383 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.97 68.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.839 -1.541 . . . . 0.18 106.839 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.31 168.2 51.51 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.965 -1.254 . . . . 0.24 109.965 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -65.9 -37.65 86.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.703 -1.221 . . . . 2.71 107.703 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -122.19 -19.79 6.42 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.151 -0.477 . . . . 0.92 109.866 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 tp -99.5 120.93 40.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 0.6 109.422 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -135.61 128.46 31.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.304 -0.873 . . . . 2.02 109.517 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.42 -175.03 47.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.303 -1.427 . . . . 0.24 110.446 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.36 152.57 41.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.646 -0.914 . . . . 1.68 108.86 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -152.65 168.02 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.34 108.801 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.1 p -138.65 160.54 39.37 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.21 109.737 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 10.4 t -157.37 162.84 39.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.23 108.594 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 43.7 mp0 -106.37 136.78 45.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.796 -0.816 . . . . 2.22 108.796 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.04 144.76 28.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.39 108.899 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' ' SD ' ' A' ' 1' ' ' MET . 19.8 m -60.04 -30.73 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.229 -0.919 . . . . 0.55 109.393 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -157.73 176.96 11.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 1.16 110.112 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.31 -38.12 87.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.526 -0.734 . . . . 0.26 109.496 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.9 61.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.982 -1.074 . . . . 0.29 109.553 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.621 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 90.2 m -69.97 -40.06 75.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.69 -1.256 . . . . 0.44 109.811 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.02 87.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.857 -0.794 . . . . 0.18 108.857 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.21 -45.44 79.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.442 -1.303 . . . . 1.06 108.824 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -67.83 -44.23 77.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 2.67 111.157 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.87 -53.01 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.23 111.34 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.558 ' CD1' HD22 ' A' ' 5' ' ' LEU . 23.8 m-85 -63.98 -37.56 87.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.861 -1.149 . . . . 0.15 110.299 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -59.94 -42.32 93.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.805 -1.184 . . . . 2.07 109.8 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -68.67 -40.14 80.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.078 -1.014 . . . . 1.84 108.741 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.4 t80 -59.95 -46.81 88.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.3 109.028 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.84 92.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.83 . . . . 0.25 109.144 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -60.01 -45.93 91.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.439 -0.788 . . . . 1.23 110.137 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.33 -25.16 65.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.051 -1.03 . . . . 1.29 109.396 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 83.3 m-20 -99.71 9.47 43.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.64 109.785 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.04 35.13 91.6 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.981 -1.104 . . . . 0.72 110.491 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 71.1 t -108.89 127.85 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.147 -1.208 . . . . 0.4 109.979 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 96.0 m-20 -140.38 148.33 41.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.485 -0.931 . . . . 1.33 108.485 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.41 -159.57 28.64 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.44 -1.362 . . . . 0.26 110.061 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -85.87 132.1 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.029 -1.1 . . . . 2.07 108.029 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -101.76 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.135 -0.978 . . . . 0.13 110.683 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.5 p -136.44 150.04 48.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 61.1 t80 -134.19 137.73 44.64 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.414 -0.804 . . . . 0.12 110.335 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -115.84 109.98 18.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.834 -0.802 . . . . 0.24 108.834 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -67.81 -29.2 68.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 1.16 110.455 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.02 94.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.3 110.32 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 p -109.18 0.13 19.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.582 -0.699 . . . . 0.42 110.209 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtmp? 50.14 42.11 24.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.851 -1.156 . . . . 2.16 108.588 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -118.79 130.06 55.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.725 0.774 . . . . 0.28 110.166 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 31.5 m-85 -99.11 139.51 34.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.949 -1.5 . . . . 0.09 106.949 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.6 m -131.96 132.82 43.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.782 -1.199 . . . . 0.14 108.463 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.1 p -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.345 -0.983 . . . . 0.12 108.345 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.3 m -119.38 126.73 52.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.51 -0.744 . . . . 0.29 109.518 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' OE2' HG13 ' A' ' 39' ' ' VAL . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.086 -0.959 . . . . 1.95 109.7 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.022 -0.733 . . . . 2.91 109.022 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.1 m -91.94 133.79 35.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.022 . . . . 0.31 109.39 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.79 145.49 43.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.807 -0.812 . . . . 0.19 108.807 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -114.38 143.42 44.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.98 108.906 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 30' ' ' PHE . 25.9 tp -119.8 126.91 52.17 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.735 -0.839 . . . . 0.13 108.735 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.9 mt -102.45 121.03 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.034 -1.469 . . . . 0.36 107.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.07 115.01 29.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.025 . . . . 0.25 109.879 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -122.48 66.0 0.94 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.628 -1.619 . . . . 0.18 106.628 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -78.6 171.89 55.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.799 -1.72 . . . . 0.24 108.799 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.38 -39.69 89.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.028 -1.278 . . . . 2.71 108.238 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.2 p -114.57 -20.12 10.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.841 -0.537 . . . . 0.92 109.757 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 9' ' ' GLY . 58.9 tp -99.93 121.65 41.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -0.918 . . . . 0.6 109.942 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -133.2 122.88 24.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.863 . . . . 2.02 108.948 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.08 -171.64 44.77 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.341 -1.409 . . . . 0.24 110.64 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 2.1 pm0 -150.46 158.61 44.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.519 -0.989 . . . . 1.68 109.591 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 t -154.55 170.37 21.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.518 -0.739 . . . . 0.34 109.707 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.3 p -138.16 160.13 40.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.33 -0.856 . . . . 0.21 109.494 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 t -155.46 162.19 40.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.959 -0.756 . . . . 0.23 108.959 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -100.22 132.08 45.8 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.088 -1.079 . . . . 2.22 108.088 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.711 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -148.39 143.24 26.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.943 -1.098 . . . . 0.39 109.477 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.46 -30.67 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.577 -0.702 . . . . 0.55 110.439 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -159.87 179.93 8.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.84 -1.162 . . . . 1.16 110.322 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -37.64 75.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.249 -0.907 . . . . 0.26 110.355 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.27 -38.52 68.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.186 . . . . 0.29 110.898 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.711 HG23 ' HB1' ' A' ' 20' ' ' ALA . 1.3 t -73.07 -34.44 66.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.271 -1.518 . . . . 0.44 109.388 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.59 86.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.65 -0.87 . . . . 0.18 108.65 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.34 -48.16 77.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.829 -1.149 . . . . 1.06 110.02 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.61 -41.14 88.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 2.67 110.96 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.3 -54.83 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 0.23 111.081 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.459 ' CD1' HD22 ' A' ' 5' ' ' LEU . 38.3 m-85 -63.76 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.01 -1.056 . . . . 0.15 110.456 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' HZ3' ' HB3' ' A' ' 31' ' ' LYS . 6.7 ttpm? -61.9 -42.64 99.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.801 -1.187 . . . . 2.07 109.935 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -67.54 -42.8 82.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.95 -1.094 . . . . 1.84 108.542 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.636 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 63.9 t80 -60.02 -47.83 84.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.425 0.631 . . . . 0.3 109.612 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.59 99.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.474 -0.766 . . . . 0.25 109.443 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -59.95 -40.66 89.73 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.191 -1.04 . . . . 1.23 108.191 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.61 -24.37 67.77 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.644 -0.66 . . . . 1.29 109.369 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 65.4 m-20 -97.63 6.94 47.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.64 109.769 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.07 34.32 70.29 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.954 -1.117 . . . . 0.72 110.711 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.87 124.52 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.03 -1.276 . . . . 0.4 108.972 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.47 101.09 2.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.003 -1.061 . . . . 1.33 110.713 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.07 -130.06 1.3 Allowed Glycine 0 N--CA 1.497 2.733 0 C-N-CA 119.268 -1.444 . . . . 0.26 111.336 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -93.78 129.3 40.2 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.972 -1.311 . . . . 2.07 110.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.55 139.97 41.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.67 -0.644 . . . . 0.13 110.059 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -136.08 149.46 48.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.756 -1.201 . . . . 0.22 107.756 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.95 135.4 41.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.12 109.924 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.45 109.55 19.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.299 -1.0 . . . . 0.24 108.299 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -68.19 -30.69 69.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.16 110.224 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.8 91.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.3 110.514 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.3 p -104.97 0.26 27.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.42 110.066 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm 50.63 40.95 25.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 2.16 108.257 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -119.79 130.54 54.99 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.536 0.684 . . . . 0.28 110.8 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -99.45 137.79 37.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.055 -1.461 . . . . 0.09 107.055 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.0 m -130.2 131.27 45.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.748 -1.22 . . . . 0.14 108.216 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.8 p -120.92 127.4 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.447 -0.946 . . . . 0.12 108.447 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -123.61 125.24 44.47 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.846 -0.798 . . . . 0.29 108.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.99 -1.005 . . . . 1.95 109.635 -179.865 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.386 -0.598 . . . . 2.91 109.386 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.41 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 23.9 m -89.84 133.05 34.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.31 109.022 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.06 147.17 42.6 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.979 -0.748 . . . . 0.19 108.979 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -118.07 143.77 46.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.487 -0.758 . . . . 1.98 109.267 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 7' ' ' LEU . 34.4 tp -119.5 129.07 54.53 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.011 -0.737 . . . . 0.13 109.011 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.46 123.72 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.066 -1.457 . . . . 0.36 107.066 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 5' ' ' LEU . 85.5 mt -104.49 116.44 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.208 -0.933 . . . . 0.25 111.035 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -114.88 71.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.113 -1.44 . . . . 0.18 107.113 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 168.91 52.61 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.434 -1.466 . . . . 0.24 109.434 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -66.05 -39.37 90.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.182 -1.187 . . . . 2.71 108.17 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.0 p -124.44 -16.56 6.31 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.023 0.44 . . . . 0.92 109.944 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -103.19 120.01 39.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.288 -0.883 . . . . 0.6 109.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -130.89 131.11 44.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.514 -0.741 . . . . 2.02 109.411 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.78 48.24 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.257 -1.449 . . . . 0.24 110.697 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 52.2 mp0 -143.88 153.26 42.14 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.479 -0.934 . . . . 1.68 108.479 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -152.51 169.17 23.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.085 -1.009 . . . . 0.34 109.34 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.9 p -135.44 159.82 40.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.353 -0.842 . . . . 0.21 109.502 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.456 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 10.6 t -157.28 160.12 38.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.23 109.216 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 55.8 mp0 -103.25 135.67 44.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.903 . . . . 2.22 108.678 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.6 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.54 144.6 27.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.39 109.264 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.88 -30.94 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.55 109.809 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -157.69 177.23 11.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.16 109.621 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.23 84.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.447 -0.783 . . . . 0.26 109.495 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -36.83 63.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.036 -1.04 . . . . 0.29 109.577 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.6 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 93.8 m -69.99 -39.63 75.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.785 -1.197 . . . . 0.44 109.651 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.71 78.83 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.735 -0.839 . . . . 0.18 108.735 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.76 -41.67 87.13 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.657 -1.217 . . . . 1.06 109.686 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.93 -45.17 71.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 2.67 110.477 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 -51.11 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.551 -0.718 . . . . 0.23 110.6 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' A' ' 18' ' ' THR . 35.0 m-85 -66.51 -38.6 87.58 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.091 -1.044 . . . . 0.15 110.549 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.0 -44.7 94.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.727 -1.233 . . . . 2.07 109.538 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -67.61 -40.88 84.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.028 -1.045 . . . . 1.84 108.573 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.2 t80 -59.99 -48.34 82.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.638 . . . . 0.3 109.78 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.21 94.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.25 109.546 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -60.0 -42.26 93.86 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.163 -0.961 . . . . 1.23 109.107 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.42 -26.47 67.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 1.29 109.696 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.8 m-20 -99.03 10.02 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.168 -0.958 . . . . 0.64 109.494 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.5 38.25 96.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.731 -1.348 . . . . 0.72 109.731 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.19 126.71 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -1.102 . . . . 0.4 110.172 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 52.4 t0 -110.19 -99.88 0.4 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.295 -1.002 . . . . 1.33 108.295 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.26 163.89 3.61 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 122.167 0.871 . . . . 0.26 112.368 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -75.2 138.48 41.99 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.348 -1.352 . . . . 2.07 107.348 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -99.57 134.99 41.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.13 110.809 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.6 p -133.57 148.19 51.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.316 -0.994 . . . . 0.22 108.316 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 66.8 t80 -130.61 134.31 46.88 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.86 . . . . 0.12 110.155 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' LYS . 62.0 t0 -112.88 107.19 15.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.738 -0.838 . . . . 0.24 108.738 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 56.5 t0 -67.36 -32.15 72.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.166 -0.959 . . . . 1.16 110.238 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.3 109.938 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -107.89 0.04 21.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.459 -0.775 . . . . 0.42 110.213 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 46' ' ' ASP . 9.5 mtmp? 49.74 42.02 22.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.806 -1.184 . . . . 2.16 108.294 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -120.01 131.44 55.14 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.625 0.726 . . . . 0.28 110.287 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.6 m-85 -99.88 137.83 37.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.28 -1.378 . . . . 0.09 107.28 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -131.0 131.7 44.52 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.804 -1.185 . . . . 0.14 108.245 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.5 p -120.58 128.06 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.077 -1.082 . . . . 0.12 108.077 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.22 125.86 49.21 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.402 -0.811 . . . . 0.29 110.845 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 38.2 mp0 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 118.034 -0.984 . . . . 1.95 109.438 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 mtt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.425 0.631 . . . . 2.91 109.679 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.6 m -92.46 131.29 37.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.31 109.458 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 95.2 m-85 -112.77 146.86 38.05 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.892 -1.151 . . . . 0.19 107.892 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -115.82 142.38 46.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.169 -0.957 . . . . 1.98 109.7 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' CD1' ' A' ' 30' ' ' PHE . 34.9 tp -122.4 128.11 50.54 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.057 -0.72 . . . . 0.13 109.057 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.69 124.16 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.605 -1.258 . . . . 0.36 107.605 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.3 mt -101.43 114.78 29.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.25 110.13 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.13 67.63 0.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.057 -1.46 . . . . 0.18 107.057 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.01 172.52 54.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.631 -1.387 . . . . 0.24 109.631 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -65.99 -39.06 90.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.221 -1.164 . . . . 2.71 108.365 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -17.57 6.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.917 -0.489 . . . . 0.92 109.859 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.3 tp -99.3 117.33 33.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 0.6 109.563 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.58 128.69 39.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.867 0.841 . . . . 2.02 109.514 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.15 -175.26 47.37 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.508 -1.329 . . . . 0.24 110.317 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -148.96 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.699 -0.883 . . . . 1.68 109.045 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -154.24 171.16 19.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.34 109.391 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 p -137.09 159.99 40.29 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.897 -0.779 . . . . 0.21 108.897 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.435 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.3 t -154.89 159.58 40.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.23 109.25 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -102.7 132.42 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.288 -0.882 . . . . 2.22 108.884 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.477 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.12 143.81 27.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.39 108.935 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.44 -27.23 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.55 109.858 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -157.96 172.21 18.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 1.16 109.939 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.68 83.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.516 -0.74 . . . . 0.26 109.941 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.48 -37.2 62.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.049 -1.032 . . . . 0.29 110.069 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.477 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 17.6 p -73.38 -34.41 65.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.615 -1.303 . . . . 0.44 109.809 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.9 87.33 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.325 -0.991 . . . . 0.18 108.325 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.67 -45.72 85.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.864 -1.134 . . . . 1.06 109.58 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.28 -42.7 83.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.078 . . . . 2.67 109.821 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.59 -54.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.23 110.737 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 5' ' ' LEU . 30.0 m-85 -63.44 -39.04 93.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.15 110.478 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -60.79 -42.45 97.57 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.721 -1.237 . . . . 2.07 109.823 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -69.61 -42.35 74.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 1.84 108.702 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.625 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.9 t80 -59.95 -44.94 94.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.665 -0.865 . . . . 0.3 108.665 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.92 99.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 0.25 109.387 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.1 -40.07 88.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 1.23 108.533 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.98 -24.22 67.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 78.1 m-20 -99.17 7.3 45.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.207 -0.933 . . . . 0.64 110.495 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.12 35.58 71.02 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.917 -1.135 . . . . 0.72 111.349 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 67.1 t -111.93 125.09 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.968 -1.313 . . . . 0.4 109.348 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 78.5 m-20 -148.47 98.8 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.252 -0.905 . . . . 1.33 110.47 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.83 -136.85 2.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.168 -1.491 . . . . 0.26 111.015 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.79 131.57 35.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.087 -1.243 . . . . 2.07 110.608 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -108.25 139.3 43.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.674 -0.641 . . . . 0.13 110.013 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 p -136.68 149.99 48.23 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 0.22 108.586 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 71.4 t80 -133.79 136.03 44.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.364 -0.835 . . . . 0.12 110.451 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -114.03 109.71 18.89 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.403 -0.962 . . . . 0.24 108.403 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.26 -29.11 67.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 1.16 110.17 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.02 94.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.005 . . . . 0.3 109.92 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -106.95 0.7 23.96 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.491 -0.756 . . . . 0.42 110.24 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.611 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 16.4 mtpp 50.51 41.66 25.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 2.16 108.451 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 132.64 55.52 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.66 0.743 . . . . 0.28 110.906 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 48.3 m-85 -99.99 139.36 35.77 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.167 -1.42 . . . . 0.09 107.167 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -130.33 131.52 45.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.665 -1.272 . . . . 0.14 108.343 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.7 p -124.85 130.01 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.862 . . . . 0.12 108.674 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.6 m -125.37 129.25 49.54 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.658 -0.651 . . . . 0.29 109.87 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.946 -1.026 . . . . 1.95 109.491 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HG2' ' H ' ' A' ' 2' ' ' THR . 28.4 ttp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 108.91 -0.774 . . . . 2.91 108.91 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.4 ' H ' ' HG2' ' A' ' 1' ' ' MET . 32.5 m -91.27 134.51 34.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.332 -0.855 . . . . 0.31 108.971 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.3 144.93 43.6 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.006 -0.739 . . . . 0.19 109.006 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -115.69 141.14 48.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 1.98 109.004 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.499 HD22 ' CD1' ' A' ' 30' ' ' PHE . 38.8 tp -120.05 128.97 54.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.13 109.336 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -105.81 123.06 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 106.983 -1.488 . . . . 0.36 106.983 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.06 115.89 31.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.311 -0.868 . . . . 0.25 110.311 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -116.59 72.8 0.83 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.967 -1.123 . . . . 0.18 107.967 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.62 169.47 54.31 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.219 -1.553 . . . . 0.24 109.219 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -62.37 -35.99 80.89 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.137 -1.213 . . . . 2.71 108.082 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 p -129.06 -11.92 4.69 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.555 -0.535 . . . . 0.92 109.555 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.6 tp -99.96 118.69 36.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.27 -0.894 . . . . 0.6 109.104 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -130.63 127.75 39.57 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 2.02 109.606 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 -177.84 48.39 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.184 -1.484 . . . . 0.24 110.555 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.17 157.15 43.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.666 -0.903 . . . . 1.68 109.014 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -152.99 169.97 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.34 109.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -136.49 159.61 41.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.21 109.309 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 11.5 t -155.67 159.0 39.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.387 -0.821 . . . . 0.23 109.138 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.37 134.04 45.06 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.042 -1.095 . . . . 2.22 108.042 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.43 26.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.928 -1.108 . . . . 0.39 109.491 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.05 -31.25 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.55 109.673 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -158.32 175.2 14.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 1.16 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.08 81.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.501 -0.749 . . . . 0.26 109.989 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.18 -36.92 61.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.008 -1.058 . . . . 0.29 109.871 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 p -74.16 -34.23 63.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.243 . . . . 0.44 109.519 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.971 -1.122 . . . . 0.18 107.971 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.07 -49.83 74.66 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.762 -1.175 . . . . 1.06 108.872 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -63.46 -44.77 93.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.83 . . . . 2.67 110.821 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.36 -53.28 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.053 -1.029 . . . . 0.23 110.763 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.499 ' CD1' HD22 ' A' ' 5' ' ' LEU . 29.2 m-85 -63.46 -37.82 88.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.15 110.456 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.685 -1.259 . . . . 2.07 109.83 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.57 -40.75 76.57 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.012 -1.055 . . . . 1.84 108.58 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -60.06 -47.77 84.5 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.749 -0.834 . . . . 0.3 108.749 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.16 99.42 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.918 -0.771 . . . . 0.25 108.918 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -60.0 -42.58 94.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.398 -0.814 . . . . 1.29 109.097 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -98.13 6.37 47.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.283 -0.886 . . . . 0.64 109.466 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.29 34.64 90.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.143 -1.183 . . . . 0.72 110.143 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.4 t -112.05 128.82 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.391 -1.064 . . . . 0.4 110.513 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 2.0 p-10 -110.52 -98.49 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.505 -1.294 . . . . 1.33 107.505 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 68.64 164.86 3.46 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-O 122.01 0.783 . . . . 0.26 111.841 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -76.31 137.46 39.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.998 -1.482 . . . . 2.07 106.998 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -98.0 134.94 40.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.13 110.544 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.38 148.77 50.73 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.996 -1.113 . . . . 0.22 107.996 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.2 t80 -135.97 135.1 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.326 -0.859 . . . . 0.12 110.29 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.65 109.95 19.8 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.31 -0.996 . . . . 0.24 108.31 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -68.68 -29.32 67.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 1.16 110.292 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.93 95.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.133 -0.98 . . . . 0.3 109.988 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.0 p -108.07 0.3 21.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.611 -0.681 . . . . 0.42 109.82 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.9 mttm 48.58 43.04 20.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.065 . . . . 2.16 108.502 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 131.75 55.26 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.543 0.687 . . . . 0.28 109.836 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.3 m-85 -100.05 138.93 36.45 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.851 -1.166 . . . . 0.09 107.851 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -131.36 131.68 43.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.803 -1.186 . . . . 0.14 108.52 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.19 130.15 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.296 -1.001 . . . . 0.12 108.296 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -117.53 124.83 49.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.504 -0.748 . . . . 0.29 109.701 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.039 -0.981 . . . . 1.95 109.588 -179.504 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 2' ' ' THR . 4.3 ppp? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.408 -0.59 . . . . 2.91 109.408 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.534 ' O ' ' SD ' ' A' ' 1' ' ' MET . 86.7 m -95.07 127.99 41.55 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.916 -1.115 . . . . 0.31 110.377 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -109.57 150.94 27.45 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.774 -1.195 . . . . 0.19 107.774 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -118.1 140.04 50.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.08 -1.013 . . . . 1.98 109.232 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 30' ' ' PHE . 37.2 tp -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.926 -0.768 . . . . 0.13 108.926 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.31 124.55 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.779 -1.193 . . . . 0.36 107.779 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.36 116.56 32.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 0.25 109.9 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -114.33 72.32 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.584 -1.265 . . . . 0.18 107.584 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.68 169.06 53.1 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.45 -1.46 . . . . 0.24 109.45 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.35 -37.93 88.55 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.312 -1.111 . . . . 2.71 108.006 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.7 p -123.78 -16.15 6.75 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.73 -0.471 . . . . 0.92 109.73 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 tp -101.74 120.18 39.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.305 -0.872 . . . . 0.6 109.573 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.15 127.9 40.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.802 . . . . 2.02 108.966 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.97 -179.22 48.65 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.174 -1.489 . . . . 0.24 110.584 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -149.48 158.2 43.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.947 . . . . 1.68 109.556 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.47 172.52 17.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.45 -0.781 . . . . 0.34 109.703 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -137.31 160.01 40.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.407 -0.808 . . . . 0.21 109.532 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.514 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 5.2 t -154.88 159.09 40.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.23 108.994 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -103.02 134.73 45.97 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.503 -0.925 . . . . 2.22 108.503 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.814 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -150.68 144.91 25.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 0.39 109.807 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 m -61.5 -30.68 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.573 -0.705 . . . . 0.55 110.296 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 24' ' ' ALA . 3.3 p30 -159.3 -179.99 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.917 -1.114 . . . . 1.16 109.825 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.39 75.0 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.076 -1.015 . . . . 0.26 110.5 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . . . -55.12 -39.37 69.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.839 -1.163 . . . . 0.29 111.088 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.814 HG23 ' HB1' ' A' ' 20' ' ' ALA . 1.3 t -74.46 -32.83 62.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.244 -1.535 . . . . 0.44 109.339 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.806 -0.813 . . . . 0.18 108.806 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.71 -47.29 82.8 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.787 -1.165 . . . . 1.06 109.436 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -64.34 -43.02 95.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 2.67 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.83 -54.47 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.305 -0.872 . . . . 0.23 111.034 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.514 ' CZ ' HG22 ' A' ' 18' ' ' THR . 33.7 m-85 -62.84 -38.87 92.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.077 -1.014 . . . . 0.15 110.783 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -61.62 -42.57 99.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.818 -1.177 . . . . 2.07 109.897 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -67.26 -43.0 82.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.84 -1.163 . . . . 1.84 108.619 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -47.57 85.28 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -0.774 . . . . 0.3 109.308 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.84 99.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.25 109.255 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.84 -42.46 97.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.23 109.059 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -62.49 -21.72 65.71 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -0.912 . . . . 1.29 108.958 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.9 m-20 -99.77 8.92 43.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.64 109.41 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.78 35.56 91.44 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.193 -1.163 . . . . 0.72 110.193 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.8 t -111.5 128.62 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.267 -1.137 . . . . 0.4 109.801 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.473 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 8.9 t70 -111.68 -96.59 0.42 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.108 -1.071 . . . . 1.33 108.108 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 68.33 164.42 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 121.237 -0.915 . . . . 0.26 112.087 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.68 137.47 42.18 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.319 -1.363 . . . . 2.07 107.319 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.18 135.61 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.958 . . . . 0.13 110.956 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -135.61 149.92 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.152 -1.055 . . . . 0.22 108.152 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 49.6 t80 -135.36 135.17 40.49 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.12 109.646 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -114.21 110.14 19.49 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.286 -0.635 . . . . 0.24 109.286 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.47 -29.54 69.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 1.16 109.852 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -40.46 94.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.3 110.167 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 76.9 p -107.94 -0.73 21.22 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.842 . . . . 0.42 110.049 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 48.9 42.48 20.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.037 -1.039 . . . . 2.16 108.694 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -120.08 130.26 54.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.822 -0.626 . . . . 0.28 109.786 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.4 m-85 -98.66 138.37 35.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.274 -1.38 . . . . 0.09 107.274 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.7 m -132.07 132.34 43.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.677 -1.264 . . . . 0.14 108.792 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.62 126.73 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.931 -1.137 . . . . 0.12 107.931 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.92 127.8 52.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.345 -0.847 . . . . 0.29 111.005 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 29.9 mp0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.014 -0.993 . . . . 1.95 109.466 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.301 -0.629 . . . . 2.91 109.301 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.5 m -92.08 131.64 37.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.052 -1.03 . . . . 0.31 109.53 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.83 145.56 42.01 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.677 -0.86 . . . . 0.19 108.677 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.404 ' HZ2' ' CG1' ' A' ' 6' ' ' ILE . 24.4 ttpp -116.64 142.13 47.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.372 -0.83 . . . . 1.98 109.073 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 30' ' ' PHE . 56.6 tp -121.9 129.41 52.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.728 . . . . 0.13 109.798 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.404 ' CG1' ' HZ2' ' A' ' 4' ' ' LYS . 93.0 mt -105.97 123.3 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.748 -1.575 . . . . 0.36 106.748 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.41 117.09 33.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 0.25 110.437 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.01 71.22 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.258 -1.386 . . . . 0.18 107.258 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 173.74 54.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.212 -1.555 . . . . 0.24 109.212 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -65.16 -39.93 93.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.189 -1.183 . . . . 2.71 108.102 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.7 p -124.99 -14.63 6.58 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.649 -0.5 . . . . 0.92 109.649 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.7 tp -99.7 114.94 28.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -0.974 . . . . 0.6 109.418 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 129.07 42.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.426 -0.796 . . . . 2.02 109.256 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.58 -175.1 47.41 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.285 -1.436 . . . . 0.24 110.312 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -148.28 156.82 43.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.608 -0.936 . . . . 1.68 108.96 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -154.67 172.9 17.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.34 109.604 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 p -137.68 159.13 42.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.752 . . . . 0.21 109.064 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -155.65 160.06 40.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.838 . . . . 0.23 108.874 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -104.31 133.82 48.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.272 -0.893 . . . . 2.22 108.931 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.17 146.27 26.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.39 109.614 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.24 -30.69 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.78 . . . . 0.55 110.194 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -159.79 179.99 8.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 1.16 110.093 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.79 82.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.628 -0.67 . . . . 0.26 110.653 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -37.03 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.874 -1.142 . . . . 0.29 110.431 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 p -73.49 -36.04 65.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.55 -1.344 . . . . 0.44 109.845 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.9 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.039 -1.097 . . . . 0.18 108.039 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.66 -45.73 85.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.13 -1.028 . . . . 1.06 110.203 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -67.35 -40.72 85.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.123 . . . . 2.67 110.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.37 -53.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.23 110.871 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CD1' HD22 ' A' ' 5' ' ' LEU . 41.0 m-85 -67.25 -40.01 86.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.923 -1.11 . . . . 0.15 110.664 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.75 -46.18 91.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.876 -1.14 . . . . 2.07 109.945 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.65 -43.01 81.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.095 -1.003 . . . . 1.84 108.782 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.9 t80 -60.09 -45.09 94.09 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.401 -0.812 . . . . 0.3 109.606 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.373 -0.829 . . . . 0.25 109.49 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -62.43 -40.12 95.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 1.23 109.007 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.62 -24.58 67.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 1.29 109.426 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 73.0 m-20 -97.14 10.08 40.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.64 109.198 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.0 93.97 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.321 -1.512 . . . . 0.72 109.321 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.4 t -109.94 123.75 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.356 -1.085 . . . . 0.4 109.867 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 97.6 m-20 -140.44 146.89 38.87 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.151 -1.055 . . . . 1.33 108.151 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.39 -155.49 22.47 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.077 -1.535 . . . . 0.26 110.105 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -88.03 130.66 34.91 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.85 -1.167 . . . . 2.07 107.85 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -103.0 138.92 39.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.13 110.463 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.8 p -136.83 150.05 48.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.341 -0.985 . . . . 0.22 108.341 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.3 t80 -135.69 137.09 41.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.435 -0.791 . . . . 0.12 110.233 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.93 109.95 20.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.901 -0.777 . . . . 0.24 108.901 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 51.9 t0 -67.15 -32.45 73.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 1.16 110.179 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.51 94.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.3 110.213 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -108.15 0.14 21.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.561 -0.712 . . . . 0.42 110.44 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 49.98 41.68 23.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.836 -1.165 . . . . 2.16 108.404 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -118.97 131.09 56.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.66 0.743 . . . . 0.28 110.264 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 44.4 m-85 -99.97 139.19 35.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.527 -1.286 . . . . 0.09 107.527 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 m -131.94 132.18 43.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.838 -1.164 . . . . 0.14 108.361 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.49 129.93 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.485 -0.932 . . . . 0.12 108.485 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -119.99 127.33 52.52 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.551 -0.718 . . . . 0.29 110.134 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 7.7 mp0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.975 -1.012 . . . . 1.95 109.238 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.344 -0.613 . . . . 2.91 109.344 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m -95.22 134.2 38.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.224 -0.923 . . . . 0.31 109.53 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.2 149.0 41.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.623 -0.88 . . . . 0.19 108.623 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -114.81 143.84 44.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.332 -0.855 . . . . 1.98 109.877 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.424 HD22 ' CD1' ' A' ' 30' ' ' PHE . 27.8 tp -121.31 127.14 51.02 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.858 -0.793 . . . . 0.13 108.858 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.9 mt -106.87 123.36 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.523 -1.288 . . . . 0.36 107.523 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -102.28 114.13 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.25 109.68 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' OD1' ' NZ ' ' A' ' 13' ' ' LYS . 43.2 t30 -114.88 71.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.72 -1.215 . . . . 0.18 107.72 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 166.43 49.76 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.416 -1.474 . . . . 0.24 109.416 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' NZ ' ' C ' ' A' ' 56' ' ' GLU . 60.0 mttp -67.41 -35.21 78.81 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -1.152 . . . . 2.71 108.027 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -22.42 4.99 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.929 -0.482 . . . . 0.92 109.849 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.37 119.96 39.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.306 -0.871 . . . . 0.6 109.338 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 8' ' ' ASN . 66.1 mttm -133.08 131.74 40.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.287 -0.883 . . . . 2.02 109.648 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.02 -179.97 48.8 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.273 -1.441 . . . . 0.24 110.426 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -142.0 151.97 42.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.609 -0.936 . . . . 1.68 108.73 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -151.89 167.65 27.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.34 109.074 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 p -139.88 160.82 39.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.21 109.411 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.9 t -155.72 161.17 40.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.686 -0.857 . . . . 0.23 108.686 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -103.45 135.03 45.82 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.484 -0.932 . . . . 2.22 108.484 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.9 144.28 27.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.39 109.549 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.36 -30.07 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.821 . . . . 0.55 109.634 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -158.35 171.06 20.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 1.16 109.582 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.78 81.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.26 109.796 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.71 68.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.115 . . . . 0.29 109.909 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.9 m -69.96 -37.17 75.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.44 109.722 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.83 75.2 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.588 -0.893 . . . . 0.18 108.588 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.43 -47.31 72.96 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.943 -1.103 . . . . 1.06 109.524 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 8.2 mptt -67.96 -40.2 83.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.794 -1.191 . . . . 2.67 110.459 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.24 -53.39 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 0.23 111.361 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.9 m-85 -64.7 -39.98 94.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.887 -1.133 . . . . 0.15 111.045 -178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -62.14 -40.01 94.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.719 -1.238 . . . . 2.07 109.932 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.94 -1.1 . . . . 1.84 108.795 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 68.6 t80 -59.89 -48.63 80.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 0.3 109.606 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -43.22 99.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.366 -0.834 . . . . 0.25 109.151 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.06 -42.53 94.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.641 -0.874 . . . . 1.23 108.641 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.72 -22.21 66.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 1.29 109.289 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 32.2 m120 -96.27 6.91 47.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.246 -0.909 . . . . 0.64 109.988 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.79 75.38 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.76 -1.21 . . . . 0.72 110.201 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 126.97 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.282 -1.128 . . . . 0.4 109.621 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -142.92 148.69 37.34 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.353 -0.98 . . . . 1.33 108.353 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.07 -150.45 14.73 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.173 -1.489 . . . . 0.26 110.147 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 59.1 mp0 -89.17 129.33 35.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.976 -1.12 . . . . 2.07 107.976 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -100.4 138.35 37.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.13 110.066 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.6 p -136.37 150.04 48.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.13 -1.063 . . . . 0.22 108.13 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -134.37 135.55 42.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.441 -0.787 . . . . 0.12 109.7 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -111.23 108.68 18.4 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.186 -1.042 . . . . 0.24 108.186 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -67.58 -30.81 70.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 1.16 110.197 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.02 94.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.3 110.112 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -104.72 0.09 27.96 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.486 -0.759 . . . . 0.42 110.417 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 49.97 40.43 21.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.886 -1.134 . . . . 2.16 108.215 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 131.05 55.01 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.685 0.755 . . . . 0.28 110.497 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -98.66 137.85 36.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.037 -1.468 . . . . 0.09 107.037 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.3 m -129.99 130.87 45.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.14 108.074 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.26 129.39 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.123 -1.066 . . . . 0.12 108.123 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -118.32 124.71 48.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.29 109.172 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' C ' ' NZ ' ' A' ' 10' ' ' LYS . 83.3 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.971 -1.014 . . . . 1.95 109.575 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 tpp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.494 0.664 . . . . 2.91 109.214 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m -91.22 134.76 34.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.428 -0.795 . . . . 0.31 109.758 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.09 145.02 40.5 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.26 -1.015 . . . . 0.19 108.26 178.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -115.97 139.95 49.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.288 -1.004 . . . . 1.98 108.288 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 52' ' ' PHE . 24.4 tp -120.52 127.71 52.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.512 -0.921 . . . . 0.13 108.512 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.0 mt -105.87 123.3 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.118 -1.438 . . . . 0.36 107.118 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.427 HD23 HG12 ' A' ' 54' ' ' VAL . 87.3 mt -103.67 115.01 29.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.25 110.034 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.71 71.15 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.353 -1.351 . . . . 0.18 107.353 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 167.12 50.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.513 -1.435 . . . . 0.24 109.513 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -64.98 -36.23 83.72 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.662 -1.236 . . . . 2.71 107.662 178.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -19.51 5.3 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.849 -0.426 . . . . 0.92 109.849 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.82 119.99 38.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.082 -1.011 . . . . 0.6 109.126 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -133.67 129.12 36.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.02 109.722 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.85 -175.08 47.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.46 -1.353 . . . . 0.24 110.443 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.53 156.95 43.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.981 . . . . 1.68 109.444 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -154.33 169.96 22.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.34 109.353 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -137.85 160.46 39.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.21 109.311 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.46 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 3.4 t -156.08 162.0 40.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.23 108.971 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 4.0 tm-20 -102.94 134.8 45.76 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.675 -0.861 . . . . 2.22 108.675 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.19 -0.944 . . . . 0.39 108.939 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.2 m -60.09 -29.89 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.55 109.356 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -158.14 176.5 12.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 1.16 109.834 -179.509 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.41 88.41 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.26 109.85 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.55 49.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.946 -1.096 . . . . 0.29 109.433 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.659 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.5 m -69.47 -39.99 77.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.827 -1.171 . . . . 0.44 109.942 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.37 97.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.312 -0.868 . . . . 0.18 109.137 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.29 -56.76 12.68 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.46 -0.896 . . . . 1.06 111.091 -178.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -69.48 -37.4 77.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.67 111.83 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.48 -53.49 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.425 -1.422 . . . . 0.23 110.637 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CZ ' HG22 ' A' ' 18' ' ' THR . 39.7 m-85 -61.81 -35.75 79.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.022 -1.049 . . . . 0.15 110.266 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.03 -40.77 90.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.946 -1.096 . . . . 2.07 108.952 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -69.41 -41.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 1.84 108.795 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.5 t80 -60.03 -49.93 75.72 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.048 -0.723 . . . . 0.3 109.048 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.77 96.28 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.476 -0.765 . . . . 0.25 109.362 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.46 -40.74 97.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 1.23 109.554 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.99 -25.7 67.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 1.29 109.271 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.2 m-20 -97.9 9.08 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.64 108.741 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.43 37.63 94.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.332 -1.107 . . . . 0.72 110.332 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.75 129.81 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.22 -1.165 . . . . 0.4 110.403 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 89.5 m-20 -111.65 -96.2 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.012 -1.107 . . . . 1.33 108.012 178.268 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.71 166.27 4.16 Favored Glycine 0 N--CA 1.491 2.351 0 CA-C-O 122.156 0.865 . . . . 0.26 112.27 177.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.52 138.6 39.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.361 -1.348 . . . . 2.07 107.361 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -100.22 135.76 41.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.119 -0.988 . . . . 0.13 110.91 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.4 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.005 -1.109 . . . . 0.22 108.005 179.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -135.32 134.97 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.233 -0.917 . . . . 0.12 110.693 -177.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.28 110.0 20.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.677 -0.86 . . . . 0.24 108.677 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -65.61 -31.7 72.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.16 110.363 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.56 -40.0 88.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.3 110.756 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.7 p -105.06 -0.41 26.76 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.42 110.469 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 50.02 40.34 21.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.888 -1.132 . . . . 2.16 108.068 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.02 54.51 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.645 0.736 . . . . 0.28 110.137 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.445 ' O ' HD12 ' A' ' 5' ' ' LEU . 45.3 m-85 -98.67 139.96 33.59 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.118 -1.438 . . . . 0.09 107.118 178.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.2 m -129.43 131.25 46.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.764 -1.21 . . . . 0.14 108.417 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG12 HD23 ' A' ' 7' ' ' LEU . 2.7 p -120.22 128.93 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.934 -1.136 . . . . 0.12 107.934 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -119.92 125.72 49.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.29 109.757 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.999 -1.0 . . . . 1.95 109.516 -179.691 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.401 0.619 . . . . 2.91 109.722 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.2 m -91.99 133.68 35.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.309 -0.869 . . . . 0.31 109.388 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 91.5 m-85 -117.93 148.69 41.92 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.772 -0.825 . . . . 0.19 108.772 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -117.07 145.28 43.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 1.98 109.324 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 7' ' ' LEU . 46.0 tp -119.45 127.53 53.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.547 -0.908 . . . . 0.13 108.547 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.09 121.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.023 -1.473 . . . . 0.36 107.023 178.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 5' ' ' LEU . 85.8 mt -102.55 116.81 33.35 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 0.25 110.308 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.0 68.29 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.509 -1.293 . . . . 0.18 107.509 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.5 171.55 54.13 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.505 -1.438 . . . . 0.24 109.505 179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -66.26 -39.86 89.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -1.128 . . . . 2.71 108.148 178.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.1 p -120.01 -20.09 7.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.999 -0.438 . . . . 0.92 109.848 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.8 tp -99.98 120.07 39.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 0.6 109.415 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -136.47 130.61 32.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 2.02 109.833 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.57 -173.62 46.42 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.392 -1.385 . . . . 0.24 110.905 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.521 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 46.4 mp0 -144.34 153.55 42.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.982 . . . . 1.68 108.958 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -153.17 168.54 25.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.34 109.446 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 p -139.36 159.78 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.863 . . . . 0.21 109.167 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -156.74 164.24 38.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.953 -0.758 . . . . 0.23 108.953 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -103.37 133.98 47.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.379 -0.826 . . . . 2.22 109.01 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.14 143.39 28.22 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.6 -0.889 . . . . 0.39 108.6 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -59.94 -29.61 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.55 109.535 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -157.74 175.19 14.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 1.16 110.022 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.13 85.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.552 -0.717 . . . . 0.26 109.871 -179.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.24 -36.58 61.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.112 . . . . 0.29 109.912 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.503 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 5.1 p -73.43 -33.47 64.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.608 -1.307 . . . . 0.44 109.732 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.18 81.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.237 -1.023 . . . . 0.18 108.237 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.01 -44.93 83.31 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.823 -1.151 . . . . 1.06 109.558 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.7 -42.72 85.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.882 -1.136 . . . . 2.67 110.579 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.63 -52.0 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.23 111.243 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.67 -40.03 88.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.025 -1.047 . . . . 0.15 111.269 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -63.51 -41.28 98.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.503 -1.373 . . . . 2.07 109.997 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -70.0 -45.68 66.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.879 -1.138 . . . . 1.84 108.939 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.545 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 72.9 t80 -60.02 -47.98 83.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.495 -0.753 . . . . 0.3 109.453 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.59 98.64 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.478 -0.764 . . . . 0.25 109.474 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.95 -40.49 89.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.392 -0.818 . . . . 1.23 108.974 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -65.08 -19.26 65.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.784 -0.821 . . . . 1.29 108.784 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.545 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 97.4 m-20 -94.68 6.7 48.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.64 109.788 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.2 30.25 63.17 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.9 -1.143 . . . . 0.72 111.153 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.02 124.26 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.901 -1.352 . . . . 0.4 108.527 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 27.7 p-10 -150.58 99.61 2.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 1.33 110.593 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.2 -125.48 0.86 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.174 -1.489 . . . . 0.26 111.317 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.79 130.3 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.898 -1.354 . . . . 2.07 110.851 -178.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -107.23 139.59 41.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 0.13 110.27 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.5 p -137.77 150.02 46.9 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.419 -0.956 . . . . 0.22 108.419 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CE1' ' CE1' ' A' ' 52' ' ' PHE . 48.9 t80 -137.79 137.75 38.53 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.175 -0.953 . . . . 0.12 110.337 -179.077 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.719 -0.845 . . . . 0.24 108.719 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.51 -31.05 71.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.346 -0.846 . . . . 1.16 110.928 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.9 94.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.3 110.537 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -103.55 0.04 30.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.381 -0.824 . . . . 0.42 110.383 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 20.4 mtpp 49.91 40.12 20.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.11 . . . . 2.16 108.255 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -120.1 131.12 54.95 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.498 0.666 . . . . 0.28 110.14 -178.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 54.3 m-85 -99.96 138.83 36.49 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.447 -1.316 . . . . 0.09 107.447 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.7 m -130.06 131.55 45.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.14 108.709 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.5 p -121.67 127.68 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.577 -0.898 . . . . 0.12 108.577 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -125.47 127.51 46.6 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.532 -0.73 . . . . 0.29 109.803 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.019 -0.991 . . . . 1.95 109.289 179.811 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.366 0.603 . . . . 2.91 109.382 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m -89.51 136.23 33.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.39 -0.819 . . . . 0.31 109.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.456 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 95.8 m-85 -114.31 141.93 46.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.691 -0.855 . . . . 0.19 108.691 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.7 140.17 48.47 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.733 -0.84 . . . . 1.98 108.733 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.59 HD22 ' CD1' ' A' ' 30' ' ' PHE . 46.6 tp -120.06 128.76 53.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.347 -0.846 . . . . 0.13 109.516 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -104.96 122.38 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.208 -1.404 . . . . 0.36 107.208 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.74 115.45 30.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -0.987 . . . . 0.25 110.282 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -118.75 72.37 0.88 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.826 -1.176 . . . . 0.18 107.826 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 171.06 54.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.351 -1.5 . . . . 0.24 109.351 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.66 -39.85 94.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.05 -1.265 . . . . 2.71 108.173 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -124.67 -16.1 6.34 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.204 -0.665 . . . . 0.92 109.204 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 9' ' ' GLY . 60.1 tp -99.8 118.04 35.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.323 -0.86 . . . . 0.6 108.794 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -135.83 133.78 38.18 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 2.02 109.916 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.54 -176.21 47.86 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.495 -1.336 . . . . 0.24 110.403 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -145.03 151.61 38.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.505 -0.924 . . . . 1.68 108.505 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -152.62 170.16 20.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.34 109.422 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -137.74 159.88 40.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -0.771 . . . . 0.21 109.196 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.421 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.2 t -156.97 162.27 39.6 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.368 -0.832 . . . . 0.23 108.796 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -106.58 136.6 46.08 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.778 -0.823 . . . . 2.22 108.778 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.91 148.52 29.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.39 109.39 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.9 -33.35 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.392 -0.817 . . . . 0.55 110.086 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -159.85 179.98 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 1.16 110.088 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.456 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -66.74 -40.03 88.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.534 -0.728 . . . . 0.26 110.469 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -37.56 63.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.873 -1.142 . . . . 0.29 110.228 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.4 m -69.99 -39.98 75.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.673 -1.267 . . . . 0.44 110.148 179.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.05 88.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.803 . . . . 0.18 109.09 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.97 -46.37 82.24 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.769 -1.172 . . . . 1.06 109.57 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -67.39 -44.11 79.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.435 -0.79 . . . . 2.67 110.67 -179.151 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.37 -53.11 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.23 110.99 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CD1' HD22 ' A' ' 5' ' ' LEU . 30.3 m-85 -63.62 -38.76 92.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.935 -1.103 . . . . 0.15 110.4 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -60.07 -45.13 93.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.856 -1.153 . . . . 2.07 109.999 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -69.07 -42.1 76.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.025 -1.047 . . . . 1.84 109.1 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.615 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -59.98 -44.65 94.36 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.717 -0.846 . . . . 0.3 108.717 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.58 -43.6 96.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.25 109.013 179.17 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -60.28 -42.39 95.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.24 -0.913 . . . . 1.23 108.814 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.9 -25.26 67.46 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.398 -0.814 . . . . 1.29 109.344 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.615 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 94.2 m-20 -100.13 8.94 43.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.392 -0.817 . . . . 0.64 109.419 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.99 36.2 92.79 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.225 -1.15 . . . . 0.72 110.225 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.13 124.79 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.196 -1.179 . . . . 0.4 109.974 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 80.2 m-20 -110.62 -98.74 0.4 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.07 -1.085 . . . . 1.33 108.07 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.29 165.97 2.73 Favored Glycine 0 N--CA 1.488 2.121 0 CA-C-O 122.146 0.859 . . . . 0.26 112.134 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -77.79 135.49 37.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.067 -1.457 . . . . 2.07 107.067 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -98.58 135.66 39.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.125 -0.985 . . . . 0.13 110.66 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.6 p -132.77 148.24 52.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.747 -1.205 . . . . 0.22 107.747 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 55.5 t80 -135.07 135.63 41.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.261 -0.899 . . . . 0.12 110.372 -178.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -113.03 110.05 19.84 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.607 -0.886 . . . . 0.24 108.607 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 45.7 t0 -68.0 -30.27 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.16 110.348 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.29 93.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.3 110.058 -179.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -107.85 0.08 21.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.476 -0.765 . . . . 0.42 110.106 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 49.98 43.52 25.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.928 -1.107 . . . . 2.16 108.581 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.81 130.23 54.82 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.592 0.71 . . . . 0.28 110.473 -178.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.527 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.9 m-85 -101.37 139.91 36.39 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.231 -1.396 . . . . 0.09 107.231 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.0 m -132.83 134.01 44.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.786 -1.196 . . . . 0.14 108.756 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -122.81 129.8 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.608 -0.886 . . . . 0.12 108.608 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -122.67 126.81 48.36 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.415 -0.803 . . . . 0.29 110.654 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.94 -1.028 . . . . 1.95 109.482 179.038 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.429 0.633 . . . . 2.91 109.829 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.6 m -91.32 134.54 34.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.544 -0.722 . . . . 0.31 109.18 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.73 148.85 37.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.463 -0.773 . . . . 0.19 109.047 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -118.75 142.44 47.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.406 -0.808 . . . . 1.98 109.228 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 30' ' ' PHE . 31.9 tp -120.84 129.43 53.54 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.483 -0.76 . . . . 0.13 109.279 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -106.58 123.08 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.404 -1.332 . . . . 0.36 107.404 179.157 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.47 115.2 30.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.242 -0.911 . . . . 0.25 110.412 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -117.57 70.15 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.352 -1.351 . . . . 0.18 107.352 178.115 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.78 54.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.977 -1.249 . . . . 0.24 109.977 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.2 -39.8 93.33 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -1.1 . . . . 2.71 108.333 178.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -15.62 6.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.947 -0.471 . . . . 0.92 109.778 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.9 tp -100.01 120.04 39.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.095 -1.003 . . . . 0.6 109.517 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -131.89 127.06 35.67 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.331 -0.856 . . . . 2.02 109.364 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.99 -177.9 48.26 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.178 -1.487 . . . . 0.24 110.676 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -148.31 156.89 43.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.625 -0.926 . . . . 1.68 109.179 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.429 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 5.6 t -154.21 170.52 21.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.347 -0.845 . . . . 0.34 109.629 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.9 p -137.98 160.02 40.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.385 -0.822 . . . . 0.21 109.415 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.414 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.9 t -155.08 160.52 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.23 109.239 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -104.36 133.55 49.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.344 -0.848 . . . . 2.22 108.757 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.95 146.07 27.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.006 -1.059 . . . . 0.39 109.637 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.61 -30.15 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.389 -0.819 . . . . 0.55 109.975 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -158.5 174.91 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 1.16 110.163 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.17 79.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.553 -0.717 . . . . 0.26 110.372 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.94 -37.82 61.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.793 -1.192 . . . . 0.29 110.092 -179.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 p -74.14 -33.06 63.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.637 -1.289 . . . . 0.44 109.685 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.18 93.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.406 -0.809 . . . . 0.18 108.934 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.67 -46.28 84.45 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.838 -1.145 . . . . 1.06 109.637 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -67.13 -40.09 86.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 2.67 110.304 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.47 -53.17 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.972 . . . . 0.23 110.673 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' HD22 ' A' ' 5' ' ' LEU . 37.4 m-85 -63.99 -38.07 89.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.15 110.551 -178.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -59.93 -40.16 87.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.624 -1.298 . . . . 2.07 109.126 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -69.38 -41.77 76.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.125 -0.984 . . . . 1.84 109.042 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 59.3 t80 -60.03 -46.6 88.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.3 109.576 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.97 95.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.25 109.308 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -40.66 90.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.148 -0.97 . . . . 1.23 108.976 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -64.51 -26.12 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.284 -0.885 . . . . 1.29 109.984 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.627 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 69.6 m-80 -99.75 4.99 45.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.017 -1.052 . . . . 0.64 110.103 -179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.4 60.82 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.034 -1.079 . . . . 0.72 111.599 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.3 t -110.67 122.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.892 -1.357 . . . . 0.4 108.39 178.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 71.1 m-20 -150.6 101.04 2.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 1.33 110.659 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.36 -131.84 1.49 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 119.297 -1.43 . . . . 0.26 111.083 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 57.8 mp0 -88.81 128.11 35.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.952 -1.322 . . . . 2.07 110.164 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -104.11 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.692 -0.63 . . . . 0.13 109.999 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.9 p -131.49 147.19 52.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.93 -1.137 . . . . 0.22 107.93 178.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 53.7 t80 -133.25 132.36 41.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.338 -0.851 . . . . 0.12 110.207 -178.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -114.65 109.94 18.99 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.381 -0.97 . . . . 0.24 108.381 178.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -69.51 -27.67 65.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 1.16 110.267 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.92 95.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.3 109.926 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.9 p -106.02 0.18 25.43 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.546 -0.721 . . . . 0.42 110.036 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtpm? 50.02 39.96 20.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.882 -1.136 . . . . 2.16 108.289 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -120.01 132.87 55.63 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 0.28 110.593 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 56.3 m-85 -100.36 139.67 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.252 -1.388 . . . . 0.09 107.252 177.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 m -130.24 131.97 45.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.763 -1.21 . . . . 0.14 108.339 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.83 129.25 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.34 -0.985 . . . . 0.12 108.34 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -124.56 128.19 48.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.621 -0.674 . . . . 0.29 110.115 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.038 -0.982 . . . . 1.95 109.296 179.8 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.265 0.555 . . . . 2.91 109.695 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.6 m -91.36 133.31 35.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.827 . . . . 0.31 109.325 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -112.35 145.37 40.18 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.366 -0.976 . . . . 0.19 108.366 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -113.43 139.97 48.47 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.124 -0.985 . . . . 1.98 108.8 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.4 tp -120.91 126.6 50.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.754 -0.832 . . . . 0.13 108.754 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.62 124.01 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.61 -1.256 . . . . 0.36 107.61 178.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 54' ' ' VAL . 90.0 mt -104.24 114.13 28.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.25 110.231 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -113.5 72.46 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.395 -1.335 . . . . 0.18 107.395 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.55 169.46 53.53 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.665 -1.374 . . . . 0.24 109.665 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -64.87 -38.51 91.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -1.129 . . . . 2.71 108.517 178.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 p -130.62 -16.58 3.37 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.527 -0.546 . . . . 0.92 109.527 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -101.76 117.36 34.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.249 -1.019 . . . . 0.6 108.249 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -133.71 137.87 45.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.207 -0.933 . . . . 2.02 110.416 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -180.0 -178.25 48.43 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.688 -1.244 . . . . 0.24 110.194 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.56 154.71 41.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.507 -0.923 . . . . 1.68 108.507 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -154.63 170.7 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.842 . . . . 0.34 109.502 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -138.32 160.03 40.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.919 -0.771 . . . . 0.21 108.919 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.1 t -156.7 161.42 39.85 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.273 -0.892 . . . . 0.23 109.239 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -102.92 134.97 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.696 -0.853 . . . . 2.22 108.696 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.61 144.87 27.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 0.39 108.912 -179.613 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.03 -30.58 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.55 109.467 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -159.73 178.51 9.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 1.16 110.02 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.76 -37.92 82.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.456 -0.777 . . . . 0.26 110.048 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.51 -37.38 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.965 -1.085 . . . . 0.29 110.136 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.402 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.8 m -69.92 -39.19 76.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.634 -1.291 . . . . 0.44 109.66 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.89 87.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.595 -0.69 . . . . 0.18 109.196 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.97 -45.81 82.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.883 -1.127 . . . . 1.06 109.504 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -67.82 -43.38 79.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 2.67 110.679 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.94 -52.53 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.32 -0.863 . . . . 0.23 111.62 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.581 ' CD1' HD22 ' A' ' 5' ' ' LEU . 27.1 m-85 -64.22 -38.47 91.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.802 -1.186 . . . . 0.15 110.482 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -60.04 -44.07 94.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.84 -1.162 . . . . 2.07 109.692 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.512 ' NE2' ' OD2' ' A' ' 36' ' ' ASP . 1.6 tm0? -67.91 -41.7 82.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 1.84 108.705 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.7 t80 -60.0 -49.02 79.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.622 -0.674 . . . . 0.3 109.503 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.42 93.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.25 109.057 179.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -60.17 -44.58 94.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 1.23 109.366 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' NE2' ' A' ' 32' ' ' GLN . 82.3 m-20 -62.72 -24.04 67.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 1.29 109.24 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.623 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.0 m-20 -97.63 7.01 47.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.816 . . . . 0.64 109.667 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.18 31.59 77.93 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.053 -1.07 . . . . 0.72 110.851 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.99 127.41 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.174 -1.192 . . . . 0.4 109.836 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 87.5 m-20 -109.99 -99.82 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.092 -1.077 . . . . 1.33 108.092 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.96 163.51 4.17 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-O 122.028 0.793 . . . . 0.26 112.339 177.133 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 58.1 mp0 -75.55 137.15 40.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.321 -1.363 . . . . 2.07 107.321 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -99.89 135.0 41.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 0.13 110.927 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.6 p -135.23 150.05 50.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.632 -1.247 . . . . 0.22 107.632 178.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -135.27 138.9 43.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.294 -0.879 . . . . 0.12 110.566 -178.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -113.66 109.99 19.48 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.65 -0.87 . . . . 0.24 108.65 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 36.5 t0 -67.5 -31.39 71.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.16 110.312 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.973 . . . . 0.3 110.573 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -105.4 0.64 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.519 -0.738 . . . . 0.42 110.14 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm 50.58 42.45 26.87 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.855 -1.165 . . . . 2.16 107.855 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -120.0 131.14 55.05 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.719 0.771 . . . . 0.28 110.945 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -99.72 138.21 37.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.115 -1.439 . . . . 0.09 107.115 177.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -130.63 131.95 45.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.662 -1.274 . . . . 0.14 109.076 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -124.23 130.02 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.402 -0.962 . . . . 0.12 108.402 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.91 126.5 51.05 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.664 -0.648 . . . . 0.29 110.181 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.981 -1.009 . . . . 1.95 109.576 -179.901 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.366 -0.605 . . . . 2.91 109.366 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 m -93.58 131.76 38.55 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.018 -1.051 . . . . 0.31 109.929 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.71 148.03 38.84 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.369 -0.975 . . . . 0.19 108.369 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -116.5 140.89 48.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.257 -0.902 . . . . 1.98 109.08 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 30' ' ' PHE . 65.7 tp -120.42 129.56 53.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.601 -0.687 . . . . 0.13 109.581 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.68 122.76 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.746 -1.576 . . . . 0.36 106.746 177.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.97 116.5 32.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.892 . . . . 0.25 109.679 -178.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -114.87 71.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 0.18 107.601 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.32 168.18 48.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.396 -1.482 . . . . 0.24 109.396 179.147 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.47 -39.51 77.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.187 -1.184 . . . . 2.71 108.459 178.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -117.82 -22.96 7.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.783 -0.573 . . . . 0.92 109.662 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.8 tp -101.45 120.37 40.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.6 109.264 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -134.38 129.9 36.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.957 . . . . 2.02 109.536 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.53 -174.0 46.58 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.369 -1.396 . . . . 0.24 110.391 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -148.56 157.21 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.631 -0.923 . . . . 1.68 108.932 179.579 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -154.8 170.8 20.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.922 . . . . 0.34 109.664 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.4 p -137.97 160.13 40.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.21 109.086 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -156.19 162.95 40.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.384 -0.822 . . . . 0.23 109.061 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -102.31 133.81 46.61 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.677 -0.861 . . . . 2.22 108.677 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.34 143.16 25.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.096 . . . . 0.39 109.525 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.79 -29.81 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.55 110.051 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -157.93 176.53 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.16 109.915 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.34 -37.58 80.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 0.26 109.827 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.82 -37.34 59.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.017 . . . . 0.29 109.94 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.405 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 3.2 p -73.31 -34.5 65.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.692 -1.255 . . . . 0.44 109.388 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.35 93.18 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.693 -0.854 . . . . 0.18 108.693 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.35 -50.05 74.18 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.634 -1.226 . . . . 1.06 109.754 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -65.88 -41.43 91.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 2.67 110.141 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.88 -55.35 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.1 -1.0 . . . . 0.23 110.259 -178.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.527 ' CD1' HD22 ' A' ' 5' ' ' LEU . 26.3 m-85 -65.12 -39.75 93.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.15 110.298 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -60.53 -44.06 96.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 2.07 109.637 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -69.23 -42.78 75.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.968 -1.082 . . . . 1.84 108.797 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 77.2 t80 -60.02 -45.92 91.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.463 -0.773 . . . . 0.3 109.18 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.24 95.95 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.507 -0.746 . . . . 0.25 109.016 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -61.32 -40.93 96.03 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 1.23 109.192 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.86 -25.1 66.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 1.29 109.513 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 92.9 m-20 -97.9 9.99 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 0.64 109.881 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.15 92.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.835 -1.306 . . . . 0.72 109.835 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.99 125.54 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.287 -1.125 . . . . 0.4 109.482 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 21.3 p-10 -141.76 148.5 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.214 -1.032 . . . . 1.33 108.214 179.017 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.43 -147.75 10.92 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.219 -1.467 . . . . 0.26 110.053 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -93.14 131.32 38.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 2.07 108.445 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -100.71 137.4 39.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 0.13 110.098 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.0 p -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.446 -0.946 . . . . 0.22 108.446 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 59.3 t80 -134.09 136.39 43.89 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.408 -0.808 . . . . 0.12 110.162 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -112.16 109.27 18.87 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.314 -0.995 . . . . 0.24 108.314 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.17 -31.2 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.973 . . . . 1.16 110.287 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.04 90.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.3 110.318 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.3 p -104.98 -0.76 26.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.251 -0.905 . . . . 0.42 110.011 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 50.06 40.77 22.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 2.16 108.362 -179.755 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.58 54.86 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.616 0.722 . . . . 0.28 110.141 -178.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 33.3 m-85 -98.75 138.32 36.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 0.09 106.999 178.278 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -131.99 132.21 43.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.878 -1.139 . . . . 0.14 108.139 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.18 132.15 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.481 -0.933 . . . . 0.12 108.481 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.7 m -119.1 126.38 51.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.608 -0.683 . . . . 0.29 109.631 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.055 -0.974 . . . . 1.95 109.584 -179.36 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.423 ' SD ' ' NZ ' ' A' ' 50' ' ' LYS . 67.8 mtt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.329 -0.619 . . . . 2.91 109.329 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -91.0 132.85 35.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.31 109.218 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.72 147.7 40.6 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.771 -0.826 . . . . 0.19 108.771 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -117.29 143.8 45.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.405 -0.809 . . . . 1.98 109.651 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 30' ' ' PHE . 40.8 tp -119.58 126.61 51.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.591 -0.892 . . . . 0.13 108.591 179.078 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.55 122.79 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.194 -1.41 . . . . 0.36 107.194 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.4 mt -100.3 117.14 33.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.25 110.265 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -122.2 66.55 0.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.334 -1.358 . . . . 0.18 107.334 178.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.33 169.87 53.04 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 0.24 109.794 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -63.61 -39.88 95.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.272 -1.134 . . . . 2.71 108.582 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.09 -19.92 6.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.955 -0.466 . . . . 0.92 109.896 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.37 119.98 38.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.228 -0.92 . . . . 0.6 109.401 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -135.14 129.99 34.73 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.268 -0.895 . . . . 2.02 109.832 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.61 -177.38 48.42 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.338 -1.411 . . . . 0.24 110.584 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -142.52 151.14 41.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.607 -0.937 . . . . 1.68 108.676 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -152.72 167.37 29.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.34 109.241 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.7 p -137.67 160.19 39.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.21 109.502 -179.16 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.465 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 5.9 t -153.77 159.94 42.09 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.672 -0.862 . . . . 0.23 108.672 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -101.43 131.95 47.28 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.45 -0.944 . . . . 2.22 108.45 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.17 142.75 27.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.39 109.22 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.06 -28.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -0.778 . . . . 0.55 109.877 -179.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -158.43 174.72 14.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 1.16 110.099 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.09 82.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.548 -0.72 . . . . 0.26 110.061 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.02 54.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.912 -1.117 . . . . 0.29 109.728 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.449 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 4.8 p -72.41 -34.86 68.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.775 -1.203 . . . . 0.44 109.459 178.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.89 94.05 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.617 -0.883 . . . . 0.18 108.617 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.11 -49.88 74.54 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.934 -1.107 . . . . 1.06 109.914 -179.147 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -66.85 -40.61 87.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.866 -1.146 . . . . 2.67 110.762 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.86 -53.6 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.949 -1.095 . . . . 0.23 110.891 -178.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 18' ' ' THR . 28.1 m-85 -62.75 -37.33 86.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.907 -1.121 . . . . 0.15 110.211 -178.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -61.46 -40.52 94.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.875 -1.14 . . . . 2.07 109.338 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.84 -43.3 72.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.818 -1.176 . . . . 1.84 108.31 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.562 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 63.8 t80 -59.99 -49.49 77.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.662 -0.866 . . . . 0.3 108.662 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.63 93.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.575 -0.703 . . . . 0.25 109.417 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -60.05 -41.17 91.73 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.829 -0.804 . . . . 1.23 108.829 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.94 -23.1 67.23 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.352 -0.843 . . . . 1.29 109.112 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.562 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 81.2 m-20 -97.11 8.39 44.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.64 109.974 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.04 32.32 69.49 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.942 -1.123 . . . . 0.72 111.004 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.8 t -109.99 124.92 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.996 -1.297 . . . . 0.4 109.089 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 32.7 p-10 -152.23 100.67 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.062 -1.024 . . . . 1.33 110.34 179.21 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 -130.19 1.37 Allowed Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.204 -1.474 . . . . 0.26 111.044 -178.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -89.94 125.2 35.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.916 -1.344 . . . . 2.07 110.359 -178.291 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -102.53 136.54 42.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.13 110.115 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -136.19 149.58 48.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.982 -1.118 . . . . 0.22 107.982 178.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -137.47 136.22 37.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.239 -0.913 . . . . 0.12 109.958 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -114.52 111.25 21.09 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.854 -0.795 . . . . 0.24 108.854 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 49.5 t0 -67.37 -28.84 68.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 1.16 110.234 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.12 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.3 110.376 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 p -105.95 -0.04 25.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.42 109.765 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 68.9 mttm 50.03 41.44 23.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 2.16 108.42 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.98 133.2 55.62 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.571 0.7 . . . . 0.28 110.366 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.0 139.43 36.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.393 -1.336 . . . . 0.09 107.393 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.2 m -130.04 131.86 45.98 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.759 -1.213 . . . . 0.14 108.476 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.62 129.15 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.61 -0.885 . . . . 0.12 108.61 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -124.01 129.94 51.76 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.471 0.653 . . . . 0.29 110.272 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.029 -0.986 . . . . 1.95 109.48 -179.7 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.6 mtp . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.033 -0.728 . . . . 2.91 109.033 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 m -92.44 133.85 35.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 0.31 109.446 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.94 147.58 43.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.722 -0.844 . . . . 0.19 108.722 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -118.24 143.61 46.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 1.98 109.441 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.23 130.0 55.24 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.103 -0.703 . . . . 0.13 109.103 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 122.58 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.919 -1.512 . . . . 0.36 106.919 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 54' ' ' VAL . 86.0 mt -103.2 116.73 33.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.25 110.543 -178.434 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -116.96 69.38 0.75 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.732 -1.21 . . . . 0.18 107.732 178.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 168.6 47.71 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.529 -1.429 . . . . 0.24 109.529 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.73 -38.91 84.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 2.71 109.172 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.3 p -117.2 -21.0 9.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.62 -0.675 . . . . 0.92 110.056 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -106.8 120.0 40.83 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.35 -0.844 . . . . 0.6 109.45 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.57 133.61 42.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 2.02 109.055 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.48 -170.28 43.38 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.075 -1.536 . . . . 0.24 110.644 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.85 155.89 42.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.661 -0.906 . . . . 1.68 108.98 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -151.87 169.28 22.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.468 -0.77 . . . . 0.34 109.291 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.9 p -138.86 159.69 41.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.258 -0.901 . . . . 0.21 109.544 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 12.6 t -156.38 160.81 39.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.977 -0.749 . . . . 0.23 108.977 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.97 134.05 44.54 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.543 -0.91 . . . . 2.22 108.543 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.3 139.18 24.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.055 -1.028 . . . . 0.39 109.23 -179.407 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.91 -26.7 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.55 109.495 -179.596 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -157.12 170.72 21.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.16 109.734 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.7 83.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.546 -0.721 . . . . 0.26 110.105 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.55 -36.47 61.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.892 -1.13 . . . . 0.29 110.016 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.429 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 11.8 p -73.7 -34.81 65.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.627 -1.296 . . . . 0.44 109.564 178.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.09 92.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.384 -0.822 . . . . 0.18 109.05 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.26 -44.62 79.88 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.679 -1.209 . . . . 1.06 109.131 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' NZ ' ' CB ' ' A' ' 28' ' ' LYS . 8.6 mtpm? -67.23 -41.64 85.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.319 -0.863 . . . . 2.67 110.573 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.59 -51.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.23 110.503 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CZ ' HG22 ' A' ' 18' ' ' THR . 33.1 m-85 -67.46 -39.92 85.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.944 -1.098 . . . . 0.15 110.736 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -61.96 -42.37 99.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.725 -1.234 . . . . 2.07 109.612 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -69.14 -41.8 76.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.112 -0.993 . . . . 1.84 108.441 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.564 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.6 t80 -60.05 -48.41 81.83 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.569 0.7 . . . . 0.3 109.175 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.53 97.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.579 -0.701 . . . . 0.25 109.31 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.06 -41.77 93.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.834 . . . . 1.23 109.011 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.83 -25.13 67.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 1.29 109.757 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.564 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.2 m-20 -96.79 10.02 40.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.139 -0.976 . . . . 0.64 110.189 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.62 34.04 87.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.975 -1.25 . . . . 0.72 109.975 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.89 126.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.242 -1.152 . . . . 0.4 109.498 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -142.63 150.12 39.84 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 1.33 108.806 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.77 -148.16 12.07 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 118.746 -1.692 . . . . 0.26 110.489 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -90.99 129.42 37.0 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.358 -0.979 . . . . 2.07 108.358 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.32 137.11 39.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.13 110.025 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -134.45 149.49 50.75 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.133 -1.062 . . . . 0.22 108.133 179.029 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.416 ' CD1' ' CE1' ' A' ' 52' ' ' PHE . 43.2 t80 -132.78 134.59 44.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.303 -0.873 . . . . 0.12 110.228 -178.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -112.81 109.85 19.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.801 -0.814 . . . . 0.24 108.801 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.6 -31.03 69.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.923 . . . . 1.16 110.513 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.95 94.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.3 110.437 -179.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -106.91 0.85 24.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.455 -0.778 . . . . 0.42 110.43 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 50.18 40.11 21.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.909 -1.119 . . . . 2.16 108.435 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 130.87 54.95 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.536 0.684 . . . . 0.28 110.648 -178.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CE1' ' CD1' ' A' ' 45' ' ' TYR . 68.6 m-85 -99.65 141.11 32.88 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.628 -1.249 . . . . 0.09 107.628 178.102 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 m -130.48 131.39 45.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.807 -1.183 . . . . 0.14 108.451 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 7' ' ' LEU . 2.4 p -123.37 130.3 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.365 -0.976 . . . . 0.12 108.365 179.537 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.4 m -119.97 126.28 50.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.498 -0.752 . . . . 0.29 109.778 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.973 -1.013 . . . . 1.95 109.546 -179.863 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 21' ' ' VAL . 61.7 mtt . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.304 0.573 . . . . 2.91 109.458 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.7 m -90.88 132.71 35.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.31 109.233 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -114.95 146.54 41.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.537 -0.912 . . . . 0.19 108.537 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -117.36 140.81 49.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.748 -0.834 . . . . 1.98 108.748 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' A' ' 30' ' ' PHE . 37.2 tp -118.92 129.31 55.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.842 -0.799 . . . . 0.13 108.842 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.9 mt -106.17 122.39 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.487 -1.301 . . . . 0.36 107.487 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.37 112.88 25.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.25 109.185 -179.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.67 71.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.687 -1.227 . . . . 0.18 107.687 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.09 165.57 43.51 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.492 -1.443 . . . . 0.24 109.492 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.456 ' HZ3' ' C ' ' A' ' 56' ' ' GLU . 10.5 mptt -68.07 -35.29 77.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.192 -1.181 . . . . 2.71 107.872 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -117.67 -25.55 6.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.746 -0.596 . . . . 0.92 110.077 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 tp -101.56 122.2 43.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.151 -0.968 . . . . 0.6 109.733 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -136.48 130.74 33.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.225 -0.922 . . . . 2.02 109.618 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.62 -172.72 45.69 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.531 -1.319 . . . . 0.24 110.499 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.11 156.28 42.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.598 -0.942 . . . . 1.68 109.285 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -153.15 170.66 19.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 0.34 109.247 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.7 p -137.84 159.95 40.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.329 -0.857 . . . . 0.21 109.397 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -156.25 160.17 39.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.23 109.624 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.78 134.31 47.3 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.251 -1.018 . . . . 2.22 108.251 179.089 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.01 144.2 26.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.39 109.417 -179.354 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' SD ' ' A' ' 1' ' ' MET . 33.5 m -60.31 -31.11 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.55 109.859 -179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -158.81 176.47 12.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 1.16 110.175 -179.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.58 -38.85 84.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.26 109.723 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.79 -38.05 64.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.29 109.772 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m -70.02 -39.8 75.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.665 -1.272 . . . . 0.44 109.994 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.501 -0.749 . . . . 0.18 109.301 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -57.88 -40.99 81.58 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.458 -1.297 . . . . 1.06 109.088 -179.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -69.89 -43.32 72.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 2.67 109.864 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.94 -52.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.23 111.072 -178.326 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD1' HD22 ' A' ' 5' ' ' LEU . 25.8 m-85 -62.86 -39.35 94.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.15 110.286 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -60.59 -44.54 96.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.75 -1.218 . . . . 2.07 109.604 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.96 -45.06 78.9 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.113 -0.992 . . . . 1.84 108.424 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.8 t80 -59.96 -48.89 79.86 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.63 -0.669 . . . . 0.3 109.262 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.36 96.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.25 109.274 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.0 -41.56 92.38 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.384 -0.969 . . . . 1.23 108.384 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.4 -22.56 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.4 -0.813 . . . . 1.29 109.006 179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.8 m-20 -96.71 9.43 41.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.64 109.703 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 33.51 87.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.836 -1.306 . . . . 0.72 109.836 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.95 130.01 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.412 -1.052 . . . . 0.4 110.214 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 71.9 m-20 -111.61 -95.03 0.43 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.525 -1.287 . . . . 1.33 107.525 178.095 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.91 164.42 3.5 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.486 -0.759 . . . . 0.26 111.962 177.202 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.1 mp0 -75.43 137.69 41.16 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.107 -1.442 . . . . 2.07 107.107 178.208 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -100.07 135.26 41.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.13 110.829 -178.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -136.67 150.57 48.56 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.11 -1.07 . . . . 0.22 108.11 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -135.77 137.89 42.09 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.174 -0.954 . . . . 0.12 110.609 -178.543 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -112.8 110.05 19.92 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.947 -0.76 . . . . 0.24 108.947 179.345 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 42.2 t0 -66.7 -32.71 74.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 1.16 110.47 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.95 95.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.031 -1.043 . . . . 0.3 110.315 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -106.76 -0.13 23.73 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.423 -0.798 . . . . 0.42 110.557 -179.304 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 49.51 41.23 20.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.838 -1.164 . . . . 2.16 108.697 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.01 130.64 55.78 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.612 0.72 . . . . 0.28 110.13 -178.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -98.81 138.66 35.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.369 -1.345 . . . . 0.09 107.369 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -130.56 131.74 45.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.77 -1.206 . . . . 0.14 108.391 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.178 -1.045 . . . . 0.12 108.178 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.66 126.57 51.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.507 -0.745 . . . . 0.29 110.123 -179.002 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' C ' ' HZ3' ' A' ' 10' ' ' LYS . 54.5 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.849 -1.072 . . . . 1.95 109.118 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.268 0.556 . . . . 2.91 109.754 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.8 m -88.42 132.17 34.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.31 108.72 179.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -114.8 143.12 45.59 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.74 -0.837 . . . . 0.19 108.74 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -115.7 140.33 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.854 -0.795 . . . . 1.98 108.854 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' CD1' ' A' ' 30' ' ' PHE . 43.1 tp -117.7 127.81 54.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.747 -0.834 . . . . 0.13 108.747 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.29 121.86 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.692 -1.596 . . . . 0.36 106.692 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -100.02 110.52 22.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.036 -1.04 . . . . 0.25 108.966 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -114.07 68.33 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.649 -1.612 . . . . 0.18 106.649 178.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 171.03 54.75 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.679 -1.368 . . . . 0.24 109.679 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.66 -39.42 94.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.023 -1.103 . . . . 2.71 108.023 178.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 p -125.05 -13.96 6.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.177 -0.465 . . . . 0.92 109.787 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.5 tp -98.13 119.96 37.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.156 -0.965 . . . . 0.6 109.043 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -133.29 126.54 31.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.351 -0.843 . . . . 2.02 109.427 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -176.22 47.88 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.559 -1.305 . . . . 0.24 110.243 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.52 156.4 42.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.714 -0.874 . . . . 1.68 108.669 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -154.93 170.72 21.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.365 -0.834 . . . . 0.34 109.632 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.9 p -136.81 158.9 43.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.21 109.235 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.4 t -154.73 160.23 41.2 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.486 -0.931 . . . . 0.23 108.486 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.94 133.56 48.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 2.22 109.467 -179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.05 143.1 25.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.942 . . . . 0.39 108.825 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.55 -26.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.55 109.859 -179.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -159.49 176.31 12.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.056 -1.028 . . . . 1.16 109.87 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.31 80.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.521 -0.737 . . . . 0.26 110.095 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.3 63.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.917 -1.114 . . . . 0.29 110.053 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.595 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 17.9 p -72.23 -36.16 69.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.536 -1.352 . . . . 0.44 109.862 179.205 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.07 91.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.748 . . . . 0.18 108.994 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.12 -50.01 72.28 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.897 -1.121 . . . . 1.06 110.024 -178.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -65.15 -40.15 93.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.883 -1.136 . . . . 2.67 110.826 -179.178 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.0 t -69.94 -54.04 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.23 111.586 -178.273 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 5' ' ' LEU . 33.0 m-85 -64.03 -39.51 94.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.942 -1.099 . . . . 0.15 111.284 -178.46 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.76 -40.06 96.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.809 -1.182 . . . . 2.07 109.957 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -69.41 -42.66 74.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.713 -1.242 . . . . 1.84 109.145 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.612 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.9 t80 -59.98 -46.01 90.84 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.879 . . . . 0.3 108.628 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.9 97.82 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.855 -0.795 . . . . 0.25 108.855 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -60.08 -44.84 94.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.492 -0.755 . . . . 1.23 109.741 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.32 -23.96 67.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 1.29 109.85 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.612 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 65.5 m-20 -96.44 7.48 46.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -0.963 . . . . 0.64 109.554 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.69 31.79 73.69 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.804 -1.189 . . . . 0.72 110.158 179.117 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.43 125.99 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.19 -1.182 . . . . 0.4 109.531 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 57.6 t0 -140.77 146.54 37.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.264 -1.013 . . . . 1.33 108.264 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.63 -153.03 16.52 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.171 -1.49 . . . . 0.26 110.134 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.59 134.35 34.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -1.053 . . . . 2.07 108.442 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -101.48 135.96 42.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 0.13 110.296 -179.42 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.2 p -135.0 149.11 50.13 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.324 -0.991 . . . . 0.22 108.324 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 69.6 t80 -135.35 136.2 41.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.376 -0.828 . . . . 0.12 110.098 -178.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -112.77 109.97 19.79 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.685 -0.857 . . . . 0.24 108.685 179.18 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.9 t0 -65.62 -31.34 72.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 1.16 110.47 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.138 -0.976 . . . . 0.3 110.372 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.8 p -106.62 -0.09 24.02 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.337 -0.852 . . . . 0.42 110.559 -179.036 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 50.01 41.25 22.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.745 -1.222 . . . . 2.16 108.361 -179.417 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.99 130.94 54.99 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.708 0.766 . . . . 0.28 110.391 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 58.7 m-85 -99.62 139.97 34.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.271 -1.381 . . . . 0.09 107.271 178.178 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.0 m -130.43 131.53 45.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.672 -1.268 . . . . 0.14 108.037 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.1 p -122.21 128.97 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.045 -1.094 . . . . 0.12 108.045 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.8 m -119.96 127.97 53.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.29 109.984 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.004 -0.998 . . . . 1.95 109.626 -179.316 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' ' NZ ' ' A' ' 50' ' ' LYS . 54.4 mtt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.31 0.576 . . . . 2.91 109.608 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.3 m -92.59 132.89 36.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.31 108.917 179.425 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.73 150.04 40.44 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.129 -0.693 . . . . 0.19 109.129 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' A' ' 15' ' ' GLU . 52.9 tttm -118.6 143.69 46.63 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.571 -0.706 . . . . 1.98 109.717 -179.031 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.0 tp -119.22 127.45 53.28 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.714 -0.847 . . . . 0.13 108.714 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.25 122.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.945 -1.502 . . . . 0.36 106.945 178.523 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.0 mt -103.24 111.6 24.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.92 . . . . 0.25 109.873 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.5 71.55 0.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.267 -1.383 . . . . 0.18 107.267 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 165.61 49.33 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.367 -1.493 . . . . 0.24 109.367 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -67.83 -36.86 81.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.218 -1.166 . . . . 2.71 108.421 178.246 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.6 m -120.73 -22.19 6.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.913 -0.492 . . . . 0.92 109.787 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.1 tp -104.69 120.48 41.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.328 -0.858 . . . . 0.6 109.421 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -132.86 133.58 43.49 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.348 -0.845 . . . . 2.02 109.896 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.3 -176.24 47.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.438 -1.363 . . . . 0.24 110.604 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.3 pm0 -147.19 155.67 42.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.719 -0.871 . . . . 1.68 108.969 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 t -154.86 170.25 22.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.34 109.675 -179.586 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -134.89 158.3 44.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.483 -0.761 . . . . 0.21 109.031 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.3 t -154.46 158.7 40.34 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.65 -0.871 . . . . 0.23 108.65 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 56.6 mp0 -102.58 134.1 46.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.214 -0.929 . . . . 2.22 109.185 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.8 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.19 143.45 27.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.112 -0.992 . . . . 0.39 108.774 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.06 -28.24 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.55 109.251 -179.273 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -158.74 176.93 11.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 1.16 109.912 -179.739 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.5 84.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.26 109.879 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.29 -37.72 62.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.04 -1.037 . . . . 0.29 110.212 -179.486 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.8 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 12.1 p -71.55 -35.94 70.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.546 -1.346 . . . . 0.44 109.59 179.052 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.52 89.76 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.351 -0.843 . . . . 0.18 108.865 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.9 -49.99 74.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.987 -1.085 . . . . 1.06 110.133 -178.852 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -66.65 -42.53 86.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 2.67 110.623 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.3 t -69.67 -53.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.983 . . . . 0.23 110.713 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CZ ' HG22 ' A' ' 18' ' ' THR . 16.6 m-85 -61.03 -37.96 84.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.917 -1.114 . . . . 0.15 109.512 -179.406 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.06 -43.51 95.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 2.07 110.009 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.41 -42.31 79.15 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 1.84 108.677 179.598 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.596 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -48.69 80.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.3 110.087 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.95 93.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.25 109.657 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -61.39 -39.95 92.58 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 1.23 109.202 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -62.28 -24.66 67.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 1.29 109.959 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.596 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 98.5 m-20 -96.35 8.79 43.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.007 . . . . 0.64 110.09 -179.227 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.82 31.71 81.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.441 -1.464 . . . . 0.72 109.441 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.6 t -107.47 126.3 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -1.084 . . . . 0.4 109.302 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -140.11 147.47 40.29 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.093 -1.077 . . . . 1.33 108.093 179.391 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.59 -154.25 19.52 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.227 -1.463 . . . . 0.26 109.943 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 38.4 mp0 -87.76 132.83 34.01 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.217 -1.031 . . . . 2.07 108.217 179.061 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -99.93 135.51 41.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 0.13 110.098 -179.302 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.2 p -136.73 150.04 48.19 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.22 108.523 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 58.7 t80 -133.48 133.63 42.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.412 -0.805 . . . . 0.12 109.812 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -111.21 107.76 17.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.485 -0.931 . . . . 0.24 108.485 179.339 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.96 -30.67 70.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 1.16 110.045 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.45 98.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.3 109.87 -179.681 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 p -104.74 1.06 28.91 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.48 -0.762 . . . . 0.42 109.887 -179.703 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 91.6 mttt 50.03 39.9 20.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 2.16 108.554 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.4 m -120.03 134.35 55.27 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.474 0.654 . . . . 0.28 110.831 -178.371 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 53.1 m-85 -99.82 139.25 35.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.09 107.271 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -131.29 130.68 43.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.561 -1.337 . . . . 0.14 108.6 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.28 127.69 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.788 -1.189 . . . . 0.12 107.788 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.1 m -120.01 127.13 52.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.452 -0.78 . . . . 0.29 109.728 -179.382 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.037 -0.982 . . . . 1.95 109.45 -179.682 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.208 -0.664 . . . . 2.91 109.208 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.6 m -89.44 134.72 33.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.089 -1.007 . . . . 0.31 109.641 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -114.96 147.43 40.05 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.869 -0.789 . . . . 0.19 108.869 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -119.73 141.46 49.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.482 -0.761 . . . . 1.98 109.465 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 30' ' ' PHE . 45.7 tp -120.65 129.85 53.88 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.915 -0.772 . . . . 0.13 108.915 179.436 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.53 124.83 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.806 -1.183 . . . . 0.36 107.806 178.462 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.5 mt -102.06 114.58 28.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 0.25 110.012 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.57 68.52 0.7 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.339 -1.356 . . . . 0.18 107.339 178.357 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.99 49.15 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.742 -1.343 . . . . 0.24 109.742 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -67.05 -37.55 84.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.368 -1.078 . . . . 2.71 108.157 178.231 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 m -119.55 -22.9 6.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.939 -0.475 . . . . 0.92 110.104 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 tp -101.59 120.27 40.06 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.18 -0.95 . . . . 0.6 109.649 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -132.12 128.67 38.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.02 109.211 179.335 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.45 -173.88 46.59 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.185 -1.484 . . . . 0.24 110.608 179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.4 pm0 -150.26 159.56 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.625 -0.927 . . . . 1.68 109.442 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 t -152.62 170.01 21.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.521 -0.737 . . . . 0.34 109.269 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -136.54 158.44 44.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.245 -0.91 . . . . 0.21 109.081 -179.651 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 t -156.55 161.9 39.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.357 -0.839 . . . . 0.23 109.061 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -101.26 132.29 46.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.317 -0.994 . . . . 2.22 108.317 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.48 142.17 26.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.39 109.551 -179.5 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.58 -30.36 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.55 110.603 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -158.58 179.4 9.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.931 -1.106 . . . . 1.16 110.295 -179.266 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.93 75.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.55 -0.719 . . . . 0.26 110.539 -179.111 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.66 65.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.776 -1.203 . . . . 0.29 109.866 -179.164 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -70.53 -39.95 73.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.741 -1.224 . . . . 0.44 109.846 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.96 92.15 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.532 -0.73 . . . . 0.18 109.258 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.82 -43.22 94.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.745 -1.182 . . . . 1.06 110.105 -179.129 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -69.73 -42.69 73.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.26 -0.9 . . . . 2.67 110.69 -179.24 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.61 -53.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.23 111.173 -178.232 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' HD22 ' A' ' 5' ' ' LEU . 32.3 m-85 -60.23 -35.84 76.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.019 -1.051 . . . . 0.15 109.864 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.13 -41.51 92.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.897 -1.127 . . . . 2.07 108.915 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -68.47 -44.82 73.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.094 -1.003 . . . . 1.84 108.755 179.372 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.661 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 66.1 t80 -60.34 -48.2 82.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.3 109.489 179.673 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.41 97.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.25 109.244 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -60.12 -39.94 88.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.229 -0.92 . . . . 1.23 108.538 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.87 -23.81 67.5 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.467 -0.771 . . . . 1.29 109.286 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.661 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.6 m-20 -96.77 6.31 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.09 -1.006 . . . . 0.64 109.46 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.06 33.23 78.4 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.864 -1.16 . . . . 0.72 110.259 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.0 t -111.16 125.38 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.091 -1.241 . . . . 0.4 108.918 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 69.6 m-20 -152.25 103.62 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.984 -1.073 . . . . 1.33 110.993 179.737 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.03 -130.13 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.557 -1.306 . . . . 0.26 110.907 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 42.2 mp0 -93.99 130.98 39.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.937 -1.331 . . . . 2.07 110.141 -178.516 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -104.09 139.3 39.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.672 -0.643 . . . . 0.13 110.244 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 p -134.31 147.77 50.65 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.963 -1.125 . . . . 0.22 107.963 178.838 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 60.3 t80 -135.84 135.16 39.57 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.188 -0.945 . . . . 0.12 110.211 -178.685 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -112.97 110.28 20.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.921 -0.77 . . . . 0.24 108.921 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 63.5 t0 -65.06 -31.83 73.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 1.16 110.528 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.99 92.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.3 110.616 -179.185 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -104.81 -0.69 26.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.42 110.554 -179.04 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 50.02 40.02 20.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.817 -1.177 . . . . 2.16 108.156 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.9 m -120.02 131.2 55.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.672 0.749 . . . . 0.28 110.282 -178.2 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m-85 -98.62 138.9 35.13 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.504 -1.295 . . . . 0.09 107.504 178.435 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -131.77 131.07 42.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.697 -1.252 . . . . 0.14 107.791 179.154 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.02 129.86 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.288 -1.005 . . . . 0.12 108.288 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -121.65 125.85 47.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.569 -0.707 . . . . 0.29 109.729 -179.232 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 27.1 mp0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.915 -1.04 . . . . 1.95 109.502 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.224 0.535 . . . . 0.34000000000000002 110.234 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.15 144.34 42.84 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.167 -1.42 . . . . 0.34999999999999998 107.167 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -115.56 140.03 49.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.37 -0.831 . . . . 2.1899999999999999 110.358 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.1 tp -120.14 129.98 54.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.723 -0.611 . . . . 0.17000000000000001 109.67 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.1 mt -107.77 125.21 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.632 -1.247 . . . . 0.65000000000000002 107.632 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.8 mt -103.87 115.44 30.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.255 -0.903 . . . . 0.25 111.03 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -111.59 59.78 0.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.53 -0.915 . . . . 1.76 108.53 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.98 165.48 53.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.23 -1.548 . . . . 0.20999999999999999 109.23 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -63.75 -39.98 95.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.881 -1.364 . . . . 2.7799999999999998 108.221 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -118.5 -20.01 8.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.11 -0.7 . . . . 1.3799999999999999 109.11 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.7 tp -98.23 118.19 34.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.518 -0.739 . . . . 0.47999999999999998 109.223 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.83 126.8 35.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.287 -1.005 . . . . 2.1699999999999999 108.287 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.84 -177.96 48.34 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 118.988 -1.577 . . . . 0.20999999999999999 109.921 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -148.07 157.67 43.64 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.455 -0.943 . . . . 2.3700000000000001 108.455 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -156.36 167.48 30.29 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.314 -0.866 . . . . 0.19 108.757 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 p -133.65 161.02 35.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.346 -0.846 . . . . 0.26000000000000001 109.169 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.9 t -156.35 162.29 40.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 0.19 109.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.87 135.48 44.46 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.574 -0.899 . . . . 2.75 108.574 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.541 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.46 140.78 23.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.16 108.601 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.01 -26.42 35.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.364 -0.835 . . . . 0.28000000000000003 109.806 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -159.94 176.59 11.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 1.0900000000000001 109.739 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.74 -32.52 72.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.22 109.796 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.19 77.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.23000000000000001 109.961 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.541 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 2.4 p -70.15 -35.5 74.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 1.24 109.12 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.02 87.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.16 108.8 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.14 -49.82 72.85 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.226 -0.99 . . . . 1.1200000000000001 109.192 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -63.84 -43.66 95.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.784 -1.197 . . . . 2.4500000000000002 111.897 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.68 -54.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.27000000000000002 110.503 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 5' ' ' LEU . 28.3 m-85 -63.8 -39.71 94.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.948 -1.095 . . . . 0.23000000000000001 110.531 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -60.52 -45.68 92.95 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.375 -0.828 . . . . 2.8799999999999999 109.252 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -67.33 -43.61 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.576 -0.898 . . . . 2.0099999999999998 108.576 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.7 t80 -59.98 -46.56 89.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.744 . . . . 0.37 109.033 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.72 94.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.846 -0.798 . . . . 0.25 108.846 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.0 -45.04 95.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.026 -0.731 . . . . 1.97 109.026 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.66 -25.3 66.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 1.1399999999999999 109.701 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 71.1 m-20 -95.92 6.72 48.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.196 -0.94 . . . . 1.1699999999999999 109.713 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.23 37.61 91.22 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.079 -1.058 . . . . 0.29999999999999999 110.46 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.91 122.26 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.297 -1.119 . . . . 0.32000000000000001 109.876 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -132.93 136.95 46.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.27 -1.381 . . . . 2.1899999999999999 107.27 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.44 -156.48 16.22 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.87 -1.634 . . . . 0.67000000000000004 109.647 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -91.82 128.55 37.69 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.955 -1.128 . . . . 2.2200000000000002 107.955 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.69 133.62 40.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.20999999999999999 110.453 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.5 p -131.68 147.9 52.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.966 -1.124 . . . . 0.23999999999999999 107.966 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.44 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 62.1 t80 -134.76 135.86 42.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.32000000000000001 109.966 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -112.04 109.48 19.25 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.28000000000000003 108.711 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 48.2 t0 -66.35 -32.71 74.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 1.1200000000000001 110.254 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -43.86 94.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.26000000000000001 110.079 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.9 p -102.62 0.41 33.23 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.213 -0.93 . . . . 0.27000000000000002 110.537 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mttm 50.12 40.5 21.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.859 -1.151 . . . . 2.3599999999999999 108.985 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.3 m -118.84 130.01 55.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.647 0.737 . . . . 0.14999999999999999 109.975 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 55.1 m-85 -97.65 137.01 37.21 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.078 -1.453 . . . . 0.17000000000000001 107.078 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.1 m -129.51 134.15 47.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.823 -1.173 . . . . 0.14000000000000001 108.614 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.8 p -125.35 129.99 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.142 -1.059 . . . . 0.20000000000000001 108.142 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -121.98 127.81 50.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.448 -0.782 . . . . 0.28999999999999998 110.218 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.995 -1.002 . . . . 2.3399999999999999 108.585 179.243 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.246 -0.65 . . . . 0.31 109.246 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.29 146.49 39.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.5 -0.926 . . . . 0.19 108.5 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.12 141.93 46.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.362 -0.836 . . . . 1.98 109.032 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 30' ' ' PHE . 22.6 tp -120.1 126.23 50.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.708 -0.849 . . . . 0.13 108.708 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.26 123.41 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.164 -1.421 . . . . 0.35999999999999999 107.164 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.472 HD23 HG12 ' A' ' 54' ' ' VAL . 93.6 mt -102.38 114.11 28.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.286 -0.884 . . . . 0.25 110.092 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -114.66 68.59 0.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.124 -1.436 . . . . 0.17999999999999999 107.124 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.1 165.15 48.66 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.813 -1.315 . . . . 0.23999999999999999 109.813 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -66.91 -35.36 79.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.499 -1.297 . . . . 2.71 107.499 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -119.83 -23.19 6.53 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.252 -0.648 . . . . 0.92000000000000004 109.252 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 9' ' ' GLY . 54.2 tp -98.35 121.48 40.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.59999999999999998 109.269 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -136.89 126.78 25.77 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.179 -0.951 . . . . 2.02 109.638 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.44 -168.31 41.43 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.636 -1.269 . . . . 0.23999999999999999 110.196 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -149.3 159.36 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.974 . . . . 1.6799999999999999 109.655 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -151.94 167.35 28.64 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.732 -0.84 . . . . 0.34000000000000002 108.732 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -138.03 159.65 41.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.20999999999999999 109.278 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -154.93 159.96 40.81 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.714 -0.847 . . . . 0.23000000000000001 108.714 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -102.22 132.91 47.86 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.53 -0.915 . . . . 2.2200000000000002 108.53 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.69 144.57 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.105 -0.997 . . . . 0.39000000000000001 109.477 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.86 -29.7 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.489 -0.757 . . . . 0.55000000000000004 110.368 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -158.02 175.66 13.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.91 -1.119 . . . . 1.1599999999999999 110.181 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.89 80.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.536 -0.727 . . . . 0.26000000000000001 110.033 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.28 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.91 -1.119 . . . . 0.28999999999999998 110.008 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 p -74.21 -34.89 63.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.726 -1.234 . . . . 0.44 109.827 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.0 92.26 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.807 -0.812 . . . . 0.17999999999999999 108.807 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.51 -49.02 73.7 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.964 -1.095 . . . . 1.0600000000000001 109.904 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.59 -40.04 92.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.261 -0.899 . . . . 2.6699999999999999 110.506 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.9 -53.1 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.149 -0.969 . . . . 0.23000000000000001 110.662 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.551 ' CD1' HD22 ' A' ' 5' ' ' LEU . 35.6 m-85 -66.72 -39.5 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 0.14999999999999999 110.596 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -60.42 -42.27 95.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.745 -1.222 . . . . 2.0699999999999998 108.819 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -67.56 -43.63 80.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 1.8400000000000001 108.948 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 65.5 t80 -60.03 -44.87 94.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.504 -0.748 . . . . 0.29999999999999999 109.311 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.67 96.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.332 -0.855 . . . . 0.25 109.229 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -61.9 -42.36 98.98 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.363 -0.836 . . . . 1.23 109.101 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.21 -26.62 67.85 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.095 -1.003 . . . . 1.29 109.304 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.447 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 5.0 m120 -97.59 9.05 43.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.64000000000000001 110.027 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.72 81.79 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.884 -1.15 . . . . 0.71999999999999997 110.456 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.3 t -106.91 127.89 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.183 -1.186 . . . . 0.40000000000000002 109.738 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -137.67 145.3 42.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.668 -1.234 . . . . 1.3300000000000001 107.668 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.91 -156.19 21.07 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.875 -1.631 . . . . 0.26000000000000001 110.334 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.64 131.11 36.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.579 -0.897 . . . . 2.0699999999999998 108.579 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -101.08 136.54 40.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.13 110.545 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.5 p -133.9 148.77 51.27 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.771 -1.196 . . . . 0.22 107.771 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.12 134.32 42.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 0.12 110.205 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -111.49 108.28 17.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.328 -0.99 . . . . 0.23999999999999999 108.328 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -67.27 -29.8 69.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 1.1599999999999999 109.865 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.9 91.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.361 -0.837 . . . . 0.29999999999999999 110.306 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.2 p -104.84 0.0 27.61 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.357 -0.84 . . . . 0.41999999999999998 109.992 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 50.04 39.89 20.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 2.1600000000000001 108.173 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -119.93 132.13 55.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.404 0.621 . . . . 0.28000000000000003 110.712 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -99.3 140.04 34.05 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.486 -1.301 . . . . 0.089999999999999997 107.486 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.6 m -130.62 131.28 44.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.655 -1.278 . . . . 0.14000000000000001 108.706 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD23 ' A' ' 7' ' ' LEU . 4.2 p -122.79 129.65 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.496 -0.927 . . . . 0.12 108.496 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.3 127.74 52.64 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.504 -0.748 . . . . 0.28999999999999998 110.444 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.965 -1.016 . . . . 1.95 109.197 179.813 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.7 m . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.597 -0.52 . . . . 0.31 109.597 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -117.67 145.81 44.14 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.857 -0.794 . . . . 0.19 108.857 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -114.74 144.15 43.93 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.328 -0.857 . . . . 1.98 109.184 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 30' ' ' PHE . 30.6 tp -121.78 128.94 52.27 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.135 -0.691 . . . . 0.13 109.135 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.9 122.3 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.747 -1.205 . . . . 0.35999999999999999 107.747 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -100.69 113.82 27.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.25 109.262 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -116.34 68.73 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.323 -1.362 . . . . 0.17999999999999999 107.323 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 169.3 52.95 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.146 -1.581 . . . . 0.23999999999999999 109.146 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -64.8 -35.75 82.12 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.196 -1.179 . . . . 2.71 107.919 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -124.86 -19.11 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.427 -0.583 . . . . 0.92000000000000004 109.427 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.0 tp -96.09 119.97 35.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.996 . . . . 0.59999999999999998 109.098 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -134.54 125.8 28.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 2.02 109.472 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.93 -178.7 48.64 Favored Glycine 0 N--CA 1.487 2.036 0 C-N-CA 119.556 -1.307 . . . . 0.23999999999999999 110.262 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.54 157.3 43.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.757 -0.849 . . . . 1.6799999999999999 108.929 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.02 170.03 21.43 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.377 -0.827 . . . . 0.34000000000000002 109.281 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 p -135.87 159.17 42.51 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.84 -0.8 . . . . 0.20999999999999999 108.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.5 t -157.61 161.67 38.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.862 . . . . 0.23000000000000001 109.515 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 56.0 mp0 -105.92 135.74 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.836 -0.802 . . . . 2.2200000000000002 108.836 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -150.24 146.4 26.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.39000000000000001 109.118 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.37 -30.1 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.466 -0.771 . . . . 0.55000000000000004 109.569 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -159.46 176.88 11.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 1.1599999999999999 109.584 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -35.3 77.85 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.29 -0.881 . . . . 0.26000000000000001 110.078 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -39.04 59.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.916 -1.115 . . . . 0.28999999999999998 110.273 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.625 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 26.3 p -75.08 -32.14 61.4 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.5 -1.375 . . . . 0.44 109.518 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.68 99.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.264 -0.898 . . . . 0.17999999999999999 108.828 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -56.94 -49.52 75.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.646 -1.222 . . . . 1.0600000000000001 108.998 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -63.54 -44.03 95.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.541 -0.724 . . . . 2.6699999999999999 110.823 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.06 -52.59 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.021 -1.049 . . . . 0.23000000000000001 110.837 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.3 m-85 -61.64 -37.9 85.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.006 . . . . 0.14999999999999999 109.957 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -61.46 -43.04 99.57 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.91 -1.119 . . . . 2.0699999999999998 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.62 -43.97 75.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.904 -1.123 . . . . 1.8400000000000001 109.07 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 57.4 t80 -60.03 -47.84 84.2 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.292 -0.88 . . . . 0.29999999999999999 108.749 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.98 99.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.454 -0.779 . . . . 0.25 109.138 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -59.99 -41.89 93.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.72 -19.78 66.03 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.001 -0.74 . . . . 1.29 109.001 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' OD1' ' CD1' ' A' ' 33' ' ' TYR . 31.0 m120 -95.08 4.31 53.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.64000000000000001 109.96 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.04 32.9 65.61 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.675 -1.25 . . . . 0.71999999999999997 110.087 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.4 t -110.22 122.99 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.184 -1.186 . . . . 0.40000000000000002 108.916 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 31.5 p-10 -148.97 97.65 2.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.915 -1.116 . . . . 1.3300000000000001 110.465 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.06 -130.68 1.37 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.31 -1.424 . . . . 0.26000000000000001 111.342 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.11 132.43 38.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.963 -1.316 . . . . 2.0699999999999998 110.316 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -107.76 139.48 42.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.429 0.633 . . . . 0.13 110.267 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.1 p -136.86 150.27 48.17 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.08 -1.081 . . . . 0.22 108.08 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -134.36 135.9 43.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.272 -0.893 . . . . 0.12 110.643 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -111.94 108.28 17.58 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.166 -1.05 . . . . 0.23999999999999999 108.166 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -67.61 -29.99 69.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 1.1599999999999999 110.366 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.04 93.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.29999999999999999 110.409 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.0 p -105.81 0.02 25.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.37 -0.831 . . . . 0.41999999999999998 110.124 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 mttm 50.33 41.34 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.131 . . . . 2.1600000000000001 108.506 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.95 129.95 54.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.478 0.656 . . . . 0.28000000000000003 110.069 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -98.87 139.64 34.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.679 -1.23 . . . . 0.089999999999999997 107.679 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.5 m -128.7 130.41 47.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.762 -1.211 . . . . 0.14000000000000001 108.437 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.06 129.42 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.285 -1.005 . . . . 0.12 108.285 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -120.96 126.0 48.83 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.114 -0.699 . . . . 0.28999999999999998 109.114 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.071 -0.966 . . . . 1.95 109.729 -179.076 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.483 -0.562 . . . . 0.31 109.483 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.528 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 90.8 m-85 -114.52 145.26 42.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.463 -0.94 . . . . 0.19 108.463 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -115.74 142.72 46.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.392 -0.818 . . . . 1.98 109.453 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 30' ' ' PHE . 40.2 tp -120.98 127.33 51.7 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.969 -0.752 . . . . 0.13 108.969 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.4 123.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.317 -1.364 . . . . 0.35999999999999999 107.317 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.34 112.75 25.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.25 110.168 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -112.1 69.0 0.68 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.765 -1.568 . . . . 0.17999999999999999 106.765 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.78 167.69 50.31 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.59 -1.404 . . . . 0.23999999999999999 109.59 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -67.77 -39.05 84.15 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.414 -1.051 . . . . 2.71 108.524 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 p -120.0 -20.03 7.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.887 -0.508 . . . . 0.92000000000000004 109.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.92 118.55 36.81 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.339 -0.851 . . . . 0.59999999999999998 109.89 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -130.71 131.43 44.79 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.67 0.748 . . . . 2.02 109.15 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.1 -178.96 48.61 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.08 -1.533 . . . . 0.23999999999999999 110.716 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.04 151.13 43.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.451 -0.944 . . . . 1.6799999999999999 108.451 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 t -150.82 165.02 34.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.34000000000000002 108.592 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.1 p -134.38 159.38 41.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 0.20999999999999999 108.97 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -154.41 158.98 40.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.772 -0.825 . . . . 0.23000000000000001 108.772 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.6 132.0 50.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.632 -0.877 . . . . 2.2200000000000002 108.632 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.63 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -147.63 142.94 27.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.05 . . . . 0.39000000000000001 109.093 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.93 -28.82 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.55000000000000004 110.091 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -158.97 177.31 11.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.043 -1.035 . . . . 1.1599999999999999 109.937 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.528 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -65.71 -38.42 89.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.457 -0.777 . . . . 0.26000000000000001 109.591 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.11 -37.76 62.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.082 -1.011 . . . . 0.28999999999999998 110.003 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.63 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 85.4 m -68.82 -39.96 79.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.692 -1.255 . . . . 0.44 109.806 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.02 93.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.246 -0.909 . . . . 0.17999999999999999 109.372 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.17 -53.88 47.32 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.152 -1.019 . . . . 1.0600000000000001 111.595 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -68.51 -36.14 78.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.678 -1.264 . . . . 2.6699999999999999 110.655 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.84 -53.83 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.943 -1.098 . . . . 0.23000000000000001 110.519 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD1' HD22 ' A' ' 5' ' ' LEU . 32.0 m-85 -63.11 -37.42 87.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.14999999999999999 110.433 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.98 -41.47 92.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.834 -1.166 . . . . 2.0699999999999998 109.296 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -68.71 -42.13 78.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 1.8400000000000001 109.102 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.498 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 62.6 t80 -59.95 -46.96 87.73 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.29999999999999999 108.95 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.08 96.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.25 108.958 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.02 -45.62 92.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 1.23 109.159 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -62.28 -24.68 67.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -0.868 . . . . 1.29 109.548 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 7.4 m120 -98.51 7.04 46.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.215 -0.928 . . . . 0.64000000000000001 109.99 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.17 33.62 83.6 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.92 -1.133 . . . . 0.71999999999999997 110.491 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.18 128.39 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.147 -1.208 . . . . 0.40000000000000002 110.539 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.501 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 96.7 m-20 -112.3 -98.62 0.42 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.511 -0.922 . . . . 1.3300000000000001 108.511 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.69 167.53 3.72 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.26000000000000001 112.455 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.5 mp0 -77.21 138.27 39.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.583 -1.266 . . . . 2.0699999999999998 107.583 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -99.91 133.78 43.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.98 . . . . 0.13 110.351 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 p -134.32 148.76 50.81 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.815 -1.18 . . . . 0.22 107.815 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -136.04 136.91 40.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.186 -0.946 . . . . 0.12 110.464 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.82 110.01 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.568 -0.901 . . . . 0.23999999999999999 108.568 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 52.4 t0 -67.94 -30.5 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.927 . . . . 1.1599999999999999 110.461 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.3 93.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.148 -0.97 . . . . 0.29999999999999999 109.892 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.3 p -105.92 -0.28 25.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.51 -0.744 . . . . 0.41999999999999998 110.048 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.408 ' NZ ' ' CZ ' ' A' ' 3' ' ' TYR . 23.6 mtpp 49.98 41.71 23.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 2.1600000000000001 108.401 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.34 131.08 55.66 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.547 0.689 . . . . 0.28000000000000003 110.506 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -100.46 139.88 35.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.455 -1.313 . . . . 0.089999999999999997 107.455 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -131.98 132.51 43.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.817 -1.177 . . . . 0.14000000000000001 108.963 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.8 p -120.3 128.29 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.029 -1.1 . . . . 0.12 108.029 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.1 m -121.36 127.57 51.37 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.359 -0.838 . . . . 0.28999999999999998 110.731 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 67.3 mm-40 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.947 -1.025 . . . . 1.95 109.453 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.233 0.54 . . . . 0.31 110.288 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.06 147.05 39.37 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.848 -1.168 . . . . 0.19 107.848 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -116.05 141.11 48.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 1.98 109.458 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.5 tp -120.66 127.99 52.58 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.742 -0.836 . . . . 0.13 108.742 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.38 123.68 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.215 -1.402 . . . . 0.35999999999999999 107.215 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -103.91 114.36 28.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.25 110.543 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -118.75 68.52 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.132 -1.433 . . . . 0.17999999999999999 107.132 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.531 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . . . -78.67 172.56 55.27 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.672 -1.771 . . . . 0.23999999999999999 108.672 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -66.23 -35.59 80.82 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.841 -1.388 . . . . 2.71 107.929 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -123.95 -18.59 5.92 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.844 -0.535 . . . . 0.92000000000000004 110.288 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 tp -98.94 113.58 25.8 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.015 -1.053 . . . . 0.59999999999999998 109.822 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -126.21 127.28 45.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 2.02 109.317 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.97 -179.84 48.81 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.192 -1.48 . . . . 0.23999999999999999 110.621 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -143.53 153.67 42.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.995 . . . . 1.6799999999999999 108.869 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -152.82 168.5 25.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.34000000000000002 109.065 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.5 p -138.46 160.02 40.61 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.881 -0.785 . . . . 0.20999999999999999 108.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -156.65 162.86 39.82 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.264 -0.898 . . . . 0.23000000000000001 109.188 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -106.48 135.01 48.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.367 -0.833 . . . . 2.2200000000000002 108.917 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.0 145.53 27.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.39000000000000001 108.898 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.42 -29.24 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.55000000000000004 110.266 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -158.51 177.53 11.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.086 -1.009 . . . . 1.1599999999999999 110.172 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.74 82.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.638 -0.664 . . . . 0.26000000000000001 110.287 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.95 -37.08 60.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.833 -1.167 . . . . 0.28999999999999998 109.769 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 p -72.23 -36.88 69.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.668 -1.27 . . . . 0.44 109.605 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.29 90.57 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.656 -0.868 . . . . 0.17999999999999999 108.656 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.21 -50.08 73.98 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.221 -0.991 . . . . 1.0600000000000001 110.196 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -66.29 -40.78 90.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.072 -1.017 . . . . 2.6699999999999999 110.688 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.0 -53.82 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.078 -1.014 . . . . 0.23000000000000001 110.597 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -63.68 -38.09 89.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.14999999999999999 110.678 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -60.08 -44.04 95.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.817 -1.177 . . . . 2.0699999999999998 109.582 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -68.36 -41.44 80.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 1.8400000000000001 108.673 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 58.1 t80 -59.94 -48.33 82.12 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.487 -0.758 . . . . 0.29999999999999999 109.05 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.87 99.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.25 109.096 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 35' ' ' ASN . 1.9 m120 -60.54 -43.33 97.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.292 -0.88 . . . . 1.23 108.897 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -64.25 -22.39 66.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 1.29 109.338 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.582 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 65.8 m-80 -98.46 6.76 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.286 -0.884 . . . . 0.64000000000000001 109.877 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.78 36.21 91.94 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.164 -1.175 . . . . 0.71999999999999997 110.164 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.59 127.42 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.277 -1.131 . . . . 0.40000000000000002 109.935 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.471 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 92.9 m-20 -111.68 -97.15 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.5 -1.296 . . . . 1.3300000000000001 107.5 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.93 166.91 2.06 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-O 122.052 0.807 . . . . 0.26000000000000001 112.407 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.55 139.16 41.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.389 -1.337 . . . . 2.0699999999999998 107.389 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.66 135.48 42.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.13 111.077 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 p -133.4 147.24 51.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.588 -0.893 . . . . 0.22 108.588 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 52.6 t80 -134.63 135.88 42.45 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.242 -0.911 . . . . 0.12 110.186 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 50' ' ' LYS . 55.2 t0 -113.11 109.96 19.67 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.941 -0.762 . . . . 0.23999999999999999 108.941 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 45.8 t0 -68.87 -30.6 69.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.07 -1.019 . . . . 1.1599999999999999 109.966 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.99 94.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.838 . . . . 0.29999999999999999 110.112 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -110.97 -0.15 16.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.651 -0.655 . . . . 0.41999999999999998 109.642 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 46' ' ' ASP . 56.7 mttp 48.9 41.81 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.137 -0.977 . . . . 2.1600000000000001 109.208 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -115.74 131.12 57.03 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.483 0.659 . . . . 0.28000000000000003 109.553 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.5 m-85 -100.61 139.91 35.62 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.092 -1.077 . . . . 0.089999999999999997 108.092 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -132.23 131.98 42.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.671 -1.268 . . . . 0.14000000000000001 108.672 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.0 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.617 -1.253 . . . . 0.12 107.617 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -120.07 126.54 51.02 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.226 -0.921 . . . . 0.28999999999999998 110.293 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 118.03 -0.986 . . . . 1.95 109.231 179.564 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.239 0.542 . . . . 0.31 110.008 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -119.35 146.41 45.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.74 -0.837 . . . . 0.19 108.74 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -116.91 144.82 44.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.409 -0.807 . . . . 1.98 109.804 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.3 tp -118.95 129.8 55.36 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.502 -0.749 . . . . 0.13 109.005 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.43 122.18 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.058 -1.46 . . . . 0.35999999999999999 107.058 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.8 mt -101.76 117.52 35.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.174 -0.954 . . . . 0.25 110.2 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.45 HD22 HG23 ' A' ' 55' ' ' THR . 54.5 t30 -124.59 66.43 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.565 -1.272 . . . . 0.17999999999999999 107.565 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 176.38 54.68 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.497 -1.441 . . . . 0.23999999999999999 109.497 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -66.07 -39.71 90.3 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.15 -1.206 . . . . 2.71 108.668 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -17.39 7.12 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.874 -0.516 . . . . 0.92000000000000004 110.523 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.66 121.9 41.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.025 -1.047 . . . . 0.59999999999999998 109.564 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -135.16 127.59 30.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.393 -0.817 . . . . 2.02 109.417 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -173.77 46.54 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.382 -1.39 . . . . 0.23999999999999999 110.515 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -149.02 156.9 42.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.622 -0.929 . . . . 1.6799999999999999 109.15 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -154.01 170.04 22.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.34000000000000002 109.61 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 p -137.39 159.24 42.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.782 . . . . 0.20999999999999999 109.13 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -157.52 162.7 38.85 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.335 -0.853 . . . . 0.23000000000000001 108.9 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -101.21 133.77 45.27 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.306 -0.998 . . . . 2.2200000000000002 108.306 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -146.88 142.12 27.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.178 -0.951 . . . . 0.39000000000000001 108.949 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.99 -31.24 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.864 . . . . 0.55000000000000004 109.552 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -157.69 179.21 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 1.1599999999999999 110.106 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.15 -38.27 87.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.466 -0.771 . . . . 0.26000000000000001 109.527 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.38 61.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.177 -0.952 . . . . 0.28999999999999998 109.971 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.628 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.5 m -69.94 -40.05 75.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.641 -1.287 . . . . 0.44 109.749 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.64 82.06 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.444 -0.947 . . . . 0.17999999999999999 108.444 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.06 -45.7 71.77 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.687 -1.205 . . . . 1.0600000000000001 108.602 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.07 -46.1 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.64 -0.662 . . . . 2.6699999999999999 110.764 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.27 -52.85 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.286 -0.884 . . . . 0.23000000000000001 111.088 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -67.48 -39.95 85.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.996 -1.065 . . . . 0.14999999999999999 110.551 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.68 -43.06 98.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.55 -1.344 . . . . 2.0699999999999998 109.229 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.5 -44.49 82.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 1.8400000000000001 108.911 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.3 t80 -60.13 -46.46 89.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.421 -0.799 . . . . 0.29999999999999999 109.046 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -45.78 90.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.25 109.33 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.08 -43.93 95.13 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.665 -0.865 . . . . 1.23 108.665 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.07 -20.32 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 1.29 109.05 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.531 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 31.6 m120 -97.76 6.63 47.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.288 -0.883 . . . . 0.64000000000000001 109.897 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.46 32.63 67.94 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.021 -1.085 . . . . 0.71999999999999997 111.184 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.5 t -110.52 124.99 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.03 -1.276 . . . . 0.40000000000000002 109.186 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 73.6 m-20 -150.67 99.78 2.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 1.3300000000000001 110.281 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 -132.24 1.73 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.342 -1.409 . . . . 0.26000000000000001 110.995 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.57 125.62 37.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.851 -1.382 . . . . 2.0699999999999998 110.677 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -103.03 137.08 41.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.672 -0.643 . . . . 0.13 109.515 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -136.1 150.03 48.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.832 -1.173 . . . . 0.22 107.832 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -137.1 137.87 39.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.225 -0.922 . . . . 0.12 110.444 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -112.55 110.07 20.01 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.387 -0.968 . . . . 0.23999999999999999 108.387 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -65.67 -30.92 71.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 1.1599999999999999 110.374 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.15 93.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.29999999999999999 110.272 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -104.33 -0.11 28.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.39 -0.819 . . . . 0.41999999999999998 110.778 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp 50.07 40.21 20.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.758 -1.214 . . . . 2.1600000000000001 108.246 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.97 131.53 55.2 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.633 0.73 . . . . 0.28000000000000003 110.621 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -100.3 140.02 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.346 -1.353 . . . . 0.089999999999999997 107.346 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.1 m -130.8 132.62 45.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.14000000000000001 108.576 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.8 130.1 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.802 -0.814 . . . . 0.12 108.802 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.45 HG23 HD22 ' A' ' 8' ' ' ASN . 79.4 m -128.07 129.78 47.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.484 0.659 . . . . 0.28999999999999998 110.169 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 74.2 mm-40 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.978 -1.01 . . . . 1.95 109.551 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.346 -0.613 . . . . 0.31 109.346 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -117.5 145.45 44.2 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.362 -0.977 . . . . 0.19 108.362 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -113.21 145.35 41.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.343 -0.848 . . . . 1.98 109.647 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.481 HD22 ' CD1' ' A' ' 30' ' ' PHE . 59.1 tp -121.62 127.66 51.08 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.564 -0.71 . . . . 0.13 109.592 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.5 mm -103.54 121.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.621 -1.622 . . . . 0.35999999999999999 106.621 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.2 mt -100.33 111.47 23.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.947 -1.096 . . . . 0.25 109.528 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.54 69.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.543 -1.28 . . . . 0.17999999999999999 107.543 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 163.96 48.1 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.345 -1.502 . . . . 0.23999999999999999 109.345 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -66.8 -37.57 84.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.529 -1.286 . . . . 2.71 107.529 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.2 p -115.16 -22.37 9.5 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.576 -0.527 . . . . 0.92000000000000004 109.576 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 9' ' ' GLY . 19.0 tp -102.29 127.99 49.03 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.342 -0.849 . . . . 0.59999999999999998 109.556 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -139.91 128.1 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 2.02 109.472 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.46 -174.33 46.86 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.107 -1.521 . . . . 0.23999999999999999 110.85 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -147.88 155.69 41.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.717 -0.873 . . . . 1.6799999999999999 109.036 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -153.97 169.36 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 0.34000000000000002 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.3 p -134.48 158.58 43.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.359 -0.838 . . . . 0.20999999999999999 109.439 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 7.7 t -155.38 159.53 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.23000000000000001 109.047 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -103.99 134.12 47.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.249 -0.907 . . . . 2.2200000000000002 108.879 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.12 143.32 27.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.39000000000000001 109.073 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 21' ' ' VAL . 14.3 m -60.39 -28.9 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.55000000000000004 109.741 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -157.53 174.96 14.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.198 -0.938 . . . . 1.1599999999999999 109.894 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.29 83.87 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.26000000000000001 109.874 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.25 -36.22 52.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.941 -1.1 . . . . 0.28999999999999998 109.607 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.553 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 6.1 p -73.45 -34.75 65.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.756 -1.215 . . . . 0.44 109.76 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.88 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.286 -1.005 . . . . 0.17999999999999999 108.286 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -49.91 75.12 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.784 -1.167 . . . . 1.0600000000000001 109.953 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -64.63 -41.43 96.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.747 -1.221 . . . . 2.6699999999999999 110.405 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.55 -53.67 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 0.23000000000000001 110.842 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.6 m-85 -64.41 -39.22 93.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.14999999999999999 111.07 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 67.2 mttm -61.78 -40.29 94.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.237 . . . . 2.0699999999999998 110.156 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -69.45 -43.79 72.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.875 -1.141 . . . . 1.8400000000000001 108.804 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.614 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -60.46 -46.65 89.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.394 -0.816 . . . . 0.29999999999999999 109.53 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.12 94.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.25 109.76 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 31' ' ' LYS . 81.4 m-20 -61.59 -40.07 93.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 1.23 109.369 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.74 -23.96 67.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.183 -0.948 . . . . 1.29 109.532 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.614 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.6 m-20 -95.23 9.92 37.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.216 -0.927 . . . . 0.64000000000000001 109.944 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.71 81.8 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.811 -1.315 . . . . 0.71999999999999997 109.811 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.02 126.12 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.333 -1.098 . . . . 0.40000000000000002 109.999 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 52.0 t0 -141.2 146.09 36.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 1.3300000000000001 107.996 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.11 -150.28 12.13 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.234 -1.46 . . . . 0.26000000000000001 110.206 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -92.05 132.35 36.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.568 -0.96 . . . . 2.0699999999999998 108.525 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -100.38 136.49 40.19 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.246 -0.909 . . . . 0.13 110.331 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 p -138.74 150.41 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.39 -0.967 . . . . 0.22 108.39 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -132.0 136.57 47.38 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.303 -0.873 . . . . 0.12 110.275 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.71 106.23 15.38 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.319 -0.993 . . . . 0.23999999999999999 108.319 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -66.73 -33.73 76.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 1.1599999999999999 110.811 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.33 -40.04 95.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.965 -1.085 . . . . 0.29999999999999999 109.881 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -102.79 0.75 33.24 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.552 -0.718 . . . . 0.41999999999999998 110.277 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp 49.92 41.21 22.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 2.1600000000000001 108.474 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -123.32 137.44 54.84 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.677 0.751 . . . . 0.28000000000000003 110.969 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -100.69 139.25 36.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.383 -1.34 . . . . 0.089999999999999997 107.383 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -130.27 130.76 44.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.653 -1.28 . . . . 0.14000000000000001 108.519 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.51 128.18 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.089 -1.078 . . . . 0.12 108.089 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -120.02 128.31 53.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.28999999999999998 110.214 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.938 -1.03 . . . . 1.95 109.351 -179.69 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.238 0.542 . . . . 0.31 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.82 148.83 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.895 -1.15 . . . . 0.19 107.895 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -116.25 140.52 49.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.103 -0.998 . . . . 1.98 109.081 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 30' ' ' PHE . 26.7 tp -123.17 128.68 50.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.681 -0.637 . . . . 0.13 109.31 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 124.8 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.266 -1.383 . . . . 0.35999999999999999 107.266 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 54' ' ' VAL . 92.4 mt -102.34 115.59 30.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.25 109.029 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -113.37 70.63 0.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.521 -1.289 . . . . 0.17999999999999999 107.521 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.77 167.54 52.92 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.709 -1.756 . . . . 0.23999999999999999 108.709 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -67.24 -37.11 83.01 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.137 -1.214 . . . . 2.71 107.733 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -120.24 -18.73 7.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.153 0.502 . . . . 0.92000000000000004 109.654 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.06 120.01 39.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.235 -0.915 . . . . 0.59999999999999998 109.577 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -132.68 127.54 35.04 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.317 -0.865 . . . . 2.02 109.902 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -175.81 47.65 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.654 -1.26 . . . . 0.23999999999999999 110.257 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.55 158.62 44.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -1.001 . . . . 1.6799999999999999 109.313 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -153.22 170.03 21.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.391 -0.818 . . . . 0.34000000000000002 109.72 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.4 p -137.87 160.04 40.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.8 . . . . 0.20999999999999999 109.317 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.437 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -155.4 159.96 40.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.23000000000000001 109.058 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -107.46 135.19 49.36 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.317 -0.994 . . . . 2.2200000000000002 108.317 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.82 149.92 31.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.39000000000000001 109.677 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.07 -29.08 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.55000000000000004 110.053 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -158.07 171.89 19.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.916 -1.115 . . . . 1.1599999999999999 110.304 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.56 83.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.567 -0.708 . . . . 0.26000000000000001 110.175 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.58 -37.33 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.995 -1.066 . . . . 0.28999999999999998 109.772 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -72.98 -34.59 66.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.682 -1.262 . . . . 0.44 109.638 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.17 90.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.37 -0.974 . . . . 0.17999999999999999 108.37 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.46 -49.18 70.68 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.185 -1.006 . . . . 1.0600000000000001 109.315 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.358 -0.839 . . . . 2.6699999999999999 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.322 -0.861 . . . . 0.23000000000000001 111.346 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CD1' HD22 ' A' ' 5' ' ' LEU . 27.2 m-85 -65.09 -39.9 93.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.83 -1.169 . . . . 0.14999999999999999 111.37 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -63.37 -41.1 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 2.0699999999999998 110.146 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.11 -42.47 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 1.8400000000000001 108.893 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 65.2 t80 -60.14 -46.77 88.54 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.708 -0.849 . . . . 0.29999999999999999 108.708 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.19 99.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.491 -0.756 . . . . 0.25 109.376 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -60.05 -40.84 90.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 1.23 109.15 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.25 -20.01 65.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 1.29 109.424 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 97.9 m-20 -96.56 4.8 51.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.093 -1.004 . . . . 0.64000000000000001 109.992 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.6 36.34 54.13 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.933 -1.127 . . . . 0.71999999999999997 110.959 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.8 t -116.26 122.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.155 -1.203 . . . . 0.40000000000000002 108.559 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 73.9 m-20 -150.28 101.09 2.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -0.961 . . . . 1.3300000000000001 110.818 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 -128.78 1.21 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.438 -1.363 . . . . 0.26000000000000001 110.687 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -94.02 130.32 40.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.896 -1.355 . . . . 2.0699999999999998 110.417 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -103.05 136.19 43.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.715 -0.616 . . . . 0.13 109.541 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.0 p -134.21 147.74 50.76 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.752 -1.203 . . . . 0.22 107.752 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -137.42 138.29 39.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.12 110.452 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -115.06 110.05 18.99 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.769 -0.826 . . . . 0.23999999999999999 108.769 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 47.2 t0 -67.06 -28.74 68.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 1.1599999999999999 109.719 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.97 95.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.29999999999999999 110.013 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.0 p -107.55 0.45 22.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.474 -0.766 . . . . 0.41999999999999998 110.218 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 50.07 41.88 24.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.757 -1.201 . . . . 2.1600000000000001 107.757 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.29 130.81 55.59 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.638 0.732 . . . . 0.28000000000000003 110.603 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -101.89 139.42 37.55 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.779 -1.193 . . . . 0.089999999999999997 107.779 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.0 m -130.98 132.63 45.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.833 -1.167 . . . . 0.14000000000000001 108.294 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 7' ' ' LEU . 2.9 p -124.32 130.55 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.593 -0.891 . . . . 0.12 108.593 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.03 126.91 51.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.639 -0.663 . . . . 0.28999999999999998 109.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.992 -1.004 . . . . 1.95 109.367 -179.463 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.512 -0.551 . . . . 0.31 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.68 140.99 49.78 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.712 -0.848 . . . . 0.19 108.712 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.81 143.34 44.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.539 -0.725 . . . . 1.98 109.052 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 52' ' ' PHE . 44.4 tp -119.19 129.38 54.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.849 -0.797 . . . . 0.13 108.849 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -106.34 124.36 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.95 -1.5 . . . . 0.35999999999999999 106.95 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.13 116.09 31.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.25 110.336 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.27 67.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.378 -1.712 . . . . 0.17999999999999999 106.378 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.52 173.11 53.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.778 -1.329 . . . . 0.23999999999999999 109.778 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.06 -40.03 82.85 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.29 -1.123 . . . . 2.71 108.231 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.1 m -121.64 -19.33 6.88 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.858 -0.526 . . . . 0.92000000000000004 109.891 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.0 tp -98.57 119.54 37.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.059 -1.026 . . . . 0.59999999999999998 109.515 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -136.39 129.07 30.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.161 -0.962 . . . . 2.02 109.526 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.21 -171.07 44.25 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.417 -1.373 . . . . 0.23999999999999999 110.065 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -148.18 157.27 43.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.63 -0.923 . . . . 1.6799999999999999 109.124 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.15 171.58 18.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.815 . . . . 0.34000000000000002 108.878 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -137.83 159.98 40.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 0.20999999999999999 109.857 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.432 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 3.5 t -156.91 160.81 39.47 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.49 -0.756 . . . . 0.23000000000000001 109.214 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -104.97 136.87 43.63 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.358 -0.979 . . . . 2.2200000000000002 108.358 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.5 141.78 26.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.082 -1.011 . . . . 0.39000000000000001 109.453 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 m -60.44 -30.86 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.435 -0.791 . . . . 0.55000000000000004 109.347 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -156.87 174.32 15.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 1.1599999999999999 109.564 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.25 81.53 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.37 -0.831 . . . . 0.26000000000000001 110.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.38 -36.11 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.28999999999999998 109.716 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -71.25 -38.25 71.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.226 . . . . 0.44 109.605 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.91 85.86 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.511 -0.922 . . . . 0.17999999999999999 108.511 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.02 -42.36 89.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.629 -1.228 . . . . 1.0600000000000001 109.301 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.03 -43.83 81.78 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.627 -1.296 . . . . 2.6699999999999999 110.449 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.11 -53.23 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.915 . . . . 0.23000000000000001 111.845 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.432 ' CZ ' HG22 ' A' ' 18' ' ' THR . 41.2 m-85 -66.56 -40.1 88.83 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.901 -1.124 . . . . 0.14999999999999999 111.88 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.53 -40.16 95.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 2.0699999999999998 110.177 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.9 -40.68 75.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.898 -1.126 . . . . 1.8400000000000001 108.685 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.58 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.4 t80 -59.99 -44.56 94.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.29999999999999999 108.982 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.29 96.73 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.396 -0.815 . . . . 0.25 108.962 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.98 -44.06 94.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.392 -0.817 . . . . 1.23 108.818 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.15 -24.19 67.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 1.29 109.341 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.58 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 81.2 m-20 -99.03 9.7 42.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.935 . . . . 0.64000000000000001 109.052 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.89 36.77 93.29 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.515 -1.434 . . . . 0.71999999999999997 109.515 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.3 125.88 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.319 -1.107 . . . . 0.40000000000000002 109.892 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 96.4 m-20 -110.86 -98.63 0.41 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.294 -1.002 . . . . 1.3300000000000001 108.294 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.81 165.21 4.79 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.083 0.824 . . . . 0.26000000000000001 112.005 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.0 135.49 39.99 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.385 -1.339 . . . . 2.0699999999999998 107.385 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -98.08 133.37 42.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.025 -1.047 . . . . 0.13 110.435 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -133.03 148.31 52.24 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.029 -1.1 . . . . 0.22 108.029 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -133.13 132.42 41.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.452 -0.78 . . . . 0.12 110.063 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -113.34 110.05 19.72 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.764 -0.828 . . . . 0.23999999999999999 108.764 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -68.46 -29.5 68.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 1.1599999999999999 110.625 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.92 89.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.29999999999999999 110.313 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 78.6 p -104.87 -0.16 27.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.378 -0.826 . . . . 0.41999999999999998 109.721 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.02 40.97 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.005 -1.06 . . . . 2.1600000000000001 108.438 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.1 m -120.04 130.89 54.91 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.597 0.713 . . . . 0.28000000000000003 110.723 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' O ' HD12 ' A' ' 5' ' ' LEU . 56.8 m-85 -98.34 139.12 34.59 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.953 -1.499 . . . . 0.089999999999999997 106.953 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 100.0 m -132.04 131.88 42.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.715 -1.241 . . . . 0.14000000000000001 108.853 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.6 p -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.036 -1.098 . . . . 0.12 108.036 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -121.45 128.32 52.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.39 -0.819 . . . . 0.28999999999999998 110.788 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.035 -0.983 . . . . 1.95 109.298 179.456 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.502 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 98.3 m . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.231 0.539 . . . . 0.31 109.776 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -112.89 147.86 36.15 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.095 -1.076 . . . . 0.19 108.095 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.45 140.12 50.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.338 -0.851 . . . . 1.98 109.079 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' A' ' 30' ' ' PHE . 36.1 tp -116.76 127.98 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.238 -1.023 . . . . 0.13 108.238 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.7 mt -101.52 121.23 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.091 -1.448 . . . . 0.35999999999999999 107.091 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.2 110.85 22.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.032 -1.043 . . . . 0.25 109.918 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -116.49 67.76 0.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.811 -1.552 . . . . 0.17999999999999999 106.811 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.67 164.93 47.38 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.163 -1.575 . . . . 0.23999999999999999 109.163 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.142 -1.21 . . . . 2.71 108.261 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.6 m -111.31 -25.06 9.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.831 -0.543 . . . . 0.92000000000000004 109.674 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 9' ' ' GLY . 40.5 tp -103.09 124.12 47.94 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.343 -0.848 . . . . 0.59999999999999998 109.899 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.32 126.39 29.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 2.02 108.99 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.77 44.83 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.187 -1.482 . . . . 0.23999999999999999 110.592 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -149.46 158.15 43.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.688 -0.889 . . . . 1.6799999999999999 109.147 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.75 170.1 22.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.34000000000000002 109.519 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.0 p -137.3 159.89 40.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.20999999999999999 109.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -154.6 159.29 40.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.604 -0.887 . . . . 0.23000000000000001 108.604 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -101.54 131.95 47.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.134 -0.979 . . . . 2.2200000000000002 108.552 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.19 143.68 27.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.39000000000000001 109.157 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.01 -29.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.446 -0.784 . . . . 0.55000000000000004 109.797 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -158.78 174.75 14.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.055 -1.028 . . . . 1.1599999999999999 110.196 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.26 82.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.595 -0.691 . . . . 0.26000000000000001 110.311 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.0 64.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.032 -1.043 . . . . 0.28999999999999998 110.368 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 p -72.48 -35.6 68.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.62 -1.3 . . . . 0.44 110.012 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.0 81.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.471 -0.768 . . . . 0.17999999999999999 108.982 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.51 -42.35 87.51 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.613 -1.235 . . . . 1.0600000000000001 109.815 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.8 -42.68 73.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 2.6699999999999999 110.24 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.12 -52.19 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.23000000000000001 110.768 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CD1' HD22 ' A' ' 5' ' ' LEU . 19.6 m-85 -61.8 -38.12 86.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.945 -1.097 . . . . 0.14999999999999999 110.07 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -59.99 -41.77 92.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.885 -1.134 . . . . 2.0699999999999998 109.782 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.92 -40.65 83.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.037 -1.039 . . . . 1.8400000000000001 108.537 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.463 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 57.9 t80 -59.94 -49.64 76.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.772 -0.825 . . . . 0.29999999999999999 108.772 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.58 84.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.25 109.351 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -60.04 -43.13 95.57 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 1.23 108.649 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.41 -25.39 65.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.077 -1.015 . . . . 1.29 108.783 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 18.9 m120 -100.01 9.86 42.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.64000000000000001 109.926 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.03 34.7 88.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.012 -1.235 . . . . 0.71999999999999997 110.012 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.04 128.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.306 -1.114 . . . . 0.40000000000000002 109.937 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 95.9 m-20 -110.02 -99.74 0.39 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.622 -0.881 . . . . 1.3300000000000001 108.622 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.02 161.6 3.37 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 121.977 0.765 . . . . 0.26000000000000001 111.849 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.68 138.01 42.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.396 -1.335 . . . . 2.0699999999999998 107.396 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -99.76 135.8 40.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -0.993 . . . . 0.13 111.115 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.68 149.75 50.54 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.213 -1.032 . . . . 0.22 108.213 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 65.6 t80 -135.97 134.57 38.74 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.12 110.065 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -111.76 110.02 20.17 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.687 -0.857 . . . . 0.23999999999999999 108.687 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.24 -31.71 72.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 1.1599999999999999 110.253 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.7 88.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.29999999999999999 110.436 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.9 p -105.09 -0.98 26.16 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.386 -0.821 . . . . 0.41999999999999998 110.158 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.1 mtpm? 49.98 40.03 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 2.1600000000000001 108.931 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 132.14 55.38 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.528 0.68 . . . . 0.28000000000000003 110.452 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.0 m-85 -99.6 139.8 34.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.384 -1.339 . . . . 0.089999999999999997 107.384 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -131.58 132.45 44.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.71 -1.244 . . . . 0.14000000000000001 108.83 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -121.88 129.31 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.35 -0.982 . . . . 0.12 108.35 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -120.02 127.2 52.38 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.477 -0.765 . . . . 0.28999999999999998 111.016 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.058 -0.972 . . . . 1.95 109.163 179.191 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.532 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 95.6 m . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.25 0.548 . . . . 0.31 109.685 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -112.1 150.29 30.94 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.891 -1.151 . . . . 0.19 107.891 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -116.48 143.4 45.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.067 -1.02 . . . . 1.98 109.418 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 30' ' ' PHE . 35.2 tp -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.688 -0.632 . . . . 0.13 109.84 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.5 mt -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.572 -1.27 . . . . 0.35999999999999999 107.572 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 54' ' ' VAL . 79.8 mt -102.85 115.94 31.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.25 -0.906 . . . . 0.25 110.01 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -116.95 70.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.666 -1.235 . . . . 0.17999999999999999 107.666 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.91 170.1 53.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.093 -1.603 . . . . 0.23999999999999999 109.093 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.413 ' NZ ' ' O ' ' A' ' 56' ' ' GLU . 62.4 mttp -64.38 -36.94 85.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.075 -1.25 . . . . 2.71 107.627 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.0 p -123.07 -15.27 7.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.903 -0.498 . . . . 0.92000000000000004 109.889 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.79 122.1 41.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.98 -1.075 . . . . 0.59999999999999998 109.969 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.92 126.68 27.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.295 -0.878 . . . . 2.02 109.814 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.27 -177.41 48.39 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.387 -1.387 . . . . 0.23999999999999999 110.154 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.77 157.03 42.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.517 -0.99 . . . . 1.6799999999999999 108.977 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -156.73 173.24 17.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.474 -0.766 . . . . 0.34000000000000002 109.523 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.2 p -137.23 160.54 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.378 -0.826 . . . . 0.20999999999999999 109.211 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 7.3 t -154.0 159.81 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.793 -0.817 . . . . 0.23000000000000001 108.793 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -102.84 131.94 49.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.265 -0.897 . . . . 2.2200000000000002 109.137 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.676 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -150.07 145.62 26.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.39000000000000001 109.105 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 21' ' ' VAL . 15.8 m -62.61 -26.89 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.55000000000000004 110.341 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -157.77 174.71 14.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.888 -1.133 . . . . 1.1599999999999999 110.431 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.36 81.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.518 -0.739 . . . . 0.26000000000000001 109.208 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.94 60.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.28999999999999998 109.828 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.676 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 20.7 p -73.12 -35.13 66.48 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.668 -1.27 . . . . 0.44 109.6 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.7 94.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.581 -0.896 . . . . 0.17999999999999999 108.581 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.27 -48.07 83.0 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.348 -1.341 . . . . 1.0600000000000001 109.27 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -65.91 -44.67 84.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 2.6699999999999999 111.013 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -52.86 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.946 -1.096 . . . . 0.23000000000000001 110.456 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CD1' HD22 ' A' ' 5' ' ' LEU . 20.9 m-85 -61.06 -36.51 79.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.14999999999999999 110.156 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -60.02 -40.5 89.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 2.0699999999999998 109.261 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.02 -41.43 74.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 1.8400000000000001 108.923 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 58.1 t80 -60.06 -49.66 76.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.29999999999999999 109.461 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -45.28 94.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.25 109.549 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.96 -41.68 92.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.334 -0.854 . . . . 1.23 109.272 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.21 -23.44 67.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 1.29 109.138 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 5.8 m120 -97.05 6.74 48.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.64000000000000001 109.592 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.04 63.52 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.059 -1.067 . . . . 0.71999999999999997 111.282 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 44.0 t -114.81 125.57 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.035 -1.274 . . . . 0.40000000000000002 108.796 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 75.1 m-20 -149.66 101.92 3.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.254 -0.904 . . . . 1.3300000000000001 110.399 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.41 -130.54 1.33 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.128 -1.51 . . . . 0.26000000000000001 111.301 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -92.29 131.66 37.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.943 -1.328 . . . . 2.0699999999999998 110.539 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.674 -0.641 . . . . 0.13 110.015 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 p -138.2 150.71 47.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.097 -1.075 . . . . 0.22 108.097 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.97 137.24 39.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -0.911 . . . . 0.12 110.532 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -113.28 109.98 19.63 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.904 -0.776 . . . . 0.23999999999999999 108.904 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 53.7 t0 -67.01 -30.93 71.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 1.1599999999999999 110.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.29999999999999999 109.688 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -104.07 -0.65 28.45 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.363 -0.835 . . . . 0.41999999999999998 109.807 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.0 mtpm? 49.66 42.79 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.881 -1.137 . . . . 2.1600000000000001 108.453 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -120.05 134.69 55.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.454 0.645 . . . . 0.28000000000000003 110.713 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -100.4 138.28 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.392 -1.336 . . . . 0.089999999999999997 107.392 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -128.8 130.17 46.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.692 -1.255 . . . . 0.14000000000000001 108.03 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.423 HG12 HD23 ' A' ' 7' ' ' LEU . 5.6 p -125.28 130.11 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.539 -0.912 . . . . 0.12 108.539 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.8 m -120.0 128.37 53.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.207 -0.664 . . . . 0.28999999999999998 109.207 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 63.9 tt0 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.972 -1.014 . . . . 1.95 109.288 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.243 0.544 . . . . 0.31 109.582 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -113.42 146.92 38.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.749 -1.204 . . . . 0.19 107.749 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.22 141.59 48.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.23 -0.919 . . . . 1.98 109.824 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.5 tp -120.11 128.38 53.4 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.045 -0.724 . . . . 0.13 109.045 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.1 123.28 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.027 -1.471 . . . . 0.35999999999999999 107.027 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 114.06 27.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.25 109.67 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.6 71.39 0.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.031 -1.47 . . . . 0.17999999999999999 107.031 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.11 169.59 53.03 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.082 -1.207 . . . . 0.23999999999999999 110.082 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -65.76 -39.84 91.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -1.039 . . . . 2.71 108.224 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.9 m -124.28 -18.42 5.82 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.419 -0.586 . . . . 0.92000000000000004 109.419 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.7 119.98 39.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.59999999999999998 109.037 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -135.31 133.63 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.253 -0.904 . . . . 2.02 109.598 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.82 -173.64 46.45 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.461 -1.352 . . . . 0.23999999999999999 110.272 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -149.44 158.2 43.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.577 -0.954 . . . . 1.6799999999999999 109.202 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.466 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 4.3 t -154.49 171.6 19.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 0.34000000000000002 109.324 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.7 p -137.33 159.92 40.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.20999999999999999 109.332 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.462 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.5 t -155.0 158.8 39.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.823 . . . . 0.23000000000000001 109.094 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.59 133.57 48.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.459 -0.941 . . . . 2.2200000000000002 108.459 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.55 146.25 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.39000000000000001 109.306 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 21' ' ' VAL . 14.5 m -59.55 -30.78 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.55000000000000004 109.564 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -159.33 174.61 14.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.981 . . . . 1.1599999999999999 110.015 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.32 81.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.411 -0.805 . . . . 0.26000000000000001 110.358 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.37 -37.32 62.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.872 -1.142 . . . . 0.28999999999999998 109.708 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.441 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 21.4 p -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.692 -1.255 . . . . 0.44 109.576 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.19 81.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.359 -0.978 . . . . 0.17999999999999999 108.359 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.13 -47.44 81.13 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.645 -1.222 . . . . 1.0600000000000001 109.439 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.71 -41.13 88.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 2.6699999999999999 110.248 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -68.27 -54.98 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.06 -1.025 . . . . 0.23000000000000001 110.814 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 18' ' ' THR . 28.2 m-85 -63.69 -38.66 91.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.14999999999999999 111.358 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.79 -40.72 96.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.701 -1.249 . . . . 2.0699999999999998 110.049 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.23 -43.86 73.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.971 -1.08 . . . . 1.8400000000000001 109.162 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 81.4 t80 -60.17 -46.98 87.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.446 -0.784 . . . . 0.29999999999999999 109.899 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.34 96.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.25 108.656 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.41 -41.16 96.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.561 -0.903 . . . . 1.23 108.561 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.64 -25.05 68.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 1.29 109.607 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 6.3 m120 -94.8 7.43 45.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.946 . . . . 0.64000000000000001 109.791 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.12 30.34 75.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.678 -1.369 . . . . 0.71999999999999997 109.678 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.0 t -105.45 125.81 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -1.165 . . . . 0.40000000000000002 109.756 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 40.0 t0 -138.64 142.32 39.07 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.98 -1.119 . . . . 1.3300000000000001 107.98 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.78 -150.13 11.6 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.247 -1.454 . . . . 0.26000000000000001 110.135 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -94.48 137.66 33.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.531 -0.982 . . . . 2.0699999999999998 108.822 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -104.89 138.33 41.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.367 -0.833 . . . . 0.13 110.77 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -136.24 149.86 48.7 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.885 -1.154 . . . . 0.22 107.885 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -137.03 137.35 39.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.185 -0.947 . . . . 0.12 110.492 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.6 109.95 20.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.316 -0.994 . . . . 0.23999999999999999 108.316 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 45.9 t0 -67.35 -30.67 70.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 1.1599999999999999 110.167 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.86 91.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.29999999999999999 110.34 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.4 p -105.93 -0.07 25.39 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.391 -0.818 . . . . 0.41999999999999998 110.278 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 50.02 41.46 23.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.927 -1.108 . . . . 2.1600000000000001 108.542 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -119.03 130.5 55.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.734 0.778 . . . . 0.28000000000000003 110.451 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -99.36 139.08 35.54 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.568 -1.271 . . . . 0.089999999999999997 107.568 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.6 m -130.69 131.35 44.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.14000000000000001 108.195 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.27 129.35 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.423 -0.954 . . . . 0.12 108.423 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.1 m -120.41 127.07 51.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.423 -0.798 . . . . 0.28999999999999998 110.188 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.027 -0.987 . . . . 1.95 109.253 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.4 m . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.384 0.611 . . . . 0.31 109.655 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -113.72 145.41 41.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.361 -0.978 . . . . 0.19 108.361 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -115.96 142.94 46.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 1.98 108.912 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.558 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.9 tp -119.92 126.62 51.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.573 -0.899 . . . . 0.13 108.573 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.48 123.73 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.151 -1.425 . . . . 0.35999999999999999 107.151 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 mt -102.73 112.89 25.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.25 110.383 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.97 68.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.839 -1.541 . . . . 0.17999999999999999 106.839 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.31 168.2 51.51 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.965 -1.254 . . . . 0.23999999999999999 109.965 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -65.9 -37.65 86.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.703 -1.221 . . . . 2.71 107.703 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -122.19 -19.79 6.42 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.151 -0.477 . . . . 0.92000000000000004 109.866 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 tp -99.5 120.93 40.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 0.59999999999999998 109.422 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -135.61 128.46 31.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.304 -0.873 . . . . 2.02 109.517 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.42 -175.03 47.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.303 -1.427 . . . . 0.23999999999999999 110.446 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.36 152.57 41.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.646 -0.914 . . . . 1.6799999999999999 108.86 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -152.65 168.02 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.34000000000000002 108.801 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.1 p -138.65 160.54 39.37 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.20999999999999999 109.737 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 10.4 t -157.37 162.84 39.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.23000000000000001 108.594 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 43.7 mp0 -106.37 136.78 45.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.796 -0.816 . . . . 2.2200000000000002 108.796 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.04 144.76 28.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.39000000000000001 108.899 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -60.04 -30.73 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.229 -0.919 . . . . 0.55000000000000004 109.393 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -157.73 176.96 11.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 1.1599999999999999 110.112 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.31 -38.12 87.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.526 -0.734 . . . . 0.26000000000000001 109.496 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.9 61.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.982 -1.074 . . . . 0.28999999999999998 109.553 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.621 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 90.2 m -69.97 -40.06 75.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.69 -1.256 . . . . 0.44 109.811 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.02 87.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.857 -0.794 . . . . 0.17999999999999999 108.857 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.21 -45.44 79.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.442 -1.303 . . . . 1.0600000000000001 108.824 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -67.83 -44.23 77.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 2.6699999999999999 111.157 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.87 -53.01 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.23000000000000001 111.34 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.558 ' CD1' HD22 ' A' ' 5' ' ' LEU . 23.8 m-85 -63.98 -37.56 87.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.861 -1.149 . . . . 0.14999999999999999 110.299 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -59.94 -42.32 93.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.805 -1.184 . . . . 2.0699999999999998 109.8 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -68.67 -40.14 80.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.078 -1.014 . . . . 1.8400000000000001 108.741 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.4 t80 -59.95 -46.81 88.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.29999999999999999 109.028 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.84 92.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.83 . . . . 0.25 109.144 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -60.01 -45.93 91.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.439 -0.788 . . . . 1.23 110.137 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.33 -25.16 65.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.051 -1.03 . . . . 1.29 109.396 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 83.3 m-20 -99.71 9.47 43.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.64000000000000001 109.785 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.04 35.13 91.6 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.981 -1.104 . . . . 0.71999999999999997 110.491 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 71.1 t -108.89 127.85 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.147 -1.208 . . . . 0.40000000000000002 109.979 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 96.0 m-20 -140.38 148.33 41.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.485 -0.931 . . . . 1.3300000000000001 108.485 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.41 -159.57 28.64 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.44 -1.362 . . . . 0.26000000000000001 110.061 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -85.87 132.1 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.029 -1.1 . . . . 2.0699999999999998 108.029 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -101.76 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.135 -0.978 . . . . 0.13 110.683 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.5 p -136.44 150.04 48.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 61.1 t80 -134.19 137.73 44.64 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.414 -0.804 . . . . 0.12 110.335 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -115.84 109.98 18.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.834 -0.802 . . . . 0.23999999999999999 108.834 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -67.81 -29.2 68.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 1.1599999999999999 110.455 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.02 94.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.29999999999999999 110.32 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 p -109.18 0.13 19.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.582 -0.699 . . . . 0.41999999999999998 110.209 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtmp? 50.14 42.11 24.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.851 -1.156 . . . . 2.1600000000000001 108.588 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -118.79 130.06 55.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.725 0.774 . . . . 0.28000000000000003 110.166 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 31.5 m-85 -99.11 139.51 34.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.949 -1.5 . . . . 0.089999999999999997 106.949 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.6 m -131.96 132.82 43.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.782 -1.199 . . . . 0.14000000000000001 108.463 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.1 p -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.345 -0.983 . . . . 0.12 108.345 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.3 m -119.38 126.73 52.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.51 -0.744 . . . . 0.28999999999999998 109.518 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' OE2' HG13 ' A' ' 39' ' ' VAL . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.086 -0.959 . . . . 1.95 109.7 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.39 -0.596 . . . . 0.31 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.79 145.49 43.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.807 -0.812 . . . . 0.19 108.807 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -114.38 143.42 44.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.98 108.906 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 30' ' ' PHE . 25.9 tp -119.8 126.91 52.17 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.735 -0.839 . . . . 0.13 108.735 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.9 mt -102.45 121.03 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.034 -1.469 . . . . 0.35999999999999999 107.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.07 115.01 29.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.025 . . . . 0.25 109.879 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -122.48 66.0 0.94 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.628 -1.619 . . . . 0.17999999999999999 106.628 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -78.6 171.89 55.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.799 -1.72 . . . . 0.23999999999999999 108.799 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.38 -39.69 89.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.028 -1.278 . . . . 2.71 108.238 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.2 p -114.57 -20.12 10.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.841 -0.537 . . . . 0.92000000000000004 109.757 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 9' ' ' GLY . 58.9 tp -99.93 121.65 41.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -0.918 . . . . 0.59999999999999998 109.942 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -133.2 122.88 24.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.863 . . . . 2.02 108.948 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.08 -171.64 44.77 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.341 -1.409 . . . . 0.23999999999999999 110.64 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 2.1 pm0 -150.46 158.61 44.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.519 -0.989 . . . . 1.6799999999999999 109.591 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 t -154.55 170.37 21.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.518 -0.739 . . . . 0.34000000000000002 109.707 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.3 p -138.16 160.13 40.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.33 -0.856 . . . . 0.20999999999999999 109.494 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 t -155.46 162.19 40.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.959 -0.756 . . . . 0.23000000000000001 108.959 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -100.22 132.08 45.8 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.088 -1.079 . . . . 2.2200000000000002 108.088 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.711 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -148.39 143.24 26.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.943 -1.098 . . . . 0.39000000000000001 109.477 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.46 -30.67 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.577 -0.702 . . . . 0.55000000000000004 110.439 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -159.87 179.93 8.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.84 -1.162 . . . . 1.1599999999999999 110.322 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -37.64 75.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.249 -0.907 . . . . 0.26000000000000001 110.355 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.27 -38.52 68.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.186 . . . . 0.28999999999999998 110.898 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.711 HG23 ' HB1' ' A' ' 20' ' ' ALA . 1.3 t -73.07 -34.44 66.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.271 -1.518 . . . . 0.44 109.388 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.59 86.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.65 -0.87 . . . . 0.17999999999999999 108.65 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.34 -48.16 77.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.829 -1.149 . . . . 1.0600000000000001 110.02 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.61 -41.14 88.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 2.6699999999999999 110.96 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.3 -54.83 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 0.23000000000000001 111.081 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.459 ' CD1' HD22 ' A' ' 5' ' ' LEU . 38.3 m-85 -63.76 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.01 -1.056 . . . . 0.14999999999999999 110.456 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' HZ3' ' HB3' ' A' ' 31' ' ' LYS . 6.7 ttpm? -61.9 -42.64 99.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.801 -1.187 . . . . 2.0699999999999998 109.935 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -67.54 -42.8 82.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.95 -1.094 . . . . 1.8400000000000001 108.542 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 63.9 t80 -60.02 -47.83 84.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.425 0.631 . . . . 0.29999999999999999 109.612 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.59 99.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.474 -0.766 . . . . 0.25 109.443 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -59.95 -40.66 89.73 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.191 -1.04 . . . . 1.23 108.191 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.61 -24.37 67.77 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.644 -0.66 . . . . 1.29 109.369 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 4.9 m120 -97.63 6.94 47.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.64000000000000001 109.769 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.07 34.32 70.29 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.954 -1.117 . . . . 0.71999999999999997 110.711 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.87 124.52 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.03 -1.276 . . . . 0.40000000000000002 108.972 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.47 101.09 2.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.003 -1.061 . . . . 1.3300000000000001 110.713 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.07 -130.06 1.3 Allowed Glycine 0 N--CA 1.497 2.733 0 C-N-CA 119.268 -1.444 . . . . 0.26000000000000001 111.336 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -93.78 129.3 40.2 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.972 -1.311 . . . . 2.0699999999999998 110.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.55 139.97 41.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.67 -0.644 . . . . 0.13 110.059 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -136.08 149.46 48.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.756 -1.201 . . . . 0.22 107.756 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.95 135.4 41.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.12 109.924 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.45 109.55 19.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.299 -1.0 . . . . 0.23999999999999999 108.299 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -68.19 -30.69 69.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.1599999999999999 110.224 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.8 91.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.29999999999999999 110.514 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.3 p -104.97 0.26 27.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.41999999999999998 110.066 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm 50.63 40.95 25.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 2.1600000000000001 108.257 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -119.79 130.54 54.99 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.536 0.684 . . . . 0.28000000000000003 110.8 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -99.45 137.79 37.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.055 -1.461 . . . . 0.089999999999999997 107.055 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.0 m -130.2 131.27 45.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.748 -1.22 . . . . 0.14000000000000001 108.216 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.8 p -120.92 127.4 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.447 -0.946 . . . . 0.12 108.447 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -123.61 125.24 44.47 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.846 -0.798 . . . . 0.28999999999999998 108.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.99 -1.005 . . . . 1.95 109.635 -179.865 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.41 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 23.9 m . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.022 -0.733 . . . . 0.31 109.022 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.06 147.17 42.6 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.979 -0.748 . . . . 0.19 108.979 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -118.07 143.77 46.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.487 -0.758 . . . . 1.98 109.267 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 7' ' ' LEU . 34.4 tp -119.5 129.07 54.53 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.011 -0.737 . . . . 0.13 109.011 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.46 123.72 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.066 -1.457 . . . . 0.35999999999999999 107.066 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 5' ' ' LEU . 85.5 mt -104.49 116.44 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.208 -0.933 . . . . 0.25 111.035 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -114.88 71.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.113 -1.44 . . . . 0.17999999999999999 107.113 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 168.91 52.61 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.434 -1.466 . . . . 0.23999999999999999 109.434 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -66.05 -39.37 90.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.182 -1.187 . . . . 2.71 108.17 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.0 p -124.44 -16.56 6.31 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.023 0.44 . . . . 0.92000000000000004 109.944 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -103.19 120.01 39.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.288 -0.883 . . . . 0.59999999999999998 109.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -130.89 131.11 44.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.514 -0.741 . . . . 2.02 109.411 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.78 48.24 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.257 -1.449 . . . . 0.23999999999999999 110.697 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 52.2 mp0 -143.88 153.26 42.14 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.479 -0.934 . . . . 1.6799999999999999 108.479 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -152.51 169.17 23.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.085 -1.009 . . . . 0.34000000000000002 109.34 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.9 p -135.44 159.82 40.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.353 -0.842 . . . . 0.20999999999999999 109.502 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.456 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 10.6 t -157.28 160.12 38.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.23000000000000001 109.216 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 55.8 mp0 -103.25 135.67 44.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.903 . . . . 2.2200000000000002 108.678 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.6 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.54 144.6 27.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.39000000000000001 109.264 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.88 -30.94 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.55000000000000004 109.809 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -157.69 177.23 11.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.1599999999999999 109.621 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.23 84.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.447 -0.783 . . . . 0.26000000000000001 109.495 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -36.83 63.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.036 -1.04 . . . . 0.28999999999999998 109.577 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.6 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 93.8 m -69.99 -39.63 75.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.785 -1.197 . . . . 0.44 109.651 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.71 78.83 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.735 -0.839 . . . . 0.17999999999999999 108.735 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.76 -41.67 87.13 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.657 -1.217 . . . . 1.0600000000000001 109.686 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.93 -45.17 71.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 2.6699999999999999 110.477 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 -51.11 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.551 -0.718 . . . . 0.23000000000000001 110.6 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' A' ' 18' ' ' THR . 35.0 m-85 -66.51 -38.6 87.58 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.091 -1.044 . . . . 0.14999999999999999 110.549 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.0 -44.7 94.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.727 -1.233 . . . . 2.0699999999999998 109.538 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -67.61 -40.88 84.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.028 -1.045 . . . . 1.8400000000000001 108.573 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.2 t80 -59.99 -48.34 82.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.638 . . . . 0.29999999999999999 109.78 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.21 94.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.25 109.546 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -60.0 -42.26 93.86 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.163 -0.961 . . . . 1.23 109.107 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.42 -26.47 67.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 1.29 109.696 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.8 m-20 -99.03 10.02 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.168 -0.958 . . . . 0.64000000000000001 109.494 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.5 38.25 96.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.731 -1.348 . . . . 0.71999999999999997 109.731 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.19 126.71 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -1.102 . . . . 0.40000000000000002 110.172 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 52.4 t0 -110.19 -99.88 0.4 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.295 -1.002 . . . . 1.3300000000000001 108.295 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.26 163.89 3.61 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 122.167 0.871 . . . . 0.26000000000000001 112.368 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -75.2 138.48 41.99 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.348 -1.352 . . . . 2.0699999999999998 107.348 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -99.57 134.99 41.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.13 110.809 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.6 p -133.57 148.19 51.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.316 -0.994 . . . . 0.22 108.316 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 66.8 t80 -130.61 134.31 46.88 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.86 . . . . 0.12 110.155 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' LYS . 62.0 t0 -112.88 107.19 15.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.738 -0.838 . . . . 0.23999999999999999 108.738 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 56.5 t0 -67.36 -32.15 72.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.166 -0.959 . . . . 1.1599999999999999 110.238 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.29999999999999999 109.938 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -107.89 0.04 21.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.459 -0.775 . . . . 0.41999999999999998 110.213 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 46' ' ' ASP . 9.5 mtmp? 49.74 42.02 22.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.806 -1.184 . . . . 2.1600000000000001 108.294 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -120.01 131.44 55.14 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.625 0.726 . . . . 0.28000000000000003 110.287 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.6 m-85 -99.88 137.83 37.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.28 -1.378 . . . . 0.089999999999999997 107.28 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -131.0 131.7 44.52 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.804 -1.185 . . . . 0.14000000000000001 108.245 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.5 p -120.58 128.06 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.077 -1.082 . . . . 0.12 108.077 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.22 125.86 49.21 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.402 -0.811 . . . . 0.28999999999999998 110.845 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.471 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 38.2 mp0 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 118.034 -0.984 . . . . 1.95 109.438 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.458 -0.571 . . . . 0.31 109.458 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 95.2 m-85 -112.77 146.86 38.05 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.892 -1.151 . . . . 0.19 107.892 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -115.82 142.38 46.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.169 -0.957 . . . . 1.98 109.7 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' CD1' ' A' ' 30' ' ' PHE . 34.9 tp -122.4 128.11 50.54 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.057 -0.72 . . . . 0.13 109.057 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.69 124.16 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.605 -1.258 . . . . 0.35999999999999999 107.605 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.3 mt -101.43 114.78 29.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.25 110.13 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.13 67.63 0.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.057 -1.46 . . . . 0.17999999999999999 107.057 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.01 172.52 54.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.631 -1.387 . . . . 0.23999999999999999 109.631 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -65.99 -39.06 90.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.221 -1.164 . . . . 2.71 108.365 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -17.57 6.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.917 -0.489 . . . . 0.92000000000000004 109.859 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.3 tp -99.3 117.33 33.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 0.59999999999999998 109.563 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.58 128.69 39.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.867 0.841 . . . . 2.02 109.514 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.15 -175.26 47.37 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.508 -1.329 . . . . 0.23999999999999999 110.317 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -148.96 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.699 -0.883 . . . . 1.6799999999999999 109.045 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -154.24 171.16 19.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.34000000000000002 109.391 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 p -137.09 159.99 40.29 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.897 -0.779 . . . . 0.20999999999999999 108.897 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.435 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.3 t -154.89 159.58 40.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.23000000000000001 109.25 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -102.7 132.42 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.288 -0.882 . . . . 2.2200000000000002 108.884 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.477 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.12 143.81 27.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.39000000000000001 108.935 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.44 -27.23 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.55000000000000004 109.858 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -157.96 172.21 18.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 1.1599999999999999 109.939 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.68 83.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.516 -0.74 . . . . 0.26000000000000001 109.941 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.48 -37.2 62.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.049 -1.032 . . . . 0.28999999999999998 110.069 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.477 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 17.6 p -73.38 -34.41 65.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.615 -1.303 . . . . 0.44 109.809 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.9 87.33 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.325 -0.991 . . . . 0.17999999999999999 108.325 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.67 -45.72 85.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.864 -1.134 . . . . 1.0600000000000001 109.58 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.28 -42.7 83.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.078 . . . . 2.6699999999999999 109.821 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.59 -54.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.23000000000000001 110.737 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 5' ' ' LEU . 30.0 m-85 -63.44 -39.04 93.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.14999999999999999 110.478 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -60.79 -42.45 97.57 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.721 -1.237 . . . . 2.0699999999999998 109.823 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -69.61 -42.35 74.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 1.8400000000000001 108.702 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.625 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.9 t80 -59.95 -44.94 94.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.665 -0.865 . . . . 0.29999999999999999 108.665 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.92 99.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 0.25 109.387 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.1 -40.07 88.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 1.23 108.533 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.98 -24.22 67.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 78.1 m-20 -99.17 7.3 45.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.207 -0.933 . . . . 0.64000000000000001 110.495 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.12 35.58 71.02 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.917 -1.135 . . . . 0.71999999999999997 111.349 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 67.1 t -111.93 125.09 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.968 -1.313 . . . . 0.40000000000000002 109.348 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 78.5 m-20 -148.47 98.8 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.252 -0.905 . . . . 1.3300000000000001 110.47 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.83 -136.85 2.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.168 -1.491 . . . . 0.26000000000000001 111.015 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.79 131.57 35.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.087 -1.243 . . . . 2.0699999999999998 110.608 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -108.25 139.3 43.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.674 -0.641 . . . . 0.13 110.013 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 p -136.68 149.99 48.23 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 0.22 108.586 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 71.4 t80 -133.79 136.03 44.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.364 -0.835 . . . . 0.12 110.451 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -114.03 109.71 18.89 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.403 -0.962 . . . . 0.23999999999999999 108.403 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.26 -29.11 67.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 1.1599999999999999 110.17 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.02 94.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.005 . . . . 0.29999999999999999 109.92 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -106.95 0.7 23.96 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.491 -0.756 . . . . 0.41999999999999998 110.24 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.611 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 16.4 mtpp 50.51 41.66 25.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 2.1600000000000001 108.451 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 132.64 55.52 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.66 0.743 . . . . 0.28000000000000003 110.906 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 48.3 m-85 -99.99 139.36 35.77 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.167 -1.42 . . . . 0.089999999999999997 107.167 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -130.33 131.52 45.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.665 -1.272 . . . . 0.14000000000000001 108.343 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.7 p -124.85 130.01 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.862 . . . . 0.12 108.674 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.6 m -125.37 129.25 49.54 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.658 -0.651 . . . . 0.28999999999999998 109.87 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.946 -1.026 . . . . 1.95 109.491 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 108.971 -0.751 . . . . 0.31 108.971 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.3 144.93 43.6 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.006 -0.739 . . . . 0.19 109.006 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -115.69 141.14 48.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 1.98 109.004 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.499 HD22 ' CD1' ' A' ' 30' ' ' PHE . 38.8 tp -120.05 128.97 54.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.13 109.336 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -105.81 123.06 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 106.983 -1.488 . . . . 0.35999999999999999 106.983 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.06 115.89 31.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.311 -0.868 . . . . 0.25 110.311 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -116.59 72.8 0.83 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.967 -1.123 . . . . 0.17999999999999999 107.967 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.62 169.47 54.31 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.219 -1.553 . . . . 0.23999999999999999 109.219 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -62.37 -35.99 80.89 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.137 -1.213 . . . . 2.71 108.082 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 p -129.06 -11.92 4.69 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.555 -0.535 . . . . 0.92000000000000004 109.555 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.6 tp -99.96 118.69 36.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.27 -0.894 . . . . 0.59999999999999998 109.104 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -130.63 127.75 39.57 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 2.02 109.606 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 -177.84 48.39 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.184 -1.484 . . . . 0.23999999999999999 110.555 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.17 157.15 43.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.666 -0.903 . . . . 1.6799999999999999 109.014 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -152.99 169.97 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.34000000000000002 109.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -136.49 159.61 41.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.20999999999999999 109.309 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 11.5 t -155.67 159.0 39.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.387 -0.821 . . . . 0.23000000000000001 109.138 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.37 134.04 45.06 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.042 -1.095 . . . . 2.2200000000000002 108.042 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.43 26.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.928 -1.108 . . . . 0.39000000000000001 109.491 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.05 -31.25 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.55000000000000004 109.673 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -158.32 175.2 14.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 1.1599999999999999 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.08 81.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.501 -0.749 . . . . 0.26000000000000001 109.989 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.18 -36.92 61.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.008 -1.058 . . . . 0.28999999999999998 109.871 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 p -74.16 -34.23 63.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.243 . . . . 0.44 109.519 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.971 -1.122 . . . . 0.17999999999999999 107.971 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.07 -49.83 74.66 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.762 -1.175 . . . . 1.0600000000000001 108.872 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -63.46 -44.77 93.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.83 . . . . 2.6699999999999999 110.821 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.36 -53.28 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.053 -1.029 . . . . 0.23000000000000001 110.763 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.499 ' CD1' HD22 ' A' ' 5' ' ' LEU . 29.2 m-85 -63.46 -37.82 88.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.14999999999999999 110.456 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.685 -1.259 . . . . 2.0699999999999998 109.83 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.57 -40.75 76.57 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.012 -1.055 . . . . 1.8400000000000001 108.58 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.46 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 51.1 t80 -60.06 -47.77 84.5 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.749 -0.834 . . . . 0.29999999999999999 108.749 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.16 99.42 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.918 -0.771 . . . . 0.25 108.918 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -60.0 -42.58 94.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.398 -0.814 . . . . 1.29 109.097 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.492 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.6 m-80 -98.13 6.37 47.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.283 -0.886 . . . . 0.64000000000000001 109.466 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.29 34.64 90.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.143 -1.183 . . . . 0.71999999999999997 110.143 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.4 t -112.05 128.82 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.391 -1.064 . . . . 0.40000000000000002 110.513 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 2.0 p-10 -110.52 -98.49 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.505 -1.294 . . . . 1.3300000000000001 107.505 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 68.64 164.86 3.46 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-O 122.01 0.783 . . . . 0.26000000000000001 111.841 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -76.31 137.46 39.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.998 -1.482 . . . . 2.0699999999999998 106.998 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -98.0 134.94 40.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.13 110.544 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.38 148.77 50.73 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.996 -1.113 . . . . 0.22 107.996 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.2 t80 -135.97 135.1 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.326 -0.859 . . . . 0.12 110.29 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.65 109.95 19.8 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.31 -0.996 . . . . 0.23999999999999999 108.31 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -68.68 -29.32 67.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 1.1599999999999999 110.292 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.93 95.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.133 -0.98 . . . . 0.29999999999999999 109.988 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.0 p -108.07 0.3 21.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.611 -0.681 . . . . 0.41999999999999998 109.82 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.9 mttm 48.58 43.04 20.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.065 . . . . 2.1600000000000001 108.502 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 131.75 55.26 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.543 0.687 . . . . 0.28000000000000003 109.836 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.3 m-85 -100.05 138.93 36.45 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.851 -1.166 . . . . 0.089999999999999997 107.851 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -131.36 131.68 43.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.803 -1.186 . . . . 0.14000000000000001 108.52 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.19 130.15 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.296 -1.001 . . . . 0.12 108.296 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -117.53 124.83 49.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.504 -0.748 . . . . 0.28999999999999998 109.701 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.039 -0.981 . . . . 1.95 109.588 -179.504 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 121.372 0.606 . . . . 0.31 110.377 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -109.57 150.94 27.45 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.774 -1.195 . . . . 0.19 107.774 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -118.1 140.04 50.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.08 -1.013 . . . . 1.98 109.232 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 30' ' ' PHE . 37.2 tp -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.926 -0.768 . . . . 0.13 108.926 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.31 124.55 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.779 -1.193 . . . . 0.35999999999999999 107.779 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.36 116.56 32.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 0.25 109.9 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -114.33 72.32 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.584 -1.265 . . . . 0.17999999999999999 107.584 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.68 169.06 53.1 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.45 -1.46 . . . . 0.23999999999999999 109.45 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.35 -37.93 88.55 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.312 -1.111 . . . . 2.71 108.006 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.7 p -123.78 -16.15 6.75 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.73 -0.471 . . . . 0.92000000000000004 109.73 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 tp -101.74 120.18 39.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.305 -0.872 . . . . 0.59999999999999998 109.573 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.15 127.9 40.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.802 . . . . 2.02 108.966 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.97 -179.22 48.65 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.174 -1.489 . . . . 0.23999999999999999 110.584 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -149.48 158.2 43.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.947 . . . . 1.6799999999999999 109.556 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.47 172.52 17.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.45 -0.781 . . . . 0.34000000000000002 109.703 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -137.31 160.01 40.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.407 -0.808 . . . . 0.20999999999999999 109.532 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.514 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 5.2 t -154.88 159.09 40.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.23000000000000001 108.994 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -103.02 134.73 45.97 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.503 -0.925 . . . . 2.2200000000000002 108.503 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.814 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -150.68 144.91 25.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 0.39000000000000001 109.807 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 m -61.5 -30.68 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.573 -0.705 . . . . 0.55000000000000004 110.296 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 24' ' ' ALA . 3.3 p30 -159.3 -179.99 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.917 -1.114 . . . . 1.1599999999999999 109.825 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.39 75.0 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.076 -1.015 . . . . 0.26000000000000001 110.5 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . . . -55.12 -39.37 69.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.839 -1.163 . . . . 0.28999999999999998 111.088 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.814 HG23 ' HB1' ' A' ' 20' ' ' ALA . 1.3 t -74.46 -32.83 62.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.244 -1.535 . . . . 0.44 109.339 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.806 -0.813 . . . . 0.17999999999999999 108.806 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.71 -47.29 82.8 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.787 -1.165 . . . . 1.0600000000000001 109.436 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -64.34 -43.02 95.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 2.6699999999999999 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.83 -54.47 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.305 -0.872 . . . . 0.23000000000000001 111.034 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.514 ' CZ ' HG22 ' A' ' 18' ' ' THR . 33.7 m-85 -62.84 -38.87 92.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.077 -1.014 . . . . 0.14999999999999999 110.783 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -61.62 -42.57 99.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.818 -1.177 . . . . 2.0699999999999998 109.897 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -67.26 -43.0 82.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.84 -1.163 . . . . 1.8400000000000001 108.619 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -47.57 85.28 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -0.774 . . . . 0.29999999999999999 109.308 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.84 99.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.25 109.255 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.84 -42.46 97.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.23 109.059 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -62.49 -21.72 65.71 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -0.912 . . . . 1.29 108.958 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.9 m-20 -99.77 8.92 43.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.64000000000000001 109.41 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.78 35.56 91.44 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.193 -1.163 . . . . 0.71999999999999997 110.193 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.8 t -111.5 128.62 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.267 -1.137 . . . . 0.40000000000000002 109.801 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.473 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 8.9 t70 -111.68 -96.59 0.42 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.108 -1.071 . . . . 1.3300000000000001 108.108 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 68.33 164.42 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 121.237 -0.915 . . . . 0.26000000000000001 112.087 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.68 137.47 42.18 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.319 -1.363 . . . . 2.0699999999999998 107.319 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.18 135.61 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.958 . . . . 0.13 110.956 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -135.61 149.92 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.152 -1.055 . . . . 0.22 108.152 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 49.6 t80 -135.36 135.17 40.49 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.12 109.646 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -114.21 110.14 19.49 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.286 -0.635 . . . . 0.23999999999999999 109.286 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.47 -29.54 69.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 1.1599999999999999 109.852 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -40.46 94.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.29999999999999999 110.167 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 76.9 p -107.94 -0.73 21.22 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.842 . . . . 0.41999999999999998 110.049 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 48.9 42.48 20.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.037 -1.039 . . . . 2.1600000000000001 108.694 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -120.08 130.26 54.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.822 -0.626 . . . . 0.28000000000000003 109.786 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.4 m-85 -98.66 138.37 35.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.274 -1.38 . . . . 0.089999999999999997 107.274 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.7 m -132.07 132.34 43.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.677 -1.264 . . . . 0.14000000000000001 108.792 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.62 126.73 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.931 -1.137 . . . . 0.12 107.931 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.92 127.8 52.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.345 -0.847 . . . . 0.28999999999999998 111.005 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 29.9 mp0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.014 -0.993 . . . . 1.95 109.466 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.53 -0.544 . . . . 0.31 109.53 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.83 145.56 42.01 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.677 -0.86 . . . . 0.19 108.677 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.404 ' HZ2' ' CG1' ' A' ' 6' ' ' ILE . 24.4 ttpp -116.64 142.13 47.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.372 -0.83 . . . . 1.98 109.073 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 30' ' ' PHE . 56.6 tp -121.9 129.41 52.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.728 . . . . 0.13 109.798 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.404 ' CG1' ' HZ2' ' A' ' 4' ' ' LYS . 93.0 mt -105.97 123.3 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.748 -1.575 . . . . 0.35999999999999999 106.748 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.41 117.09 33.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 0.25 110.437 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.01 71.22 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.258 -1.386 . . . . 0.17999999999999999 107.258 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 173.74 54.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.212 -1.555 . . . . 0.23999999999999999 109.212 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -65.16 -39.93 93.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.189 -1.183 . . . . 2.71 108.102 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.7 p -124.99 -14.63 6.58 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.649 -0.5 . . . . 0.92000000000000004 109.649 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.7 tp -99.7 114.94 28.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -0.974 . . . . 0.59999999999999998 109.418 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 129.07 42.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.426 -0.796 . . . . 2.02 109.256 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.58 -175.1 47.41 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.285 -1.436 . . . . 0.23999999999999999 110.312 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -148.28 156.82 43.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.608 -0.936 . . . . 1.6799999999999999 108.96 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -154.67 172.9 17.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 109.604 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 p -137.68 159.13 42.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.752 . . . . 0.20999999999999999 109.064 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -155.65 160.06 40.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.838 . . . . 0.23000000000000001 108.874 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -104.31 133.82 48.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.272 -0.893 . . . . 2.2200000000000002 108.931 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.17 146.27 26.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.39000000000000001 109.614 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.24 -30.69 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.78 . . . . 0.55000000000000004 110.194 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -159.79 179.99 8.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 1.1599999999999999 110.093 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.79 82.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.628 -0.67 . . . . 0.26000000000000001 110.653 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -37.03 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.874 -1.142 . . . . 0.28999999999999998 110.431 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 p -73.49 -36.04 65.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.55 -1.344 . . . . 0.44 109.845 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.9 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.039 -1.097 . . . . 0.17999999999999999 108.039 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.66 -45.73 85.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.13 -1.028 . . . . 1.0600000000000001 110.203 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -67.35 -40.72 85.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.123 . . . . 2.6699999999999999 110.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.37 -53.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.23000000000000001 110.871 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CD1' HD22 ' A' ' 5' ' ' LEU . 41.0 m-85 -67.25 -40.01 86.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.923 -1.11 . . . . 0.14999999999999999 110.664 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.75 -46.18 91.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.876 -1.14 . . . . 2.0699999999999998 109.945 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.65 -43.01 81.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.095 -1.003 . . . . 1.8400000000000001 108.782 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.9 t80 -60.09 -45.09 94.09 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.401 -0.812 . . . . 0.29999999999999999 109.606 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.373 -0.829 . . . . 0.25 109.49 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -62.43 -40.12 95.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 1.23 109.007 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.62 -24.58 67.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 1.29 109.426 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 73.0 m-20 -97.14 10.08 40.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.64000000000000001 109.198 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.0 93.97 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.321 -1.512 . . . . 0.71999999999999997 109.321 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.4 t -109.94 123.75 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.356 -1.085 . . . . 0.40000000000000002 109.867 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 97.6 m-20 -140.44 146.89 38.87 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.151 -1.055 . . . . 1.3300000000000001 108.151 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.39 -155.49 22.47 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.077 -1.535 . . . . 0.26000000000000001 110.105 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -88.03 130.66 34.91 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.85 -1.167 . . . . 2.0699999999999998 107.85 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -103.0 138.92 39.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.13 110.463 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.8 p -136.83 150.05 48.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.341 -0.985 . . . . 0.22 108.341 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.3 t80 -135.69 137.09 41.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.435 -0.791 . . . . 0.12 110.233 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.93 109.95 20.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.901 -0.777 . . . . 0.23999999999999999 108.901 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 51.9 t0 -67.15 -32.45 73.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 1.1599999999999999 110.179 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.51 94.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.29999999999999999 110.213 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -108.15 0.14 21.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.561 -0.712 . . . . 0.41999999999999998 110.44 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 49.98 41.68 23.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.836 -1.165 . . . . 2.1600000000000001 108.404 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -118.97 131.09 56.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.66 0.743 . . . . 0.28000000000000003 110.264 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 44.4 m-85 -99.97 139.19 35.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.527 -1.286 . . . . 0.089999999999999997 107.527 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 m -131.94 132.18 43.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.838 -1.164 . . . . 0.14000000000000001 108.361 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.49 129.93 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.485 -0.932 . . . . 0.12 108.485 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -119.99 127.33 52.52 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.551 -0.718 . . . . 0.28999999999999998 110.134 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 7.7 mp0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.975 -1.012 . . . . 1.95 109.238 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.283 0.563 . . . . 0.31 109.53 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.2 149.0 41.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.623 -0.88 . . . . 0.19 108.623 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -114.81 143.84 44.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.332 -0.855 . . . . 1.98 109.877 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.424 HD22 ' CD1' ' A' ' 30' ' ' PHE . 27.8 tp -121.31 127.14 51.02 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.858 -0.793 . . . . 0.13 108.858 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.9 mt -106.87 123.36 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.523 -1.288 . . . . 0.35999999999999999 107.523 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -102.28 114.13 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.25 109.68 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' OD1' ' NZ ' ' A' ' 13' ' ' LYS . 43.2 t30 -114.88 71.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.72 -1.215 . . . . 0.17999999999999999 107.72 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 166.43 49.76 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.416 -1.474 . . . . 0.23999999999999999 109.416 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.437 ' NZ ' ' C ' ' A' ' 56' ' ' GLU . 60.0 mttp -67.41 -35.21 78.81 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -1.152 . . . . 2.71 108.027 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -22.42 4.99 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.929 -0.482 . . . . 0.92000000000000004 109.849 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.37 119.96 39.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.306 -0.871 . . . . 0.59999999999999998 109.338 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 8' ' ' ASN . 66.1 mttm -133.08 131.74 40.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.287 -0.883 . . . . 2.02 109.648 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.02 -179.97 48.8 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.273 -1.441 . . . . 0.23999999999999999 110.426 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -142.0 151.97 42.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.609 -0.936 . . . . 1.6799999999999999 108.73 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -151.89 167.65 27.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.34000000000000002 109.074 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 p -139.88 160.82 39.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.20999999999999999 109.411 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.9 t -155.72 161.17 40.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.686 -0.857 . . . . 0.23000000000000001 108.686 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -103.45 135.03 45.82 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.484 -0.932 . . . . 2.2200000000000002 108.484 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.9 144.28 27.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.39000000000000001 109.549 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.36 -30.07 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.821 . . . . 0.55000000000000004 109.634 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -158.35 171.06 20.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 1.1599999999999999 109.582 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.78 81.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.26000000000000001 109.796 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.71 68.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.115 . . . . 0.28999999999999998 109.909 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.9 m -69.96 -37.17 75.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.44 109.722 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.83 75.2 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.588 -0.893 . . . . 0.17999999999999999 108.588 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.43 -47.31 72.96 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.943 -1.103 . . . . 1.0600000000000001 109.524 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 8.2 mptt -67.96 -40.2 83.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.794 -1.191 . . . . 2.6699999999999999 110.459 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.24 -53.39 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 0.23000000000000001 111.361 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.9 m-85 -64.7 -39.98 94.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.887 -1.133 . . . . 0.14999999999999999 111.045 -178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -62.14 -40.01 94.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.719 -1.238 . . . . 2.0699999999999998 109.932 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.94 -1.1 . . . . 1.8400000000000001 108.795 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 68.6 t80 -59.89 -48.63 80.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 0.29999999999999999 109.606 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -43.22 99.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.366 -0.834 . . . . 0.25 109.151 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.06 -42.53 94.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.641 -0.874 . . . . 1.23 108.641 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.72 -22.21 66.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 1.29 109.289 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.524 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 32.2 m120 -96.27 6.91 47.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.246 -0.909 . . . . 0.64000000000000001 109.988 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.79 75.38 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.76 -1.21 . . . . 0.71999999999999997 110.201 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 126.97 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.282 -1.128 . . . . 0.40000000000000002 109.621 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -142.92 148.69 37.34 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.353 -0.98 . . . . 1.3300000000000001 108.353 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.07 -150.45 14.73 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.173 -1.489 . . . . 0.26000000000000001 110.147 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 59.1 mp0 -89.17 129.33 35.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.976 -1.12 . . . . 2.0699999999999998 107.976 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -100.4 138.35 37.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.13 110.066 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.6 p -136.37 150.04 48.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.13 -1.063 . . . . 0.22 108.13 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -134.37 135.55 42.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.441 -0.787 . . . . 0.12 109.7 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -111.23 108.68 18.4 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.186 -1.042 . . . . 0.23999999999999999 108.186 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -67.58 -30.81 70.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 1.1599999999999999 110.197 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.02 94.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.29999999999999999 110.112 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -104.72 0.09 27.96 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.486 -0.759 . . . . 0.41999999999999998 110.417 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 49.97 40.43 21.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.886 -1.134 . . . . 2.1600000000000001 108.215 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 131.05 55.01 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.685 0.755 . . . . 0.28000000000000003 110.497 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -98.66 137.85 36.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.037 -1.468 . . . . 0.089999999999999997 107.037 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.3 m -129.99 130.87 45.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.14000000000000001 108.074 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.26 129.39 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.123 -1.066 . . . . 0.12 108.123 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -118.32 124.71 48.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.28999999999999998 109.172 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' C ' ' NZ ' ' A' ' 10' ' ' LYS . 83.3 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.971 -1.014 . . . . 1.95 109.575 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.15 0.5 . . . . 0.31 109.758 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.09 145.02 40.5 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.26 -1.015 . . . . 0.19 108.26 178.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -115.97 139.95 49.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.288 -1.004 . . . . 1.98 108.288 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 52' ' ' PHE . 24.4 tp -120.52 127.71 52.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.512 -0.921 . . . . 0.13 108.512 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.0 mt -105.87 123.3 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.118 -1.438 . . . . 0.35999999999999999 107.118 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.427 HD23 HG12 ' A' ' 54' ' ' VAL . 87.3 mt -103.67 115.01 29.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.25 110.034 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.71 71.15 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.353 -1.351 . . . . 0.17999999999999999 107.353 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 167.12 50.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.513 -1.435 . . . . 0.23999999999999999 109.513 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -64.98 -36.23 83.72 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.662 -1.236 . . . . 2.71 107.662 178.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -19.51 5.3 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.849 -0.426 . . . . 0.92000000000000004 109.849 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.82 119.99 38.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.082 -1.011 . . . . 0.59999999999999998 109.126 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -133.67 129.12 36.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.02 109.722 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.85 -175.08 47.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.46 -1.353 . . . . 0.23999999999999999 110.443 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.53 156.95 43.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.981 . . . . 1.6799999999999999 109.444 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -154.33 169.96 22.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.34000000000000002 109.353 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -137.85 160.46 39.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.20999999999999999 109.311 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.46 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 3.4 t -156.08 162.0 40.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.23000000000000001 108.971 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 4.0 tm-20 -102.94 134.8 45.76 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.675 -0.861 . . . . 2.2200000000000002 108.675 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.19 -0.944 . . . . 0.39000000000000001 108.939 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.2 m -60.09 -29.89 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.55000000000000004 109.356 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -158.14 176.5 12.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 1.1599999999999999 109.834 -179.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.41 88.41 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.26000000000000001 109.85 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.55 49.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.946 -1.096 . . . . 0.28999999999999998 109.433 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.659 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.5 m -69.47 -39.99 77.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.827 -1.171 . . . . 0.44 109.942 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.37 97.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.312 -0.868 . . . . 0.17999999999999999 109.137 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.29 -56.76 12.68 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.46 -0.896 . . . . 1.0600000000000001 111.091 -178.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -69.48 -37.4 77.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.6699999999999999 111.83 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.48 -53.49 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.425 -1.422 . . . . 0.23000000000000001 110.637 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CZ ' HG22 ' A' ' 18' ' ' THR . 39.7 m-85 -61.81 -35.75 79.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.022 -1.049 . . . . 0.14999999999999999 110.266 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.03 -40.77 90.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.946 -1.096 . . . . 2.0699999999999998 108.952 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -69.41 -41.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 1.8400000000000001 108.795 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.5 t80 -60.03 -49.93 75.72 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.048 -0.723 . . . . 0.29999999999999999 109.048 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.77 96.28 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.476 -0.765 . . . . 0.25 109.362 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.46 -40.74 97.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 1.23 109.554 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.99 -25.7 67.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 1.29 109.271 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.2 m-20 -97.9 9.08 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.64000000000000001 108.741 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.43 37.63 94.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.332 -1.107 . . . . 0.71999999999999997 110.332 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.75 129.81 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.22 -1.165 . . . . 0.40000000000000002 110.403 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 89.5 m-20 -111.65 -96.2 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.012 -1.107 . . . . 1.3300000000000001 108.012 178.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.71 166.27 4.16 Favored Glycine 0 N--CA 1.491 2.351 0 CA-C-O 122.156 0.865 . . . . 0.26000000000000001 112.27 177.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.52 138.6 39.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.361 -1.348 . . . . 2.0699999999999998 107.361 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -100.22 135.76 41.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.119 -0.988 . . . . 0.13 110.91 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.4 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.005 -1.109 . . . . 0.22 108.005 179.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -135.32 134.97 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.233 -0.917 . . . . 0.12 110.693 -177.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.28 110.0 20.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.677 -0.86 . . . . 0.23999999999999999 108.677 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -65.61 -31.7 72.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.1599999999999999 110.363 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.56 -40.0 88.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.29999999999999999 110.756 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.7 p -105.06 -0.41 26.76 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.41999999999999998 110.469 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 50.02 40.34 21.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.888 -1.132 . . . . 2.1600000000000001 108.068 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.02 54.51 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.645 0.736 . . . . 0.28000000000000003 110.137 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.445 ' O ' HD12 ' A' ' 5' ' ' LEU . 45.3 m-85 -98.67 139.96 33.59 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.118 -1.438 . . . . 0.089999999999999997 107.118 178.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.2 m -129.43 131.25 46.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.764 -1.21 . . . . 0.14000000000000001 108.417 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG12 HD23 ' A' ' 7' ' ' LEU . 2.7 p -120.22 128.93 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.934 -1.136 . . . . 0.12 107.934 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -119.92 125.72 49.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.28999999999999998 109.757 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.999 -1.0 . . . . 1.95 109.516 -179.691 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.388 -0.597 . . . . 0.31 109.388 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 91.5 m-85 -117.93 148.69 41.92 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.772 -0.825 . . . . 0.19 108.772 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -117.07 145.28 43.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 1.98 109.324 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 7' ' ' LEU . 46.0 tp -119.45 127.53 53.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.547 -0.908 . . . . 0.13 108.547 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.09 121.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.023 -1.473 . . . . 0.35999999999999999 107.023 178.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 5' ' ' LEU . 85.8 mt -102.55 116.81 33.35 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 0.25 110.308 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.0 68.29 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.509 -1.293 . . . . 0.17999999999999999 107.509 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.5 171.55 54.13 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.505 -1.438 . . . . 0.23999999999999999 109.505 179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -66.26 -39.86 89.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -1.128 . . . . 2.71 108.148 178.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.1 p -120.01 -20.09 7.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.999 -0.438 . . . . 0.92000000000000004 109.848 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.8 tp -99.98 120.07 39.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 0.59999999999999998 109.415 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -136.47 130.61 32.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 2.02 109.833 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.57 -173.62 46.42 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.392 -1.385 . . . . 0.23999999999999999 110.905 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 46.4 mp0 -144.34 153.55 42.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.982 . . . . 1.6799999999999999 108.958 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -153.17 168.54 25.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.34000000000000002 109.446 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 p -139.36 159.78 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.863 . . . . 0.20999999999999999 109.167 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -156.74 164.24 38.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.953 -0.758 . . . . 0.23000000000000001 108.953 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -103.37 133.98 47.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.379 -0.826 . . . . 2.2200000000000002 109.01 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.14 143.39 28.22 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.6 -0.889 . . . . 0.39000000000000001 108.6 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -59.94 -29.61 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.55000000000000004 109.535 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -157.74 175.19 14.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 1.1599999999999999 110.022 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.13 85.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.552 -0.717 . . . . 0.26000000000000001 109.871 -179.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.24 -36.58 61.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.112 . . . . 0.28999999999999998 109.912 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.503 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 5.1 p -73.43 -33.47 64.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.608 -1.307 . . . . 0.44 109.732 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.18 81.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.237 -1.023 . . . . 0.17999999999999999 108.237 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.01 -44.93 83.31 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.823 -1.151 . . . . 1.0600000000000001 109.558 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.7 -42.72 85.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.882 -1.136 . . . . 2.6699999999999999 110.579 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.63 -52.0 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.23000000000000001 111.243 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.67 -40.03 88.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.025 -1.047 . . . . 0.14999999999999999 111.269 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -63.51 -41.28 98.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.503 -1.373 . . . . 2.0699999999999998 109.997 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -70.0 -45.68 66.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.879 -1.138 . . . . 1.8400000000000001 108.939 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.545 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 72.9 t80 -60.02 -47.98 83.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.495 -0.753 . . . . 0.29999999999999999 109.453 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.59 98.64 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.478 -0.764 . . . . 0.25 109.474 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.95 -40.49 89.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.392 -0.818 . . . . 1.23 108.974 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -65.08 -19.26 65.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.784 -0.821 . . . . 1.29 108.784 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.545 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 97.4 m-20 -94.68 6.7 48.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.64000000000000001 109.788 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.2 30.25 63.17 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.9 -1.143 . . . . 0.71999999999999997 111.153 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.02 124.26 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.901 -1.352 . . . . 0.40000000000000002 108.527 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 27.7 p-10 -150.58 99.61 2.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 1.3300000000000001 110.593 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.2 -125.48 0.86 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.174 -1.489 . . . . 0.26000000000000001 111.317 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.79 130.3 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.898 -1.354 . . . . 2.0699999999999998 110.851 -178.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -107.23 139.59 41.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 0.13 110.27 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.5 p -137.77 150.02 46.9 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.419 -0.956 . . . . 0.22 108.419 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CE1' ' CE1' ' A' ' 52' ' ' PHE . 48.9 t80 -137.79 137.75 38.53 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.175 -0.953 . . . . 0.12 110.337 -179.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.719 -0.845 . . . . 0.23999999999999999 108.719 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.51 -31.05 71.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.346 -0.846 . . . . 1.1599999999999999 110.928 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.9 94.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.29999999999999999 110.537 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -103.55 0.04 30.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.381 -0.824 . . . . 0.41999999999999998 110.383 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 20.4 mtpp 49.91 40.12 20.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.11 . . . . 2.1600000000000001 108.255 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -120.1 131.12 54.95 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.498 0.666 . . . . 0.28000000000000003 110.14 -178.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 54.3 m-85 -99.96 138.83 36.49 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.447 -1.316 . . . . 0.089999999999999997 107.447 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.7 m -130.06 131.55 45.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.14000000000000001 108.709 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.5 p -121.67 127.68 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.577 -0.898 . . . . 0.12 108.577 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -125.47 127.51 46.6 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.532 -0.73 . . . . 0.28999999999999998 109.803 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.019 -0.991 . . . . 1.95 109.289 179.811 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.176 0.512 . . . . 0.31 109.776 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.456 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 95.8 m-85 -114.31 141.93 46.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.691 -0.855 . . . . 0.19 108.691 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.7 140.17 48.47 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.733 -0.84 . . . . 1.98 108.733 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.59 HD22 ' CD1' ' A' ' 30' ' ' PHE . 46.6 tp -120.06 128.76 53.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.347 -0.846 . . . . 0.13 109.516 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -104.96 122.38 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.208 -1.404 . . . . 0.35999999999999999 107.208 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.74 115.45 30.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -0.987 . . . . 0.25 110.282 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -118.75 72.37 0.88 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.826 -1.176 . . . . 0.17999999999999999 107.826 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 171.06 54.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.351 -1.5 . . . . 0.23999999999999999 109.351 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.66 -39.85 94.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.05 -1.265 . . . . 2.71 108.173 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -124.67 -16.1 6.34 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.204 -0.665 . . . . 0.92000000000000004 109.204 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 9' ' ' GLY . 60.1 tp -99.8 118.04 35.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.323 -0.86 . . . . 0.59999999999999998 108.794 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -135.83 133.78 38.18 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 2.02 109.916 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.54 -176.21 47.86 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.495 -1.336 . . . . 0.23999999999999999 110.403 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -145.03 151.61 38.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.505 -0.924 . . . . 1.6799999999999999 108.505 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -152.62 170.16 20.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.34000000000000002 109.422 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -137.74 159.88 40.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -0.771 . . . . 0.20999999999999999 109.196 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.421 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.2 t -156.97 162.27 39.6 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.368 -0.832 . . . . 0.23000000000000001 108.796 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -106.58 136.6 46.08 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.778 -0.823 . . . . 2.2200000000000002 108.778 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.91 148.52 29.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.39000000000000001 109.39 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.9 -33.35 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.392 -0.817 . . . . 0.55000000000000004 110.086 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -159.85 179.98 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 1.1599999999999999 110.088 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.456 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -66.74 -40.03 88.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.534 -0.728 . . . . 0.26000000000000001 110.469 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -37.56 63.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.873 -1.142 . . . . 0.28999999999999998 110.228 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.4 m -69.99 -39.98 75.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.673 -1.267 . . . . 0.44 110.148 179.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.05 88.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.803 . . . . 0.17999999999999999 109.09 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.97 -46.37 82.24 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.769 -1.172 . . . . 1.0600000000000001 109.57 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -67.39 -44.11 79.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.435 -0.79 . . . . 2.6699999999999999 110.67 -179.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.37 -53.11 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.23000000000000001 110.99 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CD1' HD22 ' A' ' 5' ' ' LEU . 30.3 m-85 -63.62 -38.76 92.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.935 -1.103 . . . . 0.14999999999999999 110.4 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -60.07 -45.13 93.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.856 -1.153 . . . . 2.0699999999999998 109.999 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -69.07 -42.1 76.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.025 -1.047 . . . . 1.8400000000000001 109.1 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.615 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -59.98 -44.65 94.36 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.717 -0.846 . . . . 0.29999999999999999 108.717 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.58 -43.6 96.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.25 109.013 179.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -60.28 -42.39 95.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.24 -0.913 . . . . 1.23 108.814 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.9 -25.26 67.46 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.398 -0.814 . . . . 1.29 109.344 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.615 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 94.2 m-20 -100.13 8.94 43.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.392 -0.817 . . . . 0.64000000000000001 109.419 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.99 36.2 92.79 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.225 -1.15 . . . . 0.71999999999999997 110.225 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.13 124.79 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.196 -1.179 . . . . 0.40000000000000002 109.974 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 80.2 m-20 -110.62 -98.74 0.4 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.07 -1.085 . . . . 1.3300000000000001 108.07 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.29 165.97 2.73 Favored Glycine 0 N--CA 1.488 2.121 0 CA-C-O 122.146 0.859 . . . . 0.26000000000000001 112.134 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -77.79 135.49 37.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.067 -1.457 . . . . 2.0699999999999998 107.067 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -98.58 135.66 39.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.125 -0.985 . . . . 0.13 110.66 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.6 p -132.77 148.24 52.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.747 -1.205 . . . . 0.22 107.747 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 55.5 t80 -135.07 135.63 41.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.261 -0.899 . . . . 0.12 110.372 -178.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -113.03 110.05 19.84 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.607 -0.886 . . . . 0.23999999999999999 108.607 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 45.7 t0 -68.0 -30.27 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.1599999999999999 110.348 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.29 93.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.29999999999999999 110.058 -179.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -107.85 0.08 21.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.476 -0.765 . . . . 0.41999999999999998 110.106 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 49.98 43.52 25.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.928 -1.107 . . . . 2.1600000000000001 108.581 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.81 130.23 54.82 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.592 0.71 . . . . 0.28000000000000003 110.473 -178.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.527 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.9 m-85 -101.37 139.91 36.39 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.231 -1.396 . . . . 0.089999999999999997 107.231 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.0 m -132.83 134.01 44.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.786 -1.196 . . . . 0.14000000000000001 108.756 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -122.81 129.8 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.608 -0.886 . . . . 0.12 108.608 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -122.67 126.81 48.36 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.415 -0.803 . . . . 0.28999999999999998 110.654 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.94 -1.028 . . . . 1.95 109.482 179.038 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.6 m . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.18 -0.674 . . . . 0.31 109.18 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.73 148.85 37.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.463 -0.773 . . . . 0.19 109.047 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -118.75 142.44 47.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.406 -0.808 . . . . 1.98 109.228 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 30' ' ' PHE . 31.9 tp -120.84 129.43 53.54 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.483 -0.76 . . . . 0.13 109.279 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -106.58 123.08 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.404 -1.332 . . . . 0.35999999999999999 107.404 179.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.47 115.2 30.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.242 -0.911 . . . . 0.25 110.412 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -117.57 70.15 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.352 -1.351 . . . . 0.17999999999999999 107.352 178.115 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.78 54.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.977 -1.249 . . . . 0.23999999999999999 109.977 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.2 -39.8 93.33 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -1.1 . . . . 2.71 108.333 178.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -15.62 6.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.947 -0.471 . . . . 0.92000000000000004 109.778 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.9 tp -100.01 120.04 39.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.095 -1.003 . . . . 0.59999999999999998 109.517 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -131.89 127.06 35.67 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.331 -0.856 . . . . 2.02 109.364 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.99 -177.9 48.26 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.178 -1.487 . . . . 0.23999999999999999 110.676 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -148.31 156.89 43.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.625 -0.926 . . . . 1.6799999999999999 109.179 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.429 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 5.6 t -154.21 170.52 21.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.347 -0.845 . . . . 0.34000000000000002 109.629 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.9 p -137.98 160.02 40.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.385 -0.822 . . . . 0.20999999999999999 109.415 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.414 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.9 t -155.08 160.52 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.23000000000000001 109.239 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -104.36 133.55 49.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.344 -0.848 . . . . 2.2200000000000002 108.757 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.95 146.07 27.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.006 -1.059 . . . . 0.39000000000000001 109.637 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.61 -30.15 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.389 -0.819 . . . . 0.55000000000000004 109.975 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -158.5 174.91 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 1.1599999999999999 110.163 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.17 79.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.553 -0.717 . . . . 0.26000000000000001 110.372 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.94 -37.82 61.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.793 -1.192 . . . . 0.28999999999999998 110.092 -179.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 p -74.14 -33.06 63.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.637 -1.289 . . . . 0.44 109.685 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.18 93.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.406 -0.809 . . . . 0.17999999999999999 108.934 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.67 -46.28 84.45 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.838 -1.145 . . . . 1.0600000000000001 109.637 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -67.13 -40.09 86.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 2.6699999999999999 110.304 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.47 -53.17 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.972 . . . . 0.23000000000000001 110.673 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' HD22 ' A' ' 5' ' ' LEU . 37.4 m-85 -63.99 -38.07 89.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.14999999999999999 110.551 -178.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -59.93 -40.16 87.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.624 -1.298 . . . . 2.0699999999999998 109.126 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -69.38 -41.77 76.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.125 -0.984 . . . . 1.8400000000000001 109.042 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 59.3 t80 -60.03 -46.6 88.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.29999999999999999 109.576 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.97 95.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.25 109.308 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -40.66 90.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.148 -0.97 . . . . 1.23 108.976 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -64.51 -26.12 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.284 -0.885 . . . . 1.29 109.984 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.627 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 69.6 m-80 -99.75 4.99 45.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.017 -1.052 . . . . 0.64000000000000001 110.103 -179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.4 60.82 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.034 -1.079 . . . . 0.71999999999999997 111.599 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.3 t -110.67 122.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.892 -1.357 . . . . 0.40000000000000002 108.39 178.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 71.1 m-20 -150.6 101.04 2.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 1.3300000000000001 110.659 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.36 -131.84 1.49 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 119.297 -1.43 . . . . 0.26000000000000001 111.083 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 57.8 mp0 -88.81 128.11 35.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.952 -1.322 . . . . 2.0699999999999998 110.164 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -104.11 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.692 -0.63 . . . . 0.13 109.999 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.9 p -131.49 147.19 52.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.93 -1.137 . . . . 0.22 107.93 178.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 53.7 t80 -133.25 132.36 41.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.338 -0.851 . . . . 0.12 110.207 -178.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -114.65 109.94 18.99 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.381 -0.97 . . . . 0.23999999999999999 108.381 178.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -69.51 -27.67 65.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 1.1599999999999999 110.267 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.92 95.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.29999999999999999 109.926 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.9 p -106.02 0.18 25.43 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.546 -0.721 . . . . 0.41999999999999998 110.036 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtpm? 50.02 39.96 20.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.882 -1.136 . . . . 2.1600000000000001 108.289 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -120.01 132.87 55.63 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 0.28000000000000003 110.593 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 56.3 m-85 -100.36 139.67 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.252 -1.388 . . . . 0.089999999999999997 107.252 177.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 m -130.24 131.97 45.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.763 -1.21 . . . . 0.14000000000000001 108.339 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.83 129.25 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.34 -0.985 . . . . 0.12 108.34 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -124.56 128.19 48.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.621 -0.674 . . . . 0.28999999999999998 110.115 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.038 -0.982 . . . . 1.95 109.296 179.8 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.6 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.325 -0.62 . . . . 0.31 109.325 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -112.35 145.37 40.18 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.366 -0.976 . . . . 0.19 108.366 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -113.43 139.97 48.47 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.124 -0.985 . . . . 1.98 108.8 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.4 tp -120.91 126.6 50.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.754 -0.832 . . . . 0.13 108.754 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.62 124.01 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.61 -1.256 . . . . 0.35999999999999999 107.61 178.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 54' ' ' VAL . 90.0 mt -104.24 114.13 28.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.25 110.231 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -113.5 72.46 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.395 -1.335 . . . . 0.17999999999999999 107.395 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.55 169.46 53.53 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.665 -1.374 . . . . 0.23999999999999999 109.665 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -64.87 -38.51 91.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -1.129 . . . . 2.71 108.517 178.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 p -130.62 -16.58 3.37 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.527 -0.546 . . . . 0.92000000000000004 109.527 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -101.76 117.36 34.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.249 -1.019 . . . . 0.59999999999999998 108.249 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -133.71 137.87 45.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.207 -0.933 . . . . 2.02 110.416 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -180.0 -178.25 48.43 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.688 -1.244 . . . . 0.23999999999999999 110.194 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.56 154.71 41.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.507 -0.923 . . . . 1.6799999999999999 108.507 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -154.63 170.7 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.842 . . . . 0.34000000000000002 109.502 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -138.32 160.03 40.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.919 -0.771 . . . . 0.20999999999999999 108.919 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.1 t -156.7 161.42 39.85 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.273 -0.892 . . . . 0.23000000000000001 109.239 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -102.92 134.97 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.696 -0.853 . . . . 2.2200000000000002 108.696 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.61 144.87 27.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 0.39000000000000001 108.912 -179.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.03 -30.58 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.55000000000000004 109.467 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -159.73 178.51 9.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 1.1599999999999999 110.02 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.76 -37.92 82.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.456 -0.777 . . . . 0.26000000000000001 110.048 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.51 -37.38 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.965 -1.085 . . . . 0.28999999999999998 110.136 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.402 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.8 m -69.92 -39.19 76.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.634 -1.291 . . . . 0.44 109.66 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.89 87.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.595 -0.69 . . . . 0.17999999999999999 109.196 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.97 -45.81 82.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.883 -1.127 . . . . 1.0600000000000001 109.504 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -67.82 -43.38 79.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 2.6699999999999999 110.679 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.94 -52.53 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.32 -0.863 . . . . 0.23000000000000001 111.62 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.581 ' CD1' HD22 ' A' ' 5' ' ' LEU . 27.1 m-85 -64.22 -38.47 91.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.802 -1.186 . . . . 0.14999999999999999 110.482 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -60.04 -44.07 94.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.84 -1.162 . . . . 2.0699999999999998 109.692 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.512 ' NE2' ' OD2' ' A' ' 36' ' ' ASP . 1.6 tm0? -67.91 -41.7 82.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 1.8400000000000001 108.705 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.7 t80 -60.0 -49.02 79.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.622 -0.674 . . . . 0.29999999999999999 109.503 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.42 93.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.25 109.057 179.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -60.17 -44.58 94.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 1.23 109.366 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' NE2' ' A' ' 32' ' ' GLN . 82.3 m-20 -62.72 -24.04 67.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 1.29 109.24 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.623 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.0 m-20 -97.63 7.01 47.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.816 . . . . 0.64000000000000001 109.667 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.18 31.59 77.93 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.053 -1.07 . . . . 0.71999999999999997 110.851 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.99 127.41 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.174 -1.192 . . . . 0.40000000000000002 109.836 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 87.5 m-20 -109.99 -99.82 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.092 -1.077 . . . . 1.3300000000000001 108.092 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.96 163.51 4.17 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-O 122.028 0.793 . . . . 0.26000000000000001 112.339 177.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 58.1 mp0 -75.55 137.15 40.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.321 -1.363 . . . . 2.0699999999999998 107.321 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -99.89 135.0 41.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 0.13 110.927 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.6 p -135.23 150.05 50.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.632 -1.247 . . . . 0.22 107.632 178.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -135.27 138.9 43.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.294 -0.879 . . . . 0.12 110.566 -178.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -113.66 109.99 19.48 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.65 -0.87 . . . . 0.23999999999999999 108.65 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 36.5 t0 -67.5 -31.39 71.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.1599999999999999 110.312 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.973 . . . . 0.29999999999999999 110.573 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -105.4 0.64 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.519 -0.738 . . . . 0.41999999999999998 110.14 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm 50.58 42.45 26.87 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.855 -1.165 . . . . 2.1600000000000001 107.855 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -120.0 131.14 55.05 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.719 0.771 . . . . 0.28000000000000003 110.945 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -99.72 138.21 37.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.115 -1.439 . . . . 0.089999999999999997 107.115 177.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -130.63 131.95 45.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.662 -1.274 . . . . 0.14000000000000001 109.076 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -124.23 130.02 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.402 -0.962 . . . . 0.12 108.402 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.91 126.5 51.05 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.664 -0.648 . . . . 0.28999999999999998 110.181 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.981 -1.009 . . . . 1.95 109.576 -179.901 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.281 0.562 . . . . 0.31 109.929 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.71 148.03 38.84 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.369 -0.975 . . . . 0.19 108.369 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -116.5 140.89 48.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.257 -0.902 . . . . 1.98 109.08 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 30' ' ' PHE . 65.7 tp -120.42 129.56 53.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.601 -0.687 . . . . 0.13 109.581 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.68 122.76 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.746 -1.576 . . . . 0.35999999999999999 106.746 177.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.97 116.5 32.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.892 . . . . 0.25 109.679 -178.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -114.87 71.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 0.17999999999999999 107.601 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.32 168.18 48.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.396 -1.482 . . . . 0.23999999999999999 109.396 179.147 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.47 -39.51 77.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.187 -1.184 . . . . 2.71 108.459 178.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -117.82 -22.96 7.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.783 -0.573 . . . . 0.92000000000000004 109.662 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.8 tp -101.45 120.37 40.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.59999999999999998 109.264 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -134.38 129.9 36.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.957 . . . . 2.02 109.536 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.53 -174.0 46.58 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.369 -1.396 . . . . 0.23999999999999999 110.391 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -148.56 157.21 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.631 -0.923 . . . . 1.6799999999999999 108.932 179.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -154.8 170.8 20.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.922 . . . . 0.34000000000000002 109.664 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.4 p -137.97 160.13 40.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.20999999999999999 109.086 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -156.19 162.95 40.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.384 -0.822 . . . . 0.23000000000000001 109.061 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -102.31 133.81 46.61 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.677 -0.861 . . . . 2.2200000000000002 108.677 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.34 143.16 25.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.096 . . . . 0.39000000000000001 109.525 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.79 -29.81 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.55000000000000004 110.051 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -157.93 176.53 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.1599999999999999 109.915 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.34 -37.58 80.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 0.26000000000000001 109.827 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.82 -37.34 59.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.017 . . . . 0.28999999999999998 109.94 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.405 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 3.2 p -73.31 -34.5 65.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.692 -1.255 . . . . 0.44 109.388 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.35 93.18 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.693 -0.854 . . . . 0.17999999999999999 108.693 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.35 -50.05 74.18 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.634 -1.226 . . . . 1.0600000000000001 109.754 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -65.88 -41.43 91.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 2.6699999999999999 110.141 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.88 -55.35 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.1 -1.0 . . . . 0.23000000000000001 110.259 -178.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.527 ' CD1' HD22 ' A' ' 5' ' ' LEU . 26.3 m-85 -65.12 -39.75 93.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.14999999999999999 110.298 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -60.53 -44.06 96.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 2.0699999999999998 109.637 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -69.23 -42.78 75.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.968 -1.082 . . . . 1.8400000000000001 108.797 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 77.2 t80 -60.02 -45.92 91.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.463 -0.773 . . . . 0.29999999999999999 109.18 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.24 95.95 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.507 -0.746 . . . . 0.25 109.016 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -61.32 -40.93 96.03 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 1.23 109.192 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.86 -25.1 66.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 1.29 109.513 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 92.9 m-20 -97.9 9.99 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 0.64000000000000001 109.881 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.15 92.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.835 -1.306 . . . . 0.71999999999999997 109.835 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.99 125.54 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.287 -1.125 . . . . 0.40000000000000002 109.482 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 21.3 p-10 -141.76 148.5 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.214 -1.032 . . . . 1.3300000000000001 108.214 179.017 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.43 -147.75 10.92 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.219 -1.467 . . . . 0.26000000000000001 110.053 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -93.14 131.32 38.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 2.0699999999999998 108.445 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -100.71 137.4 39.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 0.13 110.098 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.0 p -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.446 -0.946 . . . . 0.22 108.446 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 59.3 t80 -134.09 136.39 43.89 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.408 -0.808 . . . . 0.12 110.162 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -112.16 109.27 18.87 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.314 -0.995 . . . . 0.23999999999999999 108.314 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.17 -31.2 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.973 . . . . 1.1599999999999999 110.287 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.04 90.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.29999999999999999 110.318 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.3 p -104.98 -0.76 26.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.251 -0.905 . . . . 0.41999999999999998 110.011 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 50.06 40.77 22.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 2.1600000000000001 108.362 -179.755 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.58 54.86 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.616 0.722 . . . . 0.28000000000000003 110.141 -178.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 33.3 m-85 -98.75 138.32 36.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 0.089999999999999997 106.999 178.278 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -131.99 132.21 43.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.878 -1.139 . . . . 0.14000000000000001 108.139 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.18 132.15 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.481 -0.933 . . . . 0.12 108.481 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.7 m -119.1 126.38 51.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.608 -0.683 . . . . 0.28999999999999998 109.631 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.055 -0.974 . . . . 1.95 109.584 -179.36 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.218 -0.66 . . . . 0.31 109.218 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.72 147.7 40.6 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.771 -0.826 . . . . 0.19 108.771 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -117.29 143.8 45.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.405 -0.809 . . . . 1.98 109.651 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 30' ' ' PHE . 40.8 tp -119.58 126.61 51.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.591 -0.892 . . . . 0.13 108.591 179.078 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.55 122.79 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.194 -1.41 . . . . 0.35999999999999999 107.194 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.4 mt -100.3 117.14 33.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.25 110.265 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -122.2 66.55 0.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.334 -1.358 . . . . 0.17999999999999999 107.334 178.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.33 169.87 53.04 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 0.23999999999999999 109.794 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -63.61 -39.88 95.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.272 -1.134 . . . . 2.71 108.582 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.09 -19.92 6.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.955 -0.466 . . . . 0.92000000000000004 109.896 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.37 119.98 38.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.228 -0.92 . . . . 0.59999999999999998 109.401 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -135.14 129.99 34.73 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.268 -0.895 . . . . 2.02 109.832 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.61 -177.38 48.42 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.338 -1.411 . . . . 0.23999999999999999 110.584 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -142.52 151.14 41.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.607 -0.937 . . . . 1.6799999999999999 108.676 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -152.72 167.37 29.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.34000000000000002 109.241 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.7 p -137.67 160.19 39.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.20999999999999999 109.502 -179.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.465 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 5.9 t -153.77 159.94 42.09 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.672 -0.862 . . . . 0.23000000000000001 108.672 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -101.43 131.95 47.28 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.45 -0.944 . . . . 2.2200000000000002 108.45 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.17 142.75 27.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.39000000000000001 109.22 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.06 -28.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -0.778 . . . . 0.55000000000000004 109.877 -179.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -158.43 174.72 14.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 1.1599999999999999 110.099 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.09 82.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.548 -0.72 . . . . 0.26000000000000001 110.061 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.02 54.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.912 -1.117 . . . . 0.28999999999999998 109.728 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.449 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 4.8 p -72.41 -34.86 68.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.775 -1.203 . . . . 0.44 109.459 178.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.89 94.05 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.617 -0.883 . . . . 0.17999999999999999 108.617 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.11 -49.88 74.54 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.934 -1.107 . . . . 1.0600000000000001 109.914 -179.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -66.85 -40.61 87.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.866 -1.146 . . . . 2.6699999999999999 110.762 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.86 -53.6 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.949 -1.095 . . . . 0.23000000000000001 110.891 -178.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 18' ' ' THR . 28.1 m-85 -62.75 -37.33 86.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.907 -1.121 . . . . 0.14999999999999999 110.211 -178.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -61.46 -40.52 94.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.875 -1.14 . . . . 2.0699999999999998 109.338 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.84 -43.3 72.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.818 -1.176 . . . . 1.8400000000000001 108.31 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.562 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 63.8 t80 -59.99 -49.49 77.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.662 -0.866 . . . . 0.29999999999999999 108.662 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.63 93.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.575 -0.703 . . . . 0.25 109.417 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -60.05 -41.17 91.73 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.829 -0.804 . . . . 1.23 108.829 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.94 -23.1 67.23 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.352 -0.843 . . . . 1.29 109.112 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.562 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 81.2 m-20 -97.11 8.39 44.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.64000000000000001 109.974 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.04 32.32 69.49 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.942 -1.123 . . . . 0.71999999999999997 111.004 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.8 t -109.99 124.92 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.996 -1.297 . . . . 0.40000000000000002 109.089 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 32.7 p-10 -152.23 100.67 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.062 -1.024 . . . . 1.3300000000000001 110.34 179.21 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 -130.19 1.37 Allowed Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.204 -1.474 . . . . 0.26000000000000001 111.044 -178.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -89.94 125.2 35.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.916 -1.344 . . . . 2.0699999999999998 110.359 -178.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -102.53 136.54 42.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.13 110.115 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -136.19 149.58 48.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.982 -1.118 . . . . 0.22 107.982 178.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -137.47 136.22 37.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.239 -0.913 . . . . 0.12 109.958 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -114.52 111.25 21.09 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.854 -0.795 . . . . 0.23999999999999999 108.854 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 49.5 t0 -67.37 -28.84 68.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 1.1599999999999999 110.234 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.12 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.29999999999999999 110.376 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 p -105.95 -0.04 25.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.41999999999999998 109.765 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 50.03 41.44 23.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 2.1600000000000001 108.42 -179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.98 133.2 55.62 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.571 0.7 . . . . 0.28000000000000003 110.366 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.0 139.43 36.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.393 -1.336 . . . . 0.089999999999999997 107.393 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.2 m -130.04 131.86 45.98 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.759 -1.213 . . . . 0.14000000000000001 108.476 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.62 129.15 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.61 -0.885 . . . . 0.12 108.61 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -124.01 129.94 51.76 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.471 0.653 . . . . 0.28999999999999998 110.272 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.029 -0.986 . . . . 1.95 109.48 -179.7 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.446 -0.576 . . . . 0.31 109.446 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.94 147.58 43.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.722 -0.844 . . . . 0.19 108.722 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -118.24 143.61 46.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 1.98 109.441 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.23 130.0 55.24 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.103 -0.703 . . . . 0.13 109.103 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 122.58 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.919 -1.512 . . . . 0.35999999999999999 106.919 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 54' ' ' VAL . 86.0 mt -103.2 116.73 33.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.25 110.543 -178.434 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -116.96 69.38 0.75 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.732 -1.21 . . . . 0.17999999999999999 107.732 178.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 168.6 47.71 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.529 -1.429 . . . . 0.23999999999999999 109.529 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.73 -38.91 84.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 2.71 109.172 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.3 p -117.2 -21.0 9.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.62 -0.675 . . . . 0.92000000000000004 110.056 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -106.8 120.0 40.83 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.35 -0.844 . . . . 0.59999999999999998 109.45 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.57 133.61 42.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 2.02 109.055 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.48 -170.28 43.38 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.075 -1.536 . . . . 0.23999999999999999 110.644 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.85 155.89 42.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.661 -0.906 . . . . 1.6799999999999999 108.98 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -151.87 169.28 22.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.468 -0.77 . . . . 0.34000000000000002 109.291 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.9 p -138.86 159.69 41.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.258 -0.901 . . . . 0.20999999999999999 109.544 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 12.6 t -156.38 160.81 39.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.977 -0.749 . . . . 0.23000000000000001 108.977 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.97 134.05 44.54 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.543 -0.91 . . . . 2.2200000000000002 108.543 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.3 139.18 24.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.055 -1.028 . . . . 0.39000000000000001 109.23 -179.407 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.91 -26.7 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.55000000000000004 109.495 -179.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -157.12 170.72 21.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.1599999999999999 109.734 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.7 83.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.546 -0.721 . . . . 0.26000000000000001 110.105 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.55 -36.47 61.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.892 -1.13 . . . . 0.28999999999999998 110.016 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.429 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 11.8 p -73.7 -34.81 65.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.627 -1.296 . . . . 0.44 109.564 178.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.09 92.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.384 -0.822 . . . . 0.17999999999999999 109.05 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.26 -44.62 79.88 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.679 -1.209 . . . . 1.0600000000000001 109.131 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' NZ ' ' CB ' ' A' ' 28' ' ' LYS . 8.6 mtpm? -67.23 -41.64 85.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.319 -0.863 . . . . 2.6699999999999999 110.573 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.59 -51.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.23000000000000001 110.503 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CZ ' HG22 ' A' ' 18' ' ' THR . 33.1 m-85 -67.46 -39.92 85.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.944 -1.098 . . . . 0.14999999999999999 110.736 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -61.96 -42.37 99.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.725 -1.234 . . . . 2.0699999999999998 109.612 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -69.14 -41.8 76.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.112 -0.993 . . . . 1.8400000000000001 108.441 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.564 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.6 t80 -60.05 -48.41 81.83 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.569 0.7 . . . . 0.29999999999999999 109.175 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.53 97.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.579 -0.701 . . . . 0.25 109.31 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.06 -41.77 93.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.834 . . . . 1.23 109.011 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.83 -25.13 67.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 1.29 109.757 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.564 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.2 m-20 -96.79 10.02 40.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.139 -0.976 . . . . 0.64000000000000001 110.189 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.62 34.04 87.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.975 -1.25 . . . . 0.71999999999999997 109.975 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.89 126.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.242 -1.152 . . . . 0.40000000000000002 109.498 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -142.63 150.12 39.84 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 1.3300000000000001 108.806 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.77 -148.16 12.07 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 118.746 -1.692 . . . . 0.26000000000000001 110.489 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -90.99 129.42 37.0 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.358 -0.979 . . . . 2.0699999999999998 108.358 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.32 137.11 39.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.13 110.025 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -134.45 149.49 50.75 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.133 -1.062 . . . . 0.22 108.133 179.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.416 ' CD1' ' CE1' ' A' ' 52' ' ' PHE . 43.2 t80 -132.78 134.59 44.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.303 -0.873 . . . . 0.12 110.228 -178.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -112.81 109.85 19.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.801 -0.814 . . . . 0.23999999999999999 108.801 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.6 -31.03 69.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.923 . . . . 1.1599999999999999 110.513 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.95 94.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.29999999999999999 110.437 -179.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -106.91 0.85 24.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.455 -0.778 . . . . 0.41999999999999998 110.43 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 50.18 40.11 21.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.909 -1.119 . . . . 2.1600000000000001 108.435 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 130.87 54.95 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.536 0.684 . . . . 0.28000000000000003 110.648 -178.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CE1' ' CD1' ' A' ' 45' ' ' TYR . 68.6 m-85 -99.65 141.11 32.88 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.628 -1.249 . . . . 0.089999999999999997 107.628 178.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 m -130.48 131.39 45.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.807 -1.183 . . . . 0.14000000000000001 108.451 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 7' ' ' LEU . 2.4 p -123.37 130.3 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.365 -0.976 . . . . 0.12 108.365 179.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.4 m -119.97 126.28 50.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.498 -0.752 . . . . 0.28999999999999998 109.778 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.973 -1.013 . . . . 1.95 109.546 -179.863 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.233 -0.655 . . . . 0.31 109.233 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -114.95 146.54 41.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.537 -0.912 . . . . 0.19 108.537 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -117.36 140.81 49.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.748 -0.834 . . . . 1.98 108.748 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' A' ' 30' ' ' PHE . 37.2 tp -118.92 129.31 55.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.842 -0.799 . . . . 0.13 108.842 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.9 mt -106.17 122.39 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.487 -1.301 . . . . 0.35999999999999999 107.487 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.37 112.88 25.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.25 109.185 -179.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.67 71.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.687 -1.227 . . . . 0.17999999999999999 107.687 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.09 165.57 43.51 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.492 -1.443 . . . . 0.23999999999999999 109.492 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.456 ' HZ3' ' C ' ' A' ' 56' ' ' GLU . 10.5 mptt -68.07 -35.29 77.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.192 -1.181 . . . . 2.71 107.872 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -117.67 -25.55 6.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.746 -0.596 . . . . 0.92000000000000004 110.077 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 tp -101.56 122.2 43.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.151 -0.968 . . . . 0.59999999999999998 109.733 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -136.48 130.74 33.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.225 -0.922 . . . . 2.02 109.618 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.62 -172.72 45.69 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.531 -1.319 . . . . 0.23999999999999999 110.499 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.11 156.28 42.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.598 -0.942 . . . . 1.6799999999999999 109.285 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -153.15 170.66 19.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 0.34000000000000002 109.247 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.7 p -137.84 159.95 40.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.329 -0.857 . . . . 0.20999999999999999 109.397 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -156.25 160.17 39.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.23000000000000001 109.624 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.78 134.31 47.3 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.251 -1.018 . . . . 2.2200000000000002 108.251 179.089 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.01 144.2 26.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.39000000000000001 109.417 -179.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -60.31 -31.11 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.55000000000000004 109.859 -179.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -158.81 176.47 12.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 1.1599999999999999 110.175 -179.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.58 -38.85 84.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.26000000000000001 109.723 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.79 -38.05 64.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.28999999999999998 109.772 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m -70.02 -39.8 75.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.665 -1.272 . . . . 0.44 109.994 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.501 -0.749 . . . . 0.17999999999999999 109.301 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -57.88 -40.99 81.58 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.458 -1.297 . . . . 1.0600000000000001 109.088 -179.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -69.89 -43.32 72.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 2.6699999999999999 109.864 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.94 -52.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.23000000000000001 111.072 -178.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD1' HD22 ' A' ' 5' ' ' LEU . 25.8 m-85 -62.86 -39.35 94.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.14999999999999999 110.286 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -60.59 -44.54 96.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.75 -1.218 . . . . 2.0699999999999998 109.604 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.96 -45.06 78.9 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.113 -0.992 . . . . 1.8400000000000001 108.424 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.8 t80 -59.96 -48.89 79.86 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.63 -0.669 . . . . 0.29999999999999999 109.262 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.36 96.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.25 109.274 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.0 -41.56 92.38 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.384 -0.969 . . . . 1.23 108.384 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.4 -22.56 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.4 -0.813 . . . . 1.29 109.006 179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.8 m-20 -96.71 9.43 41.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.64000000000000001 109.703 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 33.51 87.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.836 -1.306 . . . . 0.71999999999999997 109.836 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.95 130.01 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.412 -1.052 . . . . 0.40000000000000002 110.214 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 71.9 m-20 -111.61 -95.03 0.43 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.525 -1.287 . . . . 1.3300000000000001 107.525 178.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.91 164.42 3.5 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.486 -0.759 . . . . 0.26000000000000001 111.962 177.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.1 mp0 -75.43 137.69 41.16 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.107 -1.442 . . . . 2.0699999999999998 107.107 178.208 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -100.07 135.26 41.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.13 110.829 -178.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -136.67 150.57 48.56 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.11 -1.07 . . . . 0.22 108.11 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -135.77 137.89 42.09 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.174 -0.954 . . . . 0.12 110.609 -178.543 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -112.8 110.05 19.92 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.947 -0.76 . . . . 0.23999999999999999 108.947 179.345 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 42.2 t0 -66.7 -32.71 74.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 1.1599999999999999 110.47 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.95 95.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.031 -1.043 . . . . 0.29999999999999999 110.315 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -106.76 -0.13 23.73 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.423 -0.798 . . . . 0.41999999999999998 110.557 -179.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 49.51 41.23 20.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.838 -1.164 . . . . 2.1600000000000001 108.697 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.01 130.64 55.78 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.612 0.72 . . . . 0.28000000000000003 110.13 -178.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -98.81 138.66 35.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.369 -1.345 . . . . 0.089999999999999997 107.369 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -130.56 131.74 45.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.77 -1.206 . . . . 0.14000000000000001 108.391 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.178 -1.045 . . . . 0.12 108.178 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.66 126.57 51.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.507 -0.745 . . . . 0.28999999999999998 110.123 -179.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' C ' ' HZ3' ' A' ' 10' ' ' LYS . 54.5 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.849 -1.072 . . . . 1.95 109.118 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 108.72 -0.844 . . . . 0.31 108.72 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -114.8 143.12 45.59 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.74 -0.837 . . . . 0.19 108.74 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -115.7 140.33 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.854 -0.795 . . . . 1.98 108.854 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' CD1' ' A' ' 30' ' ' PHE . 43.1 tp -117.7 127.81 54.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.747 -0.834 . . . . 0.13 108.747 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.29 121.86 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.692 -1.596 . . . . 0.35999999999999999 106.692 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -100.02 110.52 22.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.036 -1.04 . . . . 0.25 108.966 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -114.07 68.33 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.649 -1.612 . . . . 0.17999999999999999 106.649 178.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 171.03 54.75 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.679 -1.368 . . . . 0.23999999999999999 109.679 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.66 -39.42 94.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.023 -1.103 . . . . 2.71 108.023 178.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 p -125.05 -13.96 6.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.177 -0.465 . . . . 0.92000000000000004 109.787 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.5 tp -98.13 119.96 37.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.156 -0.965 . . . . 0.59999999999999998 109.043 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -133.29 126.54 31.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.351 -0.843 . . . . 2.02 109.427 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -176.22 47.88 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.559 -1.305 . . . . 0.23999999999999999 110.243 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.52 156.4 42.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.714 -0.874 . . . . 1.6799999999999999 108.669 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -154.93 170.72 21.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.365 -0.834 . . . . 0.34000000000000002 109.632 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.9 p -136.81 158.9 43.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.20999999999999999 109.235 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.4 t -154.73 160.23 41.2 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.486 -0.931 . . . . 0.23000000000000001 108.486 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.94 133.56 48.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 2.2200000000000002 109.467 -179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.05 143.1 25.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.942 . . . . 0.39000000000000001 108.825 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.55 -26.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.55000000000000004 109.859 -179.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -159.49 176.31 12.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.056 -1.028 . . . . 1.1599999999999999 109.87 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.31 80.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.521 -0.737 . . . . 0.26000000000000001 110.095 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.3 63.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.917 -1.114 . . . . 0.28999999999999998 110.053 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.595 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 17.9 p -72.23 -36.16 69.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.536 -1.352 . . . . 0.44 109.862 179.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.07 91.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.748 . . . . 0.17999999999999999 108.994 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.12 -50.01 72.28 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.897 -1.121 . . . . 1.0600000000000001 110.024 -178.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -65.15 -40.15 93.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.883 -1.136 . . . . 2.6699999999999999 110.826 -179.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.0 t -69.94 -54.04 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.23000000000000001 111.586 -178.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 5' ' ' LEU . 33.0 m-85 -64.03 -39.51 94.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.942 -1.099 . . . . 0.14999999999999999 111.284 -178.46 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.76 -40.06 96.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.809 -1.182 . . . . 2.0699999999999998 109.957 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -69.41 -42.66 74.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.713 -1.242 . . . . 1.8400000000000001 109.145 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.462 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 65.9 t80 -59.98 -46.01 90.84 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.879 . . . . 0.29999999999999999 108.628 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.9 97.82 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.855 -0.795 . . . . 0.25 108.855 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -60.08 -44.84 94.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.492 -0.755 . . . . 1.23 109.741 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.32 -23.96 67.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 1.29 109.85 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.462 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 4.4 m120 -96.44 7.48 46.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -0.963 . . . . 0.64000000000000001 109.554 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.69 31.79 73.69 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.804 -1.189 . . . . 0.71999999999999997 110.158 179.117 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.43 125.99 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.19 -1.182 . . . . 0.40000000000000002 109.531 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 57.6 t0 -140.77 146.54 37.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.264 -1.013 . . . . 1.3300000000000001 108.264 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.63 -153.03 16.52 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.171 -1.49 . . . . 0.26000000000000001 110.134 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.59 134.35 34.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -1.053 . . . . 2.0699999999999998 108.442 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -101.48 135.96 42.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 0.13 110.296 -179.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.2 p -135.0 149.11 50.13 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.324 -0.991 . . . . 0.22 108.324 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 69.6 t80 -135.35 136.2 41.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.376 -0.828 . . . . 0.12 110.098 -178.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -112.77 109.97 19.79 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.685 -0.857 . . . . 0.23999999999999999 108.685 179.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 53.9 t0 -65.62 -31.34 72.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 1.1599999999999999 110.47 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.138 -0.976 . . . . 0.29999999999999999 110.372 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.8 p -106.62 -0.09 24.02 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.337 -0.852 . . . . 0.41999999999999998 110.559 -179.036 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 50.01 41.25 22.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.745 -1.222 . . . . 2.1600000000000001 108.361 -179.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.99 130.94 54.99 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.708 0.766 . . . . 0.28000000000000003 110.391 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 58.7 m-85 -99.62 139.97 34.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.271 -1.381 . . . . 0.089999999999999997 107.271 178.178 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.0 m -130.43 131.53 45.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.672 -1.268 . . . . 0.14000000000000001 108.037 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.1 p -122.21 128.97 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.045 -1.094 . . . . 0.12 108.045 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.8 m -119.96 127.97 53.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.28999999999999998 109.984 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.004 -0.998 . . . . 1.95 109.626 -179.316 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 108.917 -0.772 . . . . 0.31 108.917 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.73 150.04 40.44 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.129 -0.693 . . . . 0.19 109.129 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' A' ' 15' ' ' GLU . 52.9 tttm -118.6 143.69 46.63 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.571 -0.706 . . . . 1.98 109.717 -179.031 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.0 tp -119.22 127.45 53.28 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.714 -0.847 . . . . 0.13 108.714 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.25 122.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.945 -1.502 . . . . 0.35999999999999999 106.945 178.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.0 mt -103.24 111.6 24.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.92 . . . . 0.25 109.873 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.5 71.55 0.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.267 -1.383 . . . . 0.17999999999999999 107.267 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 165.61 49.33 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.367 -1.493 . . . . 0.23999999999999999 109.367 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -67.83 -36.86 81.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.218 -1.166 . . . . 2.71 108.421 178.246 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.6 m -120.73 -22.19 6.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.913 -0.492 . . . . 0.92000000000000004 109.787 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.1 tp -104.69 120.48 41.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.328 -0.858 . . . . 0.59999999999999998 109.421 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -132.86 133.58 43.49 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.348 -0.845 . . . . 2.02 109.896 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.3 -176.24 47.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.438 -1.363 . . . . 0.23999999999999999 110.604 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.3 pm0 -147.19 155.67 42.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.719 -0.871 . . . . 1.6799999999999999 108.969 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 t -154.86 170.25 22.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.34000000000000002 109.675 -179.586 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -134.89 158.3 44.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.483 -0.761 . . . . 0.20999999999999999 109.031 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.3 t -154.46 158.7 40.34 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.65 -0.871 . . . . 0.23000000000000001 108.65 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 56.6 mp0 -102.58 134.1 46.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.214 -0.929 . . . . 2.2200000000000002 109.185 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.8 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.19 143.45 27.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.112 -0.992 . . . . 0.39000000000000001 108.774 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.06 -28.24 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.55000000000000004 109.251 -179.273 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -158.74 176.93 11.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 1.1599999999999999 109.912 -179.739 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.5 84.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.26000000000000001 109.879 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.29 -37.72 62.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.04 -1.037 . . . . 0.28999999999999998 110.212 -179.486 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.8 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 12.1 p -71.55 -35.94 70.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.546 -1.346 . . . . 0.44 109.59 179.052 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.52 89.76 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.351 -0.843 . . . . 0.17999999999999999 108.865 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.9 -49.99 74.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.987 -1.085 . . . . 1.0600000000000001 110.133 -178.852 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -66.65 -42.53 86.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 2.6699999999999999 110.623 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.3 t -69.67 -53.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.983 . . . . 0.23000000000000001 110.713 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CZ ' HG22 ' A' ' 18' ' ' THR . 16.6 m-85 -61.03 -37.96 84.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.917 -1.114 . . . . 0.14999999999999999 109.512 -179.406 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.06 -43.51 95.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 2.0699999999999998 110.009 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.41 -42.31 79.15 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 1.8400000000000001 108.677 179.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.596 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -48.69 80.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.29999999999999999 110.087 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.95 93.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.25 109.657 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -61.39 -39.95 92.58 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 1.23 109.202 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -62.28 -24.66 67.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 1.29 109.959 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.596 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 98.5 m-20 -96.35 8.79 43.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.007 . . . . 0.64000000000000001 110.09 -179.227 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.82 31.71 81.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.441 -1.464 . . . . 0.71999999999999997 109.441 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.6 t -107.47 126.3 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -1.084 . . . . 0.40000000000000002 109.302 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -140.11 147.47 40.29 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.093 -1.077 . . . . 1.3300000000000001 108.093 179.391 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.59 -154.25 19.52 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.227 -1.463 . . . . 0.26000000000000001 109.943 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 38.4 mp0 -87.76 132.83 34.01 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.217 -1.031 . . . . 2.0699999999999998 108.217 179.061 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -99.93 135.51 41.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 0.13 110.098 -179.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.2 p -136.73 150.04 48.19 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.22 108.523 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 58.7 t80 -133.48 133.63 42.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.412 -0.805 . . . . 0.12 109.812 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -111.21 107.76 17.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.485 -0.931 . . . . 0.23999999999999999 108.485 179.339 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.96 -30.67 70.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 1.1599999999999999 110.045 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.45 98.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.29999999999999999 109.87 -179.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 p -104.74 1.06 28.91 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.48 -0.762 . . . . 0.41999999999999998 109.887 -179.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.6 mttt 50.03 39.9 20.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 2.1600000000000001 108.554 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.4 m -120.03 134.35 55.27 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.474 0.654 . . . . 0.28000000000000003 110.831 -178.371 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 53.1 m-85 -99.82 139.25 35.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.089999999999999997 107.271 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -131.29 130.68 43.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.561 -1.337 . . . . 0.14000000000000001 108.6 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.28 127.69 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.788 -1.189 . . . . 0.12 107.788 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.1 m -120.01 127.13 52.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.452 -0.78 . . . . 0.28999999999999998 109.728 -179.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.037 -0.982 . . . . 1.95 109.45 -179.682 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 109.641 -0.503 . . . . 0.31 109.641 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -114.96 147.43 40.05 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.869 -0.789 . . . . 0.19 108.869 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -119.73 141.46 49.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.482 -0.761 . . . . 1.98 109.465 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 30' ' ' PHE . 45.7 tp -120.65 129.85 53.88 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.915 -0.772 . . . . 0.13 108.915 179.436 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.53 124.83 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.806 -1.183 . . . . 0.35999999999999999 107.806 178.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.5 mt -102.06 114.58 28.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 0.25 110.012 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.57 68.52 0.7 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.339 -1.356 . . . . 0.17999999999999999 107.339 178.357 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.99 49.15 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.742 -1.343 . . . . 0.23999999999999999 109.742 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -67.05 -37.55 84.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.368 -1.078 . . . . 2.71 108.157 178.231 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 m -119.55 -22.9 6.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.939 -0.475 . . . . 0.92000000000000004 110.104 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 tp -101.59 120.27 40.06 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.18 -0.95 . . . . 0.59999999999999998 109.649 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -132.12 128.67 38.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.02 109.211 179.335 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.45 -173.88 46.59 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.185 -1.484 . . . . 0.23999999999999999 110.608 179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.4 pm0 -150.26 159.56 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.625 -0.927 . . . . 1.6799999999999999 109.442 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 t -152.62 170.01 21.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.521 -0.737 . . . . 0.34000000000000002 109.269 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -136.54 158.44 44.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.245 -0.91 . . . . 0.20999999999999999 109.081 -179.651 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 t -156.55 161.9 39.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.357 -0.839 . . . . 0.23000000000000001 109.061 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -101.26 132.29 46.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.317 -0.994 . . . . 2.2200000000000002 108.317 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.48 142.17 26.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.39000000000000001 109.551 -179.5 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.58 -30.36 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.55000000000000004 110.603 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -158.58 179.4 9.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.931 -1.106 . . . . 1.1599999999999999 110.295 -179.266 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.93 75.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.55 -0.719 . . . . 0.26000000000000001 110.539 -179.111 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.66 65.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.776 -1.203 . . . . 0.28999999999999998 109.866 -179.164 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -70.53 -39.95 73.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.741 -1.224 . . . . 0.44 109.846 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.96 92.15 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.532 -0.73 . . . . 0.17999999999999999 109.258 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.82 -43.22 94.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.745 -1.182 . . . . 1.0600000000000001 110.105 -179.129 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -69.73 -42.69 73.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.26 -0.9 . . . . 2.6699999999999999 110.69 -179.24 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.61 -53.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.23000000000000001 111.173 -178.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' HD22 ' A' ' 5' ' ' LEU . 32.3 m-85 -60.23 -35.84 76.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.019 -1.051 . . . . 0.14999999999999999 109.864 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.13 -41.51 92.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.897 -1.127 . . . . 2.0699999999999998 108.915 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -68.47 -44.82 73.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.094 -1.003 . . . . 1.8400000000000001 108.755 179.372 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.511 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.1 t80 -60.34 -48.2 82.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.29999999999999999 109.489 179.673 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.41 97.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.25 109.244 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -60.12 -39.94 88.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.229 -0.92 . . . . 1.23 108.538 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.87 -23.81 67.5 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.467 -0.771 . . . . 1.29 109.286 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.511 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 9.8 m120 -96.77 6.31 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.09 -1.006 . . . . 0.64000000000000001 109.46 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.06 33.23 78.4 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.864 -1.16 . . . . 0.71999999999999997 110.259 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.0 t -111.16 125.38 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.091 -1.241 . . . . 0.40000000000000002 108.918 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 69.6 m-20 -152.25 103.62 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.984 -1.073 . . . . 1.3300000000000001 110.993 179.737 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.03 -130.13 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.557 -1.306 . . . . 0.26000000000000001 110.907 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 42.2 mp0 -93.99 130.98 39.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.937 -1.331 . . . . 2.0699999999999998 110.141 -178.516 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -104.09 139.3 39.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.672 -0.643 . . . . 0.13 110.244 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 p -134.31 147.77 50.65 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.963 -1.125 . . . . 0.22 107.963 178.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 60.3 t80 -135.84 135.16 39.57 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.188 -0.945 . . . . 0.12 110.211 -178.685 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -112.97 110.28 20.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.921 -0.77 . . . . 0.23999999999999999 108.921 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 63.5 t0 -65.06 -31.83 73.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 1.1599999999999999 110.528 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.99 92.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.29999999999999999 110.616 -179.185 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -104.81 -0.69 26.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.41999999999999998 110.554 -179.04 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 50.02 40.02 20.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.817 -1.177 . . . . 2.1600000000000001 108.156 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.9 m -120.02 131.2 55.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.672 0.749 . . . . 0.28000000000000003 110.282 -178.2 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m-85 -98.62 138.9 35.13 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.504 -1.295 . . . . 0.089999999999999997 107.504 178.435 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -131.77 131.07 42.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.697 -1.252 . . . . 0.14000000000000001 107.791 179.154 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.02 129.86 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.288 -1.005 . . . . 0.12 108.288 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -121.65 125.85 47.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.569 -0.707 . . . . 0.28999999999999998 109.729 -179.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 27.1 mp0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.915 -1.04 . . . . 1.95 109.502 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.2 mtt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.434 0.635 . . . . 3.54 109.365 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m -90.7 129.03 36.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.34000000000000002 110.234 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.15 144.34 42.84 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.167 -1.42 . . . . 0.34999999999999998 107.167 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -115.56 140.03 49.54 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.37 -0.831 . . . . 2.1899999999999999 110.358 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.1 tp -120.14 129.98 54.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.723 -0.611 . . . . 0.17000000000000001 109.67 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.1 mt -107.77 125.21 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.632 -1.247 . . . . 0.65000000000000002 107.632 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.8 mt -103.87 115.44 30.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.255 -0.903 . . . . 0.25 111.03 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -111.59 59.78 0.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.53 -0.915 . . . . 1.76 108.53 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.98 165.48 53.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.23 -1.548 . . . . 0.20999999999999999 109.23 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -63.75 -39.98 95.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.881 -1.364 . . . . 2.7799999999999998 108.221 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -118.5 -20.01 8.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.11 -0.7 . . . . 1.3799999999999999 109.11 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.7 tp -98.23 118.19 34.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.518 -0.739 . . . . 0.47999999999999998 109.223 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -131.83 126.8 35.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.287 -1.005 . . . . 2.1699999999999999 108.287 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.84 -177.96 48.34 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 118.988 -1.577 . . . . 0.20999999999999999 109.921 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -148.07 157.67 43.64 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.455 -0.943 . . . . 2.3700000000000001 108.455 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -156.36 167.48 30.29 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.314 -0.866 . . . . 0.19 108.757 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 p -133.65 161.02 35.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.346 -0.846 . . . . 0.26000000000000001 109.169 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.9 t -156.35 162.29 40.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.443 -0.786 . . . . 0.19 109.112 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.87 135.48 44.46 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.574 -0.899 . . . . 2.75 108.574 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.541 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.46 140.78 23.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.16 108.601 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.01 -26.42 35.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.364 -0.835 . . . . 0.28000000000000003 109.806 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -159.94 176.59 11.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 1.0900000000000001 109.739 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.74 -32.52 72.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.22 109.796 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -40.19 77.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.23000000000000001 109.961 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.541 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 2.4 p -70.15 -35.5 74.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 1.24 109.12 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.02 87.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.16 108.8 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.14 -49.82 72.85 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.226 -0.99 . . . . 1.1200000000000001 109.192 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -63.84 -43.66 95.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.784 -1.197 . . . . 2.4500000000000002 111.897 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.68 -54.37 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.076 . . . . 0.27000000000000002 110.503 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 5' ' ' LEU . 28.3 m-85 -63.8 -39.71 94.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.948 -1.095 . . . . 0.23000000000000001 110.531 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -60.52 -45.68 92.95 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.375 -0.828 . . . . 2.8799999999999999 109.252 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -67.33 -43.61 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.576 -0.898 . . . . 2.0099999999999998 108.576 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.7 t80 -59.98 -46.56 89.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.509 -0.744 . . . . 0.37 109.033 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.72 94.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.846 -0.798 . . . . 0.25 108.846 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.0 -45.04 95.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.026 -0.731 . . . . 1.97 109.026 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.66 -25.3 66.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 1.1399999999999999 109.701 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 71.1 m-20 -95.92 6.72 48.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.196 -0.94 . . . . 1.1699999999999999 109.713 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.23 37.61 91.22 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.079 -1.058 . . . . 0.29999999999999999 110.46 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.91 122.26 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.297 -1.119 . . . . 0.32000000000000001 109.876 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -132.93 136.95 46.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.27 -1.381 . . . . 2.1899999999999999 107.27 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.44 -156.48 16.22 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.87 -1.634 . . . . 0.67000000000000004 109.647 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -91.82 128.55 37.69 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.955 -1.128 . . . . 2.2200000000000002 107.955 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.69 133.62 40.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.20999999999999999 110.453 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.5 p -131.68 147.9 52.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.966 -1.124 . . . . 0.23999999999999999 107.966 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.44 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 62.1 t80 -134.76 135.86 42.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.32000000000000001 109.966 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -112.04 109.48 19.25 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.28000000000000003 108.711 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 48.2 t0 -66.35 -32.71 74.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 1.1200000000000001 110.254 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -43.86 94.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.26000000000000001 110.079 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.9 p -102.62 0.41 33.23 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.213 -0.93 . . . . 0.27000000000000002 110.537 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mttm 50.12 40.5 21.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.859 -1.151 . . . . 2.3599999999999999 108.985 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.3 m -118.84 130.01 55.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.647 0.737 . . . . 0.14999999999999999 109.975 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 55.1 m-85 -97.65 137.01 37.21 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.078 -1.453 . . . . 0.17000000000000001 107.078 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.1 m -129.51 134.15 47.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.823 -1.173 . . . . 0.14000000000000001 108.614 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.8 p -125.35 129.99 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.142 -1.059 . . . . 0.20000000000000001 108.142 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -121.98 127.81 50.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.448 -0.782 . . . . 0.28999999999999998 110.218 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.995 -1.002 . . . . 2.3399999999999999 108.585 179.243 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.478 0.656 . . . . 2.9100000000000001 109.832 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.7 m -93.74 135.61 34.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.397 -0.815 . . . . 0.31 109.246 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.29 146.49 39.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.5 -0.926 . . . . 0.19 108.5 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.12 141.93 46.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.362 -0.836 . . . . 1.98 109.032 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 30' ' ' PHE . 22.6 tp -120.1 126.23 50.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.708 -0.849 . . . . 0.13 108.708 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.26 123.41 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.164 -1.421 . . . . 0.35999999999999999 107.164 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.472 HD23 HG12 ' A' ' 54' ' ' VAL . 93.6 mt -102.38 114.11 28.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.286 -0.884 . . . . 0.25 110.092 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -114.66 68.59 0.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.124 -1.436 . . . . 0.17999999999999999 107.124 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.1 165.15 48.66 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.813 -1.315 . . . . 0.23999999999999999 109.813 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -66.91 -35.36 79.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.499 -1.297 . . . . 2.71 107.499 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 t -119.83 -23.19 6.53 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.252 -0.648 . . . . 0.92000000000000004 109.252 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 9' ' ' GLY . 54.2 tp -98.35 121.48 40.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.59999999999999998 109.269 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -136.89 126.78 25.77 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.179 -0.951 . . . . 2.02 109.638 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.44 -168.31 41.43 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.636 -1.269 . . . . 0.23999999999999999 110.196 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -149.3 159.36 44.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.974 . . . . 1.6799999999999999 109.655 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -151.94 167.35 28.64 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.732 -0.84 . . . . 0.34000000000000002 108.732 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -138.03 159.65 41.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.20999999999999999 109.278 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -154.93 159.96 40.81 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.714 -0.847 . . . . 0.23000000000000001 108.714 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -102.22 132.91 47.86 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.53 -0.915 . . . . 2.2200000000000002 108.53 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.69 144.57 26.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.105 -0.997 . . . . 0.39000000000000001 109.477 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.86 -29.7 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.489 -0.757 . . . . 0.55000000000000004 110.368 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -158.02 175.66 13.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.91 -1.119 . . . . 1.1599999999999999 110.181 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.89 80.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.536 -0.727 . . . . 0.26000000000000001 110.033 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.28 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.91 -1.119 . . . . 0.28999999999999998 110.008 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 p -74.21 -34.89 63.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.726 -1.234 . . . . 0.44 109.827 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.0 92.26 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.807 -0.812 . . . . 0.17999999999999999 108.807 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.51 -49.02 73.7 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.964 -1.095 . . . . 1.0600000000000001 109.904 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.59 -40.04 92.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.261 -0.899 . . . . 2.6699999999999999 110.506 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.9 -53.1 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.149 -0.969 . . . . 0.23000000000000001 110.662 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.551 ' CD1' HD22 ' A' ' 5' ' ' LEU . 35.6 m-85 -66.72 -39.5 88.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 0.14999999999999999 110.596 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -60.42 -42.27 95.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.745 -1.222 . . . . 2.0699999999999998 108.819 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -67.56 -43.63 80.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 1.8400000000000001 108.948 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 65.5 t80 -60.03 -44.87 94.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.504 -0.748 . . . . 0.29999999999999999 109.311 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.67 96.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.332 -0.855 . . . . 0.25 109.229 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -61.9 -42.36 98.98 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.363 -0.836 . . . . 1.23 109.101 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.21 -26.62 67.85 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.095 -1.003 . . . . 1.29 109.304 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.447 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 5.0 m120 -97.59 9.05 43.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.64000000000000001 110.027 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.72 81.79 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.884 -1.15 . . . . 0.71999999999999997 110.456 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.3 t -106.91 127.89 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.183 -1.186 . . . . 0.40000000000000002 109.738 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -137.67 145.3 42.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.668 -1.234 . . . . 1.3300000000000001 107.668 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.91 -156.19 21.07 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.875 -1.631 . . . . 0.26000000000000001 110.334 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.64 131.11 36.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.579 -0.897 . . . . 2.0699999999999998 108.579 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -101.08 136.54 40.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.13 110.545 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.5 p -133.9 148.77 51.27 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.771 -1.196 . . . . 0.22 107.771 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.12 134.32 42.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 0.12 110.205 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -111.49 108.28 17.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.328 -0.99 . . . . 0.23999999999999999 108.328 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -67.27 -29.8 69.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 1.1599999999999999 109.865 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.9 91.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.361 -0.837 . . . . 0.29999999999999999 110.306 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.2 p -104.84 0.0 27.61 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.357 -0.84 . . . . 0.41999999999999998 109.992 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 50.04 39.89 20.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 2.1600000000000001 108.173 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -119.93 132.13 55.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.404 0.621 . . . . 0.28000000000000003 110.712 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -99.3 140.04 34.05 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.486 -1.301 . . . . 0.089999999999999997 107.486 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.6 m -130.62 131.28 44.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.655 -1.278 . . . . 0.14000000000000001 108.706 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD23 ' A' ' 7' ' ' LEU . 4.2 p -122.79 129.65 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.496 -0.927 . . . . 0.12 108.496 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.3 127.74 52.64 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.504 -0.748 . . . . 0.28999999999999998 110.444 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.965 -1.016 . . . . 1.95 109.197 179.813 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.371 -0.603 . . . . 2.9100000000000001 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.7 m -91.05 133.73 35.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.322 -0.861 . . . . 0.31 109.597 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -117.67 145.81 44.14 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.857 -0.794 . . . . 0.19 108.857 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -114.74 144.15 43.93 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.328 -0.857 . . . . 1.98 109.184 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 30' ' ' PHE . 30.6 tp -121.78 128.94 52.27 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.135 -0.691 . . . . 0.13 109.135 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.9 122.3 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.747 -1.205 . . . . 0.35999999999999999 107.747 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -100.69 113.82 27.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.25 109.262 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -116.34 68.73 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.323 -1.362 . . . . 0.17999999999999999 107.323 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 169.3 52.95 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.146 -1.581 . . . . 0.23999999999999999 109.146 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -64.8 -35.75 82.12 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.196 -1.179 . . . . 2.71 107.919 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -124.86 -19.11 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.427 -0.583 . . . . 0.92000000000000004 109.427 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.0 tp -96.09 119.97 35.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.996 . . . . 0.59999999999999998 109.098 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -134.54 125.8 28.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 2.02 109.472 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.93 -178.7 48.64 Favored Glycine 0 N--CA 1.487 2.036 0 C-N-CA 119.556 -1.307 . . . . 0.23999999999999999 110.262 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.54 157.3 43.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.757 -0.849 . . . . 1.6799999999999999 108.929 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.02 170.03 21.43 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.377 -0.827 . . . . 0.34000000000000002 109.281 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 p -135.87 159.17 42.51 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.84 -0.8 . . . . 0.20999999999999999 108.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.5 t -157.61 161.67 38.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.862 . . . . 0.23000000000000001 109.515 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 56.0 mp0 -105.92 135.74 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.836 -0.802 . . . . 2.2200000000000002 108.836 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -150.24 146.4 26.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.39000000000000001 109.118 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.37 -30.1 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.466 -0.771 . . . . 0.55000000000000004 109.569 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -159.46 176.88 11.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 1.1599999999999999 109.584 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -35.3 77.85 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.29 -0.881 . . . . 0.26000000000000001 110.078 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.17 -39.04 59.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.916 -1.115 . . . . 0.28999999999999998 110.273 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.625 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 26.3 p -75.08 -32.14 61.4 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.5 -1.375 . . . . 0.44 109.518 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.68 99.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.264 -0.898 . . . . 0.17999999999999999 108.828 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -56.94 -49.52 75.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.646 -1.222 . . . . 1.0600000000000001 108.998 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -63.54 -44.03 95.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.541 -0.724 . . . . 2.6699999999999999 110.823 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.06 -52.59 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.021 -1.049 . . . . 0.23000000000000001 110.837 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.3 m-85 -61.64 -37.9 85.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.006 . . . . 0.14999999999999999 109.957 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -61.46 -43.04 99.57 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.91 -1.119 . . . . 2.0699999999999998 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.62 -43.97 75.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.904 -1.123 . . . . 1.8400000000000001 109.07 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CD1' ' OD1' ' A' ' 37' ' ' ASN . 57.4 t80 -60.03 -47.84 84.2 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.292 -0.88 . . . . 0.29999999999999999 108.749 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.98 99.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.454 -0.779 . . . . 0.25 109.138 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -59.99 -41.89 93.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -65.72 -19.78 66.03 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.001 -0.74 . . . . 1.29 109.001 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' OD1' ' CD1' ' A' ' 33' ' ' TYR . 31.0 m120 -95.08 4.31 53.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.64000000000000001 109.96 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.04 32.9 65.61 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.675 -1.25 . . . . 0.71999999999999997 110.087 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.4 t -110.22 122.99 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.184 -1.186 . . . . 0.40000000000000002 108.916 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 31.5 p-10 -148.97 97.65 2.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.915 -1.116 . . . . 1.3300000000000001 110.465 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.06 -130.68 1.37 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.31 -1.424 . . . . 0.26000000000000001 111.342 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.11 132.43 38.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.963 -1.316 . . . . 2.0699999999999998 110.316 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -107.76 139.48 42.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.429 0.633 . . . . 0.13 110.267 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.1 p -136.86 150.27 48.17 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.08 -1.081 . . . . 0.22 108.08 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -134.36 135.9 43.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.272 -0.893 . . . . 0.12 110.643 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -111.94 108.28 17.58 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.166 -1.05 . . . . 0.23999999999999999 108.166 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -67.61 -29.99 69.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 1.1599999999999999 110.366 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.04 93.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.29999999999999999 110.409 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.0 p -105.81 0.02 25.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.37 -0.831 . . . . 0.41999999999999998 110.124 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 mttm 50.33 41.34 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.131 . . . . 2.1600000000000001 108.506 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.95 129.95 54.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.478 0.656 . . . . 0.28000000000000003 110.069 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -98.87 139.64 34.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.679 -1.23 . . . . 0.089999999999999997 107.679 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.5 m -128.7 130.41 47.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.762 -1.211 . . . . 0.14000000000000001 108.437 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -123.06 129.42 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.285 -1.005 . . . . 0.12 108.285 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -120.96 126.0 48.83 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.114 -0.699 . . . . 0.28999999999999998 109.114 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.071 -0.966 . . . . 1.95 109.729 -179.076 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.51 0.671 . . . . 2.9100000000000001 109.234 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 m -92.44 133.74 35.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.476 -0.765 . . . . 0.31 109.483 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.528 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 90.8 m-85 -114.52 145.26 42.14 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.463 -0.94 . . . . 0.19 108.463 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -115.74 142.72 46.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.392 -0.818 . . . . 1.98 109.453 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 30' ' ' PHE . 40.2 tp -120.98 127.33 51.7 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.969 -0.752 . . . . 0.13 108.969 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.4 123.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.317 -1.364 . . . . 0.35999999999999999 107.317 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.34 112.75 25.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.25 110.168 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -112.1 69.0 0.68 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.765 -1.568 . . . . 0.17999999999999999 106.765 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.78 167.69 50.31 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.59 -1.404 . . . . 0.23999999999999999 109.59 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -67.77 -39.05 84.15 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.414 -1.051 . . . . 2.71 108.524 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.8 p -120.0 -20.03 7.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.887 -0.508 . . . . 0.92000000000000004 109.854 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.92 118.55 36.81 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.339 -0.851 . . . . 0.59999999999999998 109.89 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -130.71 131.43 44.79 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.67 0.748 . . . . 2.02 109.15 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.1 -178.96 48.61 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.08 -1.533 . . . . 0.23999999999999999 110.716 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.04 151.13 43.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.451 -0.944 . . . . 1.6799999999999999 108.451 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 t -150.82 165.02 34.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.34000000000000002 108.592 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.1 p -134.38 159.38 41.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 0.20999999999999999 108.97 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -154.41 158.98 40.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.772 -0.825 . . . . 0.23000000000000001 108.772 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.6 132.0 50.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.632 -0.877 . . . . 2.2200000000000002 108.632 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.63 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -147.63 142.94 27.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.05 . . . . 0.39000000000000001 109.093 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.93 -28.82 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.55000000000000004 110.091 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -158.97 177.31 11.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.043 -1.035 . . . . 1.1599999999999999 109.937 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.528 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -65.71 -38.42 89.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.457 -0.777 . . . . 0.26000000000000001 109.591 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.11 -37.76 62.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.082 -1.011 . . . . 0.28999999999999998 110.003 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.63 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 85.4 m -68.82 -39.96 79.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.692 -1.255 . . . . 0.44 109.806 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.02 93.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.246 -0.909 . . . . 0.17999999999999999 109.372 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.17 -53.88 47.32 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.152 -1.019 . . . . 1.0600000000000001 111.595 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -68.51 -36.14 78.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.678 -1.264 . . . . 2.6699999999999999 110.655 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.84 -53.83 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.943 -1.098 . . . . 0.23000000000000001 110.519 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.516 ' CD1' HD22 ' A' ' 5' ' ' LEU . 32.0 m-85 -63.11 -37.42 87.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.14999999999999999 110.433 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.98 -41.47 92.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.834 -1.166 . . . . 2.0699999999999998 109.296 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -68.71 -42.13 78.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 1.8400000000000001 109.102 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.498 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 62.6 t80 -59.95 -46.96 87.73 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.29999999999999999 108.95 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.08 96.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.25 108.958 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.02 -45.62 92.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 1.23 109.159 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -62.28 -24.68 67.43 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -0.868 . . . . 1.29 109.548 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 7.4 m120 -98.51 7.04 46.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.215 -0.928 . . . . 0.64000000000000001 109.99 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.17 33.62 83.6 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.92 -1.133 . . . . 0.71999999999999997 110.491 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.18 128.39 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.147 -1.208 . . . . 0.40000000000000002 110.539 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.501 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 96.7 m-20 -112.3 -98.62 0.42 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.511 -0.922 . . . . 1.3300000000000001 108.511 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.69 167.53 3.72 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.25 -0.906 . . . . 0.26000000000000001 112.455 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.5 mp0 -77.21 138.27 39.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.583 -1.266 . . . . 2.0699999999999998 107.583 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -99.91 133.78 43.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.98 . . . . 0.13 110.351 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 p -134.32 148.76 50.81 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.815 -1.18 . . . . 0.22 107.815 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -136.04 136.91 40.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.186 -0.946 . . . . 0.12 110.464 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.82 110.01 19.84 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.568 -0.901 . . . . 0.23999999999999999 108.568 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 52.4 t0 -67.94 -30.5 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.927 . . . . 1.1599999999999999 110.461 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.3 93.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.148 -0.97 . . . . 0.29999999999999999 109.892 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.3 p -105.92 -0.28 25.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.51 -0.744 . . . . 0.41999999999999998 110.048 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.408 ' NZ ' ' CZ ' ' A' ' 3' ' ' TYR . 23.6 mtpp 49.98 41.71 23.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 2.1600000000000001 108.401 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.34 131.08 55.66 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.547 0.689 . . . . 0.28000000000000003 110.506 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -100.46 139.88 35.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.455 -1.313 . . . . 0.089999999999999997 107.455 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -131.98 132.51 43.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.817 -1.177 . . . . 0.14000000000000001 108.963 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.8 p -120.3 128.29 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.029 -1.1 . . . . 0.12 108.029 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.1 m -121.36 127.57 51.37 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.359 -0.838 . . . . 0.28999999999999998 110.731 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 67.3 mm-40 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.947 -1.025 . . . . 1.95 109.453 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 tpp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.782 -0.822 . . . . 2.9100000000000001 108.782 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.5 m -93.08 129.1 39.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.814 -1.179 . . . . 0.31 110.288 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.06 147.05 39.37 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.848 -1.168 . . . . 0.19 107.848 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -116.05 141.11 48.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 1.98 109.458 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.5 tp -120.66 127.99 52.58 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.742 -0.836 . . . . 0.13 108.742 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.38 123.68 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.215 -1.402 . . . . 0.35999999999999999 107.215 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -103.91 114.36 28.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.25 110.543 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -118.75 68.52 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.132 -1.433 . . . . 0.17999999999999999 107.132 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.531 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . . . -78.67 172.56 55.27 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.672 -1.771 . . . . 0.23999999999999999 108.672 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -66.23 -35.59 80.82 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.841 -1.388 . . . . 2.71 107.929 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 t -123.95 -18.59 5.92 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.844 -0.535 . . . . 0.92000000000000004 110.288 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.3 tp -98.94 113.58 25.8 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.015 -1.053 . . . . 0.59999999999999998 109.822 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -126.21 127.28 45.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 2.02 109.317 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.97 -179.84 48.81 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.192 -1.48 . . . . 0.23999999999999999 110.621 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -143.53 153.67 42.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.995 . . . . 1.6799999999999999 108.869 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -152.82 168.5 25.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.34000000000000002 109.065 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.5 p -138.46 160.02 40.61 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.881 -0.785 . . . . 0.20999999999999999 108.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -156.65 162.86 39.82 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.264 -0.898 . . . . 0.23000000000000001 109.188 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -106.48 135.01 48.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.367 -0.833 . . . . 2.2200000000000002 108.917 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.0 145.53 27.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.39000000000000001 108.898 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -61.42 -29.24 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.55000000000000004 110.266 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -158.51 177.53 11.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.086 -1.009 . . . . 1.1599999999999999 110.172 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.16 -39.74 82.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.638 -0.664 . . . . 0.26000000000000001 110.287 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.95 -37.08 60.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.833 -1.167 . . . . 0.28999999999999998 109.769 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 p -72.23 -36.88 69.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.668 -1.27 . . . . 0.44 109.605 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.29 90.57 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.656 -0.868 . . . . 0.17999999999999999 108.656 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.21 -50.08 73.98 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.221 -0.991 . . . . 1.0600000000000001 110.196 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -66.29 -40.78 90.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.072 -1.017 . . . . 2.6699999999999999 110.688 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.0 -53.82 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.078 -1.014 . . . . 0.23000000000000001 110.597 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -63.68 -38.09 89.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.14999999999999999 110.678 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -60.08 -44.04 95.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.817 -1.177 . . . . 2.0699999999999998 109.582 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -68.36 -41.44 80.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 1.8400000000000001 108.673 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 58.1 t80 -59.94 -48.33 82.12 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.487 -0.758 . . . . 0.29999999999999999 109.05 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.87 99.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.25 109.096 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 35' ' ' ASN . 1.9 m120 -60.54 -43.33 97.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.292 -0.88 . . . . 1.23 108.897 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -64.25 -22.39 66.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 1.29 109.338 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.582 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 65.8 m-80 -98.46 6.76 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.286 -0.884 . . . . 0.64000000000000001 109.877 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.78 36.21 91.94 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.164 -1.175 . . . . 0.71999999999999997 110.164 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.59 127.42 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.277 -1.131 . . . . 0.40000000000000002 109.935 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.471 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 92.9 m-20 -111.68 -97.15 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.5 -1.296 . . . . 1.3300000000000001 107.5 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.93 166.91 2.06 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-O 122.052 0.807 . . . . 0.26000000000000001 112.407 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.55 139.16 41.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.389 -1.337 . . . . 2.0699999999999998 107.389 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.66 135.48 42.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.13 111.077 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 p -133.4 147.24 51.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.588 -0.893 . . . . 0.22 108.588 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 52.6 t80 -134.63 135.88 42.45 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.242 -0.911 . . . . 0.12 110.186 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 50' ' ' LYS . 55.2 t0 -113.11 109.96 19.67 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.941 -0.762 . . . . 0.23999999999999999 108.941 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 45.8 t0 -68.87 -30.6 69.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.07 -1.019 . . . . 1.1599999999999999 109.966 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.99 94.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.838 . . . . 0.29999999999999999 110.112 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -110.97 -0.15 16.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.651 -0.655 . . . . 0.41999999999999998 109.642 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 46' ' ' ASP . 56.7 mttp 48.9 41.81 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.137 -0.977 . . . . 2.1600000000000001 109.208 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -115.74 131.12 57.03 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.483 0.659 . . . . 0.28000000000000003 109.553 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.5 m-85 -100.61 139.91 35.62 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.092 -1.077 . . . . 0.089999999999999997 108.092 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -132.23 131.98 42.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.671 -1.268 . . . . 0.14000000000000001 108.672 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.0 126.77 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.617 -1.253 . . . . 0.12 107.617 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.3 m -120.07 126.54 51.02 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.226 -0.921 . . . . 0.28999999999999998 110.293 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 118.03 -0.986 . . . . 1.95 109.231 179.564 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.055 -0.72 . . . . 2.9100000000000001 109.055 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 m -92.6 135.94 33.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.491 -0.756 . . . . 0.31 110.008 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -119.35 146.41 45.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.74 -0.837 . . . . 0.19 108.74 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -116.91 144.82 44.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.409 -0.807 . . . . 1.98 109.804 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.3 tp -118.95 129.8 55.36 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.502 -0.749 . . . . 0.13 109.005 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.43 122.18 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.058 -1.46 . . . . 0.35999999999999999 107.058 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.8 mt -101.76 117.52 35.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.174 -0.954 . . . . 0.25 110.2 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.45 HD22 HG23 ' A' ' 55' ' ' THR . 54.5 t30 -124.59 66.43 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.565 -1.272 . . . . 0.17999999999999999 107.565 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 176.38 54.68 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.497 -1.441 . . . . 0.23999999999999999 109.497 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -66.07 -39.71 90.3 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.15 -1.206 . . . . 2.71 108.668 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -17.39 7.12 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.874 -0.516 . . . . 0.92000000000000004 110.523 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.66 121.9 41.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.025 -1.047 . . . . 0.59999999999999998 109.564 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -135.16 127.59 30.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.393 -0.817 . . . . 2.02 109.417 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -173.77 46.54 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.382 -1.39 . . . . 0.23999999999999999 110.515 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -149.02 156.9 42.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.622 -0.929 . . . . 1.6799999999999999 109.15 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -154.01 170.04 22.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.413 -0.805 . . . . 0.34000000000000002 109.61 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 p -137.39 159.24 42.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.782 . . . . 0.20999999999999999 109.13 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -157.52 162.7 38.85 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.335 -0.853 . . . . 0.23000000000000001 108.9 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -101.21 133.77 45.27 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.306 -0.998 . . . . 2.2200000000000002 108.306 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -146.88 142.12 27.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.178 -0.951 . . . . 0.39000000000000001 108.949 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.99 -31.24 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.864 . . . . 0.55000000000000004 109.552 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -157.69 179.21 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 1.1599999999999999 110.106 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.15 -38.27 87.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.466 -0.771 . . . . 0.26000000000000001 109.527 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.38 61.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.177 -0.952 . . . . 0.28999999999999998 109.971 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.628 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.5 m -69.94 -40.05 75.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.641 -1.287 . . . . 0.44 109.749 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.64 82.06 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.444 -0.947 . . . . 0.17999999999999999 108.444 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.06 -45.7 71.77 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.687 -1.205 . . . . 1.0600000000000001 108.602 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.07 -46.1 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.64 -0.662 . . . . 2.6699999999999999 110.764 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.27 -52.85 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.286 -0.884 . . . . 0.23000000000000001 111.088 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -67.48 -39.95 85.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.996 -1.065 . . . . 0.14999999999999999 110.551 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.68 -43.06 98.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.55 -1.344 . . . . 2.0699999999999998 109.229 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.5 -44.49 82.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 1.8400000000000001 108.911 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.3 t80 -60.13 -46.46 89.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.421 -0.799 . . . . 0.29999999999999999 109.046 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -45.78 90.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.18 -0.95 . . . . 0.25 109.33 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.08 -43.93 95.13 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.665 -0.865 . . . . 1.23 108.665 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.07 -20.32 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.313 -0.867 . . . . 1.29 109.05 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.531 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 31.6 m120 -97.76 6.63 47.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.288 -0.883 . . . . 0.64000000000000001 109.897 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.46 32.63 67.94 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.021 -1.085 . . . . 0.71999999999999997 111.184 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.5 t -110.52 124.99 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.03 -1.276 . . . . 0.40000000000000002 109.186 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 73.6 m-20 -150.67 99.78 2.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 1.3300000000000001 110.281 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 -132.24 1.73 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.342 -1.409 . . . . 0.26000000000000001 110.995 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.57 125.62 37.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.851 -1.382 . . . . 2.0699999999999998 110.677 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -103.03 137.08 41.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.672 -0.643 . . . . 0.13 109.515 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -136.1 150.03 48.95 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.832 -1.173 . . . . 0.22 107.832 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -137.1 137.87 39.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.225 -0.922 . . . . 0.12 110.444 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -112.55 110.07 20.01 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.387 -0.968 . . . . 0.23999999999999999 108.387 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -65.67 -30.92 71.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 1.1599999999999999 110.374 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.15 93.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.29999999999999999 110.272 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -104.33 -0.11 28.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.39 -0.819 . . . . 0.41999999999999998 110.778 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp 50.07 40.21 20.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.758 -1.214 . . . . 2.1600000000000001 108.246 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.97 131.53 55.2 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.633 0.73 . . . . 0.28000000000000003 110.621 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -100.3 140.02 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.346 -1.353 . . . . 0.089999999999999997 107.346 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.1 m -130.8 132.62 45.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.14000000000000001 108.576 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.8 130.1 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.802 -0.814 . . . . 0.12 108.802 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.45 HG23 HD22 ' A' ' 8' ' ' ASN . 79.4 m -128.07 129.78 47.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.484 0.659 . . . . 0.28999999999999998 110.169 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 40' ' ' ASP . 74.2 mm-40 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.978 -1.01 . . . . 1.95 109.551 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.7 mmm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.385 -0.598 . . . . 2.9100000000000001 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m -94.01 131.63 39.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.078 -1.014 . . . . 0.31 109.346 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -117.5 145.45 44.2 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.362 -0.977 . . . . 0.19 108.362 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -113.21 145.35 41.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.343 -0.848 . . . . 1.98 109.647 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.481 HD22 ' CD1' ' A' ' 30' ' ' PHE . 59.1 tp -121.62 127.66 51.08 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.564 -0.71 . . . . 0.13 109.592 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.5 mm -103.54 121.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.621 -1.622 . . . . 0.35999999999999999 106.621 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.2 mt -100.33 111.47 23.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.947 -1.096 . . . . 0.25 109.528 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.54 69.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.543 -1.28 . . . . 0.17999999999999999 107.543 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 163.96 48.1 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.345 -1.502 . . . . 0.23999999999999999 109.345 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -66.8 -37.57 84.82 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.529 -1.286 . . . . 2.71 107.529 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.2 p -115.16 -22.37 9.5 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.576 -0.527 . . . . 0.92000000000000004 109.576 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 9' ' ' GLY . 19.0 tp -102.29 127.99 49.03 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.342 -0.849 . . . . 0.59999999999999998 109.556 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -139.91 128.1 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 2.02 109.472 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.46 -174.33 46.86 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.107 -1.521 . . . . 0.23999999999999999 110.85 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -147.88 155.69 41.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.717 -0.873 . . . . 1.6799999999999999 109.036 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -153.97 169.36 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 0.34000000000000002 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.3 p -134.48 158.58 43.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.359 -0.838 . . . . 0.20999999999999999 109.439 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 7.7 t -155.38 159.53 39.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 0.23000000000000001 109.047 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -103.99 134.12 47.8 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.249 -0.907 . . . . 2.2200000000000002 108.879 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.12 143.32 27.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.39000000000000001 109.073 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 21' ' ' VAL . 14.3 m -60.39 -28.9 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.55000000000000004 109.741 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -157.53 174.96 14.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.198 -0.938 . . . . 1.1599999999999999 109.894 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.29 83.87 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.26000000000000001 109.874 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.25 -36.22 52.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.941 -1.1 . . . . 0.28999999999999998 109.607 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.553 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 6.1 p -73.45 -34.75 65.55 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.756 -1.215 . . . . 0.44 109.76 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.88 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.286 -1.005 . . . . 0.17999999999999999 108.286 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -57.9 -49.91 75.12 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.784 -1.167 . . . . 1.0600000000000001 109.953 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -64.63 -41.43 96.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.747 -1.221 . . . . 2.6699999999999999 110.405 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.55 -53.67 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 0.23000000000000001 110.842 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.6 m-85 -64.41 -39.22 93.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.14999999999999999 111.07 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 67.2 mttm -61.78 -40.29 94.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.237 . . . . 2.0699999999999998 110.156 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -69.45 -43.79 72.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.875 -1.141 . . . . 1.8400000000000001 108.804 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.614 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -60.46 -46.65 89.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.394 -0.816 . . . . 0.29999999999999999 109.53 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -45.12 94.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.25 109.76 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 31' ' ' LYS . 81.4 m-20 -61.59 -40.07 93.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 1.23 109.369 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.74 -23.96 67.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.183 -0.948 . . . . 1.29 109.532 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.614 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.6 m-20 -95.23 9.92 37.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.216 -0.927 . . . . 0.64000000000000001 109.944 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.71 81.8 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.811 -1.315 . . . . 0.71999999999999997 109.811 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.02 126.12 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.333 -1.098 . . . . 0.40000000000000002 109.999 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 52.0 t0 -141.2 146.09 36.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 1.3300000000000001 107.996 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.11 -150.28 12.13 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.234 -1.46 . . . . 0.26000000000000001 110.206 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -92.05 132.35 36.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.568 -0.96 . . . . 2.0699999999999998 108.525 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -100.38 136.49 40.19 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.246 -0.909 . . . . 0.13 110.331 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 p -138.74 150.41 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.39 -0.967 . . . . 0.22 108.39 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -132.0 136.57 47.38 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.303 -0.873 . . . . 0.12 110.275 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.71 106.23 15.38 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.319 -0.993 . . . . 0.23999999999999999 108.319 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -66.73 -33.73 76.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 1.1599999999999999 110.811 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.33 -40.04 95.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.965 -1.085 . . . . 0.29999999999999999 109.881 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -102.79 0.75 33.24 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.552 -0.718 . . . . 0.41999999999999998 110.277 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp 49.92 41.21 22.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 2.1600000000000001 108.474 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -123.32 137.44 54.84 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.677 0.751 . . . . 0.28000000000000003 110.969 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -100.69 139.25 36.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.383 -1.34 . . . . 0.089999999999999997 107.383 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -130.27 130.76 44.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.653 -1.28 . . . . 0.14000000000000001 108.519 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.51 128.18 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.089 -1.078 . . . . 0.12 108.089 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -120.02 128.31 53.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.28999999999999998 110.214 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.938 -1.03 . . . . 1.95 109.351 -179.69 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.484 ' SD ' ' NZ ' ' A' ' 50' ' ' LYS . 24.6 ttt . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.305 -0.628 . . . . 2.9100000000000001 109.305 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.4 m -91.19 131.61 36.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.237 -0.915 . . . . 0.31 109.806 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.82 148.83 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.895 -1.15 . . . . 0.19 107.895 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -116.25 140.52 49.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.103 -0.998 . . . . 1.98 109.081 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 30' ' ' PHE . 26.7 tp -123.17 128.68 50.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.681 -0.637 . . . . 0.13 109.31 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 124.8 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.266 -1.383 . . . . 0.35999999999999999 107.266 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 54' ' ' VAL . 92.4 mt -102.34 115.59 30.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.25 109.029 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -113.37 70.63 0.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.521 -1.289 . . . . 0.17999999999999999 107.521 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.77 167.54 52.92 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.709 -1.756 . . . . 0.23999999999999999 108.709 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -67.24 -37.11 83.01 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.137 -1.214 . . . . 2.71 107.733 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -120.24 -18.73 7.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.153 0.502 . . . . 0.92000000000000004 109.654 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.06 120.01 39.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.235 -0.915 . . . . 0.59999999999999998 109.577 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -132.68 127.54 35.04 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.317 -0.865 . . . . 2.02 109.902 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -175.81 47.65 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.654 -1.26 . . . . 0.23999999999999999 110.257 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.55 158.62 44.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -1.001 . . . . 1.6799999999999999 109.313 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -153.22 170.03 21.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.391 -0.818 . . . . 0.34000000000000002 109.72 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.4 p -137.87 160.04 40.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.8 . . . . 0.20999999999999999 109.317 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.437 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -155.4 159.96 40.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.23000000000000001 109.058 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -107.46 135.19 49.36 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.317 -0.994 . . . . 2.2200000000000002 108.317 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.82 149.92 31.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.213 -0.929 . . . . 0.39000000000000001 109.677 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.07 -29.08 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.55000000000000004 110.053 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -158.07 171.89 19.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.916 -1.115 . . . . 1.1599999999999999 110.304 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.84 -38.56 83.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.567 -0.708 . . . . 0.26000000000000001 110.175 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.58 -37.33 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.995 -1.066 . . . . 0.28999999999999998 109.772 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -72.98 -34.59 66.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.682 -1.262 . . . . 0.44 109.638 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.17 90.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.37 -0.974 . . . . 0.17999999999999999 108.37 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.46 -49.18 70.68 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.185 -1.006 . . . . 1.0600000000000001 109.315 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.358 -0.839 . . . . 2.6699999999999999 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.322 -0.861 . . . . 0.23000000000000001 111.346 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CD1' HD22 ' A' ' 5' ' ' LEU . 27.2 m-85 -65.09 -39.9 93.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.83 -1.169 . . . . 0.14999999999999999 111.37 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -63.37 -41.1 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 2.0699999999999998 110.146 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.11 -42.47 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 1.8400000000000001 108.893 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 65.2 t80 -60.14 -46.77 88.54 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.708 -0.849 . . . . 0.29999999999999999 108.708 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.19 99.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.491 -0.756 . . . . 0.25 109.376 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -60.05 -40.84 90.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 1.23 109.15 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.25 -20.01 65.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 1.29 109.424 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 97.9 m-20 -96.56 4.8 51.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.093 -1.004 . . . . 0.64000000000000001 109.992 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.6 36.34 54.13 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.933 -1.127 . . . . 0.71999999999999997 110.959 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.8 t -116.26 122.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.155 -1.203 . . . . 0.40000000000000002 108.559 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 73.9 m-20 -150.28 101.09 2.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -0.961 . . . . 1.3300000000000001 110.818 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 -128.78 1.21 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.438 -1.363 . . . . 0.26000000000000001 110.687 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -94.02 130.32 40.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.896 -1.355 . . . . 2.0699999999999998 110.417 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -103.05 136.19 43.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.715 -0.616 . . . . 0.13 109.541 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.0 p -134.21 147.74 50.76 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.752 -1.203 . . . . 0.22 107.752 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -137.42 138.29 39.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.207 -0.933 . . . . 0.12 110.452 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -115.06 110.05 18.99 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.769 -0.826 . . . . 0.23999999999999999 108.769 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 47.2 t0 -67.06 -28.74 68.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 1.1599999999999999 109.719 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.97 95.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.29999999999999999 110.013 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.0 p -107.55 0.45 22.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.474 -0.766 . . . . 0.41999999999999998 110.218 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 32.1 mmtp 50.07 41.88 24.1 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.757 -1.201 . . . . 2.1600000000000001 107.757 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.29 130.81 55.59 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.638 0.732 . . . . 0.28000000000000003 110.603 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -101.89 139.42 37.55 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.779 -1.193 . . . . 0.089999999999999997 107.779 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.0 m -130.98 132.63 45.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.833 -1.167 . . . . 0.14000000000000001 108.294 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 7' ' ' LEU . 2.9 p -124.32 130.55 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.593 -0.891 . . . . 0.12 108.593 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.0 m -120.03 126.91 51.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.639 -0.663 . . . . 0.28999999999999998 109.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.992 -1.004 . . . . 1.95 109.367 -179.463 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.065 -0.717 . . . . 2.9100000000000001 109.065 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -91.71 133.5 35.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.31 109.512 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.68 140.99 49.78 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.712 -0.848 . . . . 0.19 108.712 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.81 143.34 44.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.539 -0.725 . . . . 1.98 109.052 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 52' ' ' PHE . 44.4 tp -119.19 129.38 54.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.849 -0.797 . . . . 0.13 108.849 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.8 mt -106.34 124.36 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.95 -1.5 . . . . 0.35999999999999999 106.95 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.13 116.09 31.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.25 110.336 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.27 67.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.378 -1.712 . . . . 0.17999999999999999 106.378 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.52 173.11 53.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.778 -1.329 . . . . 0.23999999999999999 109.778 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.06 -40.03 82.85 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.29 -1.123 . . . . 2.71 108.231 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.1 m -121.64 -19.33 6.88 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.858 -0.526 . . . . 0.92000000000000004 109.891 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.0 tp -98.57 119.54 37.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.059 -1.026 . . . . 0.59999999999999998 109.515 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -136.39 129.07 30.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.161 -0.962 . . . . 2.02 109.526 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.21 -171.07 44.25 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.417 -1.373 . . . . 0.23999999999999999 110.065 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -148.18 157.27 43.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.63 -0.923 . . . . 1.6799999999999999 109.124 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 t -153.15 171.58 18.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.815 . . . . 0.34000000000000002 108.878 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -137.83 159.98 40.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 0.20999999999999999 109.857 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.432 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 3.5 t -156.91 160.81 39.47 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.49 -0.756 . . . . 0.23000000000000001 109.214 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -104.97 136.87 43.63 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.358 -0.979 . . . . 2.2200000000000002 108.358 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.5 141.78 26.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.082 -1.011 . . . . 0.39000000000000001 109.453 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 m -60.44 -30.86 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.435 -0.791 . . . . 0.55000000000000004 109.347 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -156.87 174.32 15.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.31 -0.869 . . . . 1.1599999999999999 109.564 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.25 81.53 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.37 -0.831 . . . . 0.26000000000000001 110.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.38 -36.11 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.28999999999999998 109.716 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -71.25 -38.25 71.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.226 . . . . 0.44 109.605 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.91 85.86 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.511 -0.922 . . . . 0.17999999999999999 108.511 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.02 -42.36 89.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.629 -1.228 . . . . 1.0600000000000001 109.301 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.03 -43.83 81.78 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.627 -1.296 . . . . 2.6699999999999999 110.449 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.11 -53.23 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.915 . . . . 0.23000000000000001 111.845 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.432 ' CZ ' HG22 ' A' ' 18' ' ' THR . 41.2 m-85 -66.56 -40.1 88.83 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.901 -1.124 . . . . 0.14999999999999999 111.88 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.53 -40.16 95.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.675 -1.265 . . . . 2.0699999999999998 110.177 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.9 -40.68 75.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.898 -1.126 . . . . 1.8400000000000001 108.685 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.58 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 65.4 t80 -59.99 -44.56 94.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.29999999999999999 108.982 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.29 96.73 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.396 -0.815 . . . . 0.25 108.962 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.98 -44.06 94.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.392 -0.817 . . . . 1.23 108.818 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.15 -24.19 67.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 1.29 109.341 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.58 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 81.2 m-20 -99.03 9.7 42.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.935 . . . . 0.64000000000000001 109.052 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.89 36.77 93.29 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.515 -1.434 . . . . 0.71999999999999997 109.515 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.3 125.88 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.319 -1.107 . . . . 0.40000000000000002 109.892 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 96.4 m-20 -110.86 -98.63 0.41 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.294 -1.002 . . . . 1.3300000000000001 108.294 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.81 165.21 4.79 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.083 0.824 . . . . 0.26000000000000001 112.005 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.0 135.49 39.99 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.385 -1.339 . . . . 2.0699999999999998 107.385 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -98.08 133.37 42.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.025 -1.047 . . . . 0.13 110.435 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.0 p -133.03 148.31 52.24 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.029 -1.1 . . . . 0.22 108.029 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -133.13 132.42 41.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.452 -0.78 . . . . 0.12 110.063 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -113.34 110.05 19.72 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.764 -0.828 . . . . 0.23999999999999999 108.764 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -68.46 -29.5 68.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 1.1599999999999999 110.625 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.92 89.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.29999999999999999 110.313 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 78.6 p -104.87 -0.16 27.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.378 -0.826 . . . . 0.41999999999999998 109.721 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.02 40.97 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.005 -1.06 . . . . 2.1600000000000001 108.438 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.1 m -120.04 130.89 54.91 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.597 0.713 . . . . 0.28000000000000003 110.723 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' O ' HD12 ' A' ' 5' ' ' LEU . 56.8 m-85 -98.34 139.12 34.59 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.953 -1.499 . . . . 0.089999999999999997 106.953 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 100.0 m -132.04 131.88 42.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.715 -1.241 . . . . 0.14000000000000001 108.853 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 2.6 p -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.036 -1.098 . . . . 0.12 108.036 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -121.45 128.32 52.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.39 -0.819 . . . . 0.28999999999999998 110.788 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.035 -0.983 . . . . 1.95 109.298 179.456 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' CG ' ' H ' ' A' ' 2' ' ' THR . 4.3 tpt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.443 0.639 . . . . 2.9100000000000001 109.397 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.502 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 98.3 m -93.41 131.64 38.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.578 -0.701 . . . . 0.31 109.776 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -112.89 147.86 36.15 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.095 -1.076 . . . . 0.19 108.095 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.45 140.12 50.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.338 -0.851 . . . . 1.98 109.079 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' A' ' 30' ' ' PHE . 36.1 tp -116.76 127.98 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.238 -1.023 . . . . 0.13 108.238 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.7 mt -101.52 121.23 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.091 -1.448 . . . . 0.35999999999999999 107.091 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.2 110.85 22.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.032 -1.043 . . . . 0.25 109.918 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -116.49 67.76 0.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.811 -1.552 . . . . 0.17999999999999999 106.811 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -80.67 164.93 47.38 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.163 -1.575 . . . . 0.23999999999999999 109.163 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.142 -1.21 . . . . 2.71 108.261 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.6 m -111.31 -25.06 9.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.831 -0.543 . . . . 0.92000000000000004 109.674 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 9' ' ' GLY . 40.5 tp -103.09 124.12 47.94 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.343 -0.848 . . . . 0.59999999999999998 109.899 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.32 126.39 29.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 2.02 108.99 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.58 -171.77 44.83 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.187 -1.482 . . . . 0.23999999999999999 110.592 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -149.46 158.15 43.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.688 -0.889 . . . . 1.6799999999999999 109.147 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.75 170.1 22.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.34000000000000002 109.519 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.0 p -137.3 159.89 40.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.20999999999999999 109.225 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -154.6 159.29 40.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.604 -0.887 . . . . 0.23000000000000001 108.604 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -101.54 131.95 47.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.134 -0.979 . . . . 2.2200000000000002 108.552 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.19 143.68 27.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.39000000000000001 109.157 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.01 -29.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.446 -0.784 . . . . 0.55000000000000004 109.797 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -158.78 174.75 14.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.055 -1.028 . . . . 1.1599999999999999 110.196 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.26 82.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.595 -0.691 . . . . 0.26000000000000001 110.311 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.0 64.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.032 -1.043 . . . . 0.28999999999999998 110.368 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 p -72.48 -35.6 68.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.62 -1.3 . . . . 0.44 110.012 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.0 81.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.471 -0.768 . . . . 0.17999999999999999 108.982 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.51 -42.35 87.51 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.613 -1.235 . . . . 1.0600000000000001 109.815 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.8 -42.68 73.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 2.6699999999999999 110.24 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.12 -52.19 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.23000000000000001 110.768 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CD1' HD22 ' A' ' 5' ' ' LEU . 19.6 m-85 -61.8 -38.12 86.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.945 -1.097 . . . . 0.14999999999999999 110.07 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -59.99 -41.77 92.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.885 -1.134 . . . . 2.0699999999999998 109.782 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.92 -40.65 83.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.037 -1.039 . . . . 1.8400000000000001 108.537 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.463 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 57.9 t80 -59.94 -49.64 76.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.772 -0.825 . . . . 0.29999999999999999 108.772 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.58 84.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.25 109.351 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -60.04 -43.13 95.57 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 1.23 108.649 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.41 -25.39 65.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.077 -1.015 . . . . 1.29 108.783 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.463 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 18.9 m120 -100.01 9.86 42.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.64000000000000001 109.926 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.03 34.7 88.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.012 -1.235 . . . . 0.71999999999999997 110.012 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.04 128.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.306 -1.114 . . . . 0.40000000000000002 109.937 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 95.9 m-20 -110.02 -99.74 0.39 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.622 -0.881 . . . . 1.3300000000000001 108.622 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.02 161.6 3.37 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 121.977 0.765 . . . . 0.26000000000000001 111.849 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -74.68 138.01 42.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.396 -1.335 . . . . 2.0699999999999998 107.396 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -99.76 135.8 40.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -0.993 . . . . 0.13 111.115 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.68 149.75 50.54 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.213 -1.032 . . . . 0.22 108.213 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 65.6 t80 -135.97 134.57 38.74 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.12 110.065 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -111.76 110.02 20.17 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.687 -0.857 . . . . 0.23999999999999999 108.687 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.24 -31.71 72.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 1.1599999999999999 110.253 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.7 88.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.29999999999999999 110.436 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.9 p -105.09 -0.98 26.16 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.386 -0.821 . . . . 0.41999999999999998 110.158 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.1 mtpm? 49.98 40.03 20.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 2.1600000000000001 108.931 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 132.14 55.38 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.528 0.68 . . . . 0.28000000000000003 110.452 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.0 m-85 -99.6 139.8 34.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.384 -1.339 . . . . 0.089999999999999997 107.384 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.5 m -131.58 132.45 44.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.71 -1.244 . . . . 0.14000000000000001 108.83 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -121.88 129.31 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.35 -0.982 . . . . 0.12 108.35 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -120.02 127.2 52.38 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.477 -0.765 . . . . 0.28999999999999998 111.016 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.058 -0.972 . . . . 1.95 109.163 179.191 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mmm . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.026 -0.731 . . . . 2.9100000000000001 109.026 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.532 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 95.6 m -95.6 128.8 42.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.31 109.685 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -112.1 150.29 30.94 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.891 -1.151 . . . . 0.19 107.891 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -116.48 143.4 45.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.067 -1.02 . . . . 1.98 109.418 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 30' ' ' PHE . 35.2 tp -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.688 -0.632 . . . . 0.13 109.84 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.5 mt -108.45 123.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.572 -1.27 . . . . 0.35999999999999999 107.572 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 54' ' ' VAL . 79.8 mt -102.85 115.94 31.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.25 -0.906 . . . . 0.25 110.01 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -116.95 70.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.666 -1.235 . . . . 0.17999999999999999 107.666 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.91 170.1 53.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.093 -1.603 . . . . 0.23999999999999999 109.093 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' NZ ' ' O ' ' A' ' 56' ' ' GLU . 62.4 mttp -64.38 -36.94 85.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.075 -1.25 . . . . 2.71 107.627 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.0 p -123.07 -15.27 7.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.903 -0.498 . . . . 0.92000000000000004 109.889 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.79 122.1 41.59 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.98 -1.075 . . . . 0.59999999999999998 109.969 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.92 126.68 27.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.295 -0.878 . . . . 2.02 109.814 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.27 -177.41 48.39 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.387 -1.387 . . . . 0.23999999999999999 110.154 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.77 157.03 42.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.517 -0.99 . . . . 1.6799999999999999 108.977 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -156.73 173.24 17.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.474 -0.766 . . . . 0.34000000000000002 109.523 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.2 p -137.23 160.54 38.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.378 -0.826 . . . . 0.20999999999999999 109.211 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 7.3 t -154.0 159.81 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.793 -0.817 . . . . 0.23000000000000001 108.793 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -102.84 131.94 49.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.265 -0.897 . . . . 2.2200000000000002 109.137 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.676 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -150.07 145.62 26.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.39000000000000001 109.105 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 21' ' ' VAL . 15.8 m -62.61 -26.89 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.498 -0.751 . . . . 0.55000000000000004 110.341 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -157.77 174.71 14.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.888 -1.133 . . . . 1.1599999999999999 110.431 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.36 81.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.518 -0.739 . . . . 0.26000000000000001 109.208 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.85 -37.94 60.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.28999999999999998 109.828 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.676 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 20.7 p -73.12 -35.13 66.48 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.668 -1.27 . . . . 0.44 109.6 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.7 94.89 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.581 -0.896 . . . . 0.17999999999999999 108.581 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.27 -48.07 83.0 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.348 -1.341 . . . . 1.0600000000000001 109.27 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -65.91 -44.67 84.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 2.6699999999999999 111.013 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.48 -52.86 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.946 -1.096 . . . . 0.23000000000000001 110.456 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CD1' HD22 ' A' ' 5' ' ' LEU . 20.9 m-85 -61.06 -36.51 79.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.14999999999999999 110.156 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -60.02 -40.5 89.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.885 -1.134 . . . . 2.0699999999999998 109.261 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.02 -41.43 74.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 1.8400000000000001 108.923 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 58.1 t80 -60.06 -49.66 76.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.29999999999999999 109.461 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -45.28 94.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.25 109.549 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.96 -41.68 92.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.334 -0.854 . . . . 1.23 109.272 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.21 -23.44 67.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 1.29 109.138 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 5.8 m120 -97.05 6.74 48.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.64000000000000001 109.592 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.04 63.52 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.059 -1.067 . . . . 0.71999999999999997 111.282 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 44.0 t -114.81 125.57 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.035 -1.274 . . . . 0.40000000000000002 108.796 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 75.1 m-20 -149.66 101.92 3.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.254 -0.904 . . . . 1.3300000000000001 110.399 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.41 -130.54 1.33 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.128 -1.51 . . . . 0.26000000000000001 111.301 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -92.29 131.66 37.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.943 -1.328 . . . . 2.0699999999999998 110.539 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.674 -0.641 . . . . 0.13 110.015 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 p -138.2 150.71 47.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.097 -1.075 . . . . 0.22 108.097 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.97 137.24 39.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -0.911 . . . . 0.12 110.532 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -113.28 109.98 19.63 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.904 -0.776 . . . . 0.23999999999999999 108.904 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 53.7 t0 -67.01 -30.93 71.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 1.1599999999999999 110.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.922 -1.111 . . . . 0.29999999999999999 109.688 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -104.07 -0.65 28.45 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.363 -0.835 . . . . 0.41999999999999998 109.807 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 10.0 mtpm? 49.66 42.79 23.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.881 -1.137 . . . . 2.1600000000000001 108.453 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -120.05 134.69 55.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.454 0.645 . . . . 0.28000000000000003 110.713 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -100.4 138.28 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.392 -1.336 . . . . 0.089999999999999997 107.392 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.3 m -128.8 130.17 46.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.692 -1.255 . . . . 0.14000000000000001 108.03 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.423 HG12 HD23 ' A' ' 7' ' ' LEU . 5.6 p -125.28 130.11 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.539 -0.912 . . . . 0.12 108.539 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.8 m -120.0 128.37 53.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.207 -0.664 . . . . 0.28999999999999998 109.207 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 63.9 tt0 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.972 -1.014 . . . . 1.95 109.288 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.7 mpp? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.246 -0.65 . . . . 2.9100000000000001 109.246 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.2 m -92.25 131.15 37.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.141 -0.974 . . . . 0.31 109.582 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -113.42 146.92 38.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.749 -1.204 . . . . 0.19 107.749 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -118.22 141.59 48.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.23 -0.919 . . . . 1.98 109.824 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.5 tp -120.11 128.38 53.4 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.045 -0.724 . . . . 0.13 109.045 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.1 123.28 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.027 -1.471 . . . . 0.35999999999999999 107.027 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 114.06 27.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.168 -0.957 . . . . 0.25 109.67 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.6 71.39 0.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.031 -1.47 . . . . 0.17999999999999999 107.031 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.11 169.59 53.03 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.082 -1.207 . . . . 0.23999999999999999 110.082 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -65.76 -39.84 91.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -1.039 . . . . 2.71 108.224 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.9 m -124.28 -18.42 5.82 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.419 -0.586 . . . . 0.92000000000000004 109.419 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.7 119.98 39.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.399 -0.813 . . . . 0.59999999999999998 109.037 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -135.31 133.63 39.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.253 -0.904 . . . . 2.02 109.598 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.82 -173.64 46.45 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.461 -1.352 . . . . 0.23999999999999999 110.272 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -149.44 158.2 43.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.577 -0.954 . . . . 1.6799999999999999 109.202 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.466 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 4.3 t -154.49 171.6 19.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 0.34000000000000002 109.324 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.7 p -137.33 159.92 40.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.20999999999999999 109.332 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.462 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.5 t -155.0 158.8 39.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.823 . . . . 0.23000000000000001 109.094 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.59 133.57 48.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.459 -0.941 . . . . 2.2200000000000002 108.459 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.55 146.25 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.39000000000000001 109.306 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 21' ' ' VAL . 14.5 m -59.55 -30.78 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.55000000000000004 109.564 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -159.33 174.61 14.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.981 . . . . 1.1599999999999999 110.015 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.32 81.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.411 -0.805 . . . . 0.26000000000000001 110.358 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.37 -37.32 62.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.872 -1.142 . . . . 0.28999999999999998 109.708 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.441 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 21.4 p -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.692 -1.255 . . . . 0.44 109.576 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.19 81.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.359 -0.978 . . . . 0.17999999999999999 108.359 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.13 -47.44 81.13 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.645 -1.222 . . . . 1.0600000000000001 109.439 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.71 -41.13 88.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 2.6699999999999999 110.248 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -68.27 -54.98 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.06 -1.025 . . . . 0.23000000000000001 110.814 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 18' ' ' THR . 28.2 m-85 -63.69 -38.66 91.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.14999999999999999 111.358 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.79 -40.72 96.2 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.701 -1.249 . . . . 2.0699999999999998 110.049 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.23 -43.86 73.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.971 -1.08 . . . . 1.8400000000000001 109.162 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 81.4 t80 -60.17 -46.98 87.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.446 -0.784 . . . . 0.29999999999999999 109.899 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.34 96.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.25 108.656 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.41 -41.16 96.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.561 -0.903 . . . . 1.23 108.561 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.64 -25.05 68.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 1.29 109.607 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 6.3 m120 -94.8 7.43 45.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.946 . . . . 0.64000000000000001 109.791 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.12 30.34 75.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.678 -1.369 . . . . 0.71999999999999997 109.678 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.0 t -105.45 125.81 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -1.165 . . . . 0.40000000000000002 109.756 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 40.0 t0 -138.64 142.32 39.07 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.98 -1.119 . . . . 1.3300000000000001 107.98 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.78 -150.13 11.6 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.247 -1.454 . . . . 0.26000000000000001 110.135 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -94.48 137.66 33.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.531 -0.982 . . . . 2.0699999999999998 108.822 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -104.89 138.33 41.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.367 -0.833 . . . . 0.13 110.77 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -136.24 149.86 48.7 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.885 -1.154 . . . . 0.22 107.885 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -137.03 137.35 39.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.185 -0.947 . . . . 0.12 110.492 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.6 109.95 20.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.316 -0.994 . . . . 0.23999999999999999 108.316 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 45.9 t0 -67.35 -30.67 70.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 1.1599999999999999 110.167 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.86 91.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.29999999999999999 110.34 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 74.4 p -105.93 -0.07 25.39 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.391 -0.818 . . . . 0.41999999999999998 110.278 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 50.02 41.46 23.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.927 -1.108 . . . . 2.1600000000000001 108.542 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -119.03 130.5 55.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.734 0.778 . . . . 0.28000000000000003 110.451 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -99.36 139.08 35.54 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.568 -1.271 . . . . 0.089999999999999997 107.568 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.6 m -130.69 131.35 44.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.14000000000000001 108.195 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.27 129.35 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.423 -0.954 . . . . 0.12 108.423 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.1 m -120.41 127.07 51.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.423 -0.798 . . . . 0.28999999999999998 110.188 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.027 -0.987 . . . . 1.95 109.253 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 21' ' ' VAL . 62.2 mtt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.384 -0.599 . . . . 2.9100000000000001 109.384 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.4 m -92.71 134.69 34.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.375 -0.828 . . . . 0.31 109.655 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -113.72 145.41 41.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.361 -0.978 . . . . 0.19 108.361 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -115.96 142.94 46.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 1.98 108.912 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.558 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.9 tp -119.92 126.62 51.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.573 -0.899 . . . . 0.13 108.573 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.48 123.73 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.151 -1.425 . . . . 0.35999999999999999 107.151 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 mt -102.73 112.89 25.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.366 -0.834 . . . . 0.25 110.383 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.97 68.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.839 -1.541 . . . . 0.17999999999999999 106.839 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.31 168.2 51.51 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.965 -1.254 . . . . 0.23999999999999999 109.965 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -65.9 -37.65 86.65 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.703 -1.221 . . . . 2.71 107.703 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -122.19 -19.79 6.42 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.151 -0.477 . . . . 0.92000000000000004 109.866 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 tp -99.5 120.93 40.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 0.59999999999999998 109.422 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -135.61 128.46 31.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.304 -0.873 . . . . 2.02 109.517 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.42 -175.03 47.42 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.303 -1.427 . . . . 0.23999999999999999 110.446 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.36 152.57 41.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.646 -0.914 . . . . 1.6799999999999999 108.86 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -152.65 168.02 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.34000000000000002 108.801 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.1 p -138.65 160.54 39.37 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.20999999999999999 109.737 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 10.4 t -157.37 162.84 39.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.23000000000000001 108.594 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 43.7 mp0 -106.37 136.78 45.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.796 -0.816 . . . . 2.2200000000000002 108.796 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.04 144.76 28.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.931 . . . . 0.39000000000000001 108.899 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' ' SD ' ' A' ' 1' ' ' MET . 19.8 m -60.04 -30.73 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.229 -0.919 . . . . 0.55000000000000004 109.393 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -157.73 176.96 11.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 1.1599999999999999 110.112 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.31 -38.12 87.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.526 -0.734 . . . . 0.26000000000000001 109.496 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.9 61.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.982 -1.074 . . . . 0.28999999999999998 109.553 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.621 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 90.2 m -69.97 -40.06 75.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.69 -1.256 . . . . 0.44 109.811 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.02 87.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.857 -0.794 . . . . 0.17999999999999999 108.857 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.21 -45.44 79.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.442 -1.303 . . . . 1.0600000000000001 108.824 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -67.83 -44.23 77.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 2.6699999999999999 111.157 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.87 -53.01 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.169 -0.957 . . . . 0.23000000000000001 111.34 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.558 ' CD1' HD22 ' A' ' 5' ' ' LEU . 23.8 m-85 -63.98 -37.56 87.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.861 -1.149 . . . . 0.14999999999999999 110.299 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -59.94 -42.32 93.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.805 -1.184 . . . . 2.0699999999999998 109.8 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -68.67 -40.14 80.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.078 -1.014 . . . . 1.8400000000000001 108.741 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.4 t80 -59.95 -46.81 88.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.29999999999999999 109.028 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.84 92.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.83 . . . . 0.25 109.144 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -60.01 -45.93 91.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.439 -0.788 . . . . 1.23 110.137 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.33 -25.16 65.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.051 -1.03 . . . . 1.29 109.396 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 83.3 m-20 -99.71 9.47 43.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.64000000000000001 109.785 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.04 35.13 91.6 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.981 -1.104 . . . . 0.71999999999999997 110.491 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 71.1 t -108.89 127.85 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.147 -1.208 . . . . 0.40000000000000002 109.979 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 96.0 m-20 -140.38 148.33 41.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.485 -0.931 . . . . 1.3300000000000001 108.485 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.41 -159.57 28.64 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.44 -1.362 . . . . 0.26000000000000001 110.061 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -85.87 132.1 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.029 -1.1 . . . . 2.0699999999999998 108.029 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -101.76 138.61 38.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.135 -0.978 . . . . 0.13 110.683 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.5 p -136.44 150.04 48.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 61.1 t80 -134.19 137.73 44.64 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.414 -0.804 . . . . 0.12 110.335 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -115.84 109.98 18.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.834 -0.802 . . . . 0.23999999999999999 108.834 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -67.81 -29.2 68.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 1.1599999999999999 110.455 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.02 94.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.29999999999999999 110.32 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 p -109.18 0.13 19.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.582 -0.699 . . . . 0.41999999999999998 110.209 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtmp? 50.14 42.11 24.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.851 -1.156 . . . . 2.1600000000000001 108.588 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.8 m -118.79 130.06 55.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.725 0.774 . . . . 0.28000000000000003 110.166 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 31.5 m-85 -99.11 139.51 34.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.949 -1.5 . . . . 0.089999999999999997 106.949 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.6 m -131.96 132.82 43.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.782 -1.199 . . . . 0.14000000000000001 108.463 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.1 p -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.345 -0.983 . . . . 0.12 108.345 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.3 m -119.38 126.73 52.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.51 -0.744 . . . . 0.28999999999999998 109.518 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' OE2' HG13 ' A' ' 39' ' ' VAL . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.086 -0.959 . . . . 1.95 109.7 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.022 -0.733 . . . . 2.9100000000000001 109.022 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.1 m -91.94 133.79 35.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.022 . . . . 0.31 109.39 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.79 145.49 43.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.807 -0.812 . . . . 0.19 108.807 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -114.38 143.42 44.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.418 -0.801 . . . . 1.98 108.906 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 30' ' ' PHE . 25.9 tp -119.8 126.91 52.17 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.735 -0.839 . . . . 0.13 108.735 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.9 mt -102.45 121.03 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.034 -1.469 . . . . 0.35999999999999999 107.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.07 115.01 29.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.025 . . . . 0.25 109.879 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -122.48 66.0 0.94 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.628 -1.619 . . . . 0.17999999999999999 106.628 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -78.6 171.89 55.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.799 -1.72 . . . . 0.23999999999999999 108.799 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.38 -39.69 89.25 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.028 -1.278 . . . . 2.71 108.238 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.2 p -114.57 -20.12 10.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.841 -0.537 . . . . 0.92000000000000004 109.757 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 9' ' ' GLY . 58.9 tp -99.93 121.65 41.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -0.918 . . . . 0.59999999999999998 109.942 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -133.2 122.88 24.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.863 . . . . 2.02 108.948 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.08 -171.64 44.77 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.341 -1.409 . . . . 0.23999999999999999 110.64 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 2.1 pm0 -150.46 158.61 44.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.519 -0.989 . . . . 1.6799999999999999 109.591 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 t -154.55 170.37 21.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.518 -0.739 . . . . 0.34000000000000002 109.707 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.3 p -138.16 160.13 40.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.33 -0.856 . . . . 0.20999999999999999 109.494 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 t -155.46 162.19 40.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.959 -0.756 . . . . 0.23000000000000001 108.959 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -100.22 132.08 45.8 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.088 -1.079 . . . . 2.2200000000000002 108.088 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.711 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -148.39 143.24 26.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.943 -1.098 . . . . 0.39000000000000001 109.477 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.46 -30.67 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.577 -0.702 . . . . 0.55000000000000004 110.439 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -159.87 179.93 8.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.84 -1.162 . . . . 1.1599999999999999 110.322 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -37.64 75.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.249 -0.907 . . . . 0.26000000000000001 110.355 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.27 -38.52 68.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.186 . . . . 0.28999999999999998 110.898 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.711 HG23 ' HB1' ' A' ' 20' ' ' ALA . 1.3 t -73.07 -34.44 66.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.271 -1.518 . . . . 0.44 109.388 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.59 86.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.65 -0.87 . . . . 0.17999999999999999 108.65 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.34 -48.16 77.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.829 -1.149 . . . . 1.0600000000000001 110.02 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.61 -41.14 88.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 2.6699999999999999 110.96 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.3 -54.83 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 0.23000000000000001 111.081 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.459 ' CD1' HD22 ' A' ' 5' ' ' LEU . 38.3 m-85 -63.76 -37.98 89.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.01 -1.056 . . . . 0.14999999999999999 110.456 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' HZ3' ' HB3' ' A' ' 31' ' ' LYS . 6.7 ttpm? -61.9 -42.64 99.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.801 -1.187 . . . . 2.0699999999999998 109.935 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -67.54 -42.8 82.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.95 -1.094 . . . . 1.8400000000000001 108.542 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 37' ' ' ASN . 63.9 t80 -60.02 -47.83 84.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.425 0.631 . . . . 0.29999999999999999 109.612 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.59 99.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.474 -0.766 . . . . 0.25 109.443 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -59.95 -40.66 89.73 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.191 -1.04 . . . . 1.23 108.191 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -63.61 -24.37 67.77 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.644 -0.66 . . . . 1.29 109.369 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' CE1' ' A' ' 33' ' ' TYR . 4.9 m120 -97.63 6.94 47.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.64000000000000001 109.769 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.07 34.32 70.29 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.954 -1.117 . . . . 0.71999999999999997 110.711 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.87 124.52 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.03 -1.276 . . . . 0.40000000000000002 108.972 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.47 101.09 2.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.003 -1.061 . . . . 1.3300000000000001 110.713 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.07 -130.06 1.3 Allowed Glycine 0 N--CA 1.497 2.733 0 C-N-CA 119.268 -1.444 . . . . 0.26000000000000001 111.336 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -93.78 129.3 40.2 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.972 -1.311 . . . . 2.0699999999999998 110.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.55 139.97 41.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.67 -0.644 . . . . 0.13 110.059 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.1 p -136.08 149.46 48.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.756 -1.201 . . . . 0.22 107.756 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.95 135.4 41.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.266 -0.896 . . . . 0.12 109.924 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -112.45 109.55 19.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.299 -1.0 . . . . 0.23999999999999999 108.299 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -68.19 -30.69 69.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.1599999999999999 110.224 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.8 91.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.29999999999999999 110.514 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.3 p -104.97 0.26 27.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.41999999999999998 110.066 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm 50.63 40.95 25.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 2.1600000000000001 108.257 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -119.79 130.54 54.99 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.536 0.684 . . . . 0.28000000000000003 110.8 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -99.45 137.79 37.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.055 -1.461 . . . . 0.089999999999999997 107.055 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.0 m -130.2 131.27 45.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.748 -1.22 . . . . 0.14000000000000001 108.216 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.8 p -120.92 127.4 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.447 -0.946 . . . . 0.12 108.447 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.7 m -123.61 125.24 44.47 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.846 -0.798 . . . . 0.28999999999999998 108.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.99 -1.005 . . . . 1.95 109.635 -179.865 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.386 -0.598 . . . . 2.9100000000000001 109.386 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.41 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 23.9 m -89.84 133.05 34.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.31 109.022 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.06 147.17 42.6 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.979 -0.748 . . . . 0.19 108.979 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -118.07 143.77 46.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.487 -0.758 . . . . 1.98 109.267 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 7' ' ' LEU . 34.4 tp -119.5 129.07 54.53 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.011 -0.737 . . . . 0.13 109.011 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.3 mt -106.46 123.72 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.066 -1.457 . . . . 0.35999999999999999 107.066 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 5' ' ' LEU . 85.5 mt -104.49 116.44 32.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.208 -0.933 . . . . 0.25 111.035 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -114.88 71.99 0.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.113 -1.44 . . . . 0.17999999999999999 107.113 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 168.91 52.61 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.434 -1.466 . . . . 0.23999999999999999 109.434 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -66.05 -39.37 90.08 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.182 -1.187 . . . . 2.71 108.17 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.0 p -124.44 -16.56 6.31 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.023 0.44 . . . . 0.92000000000000004 109.944 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -103.19 120.01 39.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.288 -0.883 . . . . 0.59999999999999998 109.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -130.89 131.11 44.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.514 -0.741 . . . . 2.02 109.411 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.78 48.24 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.257 -1.449 . . . . 0.23999999999999999 110.697 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 52.2 mp0 -143.88 153.26 42.14 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.479 -0.934 . . . . 1.6799999999999999 108.479 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -152.51 169.17 23.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.085 -1.009 . . . . 0.34000000000000002 109.34 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.9 p -135.44 159.82 40.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.353 -0.842 . . . . 0.20999999999999999 109.502 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.456 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 10.6 t -157.28 160.12 38.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.463 -0.773 . . . . 0.23000000000000001 109.216 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 55.8 mp0 -103.25 135.67 44.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.903 . . . . 2.2200000000000002 108.678 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.6 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.54 144.6 27.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.39000000000000001 109.264 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.88 -30.94 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.55000000000000004 109.809 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -157.69 177.23 11.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.1599999999999999 109.621 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.23 84.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.447 -0.783 . . . . 0.26000000000000001 109.495 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -36.83 63.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.036 -1.04 . . . . 0.28999999999999998 109.577 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.6 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 93.8 m -69.99 -39.63 75.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.785 -1.197 . . . . 0.44 109.651 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.71 78.83 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.735 -0.839 . . . . 0.17999999999999999 108.735 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.76 -41.67 87.13 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.657 -1.217 . . . . 1.0600000000000001 109.686 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.93 -45.17 71.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 2.6699999999999999 110.477 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 -51.11 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.551 -0.718 . . . . 0.23000000000000001 110.6 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' A' ' 18' ' ' THR . 35.0 m-85 -66.51 -38.6 87.58 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.091 -1.044 . . . . 0.14999999999999999 110.549 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.0 -44.7 94.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.727 -1.233 . . . . 2.0699999999999998 109.538 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -67.61 -40.88 84.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.028 -1.045 . . . . 1.8400000000000001 108.573 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.2 t80 -59.99 -48.34 82.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.638 . . . . 0.29999999999999999 109.78 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.21 94.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.25 109.546 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -60.0 -42.26 93.86 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.163 -0.961 . . . . 1.23 109.107 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.42 -26.47 67.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.894 . . . . 1.29 109.696 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.8 m-20 -99.03 10.02 42.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.168 -0.958 . . . . 0.64000000000000001 109.494 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.5 38.25 96.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.731 -1.348 . . . . 0.71999999999999997 109.731 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.19 126.71 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -1.102 . . . . 0.40000000000000002 110.172 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 52.4 t0 -110.19 -99.88 0.4 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.295 -1.002 . . . . 1.3300000000000001 108.295 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.26 163.89 3.61 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 122.167 0.871 . . . . 0.26000000000000001 112.368 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -75.2 138.48 41.99 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.348 -1.352 . . . . 2.0699999999999998 107.348 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -99.57 134.99 41.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.13 110.809 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.6 p -133.57 148.19 51.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.316 -0.994 . . . . 0.22 108.316 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 66.8 t80 -130.61 134.31 46.88 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.86 . . . . 0.12 110.155 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 50' ' ' LYS . 62.0 t0 -112.88 107.19 15.68 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.738 -0.838 . . . . 0.23999999999999999 108.738 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 56.5 t0 -67.36 -32.15 72.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.166 -0.959 . . . . 1.1599999999999999 110.238 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.29999999999999999 109.938 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -107.89 0.04 21.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.459 -0.775 . . . . 0.41999999999999998 110.213 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 46' ' ' ASP . 9.5 mtmp? 49.74 42.02 22.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.806 -1.184 . . . . 2.1600000000000001 108.294 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -120.01 131.44 55.14 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.625 0.726 . . . . 0.28000000000000003 110.287 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.6 m-85 -99.88 137.83 37.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.28 -1.378 . . . . 0.089999999999999997 107.28 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -131.0 131.7 44.52 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.804 -1.185 . . . . 0.14000000000000001 108.245 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.5 p -120.58 128.06 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.077 -1.082 . . . . 0.12 108.077 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -120.22 125.86 49.21 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.402 -0.811 . . . . 0.28999999999999998 110.845 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.471 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 38.2 mp0 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 118.034 -0.984 . . . . 1.95 109.438 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 mtt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.425 0.631 . . . . 2.9100000000000001 109.679 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.6 m -92.46 131.29 37.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.31 109.458 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 95.2 m-85 -112.77 146.86 38.05 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.892 -1.151 . . . . 0.19 107.892 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -115.82 142.38 46.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.169 -0.957 . . . . 1.98 109.7 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' CD1' ' A' ' 30' ' ' PHE . 34.9 tp -122.4 128.11 50.54 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.057 -0.72 . . . . 0.13 109.057 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.69 124.16 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.605 -1.258 . . . . 0.35999999999999999 107.605 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.3 mt -101.43 114.78 29.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.25 110.13 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.13 67.63 0.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.057 -1.46 . . . . 0.17999999999999999 107.057 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.01 172.52 54.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.631 -1.387 . . . . 0.23999999999999999 109.631 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -65.99 -39.06 90.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.221 -1.164 . . . . 2.71 108.365 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -17.57 6.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.917 -0.489 . . . . 0.92000000000000004 109.859 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.3 tp -99.3 117.33 33.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.148 -0.97 . . . . 0.59999999999999998 109.563 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.58 128.69 39.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.867 0.841 . . . . 2.02 109.514 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.15 -175.26 47.37 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.508 -1.329 . . . . 0.23999999999999999 110.317 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -148.96 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.699 -0.883 . . . . 1.6799999999999999 109.045 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -154.24 171.16 19.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.34000000000000002 109.391 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 p -137.09 159.99 40.29 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.897 -0.779 . . . . 0.20999999999999999 108.897 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.435 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.3 t -154.89 159.58 40.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.23000000000000001 109.25 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -102.7 132.42 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.288 -0.882 . . . . 2.2200000000000002 108.884 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.477 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.12 143.81 27.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.39000000000000001 108.935 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.44 -27.23 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.55000000000000004 109.858 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -157.96 172.21 18.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 1.1599999999999999 109.939 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.68 83.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.516 -0.74 . . . . 0.26000000000000001 109.941 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.48 -37.2 62.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.049 -1.032 . . . . 0.28999999999999998 110.069 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.477 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 17.6 p -73.38 -34.41 65.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.615 -1.303 . . . . 0.44 109.809 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.9 87.33 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.325 -0.991 . . . . 0.17999999999999999 108.325 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.67 -45.72 85.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.864 -1.134 . . . . 1.0600000000000001 109.58 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.28 -42.7 83.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.078 . . . . 2.6699999999999999 109.821 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.59 -54.33 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.412 -0.805 . . . . 0.23000000000000001 110.737 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 5' ' ' LEU . 30.0 m-85 -63.44 -39.04 93.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.14999999999999999 110.478 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -60.79 -42.45 97.57 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.721 -1.237 . . . . 2.0699999999999998 109.823 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -69.61 -42.35 74.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 1.8400000000000001 108.702 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.625 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.9 t80 -59.95 -44.94 94.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.665 -0.865 . . . . 0.29999999999999999 108.665 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.92 99.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 0.25 109.387 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.1 -40.07 88.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 1.23 108.533 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.98 -24.22 67.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 1.29 109.518 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 78.1 m-20 -99.17 7.3 45.91 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.207 -0.933 . . . . 0.64000000000000001 110.495 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.12 35.58 71.02 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.917 -1.135 . . . . 0.71999999999999997 111.349 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 67.1 t -111.93 125.09 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.968 -1.313 . . . . 0.40000000000000002 109.348 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 78.5 m-20 -148.47 98.8 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.252 -0.905 . . . . 1.3300000000000001 110.47 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.83 -136.85 2.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.168 -1.491 . . . . 0.26000000000000001 111.015 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.79 131.57 35.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.087 -1.243 . . . . 2.0699999999999998 110.608 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -108.25 139.3 43.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.674 -0.641 . . . . 0.13 110.013 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 p -136.68 149.99 48.23 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 0.22 108.586 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 71.4 t80 -133.79 136.03 44.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.364 -0.835 . . . . 0.12 110.451 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -114.03 109.71 18.89 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.403 -0.962 . . . . 0.23999999999999999 108.403 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.26 -29.11 67.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 1.1599999999999999 110.17 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.02 94.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.005 . . . . 0.29999999999999999 109.92 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.8 p -106.95 0.7 23.96 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.491 -0.756 . . . . 0.41999999999999998 110.24 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.611 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 16.4 mtpp 50.51 41.66 25.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 2.1600000000000001 108.451 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 132.64 55.52 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.66 0.743 . . . . 0.28000000000000003 110.906 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 48.3 m-85 -99.99 139.36 35.77 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.167 -1.42 . . . . 0.089999999999999997 107.167 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -130.33 131.52 45.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.665 -1.272 . . . . 0.14000000000000001 108.343 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.7 p -124.85 130.01 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.862 . . . . 0.12 108.674 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.6 m -125.37 129.25 49.54 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.658 -0.651 . . . . 0.28999999999999998 109.87 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.946 -1.026 . . . . 1.95 109.491 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HG2' ' H ' ' A' ' 2' ' ' THR . 28.4 ttp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 108.91 -0.774 . . . . 2.9100000000000001 108.91 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.4 ' H ' ' HG2' ' A' ' 1' ' ' MET . 32.5 m -91.27 134.51 34.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.332 -0.855 . . . . 0.31 108.971 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.3 144.93 43.6 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.006 -0.739 . . . . 0.19 109.006 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -115.69 141.14 48.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 1.98 109.004 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.499 HD22 ' CD1' ' A' ' 30' ' ' PHE . 38.8 tp -120.05 128.97 54.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.696 . . . . 0.13 109.336 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -105.81 123.06 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 106.983 -1.488 . . . . 0.35999999999999999 106.983 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.06 115.89 31.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.311 -0.868 . . . . 0.25 110.311 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -116.59 72.8 0.83 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.967 -1.123 . . . . 0.17999999999999999 107.967 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.62 169.47 54.31 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.219 -1.553 . . . . 0.23999999999999999 109.219 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -62.37 -35.99 80.89 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.137 -1.213 . . . . 2.71 108.082 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 p -129.06 -11.92 4.69 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.555 -0.535 . . . . 0.92000000000000004 109.555 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.6 tp -99.96 118.69 36.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.27 -0.894 . . . . 0.59999999999999998 109.104 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -130.63 127.75 39.57 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 2.02 109.606 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 -177.84 48.39 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.184 -1.484 . . . . 0.23999999999999999 110.555 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.17 157.15 43.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.666 -0.903 . . . . 1.6799999999999999 109.014 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -152.99 169.97 21.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.34000000000000002 109.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -136.49 159.61 41.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.20999999999999999 109.309 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 11.5 t -155.67 159.0 39.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.387 -0.821 . . . . 0.23000000000000001 109.138 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.37 134.04 45.06 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.042 -1.095 . . . . 2.2200000000000002 108.042 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.43 26.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.928 -1.108 . . . . 0.39000000000000001 109.491 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.05 -31.25 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.55000000000000004 109.673 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -158.32 175.2 14.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 1.1599999999999999 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.08 81.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.501 -0.749 . . . . 0.26000000000000001 109.989 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.18 -36.92 61.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.008 -1.058 . . . . 0.28999999999999998 109.871 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 p -74.16 -34.23 63.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.243 . . . . 0.44 109.519 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.971 -1.122 . . . . 0.17999999999999999 107.971 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.07 -49.83 74.66 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.762 -1.175 . . . . 1.0600000000000001 108.872 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -63.46 -44.77 93.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.83 . . . . 2.6699999999999999 110.821 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.36 -53.28 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.053 -1.029 . . . . 0.23000000000000001 110.763 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.499 ' CD1' HD22 ' A' ' 5' ' ' LEU . 29.2 m-85 -63.46 -37.82 88.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.14999999999999999 110.456 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.685 -1.259 . . . . 2.0699999999999998 109.83 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.57 -40.75 76.57 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.012 -1.055 . . . . 1.8400000000000001 108.58 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.46 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 51.1 t80 -60.06 -47.77 84.5 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.749 -0.834 . . . . 0.29999999999999999 108.749 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.16 99.42 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.918 -0.771 . . . . 0.25 108.918 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -60.0 -42.58 94.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.47 -24.03 67.65 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.398 -0.814 . . . . 1.29 109.097 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.492 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.6 m-80 -98.13 6.37 47.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.283 -0.886 . . . . 0.64000000000000001 109.466 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.29 34.64 90.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.143 -1.183 . . . . 0.71999999999999997 110.143 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.4 t -112.05 128.82 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.391 -1.064 . . . . 0.40000000000000002 110.513 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 2.0 p-10 -110.52 -98.49 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.505 -1.294 . . . . 1.3300000000000001 107.505 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 68.64 164.86 3.46 Favored Glycine 0 N--CA 1.486 2.033 0 CA-C-O 122.01 0.783 . . . . 0.26000000000000001 111.841 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -76.31 137.46 39.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.998 -1.482 . . . . 2.0699999999999998 106.998 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -98.0 134.94 40.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.13 110.544 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -134.38 148.77 50.73 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.996 -1.113 . . . . 0.22 107.996 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.2 t80 -135.97 135.1 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.326 -0.859 . . . . 0.12 110.29 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.65 109.95 19.8 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.31 -0.996 . . . . 0.23999999999999999 108.31 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -68.68 -29.32 67.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 1.1599999999999999 110.292 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.93 95.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.133 -0.98 . . . . 0.29999999999999999 109.988 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.0 p -108.07 0.3 21.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.611 -0.681 . . . . 0.41999999999999998 109.82 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.9 mttm 48.58 43.04 20.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.065 . . . . 2.1600000000000001 108.502 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 131.75 55.26 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.543 0.687 . . . . 0.28000000000000003 109.836 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 64.3 m-85 -100.05 138.93 36.45 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.851 -1.166 . . . . 0.089999999999999997 107.851 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -131.36 131.68 43.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.803 -1.186 . . . . 0.14000000000000001 108.52 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.19 130.15 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.296 -1.001 . . . . 0.12 108.296 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -117.53 124.83 49.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.504 -0.748 . . . . 0.28999999999999998 109.701 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.039 -0.981 . . . . 1.95 109.588 -179.504 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 2' ' ' THR . 4.3 ppp? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.408 -0.59 . . . . 2.9100000000000001 109.408 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.534 ' O ' ' SD ' ' A' ' 1' ' ' MET . 86.7 m -95.07 127.99 41.55 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.916 -1.115 . . . . 0.31 110.377 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -109.57 150.94 27.45 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.774 -1.195 . . . . 0.19 107.774 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -118.1 140.04 50.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.08 -1.013 . . . . 1.98 109.232 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.449 HD22 ' CD1' ' A' ' 30' ' ' PHE . 37.2 tp -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.926 -0.768 . . . . 0.13 108.926 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.31 124.55 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.779 -1.193 . . . . 0.35999999999999999 107.779 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.36 116.56 32.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 0.25 109.9 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -114.33 72.32 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.584 -1.265 . . . . 0.17999999999999999 107.584 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.68 169.06 53.1 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.45 -1.46 . . . . 0.23999999999999999 109.45 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.35 -37.93 88.55 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.312 -1.111 . . . . 2.71 108.006 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.7 p -123.78 -16.15 6.75 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.73 -0.471 . . . . 0.92000000000000004 109.73 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 tp -101.74 120.18 39.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.305 -0.872 . . . . 0.59999999999999998 109.573 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.15 127.9 40.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.802 . . . . 2.02 108.966 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.97 -179.22 48.65 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.174 -1.489 . . . . 0.23999999999999999 110.584 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -149.48 158.2 43.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.591 -0.947 . . . . 1.6799999999999999 109.556 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -154.47 172.52 17.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.45 -0.781 . . . . 0.34000000000000002 109.703 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -137.31 160.01 40.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.407 -0.808 . . . . 0.20999999999999999 109.532 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.514 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 5.2 t -154.88 159.09 40.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.23000000000000001 108.994 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -103.02 134.73 45.97 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.503 -0.925 . . . . 2.2200000000000002 108.503 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.814 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -150.68 144.91 25.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 0.39000000000000001 109.807 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 m -61.5 -30.68 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.573 -0.705 . . . . 0.55000000000000004 110.296 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 24' ' ' ALA . 3.3 p30 -159.3 -179.99 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.917 -1.114 . . . . 1.1599999999999999 109.825 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.39 75.0 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.076 -1.015 . . . . 0.26000000000000001 110.5 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . . . -55.12 -39.37 69.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.839 -1.163 . . . . 0.28999999999999998 111.088 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.814 HG23 ' HB1' ' A' ' 20' ' ' ALA . 1.3 t -74.46 -32.83 62.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.244 -1.535 . . . . 0.44 109.339 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.806 -0.813 . . . . 0.17999999999999999 108.806 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.71 -47.29 82.8 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.787 -1.165 . . . . 1.0600000000000001 109.436 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -64.34 -43.02 95.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 2.6699999999999999 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.83 -54.47 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.305 -0.872 . . . . 0.23000000000000001 111.034 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.514 ' CZ ' HG22 ' A' ' 18' ' ' THR . 33.7 m-85 -62.84 -38.87 92.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.077 -1.014 . . . . 0.14999999999999999 110.783 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -61.62 -42.57 99.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.818 -1.177 . . . . 2.0699999999999998 109.897 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -67.26 -43.0 82.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.84 -1.163 . . . . 1.8400000000000001 108.619 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -47.57 85.28 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -0.774 . . . . 0.29999999999999999 109.308 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.84 99.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.25 109.255 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.84 -42.46 97.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.23 109.059 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -62.49 -21.72 65.71 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -0.912 . . . . 1.29 108.958 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.9 m-20 -99.77 8.92 43.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.411 -0.806 . . . . 0.64000000000000001 109.41 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.78 35.56 91.44 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.193 -1.163 . . . . 0.71999999999999997 110.193 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.8 t -111.5 128.62 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.267 -1.137 . . . . 0.40000000000000002 109.801 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.473 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 8.9 t70 -111.68 -96.59 0.42 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.108 -1.071 . . . . 1.3300000000000001 108.108 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 68.33 164.42 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 121.237 -0.915 . . . . 0.26000000000000001 112.087 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.68 137.47 42.18 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.319 -1.363 . . . . 2.0699999999999998 107.319 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.18 135.61 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.958 . . . . 0.13 110.956 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -135.61 149.92 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.152 -1.055 . . . . 0.22 108.152 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 49.6 t80 -135.36 135.17 40.49 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.12 109.646 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -114.21 110.14 19.49 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.286 -0.635 . . . . 0.23999999999999999 109.286 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.47 -29.54 69.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 1.1599999999999999 109.852 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -40.46 94.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.29999999999999999 110.167 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 76.9 p -107.94 -0.73 21.22 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.842 . . . . 0.41999999999999998 110.049 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 48.9 42.48 20.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.037 -1.039 . . . . 2.1600000000000001 108.694 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -120.08 130.26 54.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.822 -0.626 . . . . 0.28000000000000003 109.786 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 59.4 m-85 -98.66 138.37 35.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.274 -1.38 . . . . 0.089999999999999997 107.274 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.7 m -132.07 132.34 43.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.677 -1.264 . . . . 0.14000000000000001 108.792 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 p -120.62 126.73 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.931 -1.137 . . . . 0.12 107.931 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.9 m -120.92 127.8 52.18 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.345 -0.847 . . . . 0.28999999999999998 111.005 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 29.9 mp0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.014 -0.993 . . . . 1.95 109.466 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.301 -0.629 . . . . 2.9100000000000001 109.301 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.5 m -92.08 131.64 37.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.052 -1.03 . . . . 0.31 109.53 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.83 145.56 42.01 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.677 -0.86 . . . . 0.19 108.677 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.404 ' HZ2' ' CG1' ' A' ' 6' ' ' ILE . 24.4 ttpp -116.64 142.13 47.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.372 -0.83 . . . . 1.98 109.073 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 30' ' ' PHE . 56.6 tp -121.9 129.41 52.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.728 . . . . 0.13 109.798 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.404 ' CG1' ' HZ2' ' A' ' 4' ' ' LYS . 93.0 mt -105.97 123.3 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.748 -1.575 . . . . 0.35999999999999999 106.748 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.41 117.09 33.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 0.25 110.437 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.01 71.22 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.258 -1.386 . . . . 0.17999999999999999 107.258 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 173.74 54.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.212 -1.555 . . . . 0.23999999999999999 109.212 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -65.16 -39.93 93.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.189 -1.183 . . . . 2.71 108.102 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.7 p -124.99 -14.63 6.58 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.649 -0.5 . . . . 0.92000000000000004 109.649 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.7 tp -99.7 114.94 28.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -0.974 . . . . 0.59999999999999998 109.418 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.35 129.07 42.69 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.426 -0.796 . . . . 2.02 109.256 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.58 -175.1 47.41 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.285 -1.436 . . . . 0.23999999999999999 110.312 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -148.28 156.82 43.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.608 -0.936 . . . . 1.6799999999999999 108.96 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -154.67 172.9 17.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 109.604 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 p -137.68 159.13 42.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.752 . . . . 0.20999999999999999 109.064 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -155.65 160.06 40.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.838 . . . . 0.23000000000000001 108.874 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -104.31 133.82 48.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.272 -0.893 . . . . 2.2200000000000002 108.931 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.17 146.27 26.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.39000000000000001 109.614 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.24 -30.69 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.78 . . . . 0.55000000000000004 110.194 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -159.79 179.99 8.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 1.1599999999999999 110.093 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.79 82.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.628 -0.67 . . . . 0.26000000000000001 110.653 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.36 -37.03 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.874 -1.142 . . . . 0.28999999999999998 110.431 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 p -73.49 -36.04 65.74 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.55 -1.344 . . . . 0.44 109.845 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.05 87.9 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.039 -1.097 . . . . 0.17999999999999999 108.039 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.66 -45.73 85.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.13 -1.028 . . . . 1.0600000000000001 110.203 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -67.35 -40.72 85.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.123 . . . . 2.6699999999999999 110.165 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.37 -53.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.23000000000000001 110.871 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CD1' HD22 ' A' ' 5' ' ' LEU . 41.0 m-85 -67.25 -40.01 86.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.923 -1.11 . . . . 0.14999999999999999 110.664 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.75 -46.18 91.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.876 -1.14 . . . . 2.0699999999999998 109.945 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.65 -43.01 81.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.095 -1.003 . . . . 1.8400000000000001 108.782 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.9 t80 -60.09 -45.09 94.09 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.401 -0.812 . . . . 0.29999999999999999 109.606 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -43.34 99.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.373 -0.829 . . . . 0.25 109.49 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -62.43 -40.12 95.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 1.23 109.007 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.62 -24.58 67.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 1.29 109.426 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 73.0 m-20 -97.14 10.08 40.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.64000000000000001 109.198 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.0 93.97 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.321 -1.512 . . . . 0.71999999999999997 109.321 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.4 t -109.94 123.75 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.356 -1.085 . . . . 0.40000000000000002 109.867 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 97.6 m-20 -140.44 146.89 38.87 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.151 -1.055 . . . . 1.3300000000000001 108.151 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.39 -155.49 22.47 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.077 -1.535 . . . . 0.26000000000000001 110.105 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -88.03 130.66 34.91 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.85 -1.167 . . . . 2.0699999999999998 107.85 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -103.0 138.92 39.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.13 110.463 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.8 p -136.83 150.05 48.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.341 -0.985 . . . . 0.22 108.341 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 64.3 t80 -135.69 137.09 41.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.435 -0.791 . . . . 0.12 110.233 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.93 109.95 20.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.901 -0.777 . . . . 0.23999999999999999 108.901 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 51.9 t0 -67.15 -32.45 73.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 1.1599999999999999 110.179 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.51 94.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.29999999999999999 110.213 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -108.15 0.14 21.38 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.561 -0.712 . . . . 0.41999999999999998 110.44 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 49.98 41.68 23.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.836 -1.165 . . . . 2.1600000000000001 108.404 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -118.97 131.09 56.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.66 0.743 . . . . 0.28000000000000003 110.264 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 44.4 m-85 -99.97 139.19 35.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.527 -1.286 . . . . 0.089999999999999997 107.527 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 m -131.94 132.18 43.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.838 -1.164 . . . . 0.14000000000000001 108.361 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.49 129.93 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.485 -0.932 . . . . 0.12 108.485 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -119.99 127.33 52.52 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.551 -0.718 . . . . 0.28999999999999998 110.134 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 7.7 mp0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.975 -1.012 . . . . 1.95 109.238 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.344 -0.613 . . . . 2.9100000000000001 109.344 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m -95.22 134.2 38.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.224 -0.923 . . . . 0.31 109.53 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.2 149.0 41.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.623 -0.88 . . . . 0.19 108.623 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -114.81 143.84 44.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.332 -0.855 . . . . 1.98 109.877 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.424 HD22 ' CD1' ' A' ' 30' ' ' PHE . 27.8 tp -121.31 127.14 51.02 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.858 -0.793 . . . . 0.13 108.858 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.9 mt -106.87 123.36 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.523 -1.288 . . . . 0.35999999999999999 107.523 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -102.28 114.13 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.25 109.68 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' OD1' ' NZ ' ' A' ' 13' ' ' LYS . 43.2 t30 -114.88 71.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.72 -1.215 . . . . 0.17999999999999999 107.72 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.25 166.43 49.76 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.416 -1.474 . . . . 0.23999999999999999 109.416 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' NZ ' ' C ' ' A' ' 56' ' ' GLU . 60.0 mttp -67.41 -35.21 78.81 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -1.152 . . . . 2.71 108.027 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -22.42 4.99 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.929 -0.482 . . . . 0.92000000000000004 109.849 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.37 119.96 39.23 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.306 -0.871 . . . . 0.59999999999999998 109.338 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 8' ' ' ASN . 66.1 mttm -133.08 131.74 40.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.287 -0.883 . . . . 2.02 109.648 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.02 -179.97 48.8 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.273 -1.441 . . . . 0.23999999999999999 110.426 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -142.0 151.97 42.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.609 -0.936 . . . . 1.6799999999999999 108.73 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -151.89 167.65 27.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.34000000000000002 109.074 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 p -139.88 160.82 39.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.20999999999999999 109.411 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.9 t -155.72 161.17 40.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.686 -0.857 . . . . 0.23000000000000001 108.686 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -103.45 135.03 45.82 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.484 -0.932 . . . . 2.2200000000000002 108.484 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.9 144.28 27.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.39000000000000001 109.549 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.36 -30.07 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.821 . . . . 0.55000000000000004 109.634 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -158.35 171.06 20.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.147 -0.971 . . . . 1.1599999999999999 109.582 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.78 81.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.26000000000000001 109.796 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.71 68.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.115 . . . . 0.28999999999999998 109.909 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.9 m -69.96 -37.17 75.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.662 -1.274 . . . . 0.44 109.722 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.83 75.2 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.588 -0.893 . . . . 0.17999999999999999 108.588 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.43 -47.31 72.96 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.943 -1.103 . . . . 1.0600000000000001 109.524 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 8.2 mptt -67.96 -40.2 83.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.794 -1.191 . . . . 2.6699999999999999 110.459 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.24 -53.39 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 0.23000000000000001 111.361 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' HG22 ' A' ' 18' ' ' THR . 24.9 m-85 -64.7 -39.98 94.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.887 -1.133 . . . . 0.14999999999999999 111.045 -178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -62.14 -40.01 94.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.719 -1.238 . . . . 2.0699999999999998 109.932 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.94 -1.1 . . . . 1.8400000000000001 108.795 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 68.6 t80 -59.89 -48.63 80.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -0.827 . . . . 0.29999999999999999 109.606 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -43.22 99.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.366 -0.834 . . . . 0.25 109.151 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.06 -42.53 94.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.641 -0.874 . . . . 1.23 108.641 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.72 -22.21 66.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 1.29 109.289 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 32.2 m120 -96.27 6.91 47.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.246 -0.909 . . . . 0.64000000000000001 109.988 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.79 75.38 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.76 -1.21 . . . . 0.71999999999999997 110.201 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 126.97 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.282 -1.128 . . . . 0.40000000000000002 109.621 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -142.92 148.69 37.34 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.353 -0.98 . . . . 1.3300000000000001 108.353 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.07 -150.45 14.73 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.173 -1.489 . . . . 0.26000000000000001 110.147 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 59.1 mp0 -89.17 129.33 35.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.976 -1.12 . . . . 2.0699999999999998 107.976 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -100.4 138.35 37.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.13 110.066 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.6 p -136.37 150.04 48.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.13 -1.063 . . . . 0.22 108.13 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -134.37 135.55 42.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.441 -0.787 . . . . 0.12 109.7 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -111.23 108.68 18.4 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.186 -1.042 . . . . 0.23999999999999999 108.186 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -67.58 -30.81 70.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 1.1599999999999999 110.197 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.02 94.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.29999999999999999 110.112 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -104.72 0.09 27.96 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.486 -0.759 . . . . 0.41999999999999998 110.417 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 49.97 40.43 21.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.886 -1.134 . . . . 2.1600000000000001 108.215 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 131.05 55.01 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.685 0.755 . . . . 0.28000000000000003 110.497 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -98.66 137.85 36.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.037 -1.468 . . . . 0.089999999999999997 107.037 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.3 m -129.99 130.87 45.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.14000000000000001 108.074 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.26 129.39 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.123 -1.066 . . . . 0.12 108.123 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -118.32 124.71 48.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.28999999999999998 109.172 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' C ' ' NZ ' ' A' ' 10' ' ' LYS . 83.3 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.971 -1.014 . . . . 1.95 109.575 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 tpp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.494 0.664 . . . . 2.9100000000000001 109.214 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m -91.22 134.76 34.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.428 -0.795 . . . . 0.31 109.758 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.09 145.02 40.5 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.26 -1.015 . . . . 0.19 108.26 178.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -115.97 139.95 49.73 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.288 -1.004 . . . . 1.98 108.288 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 52' ' ' PHE . 24.4 tp -120.52 127.71 52.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.512 -0.921 . . . . 0.13 108.512 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.0 mt -105.87 123.3 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.118 -1.438 . . . . 0.35999999999999999 107.118 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.427 HD23 HG12 ' A' ' 54' ' ' VAL . 87.3 mt -103.67 115.01 29.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.25 110.034 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.71 71.15 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.353 -1.351 . . . . 0.17999999999999999 107.353 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.97 167.12 50.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.513 -1.435 . . . . 0.23999999999999999 109.513 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -64.98 -36.23 83.72 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.662 -1.236 . . . . 2.71 107.662 178.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -19.51 5.3 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.849 -0.426 . . . . 0.92000000000000004 109.849 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.82 119.99 38.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.082 -1.011 . . . . 0.59999999999999998 109.126 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -133.67 129.12 36.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.02 109.722 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.85 -175.08 47.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.46 -1.353 . . . . 0.23999999999999999 110.443 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.53 156.95 43.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.981 . . . . 1.6799999999999999 109.444 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -154.33 169.96 22.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.34000000000000002 109.353 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -137.85 160.46 39.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.20999999999999999 109.311 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.46 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 3.4 t -156.08 162.0 40.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.23000000000000001 108.971 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 4.0 tm-20 -102.94 134.8 45.76 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.675 -0.861 . . . . 2.2200000000000002 108.675 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.19 -0.944 . . . . 0.39000000000000001 108.939 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.2 m -60.09 -29.89 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.55000000000000004 109.356 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -158.14 176.5 12.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 1.1599999999999999 109.834 -179.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.41 88.41 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.26000000000000001 109.85 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.18 -35.55 49.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.946 -1.096 . . . . 0.28999999999999998 109.433 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.659 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.5 m -69.47 -39.99 77.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.827 -1.171 . . . . 0.44 109.942 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.37 97.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.312 -0.868 . . . . 0.17999999999999999 109.137 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.29 -56.76 12.68 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.46 -0.896 . . . . 1.0600000000000001 111.091 -178.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -69.48 -37.4 77.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.6699999999999999 111.83 -178.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.48 -53.49 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.425 -1.422 . . . . 0.23000000000000001 110.637 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CZ ' HG22 ' A' ' 18' ' ' THR . 39.7 m-85 -61.81 -35.75 79.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.022 -1.049 . . . . 0.14999999999999999 110.266 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.03 -40.77 90.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.946 -1.096 . . . . 2.0699999999999998 108.952 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -69.41 -41.03 76.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 1.8400000000000001 108.795 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.5 t80 -60.03 -49.93 75.72 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.048 -0.723 . . . . 0.29999999999999999 109.048 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.77 96.28 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.476 -0.765 . . . . 0.25 109.362 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.46 -40.74 97.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 1.23 109.554 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.99 -25.7 67.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 1.29 109.271 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 98.2 m-20 -97.9 9.08 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.64000000000000001 108.741 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.43 37.63 94.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.332 -1.107 . . . . 0.71999999999999997 110.332 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.75 129.81 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.22 -1.165 . . . . 0.40000000000000002 110.403 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 89.5 m-20 -111.65 -96.2 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.012 -1.107 . . . . 1.3300000000000001 108.012 178.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.71 166.27 4.16 Favored Glycine 0 N--CA 1.491 2.351 0 CA-C-O 122.156 0.865 . . . . 0.26000000000000001 112.27 177.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.52 138.6 39.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.361 -1.348 . . . . 2.0699999999999998 107.361 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -100.22 135.76 41.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.119 -0.988 . . . . 0.13 110.91 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.4 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.005 -1.109 . . . . 0.22 108.005 179.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -135.32 134.97 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.233 -0.917 . . . . 0.12 110.693 -177.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -111.28 110.0 20.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.677 -0.86 . . . . 0.23999999999999999 108.677 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -65.61 -31.7 72.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 1.1599999999999999 110.363 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.56 -40.0 88.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.29999999999999999 110.756 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.7 p -105.06 -0.41 26.76 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.41999999999999998 110.469 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 50.02 40.34 21.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.888 -1.132 . . . . 2.1600000000000001 108.068 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.02 54.51 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.645 0.736 . . . . 0.28000000000000003 110.137 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.445 ' O ' HD12 ' A' ' 5' ' ' LEU . 45.3 m-85 -98.67 139.96 33.59 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.118 -1.438 . . . . 0.089999999999999997 107.118 178.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.2 m -129.43 131.25 46.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.764 -1.21 . . . . 0.14000000000000001 108.417 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG12 HD23 ' A' ' 7' ' ' LEU . 2.7 p -120.22 128.93 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.934 -1.136 . . . . 0.12 107.934 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -119.92 125.72 49.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.28999999999999998 109.757 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.999 -1.0 . . . . 1.95 109.516 -179.691 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.401 0.619 . . . . 2.9100000000000001 109.722 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.2 m -91.99 133.68 35.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.309 -0.869 . . . . 0.31 109.388 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 91.5 m-85 -117.93 148.69 41.92 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.772 -0.825 . . . . 0.19 108.772 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -117.07 145.28 43.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 1.98 109.324 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 7' ' ' LEU . 46.0 tp -119.45 127.53 53.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.547 -0.908 . . . . 0.13 108.547 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.09 121.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.023 -1.473 . . . . 0.35999999999999999 107.023 178.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 5' ' ' LEU . 85.8 mt -102.55 116.81 33.35 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 0.25 110.308 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.0 68.29 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.509 -1.293 . . . . 0.17999999999999999 107.509 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.5 171.55 54.13 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.505 -1.438 . . . . 0.23999999999999999 109.505 179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -66.26 -39.86 89.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.282 -1.128 . . . . 2.71 108.148 178.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.1 p -120.01 -20.09 7.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.999 -0.438 . . . . 0.92000000000000004 109.848 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.8 tp -99.98 120.07 39.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 0.59999999999999998 109.415 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -136.47 130.61 32.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 2.02 109.833 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.57 -173.62 46.42 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.392 -1.385 . . . . 0.23999999999999999 110.905 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 46.4 mp0 -144.34 153.55 42.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.982 . . . . 1.6799999999999999 108.958 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -153.17 168.54 25.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.34000000000000002 109.446 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 p -139.36 159.78 41.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.863 . . . . 0.20999999999999999 109.167 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 t -156.74 164.24 38.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.953 -0.758 . . . . 0.23000000000000001 108.953 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -103.37 133.98 47.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.379 -0.826 . . . . 2.2200000000000002 109.01 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.14 143.39 28.22 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.6 -0.889 . . . . 0.39000000000000001 108.6 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -59.94 -29.61 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.55000000000000004 109.535 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -157.74 175.19 14.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 1.1599999999999999 110.022 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.13 85.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.552 -0.717 . . . . 0.26000000000000001 109.871 -179.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.24 -36.58 61.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.112 . . . . 0.28999999999999998 109.912 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.503 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 5.1 p -73.43 -33.47 64.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.608 -1.307 . . . . 0.44 109.732 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.18 81.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.237 -1.023 . . . . 0.17999999999999999 108.237 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.01 -44.93 83.31 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.823 -1.151 . . . . 1.0600000000000001 109.558 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.7 -42.72 85.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.882 -1.136 . . . . 2.6699999999999999 110.579 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.63 -52.0 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.23000000000000001 111.243 -178.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.67 -40.03 88.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.025 -1.047 . . . . 0.14999999999999999 111.269 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -63.51 -41.28 98.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.503 -1.373 . . . . 2.0699999999999998 109.997 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -70.0 -45.68 66.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.879 -1.138 . . . . 1.8400000000000001 108.939 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.545 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 72.9 t80 -60.02 -47.98 83.62 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.495 -0.753 . . . . 0.29999999999999999 109.453 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.59 98.64 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.478 -0.764 . . . . 0.25 109.474 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -59.95 -40.49 89.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.392 -0.818 . . . . 1.23 108.974 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -65.08 -19.26 65.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.784 -0.821 . . . . 1.29 108.784 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.545 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 97.4 m-20 -94.68 6.7 48.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.64000000000000001 109.788 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.2 30.25 63.17 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.9 -1.143 . . . . 0.71999999999999997 111.153 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -110.02 124.26 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.901 -1.352 . . . . 0.40000000000000002 108.527 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 27.7 p-10 -150.58 99.61 2.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 1.3300000000000001 110.593 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.2 -125.48 0.86 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.174 -1.489 . . . . 0.26000000000000001 111.317 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.79 130.3 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.898 -1.354 . . . . 2.0699999999999998 110.851 -178.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -107.23 139.59 41.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.663 -0.648 . . . . 0.13 110.27 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.5 p -137.77 150.02 46.9 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.419 -0.956 . . . . 0.22 108.419 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CE1' ' CE1' ' A' ' 52' ' ' PHE . 48.9 t80 -137.79 137.75 38.53 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.175 -0.953 . . . . 0.12 110.337 -179.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.719 -0.845 . . . . 0.23999999999999999 108.719 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.51 -31.05 71.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.346 -0.846 . . . . 1.1599999999999999 110.928 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.9 94.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.29999999999999999 110.537 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -103.55 0.04 30.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.381 -0.824 . . . . 0.41999999999999998 110.383 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' NZ ' ' CE1' ' A' ' 3' ' ' TYR . 20.4 mtpp 49.91 40.12 20.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.11 . . . . 2.1600000000000001 108.255 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -120.1 131.12 54.95 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.498 0.666 . . . . 0.28000000000000003 110.14 -178.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 54.3 m-85 -99.96 138.83 36.49 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.447 -1.316 . . . . 0.089999999999999997 107.447 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.7 m -130.06 131.55 45.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.14000000000000001 108.709 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.5 p -121.67 127.68 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.577 -0.898 . . . . 0.12 108.577 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.5 m -125.47 127.51 46.6 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.532 -0.73 . . . . 0.28999999999999998 109.803 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.019 -0.991 . . . . 1.95 109.289 179.811 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.366 0.603 . . . . 2.9100000000000001 109.382 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m -89.51 136.23 33.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.39 -0.819 . . . . 0.31 109.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.456 ' OH ' ' N ' ' A' ' 23' ' ' ALA . 95.8 m-85 -114.31 141.93 46.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.691 -0.855 . . . . 0.19 108.691 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -113.7 140.17 48.47 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.733 -0.84 . . . . 1.98 108.733 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.59 HD22 ' CD1' ' A' ' 30' ' ' PHE . 46.6 tp -120.06 128.76 53.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.347 -0.846 . . . . 0.13 109.516 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.9 mt -104.96 122.38 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.208 -1.404 . . . . 0.35999999999999999 107.208 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.74 115.45 30.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.121 -0.987 . . . . 0.25 110.282 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -118.75 72.37 0.88 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.826 -1.176 . . . . 0.17999999999999999 107.826 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -79.85 171.06 54.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.351 -1.5 . . . . 0.23999999999999999 109.351 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.66 -39.85 94.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.05 -1.265 . . . . 2.71 108.173 178.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -124.67 -16.1 6.34 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.204 -0.665 . . . . 0.92000000000000004 109.204 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 9' ' ' GLY . 60.1 tp -99.8 118.04 35.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.323 -0.86 . . . . 0.59999999999999998 108.794 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -135.83 133.78 38.18 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 2.02 109.916 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.54 -176.21 47.86 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.495 -1.336 . . . . 0.23999999999999999 110.403 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -145.03 151.61 38.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.505 -0.924 . . . . 1.6799999999999999 108.505 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -152.62 170.16 20.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.34000000000000002 109.422 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -137.74 159.88 40.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.466 -0.771 . . . . 0.20999999999999999 109.196 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.421 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.2 t -156.97 162.27 39.6 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.368 -0.832 . . . . 0.23000000000000001 108.796 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -106.58 136.6 46.08 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.778 -0.823 . . . . 2.2200000000000002 108.778 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.91 148.52 29.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.39000000000000001 109.39 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.9 -33.35 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.392 -0.817 . . . . 0.55000000000000004 110.086 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -159.85 179.98 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 1.1599999999999999 110.088 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.456 ' N ' ' OH ' ' A' ' 3' ' ' TYR . . . -66.74 -40.03 88.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.534 -0.728 . . . . 0.26000000000000001 110.469 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -37.56 63.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.873 -1.142 . . . . 0.28999999999999998 110.228 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.4 m -69.99 -39.98 75.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.673 -1.267 . . . . 0.44 110.148 179.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.05 88.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -0.803 . . . . 0.17999999999999999 109.09 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.97 -46.37 82.24 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.769 -1.172 . . . . 1.0600000000000001 109.57 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -67.39 -44.11 79.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.435 -0.79 . . . . 2.6699999999999999 110.67 -179.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.37 -53.11 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.23000000000000001 110.99 -178.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CD1' HD22 ' A' ' 5' ' ' LEU . 30.3 m-85 -63.62 -38.76 92.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.935 -1.103 . . . . 0.14999999999999999 110.4 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -60.07 -45.13 93.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.856 -1.153 . . . . 2.0699999999999998 109.999 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -69.07 -42.1 76.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.025 -1.047 . . . . 1.8400000000000001 109.1 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.615 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 64.5 t80 -59.98 -44.65 94.36 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.717 -0.846 . . . . 0.29999999999999999 108.717 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.58 -43.6 96.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.25 109.013 179.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -60.28 -42.39 95.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.24 -0.913 . . . . 1.23 108.814 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.9 -25.26 67.46 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.398 -0.814 . . . . 1.29 109.344 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.615 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 94.2 m-20 -100.13 8.94 43.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.392 -0.817 . . . . 0.64000000000000001 109.419 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.99 36.2 92.79 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.225 -1.15 . . . . 0.71999999999999997 110.225 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.13 124.79 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.196 -1.179 . . . . 0.40000000000000002 109.974 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 80.2 m-20 -110.62 -98.74 0.4 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.07 -1.085 . . . . 1.3300000000000001 108.07 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.29 165.97 2.73 Favored Glycine 0 N--CA 1.488 2.121 0 CA-C-O 122.146 0.859 . . . . 0.26000000000000001 112.134 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -77.79 135.49 37.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.067 -1.457 . . . . 2.0699999999999998 107.067 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -98.58 135.66 39.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.125 -0.985 . . . . 0.13 110.66 -178.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.6 p -132.77 148.24 52.32 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.747 -1.205 . . . . 0.22 107.747 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 55.5 t80 -135.07 135.63 41.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.261 -0.899 . . . . 0.12 110.372 -178.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -113.03 110.05 19.84 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.607 -0.886 . . . . 0.23999999999999999 108.607 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 45.7 t0 -68.0 -30.27 69.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.263 -0.898 . . . . 1.1599999999999999 110.348 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.29 93.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.29999999999999999 110.058 -179.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -107.85 0.08 21.89 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.476 -0.765 . . . . 0.41999999999999998 110.106 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 49.98 43.52 25.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.928 -1.107 . . . . 2.1600000000000001 108.581 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.81 130.23 54.82 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.592 0.71 . . . . 0.28000000000000003 110.473 -178.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.527 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 54.9 m-85 -101.37 139.91 36.39 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.231 -1.396 . . . . 0.089999999999999997 107.231 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.0 m -132.83 134.01 44.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.786 -1.196 . . . . 0.14000000000000001 108.756 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -122.81 129.8 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.608 -0.886 . . . . 0.12 108.608 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -122.67 126.81 48.36 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.415 -0.803 . . . . 0.28999999999999998 110.654 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.94 -1.028 . . . . 1.95 109.482 179.038 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.429 0.633 . . . . 2.9100000000000001 109.829 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.514 ' O ' ' NZ ' ' A' ' 50' ' ' LYS . 24.6 m -91.32 134.54 34.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.544 -0.722 . . . . 0.31 109.18 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -114.73 148.85 37.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.463 -0.773 . . . . 0.19 109.047 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -118.75 142.44 47.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.406 -0.808 . . . . 1.98 109.228 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 30' ' ' PHE . 31.9 tp -120.84 129.43 53.54 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.483 -0.76 . . . . 0.13 109.279 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -106.58 123.08 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.404 -1.332 . . . . 0.35999999999999999 107.404 179.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.47 115.2 30.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.242 -0.911 . . . . 0.25 110.412 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -117.57 70.15 0.78 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.352 -1.351 . . . . 0.17999999999999999 107.352 178.115 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.78 54.8 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.977 -1.249 . . . . 0.23999999999999999 109.977 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.2 -39.8 93.33 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.33 -1.1 . . . . 2.71 108.333 178.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -15.62 6.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.947 -0.471 . . . . 0.92000000000000004 109.778 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.9 tp -100.01 120.04 39.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.095 -1.003 . . . . 0.59999999999999998 109.517 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -131.89 127.06 35.67 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.331 -0.856 . . . . 2.02 109.364 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.99 -177.9 48.26 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.178 -1.487 . . . . 0.23999999999999999 110.676 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 16' ' ' THR . 1.8 pp20? -148.31 156.89 43.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.625 -0.926 . . . . 1.6799999999999999 109.179 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.429 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 5.6 t -154.21 170.52 21.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.347 -0.845 . . . . 0.34000000000000002 109.629 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.9 p -137.98 160.02 40.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.385 -0.822 . . . . 0.20999999999999999 109.415 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.414 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.9 t -155.08 160.52 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.23000000000000001 109.239 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -104.36 133.55 49.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.344 -0.848 . . . . 2.2200000000000002 108.757 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.95 146.07 27.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.006 -1.059 . . . . 0.39000000000000001 109.637 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.61 -30.15 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.389 -0.819 . . . . 0.55000000000000004 109.975 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -158.5 174.91 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 1.1599999999999999 110.163 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.83 -38.17 79.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.553 -0.717 . . . . 0.26000000000000001 110.372 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.94 -37.82 61.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.793 -1.192 . . . . 0.28999999999999998 110.092 -179.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 p -74.14 -33.06 63.4 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.637 -1.289 . . . . 0.44 109.685 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.18 93.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.406 -0.809 . . . . 0.17999999999999999 108.934 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -57.67 -46.28 84.45 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.838 -1.145 . . . . 1.0600000000000001 109.637 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -67.13 -40.09 86.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 2.6699999999999999 110.304 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.47 -53.17 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.972 . . . . 0.23000000000000001 110.673 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' HD22 ' A' ' 5' ' ' LEU . 37.4 m-85 -63.99 -38.07 89.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.14999999999999999 110.551 -178.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -59.93 -40.16 87.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.624 -1.298 . . . . 2.0699999999999998 109.126 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -69.38 -41.77 76.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.125 -0.984 . . . . 1.8400000000000001 109.042 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 59.3 t80 -60.03 -46.6 88.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.29999999999999999 109.576 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.97 95.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.25 109.308 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -40.66 90.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.148 -0.97 . . . . 1.23 108.976 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -64.51 -26.12 68.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.284 -0.885 . . . . 1.29 109.984 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.627 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 69.6 m-80 -99.75 4.99 45.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.017 -1.052 . . . . 0.64000000000000001 110.103 -179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.4 60.82 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.034 -1.079 . . . . 0.71999999999999997 111.599 178.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 62.3 t -110.67 122.41 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.892 -1.357 . . . . 0.40000000000000002 108.39 178.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 71.1 m-20 -150.6 101.04 2.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 1.3300000000000001 110.659 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.36 -131.84 1.49 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 119.297 -1.43 . . . . 0.26000000000000001 111.083 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 57.8 mp0 -88.81 128.11 35.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.952 -1.322 . . . . 2.0699999999999998 110.164 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -104.11 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.692 -0.63 . . . . 0.13 109.999 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.9 p -131.49 147.19 52.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.93 -1.137 . . . . 0.22 107.93 178.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 53.7 t80 -133.25 132.36 41.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.338 -0.851 . . . . 0.12 110.207 -178.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -114.65 109.94 18.99 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.381 -0.97 . . . . 0.23999999999999999 108.381 178.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -69.51 -27.67 65.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 1.1599999999999999 110.267 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.92 95.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.29999999999999999 109.926 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.9 p -106.02 0.18 25.43 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.546 -0.721 . . . . 0.41999999999999998 110.036 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 2' ' ' THR . 9.3 mtpm? 50.02 39.96 20.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.882 -1.136 . . . . 2.1600000000000001 108.289 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -120.01 132.87 55.63 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 0.28000000000000003 110.593 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 56.3 m-85 -100.36 139.67 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.252 -1.388 . . . . 0.089999999999999997 107.252 177.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 m -130.24 131.97 45.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.763 -1.21 . . . . 0.14000000000000001 108.339 179.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.83 129.25 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.34 -0.985 . . . . 0.12 108.34 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -124.56 128.19 48.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.621 -0.674 . . . . 0.28999999999999998 110.115 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.038 -0.982 . . . . 1.95 109.296 179.8 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.265 0.555 . . . . 2.9100000000000001 109.695 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.6 m -91.36 133.31 35.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.827 . . . . 0.31 109.325 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -112.35 145.37 40.18 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.366 -0.976 . . . . 0.19 108.366 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -113.43 139.97 48.47 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.124 -0.985 . . . . 1.98 108.8 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 30' ' ' PHE . 41.4 tp -120.91 126.6 50.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.754 -0.832 . . . . 0.13 108.754 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.62 124.01 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.61 -1.256 . . . . 0.35999999999999999 107.61 178.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 54' ' ' VAL . 90.0 mt -104.24 114.13 28.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.25 110.231 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -113.5 72.46 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.395 -1.335 . . . . 0.17999999999999999 107.395 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.55 169.46 53.53 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.665 -1.374 . . . . 0.23999999999999999 109.665 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -64.87 -38.51 91.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -1.129 . . . . 2.71 108.517 178.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 p -130.62 -16.58 3.37 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.527 -0.546 . . . . 0.92000000000000004 109.527 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -101.76 117.36 34.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.249 -1.019 . . . . 0.59999999999999998 108.249 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -133.71 137.87 45.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.207 -0.933 . . . . 2.02 110.416 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -180.0 -178.25 48.43 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.688 -1.244 . . . . 0.23999999999999999 110.194 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.56 154.71 41.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.507 -0.923 . . . . 1.6799999999999999 108.507 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -154.63 170.7 20.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.842 . . . . 0.34000000000000002 109.502 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -138.32 160.03 40.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.919 -0.771 . . . . 0.20999999999999999 108.919 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 8.1 t -156.7 161.42 39.85 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.273 -0.892 . . . . 0.23000000000000001 109.239 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -102.92 134.97 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.696 -0.853 . . . . 2.2200000000000002 108.696 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 25' ' ' THR . . . -148.61 144.87 27.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 0.39000000000000001 108.912 -179.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.03 -30.58 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.55000000000000004 109.467 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -159.73 178.51 9.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 1.1599999999999999 110.02 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.76 -37.92 82.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.456 -0.777 . . . . 0.26000000000000001 110.048 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.51 -37.38 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.965 -1.085 . . . . 0.28999999999999998 110.136 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.402 ' HB ' ' HB1' ' A' ' 20' ' ' ALA . 94.8 m -69.92 -39.19 76.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.634 -1.291 . . . . 0.44 109.66 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.89 87.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.595 -0.69 . . . . 0.17999999999999999 109.196 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.97 -45.81 82.62 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.883 -1.127 . . . . 1.0600000000000001 109.504 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -67.82 -43.38 79.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 2.6699999999999999 110.679 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.94 -52.53 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.32 -0.863 . . . . 0.23000000000000001 111.62 -178.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.581 ' CD1' HD22 ' A' ' 5' ' ' LEU . 27.1 m-85 -64.22 -38.47 91.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.802 -1.186 . . . . 0.14999999999999999 110.482 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -60.04 -44.07 94.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.84 -1.162 . . . . 2.0699999999999998 109.692 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.512 ' NE2' ' OD2' ' A' ' 36' ' ' ASP . 1.6 tm0? -67.91 -41.7 82.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 1.8400000000000001 108.705 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 69.7 t80 -60.0 -49.02 79.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.622 -0.674 . . . . 0.29999999999999999 109.503 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.42 93.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.25 109.057 179.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -60.17 -44.58 94.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 1.23 109.366 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' NE2' ' A' ' 32' ' ' GLN . 82.3 m-20 -62.72 -24.04 67.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 1.29 109.24 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.623 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.0 m-20 -97.63 7.01 47.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.816 . . . . 0.64000000000000001 109.667 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.18 31.59 77.93 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.053 -1.07 . . . . 0.71999999999999997 110.851 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.99 127.41 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.174 -1.192 . . . . 0.40000000000000002 109.836 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 87.5 m-20 -109.99 -99.82 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.092 -1.077 . . . . 1.3300000000000001 108.092 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.96 163.51 4.17 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-O 122.028 0.793 . . . . 0.26000000000000001 112.339 177.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 58.1 mp0 -75.55 137.15 40.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.321 -1.363 . . . . 2.0699999999999998 107.321 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -99.89 135.0 41.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 0.13 110.927 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.6 p -135.23 150.05 50.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.632 -1.247 . . . . 0.22 107.632 178.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -135.27 138.9 43.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.294 -0.879 . . . . 0.12 110.566 -178.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -113.66 109.99 19.48 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.65 -0.87 . . . . 0.23999999999999999 108.65 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 36.5 t0 -67.5 -31.39 71.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.1599999999999999 110.312 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.973 . . . . 0.29999999999999999 110.573 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -105.4 0.64 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.519 -0.738 . . . . 0.41999999999999998 110.14 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm 50.58 42.45 26.87 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.855 -1.165 . . . . 2.1600000000000001 107.855 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -120.0 131.14 55.05 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.719 0.771 . . . . 0.28000000000000003 110.945 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -99.72 138.21 37.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.115 -1.439 . . . . 0.089999999999999997 107.115 177.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -130.63 131.95 45.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.662 -1.274 . . . . 0.14000000000000001 109.076 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.0 p -124.23 130.02 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.402 -0.962 . . . . 0.12 108.402 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.91 126.5 51.05 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.664 -0.648 . . . . 0.28999999999999998 110.181 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.981 -1.009 . . . . 1.95 109.576 -179.901 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.366 -0.605 . . . . 2.9100000000000001 109.366 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 m -93.58 131.76 38.55 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.018 -1.051 . . . . 0.31 109.929 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.71 148.03 38.84 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.369 -0.975 . . . . 0.19 108.369 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -116.5 140.89 48.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.257 -0.902 . . . . 1.98 109.08 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 30' ' ' PHE . 65.7 tp -120.42 129.56 53.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.601 -0.687 . . . . 0.13 109.581 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.68 122.76 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.746 -1.576 . . . . 0.35999999999999999 106.746 177.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.97 116.5 32.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.272 -0.892 . . . . 0.25 109.679 -178.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -114.87 71.42 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.601 -1.259 . . . . 0.17999999999999999 107.601 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.32 168.18 48.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.396 -1.482 . . . . 0.23999999999999999 109.396 179.147 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.47 -39.51 77.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.187 -1.184 . . . . 2.71 108.459 178.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -117.82 -22.96 7.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.783 -0.573 . . . . 0.92000000000000004 109.662 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.8 tp -101.45 120.37 40.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.59999999999999998 109.264 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -134.38 129.9 36.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.957 . . . . 2.02 109.536 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.53 -174.0 46.58 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.369 -1.396 . . . . 0.23999999999999999 110.391 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -148.56 157.21 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.631 -0.923 . . . . 1.6799999999999999 108.932 179.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -154.8 170.8 20.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.922 . . . . 0.34000000000000002 109.664 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.4 p -137.97 160.13 40.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.20999999999999999 109.086 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -156.19 162.95 40.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.384 -0.822 . . . . 0.23000000000000001 109.061 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -102.31 133.81 46.61 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.677 -0.861 . . . . 2.2200000000000002 108.677 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.34 143.16 25.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.096 . . . . 0.39000000000000001 109.525 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -60.79 -29.81 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.55000000000000004 110.051 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -157.93 176.53 12.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.1599999999999999 109.915 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.34 -37.58 80.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 0.26000000000000001 109.827 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.82 -37.34 59.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.017 . . . . 0.28999999999999998 109.94 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.405 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 3.2 p -73.31 -34.5 65.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.692 -1.255 . . . . 0.44 109.388 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.35 93.18 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.693 -0.854 . . . . 0.17999999999999999 108.693 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.35 -50.05 74.18 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.634 -1.226 . . . . 1.0600000000000001 109.754 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -65.88 -41.43 91.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.026 -1.046 . . . . 2.6699999999999999 110.141 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.88 -55.35 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.1 -1.0 . . . . 0.23000000000000001 110.259 -178.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.527 ' CD1' HD22 ' A' ' 5' ' ' LEU . 26.3 m-85 -65.12 -39.75 93.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.14999999999999999 110.298 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -60.53 -44.06 96.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 2.0699999999999998 109.637 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -69.23 -42.78 75.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.968 -1.082 . . . . 1.8400000000000001 108.797 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 77.2 t80 -60.02 -45.92 91.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.463 -0.773 . . . . 0.29999999999999999 109.18 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.24 95.95 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.507 -0.746 . . . . 0.25 109.016 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -61.32 -40.93 96.03 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 1.23 109.192 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.86 -25.1 66.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 1.29 109.513 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 92.9 m-20 -97.9 9.99 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 0.64000000000000001 109.881 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.15 92.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.835 -1.306 . . . . 0.71999999999999997 109.835 179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.99 125.54 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.287 -1.125 . . . . 0.40000000000000002 109.482 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 21.3 p-10 -141.76 148.5 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.214 -1.032 . . . . 1.3300000000000001 108.214 179.017 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.43 -147.75 10.92 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.219 -1.467 . . . . 0.26000000000000001 110.053 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -93.14 131.32 38.31 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 2.0699999999999998 108.445 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -100.71 137.4 39.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 0.13 110.098 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.0 p -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.446 -0.946 . . . . 0.22 108.446 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 59.3 t80 -134.09 136.39 43.89 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.408 -0.808 . . . . 0.12 110.162 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -112.16 109.27 18.87 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.314 -0.995 . . . . 0.23999999999999999 108.314 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.17 -31.2 70.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.973 . . . . 1.1599999999999999 110.287 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.04 90.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.29999999999999999 110.318 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.3 p -104.98 -0.76 26.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.251 -0.905 . . . . 0.41999999999999998 110.011 -179.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 50.06 40.77 22.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 2.1600000000000001 108.362 -179.755 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.58 54.86 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.616 0.722 . . . . 0.28000000000000003 110.141 -178.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 33.3 m-85 -98.75 138.32 36.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 0.089999999999999997 106.999 178.278 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.9 m -131.99 132.21 43.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.878 -1.139 . . . . 0.14000000000000001 108.139 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.18 132.15 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.481 -0.933 . . . . 0.12 108.481 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.7 m -119.1 126.38 51.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.608 -0.683 . . . . 0.28999999999999998 109.631 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.055 -0.974 . . . . 1.95 109.584 -179.36 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.423 ' SD ' ' NZ ' ' A' ' 50' ' ' LYS . 67.8 mtt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.329 -0.619 . . . . 2.9100000000000001 109.329 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -91.0 132.85 35.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.31 109.218 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.72 147.7 40.6 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.771 -0.826 . . . . 0.19 108.771 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -117.29 143.8 45.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.405 -0.809 . . . . 1.98 109.651 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 30' ' ' PHE . 40.8 tp -119.58 126.61 51.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.591 -0.892 . . . . 0.13 108.591 179.078 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.55 122.79 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.194 -1.41 . . . . 0.35999999999999999 107.194 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.4 mt -100.3 117.14 33.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.25 110.265 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -122.2 66.55 0.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.334 -1.358 . . . . 0.17999999999999999 107.334 178.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.33 169.87 53.04 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 0.23999999999999999 109.794 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -63.61 -39.88 95.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.272 -1.134 . . . . 2.71 108.582 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.09 -19.92 6.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.955 -0.466 . . . . 0.92000000000000004 109.896 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.37 119.98 38.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.228 -0.92 . . . . 0.59999999999999998 109.401 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -135.14 129.99 34.73 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.268 -0.895 . . . . 2.02 109.832 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.61 -177.38 48.42 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.338 -1.411 . . . . 0.23999999999999999 110.584 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -142.52 151.14 41.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.607 -0.937 . . . . 1.6799999999999999 108.676 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 t -152.72 167.37 29.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.34000000000000002 109.241 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.7 p -137.67 160.19 39.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.20999999999999999 109.502 -179.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.465 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 5.9 t -153.77 159.94 42.09 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.672 -0.862 . . . . 0.23000000000000001 108.672 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -101.43 131.95 47.28 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.45 -0.944 . . . . 2.2200000000000002 108.45 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.17 142.75 27.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.39000000000000001 109.22 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.06 -28.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -0.778 . . . . 0.55000000000000004 109.877 -179.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -158.43 174.72 14.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 1.1599999999999999 110.099 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.88 -38.09 82.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.548 -0.72 . . . . 0.26000000000000001 110.061 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.02 54.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.912 -1.117 . . . . 0.28999999999999998 109.728 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.449 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 4.8 p -72.41 -34.86 68.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.775 -1.203 . . . . 0.44 109.459 178.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.89 94.05 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.617 -0.883 . . . . 0.17999999999999999 108.617 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.11 -49.88 74.54 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.934 -1.107 . . . . 1.0600000000000001 109.914 -179.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -66.85 -40.61 87.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.866 -1.146 . . . . 2.6699999999999999 110.762 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.86 -53.6 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.949 -1.095 . . . . 0.23000000000000001 110.891 -178.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 18' ' ' THR . 28.1 m-85 -62.75 -37.33 86.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.907 -1.121 . . . . 0.14999999999999999 110.211 -178.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -61.46 -40.52 94.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.875 -1.14 . . . . 2.0699999999999998 109.338 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.84 -43.3 72.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.818 -1.176 . . . . 1.8400000000000001 108.31 178.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.562 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 63.8 t80 -59.99 -49.49 77.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.662 -0.866 . . . . 0.29999999999999999 108.662 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.63 93.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.575 -0.703 . . . . 0.25 109.417 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -60.05 -41.17 91.73 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.829 -0.804 . . . . 1.23 108.829 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.94 -23.1 67.23 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.352 -0.843 . . . . 1.29 109.112 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.562 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 81.2 m-20 -97.11 8.39 44.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.64000000000000001 109.974 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.04 32.32 69.49 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.942 -1.123 . . . . 0.71999999999999997 111.004 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.8 t -109.99 124.92 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.996 -1.297 . . . . 0.40000000000000002 109.089 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 32.7 p-10 -152.23 100.67 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.062 -1.024 . . . . 1.3300000000000001 110.34 179.21 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 -130.19 1.37 Allowed Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.204 -1.474 . . . . 0.26000000000000001 111.044 -178.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -89.94 125.2 35.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.916 -1.344 . . . . 2.0699999999999998 110.359 -178.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -102.53 136.54 42.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.535 -0.728 . . . . 0.13 110.115 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -136.19 149.58 48.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.982 -1.118 . . . . 0.22 107.982 178.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -137.47 136.22 37.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.239 -0.913 . . . . 0.12 109.958 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -114.52 111.25 21.09 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.854 -0.795 . . . . 0.23999999999999999 108.854 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 49.5 t0 -67.37 -28.84 68.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 1.1599999999999999 110.234 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.12 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.29999999999999999 110.376 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 p -105.95 -0.04 25.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.41999999999999998 109.765 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 68.9 mttm 50.03 41.44 23.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.922 -1.111 . . . . 2.1600000000000001 108.42 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.98 133.2 55.62 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.571 0.7 . . . . 0.28000000000000003 110.366 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.0 139.43 36.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.393 -1.336 . . . . 0.089999999999999997 107.393 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.2 m -130.04 131.86 45.98 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.759 -1.213 . . . . 0.14000000000000001 108.476 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.62 129.15 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.61 -0.885 . . . . 0.12 108.61 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.3 m -124.01 129.94 51.76 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.471 0.653 . . . . 0.28999999999999998 110.272 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.029 -0.986 . . . . 1.95 109.48 -179.7 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.6 mtp . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.033 -0.728 . . . . 2.9100000000000001 109.033 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 m -92.44 133.85 35.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 0.31 109.446 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -117.94 147.58 43.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.722 -0.844 . . . . 0.19 108.722 179.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -118.24 143.61 46.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 1.98 109.441 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.23 130.0 55.24 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.103 -0.703 . . . . 0.13 109.103 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 122.58 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.919 -1.512 . . . . 0.35999999999999999 106.919 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 54' ' ' VAL . 86.0 mt -103.2 116.73 33.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.25 110.543 -178.434 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -116.96 69.38 0.75 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.732 -1.21 . . . . 0.17999999999999999 107.732 178.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 168.6 47.71 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.529 -1.429 . . . . 0.23999999999999999 109.529 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -67.73 -38.91 84.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 2.71 109.172 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.3 p -117.2 -21.0 9.0 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.62 -0.675 . . . . 0.92000000000000004 110.056 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -106.8 120.0 40.83 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.35 -0.844 . . . . 0.59999999999999998 109.45 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.57 133.61 42.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.457 -0.777 . . . . 2.02 109.055 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.48 -170.28 43.38 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.075 -1.536 . . . . 0.23999999999999999 110.644 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.85 155.89 42.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.661 -0.906 . . . . 1.6799999999999999 108.98 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -151.87 169.28 22.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.468 -0.77 . . . . 0.34000000000000002 109.291 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.9 p -138.86 159.69 41.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.258 -0.901 . . . . 0.20999999999999999 109.544 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 12.6 t -156.38 160.81 39.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.977 -0.749 . . . . 0.23000000000000001 108.977 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.97 134.05 44.54 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.543 -0.91 . . . . 2.2200000000000002 108.543 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -147.3 139.18 24.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.055 -1.028 . . . . 0.39000000000000001 109.23 -179.407 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.91 -26.7 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.55000000000000004 109.495 -179.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -157.12 170.72 21.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.1599999999999999 109.734 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.7 83.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.546 -0.721 . . . . 0.26000000000000001 110.105 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.55 -36.47 61.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.892 -1.13 . . . . 0.28999999999999998 110.016 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.429 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 11.8 p -73.7 -34.81 65.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.627 -1.296 . . . . 0.44 109.564 178.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.09 92.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.384 -0.822 . . . . 0.17999999999999999 109.05 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.26 -44.62 79.88 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.679 -1.209 . . . . 1.0600000000000001 109.131 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' NZ ' ' CB ' ' A' ' 28' ' ' LYS . 8.6 mtpm? -67.23 -41.64 85.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.319 -0.863 . . . . 2.6699999999999999 110.573 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.59 -51.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.23000000000000001 110.503 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CZ ' HG22 ' A' ' 18' ' ' THR . 33.1 m-85 -67.46 -39.92 85.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.944 -1.098 . . . . 0.14999999999999999 110.736 -179.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -61.96 -42.37 99.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.725 -1.234 . . . . 2.0699999999999998 109.612 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -69.14 -41.8 76.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.112 -0.993 . . . . 1.8400000000000001 108.441 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.564 ' CE1' ' ND2' ' A' ' 37' ' ' ASN . 62.6 t80 -60.05 -48.41 81.83 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.569 0.7 . . . . 0.29999999999999999 109.175 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.53 97.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.579 -0.701 . . . . 0.25 109.31 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.06 -41.77 93.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.834 . . . . 1.23 109.011 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.83 -25.13 67.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 1.29 109.757 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.564 ' ND2' ' CE1' ' A' ' 33' ' ' TYR . 95.2 m-20 -96.79 10.02 40.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.139 -0.976 . . . . 0.64000000000000001 110.189 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.62 34.04 87.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.975 -1.25 . . . . 0.71999999999999997 109.975 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.89 126.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.242 -1.152 . . . . 0.40000000000000002 109.498 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -142.63 150.12 39.84 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 1.3300000000000001 108.806 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.77 -148.16 12.07 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 118.746 -1.692 . . . . 0.26000000000000001 110.489 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -90.99 129.42 37.0 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.358 -0.979 . . . . 2.0699999999999998 108.358 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -100.32 137.11 39.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.855 . . . . 0.13 110.025 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -134.45 149.49 50.75 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.133 -1.062 . . . . 0.22 108.133 179.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.416 ' CD1' ' CE1' ' A' ' 52' ' ' PHE . 43.2 t80 -132.78 134.59 44.9 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.303 -0.873 . . . . 0.12 110.228 -178.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -112.81 109.85 19.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.801 -0.814 . . . . 0.23999999999999999 108.801 179.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.6 -31.03 69.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.923 . . . . 1.1599999999999999 110.513 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.95 94.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.29999999999999999 110.437 -179.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -106.91 0.85 24.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.455 -0.778 . . . . 0.41999999999999998 110.43 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 50.18 40.11 21.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.909 -1.119 . . . . 2.1600000000000001 108.435 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.99 130.87 54.95 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.536 0.684 . . . . 0.28000000000000003 110.648 -178.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CE1' ' CD1' ' A' ' 45' ' ' TYR . 68.6 m-85 -99.65 141.11 32.88 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.628 -1.249 . . . . 0.089999999999999997 107.628 178.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 m -130.48 131.39 45.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.807 -1.183 . . . . 0.14000000000000001 108.451 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.408 HG12 HD23 ' A' ' 7' ' ' LEU . 2.4 p -123.37 130.3 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.365 -0.976 . . . . 0.12 108.365 179.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.4 m -119.97 126.28 50.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.498 -0.752 . . . . 0.28999999999999998 109.778 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.973 -1.013 . . . . 1.95 109.546 -179.863 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 21' ' ' VAL . 61.7 mtt . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.304 0.573 . . . . 2.9100000000000001 109.458 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.7 m -90.88 132.71 35.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.31 109.233 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -114.95 146.54 41.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.537 -0.912 . . . . 0.19 108.537 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -117.36 140.81 49.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.748 -0.834 . . . . 1.98 108.748 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' A' ' 30' ' ' PHE . 37.2 tp -118.92 129.31 55.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.842 -0.799 . . . . 0.13 108.842 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.9 mt -106.17 122.39 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.487 -1.301 . . . . 0.35999999999999999 107.487 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.37 112.88 25.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.25 109.185 -179.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.67 71.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.687 -1.227 . . . . 0.17999999999999999 107.687 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.09 165.57 43.51 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.492 -1.443 . . . . 0.23999999999999999 109.492 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.456 ' HZ3' ' C ' ' A' ' 56' ' ' GLU . 10.5 mptt -68.07 -35.29 77.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.192 -1.181 . . . . 2.71 107.872 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -117.67 -25.55 6.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.746 -0.596 . . . . 0.92000000000000004 110.077 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 tp -101.56 122.2 43.39 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.151 -0.968 . . . . 0.59999999999999998 109.733 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -136.48 130.74 33.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.225 -0.922 . . . . 2.02 109.618 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.62 -172.72 45.69 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.531 -1.319 . . . . 0.23999999999999999 110.499 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.11 156.28 42.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.598 -0.942 . . . . 1.6799999999999999 109.285 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -153.15 170.66 19.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 0.34000000000000002 109.247 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.7 p -137.84 159.95 40.59 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.329 -0.857 . . . . 0.20999999999999999 109.397 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.5 t -156.25 160.17 39.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.23000000000000001 109.624 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.78 134.31 47.3 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.251 -1.018 . . . . 2.2200000000000002 108.251 179.089 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.01 144.2 26.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.39000000000000001 109.417 -179.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' SD ' ' A' ' 1' ' ' MET . 33.5 m -60.31 -31.11 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.55000000000000004 109.859 -179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -158.81 176.47 12.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.051 -1.031 . . . . 1.1599999999999999 110.175 -179.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.58 -38.85 84.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.26000000000000001 109.723 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.79 -38.05 64.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.099 -1.001 . . . . 0.28999999999999998 109.772 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m -70.02 -39.8 75.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.665 -1.272 . . . . 0.44 109.994 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.501 -0.749 . . . . 0.17999999999999999 109.301 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -57.88 -40.99 81.58 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.458 -1.297 . . . . 1.0600000000000001 109.088 -179.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -69.89 -43.32 72.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 2.6699999999999999 109.864 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.94 -52.79 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.23000000000000001 111.072 -178.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD1' HD22 ' A' ' 5' ' ' LEU . 25.8 m-85 -62.86 -39.35 94.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.14999999999999999 110.286 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -60.59 -44.54 96.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.75 -1.218 . . . . 2.0699999999999998 109.604 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.96 -45.06 78.9 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.113 -0.992 . . . . 1.8400000000000001 108.424 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.8 t80 -59.96 -48.89 79.86 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.63 -0.669 . . . . 0.29999999999999999 109.262 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.91 -43.36 96.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.25 109.274 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.0 -41.56 92.38 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.384 -0.969 . . . . 1.23 108.384 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -61.4 -22.56 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.4 -0.813 . . . . 1.29 109.006 179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 93.8 m-20 -96.71 9.43 41.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.64000000000000001 109.703 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 33.51 87.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.836 -1.306 . . . . 0.71999999999999997 109.836 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.95 130.01 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.412 -1.052 . . . . 0.40000000000000002 110.214 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 71.9 m-20 -111.61 -95.03 0.43 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.525 -1.287 . . . . 1.3300000000000001 107.525 178.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.91 164.42 3.5 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.486 -0.759 . . . . 0.26000000000000001 111.962 177.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 42' ' ' GLU . 56.1 mp0 -75.43 137.69 41.16 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.107 -1.442 . . . . 2.0699999999999998 107.107 178.208 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -100.07 135.26 41.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.13 110.829 -178.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 p -136.67 150.57 48.56 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.11 -1.07 . . . . 0.22 108.11 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -135.77 137.89 42.09 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.174 -0.954 . . . . 0.12 110.609 -178.543 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -112.8 110.05 19.92 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.947 -0.76 . . . . 0.23999999999999999 108.947 179.345 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 42.2 t0 -66.7 -32.71 74.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 1.1599999999999999 110.47 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.95 95.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.031 -1.043 . . . . 0.29999999999999999 110.315 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -106.76 -0.13 23.73 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.423 -0.798 . . . . 0.41999999999999998 110.557 -179.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 49.51 41.23 20.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.838 -1.164 . . . . 2.1600000000000001 108.697 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.01 130.64 55.78 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.612 0.72 . . . . 0.28000000000000003 110.13 -178.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -98.81 138.66 35.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.369 -1.345 . . . . 0.089999999999999997 107.369 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -130.56 131.74 45.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.77 -1.206 . . . . 0.14000000000000001 108.391 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 p -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.178 -1.045 . . . . 0.12 108.178 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.1 m -119.66 126.57 51.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.507 -0.745 . . . . 0.28999999999999998 110.123 -179.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' C ' ' HZ3' ' A' ' 10' ' ' LYS . 54.5 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.849 -1.072 . . . . 1.95 109.118 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.268 0.556 . . . . 2.9100000000000001 109.754 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.8 m -88.42 132.17 34.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.31 108.72 179.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -114.8 143.12 45.59 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.74 -0.837 . . . . 0.19 108.74 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -115.7 140.33 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.854 -0.795 . . . . 1.98 108.854 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' CD1' ' A' ' 30' ' ' PHE . 43.1 tp -117.7 127.81 54.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.747 -0.834 . . . . 0.13 108.747 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.29 121.86 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.692 -1.596 . . . . 0.35999999999999999 106.692 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -100.02 110.52 22.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.036 -1.04 . . . . 0.25 108.966 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -114.07 68.33 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.649 -1.612 . . . . 0.17999999999999999 106.649 178.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 171.03 54.75 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.679 -1.368 . . . . 0.23999999999999999 109.679 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -63.66 -39.42 94.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.023 -1.103 . . . . 2.71 108.023 178.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 p -125.05 -13.96 6.7 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.177 -0.465 . . . . 0.92000000000000004 109.787 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.5 tp -98.13 119.96 37.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.156 -0.965 . . . . 0.59999999999999998 109.043 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -133.29 126.54 31.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.351 -0.843 . . . . 2.02 109.427 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.28 -176.22 47.88 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.559 -1.305 . . . . 0.23999999999999999 110.243 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -147.52 156.4 42.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.714 -0.874 . . . . 1.6799999999999999 108.669 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 t -154.93 170.72 21.07 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.365 -0.834 . . . . 0.34000000000000002 109.632 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.9 p -136.81 158.9 43.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.20999999999999999 109.235 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.4 t -154.73 160.23 41.2 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.486 -0.931 . . . . 0.23000000000000001 108.486 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.94 133.56 48.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 2.2200000000000002 109.467 -179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -149.05 143.1 25.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.942 . . . . 0.39000000000000001 108.825 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.55 -26.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.55000000000000004 109.859 -179.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -159.49 176.31 12.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.056 -1.028 . . . . 1.1599999999999999 109.87 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.31 80.16 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.521 -0.737 . . . . 0.26000000000000001 110.095 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.3 63.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.917 -1.114 . . . . 0.28999999999999998 110.053 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.595 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 17.9 p -72.23 -36.16 69.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.536 -1.352 . . . . 0.44 109.862 179.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.07 91.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.748 . . . . 0.17999999999999999 108.994 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.12 -50.01 72.28 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.897 -1.121 . . . . 1.0600000000000001 110.024 -178.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -65.15 -40.15 93.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.883 -1.136 . . . . 2.6699999999999999 110.826 -179.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.0 t -69.94 -54.04 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 0.23000000000000001 111.586 -178.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CD1' HD22 ' A' ' 5' ' ' LEU . 33.0 m-85 -64.03 -39.51 94.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.942 -1.099 . . . . 0.14999999999999999 111.284 -178.46 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.76 -40.06 96.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.809 -1.182 . . . . 2.0699999999999998 109.957 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -69.41 -42.66 74.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.713 -1.242 . . . . 1.8400000000000001 109.145 178.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.462 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 65.9 t80 -59.98 -46.01 90.84 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.879 . . . . 0.29999999999999999 108.628 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.15 -43.9 97.82 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.855 -0.795 . . . . 0.25 108.855 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -60.08 -44.84 94.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.492 -0.755 . . . . 1.23 109.741 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -63.32 -23.96 67.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 1.29 109.85 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 4.4 m120 -96.44 7.48 46.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -0.963 . . . . 0.64000000000000001 109.554 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.69 31.79 73.69 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.804 -1.189 . . . . 0.71999999999999997 110.158 179.117 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.43 125.99 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.19 -1.182 . . . . 0.40000000000000002 109.531 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 41' ' ' GLY . 57.6 t0 -140.77 146.54 37.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.264 -1.013 . . . . 1.3300000000000001 108.264 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 40' ' ' ASP . . . 173.63 -153.03 16.52 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.171 -1.49 . . . . 0.26000000000000001 110.134 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.59 134.35 34.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -1.053 . . . . 2.0699999999999998 108.442 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -101.48 135.96 42.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 0.13 110.296 -179.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.2 p -135.0 149.11 50.13 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.324 -0.991 . . . . 0.22 108.324 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 69.6 t80 -135.35 136.2 41.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.376 -0.828 . . . . 0.12 110.098 -178.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -112.77 109.97 19.79 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.685 -0.857 . . . . 0.23999999999999999 108.685 179.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 53.9 t0 -65.62 -31.34 72.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 1.1599999999999999 110.47 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.138 -0.976 . . . . 0.29999999999999999 110.372 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.8 p -106.62 -0.09 24.02 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.337 -0.852 . . . . 0.41999999999999998 110.559 -179.036 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 50.01 41.25 22.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.745 -1.222 . . . . 2.1600000000000001 108.361 -179.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.99 130.94 54.99 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.708 0.766 . . . . 0.28000000000000003 110.391 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 58.7 m-85 -99.62 139.97 34.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.271 -1.381 . . . . 0.089999999999999997 107.271 178.178 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.0 m -130.43 131.53 45.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.672 -1.268 . . . . 0.14000000000000001 108.037 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.1 p -122.21 128.97 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.045 -1.094 . . . . 0.12 108.045 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.8 m -119.96 127.97 53.15 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.28999999999999998 109.984 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.004 -0.998 . . . . 1.95 109.626 -179.316 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' ' NZ ' ' A' ' 50' ' ' LYS . 54.4 mtt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.31 0.576 . . . . 2.9100000000000001 109.608 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.3 m -92.59 132.89 36.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.31 108.917 179.425 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.73 150.04 40.44 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.129 -0.693 . . . . 0.19 109.129 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' A' ' 15' ' ' GLU . 52.9 tttm -118.6 143.69 46.63 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.571 -0.706 . . . . 1.98 109.717 -179.031 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.0 tp -119.22 127.45 53.28 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.714 -0.847 . . . . 0.13 108.714 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.25 122.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.945 -1.502 . . . . 0.35999999999999999 106.945 178.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.0 mt -103.24 111.6 24.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.92 . . . . 0.25 109.873 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.5 71.55 0.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.267 -1.383 . . . . 0.17999999999999999 107.267 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 165.61 49.33 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.367 -1.493 . . . . 0.23999999999999999 109.367 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -67.83 -36.86 81.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.218 -1.166 . . . . 2.71 108.421 178.246 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.6 m -120.73 -22.19 6.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.913 -0.492 . . . . 0.92000000000000004 109.787 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.1 tp -104.69 120.48 41.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.328 -0.858 . . . . 0.59999999999999998 109.421 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -132.86 133.58 43.49 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.348 -0.845 . . . . 2.02 109.896 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.3 -176.24 47.67 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.438 -1.363 . . . . 0.23999999999999999 110.604 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.3 pm0 -147.19 155.67 42.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.719 -0.871 . . . . 1.6799999999999999 108.969 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 t -154.86 170.25 22.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.34000000000000002 109.675 -179.586 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -134.89 158.3 44.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.483 -0.761 . . . . 0.20999999999999999 109.031 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 6.3 t -154.46 158.7 40.34 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.65 -0.871 . . . . 0.23000000000000001 108.65 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 56.6 mp0 -102.58 134.1 46.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.214 -0.929 . . . . 2.2200000000000002 109.185 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.8 ' HB1' ' OG1' ' A' ' 25' ' ' THR . . . -148.19 143.45 27.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.112 -0.992 . . . . 0.39000000000000001 108.774 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.06 -28.24 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.55000000000000004 109.251 -179.273 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -158.74 176.93 11.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 1.1599999999999999 109.912 -179.739 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.77 -37.5 84.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.26000000000000001 109.879 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.29 -37.72 62.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.04 -1.037 . . . . 0.28999999999999998 110.212 -179.486 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.8 ' OG1' ' HB1' ' A' ' 20' ' ' ALA . 12.1 p -71.55 -35.94 70.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.546 -1.346 . . . . 0.44 109.59 179.052 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.52 89.76 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.351 -0.843 . . . . 0.17999999999999999 108.865 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.9 -49.99 74.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.987 -1.085 . . . . 1.0600000000000001 110.133 -178.852 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -66.65 -42.53 86.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 2.6699999999999999 110.623 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.3 t -69.67 -53.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.983 . . . . 0.23000000000000001 110.713 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CZ ' HG22 ' A' ' 18' ' ' THR . 16.6 m-85 -61.03 -37.96 84.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.917 -1.114 . . . . 0.14999999999999999 109.512 -179.406 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.06 -43.51 95.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 2.0699999999999998 110.009 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.41 -42.31 79.15 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 1.8400000000000001 108.677 179.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.596 ' CE2' ' ND2' ' A' ' 37' ' ' ASN . 64.6 t80 -59.99 -48.69 80.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.29999999999999999 110.087 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.95 93.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.25 109.657 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -61.39 -39.95 92.58 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 1.23 109.202 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -62.28 -24.66 67.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 1.29 109.959 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.596 ' ND2' ' CE2' ' A' ' 33' ' ' TYR . 98.5 m-20 -96.35 8.79 43.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.007 . . . . 0.64000000000000001 110.09 -179.227 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.82 31.71 81.72 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.441 -1.464 . . . . 0.71999999999999997 109.441 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.6 t -107.47 126.3 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -1.084 . . . . 0.40000000000000002 109.302 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -140.11 147.47 40.29 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.093 -1.077 . . . . 1.3300000000000001 108.093 179.391 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.59 -154.25 19.52 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.227 -1.463 . . . . 0.26000000000000001 109.943 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 38.4 mp0 -87.76 132.83 34.01 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.217 -1.031 . . . . 2.0699999999999998 108.217 179.061 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -99.93 135.51 41.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 0.13 110.098 -179.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.2 p -136.73 150.04 48.19 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.22 108.523 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 58.7 t80 -133.48 133.63 42.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.412 -0.805 . . . . 0.12 109.812 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -111.21 107.76 17.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.485 -0.931 . . . . 0.23999999999999999 108.485 179.339 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.96 -30.67 70.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 1.1599999999999999 110.045 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.45 98.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.29999999999999999 109.87 -179.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 p -104.74 1.06 28.91 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.48 -0.762 . . . . 0.41999999999999998 109.887 -179.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 91.6 mttt 50.03 39.9 20.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 2.1600000000000001 108.554 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.4 m -120.03 134.35 55.27 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.474 0.654 . . . . 0.28000000000000003 110.831 -178.371 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 53.1 m-85 -99.82 139.25 35.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.089999999999999997 107.271 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -131.29 130.68 43.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.561 -1.337 . . . . 0.14000000000000001 108.6 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.28 127.69 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.788 -1.189 . . . . 0.12 107.788 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.1 m -120.01 127.13 52.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.452 -0.78 . . . . 0.28999999999999998 109.728 -179.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.037 -0.982 . . . . 1.95 109.45 -179.682 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.208 -0.664 . . . . 2.9100000000000001 109.208 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.6 m -89.44 134.72 33.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.089 -1.007 . . . . 0.31 109.641 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -114.96 147.43 40.05 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.869 -0.789 . . . . 0.19 108.869 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -119.73 141.46 49.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.482 -0.761 . . . . 1.98 109.465 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 30' ' ' PHE . 45.7 tp -120.65 129.85 53.88 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.915 -0.772 . . . . 0.13 108.915 179.436 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.53 124.83 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.806 -1.183 . . . . 0.35999999999999999 107.806 178.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.5 mt -102.06 114.58 28.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 0.25 110.012 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.57 68.52 0.7 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.339 -1.356 . . . . 0.17999999999999999 107.339 178.357 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.99 49.15 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.742 -1.343 . . . . 0.23999999999999999 109.742 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -67.05 -37.55 84.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.368 -1.078 . . . . 2.71 108.157 178.231 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 m -119.55 -22.9 6.78 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.939 -0.475 . . . . 0.92000000000000004 110.104 -179.391 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 tp -101.59 120.27 40.06 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.18 -0.95 . . . . 0.59999999999999998 109.649 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -132.12 128.67 38.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.02 109.211 179.335 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.45 -173.88 46.59 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.185 -1.484 . . . . 0.23999999999999999 110.608 179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 3.4 pm0 -150.26 159.56 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.625 -0.927 . . . . 1.6799999999999999 109.442 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 t -152.62 170.01 21.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.521 -0.737 . . . . 0.34000000000000002 109.269 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -136.54 158.44 44.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.245 -0.91 . . . . 0.20999999999999999 109.081 -179.651 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 t -156.55 161.9 39.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.357 -0.839 . . . . 0.23000000000000001 109.061 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -101.26 132.29 46.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.317 -0.994 . . . . 2.2200000000000002 108.317 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.48 142.17 26.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.39000000000000001 109.551 -179.5 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.58 -30.36 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.55000000000000004 110.603 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -158.58 179.4 9.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.931 -1.106 . . . . 1.1599999999999999 110.295 -179.266 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.93 75.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.55 -0.719 . . . . 0.26000000000000001 110.539 -179.111 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.66 65.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.776 -1.203 . . . . 0.28999999999999998 109.866 -179.164 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -70.53 -39.95 73.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.741 -1.224 . . . . 0.44 109.846 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.96 92.15 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.532 -0.73 . . . . 0.17999999999999999 109.258 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.82 -43.22 94.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.745 -1.182 . . . . 1.0600000000000001 110.105 -179.129 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -69.73 -42.69 73.62 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.26 -0.9 . . . . 2.6699999999999999 110.69 -179.24 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.61 -53.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.23000000000000001 111.173 -178.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.447 ' CD1' HD22 ' A' ' 5' ' ' LEU . 32.3 m-85 -60.23 -35.84 76.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.019 -1.051 . . . . 0.14999999999999999 109.864 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.13 -41.51 92.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.897 -1.127 . . . . 2.0699999999999998 108.915 179.657 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -68.47 -44.82 73.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.094 -1.003 . . . . 1.8400000000000001 108.755 179.372 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.511 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 66.1 t80 -60.34 -48.2 82.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.29999999999999999 109.489 179.673 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.41 97.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.25 109.244 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -60.12 -39.94 88.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.229 -0.92 . . . . 1.23 108.538 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.87 -23.81 67.5 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.467 -0.771 . . . . 1.29 109.286 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' OD1' ' CE2' ' A' ' 33' ' ' TYR . 9.8 m120 -96.77 6.31 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.09 -1.006 . . . . 0.64000000000000001 109.46 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.06 33.23 78.4 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.864 -1.16 . . . . 0.71999999999999997 110.259 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 63.0 t -111.16 125.38 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.091 -1.241 . . . . 0.40000000000000002 108.918 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 69.6 m-20 -152.25 103.62 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.984 -1.073 . . . . 1.3300000000000001 110.993 179.737 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.03 -130.13 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.557 -1.306 . . . . 0.26000000000000001 110.907 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 42.2 mp0 -93.99 130.98 39.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.937 -1.331 . . . . 2.0699999999999998 110.141 -178.516 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -104.09 139.3 39.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.672 -0.643 . . . . 0.13 110.244 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 p -134.31 147.77 50.65 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.963 -1.125 . . . . 0.22 107.963 178.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 52' ' ' PHE . 60.3 t80 -135.84 135.16 39.57 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.188 -0.945 . . . . 0.12 110.211 -178.685 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -112.97 110.28 20.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.921 -0.77 . . . . 0.23999999999999999 108.921 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 63.5 t0 -65.06 -31.83 73.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 1.1599999999999999 110.528 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.99 92.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.29999999999999999 110.616 -179.185 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -104.81 -0.69 26.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.41999999999999998 110.554 -179.04 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 50.02 40.02 20.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.817 -1.177 . . . . 2.1600000000000001 108.156 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.9 m -120.02 131.2 55.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.672 0.749 . . . . 0.28000000000000003 110.282 -178.2 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 57.9 m-85 -98.62 138.9 35.13 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.504 -1.295 . . . . 0.089999999999999997 107.504 178.435 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -131.77 131.07 42.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.697 -1.252 . . . . 0.14000000000000001 107.791 179.154 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.02 129.86 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.288 -1.005 . . . . 0.12 108.288 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 m -121.65 125.85 47.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.569 -0.707 . . . . 0.28999999999999998 109.729 -179.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 27.1 mp0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.915 -1.04 . . . . 1.95 109.502 179.981 . . . . . . . . 1 1 . 1 stop_ save_